| CAS No. | Saflık | Ürün Adı | BOSTON KODU |
|---|---|---|---|
| Cas.: 1256493-34-1 | Purity: 96% | Dyngo-4a | ESD-872530-25MG |
| Cas.: 557-35-7 | Purity: 85% | 2-Bromooctane (contains 3-Bromooctane) | ESD-868751-25G |
| Cas.: 5669-19-2 | Purity: 98% | 2-Benzylacrylic Acid | ESD-834912-500G |
| Cas.: 9004-34-6 | Purity: Diameter: 50nm, Length: 1~3μm, 6% dispersion (solvent is water) | Carboxylated cellulose nanofibers | ESD-916570-500G |
| Cas.: 9004-34-6 | Purity: Diameter: 4~10nm, Length: 200nm, 6% dispersion (solvent is water) | Carboxylated cellulose nanofibers | ESD-916571-2.5KG |
| Cas.: 9004-34-6 | Purity: Diameter: 4~10nm, Length: 200nm, 6% dispersion (solvent is water) | Carboxylated cellulose nanofibers | ESD-916571-500G |
| Cas.: 161797-99-5 | Purity: 98% | Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | ESD-843284-100G |
| Cas.: 111-61-5 | Purity: C16: 54%-62%; C18: 38%-44% | Ethyl stearate | ESD-916572-1KG |
| Cas.: 111-61-5 | Purity: C16: 54%-62%; C18: 38%-44% | Ethyl stearate | ESD-916572-500G |
| Cas.: 111-61-5 | Purity: C16: 54%-62%; C18: 38%-44% | Ethyl stearate | ESD-916572-2.5KG |
| Cas.: 111-61-5 | Purity: C16: 54%-62%; C18: 38%-44% | Ethyl stearate | ESD-916572-100G |
| Cas.: 1482484-62-7 | Purity: 97% | 4,6-Dichloro-2-(propylsulfonyl)pyrimidin-5-amine | ESD-916573-100MG |
| Cas.: 933191-25-4 | Purity: ≥98% | 2-(Pyrimidin-2-yl)pyrimidine-5-carboxylic acid | ESD-916574-500MG |
| Cas.: 933191-25-4 | Purity: ≥98% | 2-(Pyrimidin-2-yl)pyrimidine-5-carboxylic acid | ESD-916574-100MG |
| Cas.: 933191-25-4 | Purity: ≥98% | 2-(Pyrimidin-2-yl)pyrimidine-5-carboxylic acid | ESD-916574-5G |
| Cas.: 29700-34-3 | Purity: 98 atom% 15N | L-Phenylalanine-15N | ESD-916575-100MG |
| Cas.: 29700-34-3 | Purity: 98 atom% 15N | L-Phenylalanine-15N | ESD-916575-25MG |
| Cas.: 29700-34-3 | Purity: 98 atom% 15N | L-Phenylalanine-15N | ESD-916575-5MG |
| Cas.: 5188-07-8 | Purity: 95% | Sodium Thiomethoxide | ESD-875280-25G |
| Cas.: 58464-47-4 | Purity: ≥98% | Piperazine Dihydriodide | ESD-866121-5G |
| Cas.: 243666-14-0 | Purity: ≥98% | 2,3,5-Trifluorobenzyl Cyanide | ESD-857476-1G |
| Cas.: 1211441-98-3 | Purity: 98% | Ribociclib (LEE011) | ESD-856445-10MG |
| Cas.: 75568-11-5 | Purity: 98% | 3,5-Dibromo-1,2-phenylenediamine Monohydrochloride | ESD-916177-100MG |
| Cas.: 75568-11-5 | Purity: 98% | 3,5-Dibromo-1,2-phenylenediamine Monohydrochloride | ESD-916177-1G |
| Cas.: 16416-29-8 | Purity: 99 atom % D | N-DECANE-D22 | ESD-874533-1G |
| Cas.: 4151-97-7 | Purity: 98%, GC | 1-Chloro-3-methoxy-2-propanol | ESD-849288-1G |
| Cas.: 1912-30-7 | Purity: 95% | Ethyl ethanesulfonate | ESD-908469-25G |
| Cas.: 114926-38-4 | Purity: 98% | 4-(Trifluoromethyl)-L-phenylalanine | ESD-819715-5G |
| Cas.: 7078-98-0 | Purity: 97% | 4-Benzylidene-2,6-di-tert-butylcyclohexa-2,5-dien-1-one | ESD-914708-100G |
| Cas.: 1306-23-6 | Purity: 99.99% metals basis | Cadmium sulfide | ESD-916579-25G |
| Cas.: 1306-23-6 | Purity: 99.99% metals basis | Cadmium sulfide | ESD-916579-100G |
| Cas.: 1306-23-6 | Purity: 99.99% metals basis | Cadmium sulfide | ESD-916579-500G |
| Cas.: 137-08-6 | Purity: Analysis control, 98% | D-calcium pantothenate | ESD-916580-100MG |
| Cas.: 137-08-6 | Purity: Analysis control, 98% | D-calcium pantothenate | ESD-916580-1G |
| Cas.: 137-08-6 | Purity: 98% | D-Calcium pantothenate | ESD-805186-5G |
| Cas.: 170165-84-1 | Purity: 98% | 1,3,5-tris(4-pyridyl)benzene | ESD-856403-250MG |
| Cas.: 1126-93-8 | Purity: ≥97%(GC)(T) | 2-Ethoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-862837-1G |
| Cas.: 93942-43-9 | Purity: BR | Acid Green A | ESD-832492-1G |
| Cas.: 768-92-3 | Purity: ≥98%(GC) | 1-Adamantyl Fluoride | ESD-862994-50MG |
| Cas.: 39346-81-1 | Purity: BioReagent, for molecular biology | Agarose, low gelling temperature | ESD-916129-25G |
| Cas.: 539-86-6 | Purity: ≥95% | Allicin | ESD-875878-500G |
| Cas.: 7632-00-0 | Purity: 200μg/mL matrix: water.U=1% | ESD-821150-20ML | |
| Cas.: 11128-95-3 | Purity: Ion exchange Resin, OH type | Amberlite IRN 78 | ESD-916581-100G |
| Cas.: 52439-77-7 | Purity: OH type | Amberlite IRA402 | ESD-916582-100G |
| Cas.: 20887-95-0 | Purity: 95% | BOC-CYS-OH | ESD-821904-5G |
| Cas.: 527-20-8 | Purity: ≥97% | 2,3,4,5,6-Pentachloroaniline | ESD-860022-5G |
| Cas.: 527-20-8 | Purity: ≥97% | 2,3,4,5,6-Pentachloroaniline | ESD-860022-25G |
| Cas.: 59951-65-4 | Purity: ≥98% | 1-Bromo-4-Phenylnaphthalene | ESD-857458-5G |
| Cas.: 23688-47-3 | Purity: ≥95% | 3-bromo-1H-pyrrolo[3,2-b]pyridine | ESD-825378-5G |
| Cas.: 23688-47-3 | Purity: ≥95% | 3-bromo-1H-pyrrolo[3,2-b]pyridine | ESD-825378-25G |
| Cas.: 2516-92-9 | Purity: ≥98% | Bis(2,2,6,6-tetramethyl-4-piperidyl-1-oxyl) Sebacate | ESD-866619-5G |
| Cas.: 2516-92-9 | Purity: ≥98% | Bis(2,2,6,6-tetramethyl-4-piperidyl-1-oxyl) Sebacate | ESD-866619-25G |
| Cas.: 1823431-32-8 | Purity: 98% | 4,6-Dichloro-2-(propylsulfinyl)pyrimidin-5-amine | ESD-916583-100MG |
| Cas.: 230615-69-7 | Purity: 98% | 1-(7,8-Diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone | ESD-916584-1G |
| Cas.: 230615-69-7 | Purity: 98% | 1-(7,8-Diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone | ESD-916584-250MG |
| Cas.: 118289-55-7 | Purity: 98% | 6-Chloro-5-(2-chloroethyl)oxindole | ESD-830582-5G |
| Cas.: 2361146-30-5 | Purity: 98% | GSK840 | ESD-916585-5MG |
| Cas.: 140695-84-7 | Purity: 98% | |S|-1-Boc-3-(hydroxymethyl)piperidine | ESD-803672-25G |
| Cas.: 29927-08-0 | Purity: 97% | 2-Amino-5,6-dimethylbenzothiazole | ESD-835135-1G |
| Cas.: 590417-95-1 | Purity: 97% | 6-bromo-2-methyl-2H-indazole | ESD-825222-5G |
| Cas.: 590417-95-1 | Purity: 97% | 6-bromo-2-methyl-2H-indazole | ESD-825222-1G |
| Cas.: 425702-91-6 | Purity: ≥95% | 6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | ESD-827385-250MG |
| Cas.: 425702-91-6 | Purity: ≥95% | 6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | ESD-827385-5G |
| Cas.: 425702-91-6 | Purity: ≥95% | 6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one | ESD-827385-100MG |
| Cas.: 181140-88-5 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-2-phenylpropanoic acid | ESD-843271-100MG |
| Cas.: 123-86-4 | Purity: ACS, ≥99.5% | Butyl acetate | ESD-803143-2.5L |
| Cas.: 1450754-38-7 | Purity: 96% | 3-(But-3-yn-1-yl)-3-(2-iodoethyl)-3H-diazirine | ESD-895439-50MG |
| Cas.: 25322-68-3 | Purity: average Mn 8000 | Poly(ethylene glycol) | ESD-815616-10KG |
| Cas.: 1232028-11-3 | Purity: ≥97% | 5-(2-Nitrophenyl)isoxazole-3-carboxylic Acid | ESD-853761-250MG |
| Cas.: 342617-08-7 | Purity: 98% | 3-(3-Bromophenyl)-4H-1,2,4-triazole | ESD-845695-1G |
| Cas.: 101012-97-9 | Purity: ≥90% | Ditridecylamine mixture of isomers | ESD-875420-500G |
| Cas.: 58066-85-6 | Purity: 98% | Miltefosine | ESD-861761-5G |
| Cas.: 1416992-39-6 | Purity: 98% | GC-376 | ESD-910498-50MG |
| Cas.: 127406-56-8 | Purity: 98% | 4-(2-Pyridinyl)benzaldehyde | ESD-824167-25G |
| Cas.: 127406-56-8 | Purity: 98% | 4-(2-Pyridinyl)benzaldehyde | ESD-824167-100G |
| Cas.: 41088-52-2 | Purity: ≥95% | 3,4-Epoxycyclohexanecarboxylic acid, methyl ester | ESD-890296-100G |
| Cas.: 10025-73-7 | Purity: ≥98% | Chromium(III) chloride | ESD-885999-100G |
| Cas.: 37286-92-3 | Purity: 98% | Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) | ESD-911315-1G |
| Cas.: 37286-92-3 | Purity: 98% | Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) | ESD-911315-5G |
| Cas.: 37286-92-3 | Purity: 98% | Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) | ESD-911315-25G |
| Cas.: 36330-85-5 | Purity: 97% | Fenbufen | ESD-838502-100G |
| Cas.: 285979-85-3 | Purity: ≥98 atom % D | N-(CARBOXYMETHYL)-N,N,N-TRIMETHYL-D9-AMMONIUM CHLORIDE | ESD-874512-50MG |
| Cas.: 61358-25-6 | Purity: 98% | Bis(4-tert-butylphenyl)iodonium Hexafluorophosphate | ESD-834861-5G |
| Cas.: 61358-25-6 | Purity: 98% | Bis(4-tert-butylphenyl)iodonium Hexafluorophosphate | ESD-834861-25G |
| Cas.: 95348-44-0 | Purity: BR | Hexanoic-d11 Acid | ESD-874764-25MG |
| Cas.: 28898-02-4 | Purity: 95% | 2-Fluoro-N-(2-nitrophenyl)aniline | ESD-841617-5G |
| Cas.: 28898-02-4 | Purity: 95% | 2-Fluoro-N-(2-nitrophenyl)aniline | ESD-841617-25G |
| Cas.: 1401318-10-2 | Purity: 98% | 4,6-Dichloro-2-(propylthio)pyrimidine | ESD-916586-100MG |
| Cas.: 13838-78-3 | Purity: 95% | 5-Methyl-1,3-thiazole-2-carbaldehyde | ESD-833745-250MG |
| Cas.: 13838-78-3 | Purity: 95% | 5-Methyl-1,3-thiazole-2-carbaldehyde | ESD-833745-1G |
| Cas.: 3671-65-6 | Purity: 97% | 6-Methoxy-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-841146-1G |
| Cas.: 3671-65-6 | Purity: 97% | 6-Methoxy-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-841146-5G |
| Cas.: 3671-65-6 | Purity: 97% | 6-Methoxy-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-841146-25G |
| Cas.: 230615-70-0 | Purity: 98% | 1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone | ESD-916587-250MG |
| Cas.: 230615-70-0 | Purity: 98% | 1-(9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone | ESD-916587-100MG |
| Cas.: 230615-53-9 | Purity: 97% | 2,2,2-Trifluoro-1-(1,2,4,5-tetrahydro-7-nitro-1,5-methano-3H-3-benzazepin-3-yl)ethanone | ESD-916588-100MG |
| Cas.: 79963-95-4 | Purity: ≥96% | 2,2,2-Trifluoroethyl Nonafluorobutanesulfonate | ESD-867660-5G |
| Cas.: 107228-51-3 | Purity: 97% | 3,6-Dichloro-4-isopropylpyridazine | ESD-916589-1G |
| Cas.: 107228-51-3 | Purity: 97% | 3,6-Dichloro-4-isopropylpyridazine | ESD-916589-250MG |
| Cas.: 146137-74-8 | Purity: 98% | 2-Fluoro-6-methoxybenzaldehyde | ESD-832831-25G |
| Cas.: 15170-74-8 | Purity: 98% | (1-carboxy-3-methylsulfanylpropyl)azanide | ESD-889112-100G |
| Cas.: 15170-74-8 | Purity: 98% | (1-carboxy-3-methylsulfanylpropyl)azanide | ESD-889112-500G |
| Cas.: 832740-73-5 | Purity: 95% | 4-(Isoxazol-5-yl)aniline | ESD-916590-1G |
| Cas.: 832740-73-5 | Purity: 95% | 4-(Isoxazol-5-yl)aniline | ESD-916590-250MG |
| Cas.: 211429-79-7 | Purity: 98% | tert-Butyl 5-methyl-3-phenylisoxazole-4-carboxylate | ESD-916591-100MG |
| Cas.: 1448191-54-5 | Purity: 95% | tert-butyl (2S,4R)-4-hydroxy-2-([[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]carbamoyl)pyrrolidine-1-carboxylate | ESD-916592-100MG |
| Cas.: 158401-00-4 | Purity: 95% | 2,2,2-Trifluoro-1-(3,4,5-trichlorophenyl)ethanone | ESD-846466-1G |
| Cas.: 1639791-77-7 | Purity: ≥98%, 99%ee | (4S,4’S)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole] | ESD-854131-250MG |
| Cas.: 406476-31-1 | Purity: 97% | 1-(5-(Trifluoromethyl)pyridin-2-yl)piperidine-4-carboxylic acid | ESD-843220-5G |
| Cas.: 20662-14-0 | Purity: 99.999% metals basis | Scandium(III) chloride hexahydrate | ESD-888744-25G |
| Cas.: 416852-82-9 | Purity: ≥95% | Ethyl N-Boc-4-fluoropiperidine-4-carboxylate | ESD-850383-1G |
| Cas.: 4506-71-2 | Purity: 98% | Ethyl 2-Amino-4,5,6,7-Tetrahydrobenzo[b]Thiophene-3-Carboxylate | ESD-859980-25G |
| Cas.: 4506-71-2 | Purity: 98% | Ethyl 2-Amino-4,5,6,7-Tetrahydrobenzo[b]Thiophene-3-Carboxylate | ESD-859980-100G |
| Cas.: 480423-17-4 | Purity: 97% | 4-Bromo-2-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-849044-250MG |
| Cas.: 54678-23-8 | Purity: 99% | COPPER(I) BROMIDE-DIMETHYL SULFIDE COMPL EX | ESD-835461-500G |
| Cas.: 486422-59-7 | Purity: 95% | 4-(N,N-Dimethylsulfamoyl)phenylboronic acid | ESD-856150-5G |
| Cas.: 50743-32-3 | Purity: 98% | 6-Isopropylchromone-3-carbonitrile | ESD-834962-5G |
| Cas.: 53786-45-1 | Purity: 98% | Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate | ESD-843607-1G |
| Cas.: 53786-45-1 | Purity: 98% | Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate | ESD-843607-5G |
| Cas.: 36982-84-0 | Purity: 98%, contains 10 wt.% water as stabilizer | 2,4,6-Triisopropylbenzenesulfonyl azide | ESD-823215-5G |
| Cas.: 36982-84-0 | Purity: 98%, contains 10 wt.% water as stabilizer | 2,4,6-Triisopropylbenzenesulfonyl azide | ESD-823215-1G |
| Cas.: 542-46-1 | Purity: 95% | 9-Cycloheptadecen-1-one | ESD-906685-500G |
| Cas.: 5619-09-0 | Purity: 97% | H-DL-Trp-OMe·HCl | ESD-842852-25G |
| Cas.: 5619-09-0 | Purity: 97% | H-DL-Trp-OMe·HCl | ESD-842852-100G |
| Cas.: 85068-35-5 | Purity: 98% | 2,4-Difluorobenzophenone | ESD-806339-100G |
| Cas.: 58584-94-4 | Purity: 98% | 2,6-Dichloro-3-methylpyridine | ESD-844408-5G |
| Cas.: 58584-94-4 | Purity: 98% | 2,6-Dichloro-3-methylpyridine | ESD-844408-25G |
| Cas.: 94108-97-1 | Purity: 75% | Ditrimethylolpropane Tetraacrylate | ESD-916333-500G |
| Cas.: 50901-42-3 | Purity: 97% | Pyridazine-4-carbaldehyde | ESD-916595-1G |
| Cas.: 153813-69-5 | Purity: 98% | Methyl 4-formyl-3-nitrobenzoate | ESD-842699-5G |
| Cas.: 53896-49-4 | Purity: 95% | Pyridazine-3-carbonitrile | ESD-916596-1G |
| Cas.: 53896-49-4 | Purity: 95% | Pyridazine-3-carbonitrile | ESD-916596-250MG |
| Cas.: 66074-67-7 | Purity: 95% | acridine-9-carbonyl chloride | ESD-871768-250MG |
| Cas.: 66074-67-7 | Purity: 95% | acridine-9-carbonyl chloride | ESD-871768-50MG |
| Cas.: 771510-32-8 | Purity: 98% | 5,7-Dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine | ESD-916597-100MG |
| Cas.: 2052-49-5 | Purity: 25% in H2O, MKseal | Tetrabutylammonium hydroxide | ESD-916594-100ML |
| Cas.: 2052-49-5 | Purity: 25% in H2O, MKseal | Tetrabutylammonium hydroxide | ESD-916594-1L |
| Cas.: 1263279-79-3 | Purity: 95% | Methyl 6-methoxypyrazolo[1,5-b]pyridazine-3-carboxylate | ESD-916598-100MG |
| Cas.: 499-08-1 | Purity: 97% | 3-Fluoro-5-nitrotoluene | ESD-810257-100G |
| Cas.: 1167055-25-5 | Purity: 97% | Methyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate | ESD-916599-250MG |
| Cas.: 946426-88-6 | Purity: 95% | Methyl 5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-carboxylate | ESD-916600-100MG |
| Cas.: 79686-03-6 | Purity: 97% | Methyl 5-chloro-2-(methylthio)pyrimidine-4-carboxylate | ESD-916601-1G |
| Cas.: 79686-03-6 | Purity: 97% | Methyl 5-chloro-2-(methylthio)pyrimidine-4-carboxylate | ESD-916601-250MG |
| Cas.: 34702-59-5 | Purity: 95% | (S)-2-Amino-3-(perfluorophenyl)propanoic acid | ESD-840591-100MG |
| Cas.: 165947-52-4 | Purity: 98% | tert-Butyl 4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate | ESD-847656-500MG |
| Cas.: 23778-52-1 | Purity: 97% | Pentaethylene Glycol Monomethyl Ether | ESD-832984-25G |
| Cas.: 171764-07-1 | Purity: ≥98%, 99%ee | (2S)-2-Amino-3,3-dimethyl-N-2-pyridinylbutanamide | ESD-854186-25MG |
| Cas.: 187458-77-1 | Purity: 95% | (R)-4-Amino-5-methoxy-5-oxopentanoic acid hydrochloride | ESD-846479-1G |
| Cas.: 187458-77-1 | Purity: 95% | (R)-4-Amino-5-methoxy-5-oxopentanoic acid hydrochloride | ESD-846479-5G |
| Cas.: 187458-77-1 | Purity: 95% | (R)-4-Amino-5-methoxy-5-oxopentanoic acid hydrochloride | ESD-846479-10G |
| Cas.: 172138-95-3 | Purity: ≥98%, ≥99% ee | (1S,2S)-N,N’-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide) | ESD-853924-250MG |
| Cas.: 1260851-42-0 | Purity: 95% | Methyl 5-chloro-1H-indazole-7-carboxylate | ESD-916602-100MG |
| Cas.: 1599466-81-5 | Purity: 98% | Methanesulfonato(2-dicyclohexylphosphino-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-874867-1G |
| Cas.: 14024-63-6 | Purity: 98% | Zinc(II) acetylacetonate | ESD-829400-2.5KG |
| Cas.: 15568-85-1 | Purity: ≥97% | 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-852877-100G |
| Cas.: 15568-85-1 | Purity: ≥97% | 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-852877-5G |
| Cas.: 2528-01-0 | Purity: 95% | Methyl 5-Bromo-3-Methylfuran-2-Carboxylate | ESD-916603-100MG |
| Cas.: 15568-85-1 | Purity: ≥97% | 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-852877-1G |
| Cas.: 14976-57-9 | Purity: 98% | Clemastine Fumarate | ESD-857178-5G |
| Cas.: 14976-57-9 | Purity: 98% | Clemastine Fumarate | ESD-857178-250MG |
| Cas.: 14976-57-9 | Purity: 98% | Clemastine Fumarate | ESD-857178-100MG |
| Cas.: 216431-85-5 | Purity: 97% | 6-(Trifluoromethyl)nicotinonitrile | ESD-820181-25G |
| Cas.: 23600-83-1 | Purity: 98% | 1-(4-(Phenylamino)phenyl)ethanone | ESD-846351-500MG |
| Cas.: 23600-83-1 | Purity: 98% | 1-(4-(Phenylamino)phenyl)ethanone | ESD-846351-1G |
| Cas.: 14160-91-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde | ESD-845571-1G |
| Cas.: 14160-91-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde | ESD-845571-5G |
| Cas.: 14160-91-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrimidine-5-carbaldehyde | ESD-845571-10G |
| Cas.: 2097371-73-6 | Purity: 99% | 4-(Dibenzo [b, d) Furan-4-yl)-N-(4-(Naphthalene-1-yl)Phenyl)Aniline | ESD-916604-5G |
| Cas.: 2097371-73-6 | Purity: 99% | 4-(Dibenzo [b, d) Furan-4-yl)-N-(4-(Naphthalene-1-yl)Phenyl)Aniline | ESD-916604-1G |
| Cas.: 1389329-66-1 | Purity: ≥95%, ≥99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-N,N-bis[(1R)-1-phenylethyl]-dinaphtho[2,1-d:1′,2′ -f][1,3,2]dioxaphosphepin-4-amine | ESD-853913-50MG |
| Cas.: 1311408-02-2 | Purity: 99% | 9-(4′-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-yl)-9H-carbazole | ESD-916605-5G |
| Cas.: 1056113-44-0 | Purity: 99% | 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]dibenzo[b,d]furan | ESD-916606-5G |
| Cas.: 1056113-44-0 | Purity: 99% | 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]dibenzo[b,d]furan | ESD-916606-1G |
| Cas.: 1311408-02-2 | Purity: 99% | 9-(4′-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-yl)-9H-carbazole | ESD-916605-1G |
| Cas.: 1813574-72-9 | Purity: 99% | 2-[4-(9,9-diphenyl-9H-fluoren-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-916607-5G |
| Cas.: 1813574-72-9 | Purity: 99% | 2-[4-(9,9-diphenyl-9H-fluoren-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-916607-1G |
| Cas.: 2412445-74-8 | Purity: 99% | 2-([1,1′-biphenyl]-2-yl)-4-([1,1′-biphenyl]-4-yl)-6-(3-chlorophenyl)-1,3,5-triazine | ESD-916608-5G |
| Cas.: 2412445-74-8 | Purity: 99% | 2-([1,1′-biphenyl]-2-yl)-4-([1,1′-biphenyl]-4-yl)-6-(3-chlorophenyl)-1,3,5-triazine | ESD-916608-1G |
| Cas.: 1663490-99-0 | Purity: 99% | 9-(34-chloro[11 ,21 :24 ,31-terphenyl]-14-yl)-9H-carbazole | ESD-916609-5G |
| Cas.: 1232042-36-2 | Purity: 99% | N-(4-tert-butylphenyl)-3-(9H-carbazol-9-yl)aniline | ESD-916610-5G |
| Cas.: 162258-89-1 | Purity: ≥95% | 4-bromo-4′-tert-butylbiphenyl | ESD-827501-5G |
| Cas.: 1416992-39-6 | Purity: 98% | GC-376 | ESD-910498-500MG |
| Cas.: 4414-88-4 | Purity: 97% | (2-Benzimidazolyl)acetonitrile | ESD-802169-100G |
| Cas.: 1689538-58-6 | Purity: ≥98% | 4-([1,1′-Biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine | ESD-866978-5G |
| Cas.: 26837-42-3 | MW175, 000, beige solid | Poly(vinyl sulfate) potassium salt | ESD-916493-1G |
| Cas.: 6833-47-2 | Purity: 98% | trans-4-Ethylcyclohexanecarboxylic Acid | ESD-834803-500G |
| Cas.: 69034-12-4 | Purity: 97% | 2-Chloro-5-(trifluoromethyl)pyrimidine | ESD-839435-1G |
| Cas.: 69034-12-4 | Purity: 97% | 2-Chloro-5-(trifluoromethyl)pyrimidine | ESD-839435-5G |
| Cas.: 6582-42-9 | Purity: 99% | 3′,4′-Dichloropropiophenone | ESD-808448-1G |
| Cas.: 37031-29-1 | Purity: ≥95% | (-)-Dimethyl 2,3-O-isopropylidene-L-tartrate | ESD-857378-1G |
| Cas.: 22441-13-0 | Purity: ≥98% | 2,2,6,6-Tetramethyl-3,5-heptanedionato lithium | ESD-863501-5G |
| Cas.: LZRY | Purity: 0.5mol/L, H2O | Nitrate ion standard solution | ESD-916611-50ML |
| Cas.: 89-74-7 | Purity: 95% | 2′,4′-Dimethylacetophenone | ESD-807214-1G |
| Cas.: 7775-14-6 | Purity: CP, 88% | Sodium dithionite | ESD-817917-10KG |
| Cas.: 16880-11-8 | Purity: 95% | Methyl 3-Methoxyisoxazole-5-Carboxylate | ESD-916612-100MG |
| Cas.: 42959-38-6 | Purity: ≥95% | 2-chloro-5-nitropyridine-3-carboxylic acid | ESD-827673-100G |
| Cas.: 27072-45-3 | Purity: 5- and 6-isomer mixture 97% biotech grade | Fluorescein isothiocyanate | ESD-6121-1G |
| Cas.: 10242-12-3 | Purity: 97% | 5-Nitro-1-benzofuran-2-carboxylic acid | ESD-823356-250MG |
| Cas.: 10242-12-3 | Purity: 97% | 5-Nitro-1-benzofuran-2-carboxylic acid | ESD-823356-100MG |
| Cas.: 446859-33-2 | Purity: ≥98% | RepSox | ESD-864398-25MG |
| Cas.: 446859-33-2 | Purity: ≥98% | RepSox | ESD-864398-100MG |
| Cas.: 112-61-8 | Purity: 99% | Methyl stearate | ESD-813508-100G |
| Cas.: 1345680-97-8 | Purity: 99% | 2-[2-[[2-[Boc(methyl)amino]ethyl]amino]ethoxy]ethanol | ESD-916614-1G |
| Cas.: 1345680-97-8 | Purity: 99% | 2-[2-[[2-[Boc(methyl)amino]ethyl]amino]ethoxy]ethanol | ESD-916614-250MG |
| Cas.: 26465-81-6 | Purity: 97% | 3,3-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-843349-25G |
| Cas.: 15785-08-7 | Purity: 98% | Ethyl 2-methylquinoline-3-carboxylate | ESD-916615-1G |
| Cas.: 15785-08-7 | Purity: 98% | Ethyl 2-methylquinoline-3-carboxylate | ESD-916615-250MG |
| Cas.: 31127-39-6 | Purity: 98% | 2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde oxime | ESD-840942-1G |
| Cas.: 37526-59-3 | Purity: ≥97% | 2-(Trifluoromethoxy)benzenesulfonamide | ESD-851499-100G |
| Cas.: 4354-49-8 | Purity: ≥95% | alpha-Oxocyclohexaneacetic acid | ESD-886785-250MG |
| Cas.: 445303-12-8 | Purity: 95% | 2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-847350-250MG |
| Cas.: 108-46-3 | Purity: AR | Resorcinol | ESD-817303-2.5KG |
| Cas.: 194240-75-0 | Purity: 97% | 4-Chloro-2-fluorophenylacetic acid | ESD-806115-25G |
| Cas.: 194240-75-0 | Purity: 97% | 4-Chloro-2-fluorophenylacetic acid | ESD-806115-100G |
| Cas.: 335-67-1 | Purity: Transition Reagent, Use For LC-MS, 98% | Pentadecafluorooctanoic acid | ESD-815845-5G |
| Cas.: 335-67-1 | Purity: Transition Reagent, Use For LC-MS, 98% | Pentadecafluorooctanoic acid | ESD-815845-25G |
| Cas.: 122536-76-9 | Purity: 97% | (|S|)-(-)-3-(Boc-amino)pyrrolidine | ESD-818383-1G |
| Cas.: 399-76-8 | Purity: 99% | 5-Fluoroindole-2-carboxylic acid | ESD-810249-100G |
| Cas.: 80102-23-4 | Purity: 98% | Boc-D-Phe(2-Cl)-OH | ESD-801969-1G |
| Cas.: 80102-23-4 | Purity: 98% | Boc-D-Phe(2-Cl)-OH | ESD-801969-25G |
| Cas.: 78155-74-5 | Purity: ≥95% | Methyl 5-bromo-1H-indazole-3-carboxylate | ESD-826059-1G |
| Cas.: 78155-74-5 | Purity: ≥95% | Methyl 5-bromo-1H-indazole-3-carboxylate | ESD-826059-250MG |
| Cas.: 78155-74-5 | Purity: ≥95% | Methyl 5-bromo-1H-indazole-3-carboxylate | ESD-826059-100MG |
| Cas.: 78155-74-5 | Purity: ≥95% | Methyl 5-bromo-1H-indazole-3-carboxylate | ESD-826059-25G |
| Cas.: 2055812-54-7 | Purity: 98% | 5-Bromo-4-((2-ethylhexyl)oxy)thiophene-2-carbaldehyde | ESD-916616-1G |
| Cas.: 2055812-54-7 | Purity: 98% | 5-Bromo-4-((2-ethylhexyl)oxy)thiophene-2-carbaldehyde | ESD-916616-5G |
| Cas.: 141215-32-9 | Purity: 95% | 4,7-Dibromobenzo[c][1,2,5]thiadiazole-5,6-diamine | ESD-916617-1G |
| Cas.: 141215-32-9 | Purity: 95% | 4,7-Dibromobenzo[c][1,2,5]thiadiazole-5,6-diamine | ESD-916617-250MG |
| Cas.: 60410-99-3 | Purity: 98% | 4,4′-Diamino-2,2′-dimethylbiphenyl Dihydrochloride | ESD-916618-5G |
| Cas.: 60410-99-3 | Purity: 98% | 4,4′-Diamino-2,2′-dimethylbiphenyl Dihydrochloride | ESD-916618-1G |
| Cas.: 73387-51-6 | Purity: 95% | 3-(4-Bromophenyl)-1-methyl-1H-pyrazole | ESD-916619-1G |
| Cas.: 73387-51-6 | Purity: 95% | 3-(4-Bromophenyl)-1-methyl-1H-pyrazole | ESD-916619-250MG |
| Cas.: 210962-57-5 | Purity: 95% | 3-(3-Cyanophenoxy)propionic Acid | ESD-916620-250MG |
| Cas.: 23598-72-3 | Purity: 98% | 3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid | ESD-916621-1G |
| Cas.: 3919-74-2 | Purity: 99% | 3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid | ESD-916622-1G |
| Cas.: 6485-58-1 | Purity: 99.5 atom % D | Iodoethane-d5 | ESD-874367-5G |
| Cas.: 123533-41-5 | Purity: 98% | 2-Phenylimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-916623-250MG |
| Cas.: 20532-28-9 | Purity: 98% | Benzo[b]thiophen-5-amine | ESD-825346-1G |
| Cas.: 20532-28-9 | Purity: 98% | Benzo[b]thiophen-5-amine | ESD-825346-250MG |
| Cas.: 39736-29-3 | Purity: ≥95% | Ethyl 4-amino-2-(methylthio)thiazole-5-carboxylate | ESD-825089-250MG |
| Cas.: 581-50-0 | Purity: 98% | 2,3′-Bipyridine | ESD-830275-5G |
| Cas.: 942631-51-8 | Purity: 95% | 5-Thiazolamine hydrochloride | ESD-823381-250MG |
| Cas.: 942631-51-8 | Purity: 95% | 5-Thiazolamine hydrochloride | ESD-823381-100MG |
| Cas.: 40724-47-8 | Purity: 95% | 4-Bromomethylbenzenesulfonamide | ESD-854947-5G |
| Cas.: 40724-47-8 | Purity: 95% | 4-Bromomethylbenzenesulfonamide | ESD-854947-250MG |
| Cas.: 93-45-8 | Purity: ≥98% | N-(4-Hydroxyphenyl)-2-Naphthylamine | ESD-860375-250MG |
| Cas.: 5657-51-2 | Purity: 98% | Furo[3,4-b]pyridin-5(7H)-one | ESD-822144-250MG |
| Cas.: 5657-51-2 | Purity: 98% | Furo[3,4-b]pyridin-5(7H)-one | ESD-822144-100MG |
| Cas.: 89791-47-9 | Purity: 96% | 2-Methyltetrahydro-2H-pyran-4-ol | ESD-916624-1G |
| Cas.: 89791-47-9 | Purity: 96% | 2-Methyltetrahydro-2H-pyran-4-ol | ESD-916624-250MG |
| Cas.: 634-67-3 | Purity: ≥98% | 2,3,4-Trichloroaniline | ESD-860132-5G |
| Cas.: 58380-11-3 | Purity: 97% | 2-Bromo-5-hydroxybenzoic acid | ESD-842590-5G |
| Cas.: 157327-44-1 | Purity: ≥95% | 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-824842-1G |
| Cas.: 157327-44-1 | Purity: ≥95% | 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-824842-250MG |
| Cas.: 94158-14-2 | Purity: 95% | 2-(Benzo[d][1,3]dioxol-5-ylamino)ethanol hydrochloride | ESD-844050-25G |
| Cas.: 94158-14-2 | Purity: 95% | 2-(Benzo[d][1,3]dioxol-5-ylamino)ethanol hydrochloride | ESD-844050-100G |
| Cas.: 10486-19-8 | Purity: ≥95% | Tridecanal | ESD-868520-25ML |
| Cas.: 10486-19-8 | Purity: ≥95% | Tridecanal | ESD-868520-100ML |
| Cas.: 26685-82-5 | Purity: 98% | (+)-cis-2-Benzamidocyclohexanecarboxylic Acid | ESD-870423-250MG |
| Cas.: 65642-94-6 | Purity: >98.0%(GC) | 1-Bromodibenzothiophene | ESD-861749-500MG |
| Cas.: NONE015 | Purity: 201mg/L, Use For waterAnalyze | Chlorine solution | ESD-916625-20ML |
| Cas.: 2412-58-0 | Purity: ≥95% | 1-Methyl-3,4-dihydroisoquinoline | ESD-895561-250MG |
| Cas.: 1297538-32-9 | Purity: 99% | BAY-1841788 | ESD-872842-25MG |
| Cas.: 1655-57-8 | Purity: 99% | N-(2,4-Dinitrophenyl)-L-leucine | ESD-871291-500MG |
| Cas.: 146948-68-7 | Purity: 98% | 2-Bromo-4-chloro-6-methylaniline | ESD-916626-5G |
| Cas.: 146948-68-7 | Purity: 98% | 2-Bromo-4-chloro-6-methylaniline | ESD-916626-1G |
| Cas.: 1120-87-2 | Purity: ≥97% | 4-Bromopyridine | ESD-885984-100G |
| Cas.: 67104-97-6 | Purity: 95% | 2-Methyl-1,2,5-thiadiazolidine 1,1-dioxide | ESD-831825-250MG |
| Cas.: 67104-97-6 | Purity: 95% | 2-Methyl-1,2,5-thiadiazolidine 1,1-dioxide | ESD-831825-1G |
| Cas.: 57773-63-4 | Purity: >98% | Triptorelin | ESD-860419-25MG |
| Cas.: 57773-63-4 | Purity: >98% | Triptorelin | ESD-860419-100MG |
| Cas.: 59378-87-9 | Purity: 95% | 3-PYROLIDINE CARBOXYLIC ACID; | ESD-821994-25G |
| Cas.: 59378-87-9 | Purity: 95% | 3-PYROLIDINE CARBOXYLIC ACID; | ESD-821994-250MG |
| Cas.: 3622-40-0 | Purity: 98% | 2-Bromo-4-chlorobenzo[d]thiazole | ESD-841707-250MG |
| Cas.: 825633-93-0 | Purity: 95% | 2-Benzyl-5-iodopyridazin-3(2H)-one | ESD-916627-250MG |
| Cas.: 825633-93-0 | Purity: 95% | 2-Benzyl-5-iodopyridazin-3(2H)-one | ESD-916627-100MG |
| Cas.: 25658-42-8 | Purity: 99.5% metals basis | Zirconium nitride | ESD-888739-25G |
| Cas.: 25658-42-8 | Purity: 99.5% metals basis | Zirconium nitride | ESD-888739-100G |
| Cas.: 557-41-5 | Purity: 98% | Zinc formate | ESD-916459-5G |
| Cas.: 220641-87-2 | Purity: 97% | METHYL-(TETRAHYDRO-PYRAN-4-YL)-AMINE HCL | ESD-829722-250MG |
| Cas.: 45867-11-6 | Purity: 95% | 2-Amino-5-chloropyrimidine-4-carboxylic acid | ESD-916628-1G |
| Cas.: 45867-11-6 | Purity: 95% | 2-Amino-5-chloropyrimidine-4-carboxylic acid | ESD-916628-250MG |
| Cas.: 45867-11-6 | Purity: 95% | 2-Amino-5-chloropyrimidine-4-carboxylic acid | ESD-916628-100MG |
| Cas.: 203661-69-2 | Purity: 98% | tert-Butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate | ESD-842112-5G |
| Cas.: 76-62-0 | Purity: 98% | 3,3-Bis(3,5-dibromo-4-hydroxyphenyl)isobenzofuran-1(3H)-one | ESD-913375-10G |
| Cas.: 64724-23-8 | Purity: 97% | 2-Amino-5-chloro-3-iodobenzoic acid | ESD-916629-5G |
| Cas.: 64724-23-8 | Purity: 97% | 2-Amino-5-chloro-3-iodobenzoic acid | ESD-916629-1G |
| Cas.: 64724-23-8 | Purity: 97% | 2-Amino-5-chloro-3-iodobenzoic acid | ESD-916629-250MG |
| Cas.: 171290-52-1 | Purity: ≥98%(GC) | 3,5-Dimethoxyphenylacetylene | ESD-862958-1G |
| Cas.: 171290-52-1 | Purity: ≥98%(GC) | 3,5-Dimethoxyphenylacetylene | ESD-862958-5G |
| Cas.: 171290-52-1 | Purity: ≥98%(GC) | 3,5-Dimethoxyphenylacetylene | ESD-862958-25G |
| Cas.: 2409-52-1 | Purity: ≥98%(GC) | Diethyl Itaconate (stabilized with TBC) | ESD-862724-100G |
| Cas.: 152937-04-7 | Purity: 95% | 2-Bromo-6-fluorobenzothiazole | ESD-840896-5G |
| Cas.: 152937-04-7 | Purity: 95% | 2-Bromo-6-fluorobenzothiazole | ESD-840896-10G |
| Cas.: 152937-04-7 | Purity: 95% | 2-Bromo-6-fluorobenzothiazole | ESD-840896-25G |
| Cas.: 113237-20-0 | Purity: 98% | 2,6-Dichloro-5-fluoronicotinamide | ESD-847390-5G |
| Cas.: 113237-20-0 | Purity: 98% | 2,6-Dichloro-5-fluoronicotinamide | ESD-847390-25G |
| Cas.: 113237-20-0 | Purity: 98% | 2,6-Dichloro-5-fluoronicotinamide | ESD-847390-100G |
| Cas.: 32953-14-3 | Purity: ≥95%(GC)(T) | 3,4-Methylenedioxy-N-ethylaniline | ESD-916630-5G |
| Cas.: 58026-21-4 | Purity: 97% | 2-Amino-5-bromo-3-chlorobenzoic acid | ESD-916631-250MG |
| Cas.: 53987-60-3 | Purity: 97% | 1,3-Dibromoisoquinoline | ESD-842526-5G |
| Cas.: 500103-26-4 | Purity: 98%, ee99% | N,N-Bis-[(R)-1-phenylethyl]dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine | ESD-857079-250MG |
| Cas.: 2339-59-5 | Purity: 95% | 4-Fluorobenzamidine hydrochloride | ESD-856844-25G |
| Cas.: 3906-87-4 | Purity: 98% | 2-Fluoroterephthalic acid | ESD-842709-1G |
| Cas.: 1034343-98-0 | Purity: 97% | Graphene | ESD-835836-5G |
| Cas.: 499-51-4 | Purity: ≥95% | 4-hydroxypyridine-2,6-dicarboxylic acid | ESD-827907-5G |
| Cas.: 499-51-4 | Purity: ≥95% | 4-hydroxypyridine-2,6-dicarboxylic acid | ESD-827907-1G |
| Cas.: 1698027-17-6 | Purity: 98% | 2-Amino-4-bromo-5-chloro-3-fluorobenzoic acid | ESD-916632-1G |
| Cas.: 1698027-17-6 | Purity: 98% | 2-Amino-4-bromo-5-chloro-3-fluorobenzoic acid | ESD-916632-250MG |
| Cas.: 320740-35-0 | Purity: 95% | 2-Amino-3-bromo-4-methylbenzoic acid | ESD-916633-100MG |
| Cas.: 174566-19-9 | Purity: 97% | 2,4-Dichloro-8-nitroquinazoline | ESD-916634-100MG |
| Cas.: 479-91-4 | Purity: Analysis control, 98% | Vitexicarpin | ESD-820493-25MG |
| Cas.: 118-31-0 | Purity: 98% | 1-Naphthylmethylamine | ESD-814755-100G |
| Cas.: 129112-65-8 | Purity: 95% | 2,4-Dichloro-7-nitroquinazoline | ESD-916635-250MG |
| Cas.: NONE6772 | Purity: 0.2M, pH9.2 | Sodium Borate Buffer | ESD-916636-250ML |
| Cas.: NONE6772 | Purity: 0.2M, pH9.2 | Sodium Borate Buffer | ESD-916636-100ML |
| Cas.: NONE6772 | Purity: 0.2M, pH9.2 | Sodium Borate Buffer | ESD-916636-500ML |
| Cas.: 5066-78-4 | Purity: ≥98% (HPLC) | CHASMANINE | ESD-861469-5MG |
| Cas.: 375815-87-5 | Purity: 98% | Varenicline tartrate | ESD-820502-100MG |
| Cas.: 375815-87-5 | Purity: 98% | Varenicline tartrate | ESD-820502-250MG |
| Cas.: 375815-87-5 | Purity: 98% | Varenicline tartrate | ESD-820502-1G |
| Cas.: 51639-58-8 | Purity: ≥97% | N-Ethyl-N-(2-pyridylmethyl)amine | ESD-853190-25G |
| Cas.: 51986-17-5 | Purity: ≥95% | Ethyl 5-Hydroxy-1-methylpyrazole-3-carboxylate | ESD-851123-250MG |
| Cas.: 53903-51-8 | Purity: 95% | 4-Chloro-2-(trifluoromethyl)phenol | ESD-846078-1G |
| Cas.: 53903-51-8 | Purity: 95% | 4-Chloro-2-(trifluoromethyl)phenol | ESD-846078-250MG |
| Cas.: 5397-64-8 | Purity: 97% | 4-Chloro-1,2-dihydropyridazine-3,6-dione | ESD-846771-1G |
| Cas.: 1702815-70-0 | Purity: 97% | 2,4,8-Trichloro-6-fluoroquinazoline | ESD-916637-250MG |
| Cas.: 939412-86-9 | Purity: 97% | (3-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-846713-5G |
| Cas.: 1702815-70-0 | Purity: 97% | 2,4,8-Trichloro-6-fluoroquinazoline | ESD-916637-50MG |
| Cas.: 939412-86-9 | Purity: 97% | (3-Chloropyrazin-2-yl)methanamine hydrochloride | ESD-846713-25G |
| Cas.: 105228-46-4 | Purity: 95% | BENZYL (2S,3R)-(+)-6-OXO-2,3-DIPHENYL-4-MORPHOLINECARBOXYLATE | ESD-833631-250MG |
| Cas.: 105228-46-4 | Purity: 95% | BENZYL (2S,3R)-(+)-6-OXO-2,3-DIPHENYL-4-MORPHOLINECARBOXYLATE | ESD-833631-5G |
| Cas.: 25850-22-0 | Purity: 97% | 2,2-Dimethyltetrahydro-2H-pyran-4-ylamine | ESD-916638-100MG |
| Cas.: 142010-87-5 | Purity: ≥98%, 99%ee | (S)-3,3′-Dibromo-bis(methoxymethoxyl)-1,1′-binaphtyl | ESD-854026-250MG |
| Cas.: 1256809-21-8 | Purity: 95% | 2-(Difluoromethyl)pyridine-3-carboxylic acid | ESD-916639-100MG |
| Cas.: 655225-01-7 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperazine-1-carboxylate | ESD-847831-1G |
| Cas.: 1256818-14-0 | Purity: 95% | 2-(Difluoromethyl)isonicotinic acid | ESD-916640-100MG |
| Cas.: 67085-11-4 | Purity: 98% | 4-(4-Chlorophenyl)-1-(1H-imidazol-1-yl)butan-2-ol | ESD-843591-5G |
| Cas.: 145202-66-0 | Purity: ≥98%(HPLC) | Rizatriptan Benzoate | ESD-833003-1G |
| Cas.: 145202-66-0 | Purity: ≥98%(HPLC) | Rizatriptan Benzoate | ESD-833003-5G |
| Cas.: 796845-58-4 | Purity: 97% | 2-(1-Methyl-4-pyrazolyl)ethylamine | ESD-916641-250MG |
| Cas.: 155-58-8 | Purity: ≥98%(HPLC) | Rhaponiticin | ESD-861351-5MG |
| Cas.: 155-58-8 | Purity: ≥98%(HPLC) | Rhaponiticin | ESD-861351-100MG |
| Cas.: 21744-88-7 | Purity: 95% | 1-Phenylcyclopropanecarbaldehyde | ESD-916642-100MG |
| Cas.: 3463-26-1 | Purity: 97% | 1-Methyl-3-phenyl-1H-pyrazole | ESD-916643-250MG |
| Cas.: 17616-04-5 | Purity: 95% | 4-(1-Imidazolyl)benzoic Acid | ESD-857282-250MG |
| Cas.: 69951-03-7 | Purity: ≥98% | 2,3-Dichloro-4-nitroaniline | ESD-858647-250MG |
| Cas.: 183673-70-3 | Purity: ≥97% | 8-Boc-2,4,8-triazaspiro[4.5]decane-1,3-dione | ESD-850676-25G |
| Cas.: 70384-83-7 | Purity: 98% | Ethyl 5-chloro-2-oxo-2H-chromene-3-carboxylate | ESD-847470-500MG |
| Cas.: 3914-42-9 | Purity: 95% | 2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole | ESD-853755-250MG |
| Cas.: 3914-42-9 | Purity: 95% | 2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole | ESD-853755-100MG |
| Cas.: 69355-99-3 | Purity: 98% | Boc-O-Benzyl-D-threonine | ESD-803126-1G |
| Cas.: 902837-62-1 | Purity: 95% | 1-Ethyl-1H-pyrazole-5-carbaldehyde | ESD-916644-1G |
| Cas.: 54643-09-3 | Purity: 98% | 1-(Pyrimidin-2-yl)propan-1-one | ESD-916645-100MG |
| Cas.: 27297-39-8 | Purity: 99% | Sodium Lactobionate | ESD-837263-500G |
| Cas.: 261165-02-0 | Purity: 97% | Boc-Phe(2-Br)-OH | ESD-801954-5G |
| Cas.: 124276-32-0 | Purity: 96% | 1-(3-Chlorophenyl)cyclopropanecarbonitrile | ESD-916646-5G |
| Cas.: 261165-02-0 | Purity: 97% | Boc-Phe(2-Br)-OH | ESD-801954-25G |
| Cas.: 124276-32-0 | Purity: 96% | 1-(3-Chlorophenyl)cyclopropanecarbonitrile | ESD-916646-1G |
| Cas.: 258506-68-2 | Purity: 98% | 3-Chloro-6-(trifluoromethyl)pyridazine | ESD-855055-250MG |
| Cas.: 212191-84-9 | Purity: ≥95%, 99%ee | (S)-2,2′-Dimethoxy-3,3′-diphenyl-1,1′-binaphthalene | ESD-854050-250MG |
| Cas.: 212191-84-9 | Purity: ≥95%, 99%ee | (S)-2,2′-Dimethoxy-3,3′-diphenyl-1,1′-binaphthalene | ESD-854050-1G |
| Cas.: 258506-68-2 | Purity: 98% | 3-Chloro-6-(trifluoromethyl)pyridazine | ESD-855055-5G |
| Cas.: 258506-68-2 | Purity: 98% | 3-Chloro-6-(trifluoromethyl)pyridazine | ESD-855055-10G |
| Cas.: 886369-02-4 | Purity: 98% | 2-(3-Bromophenyl)thiazole-4-carboxylic acid | ESD-846202-5G |
| Cas.: 886500-23-8 | Purity: ≥97% | 3-Chloro-4-morpholinobenzaldehyde | ESD-852081-250MG |
| Cas.: 1195625-75-2 | Purity: 98% | [1,2,4]Triazolo[4,3-a]pyrimidin-3-amine | ESD-916647-100MG |
| Cas.: 56329-42-1 | Purity: 98% | (S)-((2-Amino-4-(methylthio)butanoyl)oxy)zinc(II) hydrogensulfate | ESD-889115-100G |
| Cas.: 56329-42-1 | Purity: 98% | (S)-((2-Amino-4-(methylthio)butanoyl)oxy)zinc(II) hydrogensulfate | ESD-889115-500G |
| Cas.: 887308-14-7 | Purity: 97% | 5-Bromo-2-chloro-3-(methylsulfonyl)pyridine | ESD-848337-250MG |
| Cas.: 29923-31-7 | Purity: 95% | Sodium lauroyl glutamate | ESD-913818-1KG |
| Cas.: 889939-42-8 | Purity: 96% | 4-Bromo-7H-pyrrolo[2,3-d]pyrimidine | ESD-844907-1G |
| Cas.: 889939-42-8 | Purity: 96% | 4-Bromo-7H-pyrrolo[2,3-d]pyrimidine | ESD-844907-5G |
| Cas.: 892292-63-6 | Purity: 95% | 2-(Methyl(phenyl)amino)-4H-thieno[3,2-d][1,3]thiazin-4-one | ESD-845974-1G |
| Cas.: 89521-55-1 | Purity: 98% | 3-(Benzyloxy)benzene-1,2-diamine | ESD-847178-250MG |
| Cas.: 1448297-52-6 | Purity: 97% | (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide | ESD-916648-50MG |
| Cas.: 25456-86-4 | Purity: 95% | L-Asparagine tert-butyl ester | ESD-801114-25G |
| Cas.: 75416-51-2 | Purity: 98% | 8-Bromo-1,2,3,4-tetrahydroisoquinoline | ESD-840782-5G |
| Cas.: 25456-86-4 | Purity: 95% | L-Asparagine tert-butyl ester | ESD-801114-250MG |
| Cas.: 89640-55-1 | Purity: 98% | 3-Iodo-4-methoxypyridine | ESD-848375-5G |
| Cas.: 138479-53-5 | Purity: 98% | 2-[1,2,4]Triazol-1-yl-benzaldehyde | ESD-842631-5G |
| Cas.: 180923-77-7 | Purity: 95% | (2S)-3-Methyl-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)butanoic acid | ESD-916649-100MG |
| Cas.: 911466-96-1 | Purity: 97% | 2-(Ethoxycarbonyl)thiazole-4-carboxylic acid | ESD-846456-1G |
| Cas.: 223259-62-9 | Purity: ≥98%, 99%ee | (R)-2,2′,3,3′-Tetrahydro-1,1′-spirobi[1H-indene]-7,7′-diol | ESD-854096-5G |
| Cas.: 223259-62-9 | Purity: ≥98%, 99%ee | (R)-2,2′,3,3′-Tetrahydro-1,1′-spirobi[1H-indene]-7,7′-diol | ESD-854096-250MG |
| Cas.: 915213-54-6 | Purity: 97% | Ethyl 2-(4,4-difluorocyclohexyl)acetate | ESD-839431-250MG |
| Cas.: 916792-62-6 | Purity: 97% | 3-Fluoro-2-iodobenzonitrile | ESD-845318-1G |
| Cas.: 199336-83-9 | Purity: ≥97% | (R)-1-Boc-3-(methylamino)pyrrolidine | ESD-853239-5G |
| Cas.: 20033-99-2 | Purity: 97% | 2-(Hydroxymethyl)-5-methoxybenzimidazole | ESD-916650-1G |
| Cas.: 20033-99-2 | Purity: 97% | 2-(Hydroxymethyl)-5-methoxybenzimidazole | ESD-916650-250MG |
| Cas.: 170709-41-8 | Purity: ≥98%, ≥99% ee | (1S,2S)-N,N’-Di-p-tosyl-1,2-diphenyl-1,2-ethylenediamine | ESD-853944-5G |
| Cas.: 923565-91-7 | Purity: 95% | N-(3-Fluorophenyl)piperidin-4-amine hydrochloride | ESD-844665-5G |
| Cas.: 923565-91-7 | Purity: 95% | N-(3-Fluorophenyl)piperidin-4-amine hydrochloride | ESD-844665-25G |
| Cas.: 932016-10-9 | Purity: 95% | 4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol hydrochloride | ESD-848082-5G |
| Cas.: 946426-89-7 | Purity: 95% | 5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-methanol | ESD-916651-1G |
| Cas.: 933759-45-6 | Purity: 95% | 2-(Dimethylamino)pyrimidine-4-carboxylic acid | ESD-847971-250MG |
| Cas.: 946426-89-7 | Purity: 95% | 5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-methanol | ESD-916651-5G |
| Cas.: 933759-45-6 | Purity: 95% | 2-(Dimethylamino)pyrimidine-4-carboxylic acid | ESD-847971-1G |
| Cas.: 937595-71-6 | Purity: 97% | 2-Chloro-3-fluoropyridine-4-boronic Acid | ESD-850692-5G |
| Cas.: 959918-19-5 | Purity: 95% | 3-Ethynylpiperidine hydrochloride | ESD-848594-1G |
| Cas.: 1010422-53-3 | Purity: 95% | 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine | ESD-888171-250MG |
| Cas.: 1010422-53-3 | Purity: 95% | 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine | ESD-888171-1G |
| Cas.: 102308-62-3 | Purity: 95% | 3-Amino-3-(4-nitrophenyl)propanoic acid | ESD-843115-5G |
| Cas.: 1030846-94-6 | Purity: 98% | Methyl 8-methylquinoline-7-carboxylate | ESD-841554-250MG |
| Cas.: 144689-63-4 | Purity: ≥98% | Olmesartan Medoxomil | ESD-833149-250MG |
| Cas.: 34157-83-0 | Purity: 98% | Celastrol | ESD-804878-250MG |
| Cas.: 144689-63-4 | Purity: ≥98% | Olmesartan Medoxomil | ESD-833149-1G |
| Cas.: 144689-63-4 | Purity: ≥98% | Olmesartan Medoxomil | ESD-833149-5G |
| Cas.: 1031927-02-2 | Purity: 97% | 4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine | ESD-847337-250MG |
| Cas.: 103440-53-5 | Purity: 97% | Methyl 4-iodo-2-methylbenzoate | ESD-840575-1G |
| Cas.: 103440-53-5 | Purity: 97% | Methyl 4-iodo-2-methylbenzoate | ESD-840575-5G |
| Cas.: 1034737-23-9 | Purity: 95% | Methyl 2-amino-5-bromopyrimidine-4-carboxylate | ESD-847434-250MG |
| Cas.: 1034737-23-9 | Purity: 95% | Methyl 2-amino-5-bromopyrimidine-4-carboxylate | ESD-847434-1G |
| Cas.: 117976-89-3 | Purity: 99% | Rabeprazole | ESD-873603-10MG |
| Cas.: 105601-13-6 | Purity: 98% | 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | ESD-847185-250MG |
| Cas.: 2044838-29-9 | Purity: 95% | [4-(4-Methyl-1,3-thiazol-5-yl)phenyl]methanamine dihydrochloride | ESD-916652-100MG |
| Cas.: 106429-38-3 | Purity: 97% | Methyl 2-amino-1H-benzo[d]imidazole-5-carboxylate | ESD-843293-250MG |
| Cas.: 106429-38-3 | Purity: 97% | Methyl 2-amino-1H-benzo[d]imidazole-5-carboxylate | ESD-843293-1G |
| Cas.: 1071974-01-0 | Purity: 97% | Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate | ESD-848159-1G |
| Cas.: 1071974-01-0 | Purity: 97% | Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate | ESD-848159-5G |
| Cas.: 110099-94-0 | Purity: 98% | 2-(Methylthio)pyrimidine-5-carboxylic acid | ESD-855232-250MG |
| Cas.: 110099-94-0 | Purity: 98% | 2-(Methylthio)pyrimidine-5-carboxylic acid | ESD-855232-5G |
| Cas.: 1448189-30-7 | Purity: 95% | (4-(4-Methylthiazol-5-yl)phenyl)methanamine | ESD-916653-1G |
| Cas.: 1448189-30-7 | Purity: 95% | (4-(4-Methylthiazol-5-yl)phenyl)methanamine | ESD-916653-250MG |
| Cas.: 1104455-41-5 | Purity: 97% | Methyl 4-chloro-5-methylpicolinate | ESD-840623-250MG |
| Cas.: 110860-60-1 | Purity: 98% | Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate | ESD-845358-1G |
| Cas.: 87611-00-5 | Purity: 97% | 2,4-Dichloro-5-fluoroquinazoline | ESD-846233-1G |
| Cas.: 87611-00-5 | Purity: 97% | 2,4-Dichloro-5-fluoroquinazoline | ESD-846233-5G |
| Cas.: 1131587-92-2 | Purity: 98% | Methyl 5-bromo-2-hydroxy-4-(trifluoromethyl)benzoate | ESD-846222-1G |
| Cas.: 90924-12-2 | Purity: 97% | (3-Phenyl-5-isoxazolyl)methanol | ESD-916654-100MG |
| Cas.: 121604-45-3 | Purity: 95% | (3-Cyclopropylisoxazol-5-yl)methanol | ESD-916655-100MG |
| Cas.: 113824-76-3 | Purity: 95% | 2-(Methyl(2-phenoxyethyl)amino)ethanol | ESD-846581-1G |
| Cas.: 113824-76-3 | Purity: 95% | 2-(Methyl(2-phenoxyethyl)amino)ethanol | ESD-846581-5G |
| Cas.: 1370411-43-0 | Purity: 97% | 5-(4-Fluorophenethylsulfonyl)-1-phenyl-1H-tetrazole | ESD-847315-250MG |
| Cas.: 1370411-43-0 | Purity: 97% | 5-(4-Fluorophenethylsulfonyl)-1-phenyl-1H-tetrazole | ESD-847315-1G |
| Cas.: 116785-23-0 | Purity: 97% | 4,6-Dimethylnicotinaldehyde | ESD-848831-1G |
| Cas.: 1350543-67-7 | Purity: ≥95% | (Z)-3-(6-fluoro-1H-indol-3-yl)acrylonitrile | ESD-824991-250MG |
| Cas.: 1175301-23-1 | Purity: 98% | 4-(1-Hydroxyethyl)benzamide | ESD-842047-250MG |
| Cas.: 1350543-67-7 | Purity: ≥95% | (Z)-3-(6-fluoro-1H-indol-3-yl)acrylonitrile | ESD-824991-100MG |
| Cas.: 1175301-23-1 | Purity: 98% | 4-(1-Hydroxyethyl)benzamide | ESD-842047-1G |
| Cas.: 15230-79-2 | Purity: ≥99.99% metals basis | Lutetium(III) chloride hexahydrate | ESD-812633-100G |
| Cas.: 1179360-44-1 | Purity: 95% | 1,6-Naphthyridine-2-carboximidamide hydrochloride | ESD-848751-250MG |
| Cas.: 1179360-44-1 | Purity: 95% | 1,6-Naphthyridine-2-carboximidamide hydrochloride | ESD-848751-1G |
| Cas.: 1186608-71-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-845966-1G |
| Cas.: 1186608-71-8 | Purity: 97% | 3-Bromo-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-845966-5G |
| Cas.: 162848-16-0 | Purity: ≥97% | 4-(1,2,4-Triazol-1-yl)benzoic Acid | ESD-851697-250MG |
| Cas.: 1211596-30-3 | Purity: 98% | 2-Iodo-6-methylpyridin-3-amine | ESD-847907-1G |
| Cas.: 1211596-30-3 | Purity: 98% | 2-Iodo-6-methylpyridin-3-amine | ESD-847907-5G |
| Cas.: 1212972-48-9 | Purity: 95% | (S)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-848457-250MG |
| Cas.: 122323-87-9 | Purity: 96% | Piperazin-2-ylmethanol dihydrochloride | ESD-845748-1G |
| Cas.: 89827-45-2 | Purity: ≥98% | 4-Bromodibenzofuran | ESD-858969-25G |
| Cas.: 1229784-79-5 | Purity: 98% | 5,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847488-250MG |
| Cas.: 1229784-79-5 | Purity: 98% | 5,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-847488-1G |
| Cas.: 91374-20-8 | Purity: ≥98% | Ropinirole Hydrochloride | ESD-857953-250MG |
| Cas.: 91374-20-8 | Purity: ≥98% | Ropinirole Hydrochloride | ESD-857953-1G |
| Cas.: 1233205-73-6 | Purity: 98% | 2-Ethynyl-6-fluoropyridine | ESD-849262-1G |
| Cas.: 1240595-43-0 | Purity: 98% | Ethyl 4-amino-5-bromonicotinate | ESD-847736-250MG |
| Cas.: 1240595-43-0 | Purity: 98% | Ethyl 4-amino-5-bromonicotinate | ESD-847736-1G |
| Cas.: 1198-97-6 | Purity: 98% | 4-Phenyl-2-pyrrolidone | ESD-842341-25G |
| Cas.: 1251012-82-4 | Purity: 95% | 5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.3]HEXANE-1-CARBOXYLIC ACID | ESD-883637-250MG |
| Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-250MG |
| Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-1G |
| Cas.: 1224944-77-7 | Purity: 97% | Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848058-5G |
| Cas.: 57116-45-7 | Purity: Solid content 99% | Pentaerythritol tris(3-(1-aziridinyl)propionate) | ESD-890763-100G |
| Cas.: 1224944-77-7 | Purity: 97% | Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-848058-25G |
| Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-5G |
| Cas.: 121758-19-8 | Purity: ≥98%, ≥99% ee | (1R,2R)-N,N’-Di-p-tosyl-1,2-diphenyl-1,2-ethylenediamine | ESD-853943-5G |
| Cas.: 1353977-72-6 | Purity: 97% | 4-((4-Aminopipidin-1-yl)methyl)benzonitrile hydrochloride | ESD-847326-250MG |
| Cas.: 1353977-72-6 | Purity: 97% | 4-((4-Aminopipidin-1-yl)methyl)benzonitrile hydrochloride | ESD-847326-1G |
| Cas.: 141362-77-8 | Purity: ≥95%, 99%ee | 2,2-Bis[(4R)-4-benzyl-2-oxazolin-2-yl]propane | ESD-854122-250MG |
| Cas.: 1354549-24-8 | Purity: 97% | Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate | ESD-843369-1G |
| Cas.: 1354549-24-8 | Purity: 97% | Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate | ESD-843369-5G |
| Cas.: 141362-77-8 | Purity: ≥95%, 99%ee | 2,2-Bis[(4R)-4-benzyl-2-oxazolin-2-yl]propane | ESD-854122-1G |
| Cas.: 1354549-24-8 | Purity: 97% | Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate | ESD-843369-25G |
| Cas.: 1359655-84-7 | Purity: 95% | 6-Boc-2,6-diazaspiro[3.4]octane oxalate | ESD-883007-250MG |
| Cas.: 1359655-84-7 | Purity: 95% | 6-Boc-2,6-diazaspiro[3.4]octane oxalate | ESD-883007-50MG |
| Cas.: 138588-22-4 | Purity: 97% | 3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine | ESD-848149-250MG |
| Cas.: 138588-22-4 | Purity: 97% | 3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine | ESD-848149-1G |
| Cas.: 138588-22-4 | Purity: 97% | 3-(Pyridin-2-yl)-1,2,4-thiadiazol-5-amine | ESD-848149-5G |
| Cas.: 139058-18-7 | Purity: 98% | 3-Bromo-4-pivalamidobenzoic acid | ESD-843559-1G |
| Cas.: 139058-18-7 | Purity: 98% | 3-Bromo-4-pivalamidobenzoic acid | ESD-843559-5G |
| Cas.: 91-14-5 | Purity: 95% | 1,2-divinylbenzene | ESD-914936-250MG |
| Cas.: 16259-78-2 | Purity: 97% | (S)-Benzyl 2,6-diaminohexanoate bis(4-methylbenzenesulfonate) | ESD-843993-5G |
| Cas.: 1391431-90-5 | Purity: 95% | (S)-1-(2,5-Difluorophenyl)propan-1-amine hydrochloride | ESD-848738-1G |
| Cas.: 1418117-82-4 | Purity: ≥97% | 7-Methoxyquinoline Hydrochloride | ESD-852293-250MG |
| Cas.: 151859-37-9 | Purity: 98% | Methyl 3-bromo-2,4-dimethylbenzoate | ESD-848570-1G |
| Cas.: 1519917-98-6 | Purity: 97% | 3-Bromo-N-methoxy-N-methyl-5-nitrobenzamide | ESD-849264-1G |
| Cas.: 1519917-98-6 | Purity: 97% | 3-Bromo-N-methoxy-N-methyl-5-nitrobenzamide | ESD-849264-50MG |
| Cas.: 1588441-09-1 | Purity: 97% | trans-4-Morpholinocyclohexanol hydrochloride | ESD-846470-1G |
| Cas.: 1588441-12-6 | Purity: 95% | 4-(Trifluoromethoxy)-2-(trifluoromethyl)aniline hydrochloride | ESD-845832-1G |
| Cas.: 1588441-12-6 | Purity: 95% | 4-(Trifluoromethoxy)-2-(trifluoromethyl)aniline hydrochloride | ESD-845832-5G |
| Cas.: 161879-12-5 | Purity: 97% | H-Phg-OtBu.HCl | ESD-848924-5G |
| Cas.: 161879-12-5 | Purity: 97% | H-Phg-OtBu.HCl | ESD-848924-25G |
| Cas.: 1646152-47-7 | Purity: 97% | Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate | ESD-848298-250MG |
| Cas.: 1646152-47-7 | Purity: 97% | Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate | ESD-848298-1G |
| Cas.: 1646152-48-8 | Purity: 97% | tert-Butylbis(oxazol-4-ylmethyl)carbamate | ESD-847355-250MG |
| Cas.: 2182-66-3 | Purity: 97% | Diacetoxydimethylsilane | ESD-916656-25G |
| Cas.: 1646152-48-8 | Purity: 97% | tert-Butylbis(oxazol-4-ylmethyl)carbamate | ESD-847355-1G |
| Cas.: 2182-66-3 | Purity: 97% | Diacetoxydimethylsilane | ESD-916656-5G |
| Cas.: 2182-66-3 | Purity: 97% | Diacetoxydimethylsilane | ESD-916656-100G |
| Cas.: 1646152-51-3 | Purity: 95% | Bis(oxazol-4-ylmethyl)amine hydrochloride | ESD-847883-250MG |
| Cas.: 1646152-51-3 | Purity: 95% | Bis(oxazol-4-ylmethyl)amine hydrochloride | ESD-847883-1G |
| Cas.: 1646152-53-5 | Purity: 95% | 4-(Indolin-5-yl)morpholine hydrochloride | ESD-847354-250MG |
| Cas.: 1646152-53-5 | Purity: 95% | 4-(Indolin-5-yl)morpholine hydrochloride | ESD-847354-1G |
| Cas.: 1646152-53-5 | Purity: 95% | 4-(Indolin-5-yl)morpholine hydrochloride | ESD-847354-5G |
| Cas.: 1708924-47-3 | Purity: 97% | 2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine | ESD-846350-250MG |
| Cas.: 1708924-47-3 | Purity: 97% | 2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine | ESD-846350-1G |
| Cas.: 1708924-47-3 | Purity: 97% | 2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine | ESD-846350-5G |
| Cas.: 76-90-4 | Purity: 98% | Mepenzolate Bromide | ESD-858051-250MG |
| Cas.: 176672-49-4 | Purity: 95% | 4-(tert-Butoxy)phenylboronic Acid | ESD-850746-5G |
| Cas.: 176672-49-4 | Purity: 95% | 4-(tert-Butoxy)phenylboronic Acid | ESD-850746-25G |
| Cas.: 1799439-18-1 | Purity: 97% | 3-Chloropyrazolo[1,5-a]pyridine | ESD-845688-250MG |
| Cas.: 796096-64-5 | Purity: 97% | (S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate | ESD-841501-5G |
| Cas.: 191478-99-6 | Purity: 98% | Methyl 4-amino-2,6-difluorobenzoate | ESD-841116-250MG |
| Cas.: 191478-99-6 | Purity: 98% | Methyl 4-amino-2,6-difluorobenzoate | ESD-841116-1G |
| Cas.: 191478-99-6 | Purity: 98% | Methyl 4-amino-2,6-difluorobenzoate | ESD-841116-5G |
| Cas.: 20348-23-6 | Purity: ≥97% | 3,4-Dihydro-2H-pyrido[3,2-b]-1,4-oxazine | ESD-852886-5G |
| Cas.: 204260-38-8 | Purity: 98% | Fmoc-D-Phe(4-Me)-OH | ESD-809443-250MG |
| Cas.: 205264-33-1 | Purity: 95% | 1-Boc-4-Isoquinolin-1-yl-piperazine | ESD-843615-5G |
| Cas.: 205264-33-1 | Purity: 95% | 1-Boc-4-Isoquinolin-1-yl-piperazine | ESD-843615-25G |
| Cas.: 80862-08-4 | Purity: 98% | 6-Methoxy-1H-pyrrolo[3,2-c]pyridine | ESD-841068-250MG |
| Cas.: 21120-76-3 | Purity: 98% | Methyl 4-(4-iodophenoxy)benzoate | ESD-845696-1G |
| Cas.: 214760-18-6 | Purity: 98% | 4-Acetyl-2-fluorobenzonitrile | ESD-888444-5G |
| Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-250MG |
| Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-1G |
| Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-5G |
| Cas.: 2286-54-6 | Purity: ≥97% | 3,3-Diphenylpropionitrile | ESD-865102-25G |
| Cas.: 81547-72-0 | Purity: ≥97% | 2-Bromo-1-(2,6-dichlorophenyl)ethanone | ESD-857585-5G |
| Cas.: 869500-07-2 | Purity: 98% | 1-Bromo-2-iodo-3-methylbenzene | ESD-846406-1G |
| Cas.: 869500-07-2 | Purity: 98% | 1-Bromo-2-iodo-3-methylbenzene | ESD-846406-250MG |
| Cas.: 887308-14-7 | Purity: 97% | 5-Bromo-2-chloro-3-(methylsulfonyl)pyridine | ESD-848337-1G |
| Cas.: 1175301-23-1 | Purity: 98% | 4-(1-Hydroxyethyl)benzamide | ESD-842047-5G |
| Cas.: 892292-63-6 | Purity: 95% | 2-(Methyl(phenyl)amino)-4H-thieno[3,2-d][1,3]thiazin-4-one | ESD-845974-5G |
| Cas.: 89521-55-1 | Purity: 98% | 3-(Benzyloxy)benzene-1,2-diamine | ESD-847178-1G |
| Cas.: 911466-96-1 | Purity: 97% | 2-(Ethoxycarbonyl)thiazole-4-carboxylic acid | ESD-846456-5G |
| Cas.: 915213-54-6 | Purity: 97% | Ethyl 2-(4,4-difluorocyclohexyl)acetate | ESD-839431-1G |
| Cas.: 915213-54-6 | Purity: 97% | Ethyl 2-(4,4-difluorocyclohexyl)acetate | ESD-839431-5G |
| Cas.: 916792-62-6 | Purity: 97% | 3-Fluoro-2-iodobenzonitrile | ESD-845318-5G |
| Cas.: 933759-45-6 | Purity: 95% | 2-(Dimethylamino)pyrimidine-4-carboxylic acid | ESD-847971-5G |
| Cas.: 1010422-53-3 | Purity: 95% | 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine | ESD-888171-5G |
| Cas.: 102308-62-3 | Purity: 95% | 3-Amino-3-(4-nitrophenyl)propanoic acid | ESD-843115-10G |
| Cas.: 1030846-94-6 | Purity: 98% | Methyl 8-methylquinoline-7-carboxylate | ESD-841554-1G |
| Cas.: 1031927-02-2 | Purity: 97% | 4-(Imidazo[1,2-a]pyrazin-2-yl)-1,2,5-oxadiazol-3-amine | ESD-847337-1G |
| Cas.: 103440-53-5 | Purity: 97% | Methyl 4-iodo-2-methylbenzoate | ESD-840575-25G |
| Cas.: 1034737-23-9 | Purity: 95% | Methyl 2-amino-5-bromopyrimidine-4-carboxylate | ESD-847434-5G |
| Cas.: 105601-13-6 | Purity: 98% | 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | ESD-847185-1G |
| Cas.: 105601-13-6 | Purity: 98% | 3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride | ESD-847185-5G |
| Cas.: 1071974-01-0 | Purity: 97% | Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate | ESD-848159-10G |
| Cas.: 1104455-41-5 | Purity: 97% | Methyl 4-chloro-5-methylpicolinate | ESD-840623-1G |
| Cas.: 110860-60-1 | Purity: 98% | Methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate | ESD-845358-5G |
| Cas.: 189321-65-1 | Purity: ≥95% | 1-Boc-4-(Boc-amino)piperidine-4-carboxylic Acid | ESD-850421-250MG |
| Cas.: 1151564-03-2 | Purity: ≥97% | 2-Chloro-3-methoxyphenylboronic Acid Pinacol Ester | ESD-850742-5G |
| Cas.: 1175301-23-1 | Purity: 98% | 4-(1-Hydroxyethyl)benzamide | ESD-842047-10G |
| Cas.: 94242-85-0 | Purity: ≥97% | Methylboronic Acid Pinacol Ester | ESD-850737-25G |
| Cas.: 94242-85-0 | Purity: ≥97% | Methylboronic Acid Pinacol Ester | ESD-850737-100G |
| Cas.: 1210451-92-5 | Purity: 98% | Methyl 6-bromo-5-methylnicotinate | ESD-848725-250MG |
| Cas.: 1210451-92-5 | Purity: 98% | Methyl 6-bromo-5-methylnicotinate | ESD-848725-1G |
| Cas.: 1212972-48-9 | Purity: 95% | (S)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-848457-1G |
| Cas.: 200192-49-0 | Purity: 97% | HD-Asn(Trt)-OH | ESD-843937-5G |
| Cas.: 122323-87-9 | Purity: 96% | Piperazin-2-ylmethanol dihydrochloride | ESD-845748-5G |
| Cas.: 122323-87-9 | Purity: 96% | Piperazin-2-ylmethanol dihydrochloride | ESD-845748-10G |
| Cas.: 1233205-73-6 | Purity: 98% | 2-Ethynyl-6-fluoropyridine | ESD-849262-5G |
| Cas.: 1240595-43-0 | Purity: 98% | Ethyl 4-amino-5-bromonicotinate | ESD-847736-5G |
| Cas.: 90600-20-7 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)pent-4-enoic acid | ESD-841792-5G |
| Cas.: 1260779-54-1 | Purity: 98% | 5-Bromo-1,2,3,4-tetrahydroisoquinolin-8-amine | ESD-846803-10G |
| Cas.: 1354549-24-8 | Purity: 97% | Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate | ESD-843369-10G |
| Cas.: 205927-03-3 | Purity: ≥98%, 99%ee | (S)-3,3′-Di-tert-butyl-5,5′,6,6′-tetramethylbiphenyl-2,2′-diol | ESD-854048-250MG |
| Cas.: 914612-23-0 | Purity: 97% | 6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine | ESD-842953-250MG |
| Cas.: 205927-03-3 | Purity: ≥98%, 99%ee | (S)-3,3′-Di-tert-butyl-5,5′,6,6′-tetramethylbiphenyl-2,2′-diol | ESD-854048-1G |
| Cas.: 151859-37-9 | Purity: 98% | Methyl 3-bromo-2,4-dimethylbenzoate | ESD-848570-5G |
| Cas.: 1519917-98-6 | Purity: 97% | 3-Bromo-N-methoxy-N-methyl-5-nitrobenzamide | ESD-849264-5G |
| Cas.: 1588441-09-1 | Purity: 97% | trans-4-Morpholinocyclohexanol hydrochloride | ESD-846470-5G |
| Cas.: 1588441-09-1 | Purity: 97% | trans-4-Morpholinocyclohexanol hydrochloride | ESD-846470-10G |
| Cas.: 929294-27-9 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide -dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854238-250MG |
| Cas.: 929294-27-9 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide -dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854238-1G |
| Cas.: 161879-12-5 | Purity: 97% | H-Phg-OtBu.HCl | ESD-848924-10G |
| Cas.: 27490-33-1 | Purity: ≥95% | (Tributylstannyl)methanol | ESD-826676-250MG |
| Cas.: 161879-12-5 | Purity: 97% | H-Phg-OtBu.HCl | ESD-848924-100G |
| Cas.: 1646152-47-7 | Purity: 97% | Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate | ESD-848298-5G |
| Cas.: 1646152-48-8 | Purity: 97% | tert-Butylbis(oxazol-4-ylmethyl)carbamate | ESD-847355-5G |
| Cas.: 1646152-51-3 | Purity: 95% | Bis(oxazol-4-ylmethyl)amine hydrochloride | ESD-847883-5G |
| Cas.: 79561-82-3 | Purity: 98% | Boc-D-Phe(4-Br)-OH | ESD-801952-100G |
| Cas.: 176672-49-4 | Purity: 95% | 4-(tert-Butoxy)phenylboronic Acid | ESD-850746-100G |
| Cas.: 1799439-18-1 | Purity: 97% | 3-Chloropyrazolo[1,5-a]pyridine | ESD-845688-1G |
| Cas.: 191478-99-6 | Purity: 98% | Methyl 4-amino-2,6-difluorobenzoate | ESD-841116-10G |
| Cas.: 3260-87-5 | Purity: 97% | 3-Chloro-2-methylphenol | ESD-829124-25G |
| Cas.: 3260-87-5 | Purity: 97% | 3-Chloro-2-methylphenol | ESD-829124-100G |
| Cas.: 20348-23-6 | Purity: ≥97% | 3,4-Dihydro-2H-pyrido[3,2-b]-1,4-oxazine | ESD-852886-100MG |
| Cas.: 204260-38-8 | Purity: 98% | Fmoc-D-Phe(4-Me)-OH | ESD-809443-5G |
| Cas.: 945954-95-0 | Purity: 97% | 6-Bromo-3-methoxypicolinaldehyde | ESD-848692-250MG |
| Cas.: 204260-38-8 | Purity: 98% | Fmoc-D-Phe(4-Me)-OH | ESD-809443-25G |
| Cas.: 20901-53-5 | Purity: ≥95% | Methyl 2-Oxo-2,3-dihydro-1H-imidazole-4-carboxylate | ESD-851160-100MG |
| Cas.: 2134-38-5 | Purity: 98% | Ethyl 2-methylpyrimidine-5-carboxylate | ESD-839688-100MG |
| Cas.: 329735-68-4 | Purity: ≥98%, 99%ee | (R)-3,3′-Di-tert-butyl-5,5′,6,6′-tetramethylbiphenyl-2,2′-diol | ESD-854047-250MG |
| Cas.: 1000342-95-9 | Purity: 97% | 4-Bromo-6-(trifluoromethyl)-1H-indazole | ESD-846116-1G |
| Cas.: 22833-69-8 | Purity: 98% | Methyl 2-hydroxy-6-methoxybenzoate | ESD-846977-10G |
| Cas.: 329735-68-4 | Purity: ≥98%, 99%ee | (R)-3,3′-Di-tert-butyl-5,5′,6,6′-tetramethylbiphenyl-2,2′-diol | ESD-854047-1G |
| Cas.: 329735-68-4 | Purity: ≥98%, 99%ee | (R)-3,3′-Di-tert-butyl-5,5′,6,6′-tetramethylbiphenyl-2,2′-diol | ESD-854047-50MG |
| Cas.: 2286-54-6 | Purity: ≥97% | 3,3-Diphenylpropionitrile | ESD-865102-100G |
| Cas.: 23851-84-5 | Purity: ≥97% | Ethyl 4-Hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylate | ESD-850953-10G |
| Cas.: 23851-84-5 | Purity: ≥97% | Ethyl 4-Hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylate | ESD-850953-25G |
| Cas.: 3985-20-4 | Purity: 90% | Diisoamyl Phosphate | ESD-859333-5G |
| Cas.: 3985-20-4 | Purity: 90% | Diisoamyl Phosphate | ESD-859333-250MG |
| Cas.: 100073-15-2 | Purity: ≥95% | Tributyl(prop-1-en-2-yl)stannane | ESD-826201-250MG |
| Cas.: 54724-00-4 | Purity: BR | CURDLAN | ESD-832451-2.5KG |
| Cas.: 25625-57-4 | Purity: 98% | 2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide | ESD-844784-1G |
| Cas.: 25625-57-4 | Purity: 98% | 2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide | ESD-844784-5G |
| Cas.: 1007206-54-3 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-847057-5G |
| Cas.: 1010814-94-4 | Purity: 97% | tert-Butyl 3-(2-(tert-butoxy)-2-oxoethyl)-4-oxopiperidine-1-carboxylate | ESD-848138-250MG |
| Cas.: 270912-79-3 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | ESD-846626-250MG |
| Cas.: 270912-79-3 | Purity: 98% | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | ESD-846626-1G |
| Cas.: 2876-22-4 | Purity: 95% | phenazin-1-ylamine | ESD-887912-100MG |
| Cas.: 288101-48-4 | Purity: 98% | 2-(2,4-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-886698-250MG |
| Cas.: 1448189-90-9 | Purity: 96% | (2S,4R)-4-Hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride | ESD-916657-100MG |
| Cas.: 288101-48-4 | Purity: 98% | 2-(2,4-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-886698-25G |
| Cas.: 288101-48-4 | Purity: 98% | 2-(2,4-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-886698-100G |
| Cas.: 304468-42-6 | Purity: 97% | 5′-BROMOSPIRO[CYCLOHEXANE-1,3′-INDOLIN]-2′-ONE | ESD-879700-100MG |
| Cas.: 313535-01-2 | Purity: 95% | 2-Amino-3,6-dichloropyridine | ESD-833760-250MG |
| Cas.: 313535-01-2 | Purity: 95% | 2-Amino-3,6-dichloropyridine | ESD-833760-1G |
| Cas.: 115754-20-6 | Purity: ≥98% | 3-chloro-4-(trifluoromethyl)benzoic acid | ESD-857679-5G |
| Cas.: 3400-22-4 | Purity: 96% | 4-Methoxy-N-methylbenzamide | ESD-841545-100MG |
| Cas.: 3400-22-4 | Purity: 96% | 4-Methoxy-N-methylbenzamide | ESD-841545-1G |
| Cas.: 3400-22-4 | Purity: 96% | 4-Methoxy-N-methylbenzamide | ESD-841545-5G |
| Cas.: 3400-22-4 | Purity: 96% | 4-Methoxy-N-methylbenzamide | ESD-841545-25G |
| Cas.: 36818-07-2 | Purity: ≥97% | Ethyl 3-Oxo-3,4-dihydro-2-quinoxalinecarboxylate | ESD-850975-1G |
| Cas.: 36818-07-2 | Purity: ≥97% | Ethyl 3-Oxo-3,4-dihydro-2-quinoxalinecarboxylate | ESD-850975-10G |
| Cas.: 84604-70-6 | Purity: 98% | 1-(2,4-Dichlorophenyl)cyclopropanecarboxylic acid | ESD-916658-1G |
| Cas.: 1173206-71-7 | Purity: 97% | tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride | ESD-847652-250MG |
| Cas.: 407640-40-8 | Purity: 97% | 2-(4-Fluoro-2-methylphenyl)acetic acid | ESD-847681-5G |
| Cas.: 407640-40-8 | Purity: 97% | 2-(4-Fluoro-2-methylphenyl)acetic acid | ESD-847681-10G |
| Cas.: 407640-40-8 | Purity: 97% | 2-(4-Fluoro-2-methylphenyl)acetic acid | ESD-847681-25G |
| Cas.: 5736-88-9 | Purity: 98% | 4-Butoxybenzaldehyde | ESD-822499-5G |
| Cas.: 4388-56-1 | Purity: 95% | 3-(1,3-Dioxolan-2-yl)propanoic acid | ESD-839777-100MG |
| Cas.: 4388-56-1 | Purity: 95% | 3-(1,3-Dioxolan-2-yl)propanoic acid | ESD-839777-1G |
| Cas.: 4388-56-1 | Purity: 95% | 3-(1,3-Dioxolan-2-yl)propanoic acid | ESD-839777-5G |
| Cas.: 4388-56-1 | Purity: 95% | 3-(1,3-Dioxolan-2-yl)propanoic acid | ESD-839777-10G |
| Cas.: 4388-56-1 | Purity: 95% | 3-(1,3-Dioxolan-2-yl)propanoic acid | ESD-839777-25G |
| Cas.: 35629-70-0 | Purity: 95% | 2-Amino-4-methyloxazole | ESD-854751-250MG |
| Cas.: 1180112-41-7 | Purity: 97% | tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate | ESD-847880-250MG |
| Cas.: 500789-41-3 | Purity: 97% | 4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate | ESD-845717-100MG |
| Cas.: 500789-41-3 | Purity: 97% | 4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate | ESD-845717-1G |
| Cas.: 500789-41-3 | Purity: 97% | 4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate | ESD-845717-5G |
| Cas.: 52107-68-3 | Purity: 98% | 5-iodo-2-methylbenzenecarbonitrile | ESD-888247-10G |
| Cas.: 52107-68-3 | Purity: 98% | 5-iodo-2-methylbenzenecarbonitrile | ESD-888247-100G |
| Cas.: 34880-70-1 | Purity: ≥95%(GC) | 1-Methoxy-1-trimethylsilyloxypropene | ESD-863349-1G |
| Cas.: 3469-63-4 | Purity: ≥95% | Ethyl 5-methoxy-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | ESD-826278-100MG |
| Cas.: 52407-92-8 | Purity: 95% | 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride | ESD-848554-100MG |
| Cas.: 52407-92-8 | Purity: 95% | 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride | ESD-848554-1G |
| Cas.: 2914-69-4 | Purity: 97% | (S)-(-)-3-Butyn-2-ol | ESD-854967-1G |
| Cas.: 749269-74-7 | Purity: 96% | 1-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic acid | ESD-916659-100MG |
| Cas.: 52407-92-8 | Purity: 95% | 3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride | ESD-848554-5G |
| Cas.: 52898-49-4 | Purity: ≥95% | N,4-Dimethoxy-N-methylbenzamide | ESD-866492-5G |
| Cas.: 52898-49-4 | Purity: ≥95% | N,4-Dimethoxy-N-methylbenzamide | ESD-866492-100MG |
| Cas.: 53090-43-0 | Purity: 97% | Ethyl 3-(3,4-dichlorophenyl)-3-oxopropanoate | ESD-848179-100MG |
| Cas.: 53090-43-0 | Purity: 97% | Ethyl 3-(3,4-dichlorophenyl)-3-oxopropanoate | ESD-848179-1G |
| Cas.: 2380-78-1 | Purity: 97% | Homovanilly alcohol | ESD-880121-500MG |
| Cas.: 2380-78-1 | Purity: 97% | Homovanilly alcohol | ESD-880121-1G |
| Cas.: 54128-01-7 | Purity: 95% | 4-Chloro-5-ethylpyrimidine | ESD-855307-100MG |
| Cas.: 54128-01-7 | Purity: 95% | 4-Chloro-5-ethylpyrimidine | ESD-855307-250MG |
| Cas.: 55270-28-5 | Purity: 97% | 4-Iodoisoquinolin-1-amine | ESD-842924-100MG |
| Cas.: 55270-28-5 | Purity: 97% | 4-Iodoisoquinolin-1-amine | ESD-842924-1G |
| Cas.: 55270-28-5 | Purity: 97% | 4-Iodoisoquinolin-1-amine | ESD-842924-5G |
| Cas.: 55270-28-5 | Purity: 97% | 4-Iodoisoquinolin-1-amine | ESD-842924-10G |
| Cas.: 55270-28-5 | Purity: 97% | 4-Iodoisoquinolin-1-amine | ESD-842924-25G |
| Cas.: 56136-84-6 | Purity: ≥97% | 4′,5′-Methylenedioxy-2′-nitroacetophenone | ESD-915938-100MG |
| Cas.: 1263378-29-5 | Purity: ≥95% | 3-Aminocyclohexanol Hydrochloride | ESD-850852-250MG |
| Cas.: 56136-84-6 | Purity: ≥97% | 4′,5′-Methylenedioxy-2′-nitroacetophenone | ESD-915938-5G |
| Cas.: 56136-84-6 | Purity: ≥97% | 4′,5′-Methylenedioxy-2′-nitroacetophenone | ESD-915938-10G |
| Cas.: 342386-78-1 | Purity: 97% | 1-(3,4-Dichlorophenyl)cyclopropane-1-carboxylic acid | ESD-916660-1G |
| Cas.: 132089-38-4 | Purity: 98% | Ethyl 2-(3,5-dichlorophenyl)thiazole-4-carboxylate | ESD-843339-5G |
| Cas.: 56241-09-9 | Purity: 97% | 4-Chloro-1(2H)-isoquinolone | ESD-842909-1G |
| Cas.: 56241-09-9 | Purity: 97% | 4-Chloro-1(2H)-isoquinolone | ESD-842909-5G |
| Cas.: 57052-99-0 | Purity: ≥97% | Dimethyl 2-Nitroisophthalate | ESD-851081-100MG |
| Cas.: 1698027-19-8 | Purity: 97% | 7-Bromo-4,6-dichloro-8-fluoroquinazoline | ESD-916661-100MG |
| Cas.: 57052-99-0 | Purity: ≥97% | Dimethyl 2-Nitroisophthalate | ESD-851081-250MG |
| Cas.: 9051-29-0 | Purity: ≥85% (PAGE) | α-Lactalbumin | ESD-890179-25MG |
| Cas.: 13726-21-1 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)acetonitrile | ESD-846838-1G |
| Cas.: 13726-21-1 | Purity: 98% | 2-(4-Chloro-3-methoxyphenyl)acetonitrile | ESD-846838-250MG |
| Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-250MG |
| Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-1G |
| Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-5G |
| Cas.: 573987-48-1 | Purity: 98% | 1-(Cyanomethyl)pyrrolidin-1-ium trifluoromethanesulfonate | ESD-846980-25G |
| Cas.: 58077-68-2 | Purity: ≥95% | 4-(4-Methyl-1-piperazinyl)butanoic Acid | ESD-851956-5G |
| Cas.: 14088-98-3 | Purity: 98% | 1-(3-Chlorophenyl)imidazolidin-2-one | ESD-847318-250MG |
| Cas.: 14088-98-3 | Purity: 98% | 1-(3-Chlorophenyl)imidazolidin-2-one | ESD-847318-1G |
| Cas.: 88965-00-8 | Purity: 98% | 6-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine | ESD-916662-1G |
| Cas.: 58422-60-9 | Purity: 95% | 2-(o-Tolyl)propanenitrile | ESD-845761-1G |
| Cas.: 58422-60-9 | Purity: 95% | 2-(o-Tolyl)propanenitrile | ESD-845761-5G |
| Cas.: 219757-68-3 | Purity: ≥98%, 99%ee | (R)-2,2′-Dimethoxy-3,3′-diphenyl-1,1′-binaphthalene | ESD-854049-500MG |
| Cas.: 219757-68-3 | Purity: ≥98%, 99%ee | (R)-2,2′-Dimethoxy-3,3′-diphenyl-1,1′-binaphthalene | ESD-854049-1G |
| Cas.: 58481-17-7 | Purity: 97% | Methyl 2-(hydroxymethyl)isonicotinate | ESD-847548-250MG |
| Cas.: 59739-05-8 | Purity: 97% | tert-Butyl 2-aminothiophene-3-carboxylate | ESD-840683-5G |
| Cas.: 59739-05-8 | Purity: 97% | tert-Butyl 2-aminothiophene-3-carboxylate | ESD-840683-10G |
| Cas.: 146651-75-4 | Purity: >97% | N-Boc-1,2-phenyldiamine | ESD-837374-1G |
| Cas.: 59739-05-8 | Purity: 97% | tert-Butyl 2-aminothiophene-3-carboxylate | ESD-840683-25G |
| Cas.: 146651-75-4 | Purity: >97% | N-Boc-1,2-phenyldiamine | ESD-837374-25G |
| Cas.: 146651-75-4 | Purity: >97% | N-Boc-1,2-phenyldiamine | ESD-837374-100G |
| Cas.: 146307-51-9 | Purity: 97% | trans-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate | ESD-846411-5G |
| Cas.: 60078-97-9 | Purity: ≥98% | 1-Phenyl-3-(2,4,6-trimethylphenyl)-2-pyrazoline | ESD-866700-5G |
| Cas.: 60078-97-9 | Purity: ≥98% | 1-Phenyl-3-(2,4,6-trimethylphenyl)-2-pyrazoline | ESD-866700-25G |
| Cas.: 6076-12-6 | Purity: 98% | Ethyl 4-methyl-1H-pyrazole-3-carboxylate | ESD-840523-100MG |
| Cas.: 130290-79-8 | Purity: 98% | 4-Aminomethyltetrahydropyran | ESD-835361-25G |
| Cas.: 6076-12-6 | Purity: 98% | Ethyl 4-methyl-1H-pyrazole-3-carboxylate | ESD-840523-5G |
| Cas.: 130290-79-8 | Purity: 98% | 4-Aminomethyltetrahydropyran | ESD-835361-100G |
| Cas.: 6076-12-6 | Purity: 98% | Ethyl 4-methyl-1H-pyrazole-3-carboxylate | ESD-840523-25G |
| Cas.: 6076-12-6 | Purity: 98% | Ethyl 4-methyl-1H-pyrazole-3-carboxylate | ESD-840523-100G |
| Cas.: 16338-48-0 | Purity: 98% | (|S|)-(-)-2-Amino-4-pentenoic acid | ESD-801261-5G |
| Cas.: 61859-96-9 | Purity: 95% | Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-848429-250MG |
| Cas.: 61859-96-9 | Purity: 95% | Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-848429-1G |
| Cas.: 1616526-80-7 | Purity: 98% | 1,5-Difluoro-3-methyl-2-nitrobenzene | ESD-844927-1G |
| Cas.: 620-80-4 | Purity: 95% | Ethyl 2-benzylidene-3-oxobutanoate | ESD-840864-100MG |
| Cas.: 942183-80-4 | Purity: 99% | SCH772984 | ESD-873835-5MG |
| Cas.: 65417-22-3 | Purity: 98% | Methyl 2-methyl-1H-indole-3-carboxylate | ESD-841735-1G |
| Cas.: 65417-22-3 | Purity: 98% | Methyl 2-methyl-1H-indole-3-carboxylate | ESD-841735-5G |
| Cas.: 65417-22-3 | Purity: 98% | Methyl 2-methyl-1H-indole-3-carboxylate | ESD-841735-10G |
| Cas.: 65417-22-3 | Purity: 98% | Methyl 2-methyl-1H-indole-3-carboxylate | ESD-841735-25G |
| Cas.: 669070-64-8 | Purity: 95% | 2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-848627-100MG |
| Cas.: 669070-64-8 | Purity: 95% | 2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-848627-1G |
| Cas.: 669070-64-8 | Purity: 95% | 2-(Pyridin-2-yl)-1H-benzo[d]imidazole-6-carboxylic acid | ESD-848627-5G |
| Cas.: 166328-14-9 | Purity: 98% | Potassium 2-furantrifluoroborate | ESD-886638-250MG |
| Cas.: 873-40-5 | Purity: 98% | 2,3,5-Trichloropyrazine | ESD-847160-250MG |
| Cas.: 873-40-5 | Purity: 98% | 2,3,5-Trichloropyrazine | ESD-847160-1G |
| Cas.: 67434-65-5 | Purity: 95% | 4-Chloro-5,6-dimethylpyrimidine | ESD-852236-5G |
| Cas.: 864529-88-4 | Purity: ≥98%, ≥99% ee | (11bR)-N,N,2,6-Tetramethyl-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-853910-250MG |
| Cas.: 7238-62-2 | Purity: 98% | Ethyl 2-chloro-4-methylthiazole-5-carboxylate | ESD-847001-5G |
| Cas.: 7238-62-2 | Purity: 98% | Ethyl 2-chloro-4-methylthiazole-5-carboxylate | ESD-847001-10G |
| Cas.: 7238-62-2 | Purity: 98% | Ethyl 2-chloro-4-methylthiazole-5-carboxylate | ESD-847001-25G |
| Cas.: 16657-07-1 | Purity: 98% | 7-Bromo-1H-indene | ESD-839341-5G |
| Cas.: 1802489-64-0 | Purity: 97% | Methyl 4-fluoropyrazolo[1,5-a]pyridine-3-carboxylate | ESD-848838-1G |
| Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-5G |
| Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-10G |
| Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-25G |
| Cas.: 73675-45-3 | Purity: 97% | 2-(4-(tert-Butyl)phenoxy)-N,N-dimethylethanamine | ESD-846545-100G |
| Cas.: 594839-88-0 | Purity: ≥99% | Tafamidis | ESD-878292-50MG |
| Cas.: 181696-35-5 | Purity: 98% | 4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid | ESD-848806-250MG |
| Cas.: 181696-35-5 | Purity: 98% | 4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid | ESD-848806-1G |
| Cas.: 85575-93-5 | Purity: 98% | 2,9-Dibutyl-1,10-phenanthroline | ESD-869807-250MG |
| Cas.: 85575-93-5 | Purity: 98% | 2,9-Dibutyl-1,10-phenanthroline | ESD-869807-1G |
| Cas.: 85575-93-5 | Purity: 98% | 2,9-Dibutyl-1,10-phenanthroline | ESD-869807-5G |
| Cas.: 75104-92-6 | Purity: 98% | 6-Bromo-N-methylbenzo[d]thiazol-2-amine | ESD-845279-1G |
| Cas.: 4105-92-4 | Purity: 98% | Triethyl benzene-1,3,5-tricarboxylate | ESD-904746-25G |
| Cas.: 75104-92-6 | Purity: 98% | 6-Bromo-N-methylbenzo[d]thiazol-2-amine | ESD-845279-5G |
| Cas.: 75104-92-6 | Purity: 98% | 6-Bromo-N-methylbenzo[d]thiazol-2-amine | ESD-845279-10G |
| Cas.: 680596-79-6 | Purity: 98% | 4,4,5,5-Tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane | ESD-847293-5G |
| Cas.: 762287-58-1 | Purity: 98% | 2-Fluoro-3-methylphenylboronic acid | ESD-855906-250MG |
| Cas.: 680596-79-6 | Purity: 98% | 4,4,5,5-Tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane | ESD-847293-25G |
| Cas.: 762287-58-1 | Purity: 98% | 2-Fluoro-3-methylphenylboronic acid | ESD-855906-5G |
| Cas.: 762287-58-1 | Purity: 98% | 2-Fluoro-3-methylphenylboronic acid | ESD-855906-10G |
| Cas.: 762287-58-1 | Purity: 98% | 2-Fluoro-3-methylphenylboronic acid | ESD-855906-25G |
| Cas.: 762287-58-1 | Purity: 98% | 2-Fluoro-3-methylphenylboronic acid | ESD-855906-100G |
| Cas.: 77497-84-8 | Purity: ≥95% | Methyl 3-(Cyclopropylamino)propanoate | ESD-851341-100MG |
| Cas.: 77497-84-8 | Purity: ≥95% | Methyl 3-(Cyclopropylamino)propanoate | ESD-851341-250MG |
| Cas.: 79707-11-2 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-8-ol | ESD-847138-1G |
| Cas.: 84766-91-6 | Purity: 95% | N-BOC PRROLIDIN-2-OL | ESD-887987-100MG |
| Cas.: 84766-91-6 | Purity: 95% | N-BOC PRROLIDIN-2-OL | ESD-887987-5G |
| Cas.: 849106-20-3 | Purity: 95% | tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-847120-250MG |
| Cas.: 849106-20-3 | Purity: 95% | tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-847120-1G |
| Cas.: 849106-20-3 | Purity: 95% | tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-847120-5G |
| Cas.: 59878-57-8 | Purity: 97% | 1-(Cyclopropylcarbonyl)piperazine | ESD-851400-10G |
| Cas.: 59878-57-8 | Purity: 97% | 1-(Cyclopropylcarbonyl)piperazine | ESD-851400-25G |
| Cas.: 839710-38-2 | Purity: 97% | (S)-4-Boc-3-morpholineacetic acid | ESD-828546-100MG |
| Cas.: 839710-38-2 | Purity: 97% | (S)-4-Boc-3-morpholineacetic acid | ESD-828546-1G |
| Cas.: 1123169-41-4 | Purity: 98% | 8-Bromoquinazoline | ESD-841046-250MG |
| Cas.: 1123169-41-4 | Purity: 98% | 8-Bromoquinazoline | ESD-841046-1G |
| Cas.: 13292-05-2 | Purity: 97% | 3-Bromophenanthrene-9,10-dione | ESD-843459-10G |
| Cas.: 13292-05-2 | Purity: 97% | 3-Bromophenanthrene-9,10-dione | ESD-843459-25G |
| Cas.: 1361110-64-6 | Purity: 95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847251-250MG |
| Cas.: 1361110-64-6 | Purity: 95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-847251-1G |
| Cas.: 856834-95-2 | Purity: 98% | 3-Bromo-2-chloro-6-methyl-5-nitropyridine | ESD-840863-100MG |
| Cas.: 856834-95-2 | Purity: 98% | 3-Bromo-2-chloro-6-methyl-5-nitropyridine | ESD-840863-5G |
| Cas.: 856834-95-2 | Purity: 98% | 3-Bromo-2-chloro-6-methyl-5-nitropyridine | ESD-840863-10G |
| Cas.: 856834-95-2 | Purity: 98% | 3-Bromo-2-chloro-6-methyl-5-nitropyridine | ESD-840863-25G |
| Cas.: 858851-27-1 | Purity: 95% | 2,2,5,5-Tetramethylpiperazine dihydrochloride | ESD-848007-250MG |
| Cas.: 858851-27-1 | Purity: 95% | 2,2,5,5-Tetramethylpiperazine dihydrochloride | ESD-848007-1G |
| Cas.: 859721-53-2 | Purity: 96% | 4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine | ESD-847893-250MG |
| Cas.: 859721-53-2 | Purity: 96% | 4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine | ESD-847893-1G |
| Cas.: 859721-53-2 | Purity: 96% | 4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine | ESD-847893-5G |
| Cas.: 86147-28-6 | Purity: 98% | 3-(4-Chlorophenyl)piperazin-2-one | ESD-848821-100MG |
| Cas.: 86147-28-6 | Purity: 98% | 3-(4-Chlorophenyl)piperazin-2-one | ESD-848821-1G |
| Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-1G |
| Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-5G |
| Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-10G |
| Cas.: 885523-43-3 | Purity: 95% | 4-Bromo-1H-indazole-6-carboxylic acid | ESD-844938-25G |
| Cas.: 886373-00-8 | Purity: 97% | 5-Bromo-2-ethoxypyridin-3-amine | ESD-840865-5G |
| Cas.: 886373-00-8 | Purity: 97% | 5-Bromo-2-ethoxypyridin-3-amine | ESD-840865-10G |
| Cas.: 89937-78-0 | Purity: ≥97% | Methyl 5-Hydroxynicotinate Hydrochloride | ESD-850995-250MG |
| Cas.: 89937-78-0 | Purity: ≥97% | Methyl 5-Hydroxynicotinate Hydrochloride | ESD-850995-25G |
| Cas.: 905281-60-9 | Purity: 98% | 4-(1-Methyl-1H-pyrazol-5-yl)pyridine | ESD-847724-250MG |
| Cas.: 905281-60-9 | Purity: 98% | 4-(1-Methyl-1H-pyrazol-5-yl)pyridine | ESD-847724-1G |
| Cas.: 905281-60-9 | Purity: 98% | 4-(1-Methyl-1H-pyrazol-5-yl)pyridine | ESD-847724-5G |
| Cas.: 94170-69-1 | Purity: 95% | 4-Chloro-6-(chloromethyl)-2-methoxypyrimidine | ESD-841163-250MG |
| Cas.: 94170-69-1 | Purity: 95% | 4-Chloro-6-(chloromethyl)-2-methoxypyrimidine | ESD-841163-1G |
| Cas.: 946598-40-9 | Purity: ≥97% | 2-Fluoro-4-morpholinobenzoic Acid | ESD-851781-250MG |
| Cas.: 957062-84-9 | Purity: ≥97% | 2-Methyl-5-nitrophenylboronic Acid Pinacol Ester | ESD-850685-250MG |
| Cas.: 957062-84-9 | Purity: ≥97% | 2-Methyl-5-nitrophenylboronic Acid Pinacol Ester | ESD-850685-25G |
| Cas.: 97364-15-3 | Purity: 97% | 4-(1-Hydroxyethyl)benzoic acid | ESD-841849-1G |
| Cas.: 103030-73-5 | Purity: 95% | 2-Amino-1,2,3,4-tetrahydronaphthalen-1-ol hydrochloride | ESD-847429-250MG |
| Cas.: 103030-73-5 | Purity: 95% | 2-Amino-1,2,3,4-tetrahydronaphthalen-1-ol hydrochloride | ESD-847429-1G |
| Cas.: 1063733-81-2 | Purity: 98% | 2-(3,5-Difluorophenyl)propan-2-amine hydrochloride | ESD-846693-1G |
| Cas.: 214759-21-4 | Purity: ≥98% | 2,4,6-Trifluorobenzyl Amine | ESD-859739-1G |
| Cas.: 1063733-81-2 | Purity: 98% | 2-(3,5-Difluorophenyl)propan-2-amine hydrochloride | ESD-846693-5G |
| Cas.: 1082040-57-0 | Purity: 97% | Methyl 6-chloro-1H-indole-4-carboxylate | ESD-848287-250MG |
| Cas.: 1082040-57-0 | Purity: 97% | Methyl 6-chloro-1H-indole-4-carboxylate | ESD-848287-1G |
| Cas.: 1082040-57-0 | Purity: 97% | Methyl 6-chloro-1H-indole-4-carboxylate | ESD-848287-5G |
| Cas.: 1107694-84-7 | Purity: 97% | 2,8-Dichloroquinazolin-4-amine | ESD-847371-1G |
| Cas.: 1107694-84-7 | Purity: 97% | 2,8-Dichloroquinazolin-4-amine | ESD-847371-5G |
| Cas.: 113210-35-8 | Purity: 95% | Methyl 2-((4-hydroxyphenyl)amino)acetate hydrochloride | ESD-847576-250MG |
| Cas.: 113210-35-8 | Purity: 95% | Methyl 2-((4-hydroxyphenyl)amino)acetate hydrochloride | ESD-847576-1G |
| Cas.: 113210-35-8 | Purity: 95% | Methyl 2-((4-hydroxyphenyl)amino)acetate hydrochloride | ESD-847576-5G |
| Cas.: 1197239-37-4 | Purity: 97% | tert-Butyl (3-aminocyclopentyl)carbamate hydrochloride | ESD-848146-1G |
| Cas.: 1197239-37-4 | Purity: 97% | tert-Butyl (3-aminocyclopentyl)carbamate hydrochloride | ESD-848146-5G |
| Cas.: 1201187-18-9 | Purity: 95% | 6-Chloro-4-(trifluoromethyl)nicotinonitrile | ESD-848947-1G |
| Cas.: 1201187-18-9 | Purity: 95% | 6-Chloro-4-(trifluoromethyl)nicotinonitrile | ESD-848947-5G |
| Cas.: 123278-03-5 | Purity: 98% | 3-Chloro-2-iodobenzoic acid | ESD-842306-250MG |
| Cas.: 123278-03-5 | Purity: 98% | 3-Chloro-2-iodobenzoic acid | ESD-842306-1G |
| Cas.: 123278-03-5 | Purity: 98% | 3-Chloro-2-iodobenzoic acid | ESD-842306-5G |
| Cas.: 123278-03-5 | Purity: 98% | 3-Chloro-2-iodobenzoic acid | ESD-842306-25G |
| Cas.: 123278-03-5 | Purity: 98% | 3-Chloro-2-iodobenzoic acid | ESD-842306-100G |
| Cas.: 1235406-28-6 | Purity: 97% | 3-Cyano-4-fluoro-N-(thiazol-2-yl)benzenesulfonamide | ESD-848151-250MG |
| Cas.: 1235406-28-6 | Purity: 97% | 3-Cyano-4-fluoro-N-(thiazol-2-yl)benzenesulfonamide | ESD-848151-1G |
| Cas.: 126541-82-0 | Purity: 98% | Methyl 3-amino-4-(trifluoromethyl)benzoate | ESD-845647-1G |
| Cas.: 126541-82-0 | Purity: 98% | Methyl 3-amino-4-(trifluoromethyl)benzoate | ESD-845647-5G |
| Cas.: 1289005-85-1 | Purity: ≥97% | 3-Fluoro-5-formylbenzoic Acid | ESD-851990-1G |
| Cas.: 1314687-82-5 | Purity: 97% | 6-Bromoquinoline-3-carbonitrile | ESD-848774-1G |
| Cas.: 1314687-82-5 | Purity: 97% | 6-Bromoquinoline-3-carbonitrile | ESD-848774-5G |
| Cas.: 1330061-11-4 | Purity: 95% | 2-Bromo-3,4,5-trichloropyridine | ESD-845357-1G |
| Cas.: 1330061-11-4 | Purity: 95% | 2-Bromo-3,4,5-trichloropyridine | ESD-845357-5G |
| Cas.: 133840-96-7 | Purity: 97% | 2-CHLORO-6-(TRIFLUOROMETHOXY)-BENZOTHIAZOLE | ESD-834309-25G |
| Cas.: 1341785-86-1 | Purity: 97% | 3-Fluoro-4-(methoxymethyl)aniline | ESD-848731-1G |
| Cas.: 1341785-86-1 | Purity: 97% | 3-Fluoro-4-(methoxymethyl)aniline | ESD-848731-5G |
| Cas.: 1353100-86-3 | Purity: 98% | 5,6-Dibromopyrazin-2-amine | ESD-841513-1G |
| Cas.: 137830-77-4 | Purity: 97% | 2-Methyl-1,2,6-thiadiazinane 1,1-dioxide | ESD-847358-250MG |
| Cas.: 137830-77-4 | Purity: 97% | 2-Methyl-1,2,6-thiadiazinane 1,1-dioxide | ESD-847358-1G |
| Cas.: 1378865-57-6 | Purity: 95% | 6′-BROMOSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-882878-250MG |
| Cas.: 14260-99-2 | Purity: 98% | Daphylloside | ESD-882523-1MG |
| Cas.: 1534358-79-6 | Purity: ≥98% | COH000 | ESD-882039-1MG |
| Cas.: 1534358-79-6 | Purity: ≥98% | COH000 | ESD-882039-50MG |
| Cas.: 1538218-73-3 | Purity: 95% | 2-Amino-N-(3-hydroxypropyl)thiazole-5-carboxamide | ESD-848454-1G |
| Cas.: 1538218-73-3 | Purity: 95% | 2-Amino-N-(3-hydroxypropyl)thiazole-5-carboxamide | ESD-848454-5G |
| Cas.: 1552-17-6 | Purity: 98% | 2-Nitro-5-phenoxyaniline | ESD-842649-1G |
| Cas.: 1610028-42-6 | Purity: 95% | 2-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride | ESD-848744-1G |
| Cas.: 1610028-42-6 | Purity: 95% | 2-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride | ESD-848744-5G |
| Cas.: 1646152-46-6 | Purity: 97% | 2-(Difluoromethyl)-5-nitropyridine | ESD-844999-1G |
| Cas.: 1646152-46-6 | Purity: 97% | 2-(Difluoromethyl)-5-nitropyridine | ESD-844999-5G |
| Cas.: 1646152-46-6 | Purity: 97% | 2-(Difluoromethyl)-5-nitropyridine | ESD-844999-25G |
| Cas.: 16494-24-9 | Purity: 97% | 4-Ethoxyphenyl 4-((butoxycarbonyl)oxy)benzoate | ESD-843692-1G |
| Cas.: 16494-24-9 | Purity: 97% | 4-Ethoxyphenyl 4-((butoxycarbonyl)oxy)benzoate | ESD-843692-5G |
| Cas.: 16675-62-0 | Purity: 98% | Methyl quinoline-5-carboxylate | ESD-846548-250MG |
| Cas.: 16675-62-0 | Purity: 98% | Methyl quinoline-5-carboxylate | ESD-846548-1G |
| Cas.: 16675-62-0 | Purity: 98% | Methyl quinoline-5-carboxylate | ESD-846548-5G |
| Cas.: 175461-34-4 | Purity: 98% | 2,6-Dichloro-N,N-dimethylpyridin-4-amine | ESD-846471-1G |
| Cas.: 175461-34-4 | Purity: 98% | 2,6-Dichloro-N,N-dimethylpyridin-4-amine | ESD-846471-5G |
| Cas.: 180576-05-0 | Purity: 95% | 4-Fmoc-1-piperazineacetic acid hydrate | ESD-913521-5G |
| Cas.: 180576-05-0 | Purity: 95% | 4-Fmoc-1-piperazineacetic acid hydrate | ESD-913521-25G |
| Cas.: 188528-95-2 | Purity: 95% | Ethyl 1-Boc-2-Oxopyrrolidine-3-Carboxylate | ESD-887947-5G |
| Cas.: 191609-45-7 | Purity: 95% | 6-Fluorochroman-4-amine hydrochloride | ESD-845762-1G |
| Cas.: 204191-40-2 | Purity: 98% | (2S)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid,hydrate | ESD-915629-100G |
| Cas.: 20826-02-2 | Purity: 96% | Ethyl 5-methylnicotinate | ESD-839780-5G |
| Cas.: 22288-79-5 | Purity: ≥97% | Methyl 3-Acetamidothiophene-2-carboxylate | ESD-851136-250MG |
| Cas.: 22288-79-5 | Purity: ≥97% | Methyl 3-Acetamidothiophene-2-carboxylate | ESD-851136-25G |
| Cas.: 25027-73-0 | Purity: 95% | N-(4-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-847061-1G |
| Cas.: 25027-73-0 | Purity: 95% | N-(4-(Aminomethyl)phenyl)acetamide hydrochloride | ESD-847061-5G |
| Cas.: 26103-78-6 | Purity: 97% | Diethyl 2-oxo-3-propylsuccinate | ESD-846481-1G |
| Cas.: 26103-78-6 | Purity: 97% | Diethyl 2-oxo-3-propylsuccinate | ESD-846481-5G |
| Cas.: 5324-84-5 | Purity: 98% | Sodium 1-octanesulfonate | ESD-817852-1KG |
| Cas.: 66357-35-5 | Purity: ≥98% | Ranitidine base | ESD-859172-100G |
| Cas.: 29508-16-5 | Purity: ≥95% | Sodium 2-Methoxy-2-oxoethanesulfonate | ESD-851137-25G |
| Cas.: 33141-66-1 | Purity: 98% | Ethyl 4-bromo-3-hydroxybenzoate | ESD-847207-5G |
| Cas.: 33141-66-1 | Purity: 98% | Ethyl 4-bromo-3-hydroxybenzoate | ESD-847207-10G |
| Cas.: 34260-72-5 | Purity: 97% | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | ESD-847580-250MG |
| Cas.: 34260-72-5 | Purity: 97% | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | ESD-847580-1G |
| Cas.: 34260-72-5 | Purity: 97% | (S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride | ESD-847580-5G |
| Cas.: 39213-71-3 | Purity: 97% | 3-Chloro-5,6-dimethylpyrazin-2-amine | ESD-840152-250MG |
| Cas.: 39213-71-3 | Purity: 97% | 3-Chloro-5,6-dimethylpyrazin-2-amine | ESD-840152-1G |
| Cas.: 39213-71-3 | Purity: 97% | 3-Chloro-5,6-dimethylpyrazin-2-amine | ESD-840152-5G |
| Cas.: 39998-27-1 | Purity: 97% | 2,6-DiMethyl-4,5-dihydropyridazin-3(2H)-one | ESD-889054-1G |
| Cas.: 42823-73-4 | Purity: 95% | Methyl 4-Carbamimidoylbenzoate Hydrochloride | ESD-851335-5G |
| Cas.: 4492-02-8 | Purity: 97% | 4,5,6,7-TETRAHYDRO-1H-INDAZOLE-3-CARBOXYLIC ACID ETHYL ESTER | ESD-888015-25G |
| Cas.: 477252-20-3 | Purity: 98% | 2-(4-Bromopyridin-2-yl)propan-2-ol | ESD-846970-250MG |
| Cas.: 477252-20-3 | Purity: 98% | 2-(4-Bromopyridin-2-yl)propan-2-ol | ESD-846970-1G |
| Cas.: 477252-20-3 | Purity: 98% | 2-(4-Bromopyridin-2-yl)propan-2-ol | ESD-846970-5G |
| Cas.: 60200-06-8 | Purity: ≥99% | Clorsulon | ESD-863918-5G |
| Cas.: 514854-13-8 | Purity: 97% | 6-Ethyl-5-iodopyrimidine-2,4-diamine | ESD-843327-250MG |
| Cas.: 514854-13-8 | Purity: 97% | 6-Ethyl-5-iodopyrimidine-2,4-diamine | ESD-843327-1G |
| Cas.: 514854-13-8 | Purity: 97% | 6-Ethyl-5-iodopyrimidine-2,4-diamine | ESD-843327-5G |
| Cas.: 517870-23-4 | Purity: ≥97% | Methyl 5-(2-Thienyl)isoxazole-3-carboxylate | ESD-851112-5G |
| Cas.: 517870-23-4 | Purity: ≥97% | Methyl 5-(2-Thienyl)isoxazole-3-carboxylate | ESD-851112-25G |
| Cas.: 85148-95-4 | Purity: 97% | 6-Formylpicolinonitrile | ESD-848851-1G |
| Cas.: 85148-95-4 | Purity: 97% | 6-Formylpicolinonitrile | ESD-848851-5G |
| Cas.: 51885-91-7 | Purity: 98% | Methyl 4-ethyl-3-iodobenzoate | ESD-841624-250MG |
| Cas.: 51885-91-7 | Purity: 98% | Methyl 4-ethyl-3-iodobenzoate | ESD-841624-1G |
| Cas.: 51885-91-7 | Purity: 98% | Methyl 4-ethyl-3-iodobenzoate | ESD-841624-5G |
| Cas.: 53090-46-3 | Purity: 97% | Ethyl 3-oxo-3-(thiophen-3-yl)propanoate | ESD-847563-250MG |
| Cas.: 53090-46-3 | Purity: 97% | Ethyl 3-oxo-3-(thiophen-3-yl)propanoate | ESD-847563-1G |
| Cas.: 53090-46-3 | Purity: 97% | Ethyl 3-oxo-3-(thiophen-3-yl)propanoate | ESD-847563-5G |
| Cas.: 79-84-5 | Purity: ≥95% | Thiophene-2-sulfonic acid | ESD-901349-50MG |
| Cas.: 55876-83-0 | Purity: 98% | Methyl 5-(dibromomethyl)picolinate | ESD-842582-250MG |
| Cas.: 55876-83-0 | Purity: 98% | Methyl 5-(dibromomethyl)picolinate | ESD-842582-1G |
| Cas.: 55876-83-0 | Purity: 98% | Methyl 5-(dibromomethyl)picolinate | ESD-842582-5G |
| Cas.: 56598-98-2 | Purity: 97% | Diethyl 2-(methylamino)malonate hydrochloride | ESD-839615-250MG |
| Cas.: 56598-98-2 | Purity: 97% | Diethyl 2-(methylamino)malonate hydrochloride | ESD-839615-1G |
| Cas.: 56598-98-2 | Purity: 97% | Diethyl 2-(methylamino)malonate hydrochloride | ESD-839615-5G |
| Cas.: 58331-97-8 | Purity: 95% | Methyl 4-chloro-2-cyanobenzoate | ESD-841084-1G |
| Cas.: 58331-97-8 | Purity: 95% | Methyl 4-chloro-2-cyanobenzoate | ESD-841084-5G |
| Cas.: 59908-47-3 | Purity: 98% | 5-Chloro-1-methyl-1H-indole-2-carboxylic acid | ESD-846906-1G |
| Cas.: 59908-47-3 | Purity: 98% | 5-Chloro-1-methyl-1H-indole-2-carboxylic acid | ESD-846906-5G |
| Cas.: 61566-34-5 | Purity: 97% | Methyl 2-(4-isobutylphenyl)propanoate | ESD-916206-5G |
| Cas.: 638160-01-7 | Purity: 95% | 5-[4-(Trifluoromethoxy)phenyl]furan-2-carboxylic Acid | ESD-852047-5G |
| Cas.: 26103-78-6 | Purity: 97% | Diethyl 2-oxo-3-propylsuccinate | ESD-846481-25G |
| Cas.: 89089-18-9 | Purity: 97% | 3-Bromo-6-chloropyridazine | ESD-840954-5G |
| Cas.: 1448296-00-1 | Purity: 98% | 5-Phenyl-5,7-dihydroindolo[2,3-b]carbazole | ESD-916663-5G |
| Cas.: 1448296-00-1 | Purity: 98% | 5-Phenyl-5,7-dihydroindolo[2,3-b]carbazole | ESD-916663-1G |
| Cas.: 22591-21-5 | Purity: ≥98.0%(GC) | 1,1-Dichloropinacolin | ESD-863928-25G |
| Cas.: 2611-67-8 | Purity: ≥90% | Cyanidin-3,5-diglucoside | ESD-861375-5MG |
| Cas.: 2611-67-8 | Purity: ≥90% | Cyanidin-3,5-diglucoside | ESD-861375-25MG |
| Cas.: 36639-50-6 | Purity: 98% | Sodium (4-nitrophenyl)methanesulfonate | ESD-846618-250MG |
| Cas.: 36639-50-6 | Purity: 98% | Sodium (4-nitrophenyl)methanesulfonate | ESD-846618-1G |
| Cas.: 6092-47-3 | Purity: ≥95% | N-CHLOROACETYL URETHANE | ESD-888820-5G |
| Cas.: 1110813-31-4 | Purity: ≥99% | Dacomitinib (PF299804, PF299) | ESD-833058-50MG |
| Cas.: 4330-21-6 | Purity: 90% | Hoffer’s chlorosugar | ESD-843760-5G |
| Cas.: 4330-21-6 | Purity: 90% | Hoffer’s chlorosugar | ESD-843760-25G |
| Cas.: 50446-43-0 | Purity: ≥98% | 1,3,5-Tri(4-Methylphenyl)Benzene | ESD-860001-25G |
| Cas.: 55304-75-1 | Purity: 98% | 2,6-Dichloro-3-(trifluoromethyl)pyridine | ESD-807608-5G |
| Cas.: 55304-75-1 | Purity: 98% | 2,6-Dichloro-3-(trifluoromethyl)pyridine | ESD-807608-25G |
| Cas.: 1333-82-0 | Purity: AR | Chrormic trioxide | ESD-805387-10KG |
| Cas.: 7664-39-3 | Purity: GR, 40.0% | Hydrofluoric acid | ESD-811357-10L |
| Cas.: 651780-27-7 | Purity: 95% | Ethyl 6-bromobenzo[d]isoxazole-3-carboxylate | ESD-842322-1G |
| Cas.: 655247-45-3 | Purity: 97% | Ethyl 3-chloropyrazine-2-carboxylate | ESD-840156-1G |
| Cas.: 655247-45-3 | Purity: 97% | Ethyl 3-chloropyrazine-2-carboxylate | ESD-840156-5G |
| Cas.: 697305-48-9 | Purity: 95% | 1-(4-Fluorophenyl)piperazin-2-one hydrochloride | ESD-848700-1G |
| Cas.: 697305-48-9 | Purity: 95% | 1-(4-Fluorophenyl)piperazin-2-one hydrochloride | ESD-848700-5G |
| Cas.: 73027-77-7 | Purity: 98% | 4,6-Dibromonicotinic acid | ESD-848560-1G |
| Cas.: 73027-77-7 | Purity: 98% | 4,6-Dibromonicotinic acid | ESD-848560-5G |
| Cas.: 7484-34-6 | Purity: 95% | 2,2′-(Ethane-1,2-diyldisulfonyl)diethanol | ESD-843919-250MG |
| Cas.: 7484-34-6 | Purity: 95% | 2,2′-(Ethane-1,2-diyldisulfonyl)diethanol | ESD-843919-1G |
| Cas.: 7484-34-6 | Purity: 95% | 2,2′-(Ethane-1,2-diyldisulfonyl)diethanol | ESD-843919-5G |
| Cas.: 788081-99-2 | Purity: 98% | Methyl 2-(bromomethyl)-5-methoxybenzoate | ESD-841970-250MG |
| Cas.: 788081-99-2 | Purity: 98% | Methyl 2-(bromomethyl)-5-methoxybenzoate | ESD-841970-1G |
| Cas.: 788081-99-2 | Purity: 98% | Methyl 2-(bromomethyl)-5-methoxybenzoate | ESD-841970-5G |
| Cas.: 909910-43-6 | Purity: ≥98% | A8301 | ESD-873239-25MG |
| Cas.: 849937-91-3 | Purity: 97% | 4,6-Difluoronicotinic acid | ESD-840736-250MG |
| Cas.: 909910-43-6 | Purity: ≥98% | A8301 | ESD-873239-100MG |
| Cas.: 849937-91-3 | Purity: 97% | 4,6-Difluoronicotinic acid | ESD-840736-1G |
| Cas.: 871224-19-0 | Purity: 95% | Methyl 3-bromo-2-chlorobenzoate | ESD-840569-1G |
| Cas.: 909910-43-6 | Purity: ≥98% | A8301 | ESD-873239-5MG |
| Cas.: 871224-19-0 | Purity: 95% | Methyl 3-bromo-2-chlorobenzoate | ESD-840569-5G |
| Cas.: 871224-19-0 | Purity: 95% | Methyl 3-bromo-2-chlorobenzoate | ESD-840569-25G |
| Cas.: 884495-42-5 | Purity: 98% | 2-Bromo-3-chloro-4-methylpyridine | ESD-839846-1G |
| Cas.: 884495-42-5 | Purity: 98% | 2-Bromo-3-chloro-4-methylpyridine | ESD-839846-5G |
| Cas.: 884495-42-5 | Purity: 98% | 2-Bromo-3-chloro-4-methylpyridine | ESD-839846-25G |
| Cas.: 904813-39-4 | Purity: 98% | 3-Methylquinoxaline-5-carboxylic acid | ESD-848660-1G |
| Cas.: 904813-39-4 | Purity: 98% | 3-Methylquinoxaline-5-carboxylic acid | ESD-848660-5G |
| Cas.: 90685-59-9 | Purity: 97% | 6,7-Dihydro-5H-cyclopenta[b]pyridin-7-yl Acetate | ESD-851154-250MG |
| Cas.: 521-17-5 | Purity: 98% | Androstenediol | ESD-878668-25MG |
| Cas.: 521-17-5 | Purity: 98% | Androstenediol | ESD-878668-100MG |
| Cas.: 940298-93-1 | Purity: 95% | (2-Fluoro-4-methoxyphenyl)hydrazine hydrochloride | ESD-848426-250MG |
| Cas.: 940298-93-1 | Purity: 95% | (2-Fluoro-4-methoxyphenyl)hydrazine hydrochloride | ESD-848426-1G |
| Cas.: 957035-32-4 | Purity: 98% | 4-Bromo-2-fluoro-6-methoxyphenylboronic acid | ESD-886868-250MG |
| Cas.: 1029720-23-7 | Purity: 95% | Methyl 3-(dibromomethyl)picolinate | ESD-848307-1G |
| Cas.: 1029720-23-7 | Purity: 95% | Methyl 3-(dibromomethyl)picolinate | ESD-848307-5G |
| Cas.: 40663-68-1 | Purity: 97% | 4-Allyloxybenzaldehyde | ESD-916111-5G |
| Cas.: 103931-19-7 | Purity: 95% | Methyl 6-ethylpicolinate | ESD-848686-250MG |
| Cas.: 103931-19-7 | Purity: 95% | Methyl 6-ethylpicolinate | ESD-848686-1G |
| Cas.: 40663-68-1 | Purity: 97% | 4-Allyloxybenzaldehyde | ESD-916111-25G |
| Cas.: 1155877-97-6 | Purity: ≥98% | D159687 | ESD-884352-50MG |
| Cas.: 1155877-97-6 | Purity: ≥98% | D159687 | ESD-884352-100MG |
| Cas.: 1207443-48-8 | Purity: 97% | (4-Ethoxy-2-methoxyphenyl)boronic acid | ESD-846064-1G |
| Cas.: 1207443-48-8 | Purity: 97% | (4-Ethoxy-2-methoxyphenyl)boronic acid | ESD-846064-5G |
| Cas.: 1208170-17-5 | Purity: 97% | 4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carbonitrile | ESD-842278-250MG |
| Cas.: 1208170-17-5 | Purity: 97% | 4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carbonitrile | ESD-842278-1G |
| Cas.: 1208170-17-5 | Purity: 97% | 4-Chloro-6-methyl-2-(methylthio)pyrimidine-5-carbonitrile | ESD-842278-5G |
| Cas.: 1211532-85-2 | Purity: 98% | 5-Chloro-3-methyl-2-nitropyridine | ESD-848647-1G |
| Cas.: 1211532-85-2 | Purity: 98% | 5-Chloro-3-methyl-2-nitropyridine | ESD-848647-5G |
| Cas.: 1214337-57-1 | Purity: 97% | Ethyl 5-bromo-6-chloropicolinate | ESD-848641-1G |
| Cas.: 1214337-57-1 | Purity: 97% | Ethyl 5-bromo-6-chloropicolinate | ESD-848641-5G |
| Cas.: 1214337-57-1 | Purity: 97% | Ethyl 5-bromo-6-chloropicolinate | ESD-848641-25G |
| Cas.: 1227048-78-3 | Purity: 98% | Methyl 2-amino-5-iodonicotinate | ESD-848222-5G |
| Cas.: 1252576-14-9 | Purity: 98%, ee99% | (S)-4-Benzyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-887898-250MG |
| Cas.: 1252576-14-9 | Purity: 98%, ee99% | (S)-4-Benzyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-887898-1G |
| Cas.: 1296201-68-7 | Purity: 95% | Ethyl 7-Chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-851330-250MG |
| Cas.: 1296201-68-7 | Purity: 95% | Ethyl 7-Chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-851330-5G |
| Cas.: 1346148-32-0 | Purity: 98% | Methyl 5-fluoro-3-methylpicolinate | ESD-848646-1G |
| Cas.: 138-92-1 | Purity: 95% | 2-(3-Pyrazolyl)ethanamine Dihydrochloride | ESD-913524-5G |
| Cas.: 139329-90-1 | Purity: 98% | Ethyl 3-acetamido-5-chloro-2-hydroxybenzoate | ESD-843110-250MG |
| Cas.: 139329-90-1 | Purity: 98% | Ethyl 3-acetamido-5-chloro-2-hydroxybenzoate | ESD-843110-1G |
| Cas.: 1609406-56-5 | Purity: 98% | 4-Methyl-1H-benzo[d]imidazol-2-amine hydrobromide | ESD-845375-1G |
| Cas.: 1620569-21-2 | Purity: 95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine 2,2,2-trifluoroacetate | ESD-848022-250MG |
| Cas.: 1620569-21-2 | Purity: 95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine 2,2,2-trifluoroacetate | ESD-848022-1G |
| Cas.: 1620569-21-2 | Purity: 95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine 2,2,2-trifluoroacetate | ESD-848022-5G |
| Cas.: 1651840-84-4 | Purity: 97% | 8-Oxa-2-azaspiro[4.5]decane oxalate(2:1) | ESD-845631-250MG |
| Cas.: 1651840-84-4 | Purity: 97% | 8-Oxa-2-azaspiro[4.5]decane oxalate(2:1) | ESD-845631-1G |
| Cas.: 1651840-84-4 | Purity: 97% | 8-Oxa-2-azaspiro[4.5]decane oxalate(2:1) | ESD-845631-5G |
| Cas.: 195457-70-6 | Purity: 95% | 3′-(Trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic acid | ESD-842616-5G |
| Cas.: 200134-22-1 | Purity: ≥98% | INH14 | ESD-880756-50MG |
| Cas.: 359015-11-5 | Purity: 95% | Ethyl 6-(aminomethyl)picolinate hydrochloride | ESD-846020-250MG |
| Cas.: 359015-11-5 | Purity: 95% | Ethyl 6-(aminomethyl)picolinate hydrochloride | ESD-846020-1G |
| Cas.: 386267-31-8 | Purity: 97% | Ethyl 3-bromo-4-iodobenzoate | ESD-847987-1G |
| Cas.: 386267-31-8 | Purity: 97% | Ethyl 3-bromo-4-iodobenzoate | ESD-847987-5G |
| Cas.: 38866-59-0 | Purity: 95% | 2-Cyanobenzyl acetate | ESD-845813-5G |
| Cas.: 38866-59-0 | Purity: 95% | 2-Cyanobenzyl acetate | ESD-845813-25G |
| Cas.: 82692-97-5 | Purity: 99% | N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline sodium salt | ESD-813713-250MG |
| Cas.: 400877-53-4 | Purity: 98% | Ethyl 4-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-846388-250MG |
| Cas.: 400877-53-4 | Purity: 98% | Ethyl 4-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-846388-1G |
| Cas.: 400877-53-4 | Purity: 98% | Ethyl 4-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-846388-5G |
| Cas.: 42491-95-2 | Purity: 97% | 2-Oxopyrrolidin-3-yl acetate | ESD-841054-5G |
| Cas.: 614750-84-4 | Purity: 97% | 6-IODO-[1,2,4]TRIAZOLO[1,5,A]PYRIDINE | ESD-887989-5G |
| Cas.: 87787-08-4 | Purity: 98% | Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-848719-1G |
| Cas.: 92223-95-5 | Purity: 97% | 5-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-848855-1G |
| Cas.: 92223-95-5 | Purity: 97% | 5-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride | ESD-848855-5G |
| Cas.: 1235441-67-4 | Purity: 98% | (3-(Cyclopentyloxy)phenyl)methanamine hydrochloride | ESD-846787-250MG |
| Cas.: 1235441-67-4 | Purity: 98% | (3-(Cyclopentyloxy)phenyl)methanamine hydrochloride | ESD-846787-1G |
| Cas.: 110-39-4 | Purity: ≥97% | Octyl Butyrate | ESD-859120-100G |
| Cas.: 1235441-67-4 | Purity: 98% | (3-(Cyclopentyloxy)phenyl)methanamine hydrochloride | ESD-846787-5G |
| Cas.: 110-39-4 | Purity: ≥97% | Octyl Butyrate | ESD-859120-500G |
| Cas.: 151509-01-2 | Purity: 97% | Methyl 2-(aminomethyl)nicotinate hydrochloride | ESD-847592-250MG |
| Cas.: 151509-01-2 | Purity: 97% | Methyl 2-(aminomethyl)nicotinate hydrochloride | ESD-847592-1G |
| Cas.: 151509-01-2 | Purity: 97% | Methyl 2-(aminomethyl)nicotinate hydrochloride | ESD-847592-5G |
| Cas.: 127274-91-3 | 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate | ESD-903624-100MG | |
| Cas.: 127274-91-3 | 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate | ESD-903624-5MG | |
| Cas.: 13477-53-7 | Purity: ≥98% | 4-Amino-2-hydroxybutanoic acid | ESD-899720-25G |
| Cas.: 13477-53-7 | Purity: ≥98% | 4-Amino-2-hydroxybutanoic acid | ESD-899720-100G |
| Cas.: 41112-74-7 | Purity: 95% | 2-Chloro-4-hydrazinylbenzoic acid hydrochloride | ESD-846173-250MG |
| Cas.: 41112-74-7 | Purity: 95% | 2-Chloro-4-hydrazinylbenzoic acid hydrochloride | ESD-846173-1G |
| Cas.: 502653-18-1 | Purity: 95% | 2-Phenyl-1-(piperazin-1-yl)ethanone hydrochloride | ESD-847309-1G |
| Cas.: 349666-24-6 | Purity: 98% | Pyrenyl-1-boronic acid pinacol ester | ESD-886617-5G |
| Cas.: 502653-18-1 | Purity: 95% | 2-Phenyl-1-(piperazin-1-yl)ethanone hydrochloride | ESD-847309-5G |
| Cas.: 50528-16-0 | Purity: 95% | 4-Chloro-1-(2,4-Difluorophenyl)Butan-1-One | ESD-888050-5G |
| Cas.: 5216-17-1 | Purity: ≥92% | 2,3,5,6-Tetrafluorobenzonitrile | ESD-868160-5G |
| Cas.: 998-93-6 | Purity: 97% | 4-Bromoheptane | ESD-836875-1G |
| Cas.: 3769-41-3 | Purity: 97% | 3-(Benzyloxy)phenol | ESD-842286-5G |
| Cas.: 10242-12-3 | Purity: 97% | 5-Nitro-1-benzofuran-2-carboxylic acid | ESD-823356-5G |
| Cas.: 3137-64-2 | Purity: ≥96% | 2-Ethylquinazolin-4-ol | ESD-858951-5G |
| Cas.: 7790-75-2 | Purity: 99,9% | Calcium tungstate | ESD-889003-5G |
| Cas.: 73789-56-7 | Purity: 95% | (Isocyanoimino)triphenylphosphorane | ESD-859353-5G |
| Cas.: 187929-82-4 | Purity: 98% | 1-Bromo-2-chloro-3,5-difluorobenzene | ESD-839143-5G |
| Cas.: 187929-82-4 | Purity: 98% | 1-Bromo-2-chloro-3,5-difluorobenzene | ESD-839143-25G |
| Cas.: 192869-49-1 | Purity: 95% | tert-Butyl 7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-842321-1G |
| Cas.: 201286-99-9 | Purity: 95% | 6-Hydroxy-3-methylindazole | ESD-842435-1G |
| Cas.: 1441674-54-9 | Purity: ≥99% | Ledipasvir (acetone) | ESD-882389-25MG |
| Cas.: 249889-68-7 | Purity: 97% | 8-Chloro-2-methoxy-1,5-naphthyridine | ESD-847181-250MG |
| Cas.: 303031-43-8 | Purity: 96% | N-Benzyl-5-bromo-nicotinamide | ESD-854732-5G |
| Cas.: 303031-43-8 | Purity: 96% | N-Benzyl-5-bromo-nicotinamide | ESD-854732-25G |
| Cas.: 56258-32-3 | Purity: 98% | Altertoxin I (Dihydroalterperylenol) | ESD-912540-100ΜG |
| Cas.: 56258-32-3 | Purity: 98% | Altertoxin I (Dihydroalterperylenol) | ESD-912540-1MG |
| Cas.: 32122-09-1 | Purity: 95% | Ethyl 2-Benzyloxyacetate | ESD-851214-25G |
| Cas.: 32601-86-8 | Purity: ≥97% | 2-Chloro-3-methylquinoxaline | ESD-852478-250MG |
| Cas.: 19255-48-2 | Purity: 98% | 9-(2-Chloroethyl)-9H-purin-6-amine | ESD-916664-1G |
| Cas.: 19255-48-2 | Purity: 98% | 9-(2-Chloroethyl)-9H-purin-6-amine | ESD-916664-250MG |
| Cas.: 2926-30-9 | Purity: 98% | Sodium trifluoromethanesulfonate | ESD-817481-500G |
| Cas.: 36449-75-9 | Purity: 97% | 1-(2-Bromoethyl)-2-methoxybenzene | ESD-846987-250MG |
| Cas.: 64741-88-4 | Purity: Viscosity Grade 100, White | Long term vacuum pump oil | ESD-916665-15L |
| Cas.: 64741-88-4 | Purity: Viscosity Grade 100, White | Long term vacuum pump oil | ESD-916665-5L |
| Cas.: 64741-88-4 | Purity: Viscosity Grade 100, White | Long term vacuum pump oil | ESD-916665-1L |
| Cas.: 6188-23-4 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine | ESD-848534-5G |
| Cas.: 6188-23-4 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine | ESD-848534-25G |
| Cas.: 49660-57-3 | Purity: 97% | 6-Bromo-4-chromanone | ESD-831975-100G |
| Cas.: 68716-49-4 | Purity: 98% | 2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-849582-100G |
| Cas.: 68716-49-4 | Purity: 98% | 2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-849582-25G |
| Cas.: 43229-65-8 | Purity: 95% | N-Benzyl-1-(4-methoxyphenyl)propan-2-amine | ESD-842653-1G |
| Cas.: 43229-65-8 | Purity: 95% | N-Benzyl-1-(4-methoxyphenyl)propan-2-amine | ESD-842653-5G |
| Cas.: 43229-65-8 | Purity: 95% | N-Benzyl-1-(4-methoxyphenyl)propan-2-amine | ESD-842653-25G |
| Cas.: 135-00-2 | Purity: 98% | 2-Benzoylthiophene | ESD-858475-25G |
| Cas.: 135-00-2 | Purity: 98% | 2-Benzoylthiophene | ESD-858475-100G |
| Cas.: 401566-79-8 | Purity: 97% | 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine | ESD-843314-5G |
| Cas.: 223127-05-7 | Purity: 96% | 6-Isopropoxynicotinic acid | ESD-840947-500MG |
| Cas.: 1917-64-2 | Purity: 97% | 5-(Methoxymethyl)furan-2-carbaldehyde | ESD-839344-5G |
| Cas.: 169448-87-7 | Purity: ≥95% | (R)-1-Boc-2-(Hydroxymethyl)piperazine | ESD-850833-25G |
| Cas.: 14161-11-6 | Purity: 97% | 3,4,5-Trichloropyridazine | ESD-844553-5G |
| Cas.: 14161-11-6 | Purity: 97% | 3,4,5-Trichloropyridazine | ESD-844553-25G |
| Cas.: 14161-11-6 | Purity: 97% | 3,4,5-Trichloropyridazine | ESD-844553-100G |
| Cas.: 1260609-97-9 | Purity: ≥97% | (S)-4-Amino-6-fluorochromane Hydrochloride | ESD-852724-5G |
| Cas.: 81-08-3 | Purity: Anhydride: 90% Acid: 10% | 2-Sulfobenzoic Anhydride | ESD-857071-25G |
| Cas.: 87407-12-3 | Purity: 97% | 3-(Trifluoromethyl)pyridine-2-carboxylic acid | ESD-829669-25G |
| Cas.: 122-75-8 | Purity: 99% | N,N’-Dibenzyl ethylenediamine diacetate | ESD-830648-500G |
| Cas.: 122-75-8 | Purity: 99% | N,N’-Dibenzyl ethylenediamine diacetate | ESD-830648-100G |
| Cas.: 7164-98-9 | Purity: 98% | 1-Phenylimidazole | ESD-838692-25G |
| Cas.: 7164-98-9 | Purity: 98% | 1-Phenylimidazole | ESD-838692-100G |
| Cas.: NONE8231 | Purity: COD≥250,000 mg/L | Carbon source | ESD-916666-100G |
| Cas.: NONE8231 | Purity: COD≥250,000 mg/L | Carbon source | ESD-916666-250G |
| Cas.: 166330-03-6 | Purity: ≥98% | (Bromomethyl)boronic Acid Pinacol Ester | ESD-859639-5G |
| Cas.: 166330-03-6 | Purity: ≥98% | (Bromomethyl)boronic Acid Pinacol Ester | ESD-859639-25G |
| Cas.: 166330-03-6 | Purity: ≥98% | (Bromomethyl)boronic Acid Pinacol Ester | ESD-859639-100G |
| Cas.: 1695-77-8 | Purity: 95% | Spectinomycin dihydrochloride hydrate | ESD-818196-500MG |
| Cas.: 1695-77-8 | Purity: 95% | Spectinomycin dihydrochloride hydrate | ESD-818196-1G |
| Cas.: 1194-18-9 | Purity: 97% | 1,3-Cycloheptanedione | ESD-832826-5G |
| Cas.: 97174-59-9 | Purity: 97% | 1,3-Bis(benzo[d][1,3]dioxol-4-yl)urea | ESD-842218-1G |
| Cas.: 97174-59-9 | Purity: 97% | 1,3-Bis(benzo[d][1,3]dioxol-4-yl)urea | ESD-842218-5G |
| Cas.: 756525-95-8 | Purity: 95% | NH2-PEG2-CH2CH2COOtBu | ESD-850191-25G |
| Cas.: 267413-27-4 | Purity: ≥95% | (1-methyl-1H-indazol-5-yl)methanamine | ESD-825641-5G |
| Cas.: 75-76-3 | Purity: 99% | Tetramethylsilane | ESD-819132-5ML |
| Cas.: 213843-90-4 | Purity: 98% | (3aR,8aR)-()-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin- 6-yl)dimethylamine | ESD-857214-500MG |
| Cas.: 164579-32-2 | Purity: 98% | PantoprazoleSodium Sesquihydrate | ESD-873434-1G |
| Cas.: 67490-21-5 | Purity: 97% | 2,4,6-Tri-tert-butylpyrimidine | ESD-856374-1G |
| Cas.: 164579-32-2 | Purity: 98% | PantoprazoleSodium Sesquihydrate | ESD-873434-5G |
| Cas.: 133099-07-7 | Purity: ≥98% | Darifenacin HBr | ESD-833120-1G |
| Cas.: 67490-21-5 | Purity: 97% | 2,4,6-Tri-tert-butylpyrimidine | ESD-856374-25G |
| Cas.: 133099-07-7 | Purity: ≥98% | Darifenacin HBr | ESD-833120-5G |
| Cas.: 133099-07-7 | Purity: ≥98% | Darifenacin HBr | ESD-833120-25G |
| Cas.: 5498-31-7 | Purity: 95% | 1-Bromo-3-hydroxynaphthalene | ESD-850920-1G |
| Cas.: 4621-66-3 | Purity: 99% | Thionicotinamide | ESD-858301-25G |
| Cas.: 4621-66-3 | Purity: 99% | Thionicotinamide | ESD-858301-100G |
| Cas.: 4621-66-3 | Purity: 99% | Thionicotinamide | ESD-858301-500G |
| Cas.: 34368-52-0 | Purity: 97% | (S)-3-Hydroxy-2-pyrrolidone | ESD-831230-100G |
| Cas.: 31301-51-6 | Purity: 97% | 2-Chloro-5-fluoropyridine | ESD-804386-100G |
| Cas.: 31301-51-6 | Purity: 97% | 2-Chloro-5-fluoropyridine | ESD-804386-500G |
| Cas.: 2565-58-4 | Purity: 98% | CHLOROMETHYLPHOSPHONIC ACID | ESD-888851-25G |
| Cas.: 93957-50-7 | Purity: 98% | (E)-3-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]acrolein | ESD-834691-100G |
| Cas.: 5036-48-6 | Purity: ≥97% | 1-(3-Aminopropyl)imidazole | ESD-822784-1KG |
| Cas.: 5036-48-6 | Purity: ≥97% | 1-(3-Aminopropyl)imidazole | ESD-822784-2.5KG |
| Cas.: 122321-04-4 | Purity: ≥98%(GC)(T) | 2-(N-Methyl-2-pyridylamino)ethanol | ESD-861921-25G |
| Cas.: 1124-08-9 | Purity: 98% | 1,4-Diiodo-2,5-dimethylbenzene | ESD-856739-5G |
| Cas.: 35554-44-0 | Purity: 100μg/ml, u=2%, Medium: methanol | Imazalil solution | ESD-811991-1.2ML |
| Cas.: 906673-24-3 | Purity: ≥98% | AN-2728 | ESD-863640-25MG |
| Cas.: 906673-24-3 | Purity: ≥98% | AN-2728 | ESD-863640-100MG |
| Cas.: 212837-49-5 | Purity: ≥97% | 2,3-Difluoro-4-Propoxylphenylboronic Acid | ESD-858637-5G |
| Cas.: 212837-49-5 | Purity: ≥97% | 2,3-Difluoro-4-Propoxylphenylboronic Acid | ESD-858637-25G |
| Cas.: 1125551-75-8 | Purity: ≥95% | ((S)-piperidin-3-yl)methanol hydrochloride | ESD-827650-5G |
| Cas.: 1125551-75-8 | Purity: ≥95% | ((S)-piperidin-3-yl)methanol hydrochloride | ESD-827650-25G |
| Cas.: 101199-38-6 | Purity: 98% | PTZ-343 | ESD-910413-5G |
| Cas.: 101199-38-6 | Purity: 98% | PTZ-343 | ESD-910413-250MG |
| Cas.: 3685-27-6 | Purity: ≥98%(GC) | trans-4-(Hydroxymethyl)cyclohexanol | ESD-863120-1G |
| Cas.: 37554-70-4 | Purity: 98% | 2-Chloro-5-fluoro-4-methoxypyrimidine | ESD-855000-5G |
| Cas.: 37554-70-4 | Purity: 98% | 2-Chloro-5-fluoro-4-methoxypyrimidine | ESD-855000-250MG |
| Cas.: 2689-68-1 | Purity: 95% | Methyl 4-oxotetrahydrothiophene-3-carboxylate | ESD-828183-5G |
| Cas.: 2689-68-1 | Purity: 95% | Methyl 4-oxotetrahydrothiophene-3-carboxylate | ESD-828183-25G |
| Cas.: 2689-68-1 | Purity: 95% | Methyl 4-oxotetrahydrothiophene-3-carboxylate | ESD-828183-100G |
| Cas.: 38170-02-4 | Purity: 97% | 2-Hydroxy-4-iodobenzaldehyde | ESD-846643-250MG |
| Cas.: 594-34-3 | Purity: 98% | 1,2-Dibromo-2-methylpropane | ESD-916435-5G |
| Cas.: 308068-56-6 | Purity: >90%, ID:30nm, OD:40nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916667-25G |
| Cas.: 148644-09-1 | Purity: 95% | 3-Methoxyazetidine hydrochloride | ESD-814365-25G |
| Cas.: 308068-56-6 | Purity: >90%, ID:30nm, OD:40nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916667-5G |
| Cas.: 148644-09-1 | Purity: 95% | 3-Methoxyazetidine hydrochloride | ESD-814365-100G |
| Cas.: 308068-56-6 | Purity: >90%, ID:30nm, OD:40nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916667-1G |
| Cas.: 20350-15-6 | Purity: from Penicillium brefeldianum, ≥98% (HPLC) | Brefeldin A | ESD-802057-100MG |
| Cas.: 39977-41-8 | Purity: 95% | 5-(Hydroxymethyl)picolinic acid | ESD-848549-1G |
| Cas.: 308068-56-6 | Purity: >90%, ID:50nm, OD:60nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916668-25G |
| Cas.: 308068-56-6 | Purity: >90%, ID:50nm, OD:60nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916668-5G |
| Cas.: 308068-56-6 | Purity: >90%, ID:50nm, OD:60nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916668-1G |
| Cas.: 308068-56-6 | Purity: >90%, ID:60nm, OD:70nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916669-100G |
| Cas.: 39977-41-8 | Purity: 95% | 5-(Hydroxymethyl)picolinic acid | ESD-848549-250MG |
| Cas.: 308068-56-6 | Purity: >90%, ID:60nm, OD:70nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916669-25G |
| Cas.: 308068-56-6 | Purity: >90%, ID:60nm, OD:70nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916669-5G |
| Cas.: 308068-56-6 | Purity: >90%, ID:60nm, OD:70nm, Length:<10μm | Carbon nanotube bundled multi-walled | ESD-916669-1G |
| Cas.: 24250-84-8 | Purity: 98% | 4-Bromo-L-phenylalanine | ESD-803201-25G |
| Cas.: 24250-84-8 | Purity: 98% | 4-Bromo-L-phenylalanine | ESD-803201-100G |
| Cas.: 43038-45-5 | Purity: ≥98% | 1-Naphthohydrazide | ESD-867840-25G |
| Cas.: 110-68-9 | Purity: 90% | N-Methylbutylamine | ESD-838753-100ML |
| Cas.: 43038-45-5 | Purity: ≥98% | 1-Naphthohydrazide | ESD-867840-5G |
| Cas.: 43038-45-5 | Purity: ≥98% | 1-Naphthohydrazide | ESD-867840-1G |
| Cas.: 104632-25-9 | Purity: 98% | Pramipexole dihydrochloride | ESD-847848-1G |
| Cas.: 103577-40-8 | Purity: 97% | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole | ESD-843690-5G |
| Cas.: 103577-40-8 | Purity: 97% | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole | ESD-843690-25G |
| Cas.: 434958-85-7 | Purity: 95% | N-Boc-5-Hydroxyindole | ESD-842593-5G |
| Cas.: 42971-09-5 | Purity: 99% | Vinpocetine | ESD-820438-25G |
| Cas.: 42971-09-5 | Purity: 99% | Vinpocetine | ESD-820438-100G |
| Cas.: 910209-21-1 | Purity: 90% | Sodium Cyclopropanesulfinate | ESD-849453-250MG |
| Cas.: 1489-97-0 | Purity: 95% | Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-844561-25G |
| Cas.: 1489-97-0 | Purity: 95% | Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | ESD-844561-100G |
| Cas.: 308068-56-6 | Purity: >90%, ID:70-80nm, OD:90-100nm, Length:<10um | Purified Multi-walled carbon nanotubes | ESD-916308-100G |
| Cas.: 174566-15-5 | Purity: ≥95% | 2,4-Dichloro-7-fluoroquinazoline | ESD-853714-5G |
| Cas.: 866395-16-6 | Purity: ≥98% | Triphenylphosphinegold(I)bis(trifluoromethanesulfonyl)imidate | ESD-856568-250MG |
| Cas.: 10125-13-0 | Purity: AR | Copric chloride dihydrate | ESD-805299-250G |
| Cas.: 10125-13-0 | Purity: AR | Copric chloride dihydrate | ESD-805299-2KG |
| Cas.: 9039-53-6 | Purity: ≥85%, potency ≥75,000 IU/mg, specific activity 100,000IU/mg | Urokinase from human urine | ESD-916670-1MG |
| Cas.: 9039-53-6 | Purity: ≥85%, potency ≥75,000 IU/mg, specific activity 100,000IU/mg | Urokinase from human urine | ESD-916670-10MG |
| Cas.: 766-46-1 | Purity: 98% | 2-Bromophenylacetylene | ESD-838615-5G |
| Cas.: 766-46-1 | Purity: 98% | 2-Bromophenylacetylene | ESD-838615-25G |
| Cas.: 9039-53-6 | Purity: ≥85%, potency ≥75,000 IU/mg, specific activity 100,000IU/mg | Urokinase from human urine | ESD-916670-50MG |
| Cas.: 51073-69-9 | Purity: 97% | (2-Amino-5-iodophenyl)(phenyl)methanone | ESD-857062-250MG |
| Cas.: 118175-10-3 | Purity: 98% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol | ESD-841978-5G |
| Cas.: 118175-10-3 | Purity: 98% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol | ESD-841978-25G |
| Cas.: 20717-86-6 | Purity: 95% | Chlorotitanium triisopropoxide | ESD-836304-500G |
| Cas.: 141646-00-6 | Purity: 97% | Mometasone furoate hydrate | ESD-846310-500MG |
| Cas.: 7491-74-9 | Purity: ≥98% | Piracetam | ESD-824187-500G |
| Cas.: 1196800-39-1 | Purity: 98% | Omadacycline hydrochloride | ESD-910843-10MG |
| Cas.: 335-57-9 | Purity: 85% | Perfluoroheptanes | ESD-902434-100G |
| Cas.: 335-57-9 | Purity: 85% | Perfluoroheptanes | ESD-902434-500G |
| Cas.: 335-57-9 | Purity: 85% | Perfluoroheptanes | ESD-902434-5G |
| Cas.: 89598-96-9 | Purity: 98% | 1-(4-Hydroxyphenyl)piperazine | ESD-824117-500G |
| Cas.: 1318-93-0 | Purity: Sodium based, specific surface area 240 m2/g | Montmorillonite K-10 | ESD-916671-500G |
| Cas.: 1318-93-0 | Purity: Sodium based, specific surface area 240 m2/g | Montmorillonite K-10 | ESD-916671-100G |
| Cas.: 59378-75-5 | Purity: 97% | 1-Boc-pyrrolidine-3-carboxylic acid | ESD-803344-25G |
| Cas.: 59378-75-5 | Purity: 97% | 1-Boc-pyrrolidine-3-carboxylic acid | ESD-803344-100G |
| Cas.: 59378-75-5 | Purity: 97% | 1-Boc-pyrrolidine-3-carboxylic acid | ESD-803344-500G |
| Cas.: 558-32-7 | Purity: 99% | Tetramethylammonium hexafluorophosphate | ESD-831075-100G |
| Cas.: 296-35-5 | Purity: 98% | 1,4,7,10,13,16-Hexaazacyclooctadecane | ESD-823749-500MG |
| Cas.: 15210-60-3 | Purity: 97% | 3,5,7-trimethyladamantan-1-amine,hydrochloride | ESD-855644-50MG |
| Cas.: 1594-58-7 | Purity: 98% | 3-Pyridinecarboxamide Oxime | ESD-834233-25G |
| Cas.: 1594-58-7 | Purity: 98% | 3-Pyridinecarboxamide Oxime | ESD-834233-100G |
| Cas.: 1594-58-7 | Purity: 98% | 3-Pyridinecarboxamide Oxime | ESD-834233-500G |
| Cas.: 1172127-44-4 | Purity: >97% | (S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine, | ESD-849617-1G |
| Cas.: 60456-22-6 | Purity: 98% | (|S|)-(-)-4-Chloromethyl-2,2-dimethyl-1,3-dioxolane | ESD-806134-100G |
| Cas.: 3520-43-2 | Purity: >95% | JC-1 | ESD-860511-50MG |
| Cas.: 83-87-4 | Purity: 95% | (3R,4S,5R,6R)-6-(Acetoxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayltetraacetate | ESD-873987-25G |
| Cas.: 19967-55-6 | Purity: 95% | 1-Bromo-3-methylbutan-2-one | ESD-916672-5G |
| Cas.: 19967-55-6 | Purity: 95% | 1-Bromo-3-methylbutan-2-one | ESD-916672-1G |
| Cas.: 19967-55-6 | Purity: 95% | 1-Bromo-3-methylbutan-2-one | ESD-916672-250MG |
| Cas.: 6283-63-2 | Purity: AR, 98% | |N|,|N|-Diethyl-|p|-phenylenediamine sulfate salt | ESD-800471-1KG |
| Cas.: 17696-11-6 | Purity: 97% | 8-Bromooctanoic Acid | ESD-832751-250G |
| Cas.: 75-30-9 | Purity: ≥99.5% (GC) | 2-Iodopropane | ESD-914344-25G |
| Cas.: 15088-78-5 | Purity: 96% | Bis(phenylacetyl) Disulfide | ESD-835315-100G |
| Cas.: 5423-22-3 | Purity: 98% | Guanidinium dihydrogen phosphate | ESD-836581-1KG |
| Cas.: 661-69-8 | Purity: >98.0%(GC) | Hexamethylditin | ESD-861159-5G |
| Cas.: 503538-68-9 | Purity: 98% | (S)-6,6′-Bis(diphenylphosphino)-2,2′,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine | ESD-916673-250MG |
| Cas.: 4291-63-8 | Purity: ≥98% | Cladribine | ESD-886117-5G |
| Cas.: 503538-68-9 | Purity: 98% | (S)-6,6′-Bis(diphenylphosphino)-2,2′,3,3′-tetrahydro-5,5′-bibenzo[b][1,4]dioxine | ESD-916673-50MG |
| Cas.: 29270-30-2 | Purity: 97% | α-Bromo-2-chlorophenylacetic acid | ESD-836402-500G |
| Cas.: 245342-14-7 | Purity: ≥98% | LED209 | ESD-880068-50MG |
| Cas.: 3168-59-0 | Purity: 97% | 5-Methoxy-2-methylbenzoicAcid | ESD-829151-25G |
| Cas.: 3168-59-0 | Purity: 97% | 5-Methoxy-2-methylbenzoicAcid | ESD-829151-100G |
| Cas.: 2129-31-9 | Purity: 97.0%(HPLC) | 4-(DIPHENYLPHOSPHINO)BENZOIC ACID | ESD-822222-25G |
| Cas.: 1418022-42-0 | Purity: ≥93% | Biotin-PEG11-Amine | ESD-868323-50MG |
| Cas.: 5931-17-9 | Purity: 96% | 1,3-Bis(4-hydroxybutyl)tetramethyldisiloxane | ESD-869222-250MG |
| Cas.: 12023-91-5 | Purity: 60nm spherical purity>99.5% | Strontium ferrite (nanopowder) | ESD-817421-5G |
| Cas.: 2131-61-5 | Purity: 98% | 4-Nitrophenyl isothiocyanate | ESD-829754-5G |
| Cas.: 2131-61-5 | Purity: 98% | 4-Nitrophenyl isothiocyanate | ESD-829754-1G |
| Cas.: 5368-81-0 | Purity: 98% | Methyl m-Anisate | ESD-870685-25G |
| Cas.: 5368-81-0 | Purity: 98% | Methyl m-Anisate | ESD-870685-100G |
| Cas.: 13547-70-1 | Purity: 95% | 1-Chloropinacolone | ESD-831218-500G |
| Cas.: 219537-97-0 | Purity: 95% | 5-Chloro-3-[2-(5-chloro-2-methylthien-3-yl)cyclopent-1-en-1-yl]-2-methylthiophene | ESD-916674-100MG |
| Cas.: 25032-74-0 | Purity: 97% | Bis(3-bromophenyl)methanone | ESD-916675-250MG |
| Cas.: 25032-74-0 | Purity: 97% | Bis(3-bromophenyl)methanone | ESD-916675-100MG |
| Cas.: 1031602-63-7 | Purity: 99% | UNC3230 | ESD-916676-5MG |
| Cas.: 656-65-5 | Purity: 98% | 4-Bromo-3-fluoroaniline | ESD-804091-500G |
| Cas.: 159857-81-5 | Purity: 98% | Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate | ESD-824598-5MG |
| Cas.: 6290-03-5 | Purity: 97% | (R)-Butane-1,3-diol | ESD-839241-100G |
| Cas.: 138219-98-4 | Purity: 98% | 4,4′-Bis(chloromethyl)-2,2′-bipyridyl | ESD-803945-250MG |
| Cas.: 130641-38-2 | Purity: ≥98% | Bindarit | ESD-833114-250MG |
| Cas.: 9002-92-0 | Purity: 30%(Brij-35) in H2O | Brij | ESD-910186-5L |
| Cas.: 100-84-5 | Purity: 97% | 3-Methylanisole | ESD-831006-5ML |
| Cas.: 479-27-6 | Purity: 99% | 1,8-Diaminonaphthalene | ESD-890237-25G |
| Cas.: 1135695-98-5 | Purity: 98% | Q-VD-Oph | ESD-873510-5MG |
| Cas.: 19771-63-2 | Purity: ≥97% | L-2-Thiazolidinone-4-carboxylic Acid | ESD-866124-5G |
| Cas.: 19771-63-2 | Purity: ≥97% | L-2-Thiazolidinone-4-carboxylic Acid | ESD-866124-25G |
| Cas.: 4823-47-6 | Purity: 98% | 2-Bromoethyl acrylate | ESD-914669-1G |
| Cas.: 4823-47-6 | Purity: 98% | 2-Bromoethyl acrylate | ESD-914669-5G |
| Cas.: 317-20-4 | Purity: 98% | 7-Fluoroisatin | ESD-830584-25G |
| Cas.: 317-20-4 | Purity: 98% | 7-Fluoroisatin | ESD-830584-1G |
| Cas.: 33529-01-0 | Purity: 95% | 1-Hexylimidazole | ESD-852271-5G |
| Cas.: 33529-01-0 | Purity: 95% | 1-Hexylimidazole | ESD-852271-25G |
| Cas.: 1337531-36-8 | Purity: ≥98% | GSK2606414 | ESD-864506-25MG |
| Cas.: 157115-85-0 | Purity: ≥98% | Noopept | ESD-866677-5G |
| Cas.: 157115-85-0 | Purity: ≥98% | Noopept | ESD-866677-25G |
| Cas.: 566939-58-0 | Purity: 98% | 1,3-Dibromo-5-octyl-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione | ESD-861090-1G |
| Cas.: 566939-58-0 | Purity: 98% | 1,3-Dibromo-5-octyl-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione | ESD-861090-5G |
| Cas.: 460053-60-5 | Purity: 98% | 1-(1H-Pyrrolo[3,2-c]pyridin-3-yl)ethanone | ESD-847671-250MG |
| Cas.: 937046-98-5 | Purity: 97% | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine | ESD-845139-1G |
| Cas.: 937046-98-5 | Purity: 97% | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine | ESD-845139-5G |
| Cas.: 175481-36-4 | Purity: 98% | Lacosamide | ESD-833190-250MG |
| Cas.: 937046-98-5 | Purity: 97% | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine | ESD-845139-25G |
| Cas.: 55377-26-9 | Purity: ≥97% | 6-Bromoquinoline Hydrochloride | ESD-859033-25G |
| Cas.: 55377-26-9 | Purity: ≥97% | 6-Bromoquinoline Hydrochloride | ESD-859033-100G |
| Cas.: 3680-71-5 | Purity: 97% | 7-Deazahypoxanthine | ESD-808529-100G |
| Cas.: 364385-54-6 | Purity: 95%, ee 98% | (1R,2S)-N1-Boc-1,2-diaminocyclohexane | ESD-857329-250MG |
| Cas.: 496775-61-2 | Purity: 99% | Eltrombopag | ESD-857954-1G |
| Cas.: 496775-61-2 | Purity: 99% | Eltrombopag | ESD-857954-5G |
| Cas.: 380843-75-4 | Purity: 99% | bosutinib | ESD-859918-1G |
| Cas.: 380843-75-4 | Purity: 99% | bosutinib | ESD-859918-5G |
| Cas.: 112275-50-0 | Purity: 98% | 1-Boc-hexahydro-1,4-diazepine | ESD-803333-25G |
| Cas.: 27017-64-7 | Purity: 97% | 6-Methoxy-1,5-naphthyridin-2(1H)-one | ESD-916677-250MG |
| Cas.: 23674-86-4 | Purity: 98% | Difluprednate | ESD-829967-1G |
| Cas.: 18870-11-6 | Purity: 95% | 2,5-Dibromoterephthalonitrile | ESD-916678-1G |
| Cas.: 18870-11-6 | Purity: 95% | 2,5-Dibromoterephthalonitrile | ESD-916678-250MG |
| Cas.: 852138-89-7 | Purity: 98% | 4,4′-Dibromo-2,2′-diiodobiphenyl | ESD-857197-1G |
| Cas.: 852138-89-7 | Purity: 98% | 4,4′-Dibromo-2,2′-diiodobiphenyl | ESD-857197-250MG |
| Cas.: 10606-72-1 | Purity: ≥97% | Ethyl (R)-(-)-Mandelate | ESD-852606-25G |
| Cas.: 124858-35-1 | Purity: ≥98% (HPLC) | Nadifloxacin | ESD-863949-1G |
| Cas.: 124858-35-1 | Purity: ≥98% (HPLC) | Nadifloxacin | ESD-863949-5G |
| Cas.: 1260817-66-0 | Purity: 96% | 3-Bromo-2-(trifluoromethyl)imidazo[1,2-b]pyridazine | ESD-848778-1G |
| Cas.: 129541-42-0 | Purity: ≥98% | 5-Bromo-4-chloro-3-indolyl octanoate | ESD-832897-100MG |
| Cas.: 1330-70-7 | Purity: 95% | 2-Hydroxyoctadecanoic acid | ESD-844808-5G |
| Cas.: 143062-84-4 | Purity: 97% | (1R,2S)-2-Fluorocyclopropanamine 4-methylbenzenesulfonate | ESD-843199-1G |
| Cas.: 143062-84-4 | Purity: 97% | (1R,2S)-2-Fluorocyclopropanamine 4-methylbenzenesulfonate | ESD-843199-5G |
| Cas.: 143062-84-4 | Purity: 97% | (1R,2S)-2-Fluorocyclopropanamine 4-methylbenzenesulfonate | ESD-843199-25G |
| Cas.: 173979-01-6 | Purity: 95% | 4-(Tri-n-butylstannyl)thiazole | ESD-854928-1G |
| Cas.: 173979-01-6 | Purity: 95% | 4-(Tri-n-butylstannyl)thiazole | ESD-854928-50MG |
| Cas.: 24292-52-2 | Purity: 98% | Hesperidin methylchalcone | ESD-910188-25G |
| Cas.: 24292-52-2 | Purity: 98% | Hesperidin methylchalcone | ESD-910188-100G |
| Cas.: 24430-27-1 | Purity: 96% | 3-Bromo-2-nitrothiophene | ESD-839506-1G |
| Cas.: 24430-27-1 | Purity: 96% | 3-Bromo-2-nitrothiophene | ESD-839506-5G |
| Cas.: 89576-29-4 | Purity: >99% | 1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | ESD-863484-100MG |
| Cas.: 53348-05-3 | Purity: 97% | 3,6-Dibromo-phenanthrenequinone | ESD-832622-100G |
| Cas.: 244205-40-1 | Purity: 97% | 2-Bromophenylboronic acid | ESD-802444-100G |
| Cas.: 392-12-1 | Purity: 98% | Indole-3-pyruvic acid | ESD-830586-250MG |
| Cas.: 36476-78-5 | Purity: 98% | 3-Azetidinecarboxylic acid | ESD-800275-100G |
| Cas.: 781-73-7 | Purity: 98% | 2-Acetylfluorene | ESD-800255-100G |
| Cas.: 220810-26-4 | Purity: 98% | Histrelin (acetate) | ESD-910343-20MG |
| Cas.: 356783-16-9 | Purity: 98% | 3,6-Dichloropyrazine-2-carbonitrile | ESD-847045-1G |
| Cas.: 356783-16-9 | Purity: 98% | 3,6-Dichloropyrazine-2-carbonitrile | ESD-847045-5G |
| Cas.: 356783-16-9 | Purity: 98% | 3,6-Dichloropyrazine-2-carbonitrile | ESD-847045-25G |
| Cas.: 129-43-1 | Purity: ≥95.0% | 1-Hydroxyanthraquinone | ESD-811578-5G |
| Cas.: 108-96-3 | Purity: 97% | 4(1H)-Pyridinone | ESD-875569-25G |
| Cas.: 108-96-3 | Purity: 97% | 4(1H)-Pyridinone | ESD-875569-100G |
| Cas.: 71607-32-4 | Purity: 99% | Di-p-toluoyl-L-tartaric acid monohydrate | ESD-823195-1KG |
| Cas.: 154229-19-3 | Purity: 98% | Abiraterone | ESD-829832-1G |
| Cas.: 154229-19-3 | Purity: 98% | Abiraterone | ESD-829832-5G |
| Cas.: 9000-90-2 | Purity: 50U/mg | α-Amylase | ESD-834633-25G |
| Cas.: 154229-19-3 | Purity: 98% | Abiraterone | ESD-829832-25G |
| Cas.: NONE6627 | natural | Apple powder | ESD-860793-500G |
| Cas.: 84680-95-5 | Purity: 98% | 1,1′-Bis(di-|tert|-butylphosphino)ferrocene | ESD-801913-25G |
| Cas.: 51811-79-1 | Purity: Model: APE-10P, 99% | Nonylphenol POE Phosphate Ester | ESD-916679-100G |
| Cas.: 51811-79-1 | Purity: Model: APE-10P, 99% | Nonylphenol POE Phosphate Ester | ESD-916679-500G |
| Cas.: 174063-87-7 | Purity: 98% | 2-Methyl-1,4-phenylene bis(4-(3-(acryloyloxy)propoxy)benzoate) | ESD-843986-25G |
| Cas.: 51811-79-1 | Purity: Model: APE-4P, ≥95% | Nonylphenol POE Phosphate Ester | ESD-916681-100G |
| Cas.: 51811-79-1 | Purity: Model: APE-4P, ≥95% | Nonylphenol POE Phosphate Ester | ESD-916681-500G |
| Cas.: 122-37-2 | Purity: 98% | 4-Hydroxydiphenylamine | ESD-849360-25G |
| Cas.: 122-37-2 | Purity: 98% | 4-Hydroxydiphenylamine | ESD-849360-100G |
| Cas.: NONE6718 | Purity: for molecular biology | Yeast Nitrogen Base Without Amino Acids | ESD-875139-500G |
| Cas.: 1134-35-6 | Purity: for spectrophotometric det., ≥99% | 4,4′-Dimethyl-2,2′-dipyridyl | ESD-909475-1G |
| Cas.: 108-33-8 | Purity: 98% | 2-AMINO-5-METHYL-1,3,4-THIADIAZOLE | ESD-916682-100G |
| Cas.: 108-33-8 | Purity: 98% | 2-AMINO-5-METHYL-1,3,4-THIADIAZOLE | ESD-916682-25G |
| Cas.: 108-33-8 | Purity: 98% | 2-AMINO-5-METHYL-1,3,4-THIADIAZOLE | ESD-916682-5G |
| Cas.: 7440-56-4 | Purity: 99.99% metals basis, 40 Mesh | Germanium | ESD-916683-100G |
| Cas.: 7440-56-4 | Purity: 99.99% metals basis, 40 Mesh | Germanium | ESD-916683-25G |
| Cas.: 7440-56-4 | Purity: 99.99% metals basis, 40 Mesh | Germanium | ESD-916683-5G |
| Cas.: 7440-56-4 | Purity: 99.99% metals basis, 40 Mesh | Germanium | ESD-916683-1G |
| Cas.: 112-24-3 | Purity: GR, 70% | Triethylenetetramine | ESD-823261-10L |
| Cas.: 9050-30-0 | Purity: 98% | Heparan Sulfate | ESD-876460-25MG |
| Cas.: 112-62-9 | Purity: Standard for GC, ≥99%(GC) | Methyl oleate | ESD-813588-25ML |
| Cas.: 3682-35-7 | Purity: Use For Fe of Spectrophotometry, ≥99% (HPLC) | 2,4,6-Tris(2-pyridyl)-s-triazine | ESD-902513-25G |
| Cas.: 17766-28-8 | Purity: ≥97% | 1-Cyclohexylpiperazine | ESD-837982-25G |
| Cas.: 17766-28-8 | Purity: ≥97% | 1-Cyclohexylpiperazine | ESD-837982-5G |
| Cas.: 530141-72-1 | Purity: ≥98% | 3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid | ESD-874787-25MG |
| Cas.: 7789-23-3 | Purity: 99% | Potassium fluoride Spary Dried | ESD-914947-2.5KG |
| Cas.: 548-62-9 | Purity: 1% in Acetic Acid | Crystal violet | ESD-916090-500ML |
| Cas.: 476-60-8 | Purity: ≥98% | Leucoquinizarin | ESD-859989-100G |
| Cas.: 476-60-8 | Purity: ≥98% | Leucoquinizarin | ESD-859989-500G |
| Cas.: 83-07-8 | Purity: Use For Determination of H2O2 and Phenol of Spectrophotometric, ≥98% | 4-Aminoantipyrine | ESD-902514-500G |
| Cas.: 4630-80-2 | Purity: ≥98% | Methyl Cyclopentanecarboxylate | ESD-867814-5G |
| Cas.: 1194-98-5 | Purity: 98% | 2,5-Dihydroxybenzaldehyde | ESD-807305-100G |
| Cas.: 2761-09-3 | Purity: 95% | 3-hydroxypropyl methacrylate | ESD-916684-250MG |
| Cas.: 2761-09-3 | Purity: 95% | 3-hydroxypropyl methacrylate | ESD-916684-50MG |
| Cas.: 14995-38-1 | Purity: >98.0%(HPLC)(T) | Sodium 4-Ethylbenzenesulfonate | ESD-864417-100G |
| Cas.: 58069-82-2 | Purity: Research grade, 99 atom % 13C | UREA-13C | ESD-824244-500MG |
| Cas.: 60166-93-0 | Purity: 99% | Iopamiro | ESD-872670-10G |
| Cas.: 28547-29-7 | Purity: 98% | 2-Bromo-4-iodobenzoic Acid | ESD-829197-10G |
| Cas.: 28547-29-7 | Purity: 98% | 2-Bromo-4-iodobenzoic Acid | ESD-829197-25G |
| Cas.: 5380-42-7 | Purity: >99% | Methyl 2-Thiophenecarboxylate | ESD-834940-100G |
| Cas.: 481-39-0 | Purity: ≥95%(HPLC) | 5-Hydroxy-1,4-naphthalenedione | ESD-861193-100MG |
| Cas.: 24276-84-4 | Purity: 95% | Sodium ferulate | ESD-836350-5G |
| Cas.: 219543-09-6 | Purity: 95% | 4-Acetamido-2,2,6,6-tetramethyl-1-oxopiperidinium Tetrafluoroborate | ESD-869052-5G |
| Cas.: 93839-89-5 | Purity: 98% | Adenosine 5′-(γ-thio)-triphosphate (lithium salt) (ATPγS) | ESD-913147-5MG |
| Cas.: 144317-44-2 | Purity: ≥99% | Triphenylsulfonium perfluoro-1-butanesufonate | ESD-909782-1G |
| Cas.: NONE6823 | Purity: 2X | Triton Lysis Buffer | ESD-885423-1L |
| Cas.: 138831-86-4 | Purity: 98% | OVA Peptide 257-264 | ESD-882816-10MG |
| Cas.: 950455-15-9 | Purity: 99% | Liproxstatin-1 | ESD-872872-25MG |
| Cas.: 7758-95-4 | Purity: 99.99% metals basis | Lead chloride | ESD-812467-1KG |
| Cas.: 1083-48-3 | Purity: for TLC derivatization, for spectrophotometric det. of phosphorus-containing pesticides, ≥98% | 4-(4-Nitrobenzyl)pyridine | ESD-909480-1G |
| Cas.: 1083-48-3 | Purity: for TLC derivatization, for spectrophotometric det. of phosphorus-containing pesticides, ≥98% | 4-(4-Nitrobenzyl)pyridine | ESD-909480-250MG |
| Cas.: 7440-20-2 | Purity: Distilled Dendritic, 99.9% (REO) | Scandium pieces | ESD-837150-250MG |
| Cas.: 19309-14-9 | Purity: >98% | Cardamonin | ESD-860576-50MG |
| Cas.: 19309-14-9 | Purity: >98% | Cardamonin | ESD-860576-100MG |
| Cas.: 521-24-4 | Purity: for spectrophotometric det. of isonicotic hydrazide, amines and amino acids, ≥98%(T) | 1,2-Naphthoquinone-4-sulfonic acid sodium salt | ESD-909376-1G |
| Cas.: 9004-34-6 | Purity: Diameter: 4~10nm, Length: 200nm, 6% dispersion (solvent is water) | Carboxylated cellulose nanofibers | ESD-916571-100G |
| Cas.: 501907-61-5 | Purity: 95% | tert-Butyl (2,6-dichloropyridin-4-yl)carbamate | ESD-846367-1G |
| Cas.: 52244-70-9 | Purity: 98% | 4-(4-Methoxyphenyl)-1-butanol | ESD-838761-25G |
| Cas.: 561314-57-6 | Purity: 95% | 2,8-Diazaspiro[4.5]decan-3-one | ESD-878449-1G |
| Cas.: 93-58-3 | Purity: AR, 98% | Methyl benzoate | ESD-813400-10L |
| Cas.: 596114-50-0 | Purity: 95% | 2-Chloro-5-isopropylpyrimidine | ESD-848946-100MG |
| Cas.: 4834-98-4 | Purity: 98% | Dodecanedioyl Dichloride | ESD-858292-1G |
| Cas.: 4834-98-4 | Purity: 98% | Dodecanedioyl Dichloride | ESD-858292-25G |
| Cas.: NONE6061 | Purity: Sensitivity 0.03EU/ml | E-TOXATE REAGENT FROM LIMULUS POLYPHEMUS | ESD-916686-0.1ML |
| Cas.: NONE6061 | Purity: Sensitivity 0.03EU/ml | E-TOXATE REAGENT FROM LIMULUS POLYPHEMUS | ESD-916686-10X0.1ML |
| Cas.: 93-58-3 | Purity: 99% | Methyl benzoate | ESD-813402-10L |
| Cas.: NONE6061 | Purity: Sensitivity 0.06EU/ml | E-TOXATE REAGENT FROM LIMULUS POLYPHEMUS | ESD-916687-0.1ML |
| Cas.: NONE6061 | Purity: Sensitivity 0.06EU/ml | E-TOXATE REAGENT FROM LIMULUS POLYPHEMUS | ESD-916687-10X0.1ML |
| Cas.: 1034343-98-0 | Purity: 97% | Graphene | ESD-835836-25G |
| Cas.: 25069-86-7 | Purity: 98% | 4-(Diphenylamino)phenol | ESD-916688-250MG |
| Cas.: 1345627-73-7 | Purity: 95% | 3,6-Dibromo-4,5-difluorobenzene-1,2-diamine | ESD-916689-100MG |
| Cas.: 1141-59-9 | Purity: 98% | 4-(2-Pyridylazo)resorcinol | ESD-816328-100G |
| Cas.: 1370411-48-5 | Purity: 95% | Pyrazine-2,6-diamine hydrochloride | ESD-845155-5G |
| Cas.: 10042-59-8 | Purity: 97% | 2-Propyl-1-heptanol | ESD-856539-5ML |
| Cas.: 444343-55-9 | Purity: ≥98% | Potassium Butyltrifluoroborate | ESD-866171-25G |
| Cas.: 35886-64-7 | Purity: 98% | Carbonyldiiodo(pentamethylcyclopentadienyl)cobalt(III) | ESD-916690-250MG |
| Cas.: 5488-16-4 | Purity: 98% | 2,2′-(2,5-Dihydroxy-1,4-phenylene)diacetic acid | ESD-916691-1G |
| Cas.: 6850-39-1 | Purity: ≥95% | 3-aminocyclohexanol | ESD-827930-1G |
| Cas.: 6850-39-1 | Purity: ≥95% | 3-aminocyclohexanol | ESD-827930-5G |
| Cas.: 1228960-86-8 | 4,4′-((2-Methyl-2-((pyridin-4-yloxy)methyl)propane-1,3-diyl)bis(oxy))dipyridine | ESD-916692-250MG | |
| Cas.: 119-79-9 | Purity: 98% | 5-Amino-2-naphthalenesulfonic acid | ESD-830789-5G |
| Cas.: NONE6411 | MW 10000 | 4-ArmPEG-OH | ESD-850277-200MG |
| Cas.: 111-30-8 | Purity: 2,5% | Glutaraldehyde | ESD-916056-2.5L |
| Cas.: 1325728-09-3 | Purity: 95% | 1,3,5-Tri(4-pyrazolyl)benzene | ESD-916693-100MG |
| Cas.: 1123-28-0 | Purity: 98% | 1-Hydroxycyclohexanecarboxylic acid | ESD-840924-5G |
| Cas.: 111562-32-4 | Purity: ≥97% | 2-(1H-Pyrazol-5-yl)aniline | ESD-868519-1G |
| Cas.: 1599440-13-7 | Purity: 98% | Deruxtecan | ESD-911077-5MG |
| Cas.: 1599440-13-7 | Purity: 98% | Deruxtecan | ESD-911077-10MG |
| Cas.: 116-63-2 | Purity: for spectrophotometric det. of Si, ≥95% | 1-Amino-2-naphthol-4-sulfonic Acid | ESD-909481-5G |
| Cas.: 116-63-2 | Purity: for spectrophotometric det. of Si, ≥95% | 1-Amino-2-naphthol-4-sulfonic Acid | ESD-909481-100G |
| Cas.: 681004-60-4 | Purity: 97% | 1,4-Di(4H-1,2,4-triazol-4-yl)benzene | ESD-916694-1G |
| Cas.: 1693758-51-8 | Purity: 99% | IPI-549 | ESD-873042-25MG |
| Cas.: 5840-01-7 | Purity: 98% | 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline | ESD-841426-5G |
| Cas.: 5840-01-7 | Purity: 98% | 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline | ESD-841426-25G |
| Cas.: 67151-63-7 | Purity: 98% | 1-[Bis[3-(dimethylamino)propyl]amino]-2-propanol | ESD-903640-100ML |
| Cas.: 67151-63-7 | Purity: 98% | 1-[Bis[3-(dimethylamino)propyl]amino]-2-propanol | ESD-903640-25ML |
| Cas.: 41994-02-9 | Purity: 98% | Biotinyl tyramide | ESD-911331-50MG |
| Cas.: 1800552-46-8 | Purity: 98% | 4′,4”’,4””’-Nitrilotris(([1,1′-biphenyl]-4-carbonitrile)) | ESD-916696-250MG |
| Cas.: 1601465-06-8 | Purity: 97% | 4,4′-(2,2-Diphenylethene-1,1-diyl)dibenzaldehyde | ESD-916697-250MG |
| Cas.: 112-62-9 | Purity: ≥99.8%(GC) | Methyl oleate | ESD-875677-100G |
| Cas.: 38153-01-4 | Purity: 98% | Naphthalene-1,4-dicarbaldehyde | ESD-916698-1G |
| Cas.: 38153-01-4 | Purity: 98% | Naphthalene-1,4-dicarbaldehyde | ESD-916698-250MG |
| Cas.: 40769-69-5 | Purity: 95% | 2,5-Diamino-4,6-dihydroxy-pyrimidine | ESD-856974-250MG |
| Cas.: 25306-75-6 | Purity: 99% | Sodium Isobutyl Xanthate | ESD-916699-25G |
| Cas.: 25306-75-6 | Purity: 99% | Sodium Isobutyl Xanthate | ESD-916699-100G |
| Cas.: 25306-75-6 | Purity: 99% | Sodium Isobutyl Xanthate | ESD-916699-500G |
| Cas.: 79793-00-3 | Purity: 50% in toluene | 2-(4-Chlorosulphonylphenyl)ethyl trichlorosilanein methylene chloride | ESD-857092-5G |
| Cas.: 320386-54-7 | Purity: 98% | SKF-34288 hydrochloride (3-Mercaptopicolinic acid) | ESD-911296-25MG |
| Cas.: 86827-10-3 | Purity: ≥97% | N-Cbz-3-piperidineacetic Acid | ESD-850444-25G |
| Cas.: 320590-29-2 | Purity: 98% | Benzyl (3-oxocyclohexyl)carbamate | ESD-847239-5G |
| Cas.: 1448693-69-3 | Purity: 98% | GCN2-IN-1 | ESD-872227-5MG |
| Cas.: 1448693-69-3 | Purity: 98% | GCN2-IN-1 | ESD-872227-25MG |
| Cas.: 874948-60-4 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854223-500MG |
| Cas.: 28781-85-3 | Purity: ≥98% | 2,2-Difluoropropionic acid ethyl ester | ESD-857471-5G |
| Cas.: 28781-85-3 | Purity: ≥98% | 2,2-Difluoropropionic acid ethyl ester | ESD-857471-10G |
| Cas.: 28781-85-3 | Purity: ≥98% | 2,2-Difluoropropionic acid ethyl ester | ESD-857471-25G |
| Cas.: 468075-00-5 | Purity: 98% | 2-bromo-1-chloro-4-(trifluoromethoxy)benzene | ESD-829063-1G |
| Cas.: 111843-78-8 | Purity: Isomer mixture | 5-(6)-Carboxy-2′,7′-dichlorofluorescein | ESD-903593-25MG |
| Cas.: 4775-98-8 | Purity: 95% | 6-Methylpiperidin-2-one | ESD-852214-250MG |
| Cas.: 876062-39-4 | Purity: 97% | 2-(2-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-840545-25G |
| Cas.: 876062-39-4 | Purity: 97% | 2-(2-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-840545-100G |
| Cas.: 267-48-1 | Purity: 97% | 5H-[1,3]Dioxolo[4,5-f]indole | ESD-842126-250MG |
| Cas.: 267-48-1 | Purity: 97% | 5H-[1,3]Dioxolo[4,5-f]indole | ESD-842126-1G |
| Cas.: 267-48-1 | Purity: 97% | 5H-[1,3]Dioxolo[4,5-f]indole | ESD-842126-5G |
| Cas.: 263333-82-0 | Purity: ≥98% | 4-Bromo-3,5-Dichlorofluorobenzene | ESD-858763-250MG |
| Cas.: 263333-82-0 | Purity: ≥98% | 4-Bromo-3,5-Dichlorofluorobenzene | ESD-858763-5G |
| Cas.: 548-62-9 | Purity: 98% | Crystal violet | ESD-916088-25G |
| Cas.: 263333-82-0 | Purity: ≥98% | 4-Bromo-3,5-Dichlorofluorobenzene | ESD-858763-25G |
| Cas.: 83266-97-1 | Purity: 97% | 4,4′,4”-(Pyridine-2,4,6-triyl)trianiline | ESD-916700-250MG |
| Cas.: 286380-59-4 | Purity: 98% | 2,2′-([2,2′-Bipyridine]-5,5′-diyl)diacetonitrile | ESD-916701-100MG |
| Cas.: 2362-63-2 | Purity: ≥98% | 3-Methyl(Thiobenzamide) | ESD-858837-5G |
| Cas.: 2362-63-2 | Purity: ≥98% | 3-Methyl(Thiobenzamide) | ESD-858837-250MG |
| Cas.: 2362-63-2 | Purity: ≥98% | 3-Methyl(Thiobenzamide) | ESD-858837-10G |
| Cas.: 3743-23-5 | Purity: 97% | 5-Chloro-2-methoxyphenol | ESD-844906-1G |
| Cas.: 51618-29-2 | Purity: 97% | 6-CHLORO-2-MERCAPTOBENZOTHIAZOLE | ESD-834315-250MG |
| Cas.: 214360-70-0 | Purity: 96% | Thiophene-3-boronic acid, pinacol ester | ESD-857258-10G |
| Cas.: 214360-70-0 | Purity: 96% | Thiophene-3-boronic acid, pinacol ester | ESD-857258-25G |
| Cas.: 403850-84-0 | Purity: 97% | 7-Bromo-4-chloro-2-methylquinazoline | ESD-847953-1G |
| Cas.: 403850-84-0 | Purity: 97% | 7-Bromo-4-chloro-2-methylquinazoline | ESD-847953-250MG |
| Cas.: 20501-56-8 | Purity: ≥98% (HPLC) | talatisamine | ESD-861476-5MG |
| Cas.: 478922-47-3 | Purity: 97% | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-844688-5G |
| Cas.: 478922-47-3 | Purity: 97% | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | ESD-844688-1G |
| Cas.: 189442-78-2 | Purity: ≥97% | 1-Boc-N-methoxy-N-methylpiperidine-3-carboxamide | ESD-850533-250MG |
| Cas.: 27257-90-5 | Purity: 98% | 2,4,6-Tri-1H-pyrazol-1-yl-1,3,5-triazine | ESD-916702-250MG |
| Cas.: 18761-31-4 | Purity: 96% | 5-Nitrobenzofuran | ESD-840309-250MG |
| Cas.: 540516-28-7 | Purity: ≥95% | 2-(Hydroxymethyl)-5-bromobenzimidazole | ESD-852650-5G |
| Cas.: 61925-55-1 | Purity: >97.0%(HPLC) | Fast Red B Salt 1,5-Naphthalenedisulfonate [for Biochemical Research] | ESD-863751-5G |
| Cas.: 61925-55-1 | Purity: >97.0%(HPLC) | Fast Red B Salt 1,5-Naphthalenedisulfonate [for Biochemical Research] | ESD-863751-25G |
| Cas.: 43193-60-8 | Purity: 95% | Pyrazinetetracarboxylic acid | ESD-916703-100MG |
| Cas.: 126937-43-7 | Purity: ≥97% | 1-Benzyl 2-methyl piperazine-1,2-dicarboxylate | ESD-858586-250MG |
| Cas.: 1366291-62-4 | Purity: 98% | Tris(4-(pyridin-4-yl)phenyl)amine | ESD-916704-1G |
| Cas.: 126937-43-7 | Purity: ≥97% | 1-Benzyl 2-methyl piperazine-1,2-dicarboxylate | ESD-858586-100MG |
| Cas.: 654655-68-2 | Purity: ≥98% | 3-Benzyl-6-Bromo-2-Chloroquinoline | ESD-858830-1G |
| Cas.: 1366291-62-4 | Purity: 98% | Tris(4-(pyridin-4-yl)phenyl)amine | ESD-916704-250MG |
| Cas.: 887250-14-8 | Purity: 95% | Ethyl 3-amino-6-bromobenzofuran-2-carboxylate | ESD-846872-500MG |
| Cas.: 1334536-88-7 | Purity: 97% | 7-Benzyl-1-oxo-2,7-diazaspiro[3.5]nonane | ESD-843200-250MG |
| Cas.: 1334536-88-7 | Purity: 97% | 7-Benzyl-1-oxo-2,7-diazaspiro[3.5]nonane | ESD-843200-1G |
| Cas.: 1108726-74-4 | Purity: 97% | 5-(1H-Pyrazol-4-yl)isophthalic acid | ESD-916705-250MG |
| Cas.: 14036-96-5 | Purity: 96% | 3-Bromo-6-methoxyquinoline | ESD-847690-1G |
| Cas.: 14036-96-5 | Purity: 96% | 3-Bromo-6-methoxyquinoline | ESD-847690-250MG |
| Cas.: 1261889-89-7 | Purity: 97% | 4′-Hydroxy-[1,1′-biphenyl]-3,5-dicarboxylic acid | ESD-916706-250MG |
| Cas.: 88738-86-7 | Purity: ≥98% | Methyl (E)-4-(Bromomethyl)cinnamate | ESD-868320-5G |
| Cas.: 88738-86-7 | Purity: ≥98% | Methyl (E)-4-(Bromomethyl)cinnamate | ESD-868320-25G |
| Cas.: 88738-86-7 | Purity: ≥98% | Methyl (E)-4-(Bromomethyl)cinnamate | ESD-868320-100G |
| Cas.: 887625-09-4 | Purity: ≥97% | 2-Amino-6-chloroimidazo[1,2-b]pyridazine | ESD-853269-5G |
| Cas.: 887625-09-4 | Purity: ≥97% | 2-Amino-6-chloroimidazo[1,2-b]pyridazine | ESD-853269-25G |
| Cas.: 14465-68-0 | Purity: ≥97% | Glyceryl trilinolenate | ESD-915037-25MG |
| Cas.: 79398-27-9 | Purity: ≥98% | Methyl 4,6-dihydroxynicotinate | ESD-857730-250MG |
| Cas.: 16162-28-0 | Purity: 95% | Benzo[1,2-d:4,5-d’]bis(thiazole)-2,6-diamine | ESD-916707-250MG |
| Cas.: 898747-24-5 | Purity: 98% | Methyl 5-bromo-1H-indazole-7-carboxylate | ESD-845565-1G |
| Cas.: 898747-24-5 | Purity: 98% | Methyl 5-bromo-1H-indazole-7-carboxylate | ESD-845565-5G |
| Cas.: 620960-26-1 | Purity: ≥98%, 99%ee | 1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea | ESD-854157-1G |
| Cas.: 620960-26-1 | Purity: ≥98%, 99%ee | 1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea | ESD-854157-5G |
| Cas.: 381218-96-8 | Purity: 97% | (4-([2,2′:6′,2”-Terpyridin]-4′-yl)phenyl)boronic acid | ESD-916708-5G |
| Cas.: 381218-96-8 | Purity: 97% | (4-([2,2′:6′,2”-Terpyridin]-4′-yl)phenyl)boronic acid | ESD-916708-1G |
| Cas.: 641569-96-2 | Purity: ≥97%(HPLC)(T) | Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate | ESD-862391-5G |
| Cas.: 686747-19-3 | Purity: 97% | Methyl 5-amino-1H-indole-3-carboxylate | ESD-847383-1G |
| Cas.: 686747-19-3 | Purity: 97% | Methyl 5-amino-1H-indole-3-carboxylate | ESD-847383-5G |
| Cas.: 147403-65-4 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | ESD-843949-1G |
| Cas.: 147403-65-4 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | ESD-843949-5G |
| Cas.: 900019-52-5 | Purity: 97% | Methyl-4-amino-3-bromo-5-methylbenzoate | ESD-833788-1G |
| Cas.: 900019-52-5 | Purity: 97% | Methyl-4-amino-3-bromo-5-methylbenzoate | ESD-833788-5G |
| Cas.: 181058-08-2 | Purity: 95% | 1,3,5-Tris(bromomethyl)-2,4,6-triethylbenzene | ESD-916709-5G |
| Cas.: 181058-08-2 | Purity: 95% | 1,3,5-Tris(bromomethyl)-2,4,6-triethylbenzene | ESD-916709-1G |
| Cas.: 148461-16-9 | Purity: 98%, ee99% | (S)-4-(tert-Butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole | ESD-887889-250MG |
| Cas.: 148461-16-9 | Purity: 98%, ee99% | (S)-4-(tert-Butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole | ESD-887889-1G |
| Cas.: 17788-93-1 | Purity: 97% | [1,1′:4′,1”-Terphenyl]-4,4”-dicarbonitrile | ESD-916710-250MG |
| Cas.: 15121-89-8 | Purity: 95% | Ethyl trans-3-Benzoylacrylate | ESD-869108-5G |
| Cas.: 15121-89-8 | Purity: 95% | Ethyl trans-3-Benzoylacrylate | ESD-869108-25G |
| Cas.: 15121-89-8 | Purity: 95% | Ethyl trans-3-Benzoylacrylate | ESD-869108-100G |
| Cas.: 1533519-92-4 | Purity: ≥97% | 4-Cyclopropylnaphthalen-1-Amine Hydrochloride | ESD-857444-10G |
| Cas.: 1533519-92-4 | Purity: ≥97% | 4-Cyclopropylnaphthalen-1-Amine Hydrochloride | ESD-857444-25G |
| Cas.: 1533519-92-4 | Purity: ≥97% | 4-Cyclopropylnaphthalen-1-Amine Hydrochloride | ESD-857444-1G |
| Cas.: 162502-65-0 | Purity: 97% | Fmoc-D-Tyr(4-Et)-OH | ESD-843946-25G |
| Cas.: 163252-36-6 | Purity: ≥99% | Clevudine | ESD-833172-50MG |
| Cas.: 163853-10-9 | Purity: ≥95% | Benzotriazole-1-carboxamidinium tosylate | ESD-874025-1G |
| Cas.: 16830-24-3 | Purity: ≥97% | 2-Methyl-4-Pyridinecarboxylic Acid Methyl Ester | ESD-858715-25G |
| Cas.: 171110-72-8 | Purity: 97% | Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate hydrochloride | ESD-844903-1G |
| Cas.: 171110-72-8 | Purity: 97% | Methyl (2S,4S)-1-Boc-4-aminopyrrolidine-2-carboxylate hydrochloride | ESD-844903-5G |
| Cas.: 17452-27-6 | Purity: 98% | 3-Pyridyl Isothiocyanate | ESD-854808-5G |
| Cas.: 175166-51-5 | Purity: ≥98%, 99%ee | (3aS,3’aS,8aR,8’aR)-2,2′-(1-Methylethylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | ESD-854126-250MG |
| Cas.: 175166-51-5 | Purity: ≥98%, 99%ee | (3aS,3’aS,8aR,8’aR)-2,2′-(1-Methylethylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | ESD-854126-1G |
| Cas.: 1799412-29-5 | Purity: 98% | tert-Butyl (3-acetylpyrazin-2-yl)carbamate | ESD-847867-250MG |
| Cas.: 87691-27-8 | Purity: 98% | N-BOC-cis-4-Hydroxy-L-proline | ESD-831589-5G |
| Cas.: 87691-27-8 | Purity: 98% | N-BOC-cis-4-Hydroxy-L-proline | ESD-831589-25G |
| Cas.: 908142-03-0 | Purity: ≥98% | (3-(Hydroxymethyl)-4-Methoxyphenyl)Boronic Acid | ESD-860355-250MG |
| Cas.: 922711-75-9 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′ ,2′-f][1,3,2]dioxaphosphepin | ESD-854236-25MG |
| Cas.: 321318-21-2 | Purity: ≥97% | 1-(3,4-Difluorophenyl)ethanol | ESD-852558-5G |
| Cas.: 321318-21-2 | Purity: ≥97% | 1-(3,4-Difluorophenyl)ethanol | ESD-852558-100G |
| Cas.: 960000-93-5 | Purity: ≥98% | 1-Bromo-4-Chloro-5-Fluoro-2-Nitrobenzene | ESD-857591-250MG |
| Cas.: 34074-22-1 | Purity: 98% | 2,6-Dichloro-4-iodophenol | ESD-849057-1G |
| Cas.: 34074-22-1 | Purity: 98% | 2,6-Dichloro-4-iodophenol | ESD-849057-5G |
| Cas.: 34074-22-1 | Purity: 98% | 2,6-Dichloro-4-iodophenol | ESD-849057-25G |
| Cas.: 96651-85-3 | Purity: 95% | 4-Spiroindane-piperidine hydrochloride | ESD-876104-100MG |
| Cas.: 38858-90-1 | Purity: 97% | 4-Methyl-3-nitro-1H-pyrazole | ESD-841401-250MG |
| Cas.: 38858-90-1 | Purity: 97% | 4-Methyl-3-nitro-1H-pyrazole | ESD-841401-1G |
| Cas.: 38858-90-1 | Purity: 97% | 4-Methyl-3-nitro-1H-pyrazole | ESD-841401-5G |
| Cas.: 111072-31-2 | Purity: 80% | XTT sodium salt | ESD-916711-25MG |
| Cas.: 111072-31-2 | Purity: 80% | XTT sodium salt | ESD-916711-100MG |
| Cas.: 38858-90-1 | Purity: 97% | 4-Methyl-3-nitro-1H-pyrazole | ESD-841401-25G |
| Cas.: 1305-62-0 | Purity: 90% | Calcium hydroxide | ESD-916712-500G |
| Cas.: 1305-62-0 | Purity: 90% | Calcium hydroxide | ESD-916712-2.5KG |
| Cas.: 1305-62-0 | Purity: 90% | Calcium hydroxide | ESD-916712-10KG |
| Cas.: 39115-96-3 | Purity: 98% | 3-Bromobenzhydrazide | ESD-842475-100G |
| Cas.: 99-20-7 | Purity: 1.5M | Trehalose solution | ESD-916328-1.5ML |
| Cas.: 1065214-95-0 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d :1′,2′-f][1,3,2]dioxaphosphepin | ESD-854234-25MG |
| Cas.: 3952-66-7 | Purity: ≥95% | Methyl 2-Oxobutanoate | ESD-850978-5G |
| Cas.: 3952-66-7 | Purity: ≥95% | Methyl 2-Oxobutanoate | ESD-850978-10G |
| Cas.: 53363-87-4 | Purity: 98% | Z-Leu-OH DCHA | ESD-820805-500G |
| Cas.: 5424-43-1 | Purity: 95% | 1-Bromo-2,3-dimethoxybenzene | ESD-839496-5G |
| Cas.: 61597-98-6 | Purity: ≥98% | L-Menthyl Lactate | ESD-860108-25G |
| Cas.: 61597-98-6 | Purity: ≥98% | L-Menthyl Lactate | ESD-860108-100G |
| Cas.: 61597-98-6 | Purity: ≥98% | L-Menthyl Lactate | ESD-860108-500G |
| Cas.: 56961-75-2 | Purity: 98% | 2,3,5-Trichlorobenzaldehyde | ESD-840224-5G |
| Cas.: 119018-29-0 | Purity: 98% | 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide | ESD-846193-5G |
| Cas.: 93413-69-5 | Purity: 99% | Venlafaxine | ESD-873649-25MG |
| Cas.: 93413-69-5 | Purity: 99% | Venlafaxine | ESD-873649-100MG |
| Cas.: 1240621-87-7 | Purity: 97% | 2-Bromopyrimidin-5-ol | ESD-846113-1G |
| Cas.: 1245816-10-7 | Purity: 98% | (5-Methyl-1H-indazol-4-yl)boronic acid | ESD-848361-5G |
| Cas.: 1245816-10-7 | Purity: 98% | (5-Methyl-1H-indazol-4-yl)boronic acid | ESD-848361-100MG |
| Cas.: 76742-48-8 | Purity: ≥95% | Methyl 2,2-diethoxyacetimidate | ESD-886160-250MG |
| Cas.: 76985-08-5 | Purity: 95% | 2-Amino-3-(4-biphenylyl)propanoic Acid | ESD-850537-5G |
| Cas.: 22368-21-4 | Purity: 98% | Eupatilin | ESD-860588-50MG |
| Cas.: 77820-58-7 | Purity: 97% | Methyl 2-amino-3-chlorobenzoate | ESD-840321-25G |
| Cas.: 77820-58-7 | Purity: 97% | Methyl 2-amino-3-chlorobenzoate | ESD-840321-100G |
| Cas.: 77820-58-7 | Purity: 97% | Methyl 2-amino-3-chlorobenzoate | ESD-840321-500G |
| Cas.: 1290626-82-2 | Purity: 97% | tert-Butyl7-fluoro-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-883421-25MG |
| Cas.: 1290626-82-2 | Purity: 97% | tert-Butyl7-fluoro-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-883421-100MG |
| Cas.: 83918-60-9 | Purity: 95% | Fumaric Acid Monoethyl Ester Magnesium Salt | ESD-859343-1G |
| Cas.: 849767-21-1 | Purity: 95% | tert-Butyl 3-(((tert-butyldimethylsilyl)oxy)methyl)-4-oxopiperidine-1-carboxylate | ESD-848816-1G |
| Cas.: 13808-65-6 | Purity: 98% | 4-Bromo-3-phenyl-1H-pyrazole | ESD-847928-100MG |
| Cas.: 13808-65-6 | Purity: 98% | 4-Bromo-3-phenyl-1H-pyrazole | ESD-847928-5G |
| Cas.: 6358-31-2 | Purity: Dye content 85% | pigment yellow 74 | ESD-916713-100G |
| Cas.: 6358-31-2 | Purity: Dye content 85% | pigment yellow 74 | ESD-916713-500G |
| Cas.: 6358-31-2 | Purity: Dye content 85% | pigment yellow 74 | ESD-916713-2.5KG |
| Cas.: 86028-91-3 | Purity: 98% | (R)-Ethyl thiazolidine-4-carboxylate hydrochloride | ESD-846200-5G |
| Cas.: 86028-91-3 | Purity: 98% | (R)-Ethyl thiazolidine-4-carboxylate hydrochloride | ESD-846200-25G |
| Cas.: 864943-23-7 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854220-250MG |
| Cas.: 864943-23-7 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854220-1G |
| Cas.: 888952-55-4 | Purity: ≥97% | Methyl 1-Boc-3-methylpiperidine-3-carboxylate | ESD-850573-250MG |
| Cas.: 925890-13-7 | Purity: 98% | 1,2,3-Trifluoro-5-methoxy-4-nitrobenzene | ESD-840001-5G |
| Cas.: 925890-13-7 | Purity: 98% | 1,2,3-Trifluoro-5-methoxy-4-nitrobenzene | ESD-840001-10G |
| Cas.: 941710-30-1 | Purity: 97% | 7-Bromochroman | ESD-847881-250MG |
| Cas.: 941710-30-1 | Purity: 97% | 7-Bromochroman | ESD-847881-1G |
| Cas.: 1011465-24-9 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2 ,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854235-250MG |
| Cas.: 1011465-24-9 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2 ,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854235-1G |
| Cas.: 105285-21-0 | Purity: 97% | 4-(tert-Butyl)-1H-pyrazole | ESD-846608-1G |
| Cas.: 105285-21-0 | Purity: 97% | 4-(tert-Butyl)-1H-pyrazole | ESD-846608-5G |
| Cas.: 10599-59-4 | Purity: 95% | 2-Isopropylfuran | ESD-844001-250MG |
| Cas.: 10599-59-4 | Purity: 95% | 2-Isopropylfuran | ESD-844001-1G |
| Cas.: 110429-36-2 | Purity: 98% | N-Methyl Paroxetine | ESD-863975-1G |
| Cas.: 111042-89-8 | Purity: ≥95% | Methyl 3-aminothieno[2,3-b]pyridine-2-carboxylate | ESD-825949-1G |
| Cas.: 111042-89-8 | Purity: ≥95% | Methyl 3-aminothieno[2,3-b]pyridine-2-carboxylate | ESD-825949-250MG |
| Cas.: 736989-93-8 | Purity: 95% | 6-(Methoxycarbonyl)Naphthalene-2-Boronic Acid Pinacol Ester | ESD-916714-100MG |
| Cas.: 1127-35-1 | Purity: ≥97% | Benzo[b]thiophene-3(2H)-one 1,1-Dioxide | ESD-851602-250MG |
| Cas.: 23720-80-1 | Purity: ≥98%(HPLC) | Nardosinone | ESD-861332-5MG |
| Cas.: 261767-10-6 | Purity: 97% | Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate | ESD-847994-250MG |
| Cas.: 261767-10-6 | Purity: 97% | Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate | ESD-847994-1G |
| Cas.: 2987-05-5 | Purity: ≥97% | 4-(Methylamino)cyclohexanol | ESD-850804-250MG |
| Cas.: NONE7976 | Hexamethylene diisocyanate trimer | ESD-909346-100G | |
| Cas.: NONE7976 | Hexamethylene diisocyanate trimer | ESD-909346-500G | |
| Cas.: NONE7976 | Hexamethylene diisocyanate trimer | ESD-909346-2.5KG | |
| Cas.: 165947-48-8 | Purity: 95% | 5-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | ESD-855042-1G |
| Cas.: 1646152-54-6 | Purity: 97% | 1-Bromo-2,5-dimethoxy-4-((4-methoxybenzyl)oxy)benzene | ESD-845444-1G |
| Cas.: 1701405-00-6 | Purity: ≥98%, 99%ee | 1-[(4S)-4,5-Dihydro-4-isopropyl-2-oxazolyl]isoquinoline | ESD-854147-25MG |
| Cas.: 91183-17-4 | Purity: 98% | 5-(Benzyloxy)-2,4-dichloropyrimidine | ESD-845673-500MG |
| Cas.: 91183-17-4 | Purity: 98% | 5-(Benzyloxy)-2,4-dichloropyrimidine | ESD-845673-1G |
| Cas.: 923289-36-5 | Purity: 95% | 1-(2-Amino-3-chloro-4-methoxyphenyl)ethanone | ESD-842429-500MG |
| Cas.: 1022150-57-7 | Purity: ≥98% | SGX-523 | ESD-863769-25MG |
| Cas.: 4255-07-6 | Purity: ≥99% | Zinc oxalate dihydrate | ESD-914747-2.5KG |
| Cas.: 103639-57-2 | Purity: 97% | (S)-2-(Piperidin-2-yl)ethanol | ESD-846802-1G |
| Cas.: 103639-57-2 | Purity: 97% | (S)-2-(Piperidin-2-yl)ethanol | ESD-846802-5G |
| Cas.: 669008-25-7 | Purity: 97% | N-(tert-Butyl)-1-methylcyclopropane-1-sulfonamide | ESD-840031-1G |
| Cas.: 669008-25-7 | Purity: 97% | N-(tert-Butyl)-1-methylcyclopropane-1-sulfonamide | ESD-840031-250MG |
| Cas.: 1048692-61-0 | Purity: ≥98%, 99%ee | (R)-1-[3,5-Bis(trifluoromethyl)phenyl]-3-[1-(dimethylamino)-3-methylbutan-2-yl]thiourea | ESD-854162-25MG |
| Cas.: 1506-76-9 | Purity: 98% | 10,15-Dihydro-5H-tribenzo[a,d,g][9]annulene-2,3,7,8,12,13-hexaol | ESD-916715-250MG |
| Cas.: 1049004-32-1 | Purity: 97% | Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate | ESD-841270-1G |
| Cas.: 1049004-32-1 | Purity: 97% | Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate | ESD-841270-5G |
| Cas.: 68790-38-5 | Purity: 95% | Boc-2-Abz-OH | ESD-854652-5G |
| Cas.: 106704-35-2 | Purity: 97% | 4,4′-(9,10-Anthracenediyl)bis[benzenamine] | ESD-916716-250MG |
| Cas.: 105544-36-3 | Purity: 97% | 7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one | ESD-842986-1G |
| Cas.: 105544-36-3 | Purity: 97% | 7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one | ESD-842986-5G |
| Cas.: 108915-08-8 | Purity: ≥95%, 99%ee | 2-[(4S)-4,5-Dihydro-4-(phenylmethyl)-2-oxazolyl]pyridine | ESD-854141-250MG |
| Cas.: 1092693-73-6 | Purity: 98% | tert-Butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate | ESD-844565-5G |
| Cas.: 1092693-73-6 | Purity: 98% | tert-Butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate | ESD-844565-25G |
| Cas.: 21168-72-9 | Purity: 97% | 2-(4-(Aminomethyl)piperidin-1-yl)ethanol | ESD-844014-1G |
| Cas.: 1154383-52-4 | Purity: ≥97% | N-Methylpyrazole-4-carboxamide | ESD-851538-250MG |
| Cas.: 141-94-6 | Purity: 95% | Hexetidine | ESD-916717-500MG |
| Cas.: 81945-73-5 | Purity: 97% | 1H-Pyrazol-1-ol | ESD-856702-5G |
| Cas.: 81945-73-5 | Purity: 97% | 1H-Pyrazol-1-ol | ESD-856702-1G |
| Cas.: 1170736-59-0 | Purity: ≥98%, 99%ee | (11bS)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854199-250MG |
| Cas.: 858516-69-5 | Purity: ≥98% | 6,8-Dichloroimidazo[1,2-a]pyridine | ESD-857830-25G |
| Cas.: 858516-69-5 | Purity: ≥98% | 6,8-Dichloroimidazo[1,2-a]pyridine | ESD-857830-1G |
| Cas.: 23617-71-2 | Purity: 95% | Methyl 2,4-dimethylbenzoate | ESD-858389-1G |
| Cas.: 141-94-6 | Purity: ≥98% | Hexetidine | ESD-882586-100MG |
| Cas.: 2435-36-1 | Purity: 95% | Dimethyl cyclopentane-1,3-dicarboxylate | ESD-839683-1G |
| Cas.: 88678-31-3 | Purity: ≥99% | Liranaftate | ESD-864190-50MG |
| Cas.: 2435-36-1 | Purity: 95% | Dimethyl cyclopentane-1,3-dicarboxylate | ESD-839683-5G |
| Cas.: 913835-65-1 | Purity: ≥98% | Pyridine-4-Boronic Acid Hydrochloride | ESD-858103-1G |
| Cas.: 1441674-54-9 | Purity: ≥99% | Ledipasvir (acetone) | ESD-882389-100MG |
| Cas.: 492-70-6 | Purity: 98% | 1,2-Diphenylethane-1,2-diol | ESD-916718-1G |
| Cas.: 492-70-6 | Purity: 98% | 1,2-Diphenylethane-1,2-diol | ESD-916718-5G |
| Cas.: 492-70-6 | Purity: 98% | 1,2-Diphenylethane-1,2-diol | ESD-916718-10G |
| Cas.: 121554-18-5 | Purity: 98% | (4′-Pentyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-843371-1G |
| Cas.: 1000576-79-3 | Purity: 95% | tert-Butyl (4-bromothiazol-2-yl)(methyl)carbamate | ESD-845665-500MG |
| Cas.: 121554-18-5 | Purity: 98% | (4′-Pentyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-843371-5G |
| Cas.: 121554-18-5 | Purity: 98% | (4′-Pentyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-843371-25G |
| Cas.: 3000-75-7 | Purity: ≥97% | N-Ethyl-N-(3-pyridylmethyl)amine | ESD-853189-250MG |
| Cas.: 305790-48-1 | Purity: ≥95% | 6-bromo-1-methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-827185-250MG |
| Cas.: 305790-48-1 | Purity: ≥95% | 6-bromo-1-methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-827185-50MG |
| Cas.: 30932-41-3 | Purity: ≥97% | 2,2-Diphenylcyclopropanecarbonitrile | ESD-858630-250MG |
| Cas.: 1223105-89-2 | Purity: ≥98%, 99%ee | 3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]amino]-3-cyclobutene-1,2- dione | ESD-854282-250MG |
| Cas.: 1139889-93-2 | Purity: 99% | Golgicide A | ESD-872847-25MG |
| Cas.: 123853-39-4 | Purity: 95% | 4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid | ESD-847885-1G |
| Cas.: 123853-39-4 | Purity: 95% | 4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid | ESD-847885-250MG |
| Cas.: 124276-34-2 | Purity: ≥97% | 1-(3-Chlorophenyl)cyclopropanecarboxylic Acid | ESD-851862-5G |
| Cas.: 2028-63-9 | Purity: 55% in water | 3-Butyn-2-ol | ESD-916719-500G |
| Cas.: 2028-63-9 | Purity: 55% in water | 3-Butyn-2-ol | ESD-916719-100G |
| Cas.: 2028-63-9 | Purity: 55% in water | 3-Butyn-2-ol | ESD-916719-25G |
| Cas.: 2028-63-9 | Purity: 55% in water | 3-Butyn-2-ol | ESD-916719-5G |
| Cas.: 35852-81-4 | Purity: 95% | 4-Chloro-1-methyl-1H-pyrazole | ESD-838956-1G |
| Cas.: 878010-24-3 | Purity: ≥97% | 2-Morpholinecarboxylic Acid Hydrochloride | ESD-850403-250MG |
| Cas.: 879505-38-1 | Purity: ≥98%, ≥99% ee | (S)-N,N’-[1,1′-Binaphthalene]-2,2′-diylbis[2-(diphenylphosphino)benzamide] | ESD-853926-250MG |
| Cas.: 879505-38-1 | Purity: ≥98%, ≥99% ee | (S)-N,N’-[1,1′-Binaphthalene]-2,2′-diylbis[2-(diphenylphosphino)benzamide] | ESD-853926-1G |
| Cas.: 394729-98-7 | Purity: ≥98% | 2-Chloro-4-methoxynicotinic acid | ESD-857568-250MG |
| Cas.: 1251734-12-9 | Purity: 97% | tert-Butyl (5-methylthiophen-3-yl)carbamate | ESD-846293-1G |
| Cas.: 1251734-12-9 | Purity: 97% | tert-Butyl (5-methylthiophen-3-yl)carbamate | ESD-846293-5G |
| Cas.: 884495-14-1 | Purity: 98% | 5-Bromo-2-methoxy-4-methyl-3-nitropyridine | ESD-829336-25G |
| Cas.: 884495-14-1 | Purity: 98% | 5-Bromo-2-methoxy-4-methyl-3-nitropyridine | ESD-829336-100G |
| Cas.: 1260384-41-5 | Purity: 97% | 6,7-Difluoro-1H-indazole | ESD-840482-1G |
| Cas.: 37288-25-8 | Purity: ≥100, 000-500, 000 units/ml | Nuclease S1 from Aspergillus oryzae | ESD-864272-50KU |
| Cas.: 1260384-41-5 | Purity: 97% | 6,7-Difluoro-1H-indazole | ESD-840482-5G |
| Cas.: 98519-65-4 | Purity: 95% | 4-Bromo-7-chloroquinoline | ESD-849159-5G |
| Cas.: 98519-65-4 | Purity: 95% | 4-Bromo-7-chloroquinoline | ESD-849159-250MG |
| Cas.: 128607-22-7 | Purity: ≥98.0% | Ospemifene | ESD-863980-250MG |
| Cas.: 128607-22-7 | Purity: ≥98.0% | Ospemifene | ESD-863980-1G |
| Cas.: 128607-22-7 | Purity: ≥98.0% | Ospemifene | ESD-863980-5G |
| Cas.: 1016258-66-4 | Purity: 95% | 1-tert-Butyl 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-847900-250MG |
| Cas.: 1016258-66-4 | Purity: 95% | 1-tert-Butyl 4-ethyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-847900-1G |
| Cas.: 1355326-35-0 | Purity: ≥98% | AGI-5198 | ESD-864202-25MG |
| Cas.: 1355326-35-0 | Purity: ≥98% | AGI-5198 | ESD-864202-100MG |
| Cas.: 102266-15-9 | Purity: 95% | 3-nitro-6-phenylpyridin-2-amine | ESD-859342-100MG |
| Cas.: 536759-91-8 | Purity: 98% | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | ESD-855120-1G |
| Cas.: 1042141-37-6 | Purity: 98% | Methyl 2-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-841812-250MG |
| Cas.: 1042141-37-6 | Purity: 98% | Methyl 2-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-841812-1G |
| Cas.: 54125-61-0 | Purity: ≥98% | Methyl 2-Methyl-1-Oxo-1,2,3,4-Tetrahydronaphthalene-2-Carboxylate | ESD-860041-250MG |
| Cas.: 1356114-40-3 | Purity: 98% | Azetidin-3-yl acetate 2,2,2-trifluoroacetate | ESD-847357-1G |
| Cas.: 1356114-40-3 | Purity: 98% | Azetidin-3-yl acetate 2,2,2-trifluoroacetate | ESD-847357-5G |
| Cas.: 1060735-14-9 | Purity: ≥98% | 9-Phenyl-3,3′-bicarbazolyl | ESD-857856-250MG |
| Cas.: 1060735-14-9 | Purity: ≥98% | 9-Phenyl-3,3′-bicarbazolyl | ESD-857856-5G |
| Cas.: 1060735-14-9 | Purity: ≥98% | 9-Phenyl-3,3′-bicarbazolyl | ESD-857856-10G |
| Cas.: 1359764-39-8 | Purity: 98%, ee99% | (11bR)-4-hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-4-oxide-Dinaphtho[2,1-d:1′,2′-f][1,3,2] dioxaphosphepin | ESD-887860-1G |
| Cas.: 137281-08-4 | Purity: 97% | N-(4-Oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-847845-1G |
| Cas.: 137281-08-4 | Purity: 97% | N-(4-Oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-847845-5G |
| Cas.: 116650-34-1 | Purity: 98% | (S)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine | ESD-842343-250MG |
| Cas.: 116650-34-1 | Purity: 98% | (S)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine | ESD-842343-1G |
| Cas.: 116650-34-1 | Purity: 98% | (S)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine | ESD-842343-5G |
| Cas.: 1398395-83-9 | Purity: 99,5% | 2-Decyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene | ESD-871402-25MG |
| Cas.: 117499-16-8 | Purity: 97% | Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-847608-5G |
| Cas.: 117499-16-8 | Purity: 97% | Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-847608-10G |
| Cas.: 1246401-49-9 | Purity: ≥95%, 99%ee | (4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole] | ESD-854130-250MG |
| Cas.: 1246401-49-9 | Purity: ≥95%, 99%ee | (4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole] | ESD-854130-1G |
| Cas.: 1313-13-9 | Purity: 90%, gamma | Manganese dioxide | ESD-916720-10KG |
| Cas.: 1313-13-9 | Purity: 90%, gamma | Manganese dioxide | ESD-916720-2.5KG |
| Cas.: 1313-13-9 | Purity: 90%, gamma | Manganese dioxide | ESD-916720-500G |
| Cas.: 1426821-11-5 | Purity: ≥97% | BOC-Oxyma | ESD-874026-25G |
| Cas.: 147403-52-9 | Purity: 98% | Methyl 2-ethoxy-1-((2′-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)methyl )-1H-benzo[d]imidazole-7-carboxylate | ESD-846136-1G |
| Cas.: 77185-71-8 | Purity: 96% | 6-Bromo-2-phenyl-1H-indole | ESD-847727-250MG |
| Cas.: 77185-71-8 | Purity: 96% | 6-Bromo-2-phenyl-1H-indole | ESD-847727-1G |
| Cas.: 1289942-66-0 | Purity: 98% | 2-[3-fluoro-4-(methylcarbamoyl)anilino]-2-methyl-propanoic acid | ESD-856331-1G |
| Cas.: 1289942-66-0 | Purity: 98% | 2-[3-fluoro-4-(methylcarbamoyl)anilino]-2-methyl-propanoic acid | ESD-856331-10G |
| Cas.: 1289942-66-0 | Purity: 98% | 2-[3-fluoro-4-(methylcarbamoyl)anilino]-2-methyl-propanoic acid | ESD-856331-25G |
| Cas.: 1313-13-9 | Purity: 99%, beta type | Manganese dioxide | ESD-916721-2.5KG |
| Cas.: 1313-13-9 | Purity: 99%, beta type | Manganese dioxide | ESD-916721-500G |
| Cas.: 1314538-55-0 | Purity: 95% | Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate | ESD-845751-1G |
| Cas.: 1496637-05-8 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis([1,1′:3′,1”-terphenyl]-5′-yl)-4-oxide-dinaphtho[2,1-d:1′ ,2′-f][1,3,2]dioxaphosphepin | ESD-854219-250MG |
| Cas.: 1314538-55-0 | Purity: 95% | Potassium (((tert-butoxycarbonyl)amino)methyl)trifluoroborate | ESD-845751-5G |
| Cas.: 1496637-05-8 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis([1,1′:3′,1”-terphenyl]-5′-yl)-4-oxide-dinaphtho[2,1-d:1′ ,2′-f][1,3,2]dioxaphosphepin | ESD-854219-1G |
| Cas.: 849062-36-8 | Purity: ≥98% | 3-Bromo-5-Methylphenylboronic Acid | ESD-858079-1G |
| Cas.: 1365655-91-9 | Purity: ≥95% | N-Boc-3-[2-(2-aminoethoxy)ethoxy]propionic Acid | ESD-852039-5G |
| Cas.: 1365655-91-9 | Purity: ≥95% | N-Boc-3-[2-(2-aminoethoxy)ethoxy]propionic Acid | ESD-852039-100MG |
| Cas.: 1370411-44-1 | Purity: 95% | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-845446-1G |
| Cas.: 1370411-44-1 | Purity: 95% | Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-845446-5G |
| Cas.: 139986-03-1 | Purity: 95% | (R)-tert-Butyl 3-(tosyloxy)pyrrolidine-1-carboxylate | ESD-848145-250MG |
| Cas.: 139986-03-1 | Purity: 95% | (R)-tert-Butyl 3-(tosyloxy)pyrrolidine-1-carboxylate | ESD-848145-1G |
| Cas.: 157904-67-1 | Purity: ≥98%, 99%ee | (4R,4’R,5S,5’S)-2,2′-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole] | ESD-854124-250MG |
| Cas.: 157904-67-1 | Purity: ≥98%, 99%ee | (4R,4’R,5S,5’S)-2,2′-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole] | ESD-854124-1G |
| Cas.: 161611-46-7 | Purity: 95% | Ethyl 6-chloropyrazine-2-carboxylate | ESD-846510-250MG |
| Cas.: 161611-46-7 | Purity: 95% | Ethyl 6-chloropyrazine-2-carboxylate | ESD-846510-1G |
| Cas.: 161611-46-7 | Purity: 95% | Ethyl 6-chloropyrazine-2-carboxylate | ESD-846510-5G |
| Cas.: 15811-32-2 | Purity: 98% | 2′,3′,5′-Tri-O-acetyl-2-fluoroadenosine | ESD-843927-5G |
| Cas.: 15811-32-2 | Purity: 98% | 2′,3′,5′-Tri-O-acetyl-2-fluoroadenosine | ESD-843927-10G |
| Cas.: 1619264-45-7 | Purity: 95% | Methyl 2-amino-6-chlorobenzoate hydrochloride | ESD-844894-5G |
| Cas.: 1619264-45-7 | Purity: 95% | Methyl 2-amino-6-chlorobenzoate hydrochloride | ESD-844894-10G |
| Cas.: 1619264-45-7 | Purity: 95% | Methyl 2-amino-6-chlorobenzoate hydrochloride | ESD-844894-25G |
| Cas.: 3055-99-0 | Purity: n=9, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-837206-2.5KG |
| Cas.: 17827-61-1 | Purity: 95% | Methyl 1-Methylpyrazole-3-carboxylate | ESD-851193-25G |
| Cas.: 10035-10-6 | Purity: AR, 40% | Hydrobromic acid | ESD-811365-500G |
| Cas.: 90004-94-7 | Purity: 98% | 1-(4-Bromo-2-nitrophenyl)ethanone | ESD-842043-1G |
| Cas.: 1619264-47-9 | Purity: 95% | (1-(Pyridin-3-yl)piperidin-4-yl)methanol | ESD-848467-1G |
| Cas.: 166328-07-0 | Purity: 98% | POTASSIUM (1-NAPHTHALENE)TRIFLUOROBORATE | ESD-886747-25G |
| Cas.: 913699-13-5 | Purity: ≥98%, 99%ee | (2S)-2-[Bis[3,5-bis(trifluoromethyl)phenyl]-[(tert-butyldimethylsilyl)oxy]methyl]pyrrolidine | ESD-854310-250MG |
| Cas.: 1706-12-3 | Purity: 98% | 1-Methyl-4-phenoxybenzene | ESD-840205-5G |
| Cas.: 1706-12-3 | Purity: 98% | 1-Methyl-4-phenoxybenzene | ESD-840205-25G |
| Cas.: 1806995-45-8 | Purity: 98% | (4-Amino-5-bromopyridin-3-yl)methanol | ESD-848018-250MG |
| Cas.: 1806995-45-8 | Purity: 98% | (4-Amino-5-bromopyridin-3-yl)methanol | ESD-848018-1G |
| Cas.: 18931-61-8 | Purity: 97% | 1-(4-Bromophenyl)-4,4,4-trifluorobutane-1,3-dione | ESD-856174-5G |
| Cas.: 1330-43-4 | Purity: 99.5% metals basis | Borax Anhydrous | ESD-916722-2.5KG |
| Cas.: 874902-19-9 | Purity: ≥99% | LY2183240 | ESD-876864-250MG |
| Cas.: 53651-69-7 | Purity: 98% | Propyl (S)-(-)-lactate | ESD-856936-100G |
| Cas.: 1330-43-4 | Purity: 99.5% metals basis | Borax Anhydrous | ESD-916722-500G |
| Cas.: 7732-18-5 | Sterile ddH2O | ESD-916723-500ML | |
| Cas.: 25878-60-8 | Purity: 95% | 1,2,3,4,6-penta-o-acetyl-d-galactopyranose | ESD-908798-500G |
| Cas.: 2005443-90-1 | Purity: ≥98%, 99%ee | (3aR,3’aR,8aS,8’aS)-2,2′-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | ESD-854132-250MG |
| Cas.: 2005443-90-1 | Purity: ≥98%, 99%ee | (3aR,3’aR,8aS,8’aS)-2,2′-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | ESD-854132-1G |
| Cas.: 2095393-15-8 | Purity: 99% | ARQ 531 | ESD-872774-10MG |
| Cas.: 7732-18-5 | Sterile ddH2O | ESD-916723-10*1ML | |
| Cas.: 471-34-1 | Purity: SP | Calcium carbonate | ESD-805320-100G |
| Cas.: 471-34-1 | Purity: SP | Calcium carbonate | ESD-805320-500G |
| Cas.: 28048-33-1 | Purity: ≥98% | 3-(2-Pyridyl)-5,6-bis(4-sulfophenyl)-1,2,4-triazine Disodium Salt Hydrate | ESD-867603-1G |
| Cas.: 736142-26-0 | Purity: 98%, ee99% | 1-(11bR)-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl-Pyrrolidine | ESD-857090-250MG |
| Cas.: 736142-26-0 | Purity: 98%, ee99% | 1-(11bR)-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl-Pyrrolidine | ESD-857090-1G |
| Cas.: 736142-26-0 | Purity: 98%, ee99% | 1-(11bR)-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl-Pyrrolidine | ESD-857090-5G |
| Cas.: 25212-74-2 | Purity: pellets, viscosity 1, 400 poise (310 °C)(lit.) | Poly(1,4-phenylene sulfide) | ESD-916725-25G |
| Cas.: 742076-06-8 | Purity: 95% | 1-(Piperidin-4-yl)-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-847084-1G |
| Cas.: 742076-06-8 | Purity: 95% | 1-(Piperidin-4-yl)-2-(trifluoromethyl)-1H-benzo[d]imidazole | ESD-847084-5G |
| Cas.: 775351-56-9 | Purity: 95% | 2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845225-1G |
| Cas.: 775351-56-9 | Purity: 95% | 2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-845225-5G |
| Cas.: 81167-60-4 | Purity: 97% | 4-(tert-Butyl)-2-chloropyridine | ESD-845650-1G |
| Cas.: 81167-60-4 | Purity: 97% | 4-(tert-Butyl)-2-chloropyridine | ESD-845650-5G |
| Cas.: 81167-60-4 | Purity: 97% | 4-(tert-Butyl)-2-chloropyridine | ESD-845650-25G |
| Cas.: 81167-60-4 | Purity: 97% | 4-(tert-Butyl)-2-chloropyridine | ESD-845650-100G |
| Cas.: 1361119-48-3 | Purity: 97% | 4,4-(Anthracene-9,10-diylbis(ethyne-2,1-diyl))dibenzaldehyde | ESD-916726-250MG |
| Cas.: 81803-60-3 | Purity: 98% | Ethyl imidazo[1,5-a]pyridine-3-carboxylate | ESD-846013-250MG |
| Cas.: 219803-57-3 | Purity: 95% | (S)-2-Aminobut-3-en-1-ol hydrochloride | ESD-838989-1G |
| Cas.: 81803-60-3 | Purity: 98% | Ethyl imidazo[1,5-a]pyridine-3-carboxylate | ESD-846013-1G |
| Cas.: 81803-60-3 | Purity: 98% | Ethyl imidazo[1,5-a]pyridine-3-carboxylate | ESD-846013-5G |
| Cas.: 10101-39-0 | Purity: 200 mesh, 99% | Calcium silicate | ESD-914765-50G |
| Cas.: 10101-39-0 | Purity: 200 mesh, 99% | Calcium silicate | ESD-914765-250G |
| Cas.: 875446-29-0 | Purity: 98% | (4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid | ESD-855213-1G |
| Cas.: 875446-29-0 | Purity: 98% | (4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid | ESD-855213-25G |
| Cas.: 22433-89-2 | Purity: 98% | 4-Bromoisophthalonitrile | ESD-840934-1G |
| Cas.: 22433-89-2 | Purity: 98% | 4-Bromoisophthalonitrile | ESD-840934-5G |
| Cas.: 1374764-27-8 | 5′-(3,5-Dicarboxyphenyl)-2′,4′,6′-trimethyl-[1,1′:3′,1”-terphenyl]-3,3”,5,5”- tetracarboxylic acid | ESD-916727-250MG | |
| Cas.: 886496-95-3 | Purity: ≥98% | 2-(3-Chloro-5-(trifluoromethyl)phenyl)acetonitrile | ESD-857685-1G |
| Cas.: 886496-95-3 | Purity: ≥98% | 2-(3-Chloro-5-(trifluoromethyl)phenyl)acetonitrile | ESD-857685-5G |
| Cas.: 886496-95-3 | Purity: ≥98% | 2-(3-Chloro-5-(trifluoromethyl)phenyl)acetonitrile | ESD-857685-25G |
| Cas.: 22775-37-7 | Purity: 98% | 3,5-Dichloro-2-methoxybenzoic acid | ESD-841769-250MG |
| Cas.: 113919-79-2 | Purity: 97% | 6′-(Pyridin-4-yl)-4,2′:4′,4”-terpyridine | ESD-916728-250MG |
| Cas.: 22775-37-7 | Purity: 98% | 3,5-Dichloro-2-methoxybenzoic acid | ESD-841769-1G |
| Cas.: 90086-41-2 | Purity: 97% | 1-(4-Iodophenyl)ethanamine | ESD-847575-250MG |
| Cas.: 90086-41-2 | Purity: 97% | 1-(4-Iodophenyl)ethanamine | ESD-847575-1G |
| Cas.: 90086-41-2 | Purity: 97% | 1-(4-Iodophenyl)ethanamine | ESD-847575-5G |
| Cas.: 136768-57-5 | Purity: 97% | N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)ethane-1,2-diamine | ESD-916729-1G |
| Cas.: 929097-92-7 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854201-250MG |
| Cas.: 929097-92-7 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854201-1G |
| Cas.: 929097-92-7 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854201-5G |
| Cas.: 170384-29-9 | Purity: 97% | tert-Butyl (2-oxopropyl)carbamate | ESD-895088-25G |
| Cas.: 939426-84-3 | Purity: 98% | Benzyl (3-hydroxycyclopentyl)carbamate | ESD-843169-250MG |
| Cas.: 939426-84-3 | Purity: 98% | Benzyl (3-hydroxycyclopentyl)carbamate | ESD-843169-1G |
| Cas.: 939426-84-3 | Purity: 98% | Benzyl (3-hydroxycyclopentyl)carbamate | ESD-843169-5G |
| Cas.: 940-07-8 | Purity: 95% | Pyrazine-2,6-dicarboxylic acid | ESD-846094-1G |
| Cas.: 940-07-8 | Purity: 95% | Pyrazine-2,6-dicarboxylic acid | ESD-846094-5G |
| Cas.: 175481-36-4 | Purity: 99,5% | Lacosamide | ESD-916730-10MG |
| Cas.: 175481-36-4 | Purity: 99,5% | Lacosamide | ESD-916730-50MG |
| Cas.: 175481-36-4 | Purity: 99,5% | Lacosamide | ESD-916730-500MG |
| Cas.: 101376-25-4 | Purity: 97% | (S)-(4-Benzylmorpholin-3-yl)methanol | ESD-841547-1G |
| Cas.: 101376-25-4 | Purity: 97% | (S)-(4-Benzylmorpholin-3-yl)methanol | ESD-841547-5G |
| Cas.: 10323-39-4 | Purity: ≥95% | 4-Bromo-2-tert-butylphenol | ESD-866966-5G |
| Cas.: 10323-39-4 | Purity: ≥95% | 4-Bromo-2-tert-butylphenol | ESD-866966-25G |
| Cas.: 10397-52-1 | Purity: 98% | 5,5′-Methylenediisophthalic acid | ESD-916731-250MG |
| Cas.: 10323-39-4 | Purity: ≥95% | 4-Bromo-2-tert-butylphenol | ESD-866966-100G |
| Cas.: 1086111-17-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845346-1G |
| Cas.: 1086111-17-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845346-5G |
| Cas.: 24522-30-3 | Purity: 98% | 2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide | ESD-864533-5G |
| Cas.: 1086111-17-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845346-25G |
| Cas.: 1086111-17-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-845346-100G |
| Cas.: 813-78-5 | Purity: 96% | Dimethyl phosphate | ESD-885091-250MG |
| Cas.: 175481-36-4 | Purity: ≥95% | Lacosamide | ESD-916732-1G |
| Cas.: 26583-60-8 | Purity: ≥95% | 2-(2-Methylphenoxy)ethylamine | ESD-853259-25G |
| Cas.: 26583-60-8 | Purity: ≥95% | 2-(2-Methylphenoxy)ethylamine | ESD-853259-250MG |
| Cas.: 175481-36-4 | Purity: ≥95% | Lacosamide | ESD-916732-250MG |
| Cas.: 1235406-42-4 | Purity: 98% | tert-Butyl thiazol-4-ylcarbamate | ESD-847694-5G |
| Cas.: 271261-71-3 | Purity: 95% | Methyl 2,4-dihydroxy-5-nitrobenzoate | ESD-846118-1G |
| Cas.: 1235406-42-4 | Purity: 98% | tert-Butyl thiazol-4-ylcarbamate | ESD-847694-25G |
| Cas.: 271261-71-3 | Purity: 95% | Methyl 2,4-dihydroxy-5-nitrobenzoate | ESD-846118-5G |
| Cas.: 7757-82-6 | Purity: Pesticide grade | Sodium sulfate anhydrous | ESD-818063-25G |
| Cas.: 1313712-35-4 | Purity: 97% | 2-(4-Fluoro-1H-indol-1-yl)acetic acid | ESD-846876-250MG |
| Cas.: 1313712-35-4 | Purity: 97% | 2-(4-Fluoro-1H-indol-1-yl)acetic acid | ESD-846876-1G |
| Cas.: 1313712-35-4 | Purity: 97% | 2-(4-Fluoro-1H-indol-1-yl)acetic acid | ESD-846876-5G |
| Cas.: 121521-90-2 | Purity: 98% | Lithospermic acid B | ESD-902412-100MG |
| Cas.: 1217501-12-6 | Purity: 98% | 2-Bromo-4-fluorophenylboronic acid | ESD-886662-250MG |
| Cas.: 28244-94-2 | Purity: ≥98% | 4-Methylphenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside | ESD-886696-25G |
| Cas.: 131674-40-3 | Purity: 98% | 1-(2-Methoxypyridin-3-yl)ethanone | ESD-845349-1G |
| Cas.: 13395-85-2 | Purity: 95% | 2-(tert-Butyl)-4-chlorophenol | ESD-839668-250MG |
| Cas.: 13395-85-2 | Purity: 95% | 2-(tert-Butyl)-4-chlorophenol | ESD-839668-1G |
| Cas.: 13395-85-2 | Purity: 95% | 2-(tert-Butyl)-4-chlorophenol | ESD-839668-5G |
| Cas.: 1360938-13-1 | Purity: 98% | (6-Chloro-5-iodopyridin-3-yl)methanol | ESD-842448-1G |
| Cas.: 1360938-13-1 | Purity: 98% | (6-Chloro-5-iodopyridin-3-yl)methanol | ESD-842448-5G |
| Cas.: 3543-02-0 | Purity: 95% | 3,5-DIHYDROXYPYRIDINE | ESD-833763-250MG |
| Cas.: 3543-02-0 | Purity: 95% | 3,5-DIHYDROXYPYRIDINE | ESD-833763-1G |
| Cas.: 3543-02-0 | Purity: 95% | 3,5-DIHYDROXYPYRIDINE | ESD-833763-5G |
| Cas.: 175481-36-4 | Purity: ≥95% | Lacosamide | ESD-916732-5G |
| Cas.: 124499-37-2 | Purity: 95% | 1,4-DIOXASPIRO[4.5]DECANE-8-ACETONITRILE | ESD-883703-250MG |
| Cas.: 35657-41-1 | Purity: 95% | tert-Butyl (4-nitrobenzoyl)oxycarbamate | ESD-847829-1G |
| Cas.: 35657-41-1 | Purity: 95% | tert-Butyl (4-nitrobenzoyl)oxycarbamate | ESD-847829-5G |
| Cas.: 284049-75-8 | Purity: 98% | 1-butyl-3-methylimidazolium acetate | ESD-831361-250G |
| Cas.: 35688-18-7 | Purity: 95% | N-(Methylsulfonyl)glycine | ESD-850521-250MG |
| Cas.: 1352925-95-1 | Purity: 95% | TERT-BUTYL 4-BENZYL-3-OXO-1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE-9-CARBOXYLATE | ESD-883065-250MG |
| Cas.: 361342-55-4 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-bis([1,1′:3′,1”-terphenyl]-5′-yl)-4-oxide-dinaphtho[2,1-d:1′ ,2′-f][1,3,2]dioxaphosphepin | ESD-854218-250MG |
| Cas.: 361342-55-4 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-bis([1,1′:3′,1”-terphenyl]-5′-yl)-4-oxide-dinaphtho[2,1-d:1′ ,2′-f][1,3,2]dioxaphosphepin | ESD-854218-1G |
| Cas.: 1352925-95-1 | Purity: 95% | TERT-BUTYL 4-BENZYL-3-OXO-1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE-9-CARBOXYLATE | ESD-883065-50MG |
| Cas.: 36635-66-2 | Purity: ≥98% | α-(p-Toluenesulfonyl)benzyl Isocyanide | ESD-868613-1G |
| Cas.: 36635-66-2 | Purity: ≥98% | α-(p-Toluenesulfonyl)benzyl Isocyanide | ESD-868613-5G |
| Cas.: 14091-16-8 | Purity: ≥98% | 4-(Trifluoromethyl)-DL-Phenylalanine | ESD-859582-50MG |
| Cas.: 38480-94-3 | Purity: 97% | 2′,3′-Dimethoxyacetophenone | ESD-846333-1G |
| Cas.: 38480-94-3 | Purity: 97% | 2′,3′-Dimethoxyacetophenone | ESD-846333-5G |
| Cas.: 39835-08-0 | Purity: 98% | 6-Nitrobenzo[d]isoxazole | ESD-841507-250MG |
| Cas.: 39835-08-0 | Purity: 98% | 6-Nitrobenzo[d]isoxazole | ESD-841507-1G |
| Cas.: 885278-74-0 | Purity: 97% | Ethyl 1H-indazole-7-carboxylate | ESD-842183-5G |
| Cas.: 689-11-2 | Purity: ≥98% | N-sec-Butylurea | ESD-860183-100G |
| Cas.: 5094-24-6 | Purity: 97% | 2-Hydroxybutyric acid sodium salt | ESD-810788-100G |
| Cas.: 89943-12-4 | Purity: ≥97% | 4-Amino-2-ethoxypyridine | ESD-853330-250MG |
| Cas.: 147740-02-1 | Purity: 96% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridine Dihydrochloride | ESD-852867-250MG |
| Cas.: 7154-66-7 | Purity: 98% | 2-Bromobenzoyl chloride | ESD-831559-100G |
| Cas.: 151075-20-6 | Purity: 97% | 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-CYCLOHEXENE-1-CARBOXYLIC ACID METHYL ESTER | ESD-832172-50MG |
| Cas.: 86347-15-1 | Purity: ≥99% | Medetomidine HCl | ESD-863907-250MG |
| Cas.: 86347-15-1 | Purity: ≥99% | Medetomidine HCl | ESD-863907-1G |
| Cas.: 86347-15-1 | Purity: ≥99% | Medetomidine HCl | ESD-863907-5G |
| Cas.: 13078-79-0 | Purity: 98% | 2-(3-Chlorophenyl)ethylamine | ESD-831089-25G |
| Cas.: 2922-42-1 | Purity: 98% | 3-Dehydroshikimic acid | ESD-915475-1G |
| Cas.: 4341-24-6 | Purity: ≥98% | 5-methylcyclohexane-1,3-dione | ESD-827805-25G |
| Cas.: 4341-24-6 | Purity: ≥98% | 5-methylcyclohexane-1,3-dione | ESD-827805-5G |
| Cas.: 136725-55-8 | Purity: 97% | (R)-3-Fluoropyrrolidine hydrochloride | ESD-848152-5G |
| Cas.: 136725-55-8 | Purity: 97% | (R)-3-Fluoropyrrolidine hydrochloride | ESD-848152-25G |
| Cas.: 4341-24-6 | Purity: ≥98% | 5-methylcyclohexane-1,3-dione | ESD-827805-1G |
| Cas.: 1611493-60-7 | Purity: ≥98% | Bictegravir | ESD-881808-25MG |
| Cas.: 1611493-60-7 | Purity: ≥98% | Bictegravir | ESD-881808-100MG |
| Cas.: 24464-63-9 | Purity: 98% | 1-Decylboronic acid | ESD-857060-25G |
| Cas.: 26032-72-4 | Purity: ≥97% | 2,4-Dichloro-6-phenylpyrimidine | ESD-852233-5G |
| Cas.: 15345-89-8 | Purity: ≥98%(HPLC) | Desmethoxyyangonin | ESD-861264-5MG |
| Cas.: 402927-97-3 | Purity: 97% | 4-Amino-1-(methylsulfonyl)piperidine | ESD-840861-5G |
| Cas.: 402927-97-3 | Purity: 97% | 4-Amino-1-(methylsulfonyl)piperidine | ESD-840861-25G |
| Cas.: 6642-29-1 | Purity: 95% | 4-Nitro-1,8-naphthalic anhydride | ESD-916557-100MG |
| Cas.: 1640995-60-3 | Purity: 97% | tert-Butyl ((6-chloropyridin-2-yl)methyl)carbamate | ESD-846477-1G |
| Cas.: 180465-84-3 | Purity: 95% | tert-Butyl spiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-881218-250MG |
| Cas.: 79932-20-0 | Purity: ≥97% | 2-Amino-4-isopropylthiazole | ESD-853286-250MG |
| Cas.: 811841-81-3 | Purity: 98% | 2-Amino-1-(butyldimethylsiloxy)butane | ESD-829463-1G |
| Cas.: 197632-75-0 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid | ESD-846607-1G |
| Cas.: 248924-59-6 | Purity: 98% | 3-Furanboronic acid pinacol ester | ESD-830156-1G |
| Cas.: 58-71-9 | Purity: 98% | Cephalothin sodium salt | ESD-854724-5G |
| Cas.: 74168-69-7 | Purity: 96% | (5-chlorothiophen-2-yl)methanol | ESD-857812-5G |
| Cas.: 144104-59-6 | Purity: ≥95% | 1H-indol-5-yl-5-boronic acid | ESD-825801-1G |
| Cas.: 144104-59-6 | Purity: ≥95% | 1H-indol-5-yl-5-boronic acid | ESD-825801-25G |
| Cas.: 850567-47-4 | Purity: 98% | 1-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole | ESD-916733-250MG |
| Cas.: 850567-47-4 | Purity: 98% | 1-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole | ESD-916733-1G |
| Cas.: 7153-22-2 | Purity: ≥98%(GC) | 4-Cyanobenzoic Acid Ethyl Ester | ESD-861969-25G |
| Cas.: 2641-34-1 | Purity: ≥95.0%(GC) | 2,5-Bis(trifluoromethyl)-3,6-dioxaundecafluorononanoyl Fluoride | ESD-855150-1G |
| Cas.: 147621-18-9 | Purity: ≥95% | 1H-indol-6-yl-6-boronic acid | ESD-825846-1G |
| Cas.: 3230-35-1 | Purity: 96% | 6-Nitronaphthalen-2-amine | ESD-848572-1G |
| Cas.: 1071224-34-4 | Purity: >98.0%(GC) | 7-Bromo-2,1,3-benzothiadiazole-4-carboxaldehyde | ESD-854474-250MG |
| Cas.: 1071224-34-4 | Purity: >98.0%(GC) | 7-Bromo-2,1,3-benzothiadiazole-4-carboxaldehyde | ESD-854474-1G |
| Cas.: 359-70-6 | Purity: 90% | Perfluorotriethylamine | ESD-889436-100G |
| Cas.: 867267-24-1 | Purity: 97% | 2,5-Dimethoxy Pyridine | ESD-829478-250MG |
| Cas.: 33142-21-1 | Purity: ≥95% | Ethyl 2-Chloro-3-oxopropanoate | ESD-852100-5G |
| Cas.: 26837-42-3 | Purity: average Mw ~(162.21)n, beige | Poly(vinyl sulfate) potassium salt | ESD-916680-5G |
| Cas.: 38257-52-2 | Purity: 98% | 4-Iodo-N,N-diphenylaniline | ESD-835811-10G |
| Cas.: 122860-33-7 | Purity: 97% | Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate | ESD-842948-25G |
| Cas.: 143900-43-0 | Purity: 97% | |R|-1-Boc-3-hydroxypiperidine | ESD-803665-100G |
| Cas.: 143900-43-0 | Purity: 97% | |R|-1-Boc-3-hydroxypiperidine | ESD-803665-500G |
| Cas.: 928773-42-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one | ESD-916734-250MG |
| Cas.: 928773-42-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one | ESD-916734-1G |
| Cas.: 885519-23-3 | Purity: 95% | 4-BroMo-6-chloro-1H-indole | ESD-832176-250MG |
| Cas.: 174722-31-7 | Purity: ≥95%, 10mg/ml Solution | Rituximab | ESD-872466-5MG |
| Cas.: 50508-66-2 | Purity: 98% | 2-AMino-3-(p-chlorobenzoyl)-4,5-diMethylthiophene | ESD-887104-5G |
| Cas.: 50508-66-2 | Purity: 98% | 2-AMino-3-(p-chlorobenzoyl)-4,5-diMethylthiophene | ESD-887104-25G |
| Cas.: 531508-46-0 | Purity: ≥95% | 4-(Aminomethyl)-2,2-difluoro-1,3-benzodioxole | ESD-853521-250MG |
| Cas.: 13148-61-3 | Purity: 97% | 2-Ethyl-1,3,4-oxadiazole | ESD-838868-1G |
| Cas.: 1374657-02-9 | Purity: 98% | 4-BroMo-1-(oxetan-3-yl)-1H-pyrazole | ESD-855626-250MG |
| Cas.: 91914-06-6 | Purity: ≥98% | 2-Hydroxy-5-Methylpyridine | ESD-858745-5G |
| Cas.: 1458-03-3 | Purity: 98% | Methyl 3-amino-6-chloropyrazine-2-carboxylate | ESD-856378-5G |
| Cas.: 1458-03-3 | Purity: 98% | Methyl 3-amino-6-chloropyrazine-2-carboxylate | ESD-856378-1G |
| Cas.: 1475-11-2 | Purity: ≥97% | 1-(3,4-Dichlorophenyl)ethanol | ESD-852559-5G |
| Cas.: 614731-04-3 | Purity: ≥97% | 1-Boc-4-fluoro-4-piperidinecarboxylic Acid | ESD-850397-250MG |
| Cas.: 62013-04-1 | Purity: ≥97% | Dirithromycin | ESD-864080-5G |
| Cas.: 158937-25-8 | Purity: 95% | (4′-(Pentyloxy)-[1,1′-biphenyl]-4-yl)boronic acid | ESD-845237-5G |
| Cas.: 62396-48-9 | Purity: 97% | Boc-D-Asp-OH | ESD-842643-25G |
| Cas.: 17193-39-4 | Purity: 97% | (S)-Methyl 2-amino-3-cyclohexylpropanoate hydrochloride | ESD-844206-5G |
| Cas.: 636559-55-2 | Purity: 98%, ee99% | 1-(11bR)-Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl-piperidine | ESD-857122-250MG |
| Cas.: 636559-55-2 | Purity: 98%, ee99% | 1-(11bR)-Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl-piperidine | ESD-857122-1G |
| Cas.: 6940-58-5 | Purity: ≥98% | 1,3,5-Pentanetricarboxylic Acid | ESD-865358-25G |
| Cas.: 80253-38-9 | Purity: 98% | Ethyl 3-Amino-2,2-dimethylpropanoate Hydrochloride | ESD-850465-5G |
| Cas.: 80253-38-9 | Purity: 98% | Ethyl 3-Amino-2,2-dimethylpropanoate Hydrochloride | ESD-850465-10G |
| Cas.: 80253-38-9 | Purity: 98% | Ethyl 3-Amino-2,2-dimethylpropanoate Hydrochloride | ESD-850465-25G |
| Cas.: 185411-12-5 | Purity: 97% | Methyl 3-(trimethylsilyl)pent-4-enoate | ESD-844833-5G |
| Cas.: 81279-39-2 | Purity: 95% | 5′-O-DMT-2′-O-iBu-N-Bz-Guanosine | ESD-848053-5G |
| Cas.: 81279-39-2 | Purity: 95% | 5′-O-DMT-2′-O-iBu-N-Bz-Guanosine | ESD-848053-10G |
| Cas.: 98977-36-7 | Purity: 98% | N-BOC-3-piperidone | ESD-824026-500G |
| Cas.: 832114-04-2 | Purity: 98% | 4,4,5,5-tetramethyl-2-[2-(trifluoromethoxy)phenyl]-1,3,2-dioxaborolane | ESD-886811-5G |
| Cas.: 83345-44-2 | Purity: 95% | Boc-HoSer-OH | ESD-847122-1G |
| Cas.: 947534-69-2 | Purity: 98% | 2,5-Dibromo-4-methyl-3-nitropyridine | ESD-855175-250MG |
| Cas.: 83345-44-2 | Purity: 95% | Boc-HoSer-OH | ESD-847122-250MG |
| Cas.: 851784-82-2 | Purity: 98% | 2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | ESD-843575-5G |
| Cas.: 851784-82-2 | Purity: 98% | 2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | ESD-843575-25G |
| Cas.: 10602-03-6 | Purity: ≥95% | Ethyl 4-Ethynylbenzoate | ESD-851085-250MG |
| Cas.: 61545-99-1 | Purity: 98% | 1-Octyl-3-methylimidazolium bromide | ESD-815123-500G |
| Cas.: 859217-67-7 | Purity: 95% | 4,4-Dimethylcyclohexene-1-boronic Acid Pinacol Ester | ESD-850740-5G |
| Cas.: 201162-53-0 | Purity: 98% | 3-Boc-3,8-Diazabicyclo[3.2.1]octane | ESD-845403-1G |
| Cas.: 202207-78-1 | Purity: ≥97% | Nt-Butyloxycarbonyl-N-Methyl-Ethylenediamine | ESD-859083-250MG |
| Cas.: 21091-98-5 | Purity: 95% | (4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone | ESD-846525-5G |
| Cas.: 1576-87-0 | Purity: 95% | trans-2-Pentenal | ESD-831327-25G |
| Cas.: 22262-60-8 | Purity: ≥97%(GC) | Methyl 3-Bromo-2-(bromomethyl)propionate | ESD-863459-1G |
| Cas.: 2174-58-5 | Purity: ≥98%(GC)(T) | (S)-(-)-Methylsuccinic Acid | ESD-863354-250MG |
| Cas.: 106-46-7 | Purity: 100μg/ml, solvent: methanol | 1,4-Dichlorobenzene solution | ESD-854502-2ML |
| Cas.: 49669-26-3 | Purity: 97% | 2,2′-BIPYRIDINE-6,6′-DICARBALDEHYDE | ESD-888133-5G |
| Cas.: 63195-39-1 | Purity: 98% | 2,5,6-Trichloro-4-methylnicotinonitrile | ESD-845709-1G |
| Cas.: 63195-39-1 | Purity: 98% | 2,5,6-Trichloro-4-methylnicotinonitrile | ESD-845709-5G |
| Cas.: 2944-47-0 | Purity: 98% | Benzene,1-methoxy-2-(1-methylethyl)- | ESD-861114-25G |
| Cas.: 42482-06-4 | Purity: 95% | 2-Octen-1-ylsuccinic anhydride, mixture of cis and trans | ESD-822473-2.5KG |
| Cas.: 65710-58-9 | Purity: ≥98% | Boc-Dap(Z)-OH (Dicyclohexylammonium) Salt | ESD-860160-5G |
| Cas.: 65710-58-9 | Purity: ≥98% | Boc-Dap(Z)-OH (Dicyclohexylammonium) Salt | ESD-860160-25G |
| Cas.: 696-01-5 | Purity: 98% | 2-Fluoro-1,4-dimethylbenzene | ESD-838873-25G |
| Cas.: 696-01-5 | Purity: 98% | 2-Fluoro-1,4-dimethylbenzene | ESD-838873-100G |
| Cas.: 122702-20-9 | Purity: 95% | D(+)-serineamidehydrochloride | ESD-855216-250MG |
| Cas.: 205445-52-9 | Purity: ≥98% | N-Boc-L-3,5-difluorophenylalanine | ESD-853961-250MG |
| Cas.: 2455-14-3 | Purity: 97% | 3,3′,5,5′-Tetra-tert-butyldiphenoquinone | ESD-830486-100G |
| Cas.: 130309-37-4 | Purity: 98% | Fmoc-Oic-OH | ESD-844759-1G |
| Cas.: 2905-65-9 | Purity: 98% | Methyl 3-chlorobenzoate | ESD-839554-500G |
| Cas.: 193614-99-2 | Purity: 98% | 1,3,5-Tri(1H-tetrazol-5-yl)benzene | ESD-916736-250MG |
| Cas.: 1005-38-5 | Purity: 97% | 4-Amino-6-chloro-2-(methylthio)pyrimidine | ESD-831344-25G |
| Cas.: 1005-38-5 | Purity: 97% | 4-Amino-6-chloro-2-(methylthio)pyrimidine | ESD-831344-100G |
| Cas.: 50530-12-6 | Purity: 97% | 10-Bromodecanoic acid | ESD-805729-100G |
| Cas.: 13754-38-6 | Purity: 97% | 1-Benzoylpiperazine | ESD-835340-1G |
| Cas.: 59717-96-3 | Purity: 98% | 5-Bromo-2-phenoxypyridine | ESD-841204-5G |
| Cas.: 608145-27-3 | Purity: 97% | 2,5-Difluoroterephthalaldehyde | ESD-916737-250MG |
| Cas.: 14884-01-6 | Purity: ≥95% | 4-methoxy-1H-pyrazole | ESD-827215-250MG |
| Cas.: 3466-15-7 | Purity: Analysis control, ≥98% | Cyperotundone | ESD-889674-250ΜL |
| Cas.: 1639134-02-3 | Purity: 97% | 4,4′,4”,4”’-([2,2′-Bi(1,3-dithiolylidene)]-4,4′,5,5′-tetrayl)tetrabenzaldehyde | ESD-916738-250MG |
| Cas.: 1660996-72-4 | Purity: 95% | 1,1,2,2-Tetrakis(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethene | ESD-916739-250MG |
| Cas.: 15884-86-3 | Purity: 97% | 5-(Methoxymethyl)-1,3,4-thiadiazol-2-amine | ESD-844986-1G |
| Cas.: 13025-99-5 | Purity: 97% | N’-(Pyridin-4-ylmethylene)isonicotinohydrazide | ESD-916740-1G |
| Cas.: 159002-17-2 | Purity: 95% | 3-Amino-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-842396-5G |
| Cas.: 56962-11-9 | Purity: 97% | 2-CHLORO-4-HYDROXYBENZALDEHYDE | ESD-835458-500MG |
| Cas.: 23308-83-0 | Purity: 98% | (2-Nitrobenzyl)triphenylphosphonium bromide monohydrate | ESD-836342-5G |
| Cas.: 272792-14-0 | Purity: ≥97% | Methyl (4-Cyanophenoxy)acetate | ESD-851083-10G |
| Cas.: 18791-75-8 | Purity: 98% | 4-Bromothiophene-2-carboxaldehyde | ESD-831329-25G |
| Cas.: 272792-14-0 | Purity: ≥97% | Methyl (4-Cyanophenoxy)acetate | ESD-851083-25G |
| Cas.: 18791-75-8 | Purity: 98% | 4-Bromothiophene-2-carboxaldehyde | ESD-831329-5G |
| Cas.: 14757-78-9 | Purity: 96% | 3-bromofuran-2-carbaldehyde | ESD-825047-1G |
| Cas.: 14757-78-9 | Purity: 96% | 3-bromofuran-2-carbaldehyde | ESD-825047-250MG |
| Cas.: 14757-78-9 | Purity: 96% | 3-bromofuran-2-carbaldehyde | ESD-825047-100MG |
| Cas.: 312753-53-0 | Purity: 98% | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848601-1G |
| Cas.: 312753-53-0 | Purity: 98% | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | ESD-848601-5G |
| Cas.: 1934269-97-2 | Purity: 97% | 5,10-Di(naphthalen-2-yl)-5,10-dihydrophenazine | ESD-916741-50MG |
| Cas.: 1934269-97-2 | Purity: 97% | 5,10-Di(naphthalen-2-yl)-5,10-dihydrophenazine | ESD-916741-250MG |
| Cas.: NONE008 | Purity: 1000μg/mL matrix: water U=0.5% | Ammonia as N IC standard | ESD-821128-20ML |
| Cas.: 22236-10-8 | Purity: 97% | 4-(Difluoromethoxy)aniline | ESD-808487-25G |
| Cas.: 3164-13-4 | Purity: ≥98% | 2-(4-Bromophenyl)benzoxazole | ESD-866755-5G |
| Cas.: 361342-50-9 | Purity: ≥98%, 99%ee | (S)-3,3′-Bis(9-anthryl)-1,1′-binaphthyl-2,2′-diol | ESD-854021-250MG |
| Cas.: 361342-50-9 | Purity: ≥98%, 99%ee | (S)-3,3′-Bis(9-anthryl)-1,1′-binaphthyl-2,2′-diol | ESD-854021-50MG |
| Cas.: 37073-15-7 | Purity: ≥97% | 1-Methylsulfonylbenzotriazole | ESD-874008-250MG |
| Cas.: 70201-43-3 | Purity: >98.0%(GC) | 3-bromopyridine-4-carbaldehyde | ESD-825475-1G |
| Cas.: 37073-15-7 | Purity: ≥97% | 1-Methylsulfonylbenzotriazole | ESD-874008-5G |
| Cas.: 128071-91-0 | Purity: ≥98% | 2,4-Dibromopyridine-3-carboxaldehyde | ESD-857503-500MG |
| Cas.: 128071-91-0 | Purity: ≥98% | 2,4-Dibromopyridine-3-carboxaldehyde | ESD-857503-5G |
| Cas.: 4574-04-3 | Purity: CP | Tetradecyltrimethylammonium chloride | ESD-828231-2.5KG |
| Cas.: 406482-19-7 | Purity: 98% | 2-Fluoro-5-methoxyphenylboronic acid | ESD-820036-10G |
| Cas.: 898559-25-6 | Purity: 95% | 3,5-Dibromopicolinaldehyde | ESD-916742-1G |
| Cas.: 898559-25-6 | Purity: 95% | 3,5-Dibromopicolinaldehyde | ESD-916742-250MG |
| Cas.: 669066-91-5 | Purity: ≥95% | 5-bromo-3-fluoropyridine-2-carboxylic acid | ESD-825577-1G |
| Cas.: 4104-35-2 | Purity: 98% | 5-Chloro-3-methylbenzo[c]isoxazole | ESD-848416-250MG |
| Cas.: 4104-35-2 | Purity: 98% | 5-Chloro-3-methylbenzo[c]isoxazole | ESD-848416-1G |
| Cas.: 15933-59-2 | Purity: 95% | 1,1,3,3-Tetramethyl Disilazane | ESD-833852-100ML |
| Cas.: 31140-42-8 | Purity: 98% | 3-Boc-Amino-2,6-dioxopiperidine | ESD-843260-5G |
| Cas.: 7770-78-7 | Purity: ≥98%(HPLC) | (-)-Arctigenin | ESD-800798-1G |
| Cas.: 35656-89-4 | Purity: 97% | 4-(4-Bromophenyl)butanoic Acid | ESD-851802-5G |
| Cas.: 745784-12-7 | Purity: 95% | 2-Quinolinylboronic acid | ESD-822190-250MG |
| Cas.: 1405-97-6 | Purity: 98% | Gramicidin | ESD-882665-250MG |
| Cas.: 388082-78-8 | Purity: 98% | Lapatinib ditosylate hydrate | ESD-837829-5G |
| Cas.: 128071-84-1 | Purity: 97% | 4-Bromo-2-chloropyridine-3-carboxaldehyde | ESD-916743-1G |
| Cas.: 128071-84-1 | Purity: 97% | 4-Bromo-2-chloropyridine-3-carboxaldehyde | ESD-916743-250MG |
| Cas.: 5468-77-9 | Purity: 97% | 2-Bromo-N,N-dimethylacetamide | ESD-839090-25G |
| Cas.: 86050-77-3 | Purity: 99% | Gadopentetate dimeglumine | ESD-822288-1G |
| Cas.: 86050-77-3 | Purity: 99% | Gadopentetate dimeglumine | ESD-822288-5G |
| Cas.: 223259-63-0 | Purity: ≥98%, 99%ee | (S)-2,2′,3,3′-Tetrahydro-1,1′-spirobi[1H-indene]-7,7′-diol | ESD-854097-5G |
| Cas.: 6416-66-6 | Purity: 95% | Tracid Brilliant Red B | ESD-910145-5KG |
| Cas.: 454-16-0 | Purity: 97% | 1-Fluoro-2-methoxy-4-nitrobenzene | ESD-840239-100G |
| Cas.: 24937-79-9 | Purity: average Mw ~534, 000, powder | Poly(vinylidene fluoride) | ESD-822262-100G |
| Cas.: 401-79-6 | Purity: 98% | 3-Methylbenzotrifluoride | ESD-814181-100G |
| Cas.: 54589-54-7 | Purity: >95% | Ethyl 3-(Chloromethyl)benzoate | ESD-834927-1G |
| Cas.: 54589-54-7 | Purity: >95% | Ethyl 3-(Chloromethyl)benzoate | ESD-834927-25G |
| Cas.: 423768-52-9 | Purity: ≥97% | 3-(Aminomethyl)-1,5-dimethylpyrazole | ESD-853389-250MG |
| Cas.: 5472-46-8 | Purity: 98% | ethyl 4-amino-2-methylpyrimidine-5-carboxylate | ESD-855030-500MG |
| Cas.: 135034-10-5 | Purity: 97% | 3-Chloro-6-iodopyridazine | ESD-841638-100G |
| Cas.: 4404-45-9 | Purity: ≥98% | Hexyl Isothiocyanate | ESD-859976-100G |
| Cas.: 518044-32-1 | Purity: 97% | Hydroxy-PEG4-t-butyl ester | ESD-854909-5G |
| Cas.: 59338-87-3 | Purity: 99% | Alizapride Hydrochloride | ESD-857949-250MG |
| Cas.: 59338-87-3 | Purity: 99% | Alizapride Hydrochloride | ESD-857949-100MG |
| Cas.: 59338-87-3 | Purity: 99% | Alizapride Hydrochloride | ESD-857949-5G |
| Cas.: 61563-25-5 | Purity: 95% | 1,2-Dibromo-3-methylbenzene | ESD-856575-1G |
| Cas.: 61563-25-5 | Purity: 95% | 1,2-Dibromo-3-methylbenzene | ESD-856575-250MG |
| Cas.: 61563-25-5 | Purity: 95% | 1,2-Dibromo-3-methylbenzene | ESD-856575-10G |
| Cas.: NONE8232 | Purity: 99%, 100,000U/g | Glucose Isomerase | ESD-916745-1KG |
| Cas.: 6542-60-5 | Purity: ≥97% | Cyclopropylacetonitrile | ESD-860155-25G |
| Cas.: 6542-60-5 | Purity: ≥97% | Cyclopropylacetonitrile | ESD-860155-1G |
| Cas.: 547-64-8 | Purity: 98% | Methyl lactate | ESD-830991-2.5L |
| Cas.: 92152-01-7 | Purity: 98% | [1,1′-Biphenyl]-3,4′-dicarboxylic acid | ESD-916746-1G |
| Cas.: 654655-69-3 | Purity: 95% | 3-Benzyl-6-bromo-2-methoxyquinoline | ESD-844914-1G |
| Cas.: 654655-69-3 | Purity: 95% | 3-Benzyl-6-bromo-2-methoxyquinoline | ESD-844914-5G |
| Cas.: 654655-69-3 | Purity: 95% | 3-Benzyl-6-bromo-2-methoxyquinoline | ESD-844914-25G |
| Cas.: 2329408-06-0 | 4,4′,4”-(1H-Imidazole-2,4,5-triyl)tribenzoic acid | ESD-916747-250MG | |
| Cas.: 591215-23-5 | Purity: 98% | 4,4′-(3′,4′,5′,6′-Tetrakis(4-(pyridin-4-yl)phenyl)-[1,1′:2′,1”-terphenyl]-4, 4”-diyl)dipyridine | ESD-916748-50MG |
| Cas.: 1457-47-2 | Purity: 98% | 3-Allylrhodanine | ESD-838442-1ML |
| Cas.: 1457-47-2 | Purity: 98% | 3-Allylrhodanine | ESD-838442-25ML |
| Cas.: 27680-31-5 | Purity: 95% | (4,4′,4′′,4′′′-Tetraaminophthalocyaninato)cobalt | ESD-916749-50MG |
| Cas.: 68892-41-1 | Purity: 98% | N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine | ESD-812078-10G |
| Cas.: 68892-41-1 | Purity: 98% | N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine | ESD-812078-25G |
| Cas.: 874948-63-7 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1′,2′-f][ 1,3,2]dioxaphosphepin | ESD-854204-250MG |
| Cas.: 874948-63-7 | Purity: ≥98%, 99%ee | (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1′,2′-f][ 1,3,2]dioxaphosphepin | ESD-854204-1G |
| Cas.: 57268-16-3 | Purity: ≥95% | 5-Bromo-2-methylthiazole | ESD-853707-1G |
| Cas.: 1128-13-8 | Purity: 97% | 2,3,5,6-Tetraaminobenzoquinone | ESD-916750-250MG |
| Cas.: 14919-77-8 | Purity: 98% | Benserazide hydrochloride | ESD-801923-100G |
| Cas.: 888504-27-6 | Purity: 98% | Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate | ESD-845314-1G |
| Cas.: 1378502-33-0 | Purity: 97% | 4,4′-(2-(4-Bromophenyl)-2-phenylethene-1,1-diyl)bis(methoxybenzene) | ESD-916751-250MG |
| Cas.: 888504-27-6 | Purity: 98% | Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate | ESD-845314-5G |
| Cas.: 3307-39-9 | Purity: 98% | 2-(4-Chlorophenoxy) propionic acid | ESD-913493-5G |
| Cas.: NONE8233 | DNase test agar with toluidine blue | ESD-916752-100G | |
| Cas.: 3307-39-9 | Purity: 98% | 2-(4-Chlorophenoxy) propionic acid | ESD-913493-25G |
| Cas.: 945212-26-0 | Purity: 95% | (R)-N-Fmoc-2-(7-octenyl)Alanine | ESD-848384-1G |
| Cas.: 99717-87-0 | Purity: 98% | 3-Vinylbicyclo[4.2.0]octa-1,3,5-triene | ESD-839462-1G |
| Cas.: 99717-87-0 | Purity: 98% | 3-Vinylbicyclo[4.2.0]octa-1,3,5-triene | ESD-839462-5G |
| Cas.: 1046818-83-0 | Purity: 95% | 2-Chloro-4-hydroxybenzamide | ESD-851547-5G |
| Cas.: 885279-92-5 | Purity: 95% | tert-Butyl 1,8-diazaspiro[4.5]decane-1-carboxylate | ESD-876771-250MG |
| Cas.: 72072-06-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-4-oxopentanoic acid | ESD-891867-1G |
| Cas.: 2432-14-6 | Purity: ≥98% | 2,6-Dibromo-4-Methylphenol | ESD-858680-5G |
| Cas.: 1041026-71-4 | Purity: 97% | 2,6-Diazaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester hemioxalate | ESD-884811-5G |
| Cas.: 1041026-71-4 | Purity: 97% | 2,6-Diazaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester hemioxalate | ESD-884811-10G |
| Cas.: 89282-38-2 | Purity: 98% | 5-Bromo-3-methoxypyrazin-2(1H)-one | ESD-847752-1G |
| Cas.: 114042-02-3 | Purity: 97% | 5-Bromo-3-methyl-2-nitropyridine | ESD-853647-5G |
| Cas.: 114042-02-3 | Purity: 97% | 5-Bromo-3-methyl-2-nitropyridine | ESD-853647-10G |
| Cas.: 904326-93-8 | Purity: 98% | 6-Morpholinopyridine-3-boronic acid | ESD-856166-250MG |
| Cas.: 1161009-88-6 | Purity: 98% | 4-bromo-9,9′-spirobi[fluorene] | ESD-835793-10G |
| Cas.: 1161009-88-6 | Purity: 98% | 4-bromo-9,9′-spirobi[fluorene] | ESD-835793-25G |
| Cas.: 120-15-0 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydroquinoline | ESD-854880-250MG |
| Cas.: 120-15-0 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydroquinoline | ESD-854880-5G |
| Cas.: 120-15-0 | Purity: 95% | 6-Methoxy-1,2,3,4-tetrahydroquinoline | ESD-854880-10G |
| Cas.: 52449-43-1 | Purity: 98% | Methyl 4-chlorophenylacetate | ESD-839672-500G |
| Cas.: 1231930-33-8 | Purity: 95% | 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-847433-250MG |
| Cas.: 1231930-33-8 | Purity: 95% | 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-847433-1G |
| Cas.: 1231930-33-8 | Purity: 95% | 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | ESD-847433-5G |
| Cas.: 1300-94-3 | Purity: ≥98% | 5-Methyl-2-N-Pentylphenol | ESD-859525-1G |
| Cas.: 1300-94-3 | Purity: ≥98% | 5-Methyl-2-N-Pentylphenol | ESD-859525-25G |
| Cas.: 175137-46-9 | Purity: 95% | 3-Amino-5-cyclopropyl-1H-pyrazole | ESD-801620-5G |
| Cas.: 4887-82-5 | Purity: 97% | 5-Chlorobenzimidazole | ESD-858290-1G |
| Cas.: 56782-52-6 | Purity: 98% | L-Isoleucine Ethyl Ester Hydrochloride | ESD-856951-500G |
| Cas.: 68104-63-2 | Purity: ≥95% | 4-Piperazin-1-yl-benzonitrile | ESD-829774-5G |
| Cas.: 74586-24-6 | Purity: 95% | 3-Amino-5-Pyrazolone | ESD-916753-5G |
| Cas.: 68104-63-2 | Purity: ≥95% | 4-Piperazin-1-yl-benzonitrile | ESD-829774-25G |
| Cas.: 74586-24-6 | Purity: 95% | 3-Amino-5-Pyrazolone | ESD-916753-1G |
| Cas.: 103914-52-9 | Purity: 95% | 2-(4-Bromo-phenyl)quinoline-4-carboxylic acid | ESD-855211-250MG |
| Cas.: 606-55-3 | Purity: 99% | Quinaldine Ethiodide | ESD-871325-25G |
| Cas.: 606-55-3 | Purity: 99% | Quinaldine Ethiodide | ESD-871325-100G |
| Cas.: 606-55-3 | Purity: 99% | Quinaldine Ethiodide | ESD-871325-500G |
| Cas.: 1204245-29-3 | Purity: 95% | Thioctic Acid Impurity A | ESD-916754-25MG |
| Cas.: 1204245-29-3 | Purity: 95% | Thioctic Acid Impurity A | ESD-916754-5MG |
| Cas.: 625120-81-2 | Purity: 97% | 3-(Methyl(pentyl)amino)propanoic acid hydrochloride | ESD-844020-25G |
| Cas.: 144163-65-5 | Purity: ≥95% | 3-(2-Thiazolyl)propionic Acid | ESD-851923-50MG |
| Cas.: 23254-43-5 | Purity: 99.9% trace metals basis | Copper(II) sulfate hydrate | ESD-916755-25G |
| Cas.: 23254-43-5 | Purity: 99.9% trace metals basis | Copper(II) sulfate hydrate | ESD-916755-100G |
| Cas.: 23254-43-5 | Purity: 99.9% trace metals basis | Copper(II) sulfate hydrate | ESD-916755-500G |
| Cas.: 23254-43-5 | Purity: 98% | Copper(II) sulfate hydrate | ESD-916756-2.5KG |
| Cas.: 23254-43-5 | Purity: 98% | Copper(II) sulfate hydrate | ESD-916756-500G |
| Cas.: 23254-43-5 | Purity: 98% | Copper(II) sulfate hydrate | ESD-916756-100G |
| Cas.: 118194-13-1 | Purity: 98% | acetyl-soyasaponin A1 | ESD-910121-5MG |
| Cas.: 698-29-3 | Purity: ≥98% | 4-Amino-2-Methylpyrimidine-5-Carbonitrile | ESD-860191-250MG |
| Cas.: 698-29-3 | Purity: ≥98% | 4-Amino-2-Methylpyrimidine-5-Carbonitrile | ESD-860191-5G |
| Cas.: 74840-34-9 | Purity: 95% | 4-chloro-2-(methylthio)pyrimidine-5-carboxylic acid | ESD-854899-1G |
| Cas.: 121577-32-0 | Purity: 98% | Gatifloxacin hydrochloride | ESD-883938-5G |
| Cas.: 767-70-4 | Purity: 98% | 7-Bromobenzo[d]thiazole | ESD-845776-250MG |
| Cas.: 767-70-4 | Purity: 98% | 7-Bromobenzo[d]thiazole | ESD-845776-1G |
| Cas.: 767-70-4 | Purity: 98% | 7-Bromobenzo[d]thiazole | ESD-845776-5G |
| Cas.: 19961-27-4 | Purity: 98% | N-ETHYLISOPROPYLAMINE | ESD-830591-100ML |
| Cas.: 63069-49-8 | Purity: 97% | 2-Amino-5-fluorobenzamide | ESD-840011-25G |
| Cas.: 63405-68-5 | Purity: 97% | (2E,2’E)-3,3′-(1,4-Phenylene)bis[2-propenal] | ESD-916757-100MG |
| Cas.: 791616-56-3 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854222-250MG |
| Cas.: 791616-56-3 | Purity: ≥98%, 99%ee | (11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854222-1G |
| Cas.: 800401-84-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | ESD-857013-250MG |
| Cas.: 800401-84-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | ESD-857013-1G |
| Cas.: 721-63-1 | Purity: 98% | Ethyl 2-(4-(trifluoromethyl)phenyl)acetate | ESD-839659-25G |
| Cas.: 861909-30-0 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis[4-(1,1-dimethylethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3 ,2]dioxaphosphepin | ESD-854205-250MG |
| Cas.: 861909-30-0 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis[4-(1,1-dimethylethyl)phenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1′,2′-f][1,3 ,2]dioxaphosphepin | ESD-854205-1G |
| Cas.: 861909-35-5 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis([1,1′-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide- dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854251-250MG |
| Cas.: 861909-35-5 | Purity: ≥98%, 99%ee | (11bR)-2,6-Bis([1,1′-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide- dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854251-1G |
| Cas.: 164073-80-7 | Purity: 97% | Dimethyl 5-formylisophthalate | ESD-916758-250MG |
| Cas.: 31852-29-6 | Purity: ≥90% | Polyinosinic–polycytidylic acid potassium salt | ESD-916759-250MG |
| Cas.: 132201-32-2 | Purity: 97% | (2R,3S)-3-Phenyliserine hydrochloride | ESD-845141-25G |
| Cas.: 2243-67-6 | Purity: 95% | Naphthalene-2,6-diamine | ESD-916760-250MG |
| Cas.: 125274-16-0 | Purity: 95% | 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol | ESD-916761-100MG |
| Cas.: 1239319-82-4 | Purity: 95% | tert-Butyl 2-amino-7-azaspiro[3.5]nonane-7-carboxylate | ESD-883732-250MG |
| Cas.: 147951-02-8 | Purity: 95% | 1,3,5-Tris[(1H-imidazol-1-yl)methyl]benzene | ESD-916762-1G |
| Cas.: 1261553-12-1 | Purity: 97% | 4-bromo-1-(chloromethyl)-2-iodobenzene | ESD-916763-1G |
| Cas.: 1261553-12-1 | Purity: 97% | 4-bromo-1-(chloromethyl)-2-iodobenzene | ESD-916763-5G |
| Cas.: 22304-67-2 | Purity: 97% | 4,6-Dihydroxy-5-methylisophthalaldehyde | ESD-916764-250MG |
| Cas.: 127404-22-2 | Purity: ≥97% | 3-(1-Imidazolyl)benzaldehyde | ESD-852071-250MG |
| Cas.: 947-92-2 | Purity: 98% | N,N-Dicyclohexylnitrous amide | ESD-916765-1G |
| Cas.: 947-92-2 | Purity: 98% | N,N-Dicyclohexylnitrous amide | ESD-916765-250MG |
| Cas.: 26921-68-6 | Purity: 98% | N-(2-Hydroxyethyl)-N-methylnitrous amide | ESD-916766-1G |
| Cas.: 26921-68-6 | Purity: 98% | N-(2-Hydroxyethyl)-N-methylnitrous amide | ESD-916766-250MG |
| Cas.: 151978-66-4 | Purity: 95% | tert-butyl 4-(4-iodophenyl)tetrahydro-1(2h)-pyrazinecarboxylate | ESD-864362-250MG |
| Cas.: 53209-19-1 | Purity: 99% | 4-Nitro-1,2-phenylenediamine Monohydrochloride | ESD-871343-250MG |
| Cas.: 2363716-37-2 | Purity: 97% | 4,5-Bis(4-formylphenyl)-3,6-dimethyl-[1,1:2,1-terphenyl]-4,4-dicarbaldehyde | ESD-916767-250MG |
| Cas.: 13093-65-7 | Purity: ≥98%(N) | DL-4-Hydroxymandelonitrile | ESD-861919-250MG |
| Cas.: 342037-22-3 | Purity: 97% | 3-(tert-Butyl)-2-hydroxy-5-(pyridin-4-yl)benzaldehyde | ESD-916768-250MG |
| Cas.: 2127-09-5 | Purity: ≥98%(T) | 2-Mercapto-5-nitropyridine | ESD-863334-1G |
| Cas.: 170508-14-2 | Purity: 95% | 6-[(tert-Butoxycarbonyl)amino]spiro[3.3]-heptane-2-carboxylic acid methyl ester | ESD-881509-100MG |
| Cas.: 21988-87-4 | Purity: ≥95% | 1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene | ESD-916769-5G |
| Cas.: 21988-87-4 | Purity: ≥95% | 1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene | ESD-916769-25G |
| Cas.: 90357-51-0 | Purity: ≥98% | N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide | ESD-860350-5G |
| Cas.: 90357-51-0 | Purity: ≥98% | N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide | ESD-860350-25G |
| Cas.: 90357-51-0 | Purity: ≥98% | N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide | ESD-860350-100G |
| Cas.: NONE6699 | Purity: AR, Lanthanum Modified | Pseudo Boehmite | ESD-871915-10KG |
| Cas.: 75-07-0 | Purity: 40% in Dichloromethane | Acetaldehyde solution | ESD-916770-500ML |
| Cas.: 75-07-0 | Purity: 40% in Dichloromethane | Acetaldehyde solution | ESD-916770-100ML |
| Cas.: 16144-91-5 | Purity: ≥98% | 3,6-Dihydroxybenzonorbornane | ESD-865543-25G |
| Cas.: 2113-05-5 | Purity: 97% | m-Chlorophenylbiguanide HCl | ESD-891421-25G |
| Cas.: 2113-05-5 | Purity: 99,5% | m-Chlorophenylbiguanide HCl | ESD-916771-1G |
| Cas.: 2113-05-5 | Purity: 99,5% | m-Chlorophenylbiguanide HCl | ESD-916771-5G |
| Cas.: 125051-32-3 | Purity: 95% | BIS(2,6-DIFLUORO-3-(1-HYDROPYRROL-1-YL)PHENYL)TITANOCENE | ESD-857289-25G |
| Cas.: 125051-32-3 | Purity: 95% | BIS(2,6-DIFLUORO-3-(1-HYDROPYRROL-1-YL)PHENYL)TITANOCENE | ESD-857289-5G |
| Cas.: 125051-32-3 | Purity: 95% | BIS(2,6-DIFLUORO-3-(1-HYDROPYRROL-1-YL)PHENYL)TITANOCENE | ESD-857289-1G |
| Cas.: 196194-58-8 | Purity: ≥98% | 4-Chloro-2,6-Difluorobenzoic Acid | ESD-859700-250MG |
| Cas.: 198995-91-4 | Purity: ≥95% | Benzyl 3-Oxocyclobutanecarboxylate | ESD-851053-250MG |
| Cas.: 25462-85-5 | Purity: 97% | 2-Chloro-6-methylisonicotinic Acid | ESD-835166-250MG |
| Cas.: 259654-73-4 | Purity: ≥97% | Methyl 2-(2-Amino-5-methyl-4-thiazolyl)acetate | ESD-851318-250MG |
| Cas.: 65078-77-5 | Purity: ≥97% | 2,3-Dichloro-6-Nitroaniline | ESD-858648-250MG |
| Cas.: 1086-80-2 | Purity: 98% | 7,8-Dimethylalloxazine | ESD-869842-50MG |
| Cas.: 1086-80-2 | Purity: 98% | 7,8-Dimethylalloxazine | ESD-869842-250MG |
| Cas.: 288251-96-7 | Purity: 95% | 2-Isobutyl-5-nitrobenzonitrile | ESD-848967-250MG |
| Cas.: 80288-49-9 | Purity: ≥99% | Furafylline | ESD-877318-50MG |
| Cas.: 80288-49-9 | Purity: ≥99% | Furafylline | ESD-877318-250MG |
| Cas.: 17857-70-4 | Purity: 95% | Cyclopropyltributylstannane | ESD-855522-250MG |
| Cas.: 1446502-11-9 | Purity: 99% | Enasidenib (AG-221) | ESD-872864-25MG |
| Cas.: 1446502-11-9 | Purity: 99% | Enasidenib (AG-221) | ESD-872864-100MG |
| Cas.: 34532-67-7 | Purity: Analysis control, ≥99%(HPLC) | Arnicolide C | ESD-903664-1MG |
| Cas.: 143606-53-5 | Purity: Extrusion grade | Poly(1,4-butylene succinate) | ESD-909171-2.5KG |
| Cas.: 49610-35-7 | Purity: 95% | 4,4′-Dibromo-1,1′-binaphthalene | ESD-916772-1G |
| Cas.: 51498-37-4 | Purity: 98% | 4-Hydroxypyridine-3-sulfonic Acid | ESD-849564-25G |
| Cas.: 313484-93-4 | Purity: 97% | 1,1′,1”,1”’-(Methanetetrayltetrakis(benzene-4,1-diyl))tetraethanone | ESD-916773-250MG |
| Cas.: 1073371-99-9 | Purity: 98% | Methyl 2-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-916774-250MG |
| Cas.: 655-14-1 | Purity: 97% | 2,5-Difluoroterephthalic acid | ESD-916775-250MG |
| Cas.: 13985-15-4 | Purity: 97% | 2,3,6,7-Tetramethoxy-9,10-dimethylanthracene | ESD-916776-250MG |
| Cas.: 39859-36-4 | Purity: 98% | 2-Benzoyl-4-bromoaniline | ESD-845420-5G |
| Cas.: 596130-35-7 | Purity: 97% | 9,10-Bis(pyridin-4-ylethynyl)anthracene | ESD-916777-250MG |
| Cas.: 175361-81-6 | Purity: 98% | Thiophene-2,5-diboronic acid bis(pinacol) ester | ESD-854818-1G |
| Cas.: 940-61-4 | Purity: 98% | Trans-P-Methylcinnamic Acid | ESD-859356-500G |
| Cas.: 502764-53-6 | Purity: 95% | thieno[3,2-b]thieno[2,2-d]thiophenedicarboxylicacid | ESD-916778-100MG |
| Cas.: 940-61-4 | Purity: 98% | Trans-P-Methylcinnamic Acid | ESD-859356-25G |
| Cas.: 192704-56-6 | Purity: 97% | 11-A-Hydroxy canrenone methyl ester | ESD-846002-5G |
| Cas.: 86710-88-5 | Purity: 97% | 4,4′-Diamino-[1,1′-biphenyl]-3-carbonitrile | ESD-916779-250MG |
| Cas.: 60088-54-2 | Purity: 98 atom % D | Terephthalic-d4 acid | ESD-874773-250MG |
| Cas.: 859315-37-0 | Purity: 98% | 4,4′-(2,2-Diphenylethene-1,1-diyl)bis(bromobenzene) | ESD-916780-250MG |
| Cas.: 2143456-42-0 | Purity: 98% | 2,5-Dipropoxyterephthalohydrazide | ESD-916781-250MG |
| Cas.: 39095-25-5 | Purity: 97% | 2,5-Dimethylterephthalonitrile | ESD-916782-1G |
| Cas.: 2103-91-5 | Purity: 98% | 2-Amino-4-(p-tolyl)thiazole | ESD-870722-25G |
| Cas.: 301-02-0 | Purity: ≥98% | Oleamide | ESD-875680-500G |
| Cas.: 49546-11-4 | Purity: 98% | 2,7-Bis(4-aminophenyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone | ESD-916783-250MG |
| Cas.: 1352642-37-5 | Purity: >96.0%(HPLC) | 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b’]dithiophene | ESD-854461-500MG |
| Cas.: 1352642-37-5 | Purity: >96.0%(HPLC) | 4,8-Bis[5-(2-ethylhexyl)thiophen-2-yl]-2,6-bis(trimethylstannyl)benzo[1,2-b:4,5-b’]dithiophene | ESD-854461-25MG |
| Cas.: 70916-98-2 | Purity: 95% | 4′-Formyl-[1,1′-Biphenyl]-4-carboxylic Acid | ESD-916784-250MG |
| Cas.: 940-71-6 | Purity: 98% | Phosphonitrilic chloride trimer | ESD-815892-2.5KG |
| Cas.: 906564-59-8 | Alkyne NHS ester (hexynoic acid NHS ester) | ESD-916785-25MG | |
| Cas.: 176706-98-2 | Purity: ≥98%, 99%ee | 2,2-Bis[(4S)-4-benzyl-2-oxazolin-2-yl]propane | ESD-854123-250MG |
| Cas.: 176706-98-2 | Purity: ≥98%, 99%ee | 2,2-Bis[(4S)-4-benzyl-2-oxazolin-2-yl]propane | ESD-854123-1G |
| Cas.: 146368-07-2 | Purity: 95% | 1-Ethyl-2,3,3-trimethyl-3H-indol-1-ium-5-sulfonate | ESD-916786-250MG |
| Cas.: 9005-25-8 | Purity: Reagent grade | Starch from corn | ESD-818266-10KG |
| Cas.: 261178-55-6 | Purity: 95% | 13-(Benzyloxy)-13-oxotridecanoic acid | ESD-916787-250MG |
| Cas.: 855230-61-4 | Purity: 98% | 3-Ethoxy-2-fluorobenzeneboronic Acid (contains varying amounts of Anhydride) | ESD-862282-5G |
| Cas.: 117490-51-4 | Purity: 97% | 2,2′-Dimethyl-[1,1′-biphenyl]-4,4′-dicarbonitrile | ESD-916788-250MG |
| Cas.: 57688-34-3 | Purity: 98% | 4′-(Trifluoromethyl)-[1,1′-biphenyl]-4-amine | ESD-916789-250MG |
| Cas.: 7597-56-0 | Purity: 98% | Ethyl 3-amino-3-oxopropanoate | ESD-840147-25G |
| Cas.: 14659-58-6 | Purity: 98% | 2-Bromo-5-fluoro-1,3-dimethylbenzene | ESD-839230-25G |
| Cas.: 61382-01-2 | Purity: 97% | 4,4′-Diamino-[1,1′-biphenyl]-3,3′-dicarbonitrile | ESD-916790-250MG |
| Cas.: 19455-23-3 | Purity: 97% | Potassium Pivalate | ESD-858416-500G |
| Cas.: 22112-79-4 | Purity: 95% | 3,3′,3”,3”’-(21H,23H-Porphine-5,10,15,20-tetrayl)tetrakisphenol | ESD-916791-250MG |
| Cas.: 1353016-70-2 | Purity: 98% | DBCO-Acid | ESD-914307-50MG |
| Cas.: 145-42-6 | Purity: 95% | Sodium taurocholate hydrate | ESD-817406-100G |
| Cas.: 84906-81-0 | Purity: 97% | 2-Hydroxyquinoline-4-carboxylic acid | ESD-837987-5G |
| Cas.: 145-42-6 | Purity: 97% | Sodium taurocholate hydrate | ESD-916792-5G |
| Cas.: 145-42-6 | Purity: 97% | Sodium taurocholate hydrate | ESD-916792-1G |
| Cas.: 59557-90-3 | Purity: 98% | 4-Bromo-3,5-dimethylaniline | ESD-840073-25G |
| Cas.: 59557-90-3 | Purity: 98% | 4-Bromo-3,5-dimethylaniline | ESD-840073-100G |
| Cas.: 64-69-7 | Purity: AR, 98% | iodoacetic acid | ESD-811708-250G |
| Cas.: 56741-94-7 | Purity: 97% | 2-Amino-6-phenylpyrimidin-4(3H)-one | ESD-842589-5G |
| Cas.: 702710-17-6 | Purity: 95% | N-Methyl-D-proline Hydrochloride | ESD-850491-25G |
| Cas.: 936011-17-5 | Purity: 98% | 5-Bromo-2-methoxyisonicotinaldehyde | ESD-847065-1G |
| Cas.: 1910-42-5 | Purity: 98% | Paraquat dichloride | ESD-813277-25G |
| Cas.: 1403764-72-6 | Purity: 99% | PFI-1 (PF-6405761) | ESD-873814-5MG |
| Cas.: 1403764-72-6 | Purity: 99% | PFI-1 (PF-6405761) | ESD-873814-25MG |
| Cas.: 1403764-72-6 | Purity: 99% | PFI-1 (PF-6405761) | ESD-873814-100MG |
| Cas.: 105515-20-6 | Purity: ≥97% | 3′-Bromo-5′-fluoroacetophenone | ESD-851636-250MG |
| Cas.: 83701-22-8 | Purity: 95% | Minoxidil sulphate | ESD-873714-25MG |
| Cas.: 83701-22-8 | Purity: 95% | Minoxidil sulphate | ESD-873714-100MG |
| Cas.: 1799434-48-2 | Purity: 97% | tert-Butyl ((2-(methylsulfonyl)pyrimidin-4-yl)methyl)carbamate | ESD-848605-250MG |
| Cas.: 1799434-48-2 | Purity: 97% | tert-Butyl ((2-(methylsulfonyl)pyrimidin-4-yl)methyl)carbamate | ESD-848605-1G |
| Cas.: 83701-22-8 | Purity: 95% | Minoxidil sulphate | ESD-873714-500MG |
| Cas.: 17515-77-4 | Purity: 98% | 2-(Bromomethyl)-5-(trifluoromethyl)furan | ESD-838984-5G |
| Cas.: 17515-77-4 | Purity: 98% | 2-(Bromomethyl)-5-(trifluoromethyl)furan | ESD-838984-25G |
| Cas.: 1632285-98-3 | Purity: 95% | tert-Butyl ((2-methoxypyrimidin-4-yl)methyl)carbamate | ESD-848809-250MG |
| Cas.: 1632285-98-3 | Purity: 95% | tert-Butyl ((2-methoxypyrimidin-4-yl)methyl)carbamate | ESD-848809-1G |
| Cas.: 1632285-98-3 | Purity: 95% | tert-Butyl ((2-methoxypyrimidin-4-yl)methyl)carbamate | ESD-848809-5G |
| Cas.: 77-52-1 | Purity: 98% | Ursolic acid | ESD-820364-25G |
| Cas.: 161024-80-2 | Purity: ≥96.0% (HPLC) | (R)-3-(Boc-amino)-3-phenylpropionic acid | ESD-832714-5G |
| Cas.: 1568043-19-5 | Purity: ≥98%, 99%ee | (2R)-2-Amino-3-methyl-N-2-pyridinylbutanamide | ESD-854187-500MG |
| Cas.: 147128-77-6 | Purity: ≥97% | (4R,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol | ESD-850883-25G |
| Cas.: 1396772-26-1 | Purity: ≥98% | EPZ005687 | ESD-833141-50MG |
| Cas.: 1341216-35-0 | Purity: ≥97% | 4-Amino-2-fluorophenol Hydrochloride | ESD-858898-5G |
| Cas.: 1341216-35-0 | Purity: ≥97% | 4-Amino-2-fluorophenol Hydrochloride | ESD-858898-250MG |
| Cas.: 1150114-42-3 | Purity: ≥98% | (2-Isopropoxypyridin-3-yl)boronic acid | ESD-857605-1G |
| Cas.: 13195-50-1 | Purity: 97% | 2-BROMO-5-NITROTHIOPHENE | ESD-835523-25G |
| Cas.: 3290-92-4 | Purity: 98%, contains 175 ppm MEHQ stabilizer | Trimethylolpropane trimethacrylate | ESD-916800-25ML |
| Cas.: 1168150-46-6 | Purity: ≥98% | (3E)-2,3-Dihydro-3-(MethoxyphenylMethylene)-2-Oxo-1H-Indole-6-Carboxylic Acid Methyl Ester | ESD-859473-5G |
| Cas.: 3290-92-4 | Purity: 98%, contains 175 ppm MEHQ stabilizer | Trimethylolpropane trimethacrylate | ESD-916800-100ML |
| Cas.: 1168150-46-6 | Purity: ≥98% | (3E)-2,3-Dihydro-3-(MethoxyphenylMethylene)-2-Oxo-1H-Indole-6-Carboxylic Acid Methyl Ester | ESD-859473-250MG |
| Cas.: 488-98-2 | Purity: 95% | 2-Fluoro-α,α,α-trichlorotoluene | ESD-916801-100G |
| Cas.: 106825-81-4 | Purity: ≥97% | (R)-3-Morpholinecarboxylic Acid | ESD-875882-5G |
| Cas.: 488-98-2 | Purity: 95% | 2-Fluoro-α,α,α-trichlorotoluene | ESD-916801-25G |
| Cas.: 488-98-2 | Purity: 95% | 2-Fluoro-α,α,α-trichlorotoluene | ESD-916801-5G |
| Cas.: 106615-61-6 | Purity: ≥95% | 5-Fluoro-6-hydroxypyrimidin-4(3H)-one | ESD-852239-250MG |
| Cas.: 1030612-90-8 | Purity: ≥98% | MK-8245 | ESD-833033-5MG |
| Cas.: 1030612-90-8 | Purity: ≥98% | MK-8245 | ESD-833033-50MG |
| Cas.: 89226-50-6 | Purity: 98% | Manidipine | ESD-843985-1G |
| Cas.: 1393642-36-8 | Purity: 99% | Trisodium methanetrisulfonate | ESD-916802-500G |
| Cas.: 101555-61-7 | Purity: 95% | Boc-D-beta-Homophenylalanine | ESD-846590-1G |
| Cas.: 101555-61-7 | Purity: 95% | Boc-D-beta-Homophenylalanine | ESD-846590-5G |
| Cas.: 1393642-36-8 | Purity: 99% | Trisodium methanetrisulfonate | ESD-916802-100G |
| Cas.: 1393642-36-8 | Purity: 99% | Trisodium methanetrisulfonate | ESD-916802-25G |
| Cas.: 26915-72-0 | Purity: Average MW ~300 | Poly(ethylene glycol) methyl ether methacrylate | ESD-816113-5L |
| Cas.: 957793-35-0 | Purity: 97% | cis-Ethyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-848394-250MG |
| Cas.: 957793-35-0 | Purity: 97% | cis-Ethyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-848394-1G |
| Cas.: 947-95-5 | Purity: ≥98% | 5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxaldehyde | ESD-866634-5G |
| Cas.: 945852-48-2 | Purity: ≥98%, 99%ee | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1′,2′- f][1,3,2]dioxaphosphepin | ESD-854245-250MG |
| Cas.: 945852-48-2 | Purity: ≥98%, 99%ee | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1′,2′- f][1,3,2]dioxaphosphepin | ESD-854245-1G |
| Cas.: 10049-21-5 | Purity: reagent grade, 98% | Sodium phosphate monobasic monohydrate | ESD-822239-10KG |
| Cas.: 24057-28-1 | Purity: 98% | Pyridinium |p|-toluenesulfonate | ESD-815852-1KG |
| Cas.: 959235-95-1 | Purity: 98% | 6-(Trifluoromethoxy)indoline | ESD-845456-250MG |
| Cas.: 959235-95-1 | Purity: 98% | 6-(Trifluoromethoxy)indoline | ESD-845456-1G |
| Cas.: 914225-70-0 | Purity: 98% | 1-(5-Fluoro-2-iodophenyl)ethanone | ESD-840222-5G |
| Cas.: 914225-70-0 | Purity: 98% | 1-(5-Fluoro-2-iodophenyl)ethanone | ESD-840222-25G |
| Cas.: 893566-75-1 | Purity: 98% | Tert-butyl 8-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-846964-250MG |
| Cas.: 893566-75-1 | Purity: 98% | Tert-butyl 8-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-846964-1G |
| Cas.: 141871-02-5 | Purity: ≥98% | 2-[[(1,1-Dimethylethoxy)carbonyl]methylamino]benzoic acid | ESD-859387-250MG |
| Cas.: 52789-62-5 | Purity: 85% | 1-Amino-8-naphthol-2,4-disulfonic Acid Monosodium Salt Hydrate | ESD-868752-25G |
| Cas.: 849939-13-5 | Purity: ≥98%, 99%ee | (S)-3-3′-Bis[3,5-bis(trifluoromethyl)phenyl]-1,1′-bi-2-naphthol | ESD-854022-250MG |
| Cas.: 849939-13-5 | Purity: ≥98%, 99%ee | (S)-3-3′-Bis[3,5-bis(trifluoromethyl)phenyl]-1,1′-bi-2-naphthol | ESD-854022-1G |
| Cas.: 81907-62-2 | Purity: >98% | Ganoderic acid A | ESD-860595-20MG |
| Cas.: 330-93-8 | Purity: ≥98% | Bis(4-fluorophenyl) Ether | ESD-866100-5G |
| Cas.: 791616-70-1 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1- d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854248-250MG |
| Cas.: 10580-19-5 | Purity: >98.0%(HPLC)(T) | Sodium 4-Hydroxybenzenesulfonate Dihydrate | ESD-864325-500G |
| Cas.: 791616-70-1 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1- d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854248-1G |
| Cas.: 10580-19-5 | Purity: >98.0%(HPLC)(T) | Sodium 4-Hydroxybenzenesulfonate Dihydrate | ESD-864325-2.5KG |
| Cas.: 924416-43-3 | Purity: 99% | SC-396658 | ESD-872571-25MG |
| Cas.: 760961-03-3 | Purity: ≥98%(HPLC) | Hederacoside D | ESD-861290-10MG |
| Cas.: 760961-03-3 | Purity: ≥98%(HPLC) | Hederacoside D | ESD-861290-5MG |
| Cas.: 194862-84-5 | Purity: 95% | 8-Oxa-2-azaspiro[4.5]decan-3-one | ESD-880861-250MG |
| Cas.: 934493-76-2 | Purity: 99% | Voxtalisib (XL765, SAR245409) | ESD-873048-25MG |
| Cas.: 10303-88-5 | Purity: 97% | (S)-Methyl 2,3-dihydroxypropanoate | ESD-839694-25G |
| Cas.: 13451-78-0 | Purity: 97% | 5-Fluorobenzoxazole-2-thiol | ESD-834359-25G |
| Cas.: 13515-65-6 | Purity: ≥97% | 2-Methylpropanethioamide | ESD-859554-25G |
| Cas.: 13515-65-6 | Purity: ≥97% | 2-Methylpropanethioamide | ESD-859554-100G |
| Cas.: 165534-79-2 | Purity: 98% | Dimethyl iodoterephthalate | ESD-856741-250MG |
| Cas.: 165534-79-2 | Purity: 98% | Dimethyl iodoterephthalate | ESD-856741-5G |
| Cas.: 259886-49-2 | Purity: 98% | Cucurbit[5]uril (CB[5]) ammonium sulfate hydrate | ESD-856618-250MG |
| Cas.: 2034-69-7 | Purity: ≥98%(HPLC) | Daphnoretin | ESD-861256-5MG |
| Cas.: 123334-03-2 | Purity: ≥97% | Melamine hydrogen flouride | ESD-916803-100G |
| Cas.: 123334-03-2 | Purity: ≥97% | Melamine hydrogen flouride | ESD-916803-25G |
| Cas.: 1446144-04-2 | Purity: 99% | CPI-203 | ESD-872250-5MG |
| Cas.: 1446144-04-2 | Purity: 99% | CPI-203 | ESD-872250-25MG |
| Cas.: 203866-14-2 | Purity: ≥98%, ≥99% ee | (2S,4R)-4-Fluoro-1,2-pyrrolidinedicarboxylic Acid tert-Butyl Ester | ESD-854003-5G |
| Cas.: 203866-14-2 | Purity: ≥98%, ≥99% ee | (2S,4R)-4-Fluoro-1,2-pyrrolidinedicarboxylic Acid tert-Butyl Ester | ESD-854003-10G |
| Cas.: 211734-49-5 | Purity: ≥98%, 99%ee | (R)-3,3′-Dibromo-bis(methoxymethoxyl)-1,1′-binaphtyl | ESD-854025-250MG |
| Cas.: 405174-97-2 | Purity: 97% | 3-bromopyridine-2-carbaldehyde | ESD-825329-5G |
| Cas.: 405174-97-2 | Purity: 97% | 3-bromopyridine-2-carbaldehyde | ESD-825329-25G |
| Cas.: 518070-22-9 | Purity: 97% | 3-Fluoro-5-methylphenylacetic acid | ESD-861127-1G |
| Cas.: 147149-84-6 | Purity: 97% | 4-Bromo-5-methylindoline-2,3-dione | ESD-844385-25G |
| Cas.: 147149-84-6 | Purity: 97% | 4-Bromo-5-methylindoline-2,3-dione | ESD-844385-100G |
| Cas.: 20577-26-8 | Purity: 98% | 2 – Bromonicotinonitrile | ESD-840858-25G |
| Cas.: 20577-26-8 | Purity: 98% | 2 – Bromonicotinonitrile | ESD-840858-100G |
| Cas.: 56679-88-0 | Purity: 95% | 3-Methoxy-2-naphthaldehyde | ESD-858251-250MG |
| Cas.: 2168-06-1 | Purity: 97% | 3,3,3-Tris(4-chlorophenyl)propionic acid | ESD-818740-5G |
| Cas.: 128071-84-1 | Purity: 97% | 4-Bromo-2-chloropyridine-3-carboxaldehyde | ESD-916743-5G |
| Cas.: 26091-79-2 | Purity: ≥98%(HPLC) | Byakangelicol | ESD-861236-5MG |
| Cas.: 27687-14-5 | Purity: 98% | trans-4-(tert-Butoxycarbonylaminomethyl)cyclohexanecarboxylic Acid | ESD-864265-1G |
| Cas.: 27687-14-5 | Purity: 98% | trans-4-(tert-Butoxycarbonylaminomethyl)cyclohexanecarboxylic Acid | ESD-864265-10G |
| Cas.: 161957-61-5 | Purity: 98% | 1-(3-Bromo-2-fluorophenyl)ethanone | ESD-844757-25G |
| Cas.: 58366-64-6 | Purity: ≥99% | 5-Methylcytosine Hydrochloride | ESD-834894-250MG |
| Cas.: 65550-81-4 | Purity: ≥98% | 2-Bromo-3-Chloro-5-Picoline | ESD-860159-250MG |
| Cas.: 473-81-4 | Purity: 95%, 20% in Water | 2,3-Dihydroxypropanoic acid (20% in water) | ESD-845847-5G |
| Cas.: 1908-87-8 | Purity: 95% | 3-Methylthiazolidine-2-thione | ESD-909202-25G |
| Cas.: 12650-88-3 | Purity: 40000U/mg | Lysozyme, from egg white | ESD-812357-250MG |
| Cas.: 575-89-3 | Purity: ≥98% | 2,4,6-Trichlorophenoxyacetic Acid | ESD-865438-250MG |
| Cas.: 55289-35-5 | Purity: 98% | 2-Bromo-6-nitrotoluene | ESD-803841-100G |
| Cas.: 107-73-3 | Purity: ≥98% | Phosphorylcholine chloride | ESD-884667-50MG |
| Cas.: 120221-69-4 | Purity: 95% | 3-Acetylindolizine-1-carboxylic acid | ESD-848748-500MG |
| Cas.: 40800-65-5 | Purity: 98% | Ethyl 4-amino-3-methylbenzoate | ESD-856963-25G |
| Cas.: 40800-65-5 | Purity: 98% | Ethyl 4-amino-3-methylbenzoate | ESD-856963-5G |
| Cas.: 13463-67-7 | Purity: 99.8% metals basis, 100nm, anatase, water-friendly | Titanium oxide, anatase | ESD-818940-25G |
| Cas.: 13463-67-7 | Purity: 99.8% metals basis, 60nm, anatase, water-friendly | Titanium dioxide, anatase | ESD-818931-25G |
| Cas.: 13360-63-9 | Purity: ≥98% | N-Ethylbutylamine | ESD-838189-100G |
| Cas.: 13360-63-9 | Purity: ≥98% | N-Ethylbutylamine | ESD-838189-500G |
| Cas.: 188589-32-4 | Purity: 98% | 1-decyl-3-methylimidazol-3-ium,bromide | ESD-856869-5G |
| Cas.: 500717-23-7 | Purity: ≥98% | Bis(9,9-dimethyl-9H-fluoren-2-yl)amine | ESD-857939-250MG |
| Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-1G |
| Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-5G |
| Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-10G |
| Cas.: 24123-14-6 | Purity: 97% | N-(2-Aminoethyl)glycine | ESD-863704-250MG |
| Cas.: 24123-14-6 | Purity: 97% | N-(2-Aminoethyl)glycine | ESD-863704-1G |
| Cas.: 84082-51-9 | Purity: 80% | Glycoproteins, bovine-whey | ESD-885092-50G |
| Cas.: 1632032-53-1 | Purity: ≥98% | LB-100 | ESD-881690-25MG |
| Cas.: 3566-61-8 | Purity: 98% | 3,3,4,4-tetramethylpyrrolidine-2,5-dione | ESD-908959-1G |
| Cas.: 14476-37-0 | Purity: ≥95% | 4-Undecanone | ESD-867618-5ML |
| Cas.: 14476-37-0 | Purity: ≥95% | 4-Undecanone | ESD-867618-25ML |
| Cas.: 14476-37-0 | Purity: ≥95% | 4-Undecanone | ESD-867618-100ML |
| Cas.: 508233-74-7 | Purity: 98% | Vortioxetine | ESD-844727-1G |
| Cas.: 508233-74-7 | Purity: 98% | Vortioxetine | ESD-844727-5G |
| Cas.: 1537170-85-6 | Purity: 98% | DBCO-PEG4-C2-acid | ESD-916812-100MG |
| Cas.: 58717-02-5 | Purity: 95% | HD-Cha-OH | ESD-841118-5G |
| Cas.: 201138-91-2 | Purity: 98% | 4,6-Dibromodibenzo[b,d]furan | ESD-845368-25G |
| Cas.: 25070-74-0 | Purity: ≥97% | 1-Cbz-pyrrolidine | ESD-852714-250MG |
| Cas.: 3420-72-2 | Purity: ≥98%(GC) | 2′-Hydroxy-4,4′,6′-trimethoxychalcone | ESD-863136-1G |
| Cas.: 40851-62-5 | Purity: 98% | Methyl o-tolylacetate | ESD-861131-1G |
| Cas.: 922182-37-4 | Purity: 95% | DMPip-βALA-OSu | ESD-916813-250MG |
| Cas.: 10537-47-0 | Purity: >98% | Tyrphostin A9 | ESD-860997-250MG |
| Cas.: 936091-26-8 | Purity: ≥98% | Fedratinib (SAR302503, TG101348) | ESD-854757-25MG |
| Cas.: 936091-26-8 | Purity: ≥98% | Fedratinib (SAR302503, TG101348) | ESD-854757-100MG |
| Cas.: 2353410-00-9 | Purity: 95% | DBCO-PEG12-acid | ESD-916814-25MG |
| Cas.: 2576471-49-1 | Purity: 95% | DBCO-SS-COOH | ESD-916815-50MG |
| Cas.: 202475-60-3 | Purity: >98% | WHI-P131 | ESD-860952-50MG |
| Cas.: 517870-18-7 | Purity: ≥97% | Methyl 5-(3-Nitrophenyl)isoxazole-3-carboxylate | ESD-853760-250MG |
| Cas.: 1064678-66-5 | Purity: 95% | 3-Bromo-5-chloropyridine-4-carboxaldehyde | ESD-916816-5G |
| Cas.: 1064678-66-5 | Purity: 95% | 3-Bromo-5-chloropyridine-4-carboxaldehyde | ESD-916816-1G |
| Cas.: 6630-99-5 | Purity: ≥98% | 1,2,3,4-Thiatriazole-5-Ylamine | ESD-854715-5G |
| Cas.: 885267-36-7 | Purity: 98% | 6-bromo-3-fluoropyridine-2-carbaldehyde | ESD-826178-5G |
| Cas.: 20788-07-2 | Purity: ≥99% | Resorantel | ESD-859725-100G |
| Cas.: 20788-07-2 | Purity: ≥99% | Resorantel | ESD-859725-500G |
| Cas.: 791616-65-4 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1′,2′- f][1,3,2]dioxaphosphepin | ESD-854244-25MG |
| Cas.: 7783-18-8 | Purity: 99% | Ammonium thiosulfate | ESD-800324-10KG |
| Cas.: 21943-15-7 | Purity: 98% | 3,5-Dibromo-2-hydroxypyrazine | ESD-808239-5G |
| Cas.: 21943-15-7 | Purity: 98% | 3,5-Dibromo-2-hydroxypyrazine | ESD-808239-1G |
| Cas.: 89115-20-8 | Purity: 98% | 4-[Bis(4-methoxyphenyl)amino]benzaldehyde | ESD-869980-1G |
| Cas.: 89115-20-8 | Purity: 98% | 4-[Bis(4-methoxyphenyl)amino]benzaldehyde | ESD-869980-5G |
| Cas.: 80-35-3 | Purity: 98% | Sulfamethoxypyridazine | ESD-916817-5G |
| Cas.: 80-35-3 | Purity: 98% | Sulfamethoxypyridazine | ESD-916817-1G |
| Cas.: 1309-48-4 | Purity: 99.99% metals basis | Magnesium oxide | ESD-813079-5KG |
| Cas.: 1378502-33-0 | Purity: 97% | 4,4′-(2-(4-Bromophenyl)-2-phenylethene-1,1-diyl)bis(methoxybenzene) | ESD-916751-1G |
| Cas.: 573762-62-6 | Purity: ≥95% | 5-Amino-3-(trifluoromethyl)picolinonitrile | ESD-846475-1G |
| Cas.: 53716-50-0 | Purity: 98% | Oxfendazole | ESD-815286-5G |
| Cas.: 53716-50-0 | Purity: 98% | Oxfendazole | ESD-815286-1G |
| Cas.: 1904-58-1 | Purity: 97% | Anthraniloyl Hydrazine | ESD-858420-25G |
| Cas.: 1904-58-1 | Purity: 97% | Anthraniloyl Hydrazine | ESD-858420-100G |
| Cas.: 920-66-1 | Purity: Use For GC derivatization, ≥99.8% (GC) | 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) | ESD-811028-250ML |
| Cas.: 14996-60-2 | Purity: 99% | Osmium(III) chloride hydrate | ESD-916818-500MG |
| Cas.: 1597403-47-8 | Purity: >98% | ISRIB (trans-isomer) | ESD-860931-10MG |
| Cas.: 58717-02-5 | Purity: 95% | HD-Cha-OH | ESD-841118-25G |
| Cas.: 94-91-7 | Purity: 98% | N,N’-Bis(salicylidene)-1,2-propanediamine | ESD-823694-100G |
| Cas.: 1427004-19-0 | Purity: 95% | DBCO-PEG4-NHS Ester | ESD-916820-50MG |
| Cas.: 20559-55-1 | Purity: ≥98.0% | Oxibendazole | ESD-863572-250MG |
| Cas.: 124-18-5 | Purity: 99%, with molecular sieves, Water≤50 ppm (by KF), MKSeal | Decane | ESD-916819-100ML |
| Cas.: 124-18-5 | Purity: 99%, with molecular sieves, Water≤50 ppm (by KF), MKSeal | Decane | ESD-916819-500ML |
| Cas.: 124-18-5 | Purity: 99%, with molecular sieves, Water≤50 ppm (by KF), MKSeal | Decane | ESD-916819-1L |
| Cas.: 2144395-59-3 | Purity: 95% | DBCO-PEG5-NHS ester | ESD-916821-50MG |
| Cas.: 7718-98-1 | Purity: 97% | Vanadium(III) chloride | ESD-916822-1G |
| Cas.: 7718-98-1 | Purity: 97% | Vanadium(III) chloride | ESD-916822-5G |
| Cas.: 28466-21-9 | Purity: 97% | 4-Amino-1,3,5-trimethyl-1H-pyrazole | ESD-863912-5G |
| Cas.: 28466-21-9 | Purity: 97% | 4-Amino-1,3,5-trimethyl-1H-pyrazole | ESD-863912-250MG |
| Cas.: 645-67-0 | Purity: ≥98% | 4-Oxopentanoic Acid Propyl Ester | ESD-865146-100G |
| Cas.: 5747-48-8 | Purity: 97% | 11-(PIPERAZIN-1-YL)DIBENZO[B,F][1,4]THIAZEPINE | ESD-887997-100MG |
| Cas.: 68-22-4 | Purity: 98% | Norehindrone | ESD-830038-25G |
| Cas.: 1435934-53-4 | Purity: 95% | DBCO-CONH-SS-NHS ester | ESD-916823-25MG |
| Cas.: 84624-28-2 | Purity: ≥95% | N’-Fmoc-L-lysine | ESD-916824-5G |
| Cas.: 60705-62-6 | Purity: 98% | 4-tert-Butylcalix[4]arene | ESD-830560-100G |
| Cas.: 12650-88-3 | Purity: 40000U/mg | Lysozyme, from egg white | ESD-812357-100G |
| Cas.: 87655-21-8 | Purity: ≥95%(GC) | (S)-(+)-3-Hydroxy-2,2-dimethylcyclohexanone | ESD-861852-25MG |
| Cas.: 1073183-32-0 | Purity: 98% | 4,4′-Bis[N-(1-naphthyl)-N-phenylamino]-4”-phenyltriphenylamine | ESD-803630-25MG |
| Cas.: 35691-65-7 | Purity: ≥98% | 2-Bromo-2-(Bromomethyl)Pentanetrile | ESD-858765-100G |
| Cas.: 35691-65-7 | Purity: ≥98% | 2-Bromo-2-(Bromomethyl)Pentanetrile | ESD-858765-25G |
| Cas.: 25617-97-4 | Purity: 99.99% metals basis | Gallium nitride | ESD-810666-1G |
| Cas.: 617-36-7 | Purity: 95% | Ethyl 2-amino-2-oxoacetate | ESD-839079-100G |
| Cas.: 5034-74-2 | Purity: 98% | 5-Bromo-2-hydroxy-3-methoxybenzaldehyde | ESD-858284-5G |
| Cas.: 5034-74-2 | Purity: 98% | 5-Bromo-2-hydroxy-3-methoxybenzaldehyde | ESD-858284-100G |
| Cas.: 24415-66-5 | Purity: ≥95% | 7-chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-827612-1G |
| Cas.: 24415-66-5 | Purity: ≥95% | 7-chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-827612-250MG |
| Cas.: 77185-71-8 | Purity: 96% | 6-Bromo-2-phenyl-1H-indole | ESD-847727-5G |
| Cas.: 822-89-9 | Purity: 95% | 2-Pyridinol-1-oxide | ESD-911497-100MG |
| Cas.: 75350-46-8 | Purity: 97% | Fluorescein 5-Maleimide | ESD-849436-100MG |
| Cas.: 2093934-94-0 | Purity: 95% | DBCO-PEG12-NHS ester | ESD-916826-25MG |
| Cas.: 18191-40-7 | Purity: 25 wt.% water solution | Carboxyethylsilanetriol Sodium Salt | ESD-914070-1G |
| Cas.: 1379761-19-9 | Purity: 95% | Sulfo-DBCO-NHS ester | ESD-916827-50MG |
| Cas.: 86626-38-2 | Purity: ≥95% | 4-bromoindoline | ESD-826614-1G |
| Cas.: 86626-38-2 | Purity: ≥95% | 4-bromoindoline | ESD-826614-250MG |
| Cas.: 1207-99-4 | Purity: ≥97% | 3-chloro-10H-phenothiazine | ESD-856356-250MG |
| Cas.: 2510-22-7 | Purity: 95% | 4-Ethynylpyridine | ESD-831915-1G |
| Cas.: 2510-22-7 | Purity: 95% | 4-Ethynylpyridine | ESD-831915-250MG |
| Cas.: 1629057-08-4 | Purity: 95% | DBCO-C3-Maleimide | ESD-916828-5MG |
| Cas.: 4425-56-3 | Purity: 98% | 2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | ESD-843776-25G |
| Cas.: 502161-03-7 | Purity: 97% | 3-Iodo-N-phenylcarbazole | ESD-822818-1G |
| Cas.: 502161-03-7 | Purity: 97% | 3-Iodo-N-phenylcarbazole | ESD-822818-5G |
| Cas.: 4465-44-5 | Purity: 99% | N-(Triphenylmethyl)-L-serine Methyl Ester | ESD-834996-25G |
| Cas.: 223437-05-6 | Purity: 98% | 1-Methyl-1-propylpyrrolidinium bis(trifluoromethanesulfonyl)imide | ESD-814166-100G |
| Cas.: 3027-05-2 | Purity: 96% | 1,4-Diacetyltetrahydro-2,5-pyrazinedione | ESD-856682-5G |
| Cas.: 3027-05-2 | Purity: 96% | 1,4-Diacetyltetrahydro-2,5-pyrazinedione | ESD-856682-1G |
| Cas.: 1480516-75-3 | Purity: 95% | DBCO-PEG4-Maleimid | ESD-916830-25MG |
| Cas.: 1430408-09-5 | Purity: 95% | Biotin-PEG3-SS-DBCO | ESD-916831-10MG |
| Cas.: 1255942-07-4 | Purity: 95% | DBCO-PEG4-Biotin | ESD-916832-5MG |
| Cas.: 872-10-6 | Purity: 97% | Amyl Sulfide | ESD-849448-100G |
| Cas.: 872-10-6 | Purity: 97% | Amyl Sulfide | ESD-849448-500G |
| Cas.: 361543-12-6 | Purity: 95% | Amino-PEG12-amine | ESD-916833-250MG |
| Cas.: 63059-25-6 | Purity: ≥95% | 2-iodobenzenesulfonic acid | ESD-825963-100G |
| Cas.: 51359-78-5 | Purity: 98% | 4-(Bromomethyl)benzaldehyde | ESD-855267-1G |
| Cas.: 51359-78-5 | Purity: 98% | 4-(Bromomethyl)benzaldehyde | ESD-855267-250MG |
| Cas.: 42055-16-3 | Purity: ≥95% | 3-(Ethylamino)-1-propanol | ESD-850843-250MG |
| Cas.: 33105-93-0 | Purity: ≥95% | Di-tert-butyl ethane-1,2-diyldicarbamate | ESD-858568-250MG |
| Cas.: 17692-31-8 | Purity: 97% | (±)-Dropropizine | ESD-807944-100G |
| Cas.: 2259859-41-9 | Purity: 95% | SiR-DBCO | ESD-916834-1MG |
| Cas.: 18794-77-9 | Purity: 98% | 2-Hexylthiophene | ESD-811229-100G |
| Cas.: 5442-91-1 | Purity: ≥95% | 4-(Ethoxycarbonyl)-3,5-dimethyl-1h-pyrrole-2-carboxylic acid | ESD-857784-5G |
| Cas.: 1807512-43-1 | Purity: 95% | Dde Biotin-PEG4-DBCO | ESD-916835-5MG |
| Cas.: 766-16-5 | Purity: 98% | 4-Fluoro-2-methylpyridine | ESD-856240-250MG |
| Cas.: 22082-99-1 | Purity: ≥99% | 2-(4-Bromophenyl)Naphthalene | ESD-859752-25G |
| Cas.: 22082-99-1 | Purity: ≥99% | 2-(4-Bromophenyl)Naphthalene | ESD-859752-1G |
| Cas.: 3209-72-1 | Purity: ≥98% | Ethyl 5-Methylisoxazole-3-Carboxylate | ESD-858992-5G |
| Cas.: 1989-53-3 | Purity: 97% | 2,6-Dimethoxybenzoyl chloride | ESD-831550-5G |
| Cas.: 1989-53-3 | Purity: 97% | 2,6-Dimethoxybenzoyl chloride | ESD-831550-25G |
| Cas.: 163442-68-0 | Purity: Generation 5.0, viscous liquid | PAMAM dendrimer, ethylenediamine core | ESD-887079-1G |
| Cas.: 540-49-8 | Purity: >98.0%(GC) | 1,2-Dibromoethylene (cis- and trans-mixture) | ESD-863962-1G |
| Cas.: 27817-67-0 | Purity: ≥97.0%(GC) | Allyl Propyl Sulfide | ESD-863810-25ML |
| Cas.: 528818-81-7 | Purity: 20-25% Ethanol solution | 1-Butyl-3-methylimidazolium hydroxide | ESD-916836-100G |
| Cas.: 528818-81-7 | Purity: 20-25% Ethanol solution | 1-Butyl-3-methylimidazolium hydroxide | ESD-916836-25G |
| Cas.: 528818-81-7 | Purity: 20-25% Ethanol solution | 1-Butyl-3-methylimidazolium hydroxide | ESD-916836-5G |
| Cas.: 2032788-37-5 | Purity: 95% | Desthiobiotin-PEG4-DBCO | ESD-916837-5MG |
| Cas.: 14690-00-7 | Purity: ≥99% | 2-Benzyloxy-1,3-propanediol | ESD-835318-5G |
| Cas.: 2093409-57-3 | Purity: 95% | DBCO-PEG3-amine | ESD-916838-50MG |
| Cas.: 1161205-04-4 | Purity: >98% | VU 0361737 | ESD-860882-50MG |
| Cas.: 1840886-10-3 | Purity: 95% | DBCO-PEG4-amine | ESD-916839-50MG |
| Cas.: 2182601-71-2 | Purity: 95% | Cyanine5 DBCO | ESD-916840-1MG |
| Cas.: 35309-35-4 | Purity: 95% | Methyl 5-oxopyrrolidine-3-carboxylate | ESD-844201-5G |
| Cas.: 35309-35-4 | Purity: 95% | Methyl 5-oxopyrrolidine-3-carboxylate | ESD-844201-25G |
| Cas.: 14431-43-7 | Purity: 98% | D-(+)-Glucose monohydrate | ESD-810458-10KG |
| Cas.: 2253710-45-9 | Purity: 95% | DBCO-Cyanine7 | ESD-916841-1MG |
| Cas.: 1557268-88-8 | Purity: ≥98% | Avitinib maleate | ESD-873179-25MG |
| Cas.: 59564-78-2 | Purity: ≥97% | 1,3-Bisbenzyl-2-Oxoimidazolidine-4,5-Dicarboxylic Acid | ESD-860087-5G |
| Cas.: 59564-78-2 | Purity: ≥97% | 1,3-Bisbenzyl-2-Oxoimidazolidine-4,5-Dicarboxylic Acid | ESD-860087-25G |
| Cas.: 59564-78-2 | Purity: ≥97% | 1,3-Bisbenzyl-2-Oxoimidazolidine-4,5-Dicarboxylic Acid | ESD-860087-100G |
| Cas.: 10294-68-5 | Purity: AR | Indium Sulfate Nine Hydrate | ESD-886130-100G |
| Cas.: 20325-40-0 | Purity: for enzymic, spectrophotometric determination | o-Dianisidine dihydrochloride | ESD-909720-50MG |
| Cas.: 883715-23-9 | Purity: Analysis control, ≥98%(HPLC) | (9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide | ESD-916842-20MG |
| Cas.: 1572037-13-8 | Purity: ≥98%(HPLC) | N-(Phenylmethyl)pentadecanamide | ESD-916843-20MG |
| Cas.: 847361-96-0 | Purity: ≥98%(HPLC) | N-(3-methoxy-benzyl)-hexadecanamide | ESD-916844-20MG |
| Cas.: 1415238-25-3 | Purity: 98% | 4,4′,4”,4”’-(pyrene-1,3,6,8-tetrayl)tetrabenzaldehyde | ESD-887351-5G |
| Cas.: 883715-19-3 | Purity: ≥98%(HPLC) | N-benzyl-heptadecanamide | ESD-916845-20MG |
| Cas.: 52709-84-9 | Purity: 99% | 4′-Octyl-4-biphenylcarbonitrile | ESD-815349-25G |
| Cas.: 5327-45-7 | Purity: ≥98%(HPLC) | N-Benzylstearamide | ESD-916846-20MG |
| Cas.: 28664-35-9 | Purity: 97% | 4,5-Dimethyl-3-hydroxy-2,5-dihydrofuran-2-one | ESD-808057-5G |
| Cas.: 26227-73-6 | Purity: 98% | N-(4-Methoxybenzylidene)-4-butylaniline | ESD-838775-100G |
| Cas.: 12008-21-8 | Purity: 500 Mesh, 99.9% | Lanthanum hexaboride | ESD-887823-250G |
| Cas.: 2496-21-1 | Purity: 98% | 4-(4-Butylphenylazo)phenol | ESD-856440-1G |
| Cas.: 2496-21-1 | Purity: 98% | 4-(4-Butylphenylazo)phenol | ESD-856440-250MG |
| Cas.: 66872-75-1 | Purity: 98% | Calcium 3-Methyl-2-oxovalerate | ESD-854854-1G |
| Cas.: 66872-75-1 | Purity: 98% | Calcium 3-Methyl-2-oxovalerate | ESD-854854-25G |
| Cas.: 135682-18-7 | Purity: ≥98%(GC) | (S)-(-)-4-(Methoxymethyl)-1,3-dioxolan-2-one | ESD-863380-1G |
| Cas.: 137-18-8 | Purity: 98% | 2,5-Dimethyl-1,4-benzoquinone | ESD-851654-1G |
| Cas.: 2432-74-8 | Purity: 95% | 6-Aminocapronitrile | ESD-908753-5G |
| Cas.: 25717-80-0 | Purity: >98.0%(HPLC)(T) | Molsidomine | ESD-861712-250MG |
| Cas.: 850583-75-4 | Purity: >95.0% | 3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione | ESD-854482-5G |
| Cas.: 850583-75-4 | Purity: >95.0% | 3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione | ESD-854482-250MG |
| Cas.: 597-63-7 | Purity: ≥98% | Tetraethylgermane | ESD-867599-1G |
| Cas.: 93413-76-4 | Purity: 98% | (1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile | ESD-834695-250MG |
| Cas.: 6084-58-8 | Purity: 95% | O-Isobutylhydroxylamine Hydrochloride | ESD-853332-250MG |
| Cas.: 400727-63-1 | Purity: 97% | N-Boc-5-Aminoisoindoline | ESD-833520-1G |
| Cas.: 400727-63-1 | Purity: 97% | N-Boc-5-Aminoisoindoline | ESD-833520-250MG |
| Cas.: 31608-22-7 | Purity: 95% | 2-(4-Bromobutoxy)tetrahydro-2H-pyran | ESD-840558-5G |
| Cas.: 17430-98-7 | Purity: 98% | (S)-(+)-1-Cyclohexylethylamine | ESD-838700-1G |
| Cas.: 11138-66-2 | Purity: transparent | Gum xanthan | ESD-915019-100G |
| Cas.: 11138-66-2 | Purity: transparent | Gum xanthan | ESD-915019-2.5KG |
| Cas.: 2616-64-0 | Purity: 98% | (2S,3S,4R,5R,6R)-6-[[[(2S,3S,4R,5R)-5-(2,4-dioxopyrimdin-1-yl)-3,4-dihydroxy-oxolan-2 -yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic | ESD-916067-250MG |
| Cas.: 2093197-94-3 | Purity: 95% | DBCO-BODIPY FL | ESD-916847-1MG |
| Cas.: 5043-05-0 | Purity: >95% | 6-(DiMethylaMino)-2-naphthoic acid | ESD-916848-100MG |
| Cas.: 5043-05-0 | Purity: >95% | 6-(DiMethylaMino)-2-naphthoic acid | ESD-916848-250MG |
| Cas.: 5043-05-0 | Purity: >95% | 6-(DiMethylaMino)-2-naphthoic acid | ESD-916848-1G |
| Cas.: 2054339-00-1 | Purity: 95% | 5-FITC-DBCO | ESD-916849-1MG |
| Cas.: 564-25-0 | Purity: ≥98%(HPLC) | Doxycycline | ESD-861182-5G |
| Cas.: 564-25-0 | Purity: ≥98%(HPLC) | Doxycycline | ESD-861182-25G |
| Cas.: 564-25-0 | Purity: ≥98%(HPLC) | Doxycycline | ESD-861182-100G |
| Cas.: 1895849-41-8 | Purity: 95% | DBCO-PEG4-TAMRA | ESD-916850-1MG |
| Cas.: 2566404-76-8 | Purity: 95% | DBCO-PEG3-OH | ESD-916851-50MG |
| Cas.: 2247286-94-6 | Purity: 95% | DBCO-Palmitic | ESD-916852-50MG |
| Cas.: 25413-61-0 | Purity: 95% | N-NITROSOETHYL-N-PROPYLAMINE | ESD-916853-100MG |
| Cas.: 25413-61-0 | Purity: 95% | N-NITROSOETHYL-N-PROPYLAMINE | ESD-916853-250MG |
| Cas.: 25413-61-0 | Purity: 95% | N-NITROSOETHYL-N-PROPYLAMINE | ESD-916853-1G |
| Cas.: 1854034-70-0 | Purity: 95% | Bis-Sulfone-PEG4-DBCO | ESD-916854-5MG |
| Cas.: 84424-96-4 | Purity: 95% | N-Nitroso-N,N-dinonylamine | ESD-916855-10MG |
| Cas.: 84424-96-4 | Purity: 95% | N-Nitroso-N,N-dinonylamine | ESD-916855-100MG |
| Cas.: 557-11-9 | Purity: 98% | Allylurea | ESD-838534-500G |
| Cas.: 82494-09-5 | Purity: 97% | Decyl β-D-maltopyranoside | ESD-863988-5G |
| Cas.: 486460-32-6 | Purity: 99% | Sitagliptin | ESD-832609-25G |
| Cas.: 54143-56-5 | Purity: ≥99% | Flecainide acetate | ESD-878552-250MG |
| Cas.: 54143-56-5 | Purity: ≥99% | Flecainide acetate | ESD-878552-1G |
| Cas.: 54143-56-5 | Purity: ≥99% | Flecainide acetate | ESD-878552-10G |
| Cas.: 6920-22-5 | Purity: 99,5% | 1,2-Hexanediol | ESD-916856-100ML |
| Cas.: 6920-22-5 | Purity: 99,5% | 1,2-Hexanediol | ESD-916856-500ML |
| Cas.: 6920-22-5 | Purity: 99,5% | 1,2-Hexanediol | ESD-916856-2.5L |
| Cas.: 6920-22-5 | Purity: 98% | 1,2-Hexanediol | ESD-811062-2.5L |
| Cas.: 149733-71-1 | Purity: ≥95% | (E)-3-(2-fluorophenyl)acrylaldehyde | ESD-826905-100MG |
| Cas.: 581-45-3 | Purity: ≥95% | 4-(pipidin-4-yl)pyridine | ESD-827140-1G |
| Cas.: 1879-58-9 | Purity: ≥97% | (3-Cyanophenoxy)acetic Acid | ESD-851817-250MG |
| Cas.: 96363-26-7 | Purity: ≥97% | 3-(Boc-amino)-3-(4-methoxyphenyl)-1-propanol | ESD-850838-250MG |
| Cas.: 199475-41-7 | Purity: ≥95% | 4-(4-Piperidyl)-1-butanol Hydrochloride | ESD-850811-250MG |
| Cas.: 1020353-46-1 | Purity: ≥95% | N-Isobutylcyclopropanamine Hydrochloride | ESD-853552-250MG |
| Cas.: 51043-72-2 | Purity: ≥97% | (Dicyclopropylmethyl)amine Hydrochloride | ESD-853514-250MG |
| Cas.: 1801863-88-6 | Purity: 95% | (4E)-TCO-PEG4-DBCO | ESD-916857-10MG |
| Cas.: 2245-52-5 | Purity: 90% | N-(4-Vinylbenzyl)-N,N-diMethylaMine | ESD-916858-1G |
| Cas.: 84057-84-1 | Purity: 98% | Lamotrigine | ESD-831516-100G |
| Cas.: 1314-23-4 | Purity: 99.99%, 2um | Zirconium dioxide | ESD-916859-2.5KG |
| Cas.: 1314-23-4 | Purity: 99.99%, 2um | Zirconium dioxide | ESD-916859-500G |
| Cas.: 1314-23-4 | Purity: 99.99%, 2um | Zirconium dioxide | ESD-916859-100G |
| Cas.: 71050-62-9 | Purity: Solid contains amount ≥30% | PCA | ESD-915773-100G |
| Cas.: 504-85-8 | Purity: 95% | 4-Methylpent-3-enoic acid | ESD-907224-250MG |
| Cas.: 504-85-8 | Purity: 95% | 4-Methylpent-3-enoic acid | ESD-907224-50MG |
| Cas.: 70340-04-4 | Purity: ≥97%(HPLC)(T) | (2-Hydroxybenzyl)triphenylphosphonium Bromide | ESD-862834-25G |
| Cas.: 25114-58-3 | Purity: 99.99% metal basis | Indium triacetate | ESD-824240-50G |
| Cas.: 31274-51-8 | Purity: ≥98.0% | 2,4,6-Tri([1,1′-biphenyl]-4-yl)-1,3,5-triazine | ESD-864635-1G |
| Cas.: 644-06-4 | Purity: 95% | Precocene II | ESD-878016-250MG |
| Cas.: 644-06-4 | Purity: 95% | Precocene II | ESD-878016-50MG |
| Cas.: 55-81-2 | Purity: 98% | 4-Methoxyphenethylamine | ESD-813226-1G |
| Cas.: 609-09-6 | Purity: 97% | Diethyl ketomalonate | ESD-831238-500G |
| Cas.: 42923-79-5 | Purity: 97% | 7-Nitro-1,2,3,4-tetrahydroisoquinoline | ESD-841459-5G |
| Cas.: 42923-79-5 | Purity: 97% | 7-Nitro-1,2,3,4-tetrahydroisoquinoline | ESD-841459-25G |
| Cas.: 252742-72-6 | Purity: 98% | 5-Chloromethyl-2,4-dihydro-[1,2,4]triazol-3-one | ESD-830408-100G |
| Cas.: 3389-54-6 | Purity: 95% | phenyl(pyrrolidin-1-yl)methanone | ESD-914093-25G |
| Cas.: 115964-29-9 | Purity: 98% | Tosufloxacin tosylate | ESD-916860-100MG |
| Cas.: 115964-29-9 | Purity: 98% | Tosufloxacin tosylate | ESD-916860-500MG |
| Cas.: 115964-29-9 | Purity: 98% | Tosufloxacin tosylate | ESD-916860-1G |
| Cas.: 18480-52-9 | Purity: 97% | 3,4-Dichloroisothiazole-5-carbonitrile | ESD-916861-250MG |
| Cas.: 18480-52-9 | Purity: 97% | 3,4-Dichloroisothiazole-5-carbonitrile | ESD-916861-1G |
| Cas.: 18480-52-9 | Purity: 97% | 3,4-Dichloroisothiazole-5-carbonitrile | ESD-916861-5G |
| Cas.: 86847-84-9 | Purity: 95% | N-(6-Chloropyridin-2-yl)pivalamide | ESD-842613-5G |
| Cas.: 86847-84-9 | Purity: 95% | N-(6-Chloropyridin-2-yl)pivalamide | ESD-842613-25G |
| Cas.: 1464-53-5 | Purity: 95% | 1,2:3,4-Diepoxybutane Solution | ESD-849800-250MG |
| Cas.: 9041-08-1 | Purity: ≥150 units/mg | Heparin sodium salt | ESD-913433-25G |
| Cas.: 1000152-84-0 | Purity: ≥95% | 2,6-Dibromo-4-(trifluoromethyl)pyridine | ESD-898026-5G |
| Cas.: 34540-22-2 | Purity: 98% | Madecassoside | ESD-813306-1G |
| Cas.: 39394-84-8 | Purity: 7.5% W/W P2O5 | Eaton’s Reagent | ESD-822708-25ML |
| Cas.: 4099-35-8 | Purity: 98% | S-(2-Aminoethyl)-L-cysteine hydrochloride | ESD-916862-250MG |
| Cas.: 67605-85-0 | Purity: 95% | (S)-N-(2-Oxotetrahydrofuran-3-yl)butyramide | ESD-916863-100MG |
| Cas.: 7636-26-2 | Purity: 96% | 2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid | ESD-916864-250MG |
| Cas.: 30211-77-9 | Purity: ≥97% | 2-Nitro-5-thiocyanatobenzoic Acid | ESD-867878-1G |
| Cas.: 3978-11-8 | Purity: 95% | N’-formyl-L-Kynurenine | ESD-916865-100MG |
| Cas.: 5336-08-3 | Purity: >97%(GC) | D-Ribono-1,4-lactone | ESD-863884-10G |
| Cas.: 1344-28-1 | Purity: 100-200 Mesh | aluminum oxide | ESD-800034-10KG |
| Cas.: 76927-70-3 | Purity: 95% | Amino-PEG6-amine | ESD-916866-250MG |
| Cas.: 332941-25-0 | Purity: 95% | Amino-PEG7-amine | ESD-916867-250MG |
| Cas.: 82209-36-7 | Purity: 95% | Amino-PEG8-amine | ESD-916868-250MG |
| Cas.: 82228-89-5 | Purity: ≥98% | 4-Formyl-1-Methyl-Pyridinium Benzenesulfonate | ESD-860279-1G |
| Cas.: 474082-35-4 | Purity: 95% | Amino-PEG9-amine | ESD-916869-250MG |
| Cas.: 479200-82-3 | Purity: 95% | Amino-PEG11-amine | ESD-916871-250MG |
| Cas.: 1332-58-7 | Purity: CP | Kaolin | ESD-812210-10KG |
| Cas.: 288-32-4 | Purity: 99% | imidazole | ESD-823674-10KG |
| Cas.: 9004-54-0 | MW 1000 | Dextran | ESD-872036-500G |
| Cas.: 37199-66-9 | Purity: ≥42% K2S basis | Potassium (poly)sulfide | ESD-916146-500G |
| Cas.: 56180-94-0 | Purity: 98% | Acarbose | ESD-832180-250MG |
| Cas.: 2792-66-7 | α-Methyl-DL-aspartic acid | ESD-916872-100MG | |
| Cas.: 1492-23-5 | Purity: 98% | O-Succinyl-L-homoserine | ESD-916873-5MG |
| Cas.: 225789-38-8 | Purity: Phosphorus contains amount: 23%-24% | Aluminum Diethylphosphinate | ESD-875852-2.5KG |
| Cas.: 10531-16-5 | Purity: 97% | 4-Butylbenzyl Bromide | ESD-869659-1G |
| Cas.: 3229-73-0 | Purity: 99% | 3-Carbamoyl-2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl | ESD-914773-250MG |
| Cas.: 1004-36-0 | Purity: 99% | 2,6-Dimethyl-γ-pyrone | ESD-807120-500G |
| Cas.: 1956-10-1 | Purity: ≥95% | 4-Nitrophenyl octanoate | ESD-838438-25G |
| Cas.: 13265-84-4 | Purity: 96% | D-Glucal | ESD-810464-100G |
| Cas.: 78-10-4 | Purity: 98% | Tetraethyl orthosilicate | ESD-819506-2.5L |
| Cas.: 1124-11-4 | Purity: 98% | 2,3,5,6-Tetramethylpyrazine | ESD-819556-2.5KG |
| Cas.: 9006-04-6 | natural rubber | ESD-909339-2.5KG | |
| Cas.: 1402836-58-1 | Purity: 98% | NLG919 | ESD-849161-250MG |
| Cas.: 1402836-58-1 | Purity: 98% | NLG919 | ESD-849161-10MG |
| Cas.: 2236-60-4 | Purity: ≥95% | 2-Amino-1,5-dihydropteridin-4-ol | ESD-891533-50MG |
| Cas.: 132172-61-3 | Purity: 99% | (2,3-Dioleyl-propyl)-trimethylamine | ESD-890288-100MG |
| Cas.: 132172-61-3 | Purity: 99% | (2,3-Dioleyl-propyl)-trimethylamine | ESD-890288-500MG |
| Cas.: 6571-51-3 | Purity: 97% | 1,11-Dioxa[11]paracyclophane | ESD-869419-1G |
| Cas.: 6571-51-3 | Purity: 97% | 1,11-Dioxa[11]paracyclophane | ESD-869419-50MG |
| Cas.: 160032-40-6 | Purity: 98% | Thieno[3,2-b]thiophene-2-boronic Acid | ESD-868432-100MG |
| Cas.: 63038-26-6 | Purity: 98% | L-tert-Leucine Methyl Ester | ESD-834842-1G |
| Cas.: 13925-00-3 | Purity: 99% | Ethylpyrazine | ESD-838730-500G |
| Cas.: 27219-07-4 | Purity: ≥98.0%(GC) | N-(tert-Butoxycarbonyl)-5-aminovaleric Acid | ESD-832740-100G |
| Cas.: 116754-58-6 | Purity: 95% | 13-Bromotridecan-1-ol | ESD-916874-100MG |
| Cas.: 116754-58-6 | Purity: 95% | 13-Bromotridecan-1-ol | ESD-916874-250MG |
| Cas.: 116754-58-6 | Purity: 95% | 13-Bromotridecan-1-ol | ESD-916874-1G |
| Cas.: 116754-58-6 | Purity: 95% | 13-Bromotridecan-1-ol | ESD-916874-5G |
| Cas.: 24660-67-1 | Purity: ≥95% | 5-Amino-1-methyl-1,2,3-triazole | ESD-853488-50MG |
| Cas.: 125827-86-3 | Purity: ≥97% | 1-(3-Fluorophenyl)cyclohexylamine | ESD-853542-50MG |
| Cas.: 25023-01-2 | Purity: 95% | 9,9-dichloro-9H-fluorene | ESD-908771-250MG |
| Cas.: 25023-01-2 | Purity: 95% | 9,9-dichloro-9H-fluorene | ESD-908771-1G |
| Cas.: 106516-24-9 | Purity: ≥95% | Sertindole | ESD-868103-50MG |
| Cas.: 17618-08-5 | Purity: >99% | 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt) | ESD-863502-100MG |
| Cas.: 590417-94-0 | Purity: ≥95% | 6-bromo-1-methyl-1H-indazole | ESD-825616-25G |
| Cas.: 590417-94-0 | Purity: ≥95% | 6-bromo-1-methyl-1H-indazole | ESD-825616-100G |
| Cas.: 307313-03-7 | Purity: ≥95% | 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-2-carboxylic acid | ESD-825592-250MG |
| Cas.: 70955-01-0 | Purity: 1mm-1.6mm, for desiccant | Molecular sieves, 4 | ESD-875241-25KG |
| Cas.: 17802-36-7 | Purity: 98% | 3,4-Dimethyldiphenylamine | ESD-806534-100G |
| Cas.: 1772-25-4 | Purity: ≥98%(GC) | 1,3,6-Hexanetricarbonitrile | ESD-863132-25G |
| Cas.: 30058-40-3 | Purity: 97% | 2-Fluorobenzenesulfonamide | ESD-838038-25G |
| Cas.: 30058-40-3 | Purity: 97% | 2-Fluorobenzenesulfonamide | ESD-838038-100G |
| Cas.: 6925-00-4 | Purity: ≥95% | Quinoxaline-6-carboxylic acid | ESD-826108-25G |
| Cas.: 9000-30-0 | Purity: 99% | GUAR GUM | ESD-916492-5KG |
| Cas.: 1643-29-4 | Purity: ≥95% | 3-(4-iodophenyl)propanoic acid | ESD-826458-1G |
| Cas.: 696-44-6 | Purity: 97% | N-Methyl-|m|-toluidine | ESD-813362-5ML |
| Cas.: 14548-50-6 | Purity: 95% | 7-Chloro-3,4-dihydroquinolin-2(1H)-one | ESD-842045-1G |
| Cas.: 14548-50-6 | Purity: 95% | 7-Chloro-3,4-dihydroquinolin-2(1H)-one | ESD-842045-5G |
| Cas.: 13362-52-2 | Purity: 97% | Tridecane-1,13-diol | ESD-842000-25G |
| Cas.: 13362-52-2 | Purity: 97% | Tridecane-1,13-diol | ESD-842000-100G |
| Cas.: 6854-07-5 | Purity: 96% | 2-Hydroxy-5-nitronicotinic acid | ESD-811445-25G |
| Cas.: 147867-65-0 | Purity: ≥98% | DSPE-MPEG2000 | ESD-875845-5G |
| Cas.: 1486470-12-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopropanecarboxylic acid | ESD-892786-25MG |
| Cas.: 24973-22-6 | Purity: 98% | 3-methoxy-4-methylbenzaldehyde | ESD-825334-5G |
| Cas.: 24973-22-6 | Purity: 98% | 3-methoxy-4-methylbenzaldehyde | ESD-825334-1G |
| Cas.: 24973-22-6 | Purity: 98% | 3-methoxy-4-methylbenzaldehyde | ESD-825334-250MG |
| Cas.: 25761-72-2 | Purity: 95% | Diallylcarbamyl chloride | ESD-863849-1G |
| Cas.: 70142-34-6 | Purity: free macrogoly, 25-40% | Polyoxyl 15 Hydroxystearate | ESD-916875-100MG |
| Cas.: 4291-60-5 | Purity: ≥98% | Tilianin | ESD-889423-10MG |
| Cas.: 40437-72-7 | Purity: ≥98%(HPLC) | Kaempferol-3-O-glucorhamnoside | ESD-861407-10MG |
| Cas.: 70195-20-9 | Purity: 99% | Papain Inhibitor | ESD-916876-25MG |
| Cas.: 141505-33-1 | Purity: 99% | Levosimendan | ESD-859294-250MG |
| Cas.: 4536-23-6 | Purity: ≥98% | 2-Methylhexanoic Acid | ESD-859981-25G |
| Cas.: 57-87-4 | Purity: 95% | Ergosterol | ESD-808836-250G |
| Cas.: 63231-66-3 | Purity: 99% | Chlorinated Polyethylene | ESD-909271-5KG |
| Cas.: 606-68-8 | Purity: 95% | β-NADH | ESD-916066-25G |
| Cas.: 148-24-3 | Purity: AR, 99.0% | 8-Hydroxyquinoline | ESD-810919-10KG |
| Cas.: 24003-67-6 | Purity: 98% | Hexanoyl Glycine (NSC 224460) | ESD-912299-25MG |
| Cas.: 493-72-1 | Purity: 98% | 5-Phenylcyclohexane-1,3-dione | ESD-842236-25G |
| Cas.: 24003-67-6 | Purity: 98% | Hexanoyl Glycine (NSC 224460) | ESD-912299-100MG |
| Cas.: 493-72-1 | Purity: 98% | 5-Phenylcyclohexane-1,3-dione | ESD-842236-100G |
| Cas.: 8000-26-8 | Purity: 99% | Pine needle oil | ESD-905671-2.5L |
| Cas.: 1092939-17-7 | Purity: 99% | Ruxolitinib Phosphate | ESD-873292-50MG |
| Cas.: 1092939-17-7 | Purity: 99% | Ruxolitinib Phosphate | ESD-873292-250MG |
| Cas.: 6975-29-7 | Purity: 98% | N-(2,4-Dichlorophenyl)acetamide | ESD-916877-2G |
| Cas.: 1326-12-1 | Thioflavine S | ESD-911727-500MG | |
| Cas.: 6975-29-7 | Purity: 98% | N-(2,4-Dichlorophenyl)acetamide | ESD-916877-10G |
| Cas.: 1326-12-1 | Thioflavine S | ESD-911727-5G | |
| Cas.: 10101-53-8 | Purity: 40% water solution | Chromium Sulfate | ESD828593-20L |
| Cas.: 129497-78-5 | Purity: 97% | Verteporfin | ESD-873899-100MG |
| Cas.: 2051-76-5 | Purity: 97% | Acrylic anhydride | ESD-822885-1G |
| Cas.: 6940-57-4 | Purity: 98% | 2-Acetyl-6-methylpyridine | ESD-839252-5G |
| Cas.: 6940-57-4 | Purity: 98% | 2-Acetyl-6-methylpyridine | ESD-839252-25G |
| Cas.: 771-15-3 | Purity: 97% | 2-bromonaphthalen-1-ol | ESD-825813-1G |
| Cas.: 161726-69-8 | Purity: >94.0%(GC) | 5-[5-(5-bromothiophen-2-yl)thiophen-2-yl]thiophene-2-carbaldehyde | ESD-854489-100MG |
| Cas.: 161726-69-8 | Purity: >94.0%(GC) | 5-[5-(5-bromothiophen-2-yl)thiophen-2-yl]thiophene-2-carbaldehyde | ESD-854489-1G |
| Cas.: 100114-57-6 | Purity: ≥95% | 3-cyclopropyl-1H-pyrazole | ESD-825586-1G |
| Cas.: 100114-57-6 | Purity: ≥95% | 3-cyclopropyl-1H-pyrazole | ESD-825586-250MG |
| Cas.: 2391-56-2 | Purity: 95% | 1,5-Bis(4-aminophenoxy)pentane | ESD-908747-250MG |
| Cas.: 2538-68-3 | Purity: 98% | Phenazine-1-carboxylic acid | ESD-843689-500MG |
| Cas.: 2550-61-0 | Cesium methanesulfonate | ESD-915663-1G | |
| Cas.: 3547-38-4 | Purity: ≥80% | Arsenazo I Hydrate | ESD-916878-5G |
| Cas.: 3547-38-4 | Purity: ≥80% | Arsenazo I Hydrate | ESD-916878-1G |
| Cas.: 79307-93-0 | Purity: 98% | Azelastine hydrochloride | ESD-859254-5G |
| Cas.: 79307-93-0 | Purity: 98% | Azelastine hydrochloride | ESD-859254-25G |
| Cas.: 1007219-73-9 | Purity: ≥97% | Methyl 1-methyl-1H-indazole-6-carboxylate | ESD-825256-1G |
| Cas.: 1007219-73-9 | Purity: ≥97% | Methyl 1-methyl-1H-indazole-6-carboxylate | ESD-825256-250MG |
| Cas.: 73455-13-7 | Purity: 95% | 4,5-dichloropyridine-2-carboxylic acid | ESD-857367-100MG |
| Cas.: 23873-81-6 | Purity: 97% | Diphenylglyoxime | ESD-838134-25G |
| Cas.: 23873-81-6 | Purity: 97% | Diphenylglyoxime | ESD-838134-100G |
| Cas.: 11120-25-5 | Purity: 99.95% metals basis | Ammonium (|para|)tungstate hydrate | ESD-800586-2.5KG |
| Cas.: 121492-06-6 | Purity: 97% | N-Boc-N-methylethylenediamine | ESD-815058-25ML |
| Cas.: 121492-06-6 | Purity: 97% | N-Boc-N-methylethylenediamine | ESD-815058-100ML |
| Cas.: 152628-02-9 | Purity: 95% | 2-N-Propyl-4-methyl-6-(1′-methylbenzimidazole-2-yl)benzimidazole | ESD-836202-5G |
| Cas.: 152628-02-9 | Purity: 95% | 2-N-Propyl-4-methyl-6-(1′-methylbenzimidazole-2-yl)benzimidazole | ESD-836202-25G |
| Cas.: 7446-20-0 | Purity: 99% | Zinc sulfate heptahydrate | ESD-820818-10KG |
| Cas.: 92-71-7 | Purity: 99%, flashing grade | 2,5-Diphenyloxazole | ESD-806337-5G |
| Cas.: 35141-30-1 | Purity: 95% | 3-[2-(2-Aminoethylamino)ethylamino]propyl-trimethoxysilane | ESD-828094-500ML |
| Cas.: 2631-40-5 | Purity: 100μg/ml, u=3%, Medium: acetone | isoprocarb solution | ESD-811877-1.2ML |
| Cas.: 547-64-8 | Purity: 98% | Methyl lactate | ESD-830991-10L |
| Cas.: 26658-46-8 | Purity: 37 wt. % in H2O | Polyethylneimine, 80% ethoxylated solution | ESD-916879-50G |
| Cas.: 1159202-33-1 | Purity: 97% | 2,3,6,7,10,11-hexaaminotriphenylene | ESD-914089-1G |
| Cas.: 7440-02-0 | Purity: 20nm-100nm, 99.9% metals basis | Nickel | ESD-814639-500G |
| Cas.: 1309-37-1 | Purity: AR, 99% | Iron(III) oxide | ESD-809610-10KG |
| Cas.: 1565-94-2 | Purity: Reagent grade | Bisphenol A glycerolate dimethacrylate | ESD-802409-5ML |
| Cas.: 899431-18-6 | Purity: 99% | A-438079 HCl | ESD-872951-25MG |
| Cas.: 516-55-2 | Purity: 98% | Alloepipregnanolone | ESD-912404-250MG |
| Cas.: 516-55-2 | Purity: 98% | Alloepipregnanolone | ESD-912404-1G |
| Cas.: 319-86-8 | Purity: δ-666 standard solution, 50μg/ml, solvent: methanol | δ-HCH | ESD-838807-1.2ML |
| Cas.: 2461-46-3 | Purity: 95% | 4,4′-bis(2,3-epoxypropoxy)biphenyl | ESD-908760-1G |
| Cas.: 18368-64-4 | Purity: 97% | 2-Chloro-5-methylpyridine | ESD-806126-500ML |
| Cas.: 7774-44-9 | Purity: ≥99%(GC) | Cyclohexyl Isovalerate | ESD-862885-100ML |
| Cas.: 222310-82-9 | Purity: ≥95% (HPLC) | Carbonate ionophore VII | ESD-863977-10MG |
| Cas.: 2133-34-8 | Purity: 99% | L-Azetidine-2-carboxylic acid | ESD-801756-5G |
| Cas.: NONE8013 | Purity: L: ~200nm, OD: ~10nm | Cellulose nanocrystal | ESD-909406-1G |
| Cas.: 17347-95-4 | Purity: 97% | Lithium hexafluorosilicate | ESD-836258-250MG |
| Cas.: 17585-69-2 | Purity: 95% | L-Phenylalanine hydrochloride | ESD-915193-250MG |
| Cas.: 5518-18-3 | Purity: 95% | N,N’-ethane-1,2-diylbishexadecan-1-amide | ESD-906954-100MG |
| Cas.: 4645-15-2 | Purity: 95% | 1,1′-oxybis(cyclohexane) | ESD-913451-1G |
| Cas.: 931-48-6 | Purity: 98% | 2-cyclohexylacetylene | ESD-832076-1G |
| Cas.: 1056634-68-4 | Purity: ≥98% | CYT387 | ESD-833046-5MG |
| Cas.: 1163-36-6 | Purity: >98% | Clemizole hydrochloride | ESD-860932-5MG |
| Cas.: 171179-06-9 | Purity: ≥97% | PD 158780 | ESD-868309-1G |
| Cas.: 171179-06-9 | Purity: ≥97% | PD 158780 | ESD-868309-5G |
| Cas.: 171179-06-9 | Purity: ≥97% | PD 158780 | ESD-868309-250MG |
| Cas.: 284035-33-2 | Purity: 99% | NPS-2143 | ESD-872547-25MG |
| Cas.: 514-78-3 | Purity: >98% | Canthaxanthin | ESD-860607-5MG |
| Cas.: 514-78-3 | Purity: >98% | Canthaxanthin | ESD-860607-1MG |
| Cas.: 614-22-2 | Purity: 98% | Benzoylurea | ESD-871025-25G |
| Cas.: 84459-32-5 | Purity: ≥95% | 2-bromo-5-nitrobenzaldehyde | ESD-827934-5G |
| Cas.: 84459-32-5 | Purity: ≥95% | 2-bromo-5-nitrobenzaldehyde | ESD-827934-1G |
| Cas.: 84459-32-5 | Purity: ≥95% | 2-bromo-5-nitrobenzaldehyde | ESD-827934-25G |
| Cas.: 1572-84-5 | Purity: >95% | 1,4-Bis(butyryloxy)-2-butene | ESD-835303-25G |
| Cas.: 1572-84-5 | Purity: >95% | 1,4-Bis(butyryloxy)-2-butene | ESD-835303-1G |
| Cas.: 51077-01-1 | Purity: 95% | N-Toluenesulfonyl-L-proline | ESD-916880-1G |
| Cas.: 185147-07-3 | Purity: 97% | 2-Fluoro-3-methylbenzonitrile | ESD-828685-1G |
| Cas.: 112734-22-2 | Purity: 98% | (4-Bromo-2-fluorophenyl)methanamine | ESD-840541-25G |
| Cas.: 399-54-2 | Purity: 98% | 4-Fluoro-2-methylanisole | ESD-828697-1G |
| Cas.: 399-54-2 | Purity: 98% | 4-Fluoro-2-methylanisole | ESD-828697-25G |
| Cas.: 297156-50-4 | Purity: ≥98%(GC) | 2-Isopropyl-2-methacryloyloxyadamantane | ESD-862868-1G |
| Cas.: 1317-61-9 | Purity: Matrix: Fe3O4, Surface Group: -COOH, Particle size: 500-600 nm, Unit: 5mg/ml | Monodispersed magnetite microspheres | ESD-814137-25ML |
| Cas.: 2648-71-7 | Purity: 96% | 3-Bromo-3-methyl-2-butanone | ESD-832032-1G |
| Cas.: 18523-47-2 | Purity: 98% | 3-Azidopropionic Acid | ESD-916881-100MG |
| Cas.: 51868-96-3 | Purity: ≥95% | Diethyl 1-Pyrrolidinemethylphosphonate | ESD-867665-5G |
| Cas.: 714951-87-8 | Purity: 98% | Di(1-adamantyl)-n-butylphosphine hydriodide | ESD-828348-5G |
| Cas.: 86917-58-0 | Purity: 98% | 1,5-Dimethyl-2-piperidone | ESD-870918-5ML |
| Cas.: 61715-75-1 | Purity: 98% | 1-Butyl-1-phenylhydrazine | ESD-871113-25G |
| Cas.: 210545-23-6 | Purity: 97% | Ac-Arg-OH dihydrate | ESD-916882-100G |
| Cas.: 210545-23-6 | Purity: 97% | Ac-Arg-OH dihydrate | ESD-916882-25G |
| Cas.: 210545-23-6 | Purity: 97% | Ac-Arg-OH dihydrate | ESD-916882-5G |
| Cas.: 2779-81-9 | Purity: ≥97% | 3,6-Dichloropyridazin-4-ol | ESD-858816-250MG |
| Cas.: 580-20-1 | Purity: 98% | 7-Quinolinol | ESD-834896-5G |
| Cas.: 580-20-1 | Purity: 98% | 7-Quinolinol | ESD-834896-25G |
| Cas.: 7425-80-1 | Tetraisobutyl Orthotitanate (contains Isopropoxide) | ESD-862011-25ML | |
| Cas.: 721401-53-2 | Purity: 97% | (R)-5-Chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide | ESD-902129-5MG |
| Cas.: 721401-53-2 | Purity: 97% | (R)-5-Chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide | ESD-902129-25MG |
| Cas.: 110026-03-4 | Purity: ≥98% | Taurodeoxychloic Acid sodium hydrate | ESD-884569-250MG |
| Cas.: 110026-03-4 | Purity: ≥98% | Taurodeoxychloic Acid sodium hydrate | ESD-884569-1G |
| Cas.: 564-35-2 | Purity: 98% | 11-keto Testosterone (CRM) | ESD-912545-50MG |
| Cas.: 602-41-5 | Purity: ≥98%(HPLC) | Thiocolchicoside | ESD-861366-5MG |
| Cas.: 564-35-2 | Purity: 98% | 11-keto Testosterone (CRM) | ESD-912545-250MG |
| Cas.: 564-35-2 | Purity: 98% | 11-keto Testosterone (CRM) | ESD-912545-1G |
| Cas.: 602-41-5 | Purity: ≥98%(HPLC) | Thiocolchicoside | ESD-861366-100MG |
| Cas.: 602-41-5 | Purity: ≥98%(HPLC) | Thiocolchicoside | ESD-861366-250MG |
| Cas.: 8008-88-6 | natural | Valerian root extract | ESD-854434-500G |
| Cas.: 198545-85-6 | Purity: 98% | Fmoc-D-Phe(F5)-OH | ESD-916883-250MG |
| Cas.: 162648-54-6 | Purity: 98% | Fmoc-Ac6c-OH | ESD-916884-1G |
| Cas.: 235114-32-6 | Purity: 98% | Micafungin | ESD-880138-25MG |
| Cas.: 756525-90-3 | Methyl-PEG8-NHS Ester | ESD-862585-100MG | |
| Cas.: 109927-44-8 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-methyl-1H-indol-3-yl)propanoic acid | ESD-916885-100MG |
| Cas.: 1310680-47-7 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-ethylpentanoic acid | ESD-916886-100MG |
| Cas.: 3392-09-4 | Purity: 96% | Boc-Leu-OSu | ESD-916887-1G |
| Cas.: 3392-09-4 | Purity: 96% | Boc-Leu-OSu | ESD-916887-5G |
| Cas.: 945947-99-9 | Purity: 95% | 3-OXA-1,8-DIAZASPIRO[4.5]DECAN-2-ONE | ESD-876222-250MG |
| Cas.: 945947-99-9 | Purity: 95% | 3-OXA-1,8-DIAZASPIRO[4.5]DECAN-2-ONE | ESD-876222-100MG |
| Cas.: 35620-71-4 | Purity: 98% | 2-Phenoxynicotinic acid | ESD-916888-5G |
| Cas.: 372144-00-8 | Purity: ≥95% | 2-Amino-2-(3,5-dichlorophenyl)ethanol | ESD-850824-50MG |
| Cas.: 372144-00-8 | Purity: ≥95% | 2-Amino-2-(3,5-dichlorophenyl)ethanol | ESD-850824-1G |
| Cas.: 200133-16-0 | Purity: 95% | 3-[2-Benzyloxycarbonylamino-3-(2-carboxy-ethoxy)-2-(2-carboxy-ethoxymethyl)-propoxy]-propionic | ESD-916889-250MG |
| Cas.: 133810-35-2 | Purity: ≥95% | 4-[(Trimethylsilyl)ethynyl]pyridine | ESD-853658-250MG |
| Cas.: 133810-35-2 | Purity: ≥95% | 4-[(Trimethylsilyl)ethynyl]pyridine | ESD-853658-100MG |
| Cas.: 133810-35-2 | Purity: ≥95% | 4-[(Trimethylsilyl)ethynyl]pyridine | ESD-853658-25MG |
| Cas.: 130120-57-9 | Purity: 99% | Prezatide copper acetate | ESD-916890-100MG |
| Cas.: 65994-07-2 | Purity: 85% | trimethoxy-[3-(2-methoxyethoxy)propyl]silane | ESD-916892-25G |
| Cas.: 37220-90-9 | Purity: 99% | Silicic acid, magnesium lithium salt | ESD-916893-100G |
| Cas.: 7727-21-1 | Purity: 99,5% | Potassium persulfate | ESD-816372-10KG |
| Cas.: 105598-27-4 | Purity: 99% | Hexaazatriphenylenehexacabonitrile | ESD-808365-5G |
| Cas.: 527-07-1 | Purity: AR, 99.0% | D-Gluconic acid sodium salt | ESD-810383-10KG |
| Cas.: 102-69-2 | Purity: AR | Tripropylamine | ESD-818830-10L |
| Cas.: 22662-39-1 | Purity: PESTANAL, analytical standard | Rafoxanide, Vetranal | ESD-838208-100G |
| Cas.: 14689-84-0 | Purity: 90% | D-ribulose 1,5-diphosphate | ESD-916911-5MG |
| Cas.: 69011-20-7 | DowexMonosphere650 H Cation Exchange Resin | ESD-916912-250G | |
| Cas.: 26993-30-6 | Purity: ≥98.0% | D-erythro-sphingosine-1-phosphate | ESD-832954-5MG |
| Cas.: 50650-59-4 | Purity: 98% | 2-HYDROXY-4-(TRIFLUOROMETHYL)PYRIDINE | ESD-833984-25G |
| Cas.: 1775-95-7 | Purity: 98% | 2-Amino-5-nitrobenzophenone | ESD-800148-500G |
| Cas.: 31972-52-8 | Purity: 95% | Boc-Gly-Gly-OH | ESD-843675-100G |
| Cas.: 9073-63-6 | Purity: Buffered solution, 10-40 units/mg protein (biuret) | Alcohol Oxidase | ESD-864213-50U |
| Cas.: 188416-28-6 | Purity: 85% | 4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine | ESD-916913-100G |
| Cas.: 188416-28-6 | Purity: 85% | 4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine | ESD-916913-25G |
| Cas.: 3385-03-3 | Purity: ≥97% | Flunisolide | ESD-863905-50MG |
| Cas.: 188416-28-6 | Purity: 85% | 4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine | ESD-916913-5G |
| Cas.: 77835-49-5 | Purity: 97% | (S)-2-amino-3-methyl-N-(4-nitrophenyl)butanamide hydrochloride | ESD-916914-250MG |
| Cas.: 57378-68-4 | Purity: 98% | Delta Damascone | ESD-916173-25G |
| Cas.: 57378-68-4 | Purity: 98% | Delta Damascone | ESD-916173-100G |
| Cas.: 57378-68-4 | Purity: 98% | Delta Damascone | ESD-916173-500G |
| Cas.: 951-77-9 | Purity: 99% | 2′-Deoxycytidine monohydrate | ESD-806817-100G |
| Cas.: 641569-96-2 | Purity: ≥97%(HPLC)(T) | Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate | ESD-862391-25G |
| Cas.: XBPY | Purity: 0.5M, pH6.5 | HEPES Buffer | ESD-885789-1L |
| Cas.: 4435-50-1 | Purity: 90%, GC | 1,2,3-Butanetriol | ESD-849411-25ML |
| Cas.: 7488-56-4 | Purity: 97% | Selenium Sulfide | ESD-838725-500G |
| Cas.: 158861-67-7 | Purity: 98% | GHRP-2 | ESD-916339-500MG |
| Cas.: 74-55-5 | Purity: 98% | Ethambutol | ESD-877559-5G |
| Cas.: 2437-29-8 | Purity: biological staining grade | Malachite green | ESD-813590-2.5KG |
| Cas.: 2103-91-5 | Purity: 98% | 2-Amino-4-(p-tolyl)thiazole | ESD-870722-200MG |
| Cas.: 14314-42-2 | Purity: 10 atom % 18O | Heavy-oxygen water | ESD-871820-25G |
| Cas.: 581-43-1 | Purity: 98% | 2,6-Dihydroxynaphthalene | ESD-829680-100G |
| Cas.: 22572-40-3 | Purity: 98% | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide methiodide | ESD-836337-5G |
| Cas.: 112965-21-6 | Purity: ≥98% | Calcipotriol | ESD-833063-50MG |
| Cas.: 112965-21-6 | Purity: ≥98% | Calcipotriol | ESD-833063-100MG |
| Cas.: 41263-94-9 | Purity: 95% | 2′-FUCOSYLLACTOSE | ESD-916915-1MG |
| Cas.: 491-07-6 | Purity: Analysis control, ≥98% | ISOMENTHONE | ESD-916916-20MG |
| Cas.: 67-07-2 | Purity: ≥92% | Creatine phosphate | ESD-916919-1G |
| Cas.: 387334-31-8 | Purity: ≥98% | BMPO | ESD-916920-1MG |
| Cas.: 1303-86-2 | Purity: 98%, 300 Mesh | Boron oxide | ESD-916922-10KG |
| Cas.: 1303-86-2 | Purity: 98%, 300 Mesh | Boron oxide | ESD-916922-2.5KG |
| Cas.: 1303-86-2 | Purity: 98%, 300 Mesh | Boron oxide | ESD-916922-500G |
| Cas.: 101-14-4 | Purity: 85% | 4,4′-Methylene-bis(2-chloroaniline) | ESD-916921-100G |
| Cas.: 1303-86-2 | Purity: 98%, 300 Mesh | Boron oxide | ESD-916922-100G |
| Cas.: 101-14-4 | Purity: 85% | 4,4′-Methylene-bis(2-chloroaniline) | ESD-916921-500G |
| Cas.: 101-14-4 | Purity: 85% | 4,4′-Methylene-bis(2-chloroaniline) | ESD-916921-2.5KG |
| Cas.: 14808-60-7 | Purity: AR, 200-250 Mesh | Silica sand | ESD-916923-25KG |
| Cas.: 1338-24-5 | Purity: 85% | Naphthenic Acid | ESD-916924-100G |
| Cas.: 14808-60-7 | Purity: AR, 200-250 Mesh | Silica sand | ESD-916923-5KG |
| Cas.: 14808-60-7 | Purity: AR, 200-250 Mesh | Silica sand | ESD-916923-500G |
| Cas.: 1338-24-5 | Purity: 85% | Naphthenic Acid | ESD-916924-25G |
| Cas.: 1338-24-5 | Purity: 85% | Naphthenic Acid | ESD-916924-500G |
| Cas.: 1338-24-5 | Purity: 85% | Naphthenic Acid | ESD-916924-2.5KG |
| Cas.: 637-03-6 | Purity: 97% | Phenylarsine Oxide | ESD-860135-1G |
| Cas.: 119-44-8 | Purity: ≥95% | Xanthopterin | ESD-916925-200MG |
| Cas.: 32426-11-2 | Purity: 80% | Octyl Decyldimethyl Ammonium Chloride | ESD-857023-2.5KG |
| Cas.: 100-07-2 | Purity: >99.0%(GC) | 4-Methoxybenzoyl chloride | ESD-916926-500G |
| Cas.: 100-07-2 | Purity: >99.0%(GC) | 4-Methoxybenzoyl chloride | ESD-916926-100G |
| Cas.: 100-07-2 | Purity: >99.0%(GC) | 4-Methoxybenzoyl chloride | ESD-916926-25G |
| Cas.: 139110-80-8 | Purity: 98% | Zanamivir | ESD-823517-500MG |
| Cas.: 105146-61-0 | Purity: ≥98% | SodiuM(tetra-n-propyl)borate | ESD-913858-100MG |
| Cas.: 129757-67-1 | Purity: 85% | Bis(1-octyloxy-2,2,6,6-tetramethyl-4-piperidyl)sebacate | ESD-916927-5G |
| Cas.: 129757-67-1 | Purity: 85% | Bis(1-octyloxy-2,2,6,6-tetramethyl-4-piperidyl)sebacate | ESD-916927-25G |
| Cas.: 129757-67-1 | Purity: 85% | Bis(1-octyloxy-2,2,6,6-tetramethyl-4-piperidyl)sebacate | ESD-916927-100G |
| Cas.: 129757-67-1 | Purity: 85% | Bis(1-octyloxy-2,2,6,6-tetramethyl-4-piperidyl)sebacate | ESD-916927-500G |
| Cas.: 201290-11-1 | Purity: 98% | HD-Trp(Boc)-OH | ESD-916929-5G |
| Cas.: 18299-85-9 | Purity: 85%, contains stabilizerMEHQ | Docosyl Acrylate | ESD-916928-25G |
| Cas.: 18299-85-9 | Purity: 85%, contains stabilizerMEHQ | Docosyl Acrylate | ESD-916928-100G |
| Cas.: 18299-85-9 | Purity: 85%, contains stabilizerMEHQ | Docosyl Acrylate | ESD-916928-500G |
| Cas.: 221352-88-1 | Purity: ≥97% (HPLC) | 2-[2-(Fmoc-amino)ethoxy]ethylamine hydrochloride | ESD-916930-250MG |
| Cas.: 221352-88-1 | Purity: ≥97% (HPLC) | 2-[2-(Fmoc-amino)ethoxy]ethylamine hydrochloride | ESD-916930-1G |
| Cas.: 35139-67-4 | Purity: 97% | 2,6-Diamino-4-chloropyrimidine 1-oxide | ESD-916931-250MG |
| Cas.: 18725-37-6 | Purity: 95% | Acetylcysteine EP impurity D | ESD-916932-1G |
| Cas.: 18725-37-6 | Purity: 95% | Acetylcysteine EP impurity D | ESD-916932-250MG |
| Cas.: 503-40-2 | Purity: ≥97% | Methanedisulphonic acid | ESD-916933-25G |
| Cas.: 26117-28-2 | Purity: 97% | (S)-2-Acetamido-3-mercaptopropanoic acid | ESD-916934-1G |
| Cas.: 26117-28-2 | Purity: 97% | (S)-2-Acetamido-3-mercaptopropanoic acid | ESD-916934-250MG |
| Cas.: 54447-68-6 | Purity: 97% | 4-azidobutyric acid | ESD-916935-1G |
| Cas.: 66575-26-6 | Purity: 95% | HD-Glu(OtBu)-NH2.HCl | ESD-916936-250MG |
| Cas.: 21145-77-7 | Purity: 95% | 1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone | ESD-842240-25G |
| Cas.: 21145-77-7 | Purity: 95% | 1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone | ESD-842240-100G |
| Cas.: 869062-42-0 | Purity: ≥95%, ≥250g/L in water | rhamnolipid | ESD-916937-250G |
| Cas.: 869062-42-0 | Purity: ≥95%, ≥250g/L in water | rhamnolipid | ESD-916937-50G |
| Cas.: 216959-91-0 | Purity: 95% | 4-(Pyrimidin-5-yl)benzoic acid | ESD-843210-5G |
| Cas.: NONE7028 | Purity: Silica contains amount: 29%～31% | Silicasol | ESD-888351-10KG |
| Cas.: 638-08-4 | Purity: >= 97% | Stearic Anhydride | ESD-838427-100G |
| Cas.: 444315-15-5 | Purity: 98% | Aminopropyllsobutyl POSS | ESD-915925-25G |
| Cas.: 444315-15-5 | Purity: 98% | Aminopropyllsobutyl POSS | ESD-915925-1G |
| Cas.: 87-90-1 | Purity: 97% | Trichloroisocyanuric acid | ESD-819398-10KG |
| Cas.: 5657-19-2 | Purity: ≥98% | N-(2-furoyl)glycine | ESD-891358-10MG |
| Cas.: 6962-44-3 | Purity: 95% | N-(2-Methoxy-5-methylphenyl)-acetamide | ESD-916938-50MG |
| Cas.: 6962-44-3 | Purity: 95% | N-(2-Methoxy-5-methylphenyl)-acetamide | ESD-916938-100MG |
| Cas.: 6962-44-3 | Purity: 95% | N-(2-Methoxy-5-methylphenyl)-acetamide | ESD-916938-250MG |
| Cas.: 5910-89-4 | Purity: 98% | 2,3-Dimethylpyrazine | ESD-806958-2.5L |
| Cas.: 503-66-2 | Purity: 30% in Water | 3-Hydroxypropanoic acid | ESD-823103-5G |
| Cas.: 7748-58-5 | Purity: 95% | 5-Bromo-6-nitrobenzo[d][1,3]dioxole | ESD-916939-1G |
| Cas.: 7748-58-5 | Purity: 95% | 5-Bromo-6-nitrobenzo[d][1,3]dioxole | ESD-916939-5G |
| Cas.: 7748-58-5 | Purity: 95% | 5-Bromo-6-nitrobenzo[d][1,3]dioxole | ESD-916939-250MG |
| Cas.: 425-75-2 | Purity: 99% | Ethyl trifluoromethanesulfonate | ESD-809284-100G |
| Cas.: 1509-34-8 | Purity: 99% | L-allo-Isoleucine | ESD-811955-1G |
| Cas.: 29741-10-4 | Purity: ≥99% | Luteolin 7-O-glucuronide | ESD-879755-50MG |
| Cas.: 27821-45-0 | Purity: ≥96.0% (HPLC) | Uridine 5′-diphosphate disodium salt hydrate | ESD-820307-25G |
| Cas.: 8002-03-7 | Peanut oil | ESD-914351-2.5L | |
| Cas.: 829-84-5 | Purity: 98% | Dicyclohexylphosphine | ESD-828358-25G |
| Cas.: 62883-00-5 | Purity: 98% | Iopamidol | ESD-859114-25G |
| Cas.: 62883-00-5 | Purity: 98% | Iopamidol | ESD-859114-100G |
| Cas.: 62883-00-5 | Purity: 99,5% | Iopamidol | ESD-916940-5G |
| Cas.: 62883-00-5 | Purity: 99,5% | Iopamidol | ESD-916940-25G |
| Cas.: 1317-61-9 | Purity: 99.99% metals basis | Iron oxide(II,III) | ESD-811696-250G |
| Cas.: 62778-11-4 | Purity: 70% HF | Hydrogen fluoride pyridine complex | ESD-829445-2.5KG |
| Cas.: 143-27-1 | Purity: >95.0%(GC) | 1-Hexadecylamine | ESD-811430-2.5KG |
| Cas.: 6254-48-4 | 3-Phenyl-L-serine | ESD-916941-100MG | |
| Cas.: 636-65-7 | Purity: 98% | (S)-4,5-Diamino-5-oxopentanoic acid | ESD-916942-250MG |
| Cas.: 1032678-07-1 | Purity: 95% | Cy5 carboxylic acid | ESD-916943-1MG |
| Cas.: 1043043-79-3 | Fmoc-2,6-Dimethyl-L-Tyr(tert-butyl)-OH | ESD-916944-5MG | |
| Cas.: 157355-79-8 | Purity: 95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid | ESD-916945-250MG |
| Cas.: 830-74-0 | Purity: 98% | 1-Allylisatin | ESD-869934-1G |
| Cas.: 410097-64-2 | Purity: 595ug/mg | Apramycin sulfate | ESD-899830-25G |
| Cas.: 1426828-06-9 | Purity: 93% | Azide-PEG3-Desthiobiotin | ESD-868824-5MG |
| Cas.: 163217-43-4 | Purity: 95% | Fmoc-Phe(4-N3)-OH | ESD-916946-100MG |
| Cas.: 506-32-1 | Purity: 90% | Arachidonic acid | ESD-875623-25G |
| Cas.: 1116-22-9 | Purity: 98% | gamma-L-Glutamyl-L-glutamic acid | ESD-849302-250MG |
| Cas.: 89031-84-5 | Purity: 97% | (3-Bromopropoxy)-|tert|-butyldimethylsilane | ESD-803114-100ML |
| Cas.: 82-45-1 | Purity: 99% | 1-Aminoanthraquinone | ESD-890238-10G |
| Cas.: 10436-25-6 | Purity: ≥98% | 11-[(tert-Butoxycarbonyl)amino]undecanoic Acid | ESD-865443-25G |
| Cas.: 68411-46-1 | Purity: 98% | Antioxidant 5057 | ESD-872037-2.5KG |
| Cas.: 62456-34-2 | Purity: 98% | 8-Bromonaphthalen-1-Amine | ESD-914712-5G |
| Cas.: 13220-57-0 | Purity: 97% | Indolo[2,1-b]quinazoline-6,12-dione | ESD-849287-25G |
| Cas.: 1343-98-2 | Purity: 99.9% metals basis | Silicic acid | ESD-818343-2.5KG |
| Cas.: 2219339-64-5 | Purity: ≥95% | N-Nitroso-1-(2-methoxyphenyl)-piperazine | ESD-916947-25MG |
| Cas.: 2219339-64-5 | Purity: ≥95% | N-Nitroso-1-(2-methoxyphenyl)-piperazine | ESD-916947-100MG |
| Cas.: 30748-47-1 | Purity: 98% | 5-Acetyl-2-amino-4-methylthiazole | ESD-800146-100G |
| Cas.: 26023-84-7 | Purity: 99.995% metals basis | Chloroplatinic acid hydrate | ESD-838399-5G |
| Cas.: 68520-00-3 | Purity: >95% | 1-[6-(dimethylamino)naphthalen-2-yl]ethanone | ESD-916948-5MG |
| Cas.: 26023-84-7 | Purity: 99.995% metals basis | Chloroplatinic acid hydrate | ESD-838399-25G |
| Cas.: 68520-00-3 | Purity: >95% | 1-[6-(dimethylamino)naphthalen-2-yl]ethanone | ESD-916948-25MG |
| Cas.: 68520-00-3 | Purity: >95% | 1-[6-(dimethylamino)naphthalen-2-yl]ethanone | ESD-916948-100MG |
| Cas.: 80508-23-2 | Purity: ≥95% | rac N’-Nitrosonornicotine | ESD-916949-25MG |
| Cas.: 80508-23-2 | Purity: ≥95% | rac N’-Nitrosonornicotine | ESD-916949-100MG |
| Cas.: 182201-77-0 | S-((9H-fluoren-9-yl)methyl)-N-((allyloxy)carbonyl)-L-cystein | ESD-916950-100MG | |
| Cas.: 17721-96-9 | Purity: ≥95% | 2-nitroso-1,2,3,4-tetrahydroisoquinoline | ESD-916951-25MG |
| Cas.: 17721-96-9 | Purity: ≥95% | 2-nitroso-1,2,3,4-tetrahydroisoquinoline | ESD-916951-100MG |
| Cas.: 186350-56-1 | Purity: 98% | Alloc-Lys(Fmoc)-OH | ESD-916952-1G |
| Cas.: 7633-57-0 | Purity: ≥95% | 1-Nitroso-2,3-dihydro-1H-indole | ESD-916953-25MG |
| Cas.: 7633-57-0 | Purity: ≥95% | 1-Nitroso-2,3-dihydro-1H-indole | ESD-916953-100MG |
| Cas.: 110-65-6 | Purity: GR, 99% | 2-Butyne-1,4-diol | ESD-802175-2.5KG |
| Cas.: 1120341-58-3 | Purity: >95% | tert-butyl 4-((6-(2-nitrophenyl)imidazo[2,1-b]thiazol-3-yl)methyl)piperazine-1-carboxylate | ESD-916954-250MG |
| Cas.: 1120341-58-3 | Purity: >95% | tert-butyl 4-((6-(2-nitrophenyl)imidazo[2,1-b]thiazol-3-yl)methyl)piperazine-1-carboxylate | ESD-916954-500MG |
| Cas.: 12136-78-6 | Purity: 99% | Molybdenum disiticide | ESD-812725-1KG |
| Cas.: 205526-28-9 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid | ESD-916955-100MG |
| Cas.: 555-60-2 | Purity: 98% | Carbonyl cyanide 3-chlorophenylhydrazone | ESD-838523-1G |
| Cas.: 268729-12-0 | Purity: 98% | Fmoc-O-tert-butyl-D-trans-4-hydroxyproline | ESD-916956-250MG |
| Cas.: 22535-49-5 | Purity: 98% | 4-Benzoylphenyl acrylate | ESD-849347-100G |
| Cas.: 52084-13-6 | Purity: 98% | H-Val-pNA | ESD-916957-250MG |
| Cas.: 56488-60-9 | Glutaurine | ESD-916958-100MG | |
| Cas.: 611-97-2 | Purity: 98% | 4,4′-Dimethylbenzophenone | ESD-807441-2.5KG |
| Cas.: 79598-53-1 | Purity: 97% | 6-Azidohexanoic Acid | ESD-916959-250MG |
| Cas.: 1205-88-5 | Glycine p-nitroanilide | ESD-916960-250MG | |
| Cas.: 6753-62-4 | Purity: ≥95% | N-Methyl-L-glutamic acid | ESD-916961-100MG |
| Cas.: 744-59-2 | Purity: 98% | Hippuryl-L-phenylalanine | ESD-916962-1G |
| Cas.: 744-59-2 | Purity: 98% | Hippuryl-L-phenylalanine | ESD-916962-5G |
| Cas.: 18999-45-6 | Purity: 95% | 3-(1-Imidazolyl)propanoic Acid | ESD-851976-250MG |
| Cas.: 4674-50-4 | Purity: 98% | (+)-Nootkatone | ESD-823793-25G |
| Cas.: 8012-95-1 | Purity: for IR-spectroscopy | Paraffin liquid | ESD-822611-100ML |
| Cas.: 32328-03-3 | Purity: 97% | Diethyl 3-hydroxyglutarate | ESD-831159-100G |
| Cas.: 32328-03-3 | Purity: 97% | Diethyl 3-hydroxyglutarate | ESD-831159-500G |
| Cas.: 51146-57-7 | Purity: 98% | (R)-(-)-Ibuprofen | ESD-864471-5G |
| Cas.: 35856-62-3 | Purity: 95% | Piperidine-1-sulfonyl chloride | ESD-844487-5G |
| Cas.: 98-33-9 | Purity: ≥98% | 2-Aminotoluene-5-sulfonic acid | ESD-854597-2.5KG |
| Cas.: 125321-66-6 | Purity: ≥95% | Poly(3-hexylthiophene-2,5-diyl) | ESD-868649-100MG |
| Cas.: 209982-56-9 | Purity: ≥97%(GC) | 2-Ethyl-2-methacryloyloxyadamantane (stabilized with MEHQ) | ESD-862080-25G |
| Cas.: 308386-36-9 | Purity: 95% | 4-(Piperidin-4-yloxy)pyridine dihydrochloride | ESD-844713-1G |
| Cas.: 1820572-07-3 | Purity: ≥97% | (1R,6S)-3-Boc-7-[(R)-1-phenylethyl]-3,7-diazabicyclo[4.2.0]octane | ESD-852966-250MG |
| Cas.: 3621-82-7 | Purity: 99% | 2,6-Dichlorobenzoxazole | ESD-832102-500G |
| Cas.: 18779-08-3 | Purity: 99.9% metals basis | Lutetium(III) acetate hydrate | ESD-830540-25G |
| Cas.: 1820572-07-3 | Purity: ≥97% | (1R,6S)-3-Boc-7-[(R)-1-phenylethyl]-3,7-diazabicyclo[4.2.0]octane | ESD-852966-50MG |
| Cas.: 155543-02-5 | Purity: ≥70%(T) | Lithium Tetrakis(pentafluorophenyl)borate – Ethyl Ether Complex | ESD-863207-5G |
| Cas.: 2442-49-1 | Purity: Analytical Standards | Methyl tetracosanoate | ESD-813813-1G |
| Cas.: 37149-18-1 | Purity: 97% | 4-Carboxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical | ESD-869488-250MG |
| Cas.: 37149-18-1 | Purity: 97% | 4-Carboxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical | ESD-869488-1G |
| Cas.: 61379-66-6 | Purity: 95% | 1-Cyclopentyl-4-nitrosopiperazine | ESD-907308-25MG |
| Cas.: 61379-66-6 | Purity: 95% | 1-Cyclopentyl-4-nitrosopiperazine | ESD-907308-5MG |
| Cas.: 33027-68-8 | Purity: ≥98% | Pentafluoro(phenoxy)cyclotriphospazene | ESD-866794-5G |
| Cas.: 395-45-9 | Purity: 98% | 2-(trifluoromethyl)styrene | ESD-906661-5G |
| Cas.: 34698-41-4 | Purity: 98% | 1-Aminoindan | ESD-801225-100G |
| Cas.: 2402-77-9 | Purity: 99% | 2,3-Dichloropyridine | ESD-808046-1KG |
| Cas.: 162558-52-3 | Purity: >99% | MQAE | ESD-860520-50MG |
| Cas.: 105628-07-7 | Purity: 98% | Fasudil Hydrochloride | ESD-845492-25G |
| Cas.: 1333-07-9 | Purity: ≥95% | O/P-TOLUENE SULFONAMIDE MIXED AMINE | ESD-916963-250G |
| Cas.: 1333-07-9 | Purity: ≥95% | O/P-TOLUENE SULFONAMIDE MIXED AMINE | ESD-916963-1KG |
| Cas.: 100684-32-0 | Purity: Reagent grade BR | Myoglobin | ESD-861419-500MG |
| Cas.: 666-52-4 | Purity: (D, 99.96%)(+0.03% V/V TMS) | Acetone-d6 | ESD-800097-0.6ML |
| Cas.: 202842-98-6 | Purity: 95% | 3,4-Dimethyl-1H-pyrazole phosphate | ESD-828391-500G |
| Cas.: 564-35-2 | Purity: 98% | 11-keto Testosterone (CRM) | ESD-912545-10MG |
| Cas.: 14434-22-1 | Purity: AR | Sodium ferrocyanide decahydrate | ESD-832723-10KG |
| Cas.: 19492-02-5 | Purity: ≥98% | 6-Chloro-7-hydroxy-4-methylcoumarin | ESD-867028-5G |
| Cas.: 62036-49-1 | Purity: 96% | 4-Ethyl-5-hydroxy-7-methyl-2H-chromen-2-one | ESD-916964-250MG |
| Cas.: 62036-49-1 | Purity: 96% | 4-Ethyl-5-hydroxy-7-methyl-2H-chromen-2-one | ESD-916964-1G |
| Cas.: 62036-49-1 | Purity: 96% | 4-Ethyl-5-hydroxy-7-methyl-2H-chromen-2-one | ESD-916964-5G |
| Cas.: 1355241-50-7 | Purity: 96% | 5-Bromo-2-chlorothiazolo[5,4-b]pyridine | ESD-916965-50MG |
| Cas.: 1355241-50-7 | Purity: 96% | 5-Bromo-2-chlorothiazolo[5,4-b]pyridine | ESD-916965-250MG |
| Cas.: 1355241-50-7 | Purity: 96% | 5-Bromo-2-chlorothiazolo[5,4-b]pyridine | ESD-916965-1G |
| Cas.: 1477-42-5 | Purity: 98% | 2-Amino-4-methylbenzothiazole | ESD-801472-500G |
| Cas.: 6233-83-6 | Purity: ≥99% | Oxytocin acetate | ESD-878144-50MG |
| Cas.: 6233-83-6 | Purity: ≥99% | Oxytocin acetate | ESD-878144-250MG |
| Cas.: 4026-18-0 | Purity: ≥98% | 2-Hydroxy-3-methylbutyric acid | ESD-863923-5G |
| Cas.: 104-58-5 | Purity: 97% | 3-(Piperidin-1-yl)propan-1-ol | ESD-844009-5G |
| Cas.: 104-58-5 | Purity: 97% | 3-(Piperidin-1-yl)propan-1-ol | ESD-844009-25G |
| Cas.: 104-58-5 | Purity: 97% | 3-(Piperidin-1-yl)propan-1-ol | ESD-844009-100G |
| Cas.: 1403254-99-8 | Purity: 99% | Tazemetostat (EPZ-6438) | ESD-872479-25MG |
| Cas.: 3392-05-0 | Purity: BR | Boc-Ala-OSu | ESD-802907-5G |
| Cas.: 1743-60-8 | Purity: 98% | β-Estradiol 17-acetate (1,3,5(10)-Estratriene-3,17β-diol 17-acetate) | ESD-911807-500MG |
| Cas.: 31558-40-4 | Purity: 98% | 4-Bromo-3,5-dimethoxybenzaldehyde | ESD-803911-1G |
| Cas.: 68443-63-0 | Purity: 98% | Butyl 2-Ethylhexanoate | ESD-870244-1G |
| Cas.: 120-72-9 | Purity: standard for GC, >99.5%(GC) | Indole | ESD-811714-25G |
| Cas.: 486-56-6 | Purity: 98% | S-(-)-Cotinine | ESD-873012-500MG |
| Cas.: 12125-01-8 | Purity: AR, 98% | Ammonium fluoride | ESD-800957-10KG |
| Cas.: 53179-13-8 | Purity: 98% | 5-Methyl-1-phenylpyridin-2(1H)-one | ESD-823669-25G |
| Cas.: 53179-13-8 | Purity: 98% | 5-Methyl-1-phenylpyridin-2(1H)-one | ESD-823669-250MG |
| Cas.: 894-71-3 | Purity: ≥98% | Nortriptyline Hydrochloride | ESD-867712-5G |
| Cas.: 894-71-3 | Purity: ≥98% | Nortriptyline Hydrochloride | ESD-867712-25G |
| Cas.: 894-71-3 | Purity: ≥98% | Nortriptyline Hydrochloride | ESD-867712-100G |
| Cas.: 886498-07-3 | Purity: ≥98% | 3-Bromo-5-(Trifluoromethoxy)Benzaldehyde | ESD-857698-5G |
| Cas.: 886498-07-3 | Purity: ≥98% | 3-Bromo-5-(Trifluoromethoxy)Benzaldehyde | ESD-857698-25G |
| Cas.: 505-52-2 | Purity: >96.0%(GC) | 1,11-Undecanedicarboxylic acid | ESD-916966-100G |
| Cas.: 505-52-2 | Purity: >96.0%(GC) | 1,11-Undecanedicarboxylic acid | ESD-916966-25G |
| Cas.: 505-52-2 | Purity: >96.0%(GC) | 1,11-Undecanedicarboxylic acid | ESD-916966-5G |
| Cas.: 505-52-2 | Purity: >96.0%(GC) | 1,11-Undecanedicarboxylic acid | ESD-916966-1G |
| Cas.: 119-68-6 | Purity: 97% | 2-(Methylamino)benzoic acid | ESD-841267-5G |
| Cas.: 646-01-5 | Purity: 98% | 3-(Methylthio)propionic Acid | ESD-858199-100G |
| Cas.: 13515-65-6 | Purity: ≥97% | 2-Methylpropanethioamide | ESD-859554-500G |
| Cas.: 26204-55-7 | Purity: ≥98% | Dodecan-1-amine Hydrobromide | ESD-866146-5G |
| Cas.: 848035-21-2 | Purity: 98% | Compound 48/80 hydrochloride | ESD-911504-50MG |
| Cas.: 26189-59-3 | Purity: 95% | 1-Chloro-N,N,2-trimethylprop-1-en-1-amine | ESD-914563-5G |
| Cas.: 65914-17-2 | Purity: 97% | Polydatin | ESD-819424-100G |
| Cas.: 70717-76-9 | Purity: 95% | tert-butyl N-[(2R)-1-amino-3-methyl-1-oxobutan-2-yl]carbamate | ESD-915551-25G |
| Cas.: 22426-30-8 | Purity: ≥95% | 2-Cyano-2-methylpropanoic acid | ESD-895145-5G |
| Cas.: 148043-73-6 | Purity: 95% | 4,4,5,5,5-Pentafluoro-1-pentanol | ESD-823099-100G |
| Cas.: 505-52-2 | Purity: >96.0%(GC) | 1,11-Undecanedicarboxylic acid | ESD-916966-500G |
| Cas.: 152-11-4 | Purity: 99% | (±)-Verapamil hydrochloride | ESD-820461-100G |
| Cas.: 2390-60-5 | Purity: 98% | Victoria Pure Blue BO | ESD-838740-500G |
| Cas.: 4891-38-7 | Purity: 98% | Methyl Phenylpropiolate | ESD-838594-25G |
| Cas.: 74431-23-5 | Purity: 98% | (5R,6S)-3-((2-Formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate | ESD-843846-25MG |
| Cas.: 2041-14-7 | Purity: 97% | (2-Aminoethyl)phosphonic acid | ESD-842162-5G |
| Cas.: 13463-41-7 | Purity: 96% | 1-Hydroxypyridine-2-thione zinc salt | ESD-811538-2.5KG |
| Cas.: 875667-84-8 | Purity: 98% | 4-Methoxy-N-(4-methoxyphenyl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)aniline | ESD-886644-250MG |
| Cas.: 51546-08-8 | Purity: 95% | 2-(5-AMINO-3-METHYL-PYRAZOL-1-YL)-ETHANOL | ESD-916967-1G |
| Cas.: 51546-08-8 | Purity: 95% | 2-(5-AMINO-3-METHYL-PYRAZOL-1-YL)-ETHANOL | ESD-916967-250MG |
| Cas.: 51546-08-8 | Purity: 95% | 2-(5-AMINO-3-METHYL-PYRAZOL-1-YL)-ETHANOL | ESD-916967-50MG |
| Cas.: 19748-66-4 | Purity: ≥95% | 3-(Pyrrolidin-1-yl)propan-1-ol | ESD-916968-1G |
| Cas.: 19748-66-4 | Purity: ≥95% | 3-(Pyrrolidin-1-yl)propan-1-ol | ESD-916968-5G |
| Cas.: 19748-66-4 | Purity: ≥95% | 3-(Pyrrolidin-1-yl)propan-1-ol | ESD-916968-250MG |
| Cas.: 501015-22-1 | Purity: ≥98% (HPLC) | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-cyanophenyl)propanoic acid | ESD-916969-100MG |
| Cas.: 501015-22-1 | Purity: ≥98% (HPLC) | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-cyanophenyl)propanoic acid | ESD-916969-500MG |
| Cas.: 10381-75-6 | Purity: ≥97% | 8-Bromotheophylline | ESD-854766-5G |
| Cas.: 364-53-4 | Purity: ≥98% | 3,4-Dinitrofluorobenzene | ESD-859897-25G |
| Cas.: 42438-90-4 | Purity: ≥98% (HPLC) | (S)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-916970-1G |
| Cas.: 42438-90-4 | Purity: ≥98% (HPLC) | (S)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-916970-250MG |
| Cas.: 778571-53-2 | Purity: 98% | (R)-3-Amino-3-(2,4-dichlorophenyl)propanoic acid | ESD-916971-250MG |
| Cas.: 143537-62-6 | Purity: 98% | N-(β-ketocaproyl)-L-Homoserine lactone (3-O-C6-(L)-HSL) | ESD-911024-10MG |
| Cas.: 143537-62-6 | Purity: 98% | N-(β-ketocaproyl)-L-Homoserine lactone (3-O-C6-(L)-HSL) | ESD-911024-50MG |
| Cas.: 127-08-2 | Purity: 99.9% metals basis | Potassium acetate | ESD-872015-1KG |
| Cas.: 911838-56-7 | Purity: 98% | Fmoc-Lys(Boc)-Thr[Psi(Me,Me)Pro]-OH | ESD-916972-1G |
| Cas.: 25038-54-4 | Purity: 30-60 Mesh | Nylon 6 | ESD-823192-2.5KG |
| Cas.: 117752-88-2 | Purity: 98% | (R)-3-AMINO-GAMMA-BUTYROLACTONE HYDROCHLORIDE | ESD-834196-25G |
| Cas.: 25038-54-4 | Purity: 30-60 Mesh | Nylon 6 | ESD-823192-100G |
| Cas.: 911838-56-7 | Purity: 98% | Fmoc-Lys(Boc)-Thr[Psi(Me,Me)Pro]-OH | ESD-916972-250MG |
| Cas.: 126496-81-9 | Purity: 98% | N-Cbz-D-tryptophan Benzyl Ester | ESD-916973-5G |
| Cas.: 126496-81-9 | Purity: 98% | N-Cbz-D-tryptophan Benzyl Ester | ESD-916973-1G |
| Cas.: 5907-38-0 | Purity: ≥98% | Metamizole sodium hydrate | ESD-878310-100MG |
| Cas.: 20235-78-3 | Purity: 98% | 2-Thiouridine | ESD-912034-100MG |
| Cas.: 20235-78-3 | Purity: 98% | 2-Thiouridine | ESD-912034-500MG |
| Cas.: 26566-13-2 | Purity: 98% | HD-Glu-OMe | ESD-916974-1G |
| Cas.: 7801-91-4 | Purity: 98% | Z-Gly-Sar-OH | ESD-916975-100MG |
| Cas.: 252049-14-2 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid | ESD-916976-1G |
| Cas.: 17135-74-9 | Purity: 98% | 1,8-DibroMonaphthalene | ESD-831459-100G |
| Cas.: 33171-05-0 | Purity: 98% | Bisdemethoxycurcumin | ESD-860708-25MG |
| Cas.: 33171-05-0 | Purity: 98% | Bisdemethoxycurcumin | ESD-860708-100MG |
| Cas.: 220497-81-4 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-bromophenyl)propanoic acid | ESD-916977-1G |
| Cas.: 214852-45-6 | Purity: 97% | Fmoc-D-cis-Hyp-OH | ESD-916978-1G |
| Cas.: 270065-89-9 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(4-cyanophenyl)butanoic acid | ESD-916979-250MG |
| Cas.: 1334179-85-9 | Purity: ≥99% | BTTAA | ESD-883186-10MG |
| Cas.: 38675-10-4 | Purity: 98% | Boc-D-PHE-PRO-OH | ESD-916980-100MG |
| Cas.: 138021-87-1 | Purity: 98% | Fmoc-Cys(Me)-OH | ESD-916981-1G |
| Cas.: 1314-87-0 | Purity: SP | Lead(II) sulfide | ESD-812449-25G |
| Cas.: 212688-51-2 | Purity: 98% | Fmoc-D-Ser(trt)-OH | ESD-916982-5G |
| Cas.: 1314-87-0 | Purity: SP | Lead(II) sulfide | ESD-812449-100G |
| Cas.: 57500-34-2 | Purity: ≥98% | 1,3-Diiminoisoindoline | ESD-865083-25G |
| Cas.: 57500-34-2 | Purity: ≥98% | 1,3-Diiminoisoindoline | ESD-865083-100G |
| Cas.: 16947-80-1 | Purity: 96% | Boc-Cys(Me)-OH | ESD-916983-1G |
| Cas.: 200616-18-8 | Purity: 97% | (S)-5-((9H-Fluoren-9-yl)methoxy)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxopentanoic acid | ESD-916984-250MG |
| Cas.: 252049-17-5 | Purity: 95% | (R)-5-((9H-Fluoren-9-yl)methoxy)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxopentanoic acid | ESD-916985-100MG |
| Cas.: 7499-60-7 | Purity: 98% | γ-Oxo-1-pyrenebutyric acid | ESD-815350-1G |
| Cas.: 112-25-4 | Purity: 98% | Ethylene glycol monohexyl ether | ESD-808904-2.5L |
| Cas.: 274262-82-7 | Purity: 95% | (R)-2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid | ESD-916986-1G |
| Cas.: 107-20-0 | Purity: 40% w/w in water | Chloroacetaldehyde | ESD-831962-100G |
| Cas.: 1198321-33-3 | Purity: 97% | Fmoc-Orn(ivDde)-OH | ESD-916987-250MG |
| Cas.: 2212-32-0 | Purity: 97% | 2-[2-(Dimethylamino)ethyl]methylamino ethanol | ESD-830971-2.5L |
| Cas.: 56296-78-7 | Purity: 98% | Fluoxetine hydrochloride | ESD-844357-100G |
| Cas.: 56296-78-7 | Purity: 98% | Fluoxetine hydrochloride | ESD-844357-500G |
| Cas.: 1004-76-8 | Purity: 85% | 5,6-Diamino-2-thiouracil | ESD-832908-5G |
| Cas.: 60280-45-7 | Purity: 95% | Boc-Met(O2)-OH | ESD-916988-5G |
| Cas.: 1004-76-8 | Purity: 95% | 5,6-Diamino-2-thiouracil | ESD-916989-25G |
| Cas.: 1004-76-8 | Purity: 95% | 5,6-Diamino-2-thiouracil | ESD-916989-5G |
| Cas.: 38017-65-1 | Purity: 97% | Methyl L-phenylalanyl-L-phenylalaninate hydrochloride | ESD-916990-250MG |
| Cas.: 462-94-2 | Purity: 98% | 1,5-Diaminopentane | ESD-808252-100G |
| Cas.: 269726-89-8 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(thiophen-2-yl)butanoic acid | ESD-916991-100MG |
| Cas.: 929-77-1 | Purity: 99% | Methyl behenate | ESD-813994-100G |
| Cas.: 269726-77-4 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-(trifluoromethyl)phenyl)butanoic acid | ESD-916992-100MG |
| Cas.: 6456-74-2 | Purity: 98% | tert-Butyl glycinate | ESD-831181-25G |
| Cas.: 218608-93-6 | Purity: 98% | (R)-N-Boc-3-Amino-4-(2-chlorophenyl)butanoic acid | ESD-916993-100MG |
| Cas.: 1445251-22-8 | Purity: 99% | ME0328 | ESD-872572-25MG |
| Cas.: 1445251-22-8 | Purity: 99% | ME0328 | ESD-872572-100MG |
| Cas.: 403661-78-9 | Purity: 98% | (S)-4-(2-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-916994-100MG |
| Cas.: 10025-84-0 | Purity: 99.9% metals basis | Lanthanum chloride heptahydrate | ESD-812330-2.5KG |
| Cas.: 76505-71-0 | Purity: >90.0%(GC) | Bis(2,2-diethoxyethyl) Disulfide | ESD-861146-250MG |
| Cas.: 269398-85-8 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(p-tolyl)butanoic acid | ESD-916995-100MG |
| Cas.: 612-12-4 | Purity: 98% | 1,2-Bis(chloromethyl)benzene | ESD-833342-2.5KG |
| Cas.: 7425-80-1 | Tetraisobutyl Orthotitanate (contains Isopropoxide) | ESD-862011-1ML | |
| Cas.: 220497-65-4 | Purity: 98% | (1R,4S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopent-2-enecarboxylic acid | ESD-916996-100MG |
| Cas.: 6960-42-5 | Purity: 98% | 7-Nitroindole | ESD-814815-100G |
| Cas.: 4026-18-0 | Purity: ≥98% | 2-Hydroxy-3-methylbutyric acid | ESD-863923-25G |
| Cas.: 7044-91-9 | Purity: ≥98% | Anthracene-9,10-dicarboxaldehyde | ESD-866987-5G |
| Cas.: 139523-49-2 | Purity: 99% | Nistose Trihydrate | ESD-871387-1G |
| Cas.: 270062-85-6 | Purity: 98% | (S)-4-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-916997-100MG |
| Cas.: 270063-45-1 | Purity: 98% | (S)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-916998-100MG |
| Cas.: 332064-67-2 | Purity: 95% | (R)-2-(2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)acetic acid | ESD-916999-100MG |
| Cas.: 218608-83-4 | Purity: 95% | (R)-3-(Boc-amino)-5-phenylpentanoic acid | ESD-917000-1G |
| Cas.: 218608-83-4 | Purity: 95% | (R)-3-(Boc-amino)-5-phenylpentanoic acid | ESD-917000-250MG |
| Cas.: 67-47-0 | Purity: 97% | 5-Hydroxymethyl-2-furaldehyde | ESD-810987-500G |
| Cas.: 67-47-0 | Purity: 95% | 5-Hydroxymethyl-2-furaldehyde | ESD-810985-500G |
| Cas.: 23354-93-0 | Purity: 97%, isomer mixture | 1,4-Di(2-thienyl)-1,3-butadiene | ESD-871461-1G |
| Cas.: 269398-83-6 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(m-tolyl)butanoic acid | ESD-917001-100MG |
| Cas.: 59564-78-2 | Purity: ≥97% | 1,3-Bisbenzyl-2-Oxoimidazolidine-4,5-Dicarboxylic Acid | ESD-860087-500G |
| Cas.: 190190-48-8 | Purity: 98% | (R)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-917002-100MG |
| Cas.: 220497-50-7 | Purity: 96% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromothiophen-2-yl)propanoic acid | ESD-917003-100MG |
| Cas.: 122-96-3 | Purity: 98% | 1,4-Bis(2-hydroxyethyl)piperazine | ESD-828539-2.5KG |
| Cas.: 270065-77-5 | Purity: ≥98% | (S)-Boc-3-(trifluoromethyl)-β-Homophe-OH | ESD-917004-1G |
| Cas.: 270065-77-5 | Purity: ≥98% | (S)-Boc-3-(trifluoromethyl)-β-Homophe-OH | ESD-917004-250MG |
| Cas.: 57-47-6 | Purity: ≥98.0% | Eserine | ESD-808827-10MG |
| Cas.: 131980-30-8 | Purity: ≥98.0% | Boc-Phe(3-CN)-OH | ESD-832729-5G |
| Cas.: 1719-57-9 | Purity: 98% | Silane, chloro(chloromethyl)dimethyl- | ESD-829468-100G |
| Cas.: 1719-57-9 | Purity: 98% | Silane, chloro(chloromethyl)dimethyl- | ESD-829468-500G |
| Cas.: 52853-40-4 | Purity: 90% | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide | ESD-845654-5G |
| Cas.: 52853-40-4 | Purity: 90% | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide | ESD-845654-25G |
| Cas.: 22821-77-8 | Purity: ≥97% | 4-(Methylsulfonyl)benzyl Alcohol | ESD-852565-25G |
| Cas.: 8018-01-7 | Purity: 90% | Mancozeb | ESD-917005-1G |
| Cas.: 8018-01-7 | Purity: 90% | Mancozeb | ESD-917005-250MG |
| Cas.: 270062-90-3 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(o-tolyl)butanoic acid | ESD-917006-100MG |
| Cas.: 13573-08-5 | Purity: 99.99% trace metals basis | Germanium(II) iodide | ESD-836136-500MG |
| Cas.: 13573-08-5 | Purity: 99.99% trace metals basis | Germanium(II) iodide | ESD-836136-1G |
| Cas.: 13573-08-5 | Purity: 99.99% trace metals basis | Germanium(II) iodide | ESD-836136-5G |
| Cas.: 218608-98-1 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic acid | ESD-917007-100MG |
| Cas.: 6889-78-7 | Purity: ≥98%(GC) | 3-Hydroxy-4′-methoxyflavone | ESD-863127-1G |
| Cas.: 2213-63-0 | Purity: 97% | 2,3-Dichloroquinoxaline | ESD-808461-500G |
| Cas.: 13478-33-6 | Purity: 98% | Cobalt(II) perchlorate hexahydrate | ESD-831255-250G |
| Cas.: 83512-85-0 | Purity: Degree of substitution: ≥90%, isoelectric point: 3-4 | Carboxymethyl chitosan | ESD-902397-25G |
| Cas.: 1359764-39-8 | Purity: 98%, ee99% | (11bR)-4-hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-4-oxide-Dinaphtho[2,1-d:1′,2′-f][1,3,2] dioxaphosphepin | ESD-887860-250MG |
| Cas.: 83512-85-0 | Purity: Degree of substitution: ≥90%, isoelectric point: 3-4 | Carboxymethyl chitosan | ESD-902397-5G |
| Cas.: 13446-30-5 | Purity: 99% | Magnesium thiosulfate hexahydrate | ESD-813743-25G |
| Cas.: 13446-30-5 | Purity: 99% | Magnesium thiosulfate hexahydrate | ESD-813743-5G |
| Cas.: 269726-94-5 | Purity: 98% | Boc-(R)-3-Amino-5-hexenoic acid | ESD-917008-250MG |
| Cas.: 13558-31-1 | Purity: laser grade | Rhodamine 110 chloride | ESD-817220-5G |
| Cas.: 218608-99-2 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic acid | ESD-917009-100MG |
| Cas.: 10347-81-6 | Purity: ≥98% | Maprotiline Hydrochloride | ESD-866789-100G |
| Cas.: 332062-06-3 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-4,4-diphenylbutanoic acid | ESD-917010-100MG |
| Cas.: 6781-42-6 | Purity: 97% | 1,3-Diacetylbenzene | ESD-808256-100G |
| Cas.: 765263-36-3 | Purity: 98% | (R)-4-(2-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-917011-250MG |
| Cas.: 626-95-9 | Purity: 98% | 1,4-Pentanediol | ESD-864415-500G |
| Cas.: 190190-50-2 | Purity: ≥98%(HPLC) | (S)-Boc-γ,γ-diphenyl-β-Homoala-OH | ESD-917012-100MG |
| Cas.: 190190-50-2 | Purity: ≥98%(HPLC) | (S)-Boc-γ,γ-diphenyl-β-Homoala-OH | ESD-917012-500MG |
| Cas.: 13921-90-9 | Purity: 97% | (R)-3-Phenyl-beta-alanine | ESD-841131-25G |
| Cas.: 7652-46-2 | Purity: 98% | (R)-Methyl 2-acetamido-3-mercaptopropanoate | ESD-917013-1G |
| Cas.: 7652-46-2 | Purity: 98% | (R)-Methyl 2-acetamido-3-mercaptopropanoate | ESD-917013-250MG |
| Cas.: 81032-58-8 | Purity: 3000ppm | Karstedt’s catalyst | ESD-855034-1G |
| Cas.: 31602-64-9 | Purity: ≥95% | 2-(5-Tetrazolyl)ethanamine | ESD-853434-250MG |
| Cas.: 352523-15-0 | Purity: 95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | ESD-917015-250MG |
| Cas.: 31602-64-9 | Purity: ≥95% | 2-(5-Tetrazolyl)ethanamine | ESD-853434-50MG |
| Cas.: 1095-78-9 | Purity: 95% | 2,2-Bis(4-aminophenyl)hexafluoropropane | ESD-833663-25G |
| Cas.: 2890-62-2 | Purity: 95% | 1-(1-Methylcyclohexyl)ethanone | ESD-851662-250MG |
| Cas.: 16895-58-2 | Purity: 95% | Thiochroman-3-one | ESD-851675-250MG |
| Cas.: 346694-77-7 | Purity: 98% | Boc-β-Homolys(Z)-OH | ESD-917016-1G |
| Cas.: 131222-99-6 | Purity: 97% | 6,12-Dibromochrysene | ESD-808437-5G |
| Cas.: 123910-26-9 | Purity: 95% | 1-(tert-Butoxycarbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-917017-1G |
| Cas.: 10160-28-8 | Purity: 95% | Non-8-yn-1-ol | ESD-845118-1G |
| Cas.: 10160-28-8 | Purity: 95% | Non-8-yn-1-ol | ESD-845118-5G |
| Cas.: 75-85-4 | Purity: 99% | tert-Amyl alcohol | ESD-800284-10L |
| Cas.: 62968-45-0 | Purity: 95% | Benzenehexathiol | ESD-903635-25MG |
| Cas.: 16369-05-4 | Purity: 97% | DL-2-AMINO-3-METHYL-1-BUTANOL | ESD-833318-100G |
| Cas.: 17643-36-6 | Purity: ≥94% | 9-Decyn-1-ol | ESD-865596-25G |
| Cas.: 591-12-8 | Purity: 98%, mixture of isomers | alpha-Angelica lactone | ESD-917018-500G |
| Cas.: 7480-32-2 | Purity: ≥95% | 4-Phenyloxazolidin-2-one | ESD-917019-1G |
| Cas.: 591-12-8 | Purity: 98%, mixture of isomers | alpha-Angelica lactone | ESD-917018-100G |
| Cas.: 7480-32-2 | Purity: ≥95% | 4-Phenyloxazolidin-2-one | ESD-917019-5G |
| Cas.: 591-12-8 | Purity: 98%, mixture of isomers | alpha-Angelica lactone | ESD-917018-25G |
| Cas.: 7480-32-2 | Purity: ≥95% | 4-Phenyloxazolidin-2-one | ESD-917019-25G |
| Cas.: 591-12-8 | Purity: 98%, mixture of isomers | alpha-Angelica lactone | ESD-917018-5G |
| Cas.: 591-12-8 | Purity: 98%, mixture of isomers | alpha-Angelica lactone | ESD-917018-1G |
| Cas.: 99585-98-5 | Purity: ≥95% | 3-Chloro-N-(3-chlorophenyl)propanamide | ESD-917020-250MG |
| Cas.: 99585-98-5 | Purity: ≥95% | 3-Chloro-N-(3-chlorophenyl)propanamide | ESD-917020-1G |
| Cas.: 99585-98-5 | Purity: ≥95% | 3-Chloro-N-(3-chlorophenyl)propanamide | ESD-917020-5G |
| Cas.: 8002-74-2 | Purity: pathological grade | Paraffin with ceresin | ESD-917021-2.5KG |
| Cas.: 8002-74-2 | Purity: pathological grade | Paraffin with ceresin | ESD-917021-500G |
| Cas.: 308068-56-6 | Purity: ID:5-10nm, OD:20-30nm, Length:<10μm, Ni:>60wt%, C:>38wt% | Ni Coated Multi-walled carbon nanotubes | ESD-917022-5G |
| Cas.: 9003-53-6 | MW 650,000, Mw/Mn 1.06 | Polystyrene standard | ESD-917023-100MG |
| Cas.: 6065-63-0 | Purity: ≥97%(GC) | Diethyl Dipropylmalonate | ESD-854859-500G |
| Cas.: 6065-63-0 | Purity: ≥97%(GC) | Diethyl Dipropylmalonate | ESD-854859-25G |
| Cas.: 61336-70-7 | Purity: CP | Amoxicillin Trihydrate | ESD-828342-500G |
| Cas.: 674-26-0 | Purity: 98% | DL-Mevalonolactone | ESD-869734-5G |
| Cas.: 1016-47-3 | Purity: ≥98% | N-Acetyltryptamine | ESD-868571-100MG |
| Cas.: 1016-47-3 | Purity: ≥98% | N-Acetyltryptamine | ESD-868571-250MG |
| Cas.: 1016-47-3 | Purity: ≥98% | N-Acetyltryptamine | ESD-868571-1G |
| Cas.: 5521-31-3 | Purity: 99% | Pigment Red 179 | ESD-917024-100G |
| Cas.: 5521-31-3 | Purity: 99% | Pigment Red 179 | ESD-917024-25G |
| Cas.: 5521-31-3 | Purity: 99% | Pigment Red 179 | ESD-917024-5G |
| Cas.: 5521-31-3 | Purity: ≥95% | Pigment Red 179 | ESD-917025-25G |
| Cas.: 5521-31-3 | Purity: ≥95% | Pigment Red 179 | ESD-917025-5G |
| Cas.: 5521-31-3 | Purity: ≥95% | Pigment Red 179 | ESD-917025-1G |
| Cas.: 220498-04-4 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-bromophenyl)propanoic acid | ESD-917026-100MG |
| Cas.: 22583-75-1 | Purity: 99 atom % D | Benzophenone-d10 | ESD-874372-500MG |
| Cas.: 74443-35-9 | Purity: ≥95% | Bis(2,6-dimethylphenyl)amine | ESD-899938-5G |
| Cas.: 238742-88-6 | Purity: 98% | Fmoc-D-Phe(4-CF3)-OH | ESD-917027-100MG |
| Cas.: 914399-98-7 | Purity: 97% | (S)-Fmoc-2-amino-3-tert-butoxy-2-methyl-propionic acid | ESD-917028-100MG |
| Cas.: 143415-62-7 | Purity: 98% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid | ESD-917029-1G |
| Cas.: 143415-62-7 | Purity: 98% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid | ESD-917029-250MG |
| Cas.: 159610-82-9 | Purity: 98% | (S,E)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid | ESD-917030-100MG |
| Cas.: NONE8234 | Purity: 5X | Nuclease S1 reaction buffer | ESD-917031-2X1ML |
| Cas.: 308068-56-6 | Purity: >95%, ID: 5-12nm, OD: 30-50nm, Length: 0.5-2um, N:3.00wt% | N-doped MWCNTS | ESD-835650-25G |
| Cas.: 59724-53-7 | Purity: ≥95% | N-(2-Hydroxypropyl)-4-methylbenzenesulfonamide | ESD-850831-250MG |
| Cas.: 871235-24-4 | Purity: ≥95% | 2-(Boc-amino)-3-methylbutylamine | ESD-853207-100MG |
| Cas.: 924818-01-9 | Purity: 95% | 1-(Boc-amino)-3-bromo-1-(4-methoxyphenyl)propane | ESD-853366-250MG |
| Cas.: 1211578-30-1 | Purity: 95% | 6-Bromo-3-chloro-2-fluoropyridine | ESD-853667-250MG |
| Cas.: 14162-95-9 | Purity: 98% | 4-Bromo-2,2′-bipyridine | ESD-856633-250MG |
| Cas.: 401-56-9 | Purity: 98% | Ethyl Chlorofluoroacetate | ESD-838041-100G |
| Cas.: 727356-19-6 | Purity: ≥95% | 2-Bromo-6-(chloromethyl)pyridine | ESD-853654-100MG |
| Cas.: 9000-92-4 | Purity: ≥90%, A 2000 | Diastase from Aspergillus oryzae | ESD-859115-500G |
| Cas.: 5524-05-0 | Purity: 98%, isomer mixture | (+)-Dihydrocarvone | ESD-916454-25G |
| Cas.: 5524-05-0 | Purity: 98%, isomer mixture | (+)-Dihydrocarvone | ESD-916454-100G |
| Cas.: 5524-05-0 | Purity: 98%, isomer mixture | (+)-Dihydrocarvone | ESD-916454-500G |
| Cas.: 40615-36-9 | Purity: 98% | DMT-Cl | ESD-807279-2.5KG |
| Cas.: 270065-86-6 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(3-cyanophenyl)butanoic acid | ESD-917032-100MG |
| Cas.: 270596-51-5 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic acid | ESD-917033-100MG |
| Cas.: 3061-91-4 | Purity: 98% | Val-Tyr | ESD-820507-1G |
| Cas.: 3061-91-4 | Purity: 98% | Val-Tyr | ESD-820507-250MG |
| Cas.: 22604-07-5 | Purity: 98% | 6-Methoxynaphthalen-1-ol | ESD-841855-5G |
| Cas.: 270065-71-9 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(4-iodophenyl)butanoic acid | ESD-917034-100MG |
| Cas.: 104620-34-0 | Purity: 95% | METHYL 2-OXO-1-INDANECARBOXYLATE | ESD-833552-5G |
| Cas.: 215190-23-1 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid | ESD-917035-250MG |
| Cas.: 36061-08-2 | Purity: 98% | (R)-2-Amino-5-phenylpentanoic acid | ESD-917036-100MG |
| Cas.: 13530-65-9 | Purity: ZnO≥61%, CrO3≥19% | ZINC CHROMATE | ESD-832301-1KG |
| Cas.: 9002-89-5 | Purity: Alcoholysis degree: 88-89mol%, Viscosity: 3.2-3.8mPa.s | Poly(vinyl alcohol) | ESD-875276-10KG |
| Cas.: 105816-04-4 | Purity: 99% | Nateglinide | ESD-830517-100G |
| Cas.: 219297-09-3 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(naphthalen-1-yl)butanoic acid | ESD-917037-100MG |
| Cas.: 112648-68-7 | Purity: 97% | U73122 | ESD-872867-25MG |
| Cas.: 559-70-6 | Purity: 98% | β-Amyrin | ESD-873388-5MG |
| Cas.: 1772-25-4 | Purity: ≥98%(GC) | 1,3,6-Hexanetricarbonitrile | ESD-863132-100G |
| Cas.: 545395-94-6 | Purity: ≥99% | AMG9810 | ESD-878534-50MG |
| Cas.: 6627-72-1 | Purity: ≥98% | Borneol oil | ESD-917038-1G |
| Cas.: 6627-72-1 | Purity: ≥98% | Borneol oil | ESD-917038-5G |
| Cas.: 6627-72-1 | Purity: ≥98% | Borneol oil | ESD-917038-25G |
| Cas.: 6627-72-1 | Purity: ≥98% | Borneol oil | ESD-917038-100G |
| Cas.: 615-16-7 | Purity: 98% | 2-Hydroxybenzimidazole | ESD-848541-500G |
| Cas.: 49543-63-7 | Purity: 97% | 4-|tert|-Butylbenzyl mercaptan | ESD-818665-2.5KG |
| Cas.: 189937-46-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3,3-diphenylpropanoic acid | ESD-917039-1G |
| Cas.: 59016-56-7 | Purity: 98% | 1-Cyano-4-dimethylaminopyridinium tetrafluoroborate | ESD-805991-1G |
| Cas.: 59-31-4 | Purity: 97% | 2-Quinolinol | ESD-830470-100G |
| Cas.: 757937-66-9 | Purity: 98% | (S)-3-Amino-3-(2,4-dichlorophenyl)propanoic acid | ESD-917040-250MG |
| Cas.: 179033-68-2 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-917041-250MG |
| Cas.: 732242-02-3 | Purity: 98% | (S)-3-Amino-3-(2-nitrophenyl)propanoic acid | ESD-917042-100MG |
| Cas.: 20736-09-8 | Purity: ≥98% | Saikosaponin A from Bupleurum falcatnum | ESD-917043-50MG |
| Cas.: 1486-48-2 | Purity: ≥98% | 3,4,5-Tris(benzyloxy)benzoic Acid | ESD-865587-25G |
| Cas.: 79559-97-0 | Purity: solid, ≥98%(HPLC) | SERTRALINE HYDROCHLORIDE | ESD-838259-25G |
| Cas.: 79559-97-0 | Purity: solid, ≥98%(HPLC) | SERTRALINE HYDROCHLORIDE | ESD-838259-100G |
| Cas.: 133395-16-1 | Purity: >97.0%(T) | Magnesium(II) Bis(trifluoromethanesulfonyl)imide | ESD-864256-25G |
| Cas.: 40828-46-4 | Purity: 99% | Suprofen | ESD-873266-10MG |
| Cas.: 40828-46-4 | Purity: 99% | Suprofen | ESD-873266-50MG |
| Cas.: 1159-54-2 | Purity: 98% | Tris(4-chlorophenyl)phosphine | ESD-819857-25G |
| Cas.: 1159-54-2 | Purity: 98% | Tris(4-chlorophenyl)phosphine | ESD-819857-100G |
| Cas.: 14214-31-4 | Purity: 95% | 2-chloro-3-isothiocyanato-prop-1-ene | ESD-906394-250MG |
| Cas.: 126825-16-9 | Purity: 98% | (S)-4-(4-(Benzyloxy)phenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-917044-250MG |
| Cas.: 109-86-4 | Purity: AR | 2-Methoxyethanol | ESD-812954-10L |
| Cas.: 158741-21-0 | Purity: 95% | (R)-2-((tert-Butoxycarbonyl)amino)-3-(3-nitrophenyl)propanoic acid | ESD-917045-250MG |
| Cas.: 446-72-0 | Purity: Analytical Standards, ≥98% | Genistein | ESD-810425-1G |
| Cas.: 499995-74-3 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(o-tolyl)propanoic acid | ESD-917046-250MG |
| Cas.: 244251-20-5 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-5-(methylthio)pentanoic acid | ESD-917047-250MG |
| Cas.: 1196156-42-9 | Purity: 98% | Methyl 1H-pyrazolo[3,4-b]pyridine-5-carboxylate | ESD-917048-250MG |
| Cas.: 133628-28-1 | Purity: 98% | (S)-Methyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoate | ESD-917049-250MG |
| Cas.: 33155-90-7 | Purity: 98% | 10-Hydroxybenzo[h]quinoline | ESD-811463-100G |
| Cas.: 580-16-5 | Purity: 98% | 6-Hydroxyquinoline | ESD-810800-1G |
| Cas.: 149725-81-5 | Purity: 95% | Hydroquinidine-2,5-diphenyl-4,6-pyri-midinediyl diether | ESD-856409-250MG |
| Cas.: 1985605-59-1 | Purity: ≥99% | Baloxavir | ESD-880789-5G |
| Cas.: 1985605-59-1 | Purity: ≥99% | Baloxavir | ESD-880789-1G |
| Cas.: 1985605-59-1 | Purity: ≥99% | Baloxavir | ESD-880789-250MG |
| Cas.: 22198-72-7 | Purity: >98.0%(HPLC)(T) | 4-Aminoantipyrine Hydrochloride | ESD-861732-100G |
| Cas.: 1985605-59-1 | Purity: ≥99% | Baloxavir | ESD-880789-100MG |
| Cas.: 481-39-0 | Purity: ≥95%(HPLC) | 5-Hydroxy-1,4-naphthalenedione | ESD-861193-500MG |
| Cas.: 163457-23-6 | Purity: 98% | 3,3-DIFLUOROPYRROLIDINE HYDROCHLORIDE | ESD-830342-25G |
| Cas.: 20736-09-8 | Purity: ≥98% | Saikosaponin A from Bupleurum falcatnum | ESD-917043-10MG |
| Cas.: 3007-31-6 | Purity: >97.0%(T) | Didodecylamine | ESD-857012-1G |
| Cas.: 618-56-4 | Purity: >98.0%(HPLC)(T) | 3,5-Diaminobenzoic Acid Dihydrochloride | ESD-860111-5G |
| Cas.: 461642-78-4 | Purity: 97% | 2-Methyl-2-[(dodecylsulfanylthiocarbonyl)sulfanyl]propanoic acid | ESD-828559-25G |
| Cas.: 363-24-6 | Purity: >98% | Prostaglandin E2 | ESD-860712-25MG |
| Cas.: 363-24-6 | Purity: >98% | Prostaglandin E2 | ESD-860712-100MG |
| Cas.: 3095-48-5 | Purity: 97% | Methyl 4-amino-3,5-dimethylbenzoate | ESD-841729-5G |
| Cas.: 1985607-66-6 | Purity: 98% | 1-Amino-3-benzyloxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid ethyl ester | ESD-917050-250MG |
| Cas.: 22208-73-7 | Purity: ≥96% | CALCIUM BROMIDE DIHYDRATE | ESD-890222-100G |
| Cas.: 22208-73-7 | Purity: ≥96% | CALCIUM BROMIDE DIHYDRATE | ESD-890222-25G |
| Cas.: 106246-33-7 | Purity: 98% | 4,4′-Methylenebis(3-chloro-2,6-diethylaniline) | ESD-870337-25G |
| Cas.: 106246-33-7 | Purity: 98% | 4,4′-Methylenebis(3-chloro-2,6-diethylaniline) | ESD-870337-100G |
| Cas.: 1985607-83-7 | Purity: 98% | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | ESD-914222-250MG |
| Cas.: 1985607-83-7 | Purity: 98% | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | ESD-914222-1G |
| Cas.: 192198-85-9 | Purity: >99%(HPLC) | TPBi; 1,3,5-Tris(1-phenyl-1H-benzimidazol-2-yl)benzene | ESD-853829-5G |
| Cas.: 1985607-83-7 | Purity: 98% | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | ESD-914222-5G |
| Cas.: 3483-11-2 | Purity: 95% | Lithium acetoacetate | ESD-812311-5G |
| Cas.: 1809249-37-3 | Purity: ≥99% | Remdesivir | ESD-881200-25MG |
| Cas.: 1809249-37-3 | Purity: ≥99% | Remdesivir | ESD-881200-100MG |
| Cas.: 425-75-2 | Purity: 99% | Ethyl trifluoromethanesulfonate | ESD-809284-500G |
| Cas.: 53559-18-5 | Purity: 98% | L-Tyrosinamide hydrochloride | ESD-917051-1G |
| Cas.: 61788-89-4 | Purity: ≥95% | Dimer Acid | ESD-858225-500G |
| Cas.: 19408-84-5 | Purity: 90% | Dihydrocapsaicin | ESD-807370-500MG |
| Cas.: 247217-28-3 | Purity: 97% | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanedioic acid | ESD-917052-250MG |
| Cas.: 275826-34-1 | Purity: 98% | (S)-3-Amino-3-(2-bromophenyl)propanoic acid | ESD-917053-100MG |
| Cas.: 275826-46-5 | Purity: 95% | (S)-3-Amino-3-(naphthalen-1-yl)propanoic acid | ESD-917054-100MG |
| Cas.: 500789-05-9 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(2-chlorophenyl)propanoic acid | ESD-917055-100MG |
| Cas.: 275826-35-2 | Purity: 98% | (S)-3-Amino-3-(3-bromophenyl)propanoic acid | ESD-917056-250MG |
| Cas.: 945651-03-6 | Purity: 97% | H-Glu-Obzl Hydrochloride | ESD-917057-250MG |
| Cas.: 102767-28-2 | Purity: 97% | Levetiracetam | ESD-831443-1G |
| Cas.: 598-10-7 | Purity: 98% | 1,1-Cyclopropanedicarboxylic acid | ESD-831297-1G |
| Cas.: 62968-45-0 | Purity: 95% | Benzenehexathiol | ESD-903635-500MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-100MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-25MG |
| Cas.: 142474-53-1 | Purity: ≥95%(HPLC) | Glyasperin C | ESD-917058-5MG |
| Cas.: 517905-85-0 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-bromophenyl)propanoic acid | ESD-917059-100MG |
| Cas.: 80370-42-9 | Purity: 97% | Ethyl 2-formyl-3-oxopropanoate | ESD-833537-25G |
| Cas.: 121091-31-4 | Purity: 98% | 1H-Imidazolium, 1,3-dimethyl-, tetrafluoroborate(1-) | ESD-857151-100G |
| Cas.: 56816-01-4 | Purity: ≥98% sum of enantiomers | Ethyl (S)-(+)-3-Hydroxybutyrate | ESD-834910-100ML |
| Cas.: 112-70-9 | Purity: 97% | 1-Tridecanol | ESD-818953-100G |
| Cas.: 29079-00-3 | Purity: 98% | 4-Ethynyl-1,1′-biphenyl | ESD-840673-25G |
| Cas.: 4122-56-9 | Purity: 98% | Methyl 2-formylbenzoate | ESD-840472-25G |
| Cas.: 4122-56-9 | Purity: 98% | Methyl 2-formylbenzoate | ESD-840472-100G |
| Cas.: 84-17-3 | Purity: 96% | Dienestrol | ESD-806378-50MG |
| Cas.: 941678-49-5 | Purity: 98% | Ruxolitinib | ESD-849100-10MG |
| Cas.: 941678-49-5 | Purity: 98% | Ruxolitinib | ESD-849100-250MG |
| Cas.: 42182-27-4 | Purity: 97% | 2-Amino-4-cyanopyridine | ESD-800941-100G |
| Cas.: 173559-74-5 | Purity: for HPLC, ≥95% | Hydroxysaikosaponin C | ESD-917060-1MG |
| Cas.: 92-82-0 | Purity: 98% | Phenazine | ESD-815701-500G |
| Cas.: 3297-72-1 | Purity: 98% | 1-Phenylisoquinoline | ESD-816913-25G |
| Cas.: 27245-31-4 | Purity: 98% | 3-(Piperazin-1-yl)propanoic acid | ESD-890255-5G |
| Cas.: 52009-64-0 | Purity: 98% | 6-Phenylphenanthridine-3,8-diamine | ESD-916506-1G |
| Cas.: 22888-70-6 | Purity: 98% | Silibinin | ESD-817885-25G |
| Cas.: 22888-70-6 | Purity: 98% | Silibinin | ESD-817885-100G |
| Cas.: 10305-73-4 | Purity: 97% | (R)-1-Aminoindane Hydrochloride | ESD-832526-25G |
| Cas.: 127369-30-6 | Purity: ≥95% | (S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate hydrochloride | ESD-897824-5G |
| Cas.: 1569-60-4 | Purity: 98% | (±)-6-Methyl-5-hepten-2-ol | ESD-915139-5G |
| Cas.: 207399-12-0 | Purity: AR | Iron(Ⅲ) citrate hydrate | ESD-886071-2.5KG |
| Cas.: 66-97-7 | Purity: 98% | Psoralen | ESD-815443-500MG |
| Cas.: 144689-93-0 | Purity: >96% | Ethyl 4-(2-Hydroxy-2-propyl)-2-propyl-1H-imidazole-5-carboxylate | ESD-835323-25G |
| Cas.: 144689-93-0 | Purity: >96% | Ethyl 4-(2-Hydroxy-2-propyl)-2-propyl-1H-imidazole-5-carboxylate | ESD-835323-100G |
| Cas.: 144689-93-0 | Purity: >96% | Ethyl 4-(2-Hydroxy-2-propyl)-2-propyl-1H-imidazole-5-carboxylate | ESD-835323-500G |
| Cas.: 27982-06-5 | Purity: ≥98% | (4-Ethoxyphenyl)Phenylmethanone | ESD-859815-5G |
| Cas.: 207605-40-1 | Purity: Ion pair Chromatography grade, ≥99% | Sodium 1-pentanesulfonate monohydrate | ESD-818432-250G |
| Cas.: 3019-71-4 | Purity: ≥97% | Trichloroacetyl Isocyanate | ESD-865960-100G |
| Cas.: 1268524-70-4 | Purity: 98% | (+)-JQ-1 | ESD-844080-500MG |
| Cas.: 1268524-70-4 | Purity: 98% | (+)-JQ-1 | ESD-844080-1G |
| Cas.: 84459-32-5 | Purity: ≥95% | 2-bromo-5-nitrobenzaldehyde | ESD-827934-100G |
| Cas.: 115-53-7 | Purity: 97% | Sinomenine | ESD-817691-250MG |
| Cas.: 5118-13-8 | Purity: 95% | 4-Bromobenzo[b]thiophene | ESD-832616-25G |
| Cas.: 5118-13-8 | Purity: 95% | 4-Bromobenzo[b]thiophene | ESD-832616-100G |
| Cas.: 131980-30-8 | Purity: ≥98.0% | Boc-Phe(3-CN)-OH | ESD-832729-25G |
| Cas.: 83701-22-8 | Purity: 95% | Minoxidil sulphate | ESD-873714-1G |
| Cas.: 1798-11-4 | Purity: ≥98% | 4-Nitrophenoxyacetic Acid | ESD-865845-500G |
| Cas.: 37380-42-0 | Purity: Particle size 0.49 – 0.69 mm | Amberlite XAD-4 | ESD-800994-1L |
| Cas.: 161099-37-2 | Purity: Analysis control, ≥98%(HPLC) | Glicoricone | ESD-917061-5MG |
| Cas.: 110-83-8 | Purity: AR | Cyclohexene | ESD-805395-10L |
| Cas.: 52939-12-5 | Purity: Analysis control, ≥98%(HPLC) | Oxypeucedanin methanolate | ESD-917062-1MG |
| Cas.: 13509-27-8 | Purity: 98% | Methyl phenyl carbonate | ESD-895743-100G |
| Cas.: 66056-20-0 | Purity: Analysis control, ≥98%(HPLC) | Gomisin h | ESD-917063-5MG |
| Cas.: 91990-63-5 | Purity: for HPLC, ≥98% | Saikosaponin H | ESD-917064-5MG |
| Cas.: 1141378-40-6 | Purity: Analysis control, ≥98%(HPLC) | 7-epi-Isogarcinol | ESD-917065-1MG |
| Cas.: 13079-95-3 | Purity: for HPLC, ≥98% | (-)-Sesamin | ESD-917066-20MG |
| Cas.: 7411-49-6 | Purity: 99% | 3,3′-Diaminobenzidine tetrahydrochloride hydrate | ESD-821273-100G |
| Cas.: 13079-95-3 | Purity: for HPLC, ≥98% | (-)-Sesamin | ESD-917066-5MG |
| Cas.: 35578-47-3 | Purity: 97% | 4,4′-Dibromobenzil | ESD-858334-100G |
| Cas.: 244285-12-9 | Purity: Analysis control, ≥98%(HPLC) | Hispidulin 4′-O-β-D-glucopyranoside | ESD-917067-5MG |
| Cas.: NONE8235 | MW 3400Da | Biotin PEG acid, Biotin-PEG-COOH | ESD-917068-100MG |
| Cas.: 146-14-5 | Purity: 97% | Flavin Adenine Dinucleotide | ESD-875773-500MG |
| Cas.: 71117-97-0 | Purity: ≥95%(HPLC) | Isogarcinol | ESD-917069-1MG |
| Cas.: 143120-47-2 | Purity: for HPLC, ≥98% | Zhebeirine | ESD-917071-1MG |
| Cas.: 143120-47-2 | Purity: for HPLC, ≥98% | Zhebeirine | ESD-917071-5MG |
| Cas.: 1036-49-3 | Purity: HPLC≥98% | Isookanin | ESD-917070-5MG |
| Cas.: 25650-68-4 | Purity: for HPLC, ≥98% | Ebeiedinone | ESD-917072-1MG |
| Cas.: 25650-68-4 | Purity: for HPLC, ≥98% | Ebeiedinone | ESD-917072-5MG |
| Cas.: 30382-18-4 | Purity: HPLC≥98% | 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-7-(bD-glucopyranosyloxy)-2,3-dihydro-, (2S)- | ESD-917073-1MG |
| Cas.: 925701-05-9 | Purity: HPLC≥98% | 2-(3,4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-8-hydroxy-4H-1-benzopyran-4-one | ESD-917074-1MG |
| Cas.: 2253791-96-5 | Purity: HPLC≥98% | INDEX NAME NOT YET ASSIGNED | ESD-917075-1MG |
| Cas.: 33118-85-3 | Purity: ≥97% | 5-Bromo-3-methylbenzofuran | ESD-852433-5G |
| Cas.: 100125-12-0 | Purity: 95% | 3,8-Dibromo-1,10-phenanthroline | ESD-823742-5G |
| Cas.: 100125-12-0 | Purity: 95% | 3,8-Dibromo-1,10-phenanthroline | ESD-823742-25G |
| Cas.: 581-71-5 | Purity: 95% | 3-Hydroxy-2-naphthaldehyde | ESD-852165-250MG |
| Cas.: 373608-48-1 | Purity: 97% | tert-Butyl 4-(3-aminopropyl)piperazine-1-carboxylate | ESD-917076-250MG |
| Cas.: 373608-48-1 | Purity: 97% | tert-Butyl 4-(3-aminopropyl)piperazine-1-carboxylate | ESD-917076-1G |
| Cas.: 373608-48-1 | Purity: 97% | tert-Butyl 4-(3-aminopropyl)piperazine-1-carboxylate | ESD-917076-5G |
| Cas.: 3099-29-4 | Purity: 98% | 2-(Chloromethyl)-6-methylpyridine | ESD-839134-10G |
| Cas.: 884495-15-2 | Purity: 95% | 5-Bromo-2-chloro-4-methyl-3-nitropyridine | ESD-841049-5G |
| Cas.: 884495-15-2 | Purity: 95% | 5-Bromo-2-chloro-4-methyl-3-nitropyridine | ESD-841049-25G |
| Cas.: 884495-15-2 | Purity: 95% | 5-Bromo-2-chloro-4-methyl-3-nitropyridine | ESD-841049-100G |
| Cas.: 1253055-87-6 | Purity: 97% | (6-Cyclopropylpyridin-3-yl)boronic acid | ESD-842184-250MG |
| Cas.: 1253055-87-6 | Purity: 97% | (6-Cyclopropylpyridin-3-yl)boronic acid | ESD-842184-1G |
| Cas.: 704911-47-7 | Purity: 97% | Methyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-845556-1G |
| Cas.: 704911-47-7 | Purity: 97% | Methyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-845556-5G |
| Cas.: 704911-47-7 | Purity: 97% | Methyl 5-bromo-1H-1,2,4-triazole-3-carboxylate | ESD-845556-10G |
| Cas.: 36969-89-8 | Purity: 95% | Dimethyl (2-Oxoheptyl)phosphonate | ESD-869096-1G |
| Cas.: 36969-89-8 | Purity: 95% | Dimethyl (2-Oxoheptyl)phosphonate | ESD-869096-5G |
| Cas.: 1967-25-5 | Purity: 97% | (4-Bromophenyl)urea | ESD-859314-5G |
| Cas.: 1967-25-5 | Purity: 97% | (4-Bromophenyl)urea | ESD-859314-25G |
| Cas.: 30987-58-7 | Purity: ≥95%(HPLC) | Isoengelitin | ESD-917077-1MG |
| Cas.: 70342-29-9 | Purity: Analysis control, ≥98%(HPLC) | Methyl kakuol | ESD-917078-5MG |
| Cas.: 129724-84-1 | Purity: >98% | Pulchinenoside A | ESD-860625-20MG |
| Cas.: 938160-21-5 | Purity: Analysis control, ≥98%(HPLC) | 3-O-α-L-rhamnopyranosyl (1→2)[β-D-glucopyranosyl (1→4)]-α-L-arabinopyranosyl-27-hydroxyoleanolic acid 28-O-α-L-rhamnopyranosyl (1→4 )-β-D-glucopyranosyl (1→6)-β-D-glucopyranoside | ESD-917079-1MG |
| Cas.: 845267-78-9 | Purity: 97% | tert-Butyl 2,4-dioxopiperidine-1-carboxylate | ESD-842576-5G |
| Cas.: 845267-78-9 | Purity: 97% | tert-Butyl 2,4-dioxopiperidine-1-carboxylate | ESD-842576-25G |
| Cas.: 1175042-33-7 | Purity: ≥95%(HPLC) | O-6-Deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl (3β)-3-[(4-O-β -D-glucopyranosyl-α-L-arabinopyranosyl)oxy]olean-12-en-28-oate | ESD-917080-1MG |
| Cas.: 845267-78-9 | Purity: 97% | tert-Butyl 2,4-dioxopiperidine-1-carboxylate | ESD-842576-100G |
| Cas.: 959573-22-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-carbamoylphenyl)propanoic acid | ESD-917081-100MG |
| Cas.: 71914-80-2 | Purity: ≥80% | S-Adenosyl-L-methionine tosylate | ESD-917082-250MG |
| Cas.: 71914-80-2 | Purity: ≥80% | S-Adenosyl-L-methionine tosylate | ESD-917082-50MG |
| Cas.: 205528-33-2 | Purity: 96% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiazol-4-yl)propanoic acid | ESD-917083-250MG |
| Cas.: 501030-96-2 | Purity: 98% | (S)-3-Amino-3-(4-nitrophenyl)propanoic acid | ESD-917084-100MG |
| Cas.: 9008-22-4 | Purity: ≥96%(HPLC) | Laminarin | ESD-812314-250MG |
| Cas.: 507472-10-8 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(naphthalen-1-yl)propanoic acid | ESD-917085-100MG |
| Cas.: 25178-38-5 | Purity: ≥95% | 2-Amino-2-(2-hydroxyphenyl)acetic acid | ESD-892695-5G |
| Cas.: 104109-35-5 | Purity: Analysis control, ≥98%(HPLC) | (3b,4a,11a,16b)-16,23,28-Trihydroxy-11-methoxyolean-12-en-3-yl O-6-deoxy-aL-mannopyranosyl-(14)-O-[bD-glucopyranosyl- (16)]-bD-glucopyranoside | ESD-917086-1MG |
| Cas.: 220497-68-7 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-bromophenyl)propanoic acid | ESD-917087-100MG |
| Cas.: 20736-08-7 | Purity: Analysis control, >98% | Saikosaponin C | ESD-817771-5MG |
| Cas.: 824401-05-0 | Purity: ≥90%(HPLC) | Raddeanoside R16 | ESD-917088-1MG |
| Cas.: 269726-84-3 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-cyanophenyl)butanoic acid | ESD-917089-100MG |
| Cas.: 79777-82-5 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-4,4-dimethylpentanoic acid | ESD-917090-100MG |
| Cas.: 96078-14-8 | Purity: Analysis control, ≥98%(HPLC) | Swertiaside | ESD-917091-1MG |
| Cas.: 511272-43-8 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid | ESD-917092-100MG |
| Cas.: 60354-05-4 | Purity: Analysis control, ≥98%(HPLC) | 1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone | ESD-917093-1MG |
| Cas.: 269067-38-1 | Purity: 97% | Fmoc-Cys(Mtt)-OH | ESD-917094-1G |
| Cas.: 266999-24-0 | Purity: 95% | Fmoc-3-(Boc-aminomethyl)-L-phenylalanine | ESD-917095-100MG |
| Cas.: 39524-08-8 | Purity: 98% | Asperosaponin VI | ESD-917096-25MG |
| Cas.: 39524-08-8 | Purity: 98% | Asperosaponin VI | ESD-917096-100MG |
| Cas.: 1654725-02-6 | Purity: 99% | ABBV-974 | ESD-872297-5MG |
| Cas.: 1654725-02-6 | Purity: 99% | ABBV-974 | ESD-872297-10MG |
| Cas.: 2167-14-8 | Purity: >98.0%(GC) | 1-Ethyl-1H-pyrrole-2-carboxaldehyde | ESD-915796-5G |
| Cas.: 122-66-7 | Purity: ≥98%(HPLC) | Hydrazobenzene | ESD-916695-25G |
| Cas.: 122-66-7 | Purity: ≥98%(HPLC) | Hydrazobenzene | ESD-916695-5G |
| Cas.: 480-16-0 | Purity: 95% | morin | ESD-917097-250MG |
| Cas.: 480-16-0 | Purity: 95% | morin | ESD-917097-1G |
| Cas.: 480-16-0 | Purity: 95% | morin | ESD-917097-5G |
| Cas.: 1799753-84-6 | Purity: 99% | BAY-876 | ESD-872881-25MG |
| Cas.: 294877-33-1 | Purity: 95% | 1-(3-Bromophenyl)-1H-pyrazole | ESD-840881-5G |
| Cas.: 9012-09-3 | Cellulose triacetate | ESD-823200-100G | |
| Cas.: 13210-29-2 | Purity: 98% | 1-(3-Hydroxypyridin-2-yl)ethanone | ESD-841241-50MG |
| Cas.: 115383-22-7 | Purity: 98% | Fullerene C70 | ESD-809596-100MG |
| Cas.: 68401-81-0 | Purity: >98.0%(HPLC) | Ceftizoxime | ESD-864700-5G |
| Cas.: 1510-21-0 | Purity: 98% | Cholesterol Hydrogen Succinate | ESD-835314-25G |
| Cas.: 5459-58-5 | Purity: 98% | n-Butyl cyanoacetate | ESD-830316-2.5KG |
| Cas.: 63-75-2 | Purity: Analysis control, >98% | Arecoline | ESD-917098-20MG |
| Cas.: 65715-93-7 | Purity: 98% | HD-Phg-OtBu | ESD-840455-5G |
| Cas.: 65715-93-7 | Purity: 98% | HD-Phg-OtBu | ESD-840455-25G |
| Cas.: 63624-28-2 | Purity: 97% | 2,4-Dimethoxybenzenesulfonyl chloride | ESD-835894-25G |
| Cas.: 63624-28-2 | Purity: 97% | 2,4-Dimethoxybenzenesulfonyl chloride | ESD-835894-1G |
| Cas.: 668983-97-9 | Purity: 97% | Dibenzo[b,d]thiophen-2-ylboronic acid | ESD-843631-25G |
| Cas.: 1647-16-1 | Purity: ≥98% | 1,9-Decadiene | ESD-864910-25ML |
| Cas.: 13537-18-3 | Purity: anhydrous, powder, 99.9% metals basis | Thulium(III) chloride | ESD-819972-250MG |
| Cas.: 1450-93-7 | Purity: 98% | 2-Aminoimidazole hemisulfate | ESD-830836-500G |
| Cas.: 294877-33-1 | Purity: 95% | 1-(3-Bromophenyl)-1H-pyrazole | ESD-840881-100MG |
| Cas.: 813-19-4 | Purity: 98% | Hexabutyldistannane | ESD-811208-100G |
| Cas.: 149709-63-7 | Purity: ≥95% | (2S,4S)-Sacubitril | ESD-917099-5MG |
| Cas.: 578-74-5 | Purity: Analysis control, ≥98%(HPLC) | Apigenin 7-glucoside | ESD-917100-20MG |
| Cas.: 10399-13-0 | Purity: ≥98% | Oxybutynin Related Compound B | ESD-859442-25G |
| Cas.: 853645-22-4 | Purity: ≥98% | Pyridoxal 5′-phosphate hydrate | ESD-864011-5G |
| Cas.: 853645-22-4 | Purity: ≥98% | Pyridoxal 5′-phosphate hydrate | ESD-864011-25G |
| Cas.: 182426-37-5 | Purity: Analysis control, 98% | Biatractylolide | ESD-916293-20MG |
| Cas.: 2245700-60-9 | Purity: for HPLC, ≥98% | Carmichasine B | ESD-917101-1MG |
| Cas.: 87004-78-2 | Purity: 97% | (R)-Benzyl 2-amino-3-phenylpropanoate hydrochloride | ESD-899204-25G |
| Cas.: 87004-78-2 | Purity: 97% | (R)-Benzyl 2-amino-3-phenylpropanoate hydrochloride | ESD-899204-100G |
| Cas.: 24404-49-7 | Purity: HPLC≥98% | epipinoresinol-4′-O-β-D-glucoside | ESD-917102-5MG |
| Cas.: 1275535-67-5 | Purity: for HPLC, ≥98% | 8,10a-Ethano-11,3,6a-ethanylylidene-8H-indeno[2,1-b]azocine-6,7,9,10-tetrol, 9-[(benzoyloxy)methyl]-1-ethyldodecahydro-3 -methyl-, 10-acetate, (3R,6S,6aR,6bR,7R,8S,9R,10R,10aS,11R,11aR,13R)- | ESD-917103-1MG |
| Cas.: 1794-89-4 | Purity: ≥97% | 9,10,12,13-Tetrabromostearic Acid | ESD-867827-5G |
| Cas.: 405229-61-0 | Purity: HPLC≥95% | Nepasaikosaponin K | ESD-917104-5MG |
| Cas.: 94596-28-8 | Purity: Analysis control, ≥98%(HPLC) | Senkyunolide I | ESD-876220-10MG |
| Cas.: XBPY | Tryptose Soya Agar | ESD-861601-1KG | |
| Cas.: 74957-57-6 | Purity: HPLC≥98% | (+)-Pinoresinol monomethyl ether 4-O-β-D-glucoside | ESD-917105-1MG |
| Cas.: 219690-93-4 | Purity: HPLC≥98% | Saikosaponin S | ESD-917106-1MG |
| Cas.: 26575-95-1 | Purity: Analysis control | Alisol B acetate | ESD-823471-20MG |
| Cas.: 2319668-87-4 | Purity: HPLC≥94% | Tibesaikosaponin V | ESD-917108-1MG |
| Cas.: 10026-24-1 | Purity: 99.999% metals basis | Cobalt sulfate heptahydrate | ESD-805745-500G |
| Cas.: 107264-09-5 | Purity: ≥95% | 1-Fluoropyridinium Tetrafluoroborate | ESD-834209-250MG |
| Cas.: 27876-94-4 | Purity: Analytical Standards, 98% | Crocetin | ESD-873358-10MG |
| Cas.: 22398-14-7 | Purity: 98% | Dimethyl Methoxymethylenemalonate | ESD-858395-25G |
| Cas.: 22398-14-7 | Purity: 98% | Dimethyl Methoxymethylenemalonate | ESD-858395-100G |
| Cas.: 55791-52-1 | Purity: 97% | 2,4-Dimethoxybenzylchloride | ESD-917109-5G |
| Cas.: 10040-98-9 | Purity: 98% | 4-(1H-IMIDAZOL-1-YL)BENZALDEHYDE | ESD-833582-100G |
| Cas.: 1883-75-6 | Purity: 98% | 2,5-Furandimethanol | ESD-834118-5G |
| Cas.: 1883-75-6 | Purity: 98% | 2,5-Furandimethanol | ESD-834118-25G |
| Cas.: 998-30-1 | Purity: 97% | Triethoxysilane | ESD-818580-2.5L |
| Cas.: 1107-00-2 | Purity: 98% | 4,4′-(Hexafluoroisopropylidene)diphthalic anhydride | ESD-810820-500G |
| Cas.: 20426-12-4 | Purity: 97% | 4-Hydroxychalcone | ESD-858406-1G |
| Cas.: 20426-12-4 | Purity: 97% | 4-Hydroxychalcone | ESD-858406-25G |
| Cas.: 14720-53-7 | Purity: AR, 99.0% | Lead bore | ESD-812510-100G |
| Cas.: 1875-89-4 | Purity: 98% | 3-Methylphenethyl alcohol | ESD-830483-100G |
| Cas.: 22245-83-6 | Purity: 98% | 2-Hydroxy-3-(trifluoromethyl)pyridine | ESD-811476-500G |
| Cas.: 16452-11-2 | Purity: 95% | 1-Chloronaphthalen-2-amine | ESD-917111-250MG |
| Cas.: 16452-11-2 | Purity: 95% | 1-Chloronaphthalen-2-amine | ESD-917111-1G |
| Cas.: 1005-56-7 | Purity: 98% | O-Phenyl chlorothionoformate | ESD-816871-100G |
| Cas.: 20191-75-7 | Purity: 97% | 1-Bromonaphthalen-2-amine | ESD-917112-250MG |
| Cas.: 20191-75-7 | Purity: 97% | 1-Bromonaphthalen-2-amine | ESD-917112-1G |
| Cas.: 88404-25-5 | Purity: ≥98% | 4-Bromomethyl-6,7-dimethoxycoumarin [for HPLC Labeling] | ESD-861839-500MG |
| Cas.: 10605-02-4 | Purity: 97% | Palmatine chloride | ESD-917113-250MG |
| Cas.: 10605-02-4 | Purity: 97% | Palmatine chloride | ESD-917113-1G |
| Cas.: 95154-01-1 | Purity: 98% | 2-(1,3-BENZOTHIAZOL-2-YLTHIO)SUCCINIC ACID | ESD-905833-100G |
| Cas.: 127903-20-2 | Purity: 97% | (9H-Fluoren-9-yl)methyl (6-hydroxyhexyl)carbamate | ESD-917114-250MG |
| Cas.: 5315-25-3 | Purity: 98% | 2-Bromo-6-methylpyridine | ESD-801938-500G |
| Cas.: 18113-18-3 | Purity: 97% | 2,5-Dimethoxyphenol | ESD-840220-5G |
| Cas.: 13478-18-7 | Purity: 99.5% trace metals basis | Molybdenum(III) chloride | ESD-836129-5G |
| Cas.: 89523-51-3 | Purity: 95% | 5-Bromobenzo[c]phenanthrene | ESD-917115-100MG |
| Cas.: 52853-40-4 | Purity: 90% | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide | ESD-845654-100G |
| Cas.: 185968-90-5 | Purity: 98% | ZD-Dapa(Fmoc)-OH | ESD-917116-250MG |
| Cas.: 68443-63-0 | Purity: 98% | Butyl 2-Ethylhexanoate | ESD-870244-25G |
| Cas.: 2391-56-2 | Purity: 95% | 1,5-Bis(4-aminophenoxy)pentane | ESD-908747-25G |
| Cas.: 94-97-3 | Purity: 98% | 5-Chlorobenzotriazole | ESD-832320-500G |
| Cas.: 487040-33-5 | Purity: Analysis control, ≥98%(HPLC) | 1-O-gentiobiosyl-3,7-dimethoxy-8-hydroxyxanthone | ESD-917117-1MG |
| Cas.: 114872-98-9 | Purity: 97% | 2,4-Dichloro-D-phenylalanine | ESD-842460-5G |
| Cas.: 114872-98-9 | Purity: 97% | 2,4-Dichloro-D-phenylalanine | ESD-842460-25G |
| Cas.: 32432-55-6 | Purity: >97% | 3,5-Diamino-2,4,6-trimethylbenzenesulfonic Acid | ESD-835111-25G |
| Cas.: 32432-55-6 | Purity: >97% | 3,5-Diamino-2,4,6-trimethylbenzenesulfonic Acid | ESD-835111-100G |
| Cas.: 1444411-75-9 | Purity: Analysis control, ≥98%(HPLC) | Kouitchenside G | ESD-917118-1MG |
| Cas.: 22026-39-7 | Purity: ≥98% | 3,4-Methylenedioxybenzhydrazide | ESD-858801-5G |
| Cas.: 22688-78-4 | Purity: ≥98%(HPLC) | Kaemppherol 3-O-β-glucuronide Kaempferol 3-O-β-D-glucuronide | ESD-917119-5MG |
| Cas.: 22688-78-4 | Purity: ≥98%(HPLC) | Kaemppherol 3-O-β-glucuronide Kaempferol 3-O-β-D-glucuronide | ESD-917119-1MG |
| Cas.: 104109-37-7 | Purity: ≥98% (HPLC) | 11α-Methoxysaikosaponin F | ESD-917120-5MG |
| Cas.: 759-67-1 | Purity: 97% | Ethyl 2-fluoro-3-oxopentanoate | ESD-917121-250MG |
| Cas.: 759-67-1 | Purity: 97% | Ethyl 2-fluoro-3-oxopentanoate | ESD-917121-1G |
| Cas.: 759-67-1 | Purity: 97% | Ethyl 2-fluoro-3-oxopentanoate | ESD-917121-5G |
| Cas.: 197705-31-0 | Purity: ≥98% (HPLC) | Bupleuroside XIII | ESD-917123-1MG |
| Cas.: 18719-76-1 | Purity: ≥95%(HPLC) | Cyanidin-3-O-Rutinoside | ESD-917122-1MG |
| Cas.: 18719-76-1 | Purity: ≥95%(HPLC) | Cyanidin-3-O-Rutinoside | ESD-917122-5MG |
| Cas.: 577-38-8 | Purity: ≥98% (HPLC) | Flavanomarein | ESD-917124-5MG |
| Cas.: 929294-27-9 | Purity: ≥98%, 99%ee | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide -dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin | ESD-854238-25MG |
| Cas.: 177-11-7 | Purity: 97% | 1,4-Dioxa-8-azaspiro[4.5]decane | ESD-831220-1G |
| Cas.: 177-11-7 | Purity: 97% | 1,4-Dioxa-8-azaspiro[4.5]decane | ESD-831220-5G |
| Cas.: 177-11-7 | Purity: 97% | 1,4-Dioxa-8-azaspiro[4.5]decane | ESD-831220-25G |
| Cas.: 899436-04-5 | Purity: Analysis control, ≥98%(HPLC) | HedysarimcouumestanB | ESD-917125-1MG |
| Cas.: 22688-79-5 | Purity: >99% | Miquelianin | ESD-860582-20MG |
| Cas.: 535-96-6 | Purity: ≥98% (HPLC) | Marein | ESD-917126-5MG |
| Cas.: 113231-05-3 | Purity: 95% | N(ALPHA),N(ALPHA)-BIS(CARBOXYMETHYL)-L-LYSINE HYDRATE | ESD-833692-25G |
| Cas.: 484-76-4 | Purity: ≥98% (HPLC) | Okanin | ESD-917127-5MG |
| Cas.: 5597-50-2 | Purity: 98% | Methyl 3-(4-hydroxyphenyl)propionate | ESD-813874-500G |
| Cas.: 102568-43-4 | Purity: ≥95% | Sulfo-SANPAH | ESD-917128-10MG |
| Cas.: 102568-43-4 | Purity: ≥95% | Sulfo-SANPAH | ESD-917128-50MG |
| Cas.: 67385-09-5 | Purity: ≥98% | 2-(Boc-amino)ethanethiol | ESD-917129-1G |
| Cas.: 67385-09-5 | Purity: ≥98% | 2-(Boc-amino)ethanethiol | ESD-917129-5G |
| Cas.: 67385-09-5 | Purity: ≥98% | 2-(Boc-amino)ethanethiol | ESD-917129-25G |
| Cas.: 81779-27-3 | Purity: 97% | 4-Hydroxy-1H-indole-3-carbaldehyde | ESD-843280-5G |
| Cas.: 113231-05-3 | Purity: 95%+ | N(ALPHA),N(ALPHA)-BIS(CARBOXYMETHYL)-L-LYSINE HYDRATE HYDROCHLORIDE | ESD-917130-1G |
| Cas.: 113231-05-3 | Purity: 95%+ | N(ALPHA),N(ALPHA)-BIS(CARBOXYMETHYL)-L-LYSINE HYDRATE HYDROCHLORIDE | ESD-917130-5G |
| Cas.: 113231-05-3 | Purity: 95%+ | N(ALPHA),N(ALPHA)-BIS(CARBOXYMETHYL)-L-LYSINE HYDRATE HYDROCHLORIDE | ESD-917130-25G |
| Cas.: 118090-09-8 | Purity: ≥95% | Benzo[d]thiazole-2-thiol | ESD-917131-5G |
| Cas.: 118090-09-8 | Purity: ≥95% | Benzo[d]thiazole-2-thiol | ESD-917131-25G |
| Cas.: 118090-09-8 | Purity: ≥95% | Benzo[d]thiazole-2-thiol | ESD-917131-100G |
| Cas.: 104376-79-6 | Purity: 98% | Ceftriaxone Disodium Salt Hemiheptahydrate | ESD-832410-500G |
| Cas.: 4215-80-9 | Purity: 97% | Triphenylsilylamine | ESD-917132-1G |
| Cas.: 4215-80-9 | Purity: 97% | Triphenylsilylamine | ESD-917132-5G |
| Cas.: XBPY | Purity: 1X | Phosphate Buffered Saline (PBS), pH7.4 | ESD-6505-1L |
| Cas.: 1257063-35-6 | Purity: ≥96% | Azido-PEG4-C2-acid | ESD-917133-100MG |
| Cas.: 1257063-35-6 | Purity: ≥96% | Azido-PEG4-C2-acid | ESD-917133-250MG |
| Cas.: 13429-07-7 | Purity: 97% | 1-(2-methoxypropoxy)propan-2-ol | ESD-917134-10MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-250MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-1G |
| Cas.: 193140-43-1 | Purity: 95% | N-(1-Iminopentyl)glycine | ESD-917135-1G |
| Cas.: 193140-43-1 | Purity: 95% | N-(1-Iminopentyl)glycine | ESD-917135-5G |
| Cas.: 9001-12-1 | Purity: ≥125 U/mg | Collagenase I | ESD-909788-1G |
| Cas.: 38245-37-3 | Purity: 99% | Samarium(III) Carbonate Hydrate | ESD-850362-100G |
| Cas.: 38245-37-3 | Purity: 99% | Samarium(III) Carbonate Hydrate | ESD-850362-500G |
| Cas.: 41044-12-6 | Purity: 98% | 7-(Diethylamino)-3-(1-methyl-2-benzimidazolyl)coumarin | ESD-870139-1G |
| Cas.: 166338-14-3 | Purity: ≥98% (HPLC) | β-D-Glucopyranoside, (3β,4α,16β)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→4) -O-[β-D-glucopyranosyl-(1→6)]- (9CI) | ESD-917136-1MG |
| Cas.: 6792-09-2 | Purity: ≥98% (HPLC) | Mesaconine | ESD-917137-5MG |
| Cas.: 104091-11-4 | Purity: 98% | Fmoc-D-Glu(OBZL)-OH | ESD-917138-250MG |
| Cas.: 1309589-79-4 | Purity: ≥98% (HPLC) | Potentillanoside A | ESD-917139-1MG |
| Cas.: 62253-63-8 | Purity: 95% | rhEGF | ESD-912664-5MG |
| Cas.: 6290-24-0 | Purity: >98.0%(GC) | Ethyl 2-ethoxybenzoate | ESD-914515-5G |
| Cas.: 7755-92-2 | Purity: 98% | 1-Formylpiperazine | ESD-809630-5G |
| Cas.: 4759-48-2 | Purity: 98% | 13-cis-Retinoic Acid | ESD-835470-100G |
| Cas.: 1849-36-1 | Purity: 96% | 4-Nitrothiophenol | ESD-875937-100G |
| Cas.: 32130-27-1 | Purity: average Mn 2000 | HO-PEG-NH2 | ESD-917141-250MG |
| Cas.: 32130-27-1 | Purity: average Mn 2000 | HO-PEG-NH2 | ESD-917141-1G |
| Cas.: 32130-27-1 | Purity: average Mn 3400 | HO-PEG-NH2 | ESD-917142-250MG |
| Cas.: 32130-27-1 | Purity: average Mn 3400 | HO-PEG-NH2 | ESD-917142-1G |
| Cas.: 32130-27-1 | Purity: average Mn 5000 | HO-PEG-NH2 | ESD-917143-250MG |
| Cas.: 32130-27-1 | Purity: average Mn 5000 | HO-PEG-NH2 | ESD-917143-1G |
| Cas.: 7778-53-2 | Purity: AR | Potassium phosphate tribasic | ESD-815669-10KG |
| Cas.: 189197-69-1 | Purity: ≥99% | Ro 48-8071 fumarate | ESD-880982-50MG |
| Cas.: 136-77-6 | Purity: 98% | 4-HEXYLRESORCINOL | ESD-835899-100G |
| Cas.: 31909-58-7 | Purity: 98% | 2-Furoylacetonitrile | ESD-917144-1G |
| Cas.: 31909-58-7 | Purity: 98% | 2-Furoylacetonitrile | ESD-917144-5G |
| Cas.: 31909-58-7 | Purity: 98% | 2-Furoylacetonitrile | ESD-917144-25G |
| Cas.: 1347750-76-8 | Purity: 95% | CBz-n-amido-peg2-acid | ESD-917145-100MG |
| Cas.: 1347750-76-8 | Purity: 95% | CBz-n-amido-peg2-acid | ESD-917145-250MG |
| Cas.: 1347750-76-8 | Purity: 95% | CBz-n-amido-peg2-acid | ESD-917145-1G |
| Cas.: 1187431-43-1 | Purity: ≥99% | Trametinib (DMSO solvate) | ESD-884154-250MG |
| Cas.: 1129-65-3 | Purity: ≥98% | 1-Phenyl-1-hexyne | ESD-867746-25ML |
| Cas.: 135529-16-7 | Purity: >95% | 4-amino-N-(4-(N-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)benzenesulfonamide | ESD-917147-5MG |
| Cas.: 135529-16-7 | Purity: >95% | 4-amino-N-(4-(N-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)benzenesulfonamide | ESD-917147-25MG |
| Cas.: 135529-16-7 | Purity: >95% | 4-amino-N-(4-(N-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)benzenesulfonamide | ESD-917147-100MG |
| Cas.: 56718-76-4 | Purity: >95% | rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol | ESD-917148-25MG |
| Cas.: 5702-16-9 | Purity: ≥98% | Dodecaethylene Glycol Monomethyl Ether | ESD-917149-250MG |
| Cas.: 56718-76-4 | Purity: >95% | rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol | ESD-917148-50MG |
| Cas.: 56718-76-4 | Purity: >95% | rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol | ESD-917148-100MG |
| Cas.: 5702-16-9 | Purity: ≥98% | Dodecaethylene Glycol Monomethyl Ether | ESD-917149-100MG |
| Cas.: 1134616-77-5 | Purity: >95% | sodium 3-methylquinoxaline-2-carboxylate | ESD-917150-10MG |
| Cas.: 1134616-77-5 | Purity: >95% | sodium 3-methylquinoxaline-2-carboxylate | ESD-917150-50MG |
| Cas.: 125220-94-2 | Purity: ≥95% | PolyMethoxypolyethylene glycol propionic acid | ESD-917151-250MG |
| Cas.: 125220-94-2 | Purity: ≥95% | PolyMethoxypolyethylene glycol propionic acid | ESD-917151-1G |
| Cas.: 251-56-9 | Purity: 97% | Thiazolo[5,4-d]thiazole | ESD-917107-1G |
| Cas.: NONE8236 | Purity: Analysis control, ≥98%(HPLC) | Gentiiridosides A | ESD-917152-1MG |
| Cas.: 84238-39-1 | Purity: 33% | Patchouli oil | ESD-905697-500G |
| Cas.: 13010-19-0 | Purity: 96% | 3-Chloropropyl isocyanate | ESD-804903-25G |
| Cas.: 324017-21-2 | Purity: 98% | Fmoc-D-Phe(4-NH2)-OH | ESD-917153-1G |
| Cas.: 2770-49-2 | Purity: ≥95% | 1,4-Phenylene Bis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate) | ESD-865503-25G |
| Cas.: 177325-13-2 | Purity: 98% | Levofloxacin hydrochloride | ESD-856309-500G |
| Cas.: 38880-58-9 | Purity: ≥95% | (2-Hydroxyethyl)dimethyl(3-sulfopropyl)ammonium Hydroxide Inner Salt | ESD-917154-5G |
| Cas.: 3095-73-6 | Purity: ≥98%(HPLC)(T) | Hexakis(bromomethyl)benzene | ESD-862156-250MG |
| Cas.: 492-27-3 | Purity: 98% | Kynurenic acid | ESD-812247-25G |
| Cas.: 1074-88-0 | Purity: 98% | Indole-7-carboxaldehyde | ESD-812158-25G |
| Cas.: 124655-09-0 | Purity: 97% | tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate | ESD-841715-5G |
| Cas.: 124655-09-0 | Purity: 97% | tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate | ESD-841715-25G |
| Cas.: 308068-56-6 | Purity: >95%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -COOH:~9.0wt% | High Purified Carboxylic Single-walled carbon nanotubes (SWCNTS-COOH) | ESD-835732-5G |
| Cas.: 2479-49-4 | Purity: ≥98% | Benzophenonetetracarboxylic acid | ESD-880049-250MG |
| Cas.: 2479-49-4 | Purity: ≥98% | Benzophenonetetracarboxylic acid | ESD-880049-1G |
| Cas.: 5700-49-2 | Purity: ≥98%(N)(T) | Ethylenediamine Dihydroiodide | ESD-862412-5G |
| Cas.: 78238-14-9 | Purity: ≥97% | 3-HYDROXY-5-NITROBENZOIC ACID | ESD-890268-25G |
| Cas.: 823-82-5 | Purity: 98% | 2,5-Diformylfurane | ESD-823965-25G |
| Cas.: 507472-25-5 | Purity: 95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid | ESD-917155-100MG |
| Cas.: 52665-69-7 | Purity: 98% | Calcium ionophore III | ESD-838422-5MG |
| Cas.: 3785-34-0 | Purity: ≥97% | 1,2-Bis(bromoacetoxy)ethane | ESD-889680-1G |
| Cas.: 599-64-4 | Purity: 99% | 4-α-Cumylphenol | ESD-834880-2.5KG |
| Cas.: 115-70-8 | Purity: 98% | 2-amino-2-ethyl-;2-amino-2-ethyl-3-propanediol | ESD-824385-2.5KG |
| Cas.: 613-13-8 | Purity: 98% | 2-Aminoanthracene | ESD-870515-5G |
| Cas.: 6386-38-5 | Purity: 98% | Methyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate | ESD-824388-2.5KG |
| Cas.: 606-26-8 | Purity: ≥98% | 2-Nitrobenzhydrazide | ESD-867428-100G |
| Cas.: 13765-26-9 | Purity: No water, powder, 99.99% metals basis | Gadolinium(III) fluoride | ESD-810659-500G |
| Cas.: 68157-60-8 | Purity: Plant cell culture grade, 98% | Forchlorfenuron | ESD-810008-500G |
| Cas.: 1217809-38-5 | Purity: 95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((diphenyl(p-tolyl)methyl)amino)butanoic acid | ESD-917156-100MG |
| Cas.: 18868-43-4 | Purity: 99% trace metals basis | Molybdenum(IV) oxide | ESD-836283-2.5KG |
| Cas.: 507472-20-0 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid | ESD-917157-100MG |
| Cas.: 1184-10-7 | Purity: 98% | Hexaphenoxycyclotriphospazene | ESD-835384-500G |
| Cas.: 1184-10-7 | Purity: 98% | Hexaphenoxycyclotriphospazene | ESD-835384-1KG |
| Cas.: 5989-81-1 | Purity: Ultrapure grade, ≥99.5% (HPLC) | α-Lactose monohydrate | ESD-812299-2.5KG |
| Cas.: 5405-63-0 | Purity: ≥90% | Triphenylphosphine,1,4-benzoquinone adduct | ESD-860036-25G |
| Cas.: 5405-63-0 | Purity: ≥90% | Triphenylphosphine,1,4-benzoquinone adduct | ESD-860036-100G |
| Cas.: 690206-97-4 | Purity: ≥98% | ZM 306416 | ESD-863582-50MG |
| Cas.: 6528-34-3 | Purity: AR | Pigment Yellow 65 | ESD-914391-500G |
| Cas.: 220851-29-6 | Purity: 97% | tert-Butyl 11-aminoundecanoate | ESD-917159-100MG |
| Cas.: 756-13-8 | Purity: ≥98% | 1,1,1,2,2,4,5,5,5-Nonafluoro-4-(trifluoromethyl)-3-pentanone | ESD-857418-500G |
| Cas.: 30652-11-0 | Purity: 98% | 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone | ESD-811544-500G |
| Cas.: 60372-77-2 | Purity: 96% | Ethyl Lauroyl Arginate Hydrochloride | ESD-857059-500G |
| Cas.: 4506-61-0 | Purity: 98% | 2,2′-(1,2-Phenylene)bis(1H-benzimidazole) | ESD-887215-5G |
| Cas.: 15813-09-9 | Purity: ≥95% | 4,5-Diiodoimidazole | ESD-852245-25G |
| Cas.: 16285-74-8 | Purity: ≥97% | 4-Aminothieno[3,2-d]pyrimidine | ESD-852884-100MG |
| Cas.: 24969-06-0 | Purity: average Mw ~700, 000 by GPC | Resin epoxy | ESD-832313-100G |
| Cas.: 908847-01-8 | Purity: 95% | N-Fmoc-6-fluoro-L-tryptophan | ESD-917160-100MG |
| Cas.: 8024-01-9 | Purity: 95% | Storax oil | ESD-905686-500G |
| Cas.: 8022-56-8 | Purity: 99% | Sage oil | ESD-905696-500ML |
| Cas.: 4896-77-9 | Purity: 99% | Glycine-d5 | ESD-874256-250MG |
| Cas.: 26117-28-2 | Purity: 97% | (S)-2-Acetamido-3-mercaptopropanoic acid | ESD-916934-5G |
| Cas.: 108084-47-5 | Purity: ≥98.0% (TLC) | 4-Aminophenyl phosphate monosodium salt hydrate | ESD-875076-50MG |
| Cas.: 108084-47-5 | Purity: ≥98.0% (TLC) | 4-Aminophenyl phosphate monosodium salt hydrate | ESD-875076-250MG |
| Cas.: 99792-79-7 | Purity: 95% | Chlorophenol red β-D-galactopyranoside (CPRG) | ESD-915818-250MG |
| Cas.: 25015-63-8 | Purity: 97% | 4,4,5,5-Tetramethyl-1,3,2-dioxaborolane | ESD-819679-500ML |
| Cas.: 1159531-18-6 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(pent-4-ynamido)hexanoic acid | ESD-917161-100MG |
| Cas.: 96702-03-3 | Purity: ≥97% | Ectoine | ESD-864812-100G |
| Cas.: 5018-30-4 | Purity: ≥95%(GC) | Dimethyl Methoxymalonate | ESD-863295-25G |
| Cas.: 4121-39-5 | Purity: >95% | NSC 77154 | ESD-917162-25MG |
| Cas.: 4121-39-5 | Purity: >95% | NSC 77154 | ESD-917162-50MG |
| Cas.: 4121-39-5 | Purity: >95% | NSC 77154 | ESD-917162-100MG |
| Cas.: 43109-77-9 | Purity: ≥97% | o-AdaMantylanisole | ESD-917163-25MG |
| Cas.: 43109-77-9 | Purity: ≥97% | o-AdaMantylanisole | ESD-917163-50MG |
| Cas.: 43109-77-9 | Purity: ≥97% | o-AdaMantylanisole | ESD-917163-100MG |
| Cas.: 881676-32-0 | Purity: 95% | 5-Bromo-1H-pyrrole-3-carbaldehyde | ESD-906441-5G |
| Cas.: 4105-92-4 | Purity: 98% | Triethyl benzene-1,3,5-tricarboxylate | ESD-904746-100G |
| Cas.: 1772-01-6 | Purity: ≥98% | 2-Pyridylamidoxime | ESD-865424-25G |
| Cas.: 13139-52-1 | Purity: 98% | ZD-Gln-OH | ESD-915588-25G |
| Cas.: 511272-36-9 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid | ESD-917164-100MG |
| Cas.: 478183-71-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-nitrophenyl)propanoic acid | ESD-917165-1G |
| Cas.: 270062-88-9 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-917166-100MG |
| Cas.: 24034-73-9 | Purity: 95% | Geranylgeraniol | ESD-832920-500MG |
| Cas.: 51-45-6 | Purity: 96% | Histamine | ESD-811227-25G |
| Cas.: 374791-04-5 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-nitrophenyl)propanoic acid | ESD-917167-250MG |
| Cas.: 3018-12-0 | Purity: 98% | Dichloroacetonitrile | ESD-807355-2.5KG |
| Cas.: 18999-28-5 | Purity: ≥90%(GC) | 2-Heptenoic Acid (contains 3-Heptenoic Acid) | ESD-863048-25ML |
| Cas.: 27167-53-9 | Purity: 95% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)propanoate | ESD-917168-5G |
| Cas.: 652-29-9 | Purity: ≥98% | 2′,3′,4′,5′,6′-Pentafluoroacetophenone | ESD-865327-25G |
| Cas.: 24292-52-2 | Purity: 98% | Hesperidin methylchalcone | ESD-910188-500G |
| Cas.: 14678-05-8 | Purity: 98% | Isoxazol-5-amine | ESD-917169-250MG |
| Cas.: 92-32-0 | Purity: ≥50% | Pyronin Y | ESD-875069-25G |
| Cas.: 3164-85-0 | Purity: ≥97% | 2-Ethylhexanoic Acid Potassium Salt | ESD-902421-2.5KG |
| Cas.: 1315449-94-5 | Purity: 95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)-2-methylhexanoic acid | ESD-917170-100MG |
| Cas.: 405060-95-9 | Purity: 99% | Salubrinal | ESD-872271-5MG |
| Cas.: 405060-95-9 | Purity: 99% | Salubrinal | ESD-872271-25MG |
| Cas.: 405060-95-9 | Purity: 99% | Salubrinal | ESD-872271-100MG |
| Cas.: 3815-86-9 | Purity: 99% | Malonic acid dihydrazide | ESD-849408-500G |
| Cas.: 3815-86-9 | Purity: 99% | Malonic acid dihydrazide | ESD-849408-2.5KG |
| Cas.: 10601-19-1 | Purity: 98% | 5-Methoxyindole-3-carboxaldehyde | ESD-814082-25G |
| Cas.: 1028749-31-6 | Purity: 98% | (6-(Cyclopropylmethoxy)pyridin-3-yl)boronic acid | ESD-917171-250MG |
| Cas.: 5508-58-7 | Purity: 98% | Andrographolide | ESD-800174-25G |
| Cas.: 5508-58-7 | Purity: 98% | Andrographolide | ESD-800174-100G |
| Cas.: 218943-31-8 | Purity: 95% | Boc-o-benzyl-l-beta-homoserine | ESD-917172-250MG |
| Cas.: 20866-48-2 | Purity: 95% | Boc-Tyr(Boc)-OH | ESD-917173-5G |
| Cas.: 21867-69-6 | Purity: 97% | 1-(4-Methoxybenzyl)piperazine | ESD-914550-5G |
| Cas.: 21867-69-6 | Purity: 97% | 1-(4-Methoxybenzyl)piperazine | ESD-914550-25G |
| Cas.: 5422-44-6 | Purity: 98% | 5-Amino-1-methyltetrazole | ESD-834934-100G |
| Cas.: 69541-68-0 | Purity: 98% | Boc-D-His(Tos)-OH | ESD-917174-1G |
| Cas.: 77078-22-9 | Purity: ≥98% | Diethylene Glycol Isopropyl Methyl Ether | ESD-865709-5ML |
| Cas.: 882033-66-1 | Purity: 97% | 4-Chloro-5-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-917175-250MG |
| Cas.: 501015-17-4 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | ESD-917176-100MG |
| Cas.: 1911578-75-0 | Purity: 95% | Remdesivir (R)-Isomer | ESD-917177-10MG |
| Cas.: 26495-91-0 | Purity: 95% | CyclohexylaminomethylTriethoxysilane | ESD-833962-25ML |
| Cas.: 163702-05-4 | Purity: 99% | ETHYL NONAFLUOROBUTYL ETHER | ESD-888212-500G |
| Cas.: 5452-37-9 | Purity: 98% | Cyclooctylamine | ESD-870603-1ML |
| Cas.: 12136-58-2 | Purity: 99.999% trace metals basis | Lithium sulfide | ESD-913995-25G |
| Cas.: 17507-03-8 | Purity: ≥97% | Dimethyl 2,3-Quinolinedicarboxylate | ESD-858649-5G |
| Cas.: 6055-52-3 | Purity: 97% | Hexane-1,6-diamine dihydrochloride | ESD-848915-500G |
| Cas.: 1222-05-5 | Purity: 100 μg/mL in methanol | Galaxolide standard solution | ESD-917178-1ML |
| Cas.: 1222-05-5 | Purity: 50% in DEP | Galaxolide solution | ESD-917180-250G |
| Cas.: 1222-05-5 | Purity: 50% in DEP | Galaxolide solution | ESD-917180-50G |
| Cas.: 1222-05-5 | Purity: 50% in DEP | Galaxolide solution | ESD-917180-1KG |
| Cas.: 1222-05-5 | Purity: ≥75% | Galaxolide | ESD-917179-25G |
| Cas.: 1222-05-5 | Purity: ≥75% | Galaxolide | ESD-917179-100G |
| Cas.: 1222-05-5 | Purity: ≥75% | Galaxolide | ESD-917179-500G |
| Cas.: 19241-16-8 | Purity: 98% | 2,6-Dimethylphenyl isothiocyanate | ESD-858417-5G |
| Cas.: 19241-16-8 | Purity: 98% | 2,6-Dimethylphenyl isothiocyanate | ESD-858417-1G |
| Cas.: 5305-45-3 | Purity: 99% | 4,6-Dichloropyrimidine-5-carbonitrile | ESD-844169-5G |
| Cas.: 5305-45-3 | Purity: 99% | 4,6-Dichloropyrimidine-5-carbonitrile | ESD-844169-25G |
| Cas.: 5305-45-3 | Purity: 99% | 4,6-Dichloropyrimidine-5-carbonitrile | ESD-844169-100G |
| Cas.: 1251005-45-4 | Purity: 95% | tert-Butyl 1,6-diazaspiro[3.5]nonane-1-carboxylate | ESD-883645-250MG |
| Cas.: 1251005-45-4 | Purity: 95% | tert-Butyl 1,6-diazaspiro[3.5]nonane-1-carboxylate | ESD-883645-100MG |
| Cas.: 354525-36-3 | Purity: ≥95% | (3-methoxy-5-nitrophenyl)methanol | ESD-826882-500MG |
| Cas.: 52622-27-2 | Purity: Acid value (mg KOH/g) ≤0.5, saponification value (mg KOH/g): 325～360 | 4,4′-Methylenebis(2,6-dimethylphenylcyanate) | ESD-905836-100G |
| Cas.: 9028-79-9 | Purity: ≥30 units/mg dry weight | Galactose Oxidase | ESD-915434-50U |
| Cas.: 503612-47-3 | Purity: 98% | Apixaban | ESD-844305-5G |
| Cas.: 503612-47-3 | Purity: 98% | Apixaban | ESD-844305-25G |
| Cas.: 143300-64-5 | Purity: 95% | N,N-Diethylpiperidin-4-amine | ESD-839306-25G |
| Cas.: 111-25-1 | Purity: 99% | 1-Bromohexane | ESD-802294-2.5KG |
| Cas.: 40114-49-6 | Purity: 97% | 1-Benzyl-3-piperidone | ESD-840790-5G |
| Cas.: 40114-49-6 | Purity: 97% | 1-Benzyl-3-piperidone | ESD-840790-25G |
| Cas.: 93793-83-0 | Purity: 98% | Roxatidine acetate hydrochloride | ESD-858105-25G |
| Cas.: 53101-49-8 | Purity: 98% | (R)-Trolox | ESD-912432-250MG |
| Cas.: 502-65-8 | Purity: biotech grade | Lycopene | ESD-812282-100MG |
| Cas.: 112-95-8 | Purity: AR | Eicosane | ESD-838344-2.5KG |
| Cas.: 36052-24-1 | Purity: 98% | Methyl 6-Aminocotinate | ESD-917183-100G |
| Cas.: 36052-24-1 | Purity: 98% | Methyl 6-Aminocotinate | ESD-917183-25G |
| Cas.: 36052-24-1 | Purity: 98% | Methyl 6-Aminocotinate | ESD-917183-5G |
| Cas.: 36052-24-1 | Purity: 98% | Methyl 6-Aminocotinate | ESD-917183-1G |
| Cas.: 147126-75-8 | Purity: 95% | (2S,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-843764-5G |
| Cas.: 147126-75-8 | Purity: 95% | (2S,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-843764-25G |
| Cas.: 13775-53-6 | Purity: AR, 325 Mesh, White | Sodium fluoroaluminate | ESD-917184-10KG |
| Cas.: 13775-53-6 | Purity: AR, 325 Mesh, White | Sodium fluoroaluminate | ESD-917184-2.5KG |
| Cas.: 13775-53-6 | Purity: AR, 325 Mesh, White | Sodium fluoroaluminate | ESD-917184-500G |
| Cas.: 26495-91-0 | Purity: 95% | CyclohexylaminomethylTriethoxysilane | ESD-833962-1ML |
| Cas.: 143426-50-0 | Purity: 97% | (4-(1H-1,2,4-Triazol-1-yl)phenyl)methanol | ESD-842756-100G |
| Cas.: 17351-61-0 | Purity: 95% | Tetraethylammonium hydrogencarbonate | ESD-917185-5G |
| Cas.: 17351-61-0 | Purity: 95% | Tetraethylammonium hydrogencarbonate | ESD-917185-25G |
| Cas.: 17351-61-0 | Purity: 95% | Tetraethylammonium hydrogencarbonate | ESD-917185-1G |
| Cas.: 67-07-2 | Purity: ≥92% | Creatine phosphate | ESD-916919-250MG |
| Cas.: 638-32-4 | Purity: 97% | Succinamic acid | ESD-914343-5G |
| Cas.: 638-32-4 | Purity: 97% | Succinamic acid | ESD-914343-25G |
| Cas.: 55-55-0 | Purity: AR, 99.0% | Motorol | ESD-813596-2.5KG |
| Cas.: 13739-02-1 | Purity: ≥95% (HPLC) | Diacerein | ESD-806488-25G |
| Cas.: 17739-47-8 | Purity: ≥99% | Azanylidynephosphane | ESD-859234-25G |
| Cas.: 81-21-0 | Purity: 97% | Dicyclopentadiene diepoxide | ESD-807821-1G |
| Cas.: 33050-38-3 | Purity: ≥95% | 3,6-dichloro-[1,2,4]triazolo[4,3-b]pyridazine | ESD-825130-1G |
| Cas.: 110580-44-4 | Purity: 95% | 4-Chloro-5-methyl-1H-pyrazol-3-amine | ESD-917186-1G |
| Cas.: 37220-90-9 | Purity: 99% | Silicic acid, magnesium lithium salt | ESD-916893-500G |
| Cas.: 1187830-91-6 | Purity: 98% | 1,2,4,5,6,7-Hexahydro-3H-pyrazolo[3,4-c]pyridin-3-one hydrochloride | ESD-917187-1G |
| Cas.: 1187830-91-6 | Purity: 98% | 1,2,4,5,6,7-Hexahydro-3H-pyrazolo[3,4-c]pyridin-3-one hydrochloride | ESD-917187-250MG |
| Cas.: 1187830-91-6 | Purity: 98% | 1,2,4,5,6,7-Hexahydro-3H-pyrazolo[3,4-c]pyridin-3-one hydrochloride | ESD-917187-100MG |
| Cas.: 62935-72-2 | Purity: 95% | 7-Methoxycoumarin-4-acetic acid | ESD-854754-5G |
| Cas.: 35266-49-0 | Purity: 98% | methoxycarbonyl isothiocyanate | ESD-856315-100G |
| Cas.: 35266-49-0 | Purity: 98% | methoxycarbonyl isothiocyanate | ESD-856315-25G |
| Cas.: 1860-58-8 | Purity: 98% | 3-Benzyloxyphenylacetic Acid | ESD-871185-1G |
| Cas.: 1860-58-8 | Purity: 98% | 3-Benzyloxyphenylacetic Acid | ESD-871185-5G |
| Cas.: 1313-13-9 | Purity: 99%, beta type | Manganese dioxide | ESD-916721-100G |
| Cas.: NONE6888 | Purity: 0.5M, pH9.6 | Carbonate Buffer | ESD-885538-500ML |
| Cas.: 637-04-7 | Purity: 97% | |m|-Tolylhydrazine hydrochloride | ESD-818593-500G |
| Cas.: 908846-88-8 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-fluoro-1H-indol-3-yl)propanoic acid | ESD-917188-100MG |
| Cas.: 35793-73-8 | Purity: 96% | N-Boc-D-glutamic acid 5-benzyl ester | ESD-854663-25G |
| Cas.: 35793-73-8 | Purity: 96% | N-Boc-D-glutamic acid 5-benzyl ester | ESD-854663-1G |
| Cas.: 65411-49-6 | Purity: 97% | Tetrabutylammonium methanesulfonate | ESD-917189-5G |
| Cas.: 8021-36-1 | Purity: 99% | Opoponax oil | ESD-905728-5G |
| Cas.: 155090-83-8 | Purity: particles | Poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) | ESD-917190-1G |
| Cas.: 162101-31-7 | Purity: 98% | 2-Fluoro-4-methoxybenzeneboronic acid | ESD-810035-100G |
| Cas.: 1353016-71-3 | Purity: 98% | 4-[(5-aza-3,4:7,8-dibenzocyclooctan-1-yne)-5-yl]-4-oxobutyrate-n-succinimide | ESD-905354-50MG |
| Cas.: 39053-43-5 | Purity: 95% | 1-bromo-2,4-dimethyl-3-nitrobenzene | ESD-917191-5G |
| Cas.: 39053-43-5 | Purity: 95% | 1-bromo-2,4-dimethyl-3-nitrobenzene | ESD-917191-1G |
| Cas.: 55579-68-5 | Purity: 95% | 5-(2-Chlorophenyl)cyclohexane-1,3-dione | ESD-917192-1G |
| Cas.: 61888-37-7 | Purity: 95% | 5-(4-Methylphenyl)cyclohexane-1,3-dione | ESD-917193-5G |
| Cas.: 61888-37-7 | Purity: 95% | 5-(4-Methylphenyl)cyclohexane-1,3-dione | ESD-917193-1G |
| Cas.: 61888-37-7 | Purity: 95% | 5-(4-Methylphenyl)cyclohexane-1,3-dione | ESD-917193-250MG |
| Cas.: 88-97-1 | Purity: ≥98% | Phthalamic Acid | ESD-867387-100G |
| Cas.: 1255792-05-2 | Purity: 95% | alpha-Methyl-5-methoxy-2-nitro-4-(2-propyn-1-yloxy)benzyl Alcohol | ESD-917194-1G |
| Cas.: 1255792-05-2 | Purity: 95% | alpha-Methyl-5-methoxy-2-nitro-4-(2-propyn-1-yloxy)benzyl Alcohol | ESD-917194-250MG |
| Cas.: 25372-03-6 | Purity: 98% | 4-(1H-imidazol-1-yl)benzonitrile | ESD-844381-25G |
| Cas.: 32435-46-4 | Bis[2-(methacryloyloxy)ethyl]phosphate | ESD-914177-25ML | |
| Cas.: 651735-60-3 | Purity: 96% | 8-Bromo-3,4-dihydronaphthalen-1(2H)-one | ESD-917195-1G |
| Cas.: 651735-60-3 | Purity: 96% | 8-Bromo-3,4-dihydronaphthalen-1(2H)-one | ESD-917195-250MG |
| Cas.: 345-92-6 | Purity: 99,9% | 4,4′-Difluorobenzophenone | ESD-861610-2.5KG |
| Cas.: 526-73-8 | Purity: 90% | 1,2,3-Trimethylbenzene | ESD-819371-500ML |
| Cas.: 8003-59-6 | Purity: AR | Acid Red 9 | ESD-867278-25G |
| Cas.: 870195-94-1 | Purity: 98% | 2-(2-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-841335-25G |
| Cas.: 6574-99-8 | Purity: 97% | 3,4-Dichlorobenzonitrile | ESD-807901-500G |
| Cas.: 500789-00-4 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid | ESD-917196-100MG |
| Cas.: 505-95-3 | Purity: ≥97% | 12-Hydroxydodecanoic acid | ESD-838024-25G |
| Cas.: 1349807-46-0 | Purity: 95% | FMoc-n-me-d-cys(trt)-oh | ESD-917197-100MG |
| Cas.: 58052-48-5 | Purity: ≥98% | Pyridoxamine Dihydrochloride Monohydrate | ESD-866236-5G |
| Cas.: 59323-54-5 | Purity: ≥97.0% (HPLC), Use For Fluorescence Analyze | 1-Pyrenesulfonic acid sodium salt | ESD-916436-1G |
| Cas.: 61790-57-6 | Purity: >98% | Cocoamine acetate | ESD-916361-25G |
| Cas.: 355408-55-8 | Purity: 98% | 5,5-Dimethyl-2-(thiophen-2-yl)-1,3,2-dioxaborinane | ESD-886371-25G |
| Cas.: 79-92-5 | Purity: 95% | Camphene | ESD-804855-5G |
| Cas.: 66246-88-6 | Purity: 98% | 1-(2-(2,4-Dichlorophenyl)pentyl)-1H-1,2,4-triazole | ESD-916566-1G |
| Cas.: 66246-88-6 | Purity: 98% | 1-(2-(2,4-Dichlorophenyl)pentyl)-1H-1,2,4-triazole | ESD-916566-5G |
| Cas.: 66246-88-6 | Purity: 98% | 1-(2-(2,4-Dichlorophenyl)pentyl)-1H-1,2,4-triazole | ESD-916566-25G |
| Cas.: 88641-55-8 | Purity: 97% | Tetrabutylammonium chloride hydrate | ESD-899797-500G |
| Cas.: 1197020-22-6 | Purity: 98% | (S)-2-(Fmoc-amino)heptanoic acid | ESD-917198-1G |
| Cas.: 868540-17-4 | Purity: 99% | Carfilzomib | ESD-858149-1G |
| Cas.: 9066-59-5 | Purity: from protein | Lysozyme Chloride | ESD-862114-25G |
| Cas.: 220497-64-3 | Purity: 98% | (1S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopent-2-enecarboxylic acid | ESD-917199-100MG |
| Cas.: 143415-31-0 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-cyclopentylpropanoic acid | ESD-917200-100MG |
| Cas.: 151144-96-6 | Purity: 98% | (S)-2-Amino-4-bromopent-4-enoic acid | ESD-917201-100MG |
| Cas.: 85227-98-1 | Purity: 97% | H-Pro-Asp-OH | ESD-917202-100MG |
| Cas.: 10314-35-9 | Purity: ≥95% | Cyclohexylsulfamoyl Chloride | ESD-851500-250MG |
| Cas.: 18441-43-5 | Purity: 97% | 5-Methylbenzofuran | ESD-852423-250MG |
| Cas.: 873651-92-4 | Purity: ≥95% | 5-Amino-2-(hydroxymethyl)pyridine | ESD-852653-250MG |
| Cas.: 2824-57-9 | Purity: 98% | Methyl N-acetyl-L-tryptophanate | ESD-917203-1G |
| Cas.: 90028-66-3 | Purity: 9%-10% gamma-linolenic acid | Evening primrose oil | ESD-905737-2.5KG |
| Cas.: 143334-20-7 | Purity: ≥95% | Graphic Carbon Nitride | ESD-862685-1G |
| Cas.: 143334-20-7 | Purity: ≥95% | Graphic Carbon Nitride | ESD-862685-5G |
| Cas.: 7098-22-8 | Purity: ≥97% | Tetratetracontane | ESD-867619-500MG |
| Cas.: 909122-14-1 | Purity: ≥97% | 1-Bromo-3-Chloro-4-Ethoxy-2-Fluorobenzene | ESD-857455-250MG |
| Cas.: 18190-44-8 | Purity: 97% | N-(2-Hydroxyethyl)succinimide | ESD-858425-25G |
| Cas.: 1073372-02-7 | Purity: 95% | Methyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate | ESD-917204-100MG |
| Cas.: 1646171-78-9 | Purity: >99% | Propylammonium Lead Iodide | ESD-904411-1G |
| Cas.: 256222-08-9 | Purity: >99% | Phenmethylammonium Lead | ESD-904413-1G |
| Cas.: 131457-08-4 | Purity: >99% | Phenethylammonium Lead Iodide | ESD-904414-1G |
| Cas.: 131457-16-4 | Purity: >99% | 2-phenylethylammonium lead bromide | ESD-904416-1G |
| Cas.: 930-33-6 | Purity: ≥97% | 1,2-Dihydro-3H-1,2,4-triazole-3-one | ESD-851452-100G |
| Cas.: 930-33-6 | Purity: ≥97% | 1,2-Dihydro-3H-1,2,4-triazole-3-one | ESD-851452-500G |
| Cas.: 183070-44-2 | Purity: 98% | Fmoc-P-carboxy-Phe(OtBu)-OH | ESD-917205-100MG |
| Cas.: 40691-33-6 | Purity: 95% | Bis(tri-o-tolylphosphine)palladium(II) Dichloride | ESD-823802-5G |
| Cas.: 34839-14-0 | Purity: 97% | (R)-1-Amino-3-chloropropan-2-ol hydrochloride | ESD-898491-5G |
| Cas.: 205391-01-1 | Purity: ≥95% | DAF-2 (4,5-Diaminofluorescein) | ESD-912053-5MG |
| Cas.: 853645-22-4 | Purity: ≥98% | Pyridoxal 5′-phosphate hydrate | ESD-864011-100G |
| Cas.: 558-57-6 | Purity: ≥98% | 1,2-Dibromo-1,1-dichloro-2,2-difluoroethane | ESD-857422-500G |
| Cas.: 60676-86-0 | Purity: 3.0-5.0mm, for Element Analyzer | Quartz chips | ESD-818473-500G |
| Cas.: 1884220-36-3 | Purity: 98% | SBI-0206965 | ESD-873878-5MG |
| Cas.: 205391-01-1 | Purity: 98% | DAF-2 (DMSO solution) | ESD-917206-100ΜG |
| Cas.: 247127-51-1 | Purity: 98% | Fmoc-Dap(Dde)-OH | ESD-917207-250MG |
| Cas.: 106536-48-5 | Purity: 95% | 1-(2-Bromoethyl)pyrrolidine hydrochloride | ESD-845168-1G |
| Cas.: 1345-07-9 | Purity: 99.99% metals basis | Bismuth(III) sulfide | ESD-888697-100G |
| Cas.: 12068-69-8 | Purity: 99.999% metals basis | Bismuth selenide | ESD-888767-25G |
| Cas.: 868-77-9 | Purity: 96%, contains 250ppmMEHQstabilizer | 2-Hydroxyethyl methacrylate | ESD-810856-2.5KG |
| Cas.: 12068-69-8 | Purity: 99.999% metals basis | Bismuth selenide | ESD-888767-100G |
| Cas.: 1634-82-8 | Purity: ≥98%(HPLC)(T) | 4′-Hydroxyazobenzene-2-carboxylic Acid [Matrix for MALDI-TOF|MS] | ESD-861923-100G |
| Cas.: 421-85-2 | Purity: 98% | TRIFLUOROMETHANESULFONAMIDE | ESD-831195-100G |
| Cas.: 13669-76-6 | Purity: BF3: 40% | Bobon trifluoride phosphoric acid complex | ESD-915114-5G |
| Cas.: 13669-76-6 | Purity: BF3: 40% | Bobon trifluoride phosphoric acid complex | ESD-915114-1G |
| Cas.: 7758-95-4 | Purity: AR, 99.5% | Lead chloride | ESD-812468-100G |
| Cas.: 1236208-20-0 | Purity: >98% | Leucomethylene blue Mesylate | ESD-860516-50MG |
| Cas.: 87915-38-6 | Purity: average mol wt 500,000 | Blue Dextran | ESD-915117-1G |
| Cas.: 76931-93-6 | Purity: >94.0%(GC) | S-Acetylthioglycolic acid N-hydroxysuccinimide ester | ESD-861728-1G |
| Cas.: 116611-64-4 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1H-imidazol-4-yl)propanoic acid | ESD-843977-25G |
| Cas.: 86-59-9 | Purity: 98% | 8-Quinolinecarboxylic acid | ESD-817185-25G |
| Cas.: 21907-50-6 | Purity: 99% | Cesium trifluoroacetate | ESD-836324-5G |
| Cas.: 1472068-56-6 | Purity: >99% | CH3NH3PbICl2(MAPbICl2 )Methylammonium Lead Chloride Iodide | ESD-853816-250MG |
| Cas.: 7567-63-7 | Purity: ≥97% | 1,3,5-Triethynylbenzene | ESD-836736-25G |
| Cas.: 9004-34-6 | Purity: Diameter: 50nm, Length: 1~3μm, 6% dispersion (solvent is water) | Carboxylated cellulose nanofibers | ESD-916570-100G |
| Cas.: 4540-33-4 | Purity: 95% | Piperidin-1-ium acetate | ESD-844334-500G |
| Cas.: 301-02-0 | Purity: ≥98% | Oleamide | ESD-875680-2.5KG |
| Cas.: 2731-06-8 | Purity: 98% | 2-(2-Methyl-1H-indol-3-yl)ethanamine | ESD-829805-25G |
| Cas.: 1671-08-5 | Purity: 95% | 5-Methoxy-2-(methylthio)pyrimidin-4(3H)-one | ESD-852240-250MG |
| Cas.: 1671-08-5 | Purity: 95% | 5-Methoxy-2-(methylthio)pyrimidin-4(3H)-one | ESD-852240-5G |
| Cas.: 2557-81-5 | Purity: ≥98% | Phenylsulfur Pentafluoride | ESD-867707-1G |
| Cas.: NONE8250 | Purity: 10000× | Gel-Green DNA Stain | ESD-917208-200ΜL |
| Cas.: NONE8250 | Purity: 10000× | Gel-Green DNA Stain | ESD-917208-500ΜL |
| Cas.: 4685-12-5 | Purity: ≥98% | H-Gly-Asp-OH | ESD-859147-250MG |
| Cas.: 216394-07-9 | Purity: 98% | (1S,2S)-(+)-2-Benzyloxycyclohexylamine | ESD-828527-5G |
| Cas.: NONE6591 | Purity: Serum Free, contains DMSO | Cryogenic Cell Stroing Medium (Serum-Free,with DMSO) | ESD-917212-10X2ML |
| Cas.: NONE6591 | Purity: Serum Free, contains DMSO | Cryogenic Cell Stroing Medium (Serum-Free,with DMSO) | ESD-917212-50ML |
| Cas.: 64090-98-8 | Purity: 98% | 3-(3-Pyridyl)-alanine(Free state) | ESD-816743-1G |
| Cas.: 18361-03-0 | Purity: >95% | 3,4-Ethylenedioxythiophene-2,5-dicarboxylic Acid | ESD-835258-5G |
| Cas.: 18361-03-0 | Purity: >95% | 3,4-Ethylenedioxythiophene-2,5-dicarboxylic Acid | ESD-835258-25G |
| Cas.: NONE8244 | Purity: 0.1-2kb, 6 bands | DNA Ladder | ESD-917217-250ΜL |
| Cas.: 859299-66-4 | Purity: 98% | 4,5-dibromophthalic acid dimethyl ester | ESD-856516-250MG |
| Cas.: 859299-66-4 | Purity: 98% | 4,5-dibromophthalic acid dimethyl ester | ESD-856516-1G |
| Cas.: NONE8237 | Endonuclease DpnI | ESD-917209-1KU | |
| Cas.: NONE8237 | Endonuclease DpnI | ESD-917209-2KU | |
| Cas.: NONE6591 | Purity: Serum Free, contains DMSO | Cryogenic Cell Stroing Medium (Serum-Free,with DMSO) | ESD-917212-2X50ML |
| Cas.: NONE8245 | Purity: 0.1-1.5kb, 11 bands | DNA Ladder | ESD-917218-250ΜL |
| Cas.: NONE8238 | Endonuclease EcoRI | ESD-917210-12KU | |
| Cas.: NONE8238 | Endonuclease EcoRI | ESD-917210-24KU | |
| Cas.: NONE8246 | Purity: 0.25-15kb, 7 bands | DNA Ladder | ESD-917219-250ΜL |
| Cas.: NONE8251 | Purity: No HEPES, L-Glutamine, Phenol Red | RPMI 1640 Medium | ESD-917220-500ML |
| Cas.: NONE8239 | Endonuclease HindIII | ESD-917211-10KU | |
| Cas.: NONE8239 | Endonuclease HindIII | ESD-917211-20KU | |
| Cas.: NONE8247 | Purity: 1-10kb, 8 bands | DNA Ladder | ESD-917221-250ΜL |
| Cas.: NONE8252 | Endonuclease SacII | ESD-917222-1000U | |
| Cas.: NONE8252 | Endonuclease SacII | ESD-917222-2000U | |
| Cas.: NONE8248 | Purity: 0.1-10kb, 13 bands | DNA Ladder | ESD-917223-250ΜL |
| Cas.: NONE8240 | Endonuclease KpnI | ESD-917213-4KU | |
| Cas.: NONE8240 | Endonuclease KpnI | ESD-917213-8KU | |
| Cas.: NONE8249 | Purity: 0.1-5kb, 8 bands | DNA Ladder | ESD-917226-250ΜL |
| Cas.: NONE8253 | Endonuclease SpeI | ESD-917224-1000U | |
| Cas.: NONE8253 | Endonuclease SpeI | ESD-917224-2000U | |
| Cas.: NONE8254 | Endonuclease FspI | ESD-917225-1000U | |
| Cas.: NONE8255 | Cell Counting Kit-8 | ESD-917227-5X100T/EA | |
| Cas.: NONE8241 | Endonuclease NdeI | ESD-917214-400U | |
| Cas.: NONE8241 | Endonuclease NdeI | ESD-917214-4KU | |
| Cas.: NONE8241 | Endonuclease NdeI | ESD-917214-8KU | |
| Cas.: NONE8242 | Endonuclease SacI | ESD-917215-2KU | |
| Cas.: NONE8242 | Endonuclease SacI | ESD-917215-4KU | |
| Cas.: 17103-52-5 | Purity: >95% | Sulfamethoxazole EP Impurity F | ESD-917228-5MG |
| Cas.: 17103-52-5 | Purity: >95% | Sulfamethoxazole EP Impurity F | ESD-917228-25MG |
| Cas.: 17103-52-5 | Purity: >95% | Sulfamethoxazole EP Impurity F | ESD-917228-50MG |
| Cas.: NONE8243 | Endonuclease XhoI | ESD-917216-2KU | |
| Cas.: NONE8243 | Endonuclease XhoI | ESD-917216-10KU | |
| Cas.: NONE8243 | Endonuclease XhoI | ESD-917216-20KU | |
| Cas.: 66492-51-1 | Purity: ≥98%(GC) | Acrylic Acid (5-Ethyl-1,3-dioxan-5-yl)methyl Ester (stabilized with MEHQ) | ESD-862557-500G |
| Cas.: 5422-44-6 | Purity: 98% | 5-Amino-1-methyltetrazole | ESD-834934-500G |
| Cas.: 28721-07-5 | Purity: 98% | Oxcarbazepine | ESD-815153-100G |
| Cas.: 22306-37-2 | Purity: ≥99.99% | Bismuth(III) acetate | ESD-838660-25G |
| Cas.: 23194-93-6 | Purity: 98% | 5,6-Dihydrodibenzo[b,f]azocine | ESD-917229-100MG |
| Cas.: 2650-50-2 | Purity: ≥98% | Trimethylpropylammonium Bromide | ESD-867558-100G |
| Cas.: 668270-12-0 | Purity: 98% | Linagliptin | ESD-843952-25G |
| Cas.: 668270-12-0 | Purity: 98% | Linagliptin | ESD-843952-5G |
| Cas.: 872205-11-3 | Purity: 97% | 9-Mesiyl-10-methylacridin-10-ium hexafluorophosphate(V) | ESD-917230-100MG |
| Cas.: 552309-42-9 | Purity: 97% | T16Ainh-A01 | ESD-873371-5MG |
| Cas.: 552309-42-9 | Purity: 97% | T16Ainh-A01 | ESD-873371-25MG |
| Cas.: 1442433-71-7 | Purity: 97% | 9-Mesiyl-10-methylacridin-10-ium tetrafluoroborate | ESD-917231-100MG |
| Cas.: 547-25-1 | Purity: biotech grade | D-Turanose | ESD-6188-5G |
| Cas.: 32647-67-9 | Purity: 98% | 1,3:2,4 – Dibenzylidene Sorbitol | ESD-914775-500G |
| Cas.: 35059-50-8 | Purity: ≥80% | tert-Butyl diazoacetate | ESD-863584-5G |
| Cas.: 7699-41-4 | Purity: AR | Silicic Acid Hydrate | ESD-902508-2.5KG |
| Cas.: 636-09-9 | Purity: ≥98.0% | Diethyl Terephthalate | ESD-864507-500G |
| Cas.: 1075705-01-9 | Purity: 98% | 4-Fluoro-2-methoxy-5-nitroaniline | ESD-856981-100G |
| Cas.: 1075705-01-9 | Purity: 98% | 4-Fluoro-2-methoxy-5-nitroaniline | ESD-856981-5G |
| Cas.: 2054779-48-3 | Purity: 97% | 3,6-Di-tert-butyl-9-mesityl-10-methylacridin-10-ium tetrafluoroborate | ESD-917232-100MG |
| Cas.: 19438-64-3 | Purity: 95% | 6-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione | ESD-915857-1KG |
| Cas.: 927-58-2 | Purity: 95% | 4-Bromobutyryl chloride | ESD-802027-100G |
| Cas.: 1810004-87-5 | Purity: 97% | 3,6-Di-tert-butyl-9-mesityl-10-phenylacridin-10-ium tetrafluoroborate | ESD-917233-100MG |
| Cas.: 608141-41-9 | Purity: 98%, | Apremilast | ESD-857891-1G |
| Cas.: 252881-76-8 | Purity: 95% | BIOtin-peg3-acid | ESD-917234-100MG |
| Cas.: 68578-79-0 | Purity: 97% | 4-[2-(4-hydroxyphenyl)-1,2-diphenylehenyl]phenol | ESD-828252-5G |
| Cas.: 1374666-32-6 | Purity: >98.0%(HPLC) | Mal-PEG2-acid | ESD-917235-50MG |
| Cas.: 113104-25-9 | Purity: 99% | NSC228155 | ESD-872619-25MG |
| Cas.: 113104-25-9 | Purity: 99% | NSC228155 | ESD-872619-100MG |
| Cas.: 518044-40-1 | Purity: 99% | Maleimido-Tri(Ethylene Glycol)-Propionic Acid | ESD-917236-100MG |
| Cas.: 24463-19-2 | Purity: 98% | 9-(Chloromethyl)anthracene | ESD-823113-100G |
| Cas.: 593-04-4 | Purity: BF3: 30.0 – 35.0 % | Boron trifluoride dibutyl etherate | ESD-822336-2.5L |
| Cas.: 1433997-01-3 | Purity: 98% | Mal-PEG2-NHS Ester | ESD-917237-250MG |
| Cas.: 169332-61-0 | Purity: ≥99% | Ac-DEVD-AMC | ESD-881543-25MG |
| Cas.: 9014-85-1 | Purity: average Mn ~670, average Mw ~700 | 2,4,7,9-Tetramethyl-5-decyne-4,7-diol ethoxylate | ESD-864203-500ML |
| Cas.: 1325208-25-0 | Purity: 95% | MEL-Tetra-EG-Osu | ESD-917238-50MG |
| Cas.: 2226-96-2 | Purity: 98% | 4-Hydroxy-TEMPO | ESD-810914-2.5KG |
| Cas.: 34598-33-9 | Purity: ≥97%(GC)(T) | 2H,2H,3H,3H-Heptadecafluoroundecanoic Acid | ESD-863131-5G |
| Cas.: 756525-98-1 | Purity: 98% | Mal-amido-PEG2-C2-acid | ESD-917239-100MG |
| Cas.: 69430-36-0 | Purity: 5%water solution | Keratin (5% in Water) | ESD-862558-500G |
| Cas.: 1099-87-2 | Purity: 98% | Sodium prasterone sulfate | ESD-830012-25MG |
| Cas.: 1780-40-1 | Purity: 98% | 2,4,5,6-Tetrachloropyrimidine | ESD-839944-100G |
| Cas.: 2055353-75-6 | Purity: 95% | Mal-amido-PEG3-acid | ESD-917240-100MG |
| Cas.: 14484-69-6 | Purity: CP | Potassium fluoroaluminate | ESD-829612-10KG |
| Cas.: 2418-14-6 | Purity: ≥98% | Dimercaptosuccinic Acid | ESD-859771-100G |
| Cas.: 1137109-21-7 | Purity: 95% | 4,7,10,13,16,19-Hexaoxa-22-azapentacosanoic acid, 25-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-23-oxo-, 2, 5-dioxo-1-pyrrolidinyl ester | ESD-917241-100MG |
| Cas.: 756526-02-0 | Purity: 98% | 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester | ESD-837181-250MG |
| Cas.: 682-09-7 | Purity: ≥85%, contains mono- and tri-substitutions | 2,2-Bis(allyloxymethyl)-1-butanol | ESD-865732-2.5KG |
| Cas.: 652-36-8 | Purity: 97% | Tetrafluoroterephthalic Acid | ESD-838792-25G |
| Cas.: 652-36-8 | Purity: 97% | Tetrafluoroterephthalic Acid | ESD-838792-100G |
| Cas.: 2139348-63-1 | Purity: 95% | Pomalidomide 4′-PEG5-acid | ESD-917242-50MG |
| Cas.: 6439-57-2 | Purity: >95.0%(GC) | Monobutyl Itaconate | ESD-863911-100G |
| Cas.: 2267306-14-7 | Purity: 95% | Pomalidomide-PEG2-azide | ESD-917243-50MG |
| Cas.: 106-91-2 | Purity: 97%, contains 100ppmMEHQstabilizer | Glycidyl methacrylate | ESD-810427-2.5KG |
| Cas.: 5799-76-8 | Purity: 97% | 4-(Prop-2-yn-1-yl)morpholine | ESD-848235-5G |
| Cas.: 5799-76-8 | Purity: 97% | 4-(Prop-2-yn-1-yl)morpholine | ESD-848235-25G |
| Cas.: 51311-17-2 | Purity: 99% | Graphite Fluoride | ESD-888822-25G |
| Cas.: 13114-27-7 | Purity: Plant cell culture grade, 99% | ZEATIN MIXED ISOMERS-PLANT CELL CULTURE TESTED | ESD-832335-250MG |
| Cas.: 13114-27-7 | Purity: Plant cell culture grade, 99% | ZEATIN MIXED ISOMERS-PLANT CELL CULTURE TESTED | ESD-832335-5G |
| Cas.: 59414-23-2 | Purity: ≥95%(GC) | 1-Methoxy-3-(trimethylsilyloxy)-1,3-butadiene | ESD-863287-1ML |
| Cas.: 102696-71-9 | Purity: 97% | (E)-3-(Thiophen-3-yl)acrylic acid | ESD-887984-25G |
| Cas.: 18355-96-9 | Purity: 98% | (3-(Dimethylamino)propyl)triphenylphosphonium bromide | ESD-832770-1G |
| Cas.: 672-89-9 | Purity: ≥98% | 4-Methoxy-6-Methyl-2H-Pyran-2-One | ESD-858025-5G |
| Cas.: 19780-94-0 | Purity: 97% | Dimethyl 2-Methyladipate | ESD-857173-5G |
| Cas.: 19780-94-0 | Purity: 97% | Dimethyl 2-Methyladipate | ESD-857173-1G |
| Cas.: 205194-33-8 | Purity: ≥98%(GC) | 4-(3-Hydroxypropyl)thiomorpholine 1,1-Dioxide | ESD-863108-1G |
| Cas.: 63422-71-9 | Purity: 97% | (R)-α-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]benzeneacetic Acid | ESD-838068-1G |
| Cas.: 353245-99-5 | Purity: 95% | Fmoc-β-HomoThr(tBu)-OH | ESD-917244-100MG |
| Cas.: 76410-58-7 | Purity: ≥98% | 4-Borono-L-phenylalanine | ESD-887324-100MG |
| Cas.: 22047-49-0 | Purity: 98%, mixture of isomers | 2-Ethylhexyl stearate | ESD-917245-5G |
| Cas.: 18323-44-9 | Purity: 99% | Clindamycin | ESD-873783-250MG |
| Cas.: 22047-49-0 | Purity: 98%, mixture of isomers | 2-Ethylhexyl stearate | ESD-917245-25G |
| Cas.: 22047-49-0 | Purity: 98%, mixture of isomers | 2-Ethylhexyl stearate | ESD-917245-100G |
| Cas.: 22047-49-0 | Purity: 98%, mixture of isomers | 2-Ethylhexyl stearate | ESD-917245-500G |
| Cas.: 6338-55-2 | Purity: 97% | 2-(2-(2-Aminoethoxy)ethoxy)ethanol | ESD-839898-25G |
| Cas.: 57616-69-0 | Purity: ≥95% | N-(3-Chloropropyl)pyrrolidine Hydrochloride | ESD-852700-25G |
| Cas.: 905-99-7 | Purity: ≥98% | Cryptochlorogenic acid | ESD-917247-100MG |
| Cas.: 103-20-8 | Purity: ≥98% | 7-Ethyl-2-methyl-4-undecanol | ESD-865922-5ML |
| Cas.: 7158-32-9 | Purity: 98% | 4,4′-Oxybis(benzoyl Chloride) | ESD-834779-100G |
| Cas.: 7158-32-9 | Purity: 98% | 4,4′-Oxybis(benzoyl Chloride) | ESD-834779-500G |
| Cas.: 7727-73-3 | Purity: AR, ≥99.0% | Sodium sulfafe decahydrate | ESD-817927-10KG |
| Cas.: 76704-05-7 | Purity: 98% | (+)-Corey lactone Diol | ESD-850011-5G |
| Cas.: 5753-26-4 | Purity: 97% | 1-(2-Chloroethyl)-4-methylpiperazine dihydrochloride | ESD-848348-5G |
| Cas.: 530-57-4 | Purity: 98% | Syringic acid | ESD-817529-250G |
| Cas.: 142289-08-5 | Purity: 99,5% | 4,4′-Bis(2,2-diphenylvinyl)biphenyl | ESD-857316-5G |
| Cas.: 142289-08-5 | Purity: 99,5% | 4,4′-Bis(2,2-diphenylvinyl)biphenyl | ESD-857316-1G |
| Cas.: 142289-08-5 | Purity: 99,5% | 4,4′-Bis(2,2-diphenylvinyl)biphenyl | ESD-857316-200MG |
| Cas.: 1008-75-9 | Purity: 97% | 3-METHYL-5-PHENYLISOXAZOLE | ESD-833420-1G |
| Cas.: 1009307-13-4 | Purity: ≥95% | (E)-ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate | ESD-825050-1G |
| Cas.: 79757-77-0 | Purity: ≥95% | (4-Bromo-2-thienyl)methanol | ESD-852640-5G |
| Cas.: 5813-86-5 | Purity: 98% | 3-Methoxybenzamide | ESD-858506-1G |
| Cas.: 4362-40-7 | Purity: 97% | 4-Chloromethyl-2,2-dimethyl-1,3-dioxolane | ESD-838030-1G |
| Cas.: 547-75-1 | Purity: ≥95% | Hyocholic Acid | ESD-915265-500G |
| Cas.: 210992-28-2 | Purity: ≥95% | 3-Amino-5-fluorobenzonitrile | ESD-917249-1G |
| Cas.: 14807-96-6 | Purity: 5000 Mesh | Talc | ESD-823199-100G |
| Cas.: 32943-25-2 | Purity: 99% | 3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine | ESD-854747-5G |
| Cas.: 382148-47-2 | Purity: Analysis control, ≥98%(HPLC) | Bacopaside I | ESD-917250-5MG |
| Cas.: 382148-47-2 | Purity: Analysis control, ≥98%(HPLC) | Bacopaside I | ESD-917250-20MG |
| Cas.: 32943-25-2 | Purity: 99% | 3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine | ESD-854747-1G |
| Cas.: 116751-24-7 | Purity: 98,5% | 3-Hydroxy-2,4,5-trifluorobenzoic acid | ESD-830626-25G |
| Cas.: 116751-24-7 | Purity: 98,5% | 3-Hydroxy-2,4,5-trifluorobenzoic acid | ESD-830626-1G |
| Cas.: 61563-43-7 | Purity: ≥95% | Isoquinoline-8-carboxylic acid | ESD-825212-250MG |
| Cas.: 2657-25-2 | Purity: 97% | 4′-Hydroxychalcone | ESD-856312-100G |
| Cas.: 2657-25-2 | Purity: 97% | 4′-Hydroxychalcone | ESD-856312-25G |
| Cas.: 2657-25-2 | Purity: 97% | 4′-Hydroxychalcone | ESD-856312-5G |
| Cas.: 2657-25-2 | Purity: 97% | 4′-Hydroxychalcone | ESD-856312-1G |
| Cas.: 537-92-8 | Purity: 98% | 3′-Methylacetanilide | ESD-830203-100G |
| Cas.: 157408-08-7 | Purity: Analysis control, ≥98%(HPLC) | Bacoside A3 | ESD-917251-10MG |
| Cas.: 38212-30-5 | Purity: 97% | 1-(4-Methoxyphenyl)piperazine | ESD-814460-100G |
| Cas.: 382146-66-9 | Purity: Analysis control, ≥98%(HPLC) | Bacopaside II | ESD-917252-10MG |
| Cas.: 51-43-4 | Purity: 98% | (-)-Epinephrine | ESD-917253-5G |
| Cas.: 51-43-4 | Purity: 98% | (-)-Epinephrine | ESD-917253-1G |
| Cas.: 51-43-4 | Purity: 98% | (-)-Epinephrine | ESD-917253-25G |
| Cas.: 178064-13-6 | Purity: Analysis control, ≥98%(HPLC) | Bacopasaponin C | ESD-917254-10MG |
| Cas.: 1446121-07-8 | Purity: >99% | Methylammonium lead Chloride Iodide | ESD-853817-250MG |
| Cas.: 21535-47-7 | Purity: ≥98% | Mianserin HCl | ESD-832932-5G |
| Cas.: 100643-27-4 | Purity: 97% | 2,6-Diaminopyrimidin-4-ol | ESD-848517-500G |
| Cas.: 94443-88-6 | Purity: Analysis control, ≥98%(HPLC) | Bacopaside VII | ESD-917255-10MG |
| Cas.: 1071-99-4 | Purity: AR | O-(3-sulfanylpropyl)hydroxylamine | ESD-873998-50MG |
| Cas.: 479066-09-6 | Purity: 98% | Methylammonium Lead Chloride Bromide | ESD-904405-1G |
| Cas.: 1279123-64-6 | Purity: 95% | Potassium (chloromethyl)trifluoroborate | ESD-905246-25G |
| Cas.: 537-42-8 | Purity: 97% | Pterostilbene | ESD-815985-100G |
| Cas.: 101990-73-2 | Purity: 97% | 2-Chloro-4-(chloromethyl)pyridine | ESD-844308-5G |
| Cas.: 908350-80-1 | Purity: 95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | ESD-845785-5G |
| Cas.: 936224-52-1 | Purity: 50μg in 500μL Ethanol | DEPMPO-biotin solution | ESD-917256-1EA |
| Cas.: 112918-82-8 | Purity: 98% | Fmoc-Ida-OH | ESD-917257-5G |
| Cas.: 865-21-4 | Purity: ≥98% | Vinblastine | ESD-861369-100MG |
| Cas.: 881-95-8 | Purity: >95% | rac Metanephrine Hydrochloride Salt | ESD-849450-10MG |
| Cas.: 138529-46-1 | Purity: 97% | Biotin-PEG2-Amine | ESD-863625-10MG |
| Cas.: 3575-80-2 | Purity: ≥95% | Melperone | ESD-868409-100MG |
| Cas.: 91366-65-3 | Purity: ≥98% | ABD-F [=4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for Determination of Thiols] | ESD-861780-25MG |
| Cas.: 211859-73-3 | Purity: 97% | 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-amine | ESD-833234-250MG |
| Cas.: 211859-73-3 | Purity: 97% | 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-amine | ESD-833234-100MG |
| Cas.: 948995-62-8 | Purity: ≥96% | Succinimidyl 4-[3,5-Dimethyl-4-(4-nitrobenzyloxy)phenyl]-4-oxobutyrate | ESD-861783-25MG |
| Cas.: 139243-55-3 | Purity: 96% | (S)-Methyl 3-aminobutanoate hydrochloride | ESD-917258-1G |
| Cas.: 608141-41-9 | Purity: 98%, | Apremilast | ESD-857891-5G |
| Cas.: 24165-03-5 | Purity: ≥96% | Triphenylmethanesulfenyl Chloride | ESD-868050-5G |
| Cas.: 170643-02-4 | Purity: 98% | Fmoc-D-Allo-Thr(tBu)-OH | ESD-917259-100MG |
| Cas.: 1380437-47-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3′-chloro-[1,1′-biphenyl]-4-yl)propanoic acid | ESD-917260-100MG |
| Cas.: 41593-58-2 | Purity: 98% | Borane diphenylphosphine complex | ESD-857084-250MG |
| Cas.: 1079-02-3 | Purity: ≥99 atom % D, ≥99% (CP) | Benzoic-d5 acid | ESD-874685-250MG |
| Cas.: 944904-66-9 | Purity: 95% | 2-(6-Bromo-1H-indazol-3-yl)acetic acid | ESD-917261-100MG |
| Cas.: 61-73-4 | Purity: 0,2% | Methylene Blue Solution | ESD-917262-250ML |
| Cas.: 61-73-4 | Purity: 0,1% | Methylene Blue Solution | ESD-917263-250ML |
| Cas.: 81306-93-6 | Purity: 95% | (R)-3-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-917264-1G |
| Cas.: 61-73-4 | Purity: 1% | Methylene Blue Solution | ESD-917265-250ML |
| Cas.: 101-53-1 | Purity: ≥98%(GC) | 4-Benzylphenol | ESD-863038-100G |
| Cas.: 61-73-4 | Purity: 0,05% | Methylene Blue Solution | ESD-917266-250ML |
| Cas.: 551-68-8 | Purity: 98% | D-Psicose | ESD-816951-5G |
| Cas.: 551-68-8 | Purity: 98% | D-Psicose | ESD-816951-25G |
| Cas.: 597-12-6 | Purity: >98% | D-(+)-Melezitose | ESD-860556-1G |
| Cas.: 64-17-5 | Purity: 99,7% | Ethanol | ESD-809062-2.5L |
| Cas.: 31098-20-1 | Purity: 98% | 3-Sulfopropyl Acrylate Potassium Salt | ESD-869784-100G |
| Cas.: 210282-32-9 | Purity: 98% | Fmoc-Phe(2-I)-OH | ESD-917268-100MG |
| Cas.: 4452-61-3 | Purity: mixture of oligomers, 98% | Gallium(III) isopropoxide | ESD-836527-250MG |
| Cas.: 281655-37-6 | Purity: 95% | (S)-4-(((9H-Fluoren-9-yl)methoxy)carbonyl)morpholine-3-carboxylic acid | ESD-917269-100MG |
| Cas.: 120-73-0 | Purity: ≥98% | Purine | ESD-835373-5G |
| Cas.: 270263-03-1 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)hex-5-enoic acid | ESD-917270-100MG |
| Cas.: 50632-57-0 | Purity: ≥98%(HPLC) | 2-Methoxy-2,4-diphenyl-3(2H)-furanone | ESD-861842-250MG |
| Cas.: 131-70-4 | Purity: 98% | mono-n-butyl ester | ESD-814384-25G |
| Cas.: 512-66-3 | Purity: ≥98% | Xylosucrose | ESD-868085-500MG |
| Cas.: 272442-27-0 | Purity: ≥95% | 5-Benzyl-4,5,6,7-tetrahydro-5-azaindole | ESD-853044-250MG |
| Cas.: 272442-27-0 | Purity: ≥95% | 5-Benzyl-4,5,6,7-tetrahydro-5-azaindole | ESD-853044-50MG |
| Cas.: 1031351-95-7 | Purity: ≥95% | Methyl 3-formyl-1-methyl-1H-pyrazole-5-carboxylate | ESD-826884-250MG |
| Cas.: 1031351-95-7 | Purity: ≥95% | Methyl 3-formyl-1-methyl-1H-pyrazole-5-carboxylate | ESD-826884-100MG |
| Cas.: 131833-90-4 | Purity: 95% | Bis[(S)-4-isopropyl-4,5-dihydrooxazol-2-yl]methane | ESD-853748-250MG |
| Cas.: 1418117-90-4 | Purity: ≥97% | 2-(Aminomethyl)-5-nitrothiophene Hydrochloride | ESD-852059-250MG |
| Cas.: 1418117-90-4 | Purity: ≥97% | 2-(Aminomethyl)-5-nitrothiophene Hydrochloride | ESD-852059-50MG |
| Cas.: 1620128-54-2 | Purity: 95% | Methyl cis-1-Boc-4-aminopiperidine-3-carboxylate | ESD-850559-250MG |
| Cas.: 1620128-54-2 | Purity: 95% | Methyl cis-1-Boc-4-aminopiperidine-3-carboxylate | ESD-850559-50MG |
| Cas.: 203869-80-1 | Purity: 98% | 1-Boc-2-methyl-DL-proline | ESD-917271-1G |
| Cas.: 18851-33-7 | Purity: 97% | 1,10-Phenanthroline hydrochloride monohydrate | ESD-815543-100G |
| Cas.: 629-98-1 | Purity: ≥98% | cis-13-Docosenol | ESD-866128-5G |
| Cas.: 147959-18-0 | Purity: ≥97% | (S)-N-Boc-4-(2-hydroxyethyl)-2,2-dimethyloxazolidine | ESD-852656-100MG |
| Cas.: 43088-64-8 | Purity: 97% | 5-Methyl-3,4-Dihydrothieno[2,3-d]Pyrimid-4-One | ESD-858991-250MG |
| Cas.: 544-72-9 | Purity: 98%, 10mg/ml in Methanol | 9(Z),11(E),13(Z)-Octadecatrienoic Acid | ESD-917272-0.5ML |
| Cas.: 221681-92-1 | Purity: 97% | 1,3-dimethyl-1H-indazol-6-amine | ESD-857196-250MG |
| Cas.: 221681-92-1 | Purity: 97% | 1,3-dimethyl-1H-indazol-6-amine | ESD-857196-100MG |
| Cas.: 67828-42-6 | Purity: 95% | Methyl 2,4-Dihydroxyphenylacetate | ESD-850896-250MG |
| Cas.: 2177-70-0 | Purity: 97% | Phenyl methacrylate | ESD-817050-500G |
| Cas.: 6963-32-2 | Purity: 95% | 2,3-Dibromopropylamine Hydrobromide | ESD-853222-250MG |
| Cas.: 1780-31-0 | Purity: 98% | 2,4-Dichloro-5-methylpyrimidine | ESD-807817-500G |
| Cas.: 270088-04-5 | Purity: ≥98%(GC) | 7-Ethynylcoumarin | ESD-862676-100MG |
| Cas.: 254881-77-1 | Purity: ≥95% | 1,2-Pyrrolidinedicarboxylic acid, 4-amino-, 1-(1,1-dimethylethyl) 2-methyl ester, (2R,4S)- | ESD-827662-250MG |
| Cas.: 254881-77-1 | Purity: ≥95% | 1,2-Pyrrolidinedicarboxylic acid, 4-amino-, 1-(1,1-dimethylethyl) 2-methyl ester, (2R,4S)- | ESD-827662-100MG |
| Cas.: 37865-86-4 | Purity: 98% | 6-Ethoxy-1H-indole | ESD-841202-5G |
| Cas.: 18931-64-1 | Purity: 98% | 1,1,1-Trifluoro-6-phenylhex-5-ene-2,4-dione | ESD-831676-250MG |
| Cas.: 279262-15-6 | Purity: 97% | (4-(2-Ethoxyethoxy)phenyl)boronic acid | ESD-899706-250MG |
| Cas.: 3952-78-1 | Purity: Indicator | 1,2-Dihydroxyanthraquinonyl-3-methylamine-N,N-diacetic Acid | ESD-800681-100G |
| Cas.: 2922-61-4 | Purity: ≥97%(Ti) | Pyruvic Acid Lithium Salt | ESD-859112-5G |
| Cas.: 91188-15-7 | Purity: 95% | 3-(Boc-aminomethyl)azetidine | ESD-803746-5G |
| Cas.: 1083-57-4 | Purity: 98% | Bucetin | ESD-838400-25G |
| Cas.: 1083-57-4 | Purity: 98% | Bucetin | ESD-838400-100G |
| Cas.: 71418-44-5 | Purity: 98% | Bromobimane | ESD-860548-25MG |
| Cas.: 71418-44-5 | Purity: 98% | Bromobimane | ESD-860548-100MG |
| Cas.: 78-59-1 | Purity: 99% | Isophorone | ESD-823929-10L |
| Cas.: 1121-55-7 | Purity: 97%, contains TBCstabilizer | 3-vinylpyridine | ESD-825345-100MG |
| Cas.: 13283-01-7 | Purity: 99% | Tungsten(VI) chloride | ESD-819058-2.5KG |
| Cas.: 111-06-8 | Purity: ≥95% | Butyl Palmitate | ESD-867405-25ML |
| Cas.: 22990-34-7 | Purity: 97% | 2-(Piperidin-4-yl)propan-2-ol | ESD-839375-5G |
| Cas.: 383907-53-7 | Purity: >99% | PA (egg PC) (sodiuM salt) | ESD-864046-5MG |
| Cas.: 1628556-99-9 | Purity: 97% | 3-Bromo-5-fluoro-2-nitrobenzoic acid | ESD-845529-5G |
| Cas.: 53616-34-5 | Purity: 95% | 3-Furanethanol | ESD-906942-100MG |
| Cas.: 4352-42-5 | Purity: 98% | 1-Cyclohexyl-1-butanol | ESD-870388-5G |
| Cas.: 638-56-2 | Purity: 97% | Diethylene Glycol Bis(2-chloroethyl) Ether | ESD-858202-100G |
| Cas.: 189373-41-9 | Purity: AR | DBD-ED [=4-(N,N-Dimethylaminosulfonyl)-7-(2-aminoethylamino)-2,1,3-benzoxadiazole] | ESD-871523-50MG |
| Cas.: 622-75-3 | Purity: 97% | 1,4-Phenylenediacetonitrile | ESD-829775-100G |
| Cas.: 272-12-8 | Purity: ≥95% | Thieno[2,3-c]pyridine | ESD-825328-250MG |
| Cas.: 272-12-8 | Purity: ≥95% | Thieno[2,3-c]pyridine | ESD-825328-100MG |
| Cas.: 272-12-8 | Purity: ≥95% | Thieno[2,3-c]pyridine | ESD-825328-5G |
| Cas.: 594-27-4 | Purity: 96% | Tetramethyltin | ESD-858240-25G |
| Cas.: 126-71-6 | Purity: 98% | Triisobutyl phosphate | ESD-834116-500ML |
| Cas.: 7650-89-7 | Purity: 98% | Tribenzylphosphine | ESD-836743-250MG |
| Cas.: 1799438-97-3 | Purity: ≥95% | (R)-tert-Butyl (1-(2-bromo-4-chlorophenyl)ethyl)carbamate | ESD-891826-1G |
| Cas.: 103478-12-2 | Purity: ≥97% | (S)-3-(Cbz-amino)-2-oxoazepane | ESD-852191-250MG |
| Cas.: 115532-52-0 | Purity: 98% | TMRE | ESD-884355-50MG |
| Cas.: 5431-44-7 | Purity: >98.0%(GC) | 2,6-Pyridinedicarboxaldehyde | ESD-817072-25G |
| Cas.: 4857-42-5 | Purity: ≥95% | 3-methylisoxazole-5-carboxylic acid | ESD-826336-1G |
| Cas.: 4857-42-5 | Purity: ≥95% | 3-methylisoxazole-5-carboxylic acid | ESD-826336-250MG |
| Cas.: 13478-18-7 | Purity: 99.5% trace metals basis | Molybdenum(III) chloride | ESD-836129-25G |
| Cas.: 29091-40-5 | Purity: ≥97% | 4-Methyl-2,1,3-benzoxadiazole | ESD-853742-1G |
| Cas.: 29091-40-5 | Purity: ≥97% | 4-Methyl-2,1,3-benzoxadiazole | ESD-853742-250MG |
| Cas.: 96996-90-6 | Purity: ≥98% | 1,2,3,4,6-Penta-O-benzoyl-D-mannopyranose | ESD-886444-1G |
| Cas.: 152751-57-0 | Purity: BR | Sevelamer HCl | ESD-873431-100G |
| Cas.: 412281-11-9 | Purity: ≥95% | 1-methylpyrrolidine-3-carboxylic acid | ESD-826592-1G |
| Cas.: 412281-11-9 | Purity: ≥95% | 1-methylpyrrolidine-3-carboxylic acid | ESD-826592-250MG |
| Cas.: 33786-93-5 | Purity: 95% | 3,5-diaminobenzonitrile | ESD-908931-5G |
| Cas.: 995-32-4 | Purity: ≥98% | Tetraethyl Ethylenediphosphonate | ESD-865966-5G |
| Cas.: 5308-51-0 | Purity: 97% | 1-Bromobutane-2,3-dione | ESD-844586-25G |
| Cas.: 14002-51-8 | Purity: 98% | 4-Biphenylcarbonyl chloride | ESD-831544-100G |
| Cas.: 153139-56-1 | Purity: >95% | 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | ESD-917274-25MG |
| Cas.: 153139-56-1 | Purity: >95% | 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | ESD-917274-50MG |
| Cas.: 153139-56-1 | Purity: >95% | 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | ESD-917274-100MG |
| Cas.: 102767-31-7 | Purity: >95% | (S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide | ESD-917275-50MG |
| Cas.: 102767-31-7 | Purity: >95% | (S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide | ESD-917275-250MG |
| Cas.: 102767-31-7 | Purity: >95% | (S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide | ESD-917275-1G |
| Cas.: 28289-54-5 | Purity: >95% | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | ESD-917276-50MG |
| Cas.: 28289-54-5 | Purity: >95% | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | ESD-917276-250MG |
| Cas.: 28289-54-5 | Purity: >95% | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | ESD-917276-1G |
| Cas.: 109632-08-8 | Purity: >95% | C-Desmethyl Metoprolol | ESD-917277-50MG |
| Cas.: 109632-08-8 | Purity: >95% | C-Desmethyl Metoprolol | ESD-917277-250MG |
| Cas.: 109632-08-8 | Purity: >95% | C-Desmethyl Metoprolol | ESD-917277-1G |
| Cas.: 7778-53-2 | Purity: 90% | Potassium phosphate tribasic | ESD-917278-500G |
| Cas.: 7778-53-2 | Purity: 90% | Potassium phosphate tribasic | ESD-917278-2.5KG |
| Cas.: 7778-53-2 | Purity: 90% | Potassium phosphate tribasic | ESD-917278-10KG |
| Cas.: 1783-84-2 | Purity: ≥99% | cis-8,11,14-Eicosatrienoic Acid | ESD-838506-100MG |
| Cas.: 142-90-5 | Purity: 97%, mixture of isomers | Lauryl methacrylate | ESD-917279-100ML |
| Cas.: 142-90-5 | Purity: 97%, mixture of isomers | Lauryl methacrylate | ESD-917279-500ML |
| Cas.: 142-90-5 | Purity: 97%, mixture of isomers | Lauryl methacrylate | ESD-917279-2.5L |
| Cas.: 142-90-5 | Purity: 97%, mixture of isomers | Lauryl methacrylate | ESD-917279-25ML |
| Cas.: 53956-04-1 | Purity: ≥98% | Glycyrrhizic acid ammonium salt | ESD-917281-100MG |
| Cas.: 10043-11-5 | Purity: 99.9% metals basis, <200nm | Boron nitride | ESD-917280-25G |
| Cas.: 10043-11-5 | Purity: 99.9% metals basis, <200nm | Boron nitride | ESD-917280-100G |
| Cas.: 10043-11-5 | Purity: 99.9% metals basis, <200nm | Boron nitride | ESD-917280-500G |
| Cas.: 57079-01-3 | Purity: 97% | 11-Maleimidoundecanoic Acid | ESD-849572-25G |
| Cas.: 3069-42-9 | Purity: ≥95% | Trimethoxy(octadecyl)silane | ESD-917282-5ML |
| Cas.: 3069-42-9 | Purity: ≥95% | Trimethoxy(octadecyl)silane | ESD-917282-25ML |
| Cas.: 3069-42-9 | Purity: ≥95% | Trimethoxy(octadecyl)silane | ESD-917282-100ML |
| Cas.: 83306-52-9 | Purity: 97% | 4-Oxo-4-(((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)amino)butanoic acid | ESD-917283-100MG |
| Cas.: 159898-10-9 | Purity: 96% | (S)-2-(1-(tert-Butoxycarbonyl)piperidin-2-yl)acetic acid | ESD-917284-100MG |
| Cas.: 634-97-9 | Purity: 97% | Pyrrole-2-carboxylic acid | ESD-815858-100G |
| Cas.: 68412-54-4 | Purity: Igepal CO-520 | Igepal CO-520 | ESD-828402-2.5KG |
| Cas.: 24807-55-4 | Purity: 98% | 3-Nitro-1,2,4-Triazole | ESD-824071-500G |
| Cas.: 24003-67-6 | Purity: 98% | Hexanoyl Glycine (NSC 224460) | ESD-912299-500MG |
| Cas.: 105827-78-9 | Purity: ≥97% | Admire | ESD-859445-5G |
| Cas.: 105827-78-9 | Purity: ≥97% | Admire | ESD-859445-25G |
| Cas.: 105827-78-9 | Purity: ≥97% | Admire | ESD-859445-100G |
| Cas.: 5094-33-7 | Purity: 98% | 4-Aminophenyl beta-D-Galactopyranoside | ESD-870519-1G |
| Cas.: 10124-56-8 | Purity: AR | Sodium Metaphosphate | ESD-817849-10KG |
| Cas.: 67605-85-0 | Purity: 95% | (S)-N-(2-Oxotetrahydrofuran-3-yl)butyramide | ESD-916863-500MG |
| Cas.: 195314-59-1 | Purity: ≥95% | Tert-butyl 4-aminocyclohexylcarbamate | ESD-827735-5G |
| Cas.: 32190-95-7 | Purity: ≥95% | 2-Aminobenzene-1,4-diol hydrochloride | ESD-901389-50MG |
| Cas.: 1257-08-5 | Purity: 98% | Epicatechin gallate | ESD-837315-250MG |
| Cas.: 7789-04-0 | Purity: AR | CHROMIUM(III) PHOSPHATE | ESD-888080-100G |
| Cas.: 131211-27-3 | Purity: 97% | Di-1-adamantylphosphine | ESD-807811-5G |
| Cas.: 605-38-9 | Purity: 98% | Dimethyl pyridine-2,3-dicarboxylate | ESD-840085-25G |
| Cas.: 605-38-9 | Purity: 98% | Dimethyl pyridine-2,3-dicarboxylate | ESD-840085-100G |
| Cas.: 17527-29-6 | Purity: 97%, contains stabilizerMEHQ | 3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl acrylate | ESD-917285-25ML |
| Cas.: 17527-29-6 | Purity: 97%, contains stabilizerMEHQ | 3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl acrylate | ESD-917285-100ML |
| Cas.: 14099-05-9 | Purity: ≥95% | Sodium Pentacyanoammineferroate(II) Hydrate | ESD-867490-25G |
| Cas.: 117-83-9 | Purity: >95%(HPLC) | Bis(2-butoxyethyl) phthalate | ESD-917286-1G |
| Cas.: 117-83-9 | Purity: >95%(HPLC) | Bis(2-butoxyethyl) phthalate | ESD-917286-5G |
| Cas.: 114798-26-4 | Purity: 99% | Losartan | ESD-873676-50MG |
| Cas.: 114798-26-4 | Purity: 99% | Losartan | ESD-873676-250MG |
| Cas.: 114798-26-4 | Purity: 99% | Losartan | ESD-873676-1G |
| Cas.: 114798-26-4 | Purity: 99% | Losartan | ESD-873676-5G |
| Cas.: 300364-84-5 | Purity: 98% | trans-2-[3-(4-tert-Butylphenyl)-2-methyl-2-propenylidene]malononitrile | ESD-870485-500MG |
| Cas.: 1792-17-2 | Purity: 98% | |N|,|N|’-Di-n-butylurea | ESD-807565-1G |
| Cas.: 50606-96-7 | Purity: >98.0%(T) | 4-Heptylbenzoyl Chloride | ESD-863529-25G |
| Cas.: 159847-83-3 | Purity: 98% | Methyl 2-amino-4-cyanobenzoate | ESD-899668-250MG |
| Cas.: NONE8256 | Purity: 98% | Lys-Lys-Lys hydrochloride | ESD-917289-50MG |
| Cas.: NONE8256 | Purity: 98% | Lys-Lys-Lys hydrochloride | ESD-917289-10MG |
| Cas.: 4576-90-3 | Purity: 98% | Isothiazole-3-carboxylic acid | ESD-827845-250MG |
| Cas.: 4576-90-3 | Purity: 98% | Isothiazole-3-carboxylic acid | ESD-827845-100MG |
| Cas.: 100900-07-0 | Purity: 97% | 5-(2-Aminoethylamino)-1-naphthalenesulfonic acid sodium salt | ESD-837153-250MG |
| Cas.: 100900-07-0 | Purity: 97% | 5-(2-Aminoethylamino)-1-naphthalenesulfonic acid sodium salt | ESD-837153-1G |
| Cas.: 1021868-92-7 | Purity: ≥98% | ZM 39923 HCl | ESD-855360-10MG |
| Cas.: 1174223-25-6 | Purity: 98% | benzo[1,2-b:3,4-b’:5,6-b”]tristhiophene-2,5,8-tricarboxylic acid | ESD-887590-1G |
| Cas.: 10041-06-2 | Purity: ≥97% | 4′-(1-Imidazolyl)acetophenone | ESD-851578-5G |
| Cas.: 10041-06-2 | Purity: ≥97% | 4′-(1-Imidazolyl)acetophenone | ESD-851578-25G |
| Cas.: 69094-18-4 | Purity: 95% | 2,2-Dibromo-2-nitroethanol | ESD-854976-5G |
| Cas.: 2517-04-6 | Purity: 98% | Azetidine-2-carboxylic acid | ESD-844464-5G |
| Cas.: 25493-17-8 | Purity: ≥98 atom % D | 1-Butanol-d9 | ESD-874380-1G |
| Cas.: 547-65-9 | Purity: 96% | α-Methylene-γ-butyrolactone | ESD-813368-100G |
| Cas.: 6290-24-0 | Purity: >98.0%(GC) | Ethyl 2-ethoxybenzoate | ESD-914515-500G |
| Cas.: 36421-15-5 | Purity: ≥99% | N-(3-chloropropyl)dibutylamine | ESD-859065-25G |
| Cas.: 136236-51-6 | Purity: 98% | Rasagiline | ESD-841077-5G |
| Cas.: 147795-39-9 | Purity: ≥97% | N-(3-Oxooctanoyl)-L-homoserine lactone | ESD-915077-50MG |
| Cas.: 626-00-6 | Purity: 98% | 1,3-DIIODOBENZENE | ESD-830272-500G |
| Cas.: 913613-82-8 | Purity: 97% | 7-(4-Chlorobutoxy)quinolin-2(1H)-one | ESD-844899-5G |
| Cas.: 22306-37-2 | Purity: ≥99.99% | Bismuth(III) acetate | ESD-838660-100G |
| Cas.: 135236-72-5 | Purity: >97% | Calcium 3-Hydroxy-3-methylbutyrate Hydrate | ESD-835348-2.5KG |
| Cas.: 453-20-3 | Purity: 98% | 3-Hydroxytetrahydrofuran | ESD-811172-500G |
| Cas.: 61422-45-5 | Purity: ≥98% | Carmofur | ESD-862938-1G |
| Cas.: 18684-24-7 | Purity: 98% | Dipeptide-6 | ESD-917290-250MG |
| Cas.: 18684-24-7 | Purity: 98% | Dipeptide-6 | ESD-917290-1G |
| Cas.: 30470-60-1 | Purity: BR | Adamantane-d16 | ESD-874574-100MG |
| Cas.: 824-94-2 | Purity: 98% | 4-Methoxybenzylchloride | ESD-823416-500G |
| Cas.: 56309-94-5 | Purity: >98.0%(GC) | Bicyclohexane-4,4′-dione Monoethylene Ketal | ESD-804087-100G |
| Cas.: 36077-39-1 | Purity: 98% | H-Leu-Met-OH | ESD-917291-250MG |
| Cas.: 36077-39-1 | Purity: 98% | H-Leu-Met-OH | ESD-917291-1G |
| Cas.: 5176-27-2 | Purity: 97% | N-Boc-pyrrole | ESD-823222-100G |
| Cas.: 18545-96-5 | Purity: 95% | 1-Deoxy-D-glucitol | ESD-917292-5MG |
| Cas.: 5536-61-8 | Purity: CP | Sodium methacrylate | ESD-828267-5KG |
| Cas.: 15548-61-5 | Purity: 98% | 6-Bromo-2-naphthyl β-D-glucopyranoside | ESD-917246-25G |
| Cas.: 15548-61-5 | Purity: 98% | 6-Bromo-2-naphthyl β-D-glucopyranoside | ESD-917246-10G |
| Cas.: 15548-61-5 | Purity: 98% | 6-Bromo-2-naphthyl β-D-glucopyranoside | ESD-917246-5G |
| Cas.: 15548-61-5 | Purity: 98% | 6-Bromo-2-naphthyl β-D-glucopyranoside | ESD-917246-1G |
| Cas.: 13992-25-1 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl Azide | ESD-917293-5G |
| Cas.: 13992-25-1 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl Azide | ESD-917293-2G |
| Cas.: 13992-25-1 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl Azide | ESD-917293-1G |
| Cas.: 13992-25-1 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl Azide | ESD-917293-500MG |
| Cas.: 120375-52-2 | Purity: >99% | Benzenebutanammonium Bromide | ESD-904403-1G |
| Cas.: 1947-42-8 | Purity: 97% | ZD-Arg(Cbz)2-OH | ESD-917294-100MG |
| Cas.: 526-18-1 | Purity: 98% | Osalmid | ESD-831489-100G |
| Cas.: 526-18-1 | Purity: 98% | Osalmid | ESD-831489-25G |
| Cas.: 25085-53-4 | Purity: average Mw ~250, 000 by GPC | Polypropylene, isotactic | ESD-909211-500G |
| Cas.: 25085-53-4 | Purity: average Mw ~250, 000 by GPC | Polypropylene, isotactic | ESD-909211-2.5KG |
| Cas.: 16921-30-5 | Purity: 99.9% metals basis | Potassium hexachloroplatinate(IV) | ESD-817080-25G |
| Cas.: 71022-43-0 | Purity: ≥98% | 3,5-Dinitrobenzyl Alcohol | ESD-860201-5G |
| Cas.: 1250510-22-5 | Purity: 90% | 1-(3,5-difluorophenyl)cyclopropane-1-carboxylic acid | ESD-902997-5G |
| Cas.: 1956-11-2 | Purity: >98.0%(GC) | 4-Nitrophenyl Laurate | ESD-864172-25G |
| Cas.: 141743-16-0 | Purity: 95% | Fmoc-N-(tert-butyloxycarbonylmethyl)glycine | ESD-917295-100MG |
| Cas.: 5293-84-5 | Purity: 98% | (Chloromethyl)triphenylphosphonium Chloride | ESD-821418-1G |
| Cas.: 39394-84-8 | Purity: 7.5% W/W P2O5 | Eaton’s Reagent | ESD-822708-2.5L |
| Cas.: 263707-16-0 | Purity: 99% | ESI-09 | ESD-872970-25MG |
| Cas.: 10025-91-9 | Purity: 99.999% metals basis | Antimony trichloride | ESD-888781-25G |
| Cas.: 7037-49-2 | Purity: 97% | 3-(Piperidin-4-yl)propan-1-ol | ESD-839607-5G |
| Cas.: 871-84-1 | Purity: 98% | 1,7-Octadiyne | ESD-815227-100ML |
| Cas.: 1206161-97-8 | Purity: 98% | Filgotinib (GLPG0634) | ESD-873760-25MG |
| Cas.: 1206161-97-8 | Purity: 98% | Filgotinib (GLPG0634) | ESD-873760-100MG |
| Cas.: 2363-89-5 | Purity: 98% | 2-Octenal | ESD-886534-100G |
| Cas.: 2363-89-5 | Purity: 98% | 2-Octenal | ESD-886534-500G |
| Cas.: 2465-93-2 | Purity: ≥97% | 1,2,3-Tris(2-cyanoethoxy)propane | ESD-865684-500G |
| Cas.: 500789-04-8 | Purity: 98% | (R)-3-tert-Butoxycarbonylamino-3-(3-fluorophenyl)propionic acid | ESD-917296-250MG |
| Cas.: 127191-97-3 | Purity: 99% | KN-62 | ESD-872954-25MG |
| Cas.: 85201-91-8 | Purity: 97% | Z-Hyp(Tbu)-OH | ESD-917297-1G |
| Cas.: 3972-65-4 | Purity: 97% | 1-Bromo-4-|tert|-butylbenzene | ESD-802692-2.5KG |
| Cas.: 13760-78-6 | Purity: No water, 99.9% metals basis | Holmium(III) fluoride | ESD-811501-250G |
| Cas.: 499995-77-6 | Purity: 98% | (S)-Boc-3-methoxy-β-Phe-OH | ESD-917298-100MG |
| Cas.: 606-68-8 | Purity: 98% | β-NADH | ESD-814672-25G |
| Cas.: 499995-77-6 | Purity: 98% | (S)-Boc-3-methoxy-β-Phe-OH | ESD-917298-500MG |
| Cas.: 14404-33-2 | Purity: 99.99% metals basis | Potassium aquapentachlororuthenate(III) | ESD-817084-25G |
| Cas.: 94856-25-4 | Purity: 98% | Aberchrome 670 | ESD-870564-200MG |
| Cas.: 2494-89-5 | Purity: 96% | 2-((4-Aminophenyl)sulfonyl)ethyl hydrogen sulfate | ESD-908768-25G |
| Cas.: 3055-99-0 | Purity: n=10, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-917299-2.5KG |
| Cas.: 3055-99-0 | Purity: n=10, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-917299-500G |
| Cas.: 3055-99-0 | Purity: n=10, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-917299-100G |
| Cas.: 3055-99-0 | Purity: n=10, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-917299-25G |
| Cas.: 3055-99-0 | Purity: n=10, nonionic surfactant | Nonaethylene glycol monododecyl ether | ESD-917299-5G |
| Cas.: 2162-74-5 | Purity: 98% | Bis(2,6-diisopropylphenyl)carbodiimide | ESD-823295-500G |
| Cas.: 465-21-4 | Purity: 99% | Bufalin | ESD-860643-25MG |
| Cas.: 2688-48-4 | Purity: ≥98%(GC) | Homogentisic Acid γ-Lactone | ESD-862349-5G |
| Cas.: 6850-35-7 | Purity: 96% | 3-Methylcyclohexylamine (cis- and trans-mixture) | ESD-917300-5G |
| Cas.: 6850-35-7 | Purity: 96% | 3-Methylcyclohexylamine (cis- and trans-mixture) | ESD-917300-1G |
| Cas.: 607-90-9 | Purity: ≥98% | Propyl Salicylate | ESD-867311-25G |
| Cas.: 607-90-9 | Purity: ≥98% | Propyl Salicylate | ESD-867311-100G |
| Cas.: 430-67-1 | Purity: 98% | 2,2-Difluoroethylamine | ESD-831111-500G |
| Cas.: 705-76-0 | Purity: 98% | 3,5-Dimethoxybenzyl alcohol | ESD-830615-500G |
| Cas.: 207738-11-2 | Purity: 99,9% | Thulium(III) acetate hydrate | ESD-886077-25G |
| Cas.: 142-16-5 | Purity: 95% | Bis(2-ethylhexyl) maleate | ESD-832814-2.5L |
| Cas.: 54149-17-6 | Purity: 95% | 1-Bromo-2-(2-methoxyethoxy)ethane | ESD-858261-100G |
| Cas.: 6968-76-9 | Purity: 98% | 1-(3-Methoxyphenyl)piperazine dihydrochloride | ESD-831533-25G |
| Cas.: 6968-76-9 | Purity: 98% | 1-(3-Methoxyphenyl)piperazine dihydrochloride | ESD-831533-100G |
| Cas.: 2527-66-4 | Purity: 95% | 2-Methyl-1,2-benzothiazol-3(2H)-one | ESD-908780-100G |
| Cas.: 159989-64-7 | Purity: ≥98% | Nelfinavir | ESD-881868-25MG |
| Cas.: 24615-84-7 | Purity: 98% | 2-Carboxyethyl acrylate | ESD-823873-2.5KG |
| Cas.: 58859-46-4 | Purity: 96% | Ethyl 4-amino-1-piperidinecarboxylate | ESD-838159-25G |
| Cas.: 58859-46-4 | Purity: 96% | Ethyl 4-amino-1-piperidinecarboxylate | ESD-838159-100G |
| Cas.: NONE6711 | Purity: Fe≥21% | Polymerized ferrous sulfate | ESD-874942-10KG |
| Cas.: 33225-72-8 | Purity: 97% | 2-Nitronicotinic acid | ESD-843142-5G |
| Cas.: 207857-35-0 | Purity: 95% | Fmoc-Arg(Z)2-OH | ESD-917301-100MG |
| Cas.: 544-13-8 | Purity: ≥98% | Glutaronitrile | ESD-834930-100G |
| Cas.: 9002-89-5 | Purity: Alcoholysis degree: 87.0～89.0%(mol/mol) | Poly(vinyl alcohol) 2488 | ESD-868684-2.5KG |
| Cas.: 9002-89-5 | Purity: Alcoholysis degree: 87.0～89.0%(mol/mol) | Poly(vinyl alcohol) 2488 | ESD-868684-10KG |
| Cas.: 483-04-5 | Purity: ≥98% (HPLC) | Raubasine | ESD-861474-25MG |
| Cas.: 607366-20-1 | Purity: 95% | Fmoc-DAP(ivDDE)-OH | ESD-917302-250MG |
| Cas.: 6829-41-0 | Purity: tech. 90% | Diethyl Isonitrosomalonate | ESD-917303-1G |
| Cas.: 6829-41-0 | Purity: tech. 90% | Diethyl Isonitrosomalonate | ESD-917303-250MG |
| Cas.: 1235005-44-3 | Purity: 98% | Fmoc-Phe(2,6-DiF)-OH | ESD-917304-100MG |
| Cas.: 13705-05-0 | Purity: ≥95% | 2,4-Dichloro-6-(methylthio)-1,3,5-triazine | ESD-853793-50MG |
| Cas.: 2516-47-4 | Purity: 98% | Cyclopropylmethylamine | ESD-917305-100G |
| Cas.: 2516-47-4 | Purity: 98% | Cyclopropylmethylamine | ESD-917305-25G |
| Cas.: 2516-47-4 | Purity: 98% | Cyclopropylmethylamine | ESD-917305-5G |
| Cas.: 2516-47-4 | Purity: 98% | Cyclopropylmethylamine | ESD-917305-1G |
| Cas.: 2516-47-4 | Purity: >95.0%(GC) | Cyclopropylmethanamine | ESD-917306-100G |
| Cas.: 2516-47-4 | Purity: >95.0%(GC) | Cyclopropylmethanamine | ESD-917306-25G |
| Cas.: 2516-47-4 | Purity: >95.0%(GC) | Cyclopropylmethanamine | ESD-917306-5G |
| Cas.: 2516-47-4 | Purity: >95.0%(GC) | Cyclopropylmethanamine | ESD-917306-1G |
| Cas.: 166172-66-3 | Purity: 97% | (S)-1-{(RP)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine | ESD-835560-50MG |
| Cas.: 166172-66-3 | Purity: 97% | (S)-1-{(RP)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine | ESD-835560-100MG |
| Cas.: 166172-66-3 | Purity: 97% | (S)-1-{(RP)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine | ESD-835560-250MG |
| Cas.: 10017-37-5 | Purity: 98% | tert-butylamine hydrochloride | ESD-904494-5G |
| Cas.: 3279-54-7 | Purity: 98% | Disodium Phenyl Phosphate Hydrate | ESD-831981-500G |
| Cas.: 351-35-9 | Purity: 98% | 3-(Trifluoromethyl)phenylacetic acid | ESD-819100-500G |
| Cas.: 6279-86-3 | Purity: 97% | Triethyl methanetricarboxylate | ESD-836650-500G |
| Cas.: 8047-15-2 | Purity: ≥95%, derived from Camellia oleifera seeds | Saponin | ESD-875798-500G |
| Cas.: 80-65-9 | Purity: 98% | AOZ | ESD-915369-1G |
| Cas.: 420831-40-9 | Purity: ≥99% | AK-7 | ESD-879080-250MG |
| Cas.: 59-89-2 | Purity: >99.0%(GC) | N-Nitrosomorpholine | ESD-913891-1G |
| Cas.: 92050-17-4 | Purity: >99.5% | 1,8-Octanedi ammonium Bromide | ESD-904397-1G |
| Cas.: 5301-78-0 | Purity: 98% | 2,6,7-Trioxa-1-phosphabicyclo[2.2.2]octane-4-methanol | ESD-828420-500G |
| Cas.: 61699-62-5 | Purity: 99% | 3,4-Diisopropoxycyclobut-3-ene-1,2-dione | ESD-838123-100G |
| Cas.: 515-69-5 | Purity: 90% | alpha-Bisabolol | ESD-859318-500G |
| Cas.: 2822-41-5 | Purity: ≥98.0% | 2,3,4-Trifluorophenol | ESD-820256-25G |
| Cas.: 4160-51-4 | Purity: ≥98%(GC) | 4′-Methoxybutyrophenone | ESD-862121-5G |
| Cas.: 4160-51-4 | Purity: ≥98%(GC) | 4′-Methoxybutyrophenone | ESD-862121-25G |
| Cas.: 16801-62-0 | Purity: ≥95% | 4-(Z-amino)Cyclohexanol | ESD-859644-5G |
| Cas.: 16801-62-0 | Purity: ≥95% | 4-(Z-amino)Cyclohexanol | ESD-859644-25G |
| Cas.: 7210-77-7 | Purity: ≥97% | Ethyl 2,4-Dimethylthiazole-5-Carboxylate | ESD-858659-5G |
| Cas.: 7210-77-7 | Purity: ≥97% | Ethyl 2,4-Dimethylthiazole-5-Carboxylate | ESD-858659-10G |
| Cas.: 5988-53-4 | Purity: 99% | D-Hydroorotic Acid | ESD-856784-250MG |
| Cas.: 24980-41-4 | Purity: average Mn 2,000 | Polycaprolactone | ESD-917307-500G |
| Cas.: 24980-41-4 | Purity: average Mn 2,000 | Polycaprolactone | ESD-917307-100G |
| Cas.: 24980-41-4 | Purity: average Mn 2,000 | Polycaprolactone | ESD-917307-25G |
| Cas.: 24980-41-4 | Purity: average Mn 2,000 | Polycaprolactone | ESD-917307-5G |
| Cas.: 1306-06-5 | Purity: Short rod, 99%, Particle size : 20nm | Hydroxylapatite | ESD-875585-100G |
| Cas.: 1306-06-5 | Purity: Short rod, 99%, Particle size : 20nm | Hydroxylapatite | ESD-875585-500G |
| Cas.: 73094-35-6 | Purity: ≥98%(GC) | cis-4-(Hydroxymethyl)cyclohexanecarboxylic Acid | ESD-863118-1G |
| Cas.: 84000-14-6 | Purity: ≥98.0% | Fmoc-N-Me-Ser(Bzl)-OH | ESD-863535-5G |
| Cas.: 6141-13-5 | Purity: ≥95% | 2-chloroquinazoline | ESD-827777-1G |
| Cas.: 6141-13-5 | Purity: ≥95% | 2-chloroquinazoline | ESD-827777-250MG |
| Cas.: 1737-19-5 | Purity: 98% | 1-(3-Fluorophenyl)propan-2-one | ESD-839161-5G |
| Cas.: 2679-14-3 | Purity: ≥95% | 3-(Methylamino)propanoic Acid | ESD-850425-1G |
| Cas.: 2679-14-3 | Purity: ≥95% | 3-(Methylamino)propanoic Acid | ESD-850425-250MG |
| Cas.: 35671-83-1 | Purity: 97% | Ac-Met-OMe | ESD-917312-250MG |
| Cas.: 1441670-89-8 | Purity: 97% | (S)-tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5 -carboxylate | ESD-899409-25G |
| Cas.: 187148-77-2 | Purity: 97% | 9-(2-Ethylhexyl)carbazole | ESD-835254-5G |
| Cas.: 673474-73-2 | Purity: 98% | 2,7-Dibromo-9,9-bis[3-(dimethylamino)propyl]fluorene | ESD-856649-1G |
| Cas.: 673474-73-2 | Purity: 98% | 2,7-Dibromo-9,9-bis[3-(dimethylamino)propyl]fluorene | ESD-856649-250MG |
| Cas.: 4065-92-3 | Purity: ≥97%, isomer mixture | 1,2-Cyclopentanediol | ESD-852573-1G |
| Cas.: 74029-40-6 | Purity: 98% | 1,4-Diethynyl-2,5-dimethoxybenzene | ESD-856734-200MG |
| Cas.: 74029-40-6 | Purity: 98% | 1,4-Diethynyl-2,5-dimethoxybenzene | ESD-856734-5G |
| Cas.: 433967-28-3 | Purity: 98% | VU 0357121 | ESD-855314-50MG |
| Cas.: 433967-28-3 | Purity: 98% | VU 0357121 | ESD-855314-10MG |
| Cas.: 1202759-32-7 | Purity: 99% | CNX-774 | ESD-872510-10MG |
| Cas.: 24587-49-3 | Purity: ≥95% | (E)-4-Hydroxy-2-butenoic Acid | ESD-915727-50MG |
| Cas.: 60889-32-9 | Purity: 95% | hexahydro-1H-furo[3,4-c]pyrrole | ESD-902549-500MG |
| Cas.: 53531-34-3 | Purity: ≥99% | (R)-(-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol | ESD-867685-50MG |
| Cas.: 119812-29-2 | Purity: >95% | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | ESD-917314-25MG |
| Cas.: 119812-29-2 | Purity: >95% | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | ESD-917314-50MG |
| Cas.: 119812-29-2 | Purity: >95% | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | ESD-917314-100MG |
| Cas.: NONE8257 | cleaning solvent | ESD-917315-1L | |
| Cas.: NONE8257 | cleaning solvent | ESD-917315-2.5L | |
| Cas.: 149457-03-4 | Purity: 99% | N-{[4-[2-(Formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl}methanesulfonamide | ESD-905875-25G |
| Cas.: 18550-98-6 | Purity: 99% | 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one | ESD-872919-25MG |
| Cas.: 9001-59-6 | Purity: 50U/mg protein | Pyruvate Kinase | ESD-915245-5KU |
| Cas.: 261948-85-0 | Purity: 97% | Ru(OCOCH3)2((S)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl) | ESD-856501-5G |
| Cas.: 15318-45-3 | Purity: 99,5% | Thiamphenicol | ESD-819566-500G |
| Cas.: 70-00-8 | Purity: ≥99% | Trifluorothymidine | ESD-834794-500MG |
| Cas.: 621-36-3 | Purity: 99% | m-Tolylacetic acid | ESD-837929-25G |
| Cas.: 323194-76-9 | Purity: 98% (TLC) | L-Aspartic acid sodium salt monohydrate | ESD-864326-100G |
| Cas.: 323194-76-9 | Purity: 98% (TLC) | L-Aspartic acid sodium salt monohydrate | ESD-864326-500G |
| Cas.: 31570-97-5 | Purity: 97% | 5-Hydroxyquinolin-2(1H)-one | ESD-843036-1G |
| Cas.: 554-52-9 | Purity: ≥95% | 4-(2-Aminoethyl)-2-methoxyphenol | ESD-917316-100MG |
| Cas.: 99-14-9 | Purity: 99% | 1,2,3-Propanetricarboxylic Acid | ESD-835428-500G |
| Cas.: 114798-26-4 | Purity: 99% | Losartan | ESD-873676-25G |
| Cas.: 2650-50-2 | Purity: ≥98% | Trimethylpropylammonium Bromide | ESD-867558-500G |
| Cas.: 1351279-73-6 | Purity: 95% | 1,1,2,2-Tetra(4-carboxylphenyl)ethylene | ESD-856438-5G |
| Cas.: 77-79-2 | Purity: 98% | 3-SULFOLENE | ESD-830238-2.5KG |
| Cas.: 34582-32-6 | Purity: 98% | Boc-Asp-OtBu | ESD-822006-25G |
| Cas.: 34582-32-6 | Purity: 98% | Boc-Asp-OtBu | ESD-822006-100G |
| Cas.: 53902-12-8 | Purity: 98% | TRANILAST | ESD-838260-25G |
| Cas.: 9029-90-7 | Purity: ammonium sulfate suspension, ≥50 units/mg protein | Carnitine Acetyltransferase from pigeon breast muscle | ESD-917317-1MG |
| Cas.: 2991-42-6 | Purity: 98% | 4-(Trifluoromethyl)benzene-1-sulfonyl chloride | ESD-824425-500G |
| Cas.: 73836-78-9 | Purity: 97%, 100 μg/mL in Ethanol | Leukotriene D4 (LTD4) | ESD-917318-100ΜL |
| Cas.: 73836-78-9 | Purity: 97%, 100 μg/mL in Ethanol | Leukotriene D4 (LTD4) | ESD-917318-250ΜL |
| Cas.: 82200-53-1 | Purity: 97% | 4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate | ESD-899081-25G |
| Cas.: 5786-21-0 | Purity: 98% | Clozapine | ESD-831495-500G |
| Cas.: 5779-95-3 | Purity: 95% | 3,5-dimethylbenzaldehyde | ESD-829200-500G |
| Cas.: 6402-23-9 | Purity: 98% | Ethacridine lactate monohydrate | ESD-850025-500G |
| Cas.: 1559064-12-8 | Purity: 97% | 3-Methoxy-2-methylpyridin-4-amine | ESD-917319-250MG |
| Cas.: 594-70-7 | Purity: 99% | 2-Methyl-2-nitropropane | ESD-834884-1G |
| Cas.: 694-80-4 | Purity: ≥98.0% | 2-Bromochlorobenzene | ESD-802810-1KG |
| Cas.: 56219-06-8 | Purity: 98% | Myristoleic Acid methyl ester | ESD-912539-250MG |
| Cas.: 102-20-5 | Purity: ≥98% | Phenethyl phenylacetate | ESD-859102-2.5KG |
| Cas.: 542-28-9 | Purity: 98% | δ-Valerolactone | ESD-820374-2.5KG |
| Cas.: 392-57-4 | Purity: 97% | 1,4-Diiodotetrafluorobenzene | ESD-854894-5G |
| Cas.: 6191-99-7 | Purity: ≥88%(GC) | 3-Ethoxyacryloyl Chloride | ESD-862029-25G |
| Cas.: 7440-42-8 | Purity: 90% | Boron | ESD-887049-500G |
| Cas.: 6382-01-0 | Purity: 97% | L-Glutamic Acid Monopotassium Salt Monohydrate | ESD-915112-1KG |
| Cas.: 61990-51-0 | Purity: 97% | 2-Hydroxy-N,N-dimethylpropan-1-aminium 4-acetamidobenzoate | ESD-891369-100G |
| Cas.: 144-68-3 | Purity: HPLC≥85% | zeaxanthin | ESD-854449-500MG |
| Cas.: 1476067-44-3 | Purity: ≥98%(HPLC) | (1R,3S,5R,7R,8aS)-7-Ethylhexahydro-1-(6-hydroxy-4-quinolinyl)-3,7-methano-1H-pyrrolo[2,1-c][1,4]oxazine | ESD-861810-25MG |
| Cas.: 212631-79-3 | Purity: ≥98% | PD 184352 | ESD-868640-100MG |
| Cas.: 212779-48-1 | Purity: >98% | NG-52 | ESD-860951-5MG |
| Cas.: 1011301-27-1 | Purity: >98% | Tenovin-3 | ESD-860857-1MG |
| Cas.: 171364-78-6 | Purity: 98% | |N|,|N|-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-808065-100G |
| Cas.: 29261-33-4 | Purity: 97% | 2,3,5,6-Tetrafluoro-7,7′,8,8′-tetracyanoquinodimethane | ESD-818614-1G |
| Cas.: 3365-85-3 | Purity: 95% | 4,4”-Diamino-|p|-terphenyl | ESD-808218-100G |
| Cas.: 351422-73-6 | Purity: 98% | 3-Aminocarbonylphenylboronic acid | ESD-800190-100G |
| Cas.: 13176-46-0 | Purity: 90% | Ethyl 4-bromo-3-oxobutanoate | ESD-839560-25G |
| Cas.: 3999-42-6 | Purity: 98% | (2,6-Dimethylpyridin-1-ium-1-yl)trihydroborate | ESD-848651-1G |
| Cas.: 526-18-1 | Purity: 98% | Osalmid | ESD-831489-500G |
| Cas.: 657-36-3 | Purity: 98% | 4-Trifluoromethylpiperidine | ESD-844575-25G |
| Cas.: 57-66-9 | Purity: 98% | Probenecid | ESD-822733-1KG |
| Cas.: 26204-55-7 | Purity: ≥98% | Dodecan-1-amine Hydrobromide | ESD-866146-25G |
| Cas.: 66246-88-6 | Purity: 98% | 1-(2-(2,4-Dichlorophenyl)pentyl)-1H-1,2,4-triazole | ESD-916566-100G |
| Cas.: 3069-42-9 | Purity: ≥95% | Trimethoxy(octadecyl)silane | ESD-917282-500ML |
| Cas.: 706-14-9 | Purity: 98% | γ-Decanolactone | ESD-806423-500ML |
| Cas.: 625-28-5 | Purity: 98% | Isovaleronitrile | ESD-858217-100ML |
| Cas.: 593-82-8 | Purity: 98%, T | 1,1-Dimethylhydrazine Hydrochloride | ESD-849299-25G |
| Cas.: 142825-10-3 | Purity: 98% | (R)-Sulforaphane | ESD-832951-50MG |
| Cas.: 26621-44-3 | Purity: >98% | 3-Nitro-1H-pyrazole | ESD-917324-25G |
| Cas.: 26621-44-3 | Purity: >98% | 3-Nitro-1H-pyrazole | ESD-917324-5G |
| Cas.: 32443-99-5 | Purity: 98% | D-Cysteine hydrochloride monohydrate | ESD-805145-2.5KG |
| Cas.: 473416-12-5 | Purity: ≥95% | Methyl 1H-indazole-5-carboxylate | ESD-825172-5G |
| Cas.: 473416-12-5 | Purity: ≥98% | Methyl 1H-indazole-5-carboxylate | ESD-917325-5G |
| Cas.: 133627-17-5 | Purity: >95% | 5,11-dihydro-6H-11-ethyl-4-Methyl-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one | ESD-917326-10MG |
| Cas.: 133627-17-5 | Purity: >95% | 5,11-dihydro-6H-11-ethyl-4-Methyl-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one | ESD-917326-100MG |
| Cas.: 64622-17-9 | Purity: >95% | isopropyl 2-(4-isobutylphenyl)propanoate | ESD-917327-100MG |
| Cas.: 132351-58-7 | Purity: >97% | 5-Acetoxy-7-hydroxyflavone | ESD-883236-5MG |
| Cas.: 132351-58-7 | Purity: >97% | 5-Acetoxy-7-hydroxyflavone | ESD-883236-25MG |
| Cas.: 132351-58-7 | Purity: >97% | 5-Acetoxy-7-hydroxyflavone | ESD-883236-100MG |
| Cas.: 56441-97-5 | Purity: 98% | Methyl 4-(benzyloxy)-3-methoxybenzoate | ESD-848876-5G |
| Cas.: 56441-97-5 | Purity: 98% | Methyl 4-(benzyloxy)-3-methoxybenzoate | ESD-848876-25G |
| Cas.: 56441-97-5 | Purity: 98% | Methyl 4-(benzyloxy)-3-methoxybenzoate | ESD-848876-100G |
| Cas.: 5963-14-4 | Purity: 98% | 8-methyl Nonanoic Acid (Isocapric Acid) | ESD-912621-250MG |
| Cas.: 479066-07-4 | Purity: 98% | Methylammonium Lead Chloride Bromide | ESD-904406-1G |
| Cas.: 8016-31-7 | natural | Angelica polyclada tincture | ESD-860267-500G |
| Cas.: 2687-27-6 | Purity: 98% | 1,3-Bis[2-(4-aminophenyl)-2-propyl]benzene | ESD-871164-25G |
| Cas.: 2304634-36-2 | Purity: 99% | 4,4,5,5-tetramethyl-2-((tetrahydro-4H-pyran-4-ylidene)methyl)-1,3,2-dioxaborolane | ESD-909841-100MG |
| Cas.: 101-77-9 | Purity: 99% | 4,4′-Diaminodiphenylmethane | ESD-807233-10KG |
| Cas.: 17766-28-8 | Purity: 99% | 1-Cyclohexylpiperazine | ESD-917328-25G |
| Cas.: 17766-28-8 | Purity: 99% | 1-Cyclohexylpiperazine | ESD-917328-5G |
| Cas.: 17766-28-8 | Purity: 99% | 1-Cyclohexylpiperazine | ESD-917328-100G |
| Cas.: 1314-23-4 | Purity: 99.9%, 200 Mesh, square phase | Zirconium dioxide | ESD-917329-500G |
| Cas.: 1314-23-4 | Purity: 99.9%, 200 Mesh, square phase | Zirconium dioxide | ESD-917329-100G |
| Cas.: 363-24-6 | Purity: >98% | Prostaglandin E2 | ESD-860712-500MG |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with MEHQ) | N-(2-Hydroxyethyl)acrylamide | ESD-830731-2.5KG |
| Cas.: 85-85-8 | Purity: 98% | 1-(2-Pyridylazo)-2-naphthol | ESD-815772-500G |
| Cas.: 2827-56-7 | Purity: 98% | 1-Aminohydantoin hydrochloride | ESD-801254-100G |
| Cas.: 147403-03-0 | Purity: ≥98% (HPLC) | Azilsartan | ESD-801647-25G |
| Cas.: 31690-09-2 | Purity: ≥98% | Levomefolic acid | ESD-879619-10MG |
| Cas.: 31690-09-2 | Purity: ≥98% | Levomefolic acid | ESD-879619-50MG |
| Cas.: 31690-09-2 | Purity: ≥98% | Levomefolic acid | ESD-879619-250MG |
| Cas.: 5350-03-8 | Purity: ≥97%(GC) | Amyl Laurate | ESD-862613-100ML |
| Cas.: 148757-94-2 | Purity: ≥95% | 6-Aminoquinolyl-N-hydroxysuccinimidyl carbamate | ESD-885833-250MG |
| Cas.: 1205-91-0 | Purity: 98% | 1,4-Diacetoxybenzene | ESD-838138-25ML |
| Cas.: 40497-31-2 | Purity: 98% | 2-Aminopyrimidine-4,6-diol | ESD-899752-100G |
| Cas.: 3073-87-8 | Purity: Blinking grade, ≥98%(TLC) | 1,4-Bis(4-methyl-5-phenyl-2-oxazolyl)benzene | ESD-803651-1G |
| Cas.: 3073-87-8 | Purity: Blinking grade, ≥98%(TLC) | 1,4-Bis(4-methyl-5-phenyl-2-oxazolyl)benzene | ESD-803651-250MG |
| Cas.: 28479-22-3 | Purity: 98% | 3-Chloro-4-methylphenyl isocyanate | ESD-831157-25G |
| Cas.: 1205-91-0 | Purity: 98% | 1,4-Diacetoxybenzene | ESD-838138-1ML |
| Cas.: 53087-13-1 | Purity: 98% | 1-(Benzyloxy)-3-bromobenzene | ESD-841774-25G |
| Cas.: 120-11-6 | Purity: 98% | 1-(Benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene | ESD-842831-25G |
| Cas.: 120-11-6 | Purity: 98% | 1-(Benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene | ESD-842831-100G |
| Cas.: 13676-54-5 | Purity: 98% | Bismaleimide | ESD-830276-5G |
| Cas.: 4511-42-6 | Purity: 98%, optically pure | L-Lactide | ESD-829915-500G |
| Cas.: 67843-74-7 | Purity: 98% | (|S|)-(+)-Epichlorohydrin | ESD-808608-2.5KG |
| Cas.: 2516-33-8 | Purity: 98% | Cyclopropylcarbinol | ESD-804922-500ML |
| Cas.: 16941-12-1 | Purity: 8 wt. % in H2O | Chloroplatinic acid | ESD-874875-50ML |
| Cas.: 2446-83-5 | Purity: ≥98% | Diisopropyl azodicarboxylate | ESD-902396-2.5KG |
| Cas.: 24856-58-4 | Purity: ≥98% | 4-Bromobenzaldehyde Dimethyl Acetal | ESD-864851-25G |
| Cas.: 16654-74-3 | Purity: ≥98% | Bis[2-(trimethylsilyloxy)ethyl] Ether | ESD-864929-25G |
| Cas.: 37340-58-2 | Purity: ≥8U/mg protein | Creatinase/Creatine Amidinohydrolase | ESD-861427-2.5KU |
| Cas.: 624-95-3 | Purity: 98% | 3,3-Dimethyl-1-butanol | ESD-832027-500G |
| Cas.: 71022-43-0 | Purity: ≥98% | 3,5-Dinitrobenzyl Alcohol | ESD-860201-25G |
| Cas.: 1194-02-1 | Purity: 99,8% | 4-Fluorobenzonitrile | ESD-821296-500G |
| Cas.: 18830-44-9 | Purity: ≥98% | Methyl 3,3,3-Trifluoropropionate | ESD-866375-25G |
| Cas.: 73500-82-0 | Purity: ≥98% | Carbazole-9-carbonyl Chloride | ESD-866880-5G |
| Cas.: 32710-65-9 | Purity: 98% | 2,6-Dichloroisonicotinonitrile | ESD-839656-5G |
| Cas.: 76-38-0 | Purity: 97% | 2,2-Dichloro-1,1-difluoroethyl methyl ether | ESD-836740-5G |
| Cas.: 76-38-0 | Purity: 97% | 2,2-Dichloro-1,1-difluoroethyl methyl ether | ESD-836740-25G |
| Cas.: 76-38-0 | Purity: 97% | 2,2-Dichloro-1,1-difluoroethyl methyl ether | ESD-836740-1G |
| Cas.: 76-38-0 | Purity: 97% | 2,2-Dichloro-1,1-difluoroethyl methyl ether | ESD-836740-100G |
| Cas.: 31251-41-9 | Purity: ≥98% | 8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one | ESD-865273-25G |
| Cas.: 551-68-8 | Purity: ≥95% | D-Psicose | ESD-917346-1G |
| Cas.: 551-68-8 | Purity: ≥95% | D-Psicose | ESD-917346-5G |
| Cas.: 551-68-8 | Purity: ≥95% | D-Psicose | ESD-917346-25G |
| Cas.: 551-68-8 | Purity: ≥95% | D-Psicose | ESD-917346-100G |
| Cas.: 23787-90-8 | Purity: mix.80% | Isolongifolione | ESD-917348-250G |
| Cas.: 23787-90-8 | Purity: mix.80% | Isolongifolione | ESD-917348-100G |
| Cas.: 34031-32-8 | Purity: ≥98% | Auranofin | ESD-879493-500MG |
| Cas.: 39746-00-4 | Purity: 98% | (-)-Corey lactone benzoate | ESD-804344-25G |
| Cas.: 66108-95-0 | Purity: ≥98% | Iohexol | ESD-837877-500G |
| Cas.: 53-59-8 | Purity: ≥95% | β-Nicotinamide adenine dinucleotide phosphate | ESD-917352-100MG |
| Cas.: 53-59-8 | Purity: ≥95% | β-Nicotinamide adenine dinucleotide phosphate | ESD-917352-500MG |
| Cas.: 53-59-8 | Purity: ≥95% | β-Nicotinamide adenine dinucleotide phosphate | ESD-917352-1G |
| Cas.: 53-59-8 | Purity: ≥95% | β-Nicotinamide adenine dinucleotide phosphate | ESD-917352-25MG |
| Cas.: 14476-37-0 | Purity: 90% | 4-Undecanone | ESD-917356-25ML |
| Cas.: 14476-37-0 | Purity: 90% | 4-Undecanone | ESD-917356-5ML |
| Cas.: 1674-62-0 | Purity: ≥98% | Metformin Related Compound B | ESD-835584-50MG |
| Cas.: 1674-62-0 | Purity: ≥98% | Metformin Related Compound B | ESD-835584-100MG |
| Cas.: 20101-92-2 | Purity: ≥95% | 2-(4-Chlorophenyl)acetamide | ESD-893027-5G |
| Cas.: NONE7134 | Purity: CH-93 | High salt water calcium magnesium chelating resin | ESD-889302-2.5KG |
| Cas.: 71484-85-0 | Purity: ≥97% | 4-Nitrophenyl α-D-Glucuronide | ESD-868324-25MG |
| Cas.: 71449-78-0 | Purity: ≥98% | 4-Thiophenyl Phenyl Diphenyl Sulfonium Hexafluoroantimonate | ESD-856975-500G |
| Cas.: 106266-06-2 | Purity: 99% | Risperidal | ESD-830746-100G |
| Cas.: 69011-19-4 | Purity: chloride form, 100-200 mesh | Dowex<<@>> 1X8 chloride form | ESD-808497-25G |
| Cas.: 24767-82-6 | Purity: ≥98% | Heptyl p-Toluenesulfonate | ESD-867320-25G |
| Cas.: 24767-82-6 | Purity: ≥98% | Heptyl p-Toluenesulfonate | ESD-867320-100G |
| Cas.: 22862-76-6 | Purity: 97% | Anisomycin from Streptomyces griseolus | ESD-800223-500MG |
| Cas.: 169332-60-9 | Purity: >98% | Ac-DEVD-CHO,N-Acetyl-Asp-Glu-Val-Asp-al | ESD-860453-5MG |
| Cas.: 169332-60-9 | Purity: >98% | Ac-DEVD-CHO,N-Acetyl-Asp-Glu-Val-Asp-al | ESD-860453-25MG |
| Cas.: 1492-23-5 | Purity: 98% | O-Succinyl-L-homoserine | ESD-916873-25MG |
| Cas.: 1492-23-5 | Purity: 98% | O-Succinyl-L-homoserine | ESD-916873-100MG |
| Cas.: 1492-23-5 | Purity: 98% | O-Succinyl-L-homoserine | ESD-916873-500MG |
| Cas.: 73018-10-7 | Purity: 98% | Pyridine-2-thiol | ESD-914146-500G |
| Cas.: 26161-33-1 | Purity: 99% | Polyquaternium-37 | ESD-909980-500G |
| Cas.: 1206161-97-8 | Purity: 98% | Filgotinib (GLPG0634) | ESD-873760-500MG |
| Cas.: 21736-83-4 | Purity: >98% | Spectinomycin dihydrochloride | ESD-860720-500G |
| Cas.: 5538-95-4 | Purity: 85% | LAURYLAMINO PROPYLAMINE | ESD-917379-500G |
| Cas.: 5538-95-4 | Purity: 85% | LAURYLAMINO PROPYLAMINE | ESD-917379-1KG |
| Cas.: 9004-65-3 | Purity: Type II, Viscosity: 1000mPa.s | Hydroxypropylmethylcellulose (HPMC) | ESD-917380-2.5KG |
| Cas.: 9004-65-3 | Purity: Type II, Viscosity: 1000mPa.s | Hydroxypropylmethylcellulose (HPMC) | ESD-917380-500G |
| Cas.: 9004-65-3 | Purity: Type II, Viscosity: 1000mPa.s | Hydroxypropylmethylcellulose (HPMC) | ESD-917380-100G |
| Cas.: XBPY | Purity: Ready-to-use tablet, 1EA can be made into 100mL solution | PBS Buffer Premixed Tablets, pH 7.4 | ESD-915553-250EA |
| Cas.: 13823-29-5 | Purity: AR, 98% | Thorium nitrate hydrate | ESD-819076-50G |
| Cas.: 55963-78-5 | Polyanetholesulfonic acid sodium | ESD-821793-500G | |
| Cas.: 519-23-3 | Purity: 98% | Ellipticine | ESD-878677-50MG |
| Cas.: 57-22-7 | Purity: ≥98% | Vincristine | ESD-861370-5MG |
| Cas.: NONE8254 | Endonuclease FspI | ESD-917225-500U | |
| Cas.: 101987-86-4 | Purity: 99% | Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate | ESD-856935-100G |
| Cas.: 210353-53-0 | Purity: ≥99% | Gemifloxacin mesylate | ESD-880520-250MG |
| Cas.: NONE8184 | Poly(n-butyl vinyl ether) | ESD-913363-500G | |
| Cas.: NONE8184 | Poly(n-butyl vinyl ether) | ESD-913363-100G | |
| Cas.: 9033-06-1 | Purity: 30000 u/g, derived from almond flour | glucosidase from aspergillus niger | ESD-917388-1G |
| Cas.: 9033-06-1 | Purity: 30000 u/g, derived from almond flour | glucosidase from aspergillus niger | ESD-917388-5G |
| Cas.: 28342-75-8 | Purity: 97% | 1,5-Dibromo-2,4-difluorobenzene | ESD-839182-5G |
| Cas.: 28342-75-8 | Purity: 97% | 1,5-Dibromo-2,4-difluorobenzene | ESD-839182-25G |
| Cas.: 28342-75-8 | Purity: 97% | 1,5-Dibromo-2,4-difluorobenzene | ESD-839182-100G |
| Cas.: 98138-05-7 | Purity: 95% | 2,4-Dichloropteridine | ESD-902144-250MG |
| Cas.: 39028-27-8 | Purity: ≥95% | N-Succinimidyl Iodoacetate | ESD-917389-250MG |
| Cas.: 14132-51-5 | Purity: BR | Benzaldehyde-2,3,4,5,6-d5 | ESD-874357-500MG |
| Cas.: 5996-10-1 | Purity: 98% | D-Glucose monohydrate | ESD-916323-250G |
| Cas.: 69304-37-6 | Purity: 97% | 1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane | ESD-823432-500G |
| Cas.: 10525-37-8 | Purity: 80% | icosan-1-amine | ESD-907105-5G |
| Cas.: 22832-87-7 | Purity: 98% | (±)-Miconazole nitrate salt | ESD-812862-100G |
| Cas.: 22832-87-7 | Purity: 98% | (±)-Miconazole nitrate salt | ESD-812862-500G |
| Cas.: 1926-80-3 | Purity: 98% | Methyl 6-aminohexanoate hydrochloride | ESD-844025-100G |
| Cas.: 1067-74-9 | Purity: 98% | Methyl diethylphosphonoacetate | ESD-830210-500G |
| Cas.: 503-40-2 | Purity: ≥97% | Methanedisulphonic acid | ESD-916933-100G |
| Cas.: 68716-52-9 | Purity: ≥98% | 4,4,5,5-Tetramethyl-2-(1-naphthyl)-1,3,2-dioxaborolane | ESD-866042-25G |
| Cas.: 220927-27-5 | Purity: 95% | (S,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl) phenyl)propyl)thio)methyl)cyclopropyl)acetic acid | ESD-917390-100MG |
| Cas.: 220927-27-5 | Purity: 95% | (S,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl) phenyl)propyl)thio)methyl)cyclopropyl)acetic acid | ESD-917390-20MG |
| Cas.: 220927-27-5 | Purity: 95% | (S,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl) phenyl)propyl)thio)methyl)cyclopropyl)acetic acid | ESD-917390-10MG |
| Cas.: 220927-27-5 | Purity: 95% | (S,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl) phenyl)propyl)thio)methyl)cyclopropyl)acetic acid | ESD-917390-5MG |
| Cas.: 4972-31-0 | Purity: ≥97% | 1-(Phenylsulfinyl)piperidine | ESD-863738-1G |
| Cas.: 1111732-87-6 | Purity: ≥98% | Potassium 4-Pyridyltrifluoroborate | ESD-866261-25G |
| Cas.: 267006-26-8 | Purity: 98% | Potassium (3,5-difluorophenyl)trifluoroborate | ESD-886464-25G |
| Cas.: 7757-82-6 | Purity: AR, 99% | Sodium sulfate anhydrous | ESD-818056-10KG |
| Cas.: 7440-42-8 | Purity: Amorphous, 0.5-2μm, 99.9% | Boron | ESD-917391-250G |
| Cas.: 7440-42-8 | Purity: Amorphous, 0.5-2μm, 99.9% | Boron | ESD-917391-50G |
| Cas.: 611-14-3 | Purity: 99% | 2-Ethyltoluene | ESD-809370-500G |
| Cas.: 7440-47-3 | Purity: 99.5%, 200 Mesh | Chromium | ESD-915978-2.5KG |
| Cas.: 69610-40-8 | Purity: 98% | Boc-L-Prolinol | ESD-802793-500G |
| Cas.: 148757-94-2 | Purity: ≥95% | 6-Aminoquinolyl-N-hydroxysuccinimidyl carbamate | ESD-885833-1G |
| Cas.: 13078-04-1 | Purity: 97% | Anabasine | ESD-832766-1G |
| Cas.: 142-45-0 | Purity: 98% | Acetylenedicarboxylic acid | ESD-801124-500G |
| Cas.: 13001-38-2 | Purity: 97% | 1-(2-Cyanostyryl)-4-(4-cyanostyryl)benzene | ESD-908985-500G |
| Cas.: 21142-29-0 | Purity: 98% | 3-(Triethoxysilyl)propyl Methacrylate (stabilized with BHT) | ESD-833973-500G |
| Cas.: 64967-39-1 | Purity: ≥95% | N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly | ESD-835544-500MG |
| Cas.: 366-29-0 | Purity: >= 95% | N,N,N’,N’-Tetramethylbenzidine | ESD-838403-25G |
| Cas.: 1327-41-9 | Purity: Golden yellow, AL2O3≥30% | Aluminum chlorohydrate | ESD-915910-100G |
| Cas.: 16984-48-8 | Purity: 100mg/L, Matrix:water | Fluoride standard | ESD-849985-250ML |
| Cas.: 13325-10-5 | Purity: 98% | 4-Amino-1-butanol | ESD-800773-500G |
| Cas.: 2498-50-2 | Purity: 97% | 4-Aminobenzamidine dihydrochloride | ESD-801163-500G |
| Cas.: 14214-31-4 | Purity: 95% | 2-chloro-3-isothiocyanato-prop-1-ene | ESD-906394-25G |
| Cas.: 22583-75-1 | Purity: 99 atom % D | Benzophenone-d10 | ESD-874372-1G |
| Cas.: 138844-81-2 | Purity: 95% | Sodium Ibandronate | ESD-854873-5G |
| Cas.: 6627-72-1 | Purity: ≥98% | Borneol oil | ESD-917038-500G |
| Cas.: 18771-50-1 | Purity: 80% | Tetrahydrouridine | ESD-881017-5MG |
| Cas.: 4325-85-3 | Purity: 99% | Tris(trimethylsilyl) borate | ESD-829573-500G |
| Cas.: 152751-57-0 | Purity: BR | Sevelamer HCl | ESD-873431-25G |
| Cas.: 152751-57-0 | Purity: BR | Sevelamer HCl | ESD-873431-5G |
| Cas.: 152751-57-0 | Purity: BR | Sevelamer HCl | ESD-873431-500G |
| Cas.: 16034-40-5 | Purity: 97% | N,N-Diphenyl-4-methoxybenzamide | ESD-869472-5G |
| Cas.: 42538-31-8 | Purity: 97% | (S)-3-Aminopipidin-2-one hydrochloride | ESD-844793-1G |
| Cas.: 140-39-6 | Purity: >98.0%(GC) | p-Tolyl Acetate | ESD-859580-100G |
| Cas.: 140-39-6 | Purity: >98.0%(GC) | p-Tolyl Acetate | ESD-859580-500G |
| Cas.: 26495-91-0 | Purity: 95% | CyclohexylaminomethylTriethoxysilane | ESD-833962-100ML |
| Cas.: 19387-91-8 | Purity: 99% | 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole | ESD-823311-2.5KG |
| Cas.: 38275-57-9 | Purity: 97% | 5-Bromopyrimidine-2-carbonitrile | ESD-829723-25G |
| Cas.: 138253-30-2 | Purity: 95% | 4-(2,2′:6′,2”-TERPYRIDIN-4′-YL)BENZALDEHYDE | ESD-888140-100MG |
| Cas.: 580-51-8 | Purity: 97% | 3-Phenylphenol | ESD-816936-100G |
| Cas.: 1103738-29-9 | Purity: 98% | 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene | ESD-843123-100G |
| Cas.: 86-00-0 | Purity: ≥98% | 2-Nitrobiphenyl | ESD-865673-100G |
| Cas.: 63799-11-1 | Purity: 97% | (|S|)-4′-(2-Methylbutyl)[1,1′-biphenyl]-4′-carbonitrile | ESD-818419-25G |
| Cas.: 14098-41-0 | Purity: 96% | Dibenzo-21-crown 7-Ether | ESD-869178-1G |
| Cas.: 120-11-6 | Purity: 98% | 1-(Benzyloxy)-2-methoxy-4-(prop-1-en-1-yl)benzene | ESD-842831-500G |
| Cas.: 27072-45-3 | Purity: 5- and 6-isomer mixture 97% biotech grade | Fluorescein isothiocyanate | ESD-6121-5G |
| Cas.: 5098-14-6 | Purity: 97% | 2-Aminoomalononitrile 4-methylbenzenesulfonate | ESD-843650-100G |
| Cas.: 1170108-38-9 | Purity: ≥95% | 3-(BOC-AMINOMETHYL)AZETIDINE-HCL | ESD-827864-5G |
| Cas.: 61336-70-7 | Purity: 98%, HPLC | Amoxicillin Trihydrate | ESD-822840-500G |
| Cas.: 96-88-8 | Purity: 97% | N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide | ESD-842740-25G |
| Cas.: 96-88-8 | Purity: 97% | N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide | ESD-842740-100G |
| Cas.: 1616493-44-7 | Purity: 99% | HBI-8000, CS-055 | ESD-872857-25MG |
| Cas.: 7472-54-0 | Purity: 98% | 4′-Methoxybenzanilide | ESD-871034-100G |
| Cas.: 110-26-9 | Purity: 99% | N,N′-Methylenebis(acrylamide) | ESD-917392-100G |
| Cas.: 110-26-9 | Purity: 99% | N,N′-Methylenebis(acrylamide) | ESD-917392-250G |
| Cas.: 110-26-9 | Purity: 99% | N,N′-Methylenebis(acrylamide) | ESD-917392-1KG |
| Cas.: 5394-50-3 | Purity: ≥95% | 1,2-Dicarbobenzyloxyhydrazine | ESD-874002-50MG |
| Cas.: 5394-50-3 | Purity: ≥95% | 1,2-Dicarbobenzyloxyhydrazine | ESD-874002-100MG |
| Cas.: 9004-54-0 | Mw=63300g/mol, U=7.6%, K=2 | Molecular Weignt CRM of Dextran | ESD-917395-200MG |
| Cas.: 9004-54-0 | Mw=287000g/mol, U=7.6%, K=2 | Molecular Weignt CRM of Dextran | ESD-917394-200MG |
| Cas.: 9004-54-0 | Mw=556000g/mol, U=7.6%, K=2 | Molecular Weignt CRM of Dextran | ESD-917393-200MG |
| Cas.: 17351-75-6 | Purity: ≥97% | 1,4-Cyclohexanedimethanol divinyl ether | ESD-915252-25G |
| Cas.: 7783-16-6 | Purity: ≥98.5% | Manganese hypophosphite monohydrate | ESD-864414-100G |
| Cas.: 3506-09-0 | Purity: 98% | Propranolol hydrochloride | ESD-854705-5G |
| Cas.: 3506-09-0 | Purity: 98% | Propranolol hydrochloride | ESD-854705-25G |
| Cas.: 3506-09-0 | Purity: 98% | Propranolol hydrochloride | ESD-854705-100G |
| Cas.: 88054-14-2 | Purity: 98% | 5-Methyl-1H-pyrazole | ESD-899742-100G |
| Cas.: 88054-14-2 | Purity: 98% | 5-Methyl-1H-pyrazole | ESD-899742-500G |
| Cas.: 20449-79-0 | Purity: ≥97% (HPLC) | Melittin | ESD-814002-50MG |
| Cas.: 99-40-1 | Purity: 99% | 2-Chloro-3′,4′-dihydroxyacetophenone | ESD-917397-500G |
| Cas.: 99-40-1 | Purity: 99% | 2-Chloro-3′,4′-dihydroxyacetophenone | ESD-917397-100G |
| Cas.: 99-40-1 | Purity: 99% | 2-Chloro-3′,4′-dihydroxyacetophenone | ESD-917397-25G |
| Cas.: 1612-65-3 | Purity: ≥95% | 2-Methyl-1,2,3,4-tetrahydroisoquinoline | ESD-895710-25MG |
| Cas.: 125-65-5 | Purity: ≥95% | (3aS,4R,5S,6S,8R,9R,9aR,12R)-5-Hydroxy-4,6,9,12-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen- 8-yl 2-hydroxyacetate | ESD-850021-5G |
| Cas.: 586379-66-0 | Purity: 98% | PH-797804 | ESD-873797-50MG |
| Cas.: 4124-41-8 | Purity: 98% | p-Toluenesulfonic anhydride | ESD-829595-500G |
| Cas.: 1071-37-0 | Purity: 98% | S-Ethylisothiourea Hydrobromide | ESD-875503-100G |
| Cas.: 39994-75-7 | Purity: 98% | L-Threonine methyl ester hydrochloride | ESD-819885-500G |
| Cas.: 2380-36-1 | Purity: ≥96% | 3,5-Di-Tert-Butylaniline | ESD-858810-250MG |
| Cas.: 149-74-6 | Purity: 99% | Phenylmethyldichlorosilane | ESD-828568-2.5KG |
| Cas.: 1303-58-8 | Purity: 99,9% | Auric oxide | ESD-917398-5G |
| Cas.: 1303-58-8 | Purity: 99,9% | Auric oxide | ESD-917398-1G |
| Cas.: 2495-25-2 | Purity: 98% | Tridecyl Methacrylate | ESD-856940-100ML |
| Cas.: 446-08-2 | Purity: 98% | 2-Amino-5-fluorobenzoic acid | ESD-824056-500G |
| Cas.: 591-12-8 | Purity: 98% | alpha-Angelica lactone | ESD-833324-500G |
| Cas.: 7787-33-9 | Purity: AR | Barium iodide dihydrate | ESD-886137-500G |
| Cas.: 1731-92-6 | Purity: Standard for GC , ≥99%(GC) | Methyl heptadecanoate | ESD-813243-250MG |
| Cas.: 7787-33-9 | Purity: AR | Barium iodide dihydrate | ESD-886137-100G |
| Cas.: 73-03-0 | Purity: 98% | Cordycepin | ESD-805133-1G |
| Cas.: 1201902-80-8 | Purity: ≥98% | MLN9708 | ESD-833081-50MG |
| Cas.: 1201902-80-8 | Purity: ≥98% | MLN9708 | ESD-833081-250MG |
| Cas.: 937-14-4 | Purity: 85% | 3-Chloroperoxybenzoic acid | ESD-804781-1KG |
| Cas.: 6902-77-8 | Purity: 98% | Genipin | ESD-810338-5G |
| Cas.: 7447-40-7 | Purity: 1M | Potassium Chloride Solution | ESD-885141-25ML |
| Cas.: 153773-82-1 | Purity: GR | Ertapenem sodium | ESD-873618-100MG |
| Cas.: 153773-82-1 | Purity: GR | Ertapenem sodium | ESD-873618-500MG |
| Cas.: 49609-84-9 | Purity: 98% | 2-Chloronicotinoyl chloride | ESD-805860-500G |
| Cas.: 19423-85-9 | Purity: 99.99% (REO) | Erbium(III) chloride hydrate | ESD-837121-100G |
| Cas.: 147102-97-4 | Purity: ≥97% | 4-Chloronaphthalene-1-Boronic Acid | ESD-857751-5G |
| Cas.: 147102-97-4 | Purity: ≥97% | 4-Chloronaphthalene-1-Boronic Acid | ESD-857751-25G |
| Cas.: 1332-65-6 | Purity: 95% | Copper oxychloride | ESD-905321-100G |
| Cas.: 7085-85-0 | Purity: 98% | Ethyl 2-cyanoacrylate | ESD-885071-500G |
| Cas.: 7085-85-0 | Purity: ≥95% | Ethyl 2-cyanoacrylate | ESD-887045-500G |
| Cas.: 65218-33-7 | Purity: ≥70% | Fatty acid methyl ester ethoxylate(FMEE) | ESD-905810-2.5KG |
| Cas.: 5137-70-2 | Purity: 98% | Dodecylphosphonic Acid | ESD-849494-100G |
| Cas.: 1254053-43-4 | Purity: 99% | Gilteritinib (ASP2215) | ESD-873062-25MG |
| Cas.: 1254053-43-4 | Purity: 99% | Gilteritinib (ASP2215) | ESD-873062-100MG |
| Cas.: 1670-89-9 | Purity: 97% | 1H-Indole-7-carboxamide | ESD-889962-100MG |
| Cas.: 1670-89-9 | Purity: 97% | 1H-Indole-7-carboxamide | ESD-889962-1G |
| Cas.: 27741-01-1 | Purity: 99% | Geniposidic acid | ESD-917402-100MG |
| Cas.: 27741-01-1 | Purity: 99% | Geniposidic acid | ESD-917402-500MG |
| Cas.: 10519-96-7 | Purity: ≥90%(T) | Potassium trimethylsilanolate | ESD-833301-500G |
| Cas.: 26944-48-9 | Purity: 98% | Glibornuride | ESD-917403-10MG |
| Cas.: 1069-72-3 | Purity: 98% | 2-(Diethylamino)ethyl Bromide Hydrobromide | ESD-870946-25G |
| Cas.: 26944-48-9 | Purity: 98% | Glibornuride | ESD-917403-20MG |
| Cas.: 26944-48-9 | Purity: 98% | Glibornuride | ESD-917403-5MG |
| Cas.: 53179-09-2 | Purity: >98% | Sisomicin sulfate | ESD-860740-25G |
| Cas.: 14418-84-9 | Purity: ≥95% | Prop-2-ene-1-sulfonyl chloride | ESD-915033-25G |
| Cas.: 70693-62-8 | Purity: 42%~46% KHSO5 basis | Potassium monopersulfate triple salt | ESD-821910-2.5KG |
| Cas.: 37222-66-5 | Purity: 4.5%(active oxygen) | Potassium peroxomonosulfate | ESD-829443-1KG |
| Cas.: 37222-66-5 | Purity: 4.5%(active oxygen) | Potassium peroxomonosulfate | ESD-829443-5KG |
| Cas.: 6957-22-8 | Purity: 98% | isonicotinaldehyde (4-pyridylmethylene)hydrazone | ESD-887203-50MG |
| Cas.: 6957-22-8 | Purity: 98% | isonicotinaldehyde (4-pyridylmethylene)hydrazone | ESD-887203-5G |
| Cas.: 1128-67-2 | Purity: ≥95% | 2-Hydrazono-3-methyl-2,3-dihydrobenzo[d]thiazole | ESD-885990-1G |
| Cas.: 160807-49-8 | Purity: ≥98%(HPLC) | Indirubin-3′-oxime | ESD-864250-5MG |
| Cas.: 160807-49-8 | Purity: ≥98%(HPLC) | Indirubin-3′-oxime | ESD-864250-25MG |
| Cas.: 160807-49-8 | Purity: ≥98%(HPLC) | Indirubin-3′-oxime | ESD-864250-100MG |
| Cas.: 1084-76-0 | Purity: 98% | N-(2,4-Dinitrophenyl)glycine | ESD-869851-500MG |
| Cas.: 3585-47-5 | Purity: 95% | 2-(4-propylphenyl)propanoic acid | ESD-909694-100MG |
| Cas.: 3585-47-5 | Purity: 95% | 2-(4-propylphenyl)propanoic acid | ESD-909694-25MG |
| Cas.: 3585-47-5 | Purity: 95% | 2-(4-propylphenyl)propanoic acid | ESD-909694-5MG |
| Cas.: 598-19-6 | Purity: ≥97% | 2-Bromoallyl Alcohol | ESD-860089-100G |
| Cas.: 875756-97-1 | Purity: 98% | HOE 33342 trihydrochloride | ESD-860514-500MG |
| Cas.: 875756-97-1 | Purity: 98% | HOE 33342 trihydrochloride | ESD-860514-100MG |
| Cas.: 875756-97-1 | Purity: 98% | HOE 33342 trihydrochloride | ESD-860514-25MG |
| Cas.: 33252-63-0 | Purity: 97% | 2-Hydroxy-5-(trifluoromethyl)pyridine | ESD-811285-500G |
| Cas.: 610-88-8 | Purity: 99% | Tenuazonic acid | ESD-917404-5MG |
| Cas.: 610-88-8 | Purity: 99% | Tenuazonic acid | ESD-917404-1MG |
| Cas.: 5508-58-7 | Purity: 98% | Andrographolide | ESD-800174-500G |
| Cas.: 4276-49-7 | Purity: 95% | 1-Bromoeicosane | ESD-869102-25G |
| Cas.: 70110-59-7 | Purity: 98% | 5-Heneicosylresorcinol | ESD-877745-25MG |
| Cas.: 70110-59-7 | Purity: 95% | 5-Heneicosylresorcinol | ESD-917405-25MG |
| Cas.: 70110-59-7 | Purity: 95% | 5-Heneicosylresorcinol | ESD-917405-100MG |
| Cas.: 120068-37-3 | Purity: 97% | Fipronil | ESD-902393-100G |
| Cas.: 2524-04-1 | Purity: 97% | Diethyl Chlorothiophosphate | ESD-858380-100G |
| Cas.: 2219-82-1 | Purity: 98% | 2-|tert|-Butyl-6-methyl-phenol | ESD-819685-500G |
| Cas.: 232938-43-1 | Purity: 99% | Benzenesulfonamide,4-methyl-N-[[[3-[[(4-methylphenyl)sulfonyl]oxy]phenyl]amino]carbonyl]- | ESD-916358-50G |
| Cas.: NONE8258 | Purity: pH4.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917406-100ML |
| Cas.: NONE8258 | Purity: pH4.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917406-250ML |
| Cas.: NONE8258 | Purity: pH5.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917407-100ML |
| Cas.: NONE8258 | Purity: pH5.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917407-250ML |
| Cas.: NONE8258 | Purity: pH6.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917408-100ML |
| Cas.: NONE8258 | Purity: pH6.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917408-250ML |
| Cas.: NONE8258 | Purity: pH7.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917409-100ML |
| Cas.: NONE8258 | Purity: pH7.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917409-250ML |
| Cas.: NONE8258 | Purity: pH8.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917410-100ML |
| Cas.: NONE8258 | Purity: pH8.0 | Sodium phosphate dibasic-Citric acid buffer | ESD-917410-250ML |
| Cas.: 363600-92-4 | Purity: ≥98% | C29 | ESD-879345-25MG |
| Cas.: 363600-92-4 | Purity: ≥98% | C29 | ESD-879345-100MG |
| Cas.: 20208-23-5 | Purity: >99.5% | hexane-1,6-diamine dihydroiodide | ESD-904395-1G |
| Cas.: 818-08-6 | Purity: 98% | DIBUTYLTIN OXIDE | ESD-835434-100G |
| Cas.: 2720-73-2 | Purity: >97.0%(T) | Potassium Amylxanthate | ESD-864692-100G |
| Cas.: 6343-54-0 | Purity: ≥98% | N-Benzylformamide | ESD-864874-25G |
| Cas.: 525-66-6 | Purity: >98% | Propranolol | ESD-913471-10MG |
| Cas.: 525-66-6 | Purity: >98% | Propranolol | ESD-913471-50MG |
| Cas.: 525-66-6 | Purity: >98% | Propranolol | ESD-913471-250MG |
| Cas.: 1418013-75-8 | Purity: >98% | NMS-873 | ESD-860874-100MG |
| Cas.: 53220-82-9 | Purity: 95% | Naphthalene, 1-bromo-4-chloro- | ESD-906838-25G |
| Cas.: 39028-27-8 | Purity: ≥95% | N-Succinimidyl Iodoacetate | ESD-917389-1G |
| Cas.: 39028-27-8 | Purity: ≥95% | N-Succinimidyl Iodoacetate | ESD-917389-100MG |
| Cas.: 39028-27-8 | Purity: ≥95% | N-Succinimidyl Iodoacetate | ESD-917389-25MG |
| Cas.: 103177-37-3 | Purity: 99% | Pranlukast | ESD-834103-25G |
| Cas.: 72846-00-5 | Purity: ≥98% | 1-Phenylmethyl-5-phenyl-barbituric acid | ESD-834617-100G |
| Cas.: 107667-60-7 | Purity: 98% | Polaprezinc | ESD-884668-5G |
| Cas.: 107667-60-7 | Purity: 98% | Polaprezinc | ESD-884668-25G |
| Cas.: 107667-60-7 | Purity: 98% | Polaprezinc | ESD-884668-100G |
| Cas.: 14176-50-2 | Purity: BR | Tiletamine Hydrochloride | ESD-872953-25MG |
| Cas.: 28395-03-1 | Purity: 98% | Bumetanide | ESD829399-5G |
| Cas.: 7440-05-3 | Purity: 5.0% Pd basis | Palladium | ESD-823855-25G |
| Cas.: 6250-70-0 | Purity: ≥98% | Nonadecanedioic Acid | ESD-868189-1G |
| Cas.: 6250-70-0 | Purity: ≥98% | Nonadecanedioic Acid | ESD-868189-5G |
| Cas.: 5918-29-6 | Purity: 98% | 14-methyl Palmitic Acid | ESD-912610-5MG |
| Cas.: 1517-22-2 | Purity: 98%, 98 atom%D | Phenanthrene-d10 | ESD-913867-100MG |
| Cas.: 1517-22-2 | Purity: 98%, 98 atom%D | Phenanthrene-d10 | ESD-913867-500MG |
| Cas.: 56296-78-7 | Purity: Analysis control, ≥99%(HPLC) | Fluoxetine hydrochloride | ESD-917411-500MG |
| Cas.: 56296-78-7 | Purity: Analysis control, ≥99%(HPLC) | Fluoxetine hydrochloride | ESD-917411-100MG |
| Cas.: 50-01-1 | Purity: 8M, filter sterilized | DNA-Grade Guanidine Hydrochloride Solution | ESD-917412-100ML |
| Cas.: 50-01-1 | Purity: 8M, filter sterilized | DNA-Grade Guanidine Hydrochloride Solution | ESD-917412-250ML |
| Cas.: 3483-12-3 | Purity: 99.5%, DTT, no enzyme | DL-Dithiothreitol | ESD-917413-1G |
| Cas.: 3483-12-3 | Purity: 99.5%, DTT, no enzyme | DL-Dithiothreitol | ESD-917413-5G |
| Cas.: 3483-12-3 | Purity: 99.5%, DTT, no enzyme | DL-Dithiothreitol | ESD-917413-10G |
| Cas.: 593-84-0 | Purity: filter sterilization | Guanidine Thiocyanate Solution | ESD-917415-100ML |
| Cas.: 593-84-0 | Purity: filter sterilization | Guanidine Thiocyanate Solution | ESD-917415-250ML |
| Cas.: 5961-85-3 | Purity: ≥99%, TCEP, no enzyme | Tris(2-carboxyethyl)phosphine | ESD-917416-5G |
| Cas.: 5961-85-3 | Purity: ≥99%, TCEP, no enzyme | Tris(2-carboxyethyl)phosphine | ESD-917416-25G |
| Cas.: 69-57-8 | Purity: 10KU/mL, filter sterilized, for cell culture | Penicillin G | ESD-917417-100ML |
| Cas.: 7727-54-0 | Purity: 10% | APS Solution | ESD-917418-1ML |
| Cas.: 7727-54-0 | Purity: 10% | APS Solution | ESD-917418-5X1ML |
| Cas.: 7727-54-0 | Purity: 10% | APS Solution | ESD-917418-20X5ML |
| Cas.: 7732-18-5 | Purity: 18.2MΩ, double sterilization by filtration and high temperature, suitable for PCR | Water | ESD-917419-100ML |
| Cas.: 7732-18-5 | Purity: 18.2MΩ, double sterilization by filtration and high temperature, suitable for PCR | Water | ESD-917419-500ML |
| Cas.: 7786-30-3 | Purity: 25mM, double sterilized by filtration and high temperature, suitable for PCR | Magnesium Chloride Solution | ESD-917420-5ML |
| Cas.: 9048-46-8 | Purity: No enzyme | BSA | ESD-917421-50G |
| Cas.: 9048-46-8 | Purity: No enzyme | BSA | ESD-917421-200G |
| Cas.: NONE8259 | Purity: Iron Unbound, Dry Powder, For Cell Culture | APO | ESD-917422-100MG |
| Cas.: NONE8260 | Purity: Iron Saturated, Dry Powder, For Cell Culture | HOLO | ESD-917423-100MG |
| Cas.: NONE8261 | Purity: 35.0 g/L Glucose, No Sodium Chloride, No L-Glutamine, No Sodium Bicarbonate, No Phenol Red, Dry Powder, For Cell Culture | Feed 4 | ESD-917424-10L |
| Cas.: NONE8262 | Purity: Dry Powder, for cell culture | Phosphoprotease | ESD-917425-100G |
| Cas.: NONE8262 | Purity: Dry Powder, for cell culture | Phosphoprotease | ESD-917425-1KG |
| Cas.: NONE8263 | Purity: Dry Powder, for cell culture | Collagenase, Type I | ESD-917426-100MG |
| Cas.: NONE8264 | Purity: Dry Powder, for cell culture | Collagenase,Type II | ESD-917427-100MG |
| Cas.: NONE8265 | Purity: Dry Powder, for cell culture | Collagenase, Type IV | ESD-917428-100MG |
| Cas.: NONE8266 | Purity: Low Endotoxin, Low Fatty Acid, Dry Powder, Cell Culture | Bovine Serum Albumin | ESD-917429-10G |
| Cas.: NONE8267 | Purity: Low Endotoxin, Dry Powder, For Cell Culture | Bovine Serum Albumin | ESD-917430-10G |
| Cas.: NONE8268 | Purity: Dry Powder, for cell culture | Block Polyether F-68 | ESD-917431-1KG |
| Cas.: NONE8269 | Purity: High Glucose, Sodium acetone, Sodium Bicarbonate Free, HEPES Free, Phenol Red, Dry Powder, For Cell Culture | DMEM Medium | ESD-917432-10L |
| Cas.: NONE8270 | Purity: High Glucose, Sodium acetone, Sodium Bicarbonate Free, HEPES, L-Glutamine, Phenol Red, Dry Powder, For Cell Culture | DMEM Medium | ESD-917433-100L |
| Cas.: NONE8271 | Purity: Earle’s Balanced Salts, L-Glutamine, Phenol Red, Non-Essential Amino Acids, Powder, For Cell Culture | MEMα Medium | ESD-917434-10L |
| Cas.: NONE8272 | Purity: High Sugar, No Sodium Bicarbonate, No L-Glutamine, No HT Additives, No Phenol Red, Dry Powder, For Cell Culture | CHO CD1 Serum-Free Medium | ESD-917435-10L |
| Cas.: NONE8273 | Purity: 6.0 g/L Glucose, No Sodium Bicarbonate, No L-Glutamine, No HT Additive, No Phenol Red, No Sodium Chloride, Dry Powder, For Cell Culture | CHO CD2 Serum-Free Medium | ESD-917436-10L |
| Cas.: NONE8274 | Purity: High Sugar, No Sodium Bicarbonate, No L-Glutamine, No Phenol Red, Dry Powder, For Cell Culture | CHO CD3 Serum-Free Medium | ESD-917437-10L |
| Cas.: NONE8275 | Purity: 5.5 g/L Glucose, No Sodium Bicarbonate, No L-Glutamine, No HT Additive, No Phenol Red, No Sodium Chloride, Dry Powder, For Cell Culture | CHO CD4 Serum-Free Medium | ESD-917438-10L |
| Cas.: NONE8276 | Purity: Dry Powder, for cell culture | CHO CD5 Serum-Free Medium | ESD-917439-10L |
| Cas.: NONE8277 | Purity: High Sugar, No Sodium Bicarbonate, No L-Glutamine, No Phenol Red, Dry Powder, For Cell Culture | CHO CD18 Serum-Free Medium | ESD-917440-10L |
| Cas.: NONE8278 | Purity: High Sugar, No Sodium Bicarbonate, No L-Glutamine, No Phenol Red, Dry Powder, For Cell Culture | CHO CD19 Serum-Free Medium | ESD-917441-10L |
| Cas.: NONE8279 | Purity: 15.0 g/L Glucose, No Sodium Chloride, No L-Glutamine, No Sodium Bicarbonate, No Phenol Red, Dry Powder, For Cell Culture | Feed 1 | ESD-917442-10L |
| Cas.: NONE8280 | Purity: 24.0 g/L Glucose, Sodium Bicarbonate, Sodium Chloride Free, L-Glutamine Free, Phenol Red Free, Dry Powder, for Cell Culture | Feed 2 | ESD-917443-10L |
| Cas.: NONE8281 | Purity: 80.0 g/L Glucose, Sodium Chloride, No L-Glutamine, No Sodium Bicarbonate, No Phenol Red, Dry Powder, For Cell Culture | Feed 3 | ESD-917444-10L |
| Cas.: NONE8282 | Purity: 60.0 g/L Glucose, No HT Additive, No L-Glutamine, No Sodium Bicarbonate, No Phenol Red, Dry Powder, For Cell Culture | Feed 18 Set | ESD-917445-10+1L/EA |
| Cas.: NONE8283 | Purity: 60.0 g/L Glucose, No L-Glutamine, No Sodium Bicarbonate, No Phenol Red, Dry Powder, For Cell Culture | Feed 19 Set | ESD-917446-10+1L/EA |
| Cas.: NONE8284 | Purity: Dry Powder, for cell culture | CEF Cell Low-Serum Medium | ESD-917447-10L |
| Cas.: NONE8285 | Purity: Dry Powder, for cell culture | BHK-21 Serum-free Medium | ESD-917448-10L |
| Cas.: NONE8286 | Purity: Dry Powder, for cell culture | CD BHK Serum-free Medium | ESD-917449-10L |
| Cas.: NONE8287 | Purity: Dry Powder, for cell culture | CD Hela Serum-free Medium | ESD-917450-10L |
| Cas.: NONE8288 | Purity: Dry Powder, for cell culture | MDBK-S Serum-free Medium | ESD-917451-10L |
| Cas.: NONE8289 | Purity: Dry Powder, for cell culture | MDCK-S Serum-free Medium | ESD-917452-10L |
| Cas.: NONE8290 | Purity: Medium to High Sugar, No Sodium Bicarbonate, No L-Glutamine, Phenol Red, Dry Powder, For Cell Culture | MSVP Serum-free Medium | ESD-917453-10L |
| Cas.: NONE8291 | Purity: High Glucose, L-Glutamine, Sodium Bicarbonate Free, Phenol Red, Dry Powder, For Cell Culture | PK-15-S Serum-free Medium | ESD-917454-10L |
| Cas.: NONE8292 | Purity: Dry Powder, for cell culture | ST Serum-free Medium | ESD-917455-10L |
| Cas.: NONE8293 | Purity: Dry Powder, for cell culture | ST-S Serum-free Medium | ESD-917456-10L |
| Cas.: NONE8294 | Purity: Dry Powder, for cell culture | CD Vero-S Serum-free Medium | ESD-917457-10L |
| Cas.: NONE8295 | Purity: Dry Powder, for cell culture | Vero-A Serum-free Medium | ESD-917458-10L |
| Cas.: NONE8296 | Purity: Dry Powder, for cell culture | DF-1 Serum-free Medium | ESD-917459-10L |
| Cas.: NONE8297 | Purity: Dry Powder, for cell culture | LMH Low-Serum Medium | ESD-917460-10L |
| Cas.: NONE8298 | Purity: Dry Powder, for cell culture | HDC Serum-free Medium | ESD-917461-10L |
| Cas.: NONE8299 | Purity: Dry Powder, for cell culture | Mycoplasma Serum-free Medium | ESD-917462-10L |
| Cas.: NONE8300 | Purity: Dry Powder, for cell culture | Insect Serum-free Medium | ESD-917463-10L |
| Cas.: NONE8301 | Purity: Animal Origin Free, Dry Powder, For Cell Culture | Sf9 Insect Serum-free Medium | ESD-917464-10L |
| Cas.: NONE8302 | Purity: Dry Powder, for cell culture | Insect Serum-free Medium Feed | ESD-917465-10L |
| Cas.: NONE8303 | Purity: Dry Powder, for cell culture | Reduced Glutathione | ESD-917466-5G |
| Cas.: NONE8304 | Purity: Ready-to-use Dry Powder, enzyme free | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917467-1L |
| Cas.: NONE8304 | Purity: Ready-to-use Dry Powder, enzyme free | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917467-10L |
| Cas.: NONE8305 | Purity: Ready-to-use Dry Powder, enzyme free | Native-PAGE Electrophoresis Buffer | ESD-917468-1L |
| Cas.: NONE8305 | Purity: Ready-to-use Dry Powder, enzyme free | Native-PAGE Electrophoresis Buffer | ESD-917468-10L |
| Cas.: NONE8307 | Purity: Does not contain calcium, magnesium and phenol red, Dry Powder, sterile without enzymes, suitable for cell culture | EBSS | ESD-917470-100L |
| Cas.: NONE8308 | Purity: Dry Powder, sterile, enzyme-free, for cell culture | HEPES | ESD-917471-100G |
| Cas.: NONE8308 | Purity: Dry Powder, sterile, enzyme-free, for cell culture | HEPES | ESD-917471-1KG |
| Cas.: NONE8309 | Purity: Denatured, 10%, 10-well, sterile enzyme-free | Precast Nucleic Acid Gel | ESD-917472-10EA |
| Cas.: NONE8310 | Purity: Denatured, 10%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917473-10EA |
| Cas.: NONE8311 | Purity: Native, 10%, 10-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917474-10EA |
| Cas.: NONE8312 | Purity: Native, 10%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917475-10EA |
| Cas.: NONE8313 | Purity: Denatured, 15%, 10-well, sterile enzyme-free | Precast Nucleic Acid Gel | ESD-917476-10EA |
| Cas.: NONE8314 | Purity: Denatured, 15%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917477-10EA |
| Cas.: NONE8315 | Purity: Native, 15%, 10-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917478-10EA |
| Cas.: NONE8316 | Purity: Native, 15%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917479-10EA |
| Cas.: NONE8317 | Purity: Denatured, 5%, 10-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917480-10EA |
| Cas.: NONE8318 | Purity: Denatured, 5%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917481-10EA |
| Cas.: NONE8319 | Purity: Native, 5%, 10-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917482-10EA |
| Cas.: NONE8320 | Purity: Native, 5%, 15-well, sterile, enzyme-free | Precast Nucleic Acid Gel | ESD-917483-10EA |
| Cas.: NONE8321 | Purity: 100mM, double sterilized by filtration and high temperature | dATP | ESD-917484-100ΜL |
| Cas.: NONE8321 | Purity: 100mM, double sterilized by filtration and high temperature | dATP | ESD-917484-400ΜL |
| Cas.: NONE8322 | Purity: 100mM, double sterilized by filtration and high temperature | dCTP | ESD-917485-100ΜL |
| Cas.: NONE8322 | Purity: 100mM, double sterilized by filtration and high temperature | dCTP | ESD-917485-400ΜL |
| Cas.: NONE8323 | Purity: 100mM, double sterilized by filtration and high temperature | dGTP | ESD-917486-100ΜL |
| Cas.: NONE8323 | Purity: 100mM, double sterilized by filtration and high temperature | dGTP | ESD-917486-400ΜL |
| Cas.: NONE8324 | Purity: 100mM, double sterilized by filtration and high temperature | dTTP | ESD-917487-500ΜL |
| Cas.: NONE8324 | Purity: 100mM, double sterilized by filtration and high temperature | dTTP | ESD-917487-1ML |
| Cas.: NONE8325 | Purity: 100mM, double sterilized by filtration and high temperature | dUTP | ESD-917488-250ΜL |
| Cas.: NONE8325 | Purity: 100mM, double sterilized by filtration and high temperature | dUTP | ESD-917488-1ML |
| Cas.: NONE8326 | Purity: each 100mM, 4×, double sterilized by filtration and high temperature | dNTPs | ESD-917489-1ML |
| Cas.: NONE8326 | Purity: each 100mM, 4×, double sterilized by filtration and high temperature | dNTPs | ESD-917489-5ML |
| Cas.: NONE8327 | Purity: each 10mM, double sterilized by filtration and high temperature | dNTPs Mix | ESD-917490-4X100ΜL |
| Cas.: NONE8327 | Purity: each 10mM, double sterilized by filtration and high temperature | dNTPs Mix | ESD-917490-4X400ΜL |
| Cas.: NONE8327 | Purity: each 10mM, double sterilized by filtration and high temperature | dNTPs Mix | ESD-917490-4X1ML |
| Cas.: NONE8328 | Purity: each 2.5mM, double sterilized by filtration and high temperature | dNTP Mixture | ESD-917491-500ΜL |
| Cas.: NONE8328 | Purity: each 2.5mM, double sterilized by filtration and high temperature | dNTP Mixture | ESD-917491-1ML |
| Cas.: NONE8328 | Purity: each 2.5mM, double sterilized by filtration and high temperature | dNTP Mixture | ESD-917491-10X1ML |
| Cas.: NONE8329 | Purity: each 25mM, double sterilized by filtration and high temperature | dNTP Mixture | ESD-917492-1ML |
| Cas.: NONE8330 | Purity: each 2.5/5mM, double sterilized by filtration and high temperature | dNTP/dUTP Mixture | ESD-917493-100ΜL |
| Cas.: NONE8330 | Purity: each 2.5/5mM, double sterilized by filtration and high temperature | dNTP/dUTP Mixture | ESD-917493-400ΜL |
| Cas.: NONE8331 | Purity: 0.1M, pH8.0, 10×, double sterilization by filtration and high temperature | TE Buffer | ESD-917494-100ML |
| Cas.: NONE8331 | Purity: 0.1M, pH8.0, 10×, double sterilization by filtration and high temperature | TE Buffer | ESD-917494-250ML |
| Cas.: NONE8332 | Purity: 0.2M, pH7.4, 20×, double sterilization by filtration and high temperature | TE Buffer | ESD-917495-100ML |
| Cas.: NONE8332 | Purity: 0.2M, pH7.4, 20×, double sterilization by filtration and high temperature | TE Buffer | ESD-917495-250ML |
| Cas.: NONE8333 | Purity: 10mM, pH7.4, 1×, double sterilized by filtration and high temperature | TE Buffer | ESD-917496-100ML |
| Cas.: NONE8333 | Purity: 10mM, pH7.4, 1×, double sterilized by filtration and high temperature | TE Buffer | ESD-917496-250ML |
| Cas.: NONE8334 | Purity: 0.25%, filter sterilized, for cell culture | Pancreatin EDTA solution | ESD-917497-100ML |
| Cas.: NONE8334 | Purity: 0.25%, filter sterilized, for cell culture | Pancreatin EDTA solution | ESD-917497-500ML |
| Cas.: NONE8335 | Purity: 0.25%, does not contain phenol red, filter sterilized, suitable for cell culture | Trypsin-EDTA Solution | ESD-917498-100ML |
| Cas.: NONE8336 | Purity: 0.005, filter sterilized, for cell culture | Trypsin-EDTA Solution | ESD-917499-100ML |
| Cas.: NONE8337 | Purity: 0.0025, filter sterilized, for cell culture | Trypsin-EDTA Solution | ESD-917500-100ML |
| Cas.: NONE8337 | Purity: 0.0025, filter sterilized, for cell culture | Trypsin-EDTA Solution | ESD-917500-500ML |
| Cas.: NONE8338 | Purity: 10×, filter sterilized, for cell culture | Recombinant Trypsin Solution | ESD-917501-100ML |
| Cas.: NONE8338 | Purity: 10×, filter sterilized, for cell culture | Recombinant Trypsin Solution | ESD-917501-500ML |
| Cas.: NONE8339 | Purity: 0.0025, filter sterilized, for cell culture | trypsin | ESD-917502-100ML |
| Cas.: NONE8340 | Purity: 0.25%, dissolved in PBS, filter sterilized, suitable for cell culture | trypsin | ESD-917503-100ML |
| Cas.: NONE8341 | Purity: 0.25%/0.02%, filter sterilized, for cell culture | Trypsin/EYCA | ESD-917504-100ML |
| Cas.: NONE8342 | Purity: 0.05%/0.02%, dissolved in PBS, filter sterilized, suitable for cell culture | Trypsin/EYCA | ESD-917505-100ML |
| Cas.: NONE8343 | Purity: 200mM, 100×, filter sterilized, for cell culture | L-Glutamine Solution | ESD-917506-100ML |
| Cas.: NONE8344 | Purity: 100×, filter sterilized, for cell culture | MEM Vitamin Solution | ESD-917507-100ML |
| Cas.: NONE8345 | Purity: 50×, filter sterilized, for cell culture | HAT Additive | ESD-917508-100ML |
| Cas.: NONE8346 | Purity: 50×, filter sterilized, for cell culture | GS Additives | ESD-917509-100ML |
| Cas.: NONE8346 | Purity: 50×, filter sterilized, for cell culture | GS Additives | ESD-917509-500ML |
| Cas.: NONE8347 | Purity: Does not contain phenol red, filter sterilized, suitable for cell culture | MSC Amplification Medium | ESD-917510-100ML |
| Cas.: NONE8347 | Purity: Does not contain phenol red, filter sterilized, suitable for cell culture | MSC Amplification Medium | ESD-917510-500ML |
| Cas.: NONE8348 | Purity: contains serum and PHA-M, filter sterilized, suitable for cell culture | Peripheral Blood Lymphocyte Medium | ESD-917511-5ML |
| Cas.: NONE8349 | Purity: 50×, filter sterilized, for cell culture | B-27 Serum-free Additives | ESD-917512-10ML |
| Cas.: NONE8350 | Purity: 50×, does not contain vitamin A, filter sterilized, suitable for cell culture | B-27 Serum-free Additives | ESD-917513-10ML |
| Cas.: NONE8351 | Purity: 50×, does not contain antioxidants, filter sterilized, for cell culture | B-27 Serum-free Additives | ESD-917514-10ML |
| Cas.: NONE8352 | Purity: 100×, filter sterilized, for cell culture | B-27 Serum-free Additives | ESD-917515-5ML |
| Cas.: NONE8353 | Purity: contains EDTA, does not contain phenol red, filter sterilized, suitable for cell culture | Trypsin-EDTA Solution | ESD-917516-100ML |
| Cas.: NONE8354 | Purity: contains EDTA, contains phenol red, filter sterilized, suitable for cell culture | Trypsin-EDTA Solution | ESD-917517-100ML |
| Cas.: NONE8355 | Purity: Does not contain EDTA, does not contain phenol red, filter sterilized, suitable for cell culture | Trypsin Solution | ESD-917518-100ML |
| Cas.: NONE8356 | Purity: 10×, does not contain phenol red, filter sterilized, suitable for cell culture | Recombinant trypsin digestive fluid | ESD-917519-100ML |
| Cas.: NONE8356 | Purity: 10×, does not contain phenol red, filter sterilized, suitable for cell culture | Recombinant trypsin digestive fluid | ESD-917519-500ML |
| Cas.: NONE8357 | Purity: Does not contain phenol red, filter sterilized, suitable for cell culture | Recombinant Trypsin Solution | ESD-917520-100ML |
| Cas.: NONE8357 | Purity: Does not contain phenol red, filter sterilized, suitable for cell culture | Recombinant Trypsin Solution | ESD-917520-500ML |
| Cas.: NONE8358 | Purity: 100×, filter sterilized, for cell culture | Sodium Pyruvate Solution | ESD-917521-100ML |
| Cas.: NONE8359 | Purity: 100×, filter sterilized, for cell culture | Promoting Cell Adhesion Additives | ESD-917522-1ML |
| Cas.: NONE8360 | Purity: 0.02%, filter sterilized, for cell culture | EDTA | ESD-917523-100ML |
| Cas.: NONE8361 | Purity: High sugar, sodium acetone, low sodium bicarbonate, HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917524-500ML |
| Cas.: NONE8362 | Purity: High sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917525-500ML |
| Cas.: NONE8363 | Purity: High sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red free, filter sterilized, for cell culture | DMEM Medium | ESD-917526-500ML |
| Cas.: NONE8364 | Purity: High sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine free, phenol red free, filter sterilized, cell culture friendly | DMEM Medium | ESD-917527-500ML |
| Cas.: NONE8365 | Purity: High sugar, sodium acetone free, low sodium bicarbonate, low HEPES, L-glutamine, phenol red, filter sterilized, cell culture friendly | DMEM Medium | ESD-917528-500ML |
| Cas.: NONE8366 | Purity: pH7.0-7.5, high sugar, sodium acetone, sodium bicarbonate, HEPES free, high L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917529-500ML |
| Cas.: NONE8367 | Purity: pH7.0-7.5, high sugar, sodium acetone, sodium bicarbonate, high HEPES, high L-glutamine, phenol red, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917530-500ML |
| Cas.: NONE8368 | Purity: pH7.0-7.5, high sugar, no sodium acetone, low sodium bicarbonate, L-glutamine, phenol red, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917531-500ML |
| Cas.: NONE8369 | Purity: pH7.0-7.5, high sugar, sodium acetone, sodium bicarbonate, high L-glutamine, phenol red free, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917532-500ML |
| Cas.: NONE8370 | Purity: High sugar, sodium acetone, HEPES free, high L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917533-500ML |
| Cas.: NONE8371 | Purity: High sugar, sodium acetone free, HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917534-500ML |
| Cas.: NONE8372 | Purity: High sugar, sodium acetone free, HEPES, high L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917535-500ML |
| Cas.: NONE8373 | Purity: High in sugar, sodium acetone, free of HEPES and L-glutamine, phenol red, nonessential amino acids, filter sterilized, for cell culture | DMEM Medium | ESD-917536-500ML |
| Cas.: NONE8374 | Purity: High Glucose, L-Glutamine Free, Phenol Red, Filter Sterilized, For Cell Culture | DMEM Medium | ESD-917537-500ML |
| Cas.: NONE8375 | Purity: Low sugar, sodium acetone, low sodium bicarbonate, HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917538-500ML |
| Cas.: NONE8376 | Purity: Low sugar, sodium acetone, low sodium bicarbonate, low HEPES, no L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917539-500ML |
| Cas.: NONE8377 | Purity: Low sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red free, filter sterilized, for cell culture | DMEM Medium | ESD-917540-500ML |
| Cas.: NONE8378 | Purity: Low sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917541-500ML |
| Cas.: NONE8379 | Purity: sugar free, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917542-500ML |
| Cas.: NONE8380 | Purity: pH7.0-7.5, low sugar, sodium acetone, sodium bicarbonate, high HEPES, high L-glutamine, phenol red, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917543-500ML |
| Cas.: NONE8381 | Purity: pH7.0-7.5, low sugar, sodium acetone, sodium bicarbonate, high L-glutamine, phenol red, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917544-500ML |
| Cas.: NONE8382 | Purity: Low sugar, sodium acetone, HEPES free, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM Medium | ESD-917545-500ML |
| Cas.: NONE8383 | Purity: pH7.0-7.5, sugar free, sodium acetone, phenol red, L-alanyl-glutamine, filter sterilized, suitable for cell culture | DMEM Medium | ESD-917546-500ML |
| Cas.: NONE8384 | Purity: Earle’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917547-500ML |
| Cas.: NONE8385 | Purity: Earle’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, Low HEPES, No L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917548-500ML |
| Cas.: NONE8386 | Purity: Hanks’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917549-500ML |
| Cas.: NONE8387 | Purity: Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917550-500ML |
| Cas.: NONE8388 | Purity: Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, Nonessential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917551-500ML |
| Cas.: NONE8389 | Purity: Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917552-500ML |
| Cas.: NONE8390 | Purity: Earle’s Balanced Salts, Ultra High Sugar, Sodium Bicarbonate, Low HEPES, No L-Glutamine, Phenol Red, Nonessential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917553-500ML |
| Cas.: NONE8391 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine Free, Phenol Red, Filter Sterile, Cell Culture Suitable | MEM Medium | ESD-917554-500ML |
| Cas.: NONE8392 | Purity: pH7.0-7.5, Hanks’ Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Suitable | MEM Medium | ESD-917555-500ML |
| Cas.: NONE8393 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Suitable | MEM Medium | ESD-917556-500ML |
| Cas.: NONE8394 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, Nonessential Amino Acids, Filter Sterile, Cell Culture Suitable | MEM Medium | ESD-917557-500ML |
| Cas.: NONE8395 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Low Sugar, Low Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Suitable | MEM Medium | ESD-917558-500ML |
| Cas.: NONE8396 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Ultra High Sugar, Sodium Bicarbonate, Low HEPES, L-Alanyl-Glutamine Free, Phenol Red, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917559-500ML |
| Cas.: NONE8397 | Purity: pH7.0-7.5, Earle’s Balanced Salts, Low Sugar, Sodium Bicarbonate, HEPES, L-Alanyl-Glutamine, Phenol Red, Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | MEM Medium | ESD-917560-500ML |
| Cas.: NONE8398 | Purity: Earle’s Balanced Salts, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | MEM Medium | ESD-917561-500ML |
| Cas.: NONE8399 | Purity: Sodium acetone, L-Glutamine Free, Phenol Red, Non-Essential Amino Acids, Filter Sterile, For Cell Culture | MEM Medium | ESD-917562-500ML |
| Cas.: NONE8400 | Purity: Sodium acetone, HEPESL-glutamine, phenol red, reduced serum, filter sterilized, for cell culture | MEM Medium | ESD-917563-100ML |
| Cas.: NONE8400 | Purity: Sodium acetone, HEPESL-glutamine, phenol red, reduced serum, filter sterilized, for cell culture | MEM Medium | ESD-917563-500ML |
| Cas.: NONE8401 | Purity: Sodium acetone, low sodium bicarbonate, L-glutamine, phenol red, nonessential amino acids, filter sterilized, for cell culture | MEM Medium | ESD-917564-500ML |
| Cas.: NONE8402 | Purity: Earle’s Balanced Salts, L-Glutamine, Phenol Red, Nonessential Amino Acids, Filter Sterile, For Cell Culture | MEM Medium | ESD-917565-500ML |
| Cas.: NONE8403 | Purity: L-Glutamine, Phenol Red, Nucleoside and Deoxynucleoside Free, Filter Sterile, For Cell Culture | MEMα Medium | ESD-917566-500ML |
| Cas.: NONE8404 | Purity: L-Glutamine, Phenol Red Free, Nucleoside Free, Deoxynucleoside, Filter Sterilized, For Cell Culture | MEMα Medium | ESD-917567-500ML |
| Cas.: NONE8405 | Purity: L-Glutamine, Phenol Red, Nucleosides, Deoxynucleosides, Filter Sterilized, For Cell Culture | MEMα Medium | ESD-917568-500ML |
| Cas.: NONE8406 | Purity: Earle’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Suitable | RPMI 1640 Medium | ESD-917569-500ML |
| Cas.: NONE8407 | Purity: High sugar, sodium acetone, low sodium bicarbonate, low HEPES, L-glutamine, phenol red, ATCC modified, filter sterilized, cell culture suitable | RPMI 1640 Medium | ESD-917570-500ML |
| Cas.: NONE8408 | Purity: Earle’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, Low HEPES, No L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Friendly | RPMI 1640 Medium | ESD-917571-500ML |
| Cas.: NONE8409 | Purity: Earle’s Balanced Salts, Low to Medium Sugar, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red Free, Filter Sterile, Cell Culture Friendly | RPMI 1640 Medium | ESD-917572-500ML |
| Cas.: NONE8410 | Purity: Low to Medium Sugar, Low Sodium Bicarbonate, L-Glutamine Free, Phenol Red, Filter Sterilized, For Cell Culture | RPMI 1640 Medium | ESD-917573-500ML |
| Cas.: NONE8411 | Purity: Medium to high sugar, sodium acetone, low sodium bicarbonate, L-glutamine, phenol red, filter sterilized, for cell culture | RPMI 1640 Medium | ESD-917574-500ML |
| Cas.: NONE8412 | Purity: Low to medium sugar, low sodium bicarbonate, low HEPES, L-glutamine, phenol red free, filter sterilized, for cell culture | RPMI 1640 Medium | ESD-917575-500ML |
| Cas.: NONE8413 | Purity: Medium to high sugar, sodium acetone, low sodium bicarbonate, high HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | RPMI 1640 Medium | ESD-917576-500ML |
| Cas.: NONE8414 | Purity: HEPES, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | RPMI 1640 Medium | ESD-917577-500ML |
| Cas.: NONE8415 | Purity: HEPES Free, L-Glutamine Free, Phenol Red Free, Filter Sterilized, For Cell Culture | RPMI 1640 Medium | ESD-917578-500ML |
| Cas.: NONE8416 | Purity: High Glucose, Sodium acetone, Low Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red, Reduced Serum, Filter Sterile, Cell Culture Suitable | RPMI 1640 Medium | ESD-917579-500ML |
| Cas.: NONE8417 | Purity: Sugar Free, HEPES Free, L-Glutamine, Phenol Red, Filter Sterilized, For Cell Culture | RPMI 1640 Medium | ESD-917580-500ML |
| Cas.: NONE8418 | Purity: Pyridoxine hydrochloride, low sodium bicarbonate, HEPES, L-glutamine, phenol red, filter sterilized, for cell culture | DMEM/F12 | ESD-917581-500ML |
| Cas.: NONE8419 | Purity: Pyridoxine hydrochloride, low sodium bicarbonate, HEPES, L-glutamine, phenol red free, filter sterilized, for cell culture | DMEM/F12 | ESD-917582-500ML |
| Cas.: NONE8420 | Purity: Pyridoxine hydrochloride, low sodium bicarbonate, HEPES, L-glutamine free, phenol red, filter sterilized, for cell culture | DMEM/F12 | ESD-917583-500ML |
| Cas.: NONE8421 | Purity: pH7.2±0.2, Pyridoxine Hydrochloride, Sodium Bicarbonate, Low HEPES, No L-Glutamine, Phenol Red, Filter Sterile, Cell Culture Applicable | DMEM/F12 | ESD-917584-500ML |
| Cas.: NONE8422 | Purity: pH7.2±0.2, Pyridoxine Hydrochloride, Sodium Bicarbonate, Low HEPES, L-Glutamine, Phenol Red Free, Filter Sterile, Cell Culture Applicable | DMEM/F12 | ESD-917585-500ML |
| Cas.: NONE8423 | Purity: pH7.2±0.2, Pyridoxine Hydrochloride, Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, Filter Sterilized, Suitable for Cell Culture | DMEM/F12 | ESD-917586-500ML |
| Cas.: NONE8424 | Purity: HEPES, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | DMEM/F12 | ESD-917587-500ML |
| Cas.: NONE8425 | Purity: HEPES Free, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | DMEM/F12 | ESD-917588-500ML |
| Cas.: NONE8426 | Purity: HEPES Free, L-Glutamine Free, Phenol Red, Filter Sterilized, For Cell Culture | DMEM/F12 | ESD-917589-500ML |
| Cas.: NONE8427 | Purity: Sodium acetone, HEPES, L-glutamine, phenol red free, filter sterilized, for cell culture | DMEM/F12 | ESD-917590-500ML |
| Cas.: NONE8428 | Purity: HEPES, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | DMEM/F12 | ESD-917591-500ML |
| Cas.: NONE8429 | Purity: HEPES free, L-glutamine free, filter sterilized, for cell culture | DMEM/F12 | ESD-917592-500ML |
| Cas.: NONE8430 | Purity: L-Glutamine, Phenol Red, Filter Sterilized, For Cell Culture | F-12 Medium | ESD-917593-500ML |
| Cas.: NONE8431 | Purity: Kaighn’s Modified, L-Glutamine, Phenol Red, Filter Sterile, For Cell Culture | F-12K Medium | ESD-917594-500ML |
| Cas.: NONE8432 | Purity: Sugar Free, Sodium Bicarbonate, HEPES, L-Glutamine, Phenol Red, No Non-Essential Amino Acids, Filter Sterile, Cell Culture Friendly | IMDM Medium | ESD-917595-500ML |
| Cas.: NONE8433 | Purity: pH7.0-7.5, High Sugar, Sodium Bicarbonate, HEPES, L-Alanyl-Glutamine, Phenol Red, Filter Sterile, Suitable for Cell Culture | IMDM Medium | ESD-917596-500ML |
| Cas.: NONE8434 | Purity: Sodium acetone, HEPES L-glutamine, free of α-thioglycerol and β-mercapto Ethanol, filter sterilized, for cell culture | IMDM Medium | ESD-917597-500ML |
| Cas.: NONE8435 | Purity: Sugar Free, HEPES Free, L-Glutamine, Phenol Red, Filter Sterilized, For Cell Culture | L-15 Medium | ESD-917598-500ML |
| Cas.: NONE8436 | Purity: pH7.2±0.2, no glucose, no sodium bicarbonate, L-alanyl-glutamine, phenol red, filter sterilized, suitable for cell culture | L-15 Medium | ESD-917599-500ML |
| Cas.: NONE8437 | Purity: Glucose free, D-Galactose free, Sodium acetone free, Sodium bicarbonate free, L-Glutamine free, Phenol red, Filter sterilized, Cell culture friendly | L-15 Medium | ESD-917600-500ML |
| Cas.: NONE8438 | Purity: Low to medium sugar, low sodium bicarbonate, HEPES free, L-glutamine, phenol red, filter sterilized, for cell culture | M199 Medium | ESD-917601-500ML |
| Cas.: NONE8439 | Purity: HEPESL-Glutamine Free, Phenol Red, Filter Sterilized, For Cell Culture | M199 Medium | ESD-917602-500ML |
| Cas.: NONE8440 | Purity: Low to Medium Sugar, Low Sodium Bicarbonate, L-Glutamine, Phenol Red, Non-Essential Amino Acids, Filter Sterilized, For Cell Culture | McCoy’s 5A Medium | ESD-917603-500ML |
| Cas.: NONE8441 | Purity: pH7.0-7.5, low to medium sugar, low sodium bicarbonate, L-alanyl-glutamine, phenol red, filter sterilized, suitable for cell culture | McCoy’s 5A Medium | ESD-917604-500ML |
| Cas.: NONE8442 | Purity: Low to medium sugar, HEPES free, Sodium acetone free, Bacterial peptone, Filter sterilized, for cell culture | McCoy’s 5A Medium | ESD-917605-500ML |
| Cas.: NONE8443 | Purity: Low to medium sugar, sodium acetone, low sodium bicarbonate, HEPES free, L-glutamine free, phenol red free, glycine, filter sterilized, for cell culture | Williams Medium E | ESD-917606-500ML |
| Cas.: NONE8444 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, No HT Additives, Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD1 Serum-Free Medium | ESD-917607-500ML |
| Cas.: NONE8445 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, No HT Additives, Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD2 Serum-Free Medium | ESD-917608-500ML |
| Cas.: NONE8446 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, No HT Additives, No Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD3 Serum-Free Medium | ESD-917609-500ML |
| Cas.: NONE8447 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, No HT Additives, Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD4 Serum-Free Medium | ESD-917610-500ML |
| Cas.: NONE8448 | Purity: High Sugar, Sodium Bicarbonate, L-Glutamine Free, HT Additive, Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD6 Serum-Free Medium | ESD-917611-500ML |
| Cas.: NONE8449 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, HT Additive, No Phenol Red, Filter Sterilized, For Cell Culture | CHO CD18 Serum-Free Medium | ESD-917612-500ML |
| Cas.: NONE8450 | Purity: High Sugar, Sodium Bicarbonate, No L-Glutamine, No HT Additives, No Phenol Red, Filter Sterile, Cell Culture Suitable | CHO CD19 Serum-Free Medium | ESD-917613-500ML |
| Cas.: NONE8451 | Purity: 15.0 g/L glucose, no sodium chloride, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | Feed 1 | ESD-917614-500ML |
| Cas.: NONE8452 | Purity: 24.0 g/L glucose, sodium bicarbonate, sodium chloride free, L-glutamine free, phenol red free, filter sterilized, cell culture suitable | Feed 2 | ESD-917615-500ML |
| Cas.: NONE8453 | Purity: 80.0 g/L glucose, sodium chloride, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | Feed 3 | ESD-917616-500ML |
| Cas.: NONE8454 | Purity: 35.0 g/L glucose, no sodium chloride, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | Feed 4 | ESD-917617-500ML |
| Cas.: NONE8455 | Purity: filter sterilization, for cell culture, filter sterilization, for cell culture | CHO Feed for Transfection and Expression | ESD-917618-100ML |
| Cas.: NONE8455 | Purity: filter sterilization, for cell culture, filter sterilization, for cell culture | CHO Feed for Transfection and Expression | ESD-917618-500ML |
| Cas.: NONE8456 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Feed 18 Set | ESD-917619-100+10ML/EA |
| Cas.: NONE8456 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Feed 18 Set | ESD-917619-500+50ML/EA |
| Cas.: NONE8457 | Purity: 60.0 g/L glucose, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | Feed 19 Set | ESD-917620-100+10ML/EA |
| Cas.: NONE8457 | Purity: 60.0 g/L glucose, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | Feed 19 Set | ESD-917620-500+50ML/EA |
| Cas.: NONE8458 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Component A of Feed 19 | ESD-917621-100ML |
| Cas.: NONE8458 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Component A of Feed 19 | ESD-917621-500ML |
| Cas.: NONE8459 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Component B of Feed 19 | ESD-917622-10ML |
| Cas.: NONE8459 | Purity: 60.0 g/L glucose, no HT additive, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, suitable for cell culture | Component B of Feed 19 | ESD-917622-50ML |
| Cas.: NONE8460 | Purity: 60.0 g/L glucose, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | 293 Feed for Transfection and Expression | ESD-917623-1SET/EA |
| Cas.: NONE8460 | Purity: 60.0 g/L glucose, no L-glutamine, no sodium bicarbonate, no phenol red, filter sterilized, for cell culture | 293 Feed for Transfection and Expression | ESD-917623-5SET/EA |
| Cas.: NONE8461 | Purity: High Sugar, L-Glutamine, Sodium Bicarbonate, Phenol Red Free, L-Alanyl-Glutamine, Filter Sterile, For Cell Culture | 293M Serum-Free Medium | ESD-917624-500ML |
| Cas.: NONE8462 | Purity: High Sugar, L-Glutamine, Sodium Bicarbonate, Phenol Red, Filter Sterile, For Cell Culture | 293 S Serum-Free Medium | ESD-917625-500ML |
| Cas.: NONE8463 | Purity: Medium to High Sugar, Sodium Bicarbonate, L-Glutamine Free, Filter Sterilized, For Cell Culture | MSVP Serum-free Medium | ESD-917626-500ML |
| Cas.: NONE8464 | Purity: High Sugar, L-Glutamine, Sodium Bicarbonate, Phenol Red, Filter Sterile, For Cell Culture | PK-15-S Serum-free Medium | ESD-917627-500ML |
| Cas.: NONE8465 | Purity: contains HAS, D-glucose, L-glutamine, gentamicin, phenol red, filter sterilized, for cell culture | Lymphocyte Serum-free Medium | ESD-917628-500ML |
| Cas.: NONE8466 | Purity: contains HAS, D-glucose, L-glutamine, gentamicin, does not contain phenol red, filter sterilized, suitable for cell culture | Lymphocyte Serum-free Medium | ESD-917629-500ML |
| Cas.: NONE8467 | Purity: Free of animal origin, filter sterilized, for cell culture | Sf9 Insect Serum-free Medium | ESD-917630-500ML |
| Cas.: NONE8468 | Purity: 200mM, 100×, filter sterilized, for cell culture | L-Alanine-Glutamine Solution | ESD-917631-100ML |
| Cas.: NONE8471 | Purity: 100×, filter sterilized, for cell culture | HT Additive | ESD-917634-50ML |
| Cas.: NONE8472 | Purity: 100×, filter sterilized, for cell culture | ITS-G | ESD-917635-10ML |
| Cas.: NONE8473 | Purity: 100×, filter sterilized, for cell culture | ITS-A | ESD-917636-10ML |
| Cas.: NONE8474 | Purity: 100×, filter sterilized, for cell culture | ITS-X | ESD-917637-10ML |
| Cas.: NONE8475 | Purity: 55mM, 1000×, filter sterilized, for cell culture | β-Mercaptoethanol Solution | ESD-917638-10ML |
| Cas.: NONE8475 | Purity: 55mM, 1000×, filter sterilized, for cell culture | β-Mercaptoethanol Solution | ESD-917638-100ML |
| Cas.: NONE8476 | Purity: 5%, 5%, filter sterilized, no enzymes | PBSTw-BSA Blocking Buffer | ESD-917639-10ML |
| Cas.: NONE8476 | Purity: 5%, 5%, filter sterilized, no enzymes | PBSTw-BSA Blocking Buffer | ESD-917639-100ML |
| Cas.: NONE8476 | Purity: 5%, 5%, filter sterilized, no enzymes | PBSTw-BSA Blocking Buffer | ESD-917639-500ML |
| Cas.: NONE8477 | Purity: 2×, non-reducing, filter sterilized, enzyme free | Tricine-SDS PAGE Loading Buffer | ESD-917640-5ML |
| Cas.: NONE8478 | Purity: 4×, non-reducing, filter sterilized, enzyme free | SDS-PAGE Loading Buffer | ESD-917641-10ML |
| Cas.: NONE8479 | Purity: 6×, non-reducing, filter sterilized, enzyme free | SDS-PAGE Loading Buffer | ESD-917642-2ML |
| Cas.: NONE8480 | Purity: 2×, odorless reducing agent, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917643-5ML |
| Cas.: NONE8481 | Purity: 5×, odorless reducing agent, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917644-2ML |
| Cas.: NONE8481 | Purity: 5×, odorless reducing agent, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917644-15ML |
| Cas.: NONE8482 | Purity: 6×, odorless reducing agent, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917645-2ML |
| Cas.: NONE8483 | Purity: 2×, contains sulfhydryl reducing agent, filter sterilized, no enzyme | SDS-PAGE Loading Buffer | ESD-917646-10ML |
| Cas.: NONE8484 | Purity: 4×, contains sulfhydryl reducing agent, filter sterilized, no enzyme | SDS-PAGE Loading Buffer | ESD-917647-10ML |
| Cas.: NONE8485 | Purity: 4×, contains sulfhydryl reducing agent, filter sterilized, no enzyme | Native-PAGE Loading Buffer | ESD-917648-10ML |
| Cas.: NONE8486 | Purity: 2×, contains DTT, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917649-5ML |
| Cas.: NONE8486 | Purity: 2×, contains DTT, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917649-10ML |
| Cas.: NONE8487 | Purity: 4×, contains DTT, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917650-10ML |
| Cas.: NONE8488 | Purity: 5×, contains DTT, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917651-15ML |
| Cas.: NONE8488 | Purity: 5×, contains DTT, filter sterilized, no enzymes | SDS-PAGE Loading Buffer | ESD-917651-10ML |
| Cas.: NONE8489 | Purity: 2×, reduced, filter sterilized, without enzymes | Tricine-SDS PAGE Loading Buffer | ESD-917652-5ML |
| Cas.: NONE8490 | Purity: 1×, odorless, filter sterilized, without enzymes | all-in-one Lysis & Loading Buffer | ESD-917653-1ML |
| Cas.: NONE8490 | Purity: 1×, odorless, filter sterilized, without enzymes | all-in-one Lysis & Loading Buffer | ESD-917653-2ML |
| Cas.: NONE8491 | Purity: 1M, filter sterilized, enzyme free | DTT Solution | ESD-917654-1ML |
| Cas.: NONE8491 | Purity: 1M, filter sterilized, enzyme free | DTT Solution | ESD-917654-5ML |
| Cas.: NONE8492 | Purity: 1.5M, pH6.8, filter sterilized, enzyme free | Tris-HCl | ESD-917655-100ML |
| Cas.: NONE8492 | Purity: 1.5M, pH6.8, filter sterilized, enzyme free | Tris-HCl | ESD-917655-500ML |
| Cas.: NONE8493 | Purity: 1.5M, pH8.8, filter sterilized, enzyme free | Tris-HCl | ESD-917656-100ML |
| Cas.: NONE8493 | Purity: 1.5M, pH8.8, filter sterilized, enzyme free | Tris-HCl | ESD-917656-500ML |
| Cas.: NONE8494 | Purity: 1M, pH6.8, filter sterilized, enzyme free | Tris-HCl | ESD-917657-100ML |
| Cas.: NONE8494 | Purity: 1M, pH6.8, filter sterilized, enzyme free | Tris-HCl | ESD-917657-500ML |
| Cas.: NONE8495 | Purity: 1M, pH8.8, filter sterilized, enzyme free | Tris-HCl | ESD-917658-100ML |
| Cas.: NONE8495 | Purity: 1M, pH8.8, filter sterilized, enzyme free | Tris-HCl | ESD-917658-500ML |
| Cas.: NONE8496 | Purity: 1.25M, pH6.5-6.8, filter sterilized, no enzymes | Bis-Tris-HCl Buffer | ESD-917659-100ML |
| Cas.: NONE8496 | Purity: 1.25M, pH6.5-6.8, filter sterilized, no enzymes | Bis-Tris-HCl Buffer | ESD-917659-500ML |
| Cas.: NONE8497 | Purity: 10%, filter sterilized, no enzymes | SDS Solution | ESD-917660-100ML |
| Cas.: NONE8497 | Purity: 10%, filter sterilized, no enzymes | SDS Solution | ESD-917660-500ML |
| Cas.: NONE8498 | Purity: 2M, pH7.0, filter sterilized, enzyme free | Tris-Acetate Buffer | ESD-917661-100ML |
| Cas.: NONE8498 | Purity: 2M, pH7.0, filter sterilized, enzyme free | Tris-Acetate Buffer | ESD-917661-500ML |
| Cas.: NONE8499 | Purity: 10×, filter sterilized, no enzymes | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917662-100ML |
| Cas.: NONE8499 | Purity: 10×, filter sterilized, no enzymes | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917662-500ML |
| Cas.: NONE8500 | Purity: 5×, filter sterilized, no enzymes | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917663-100ML |
| Cas.: NONE8500 | Purity: 5×, filter sterilized, no enzymes | Tris-Glycine-SDS-PAGE Running Buffer | ESD-917663-500ML |
| Cas.: NONE8501 | Purity: 20×, filter sterilized, no enzymes | MES Running Buffer | ESD-917664-100ML |
| Cas.: NONE8501 | Purity: 20×, filter sterilized, no enzymes | MES Running Buffer | ESD-917664-250ML |
| Cas.: NONE8502 | Purity: 20×, filter sterilized, no enzymes | MOPS Running Buffer | ESD-917665-100ML |
| Cas.: NONE8502 | Purity: 20×, filter sterilized, no enzymes | MOPS Running Buffer | ESD-917665-250ML |
| Cas.: NONE8503 | Purity: 10×, filter sterilized, no enzymes | Tris-Tricine PAGE Cathode Running Buffer | ESD-917666-100ML |
| Cas.: NONE8503 | Purity: 10×, filter sterilized, no enzymes | Tris-Tricine PAGE Cathode Running Buffer | ESD-917666-500ML |
| Cas.: NONE8504 | Purity: 10×, filter sterilized, no enzymes | Tris-Tricine PAGE Anode Running Buffer | ESD-917667-100ML |
| Cas.: NONE8504 | Purity: 10×, filter sterilized, no enzymes | Tris-Tricine PAGE Anode Running Buffer | ESD-917667-500ML |
| Cas.: NONE8505 | Purity: 10×, filter sterilized, no enzymes | Tris-Acetate PAGE Running Buffer | ESD-917668-100ML |
| Cas.: NONE8505 | Purity: 10×, filter sterilized, no enzymes | Tris-Acetate PAGE Running Buffer | ESD-917668-250ML |
| Cas.: NONE8506 | Purity: 1×, in PBS, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917669-100ML |
| Cas.: NONE8506 | Purity: 1×, in PBS, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917669-500ML |
| Cas.: NONE8507 | Purity: 1×, in PBSTw, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917670-100ML |
| Cas.: NONE8508 | Purity: 1×, in PBSTx, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917671-100ML |
| Cas.: NONE8509 | Purity: 1×, in TBS, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917672-100ML |
| Cas.: NONE8510 | Purity: 1×, in TBSTw, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917673-100ML |
| Cas.: NONE8511 | Purity: 1×, in TBSTx, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917674-100ML |
| Cas.: NONE8512 | Purity: 10×, in PBS, filter sterilized, without enzymes | Rapid Blocking Buffer | ESD-917675-100ML |
| Cas.: NONE8513 | Purity: 10×, filter sterilized, no enzymes | PBSTw Solution | ESD-917676-50ML |
| Cas.: NONE8514 | Purity: 20×, filter sterilized, no enzymes | PBSTw Solution | ESD-917677-50ML |
| Cas.: NONE8514 | Purity: 20×, filter sterilized, no enzymes | PBSTw Solution | ESD-917677-100ML |
| Cas.: NONE8514 | Purity: 20×, filter sterilized, no enzymes | PBSTw Solution | ESD-917677-250ML |
| Cas.: NONE8515 | Purity: 1×, filter sterilized, no enzymes | Western Blot Wash Buffer | ESD-917678-250ML |
| Cas.: NONE8515 | Purity: 1×, filter sterilized, no enzymes | Western Blot Wash Buffer | ESD-917678-1000ML |
| Cas.: NONE8516 | Purity: 10×, filter sterilized, no enzymes | Western Blot Wash Buffer | ESD-917679-100ML |
| Cas.: NONE8516 | Purity: 10×, filter sterilized, no enzymes | Western Blot Wash Buffer | ESD-917679-1000ML |
| Cas.: NONE8517 | Purity: 0.1M, pH7.4, 10×, filter sterilized, no enzymes | TBST Solution | ESD-917680-50ML |
| Cas.: NONE8518 | Purity: 0.2M, pH7.4, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917681-50ML |
| Cas.: NONE8518 | Purity: 0.2M, pH7.4, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917681-100ML |
| Cas.: NONE8518 | Purity: 0.2M, pH7.4, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917681-250ML |
| Cas.: NONE8519 | Purity: 0.2M, pH7.6, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917682-50ML |
| Cas.: NONE8519 | Purity: 0.2M, pH7.6, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917682-100ML |
| Cas.: NONE8519 | Purity: 0.2M, pH7.6, 20×, filter sterilized, no enzymes | TBST Solution | ESD-917682-250ML |
| Cas.: NONE8520 | Purity: 0.1M, pH7.4, 10×, filter sterilized, no enzymes | TBS Buffer | ESD-917683-50ML |
| Cas.: NONE8521 | Purity: 0.1M, pH7.6, 10×, filter sterilized, no enzymes | TBS Buffer | ESD-917684-50ML |
| Cas.: NONE8521 | Purity: 0.1M, pH7.6, 10×, filter sterilized, no enzymes | TBS Buffer | ESD-917684-100ML |
| Cas.: NONE8521 | Purity: 0.1M, pH7.6, 10×, filter sterilized, no enzymes | TBS Buffer | ESD-917684-250ML |
| Cas.: NONE8522 | Purity: 10×, filter sterilized, no enzymes | Western Blot Transfer Buffer | ESD-917685-500ML |
| Cas.: NONE8523 | Purity: 10×, filter sterilized, no enzymes | Western Blot rapid Transfer Buffer | ESD-917686-500ML |
| Cas.: NONE8524 | Purity: 0.04, filter sterilized, no enzymes | SDS/Native-PAGE Stacking Gel Premix | ESD-917687-25T/EA |
| Cas.: NONE8524 | Purity: 0.04, filter sterilized, no enzymes | SDS/Native-PAGE Stacking Gel Premix | ESD-917687-50T/EA |
| Cas.: NONE8525 | Purity: 0.06, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917688-25T/EA |
| Cas.: NONE8525 | Purity: 0.06, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917688-50T/EA |
| Cas.: NONE8525 | Purity: 0.06, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917688-125T/EA |
| Cas.: NONE8526 | Purity: 0.08, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917689-25T/EA |
| Cas.: NONE8526 | Purity: 0.08, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917689-50T/EA |
| Cas.: NONE8526 | Purity: 0.08, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917689-125T/EA |
| Cas.: NONE8527 | Purity: 0.1, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917690-25T/EA |
| Cas.: NONE8527 | Purity: 0.1, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917690-50T/EA |
| Cas.: NONE8527 | Purity: 0.1, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917690-125T/EA |
| Cas.: NONE8528 | Purity: 0.12, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917691-25T/EA |
| Cas.: NONE8528 | Purity: 0.12, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917691-50T/EA |
| Cas.: NONE8528 | Purity: 0.12, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917691-125T/EA |
| Cas.: NONE8529 | Purity: 0.15, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917692-25T/EA |
| Cas.: NONE8529 | Purity: 0.15, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917692-50T/EA |
| Cas.: NONE8529 | Purity: 0.15, filter sterilized, no enzymes | SDS/Native-PAGE Separating Gel Premix | ESD-917692-125T/EA |
| Cas.: NONE8530 | Purity: 30%, 29:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917693-100ML |
| Cas.: NONE8530 | Purity: 30%, 29:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917693-500ML |
| Cas.: NONE8531 | Purity: 32%, 30:2, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917694-100ML |
| Cas.: NONE8531 | Purity: 32%, 30:2, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917694-500ML |
| Cas.: NONE8532 | Purity: 40%, 19:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917695-100ML |
| Cas.: NONE8532 | Purity: 40%, 19:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917695-500ML |
| Cas.: NONE8533 | Purity: 40%, 37.5:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917696-100ML |
| Cas.: NONE8533 | Purity: 40%, 37.5:1, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917696-500ML |
| Cas.: NONE8534 | Purity: 49.5%, 3%C, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917697-100ML |
| Cas.: NONE8534 | Purity: 49.5%, 3%C, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917697-500ML |
| Cas.: NONE8535 | Purity: 49.5%, 6%C, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917698-100ML |
| Cas.: NONE8535 | Purity: 49.5%, 6%C, filter sterilized, no enzymes | Acr-Bis Solution | ESD-917698-500ML |
| Cas.: NONE8536 | Purity: powder, filter sterilized, without enzymes | Western Blot Transfer Buffer | ESD-917699-1L |
| Cas.: NONE8536 | Purity: powder, filter sterilized, without enzymes | Western Blot Transfer Buffer | ESD-917699-10L |
| Cas.: NONE8537 | Purity: 1M, pH7.0-7.4, filter sterilized, sterile without enzymes, suitable for cell culture | Hepes Buffer | ESD-917700-500ML |
| Cas.: NONE8538 | Purity: Does not contain calcium and magnesium ions, filter sterilized, sterile without enzymes, suitable for cell culture | Hanks’ Balanced Salt Solution | ESD-917701-100ML |
| Cas.: NONE8539 | Purity: contains calcium and magnesium ions, filter sterilized, sterile without enzymes, suitable for cell culture | Hanks’ Balanced Salt Solution | ESD-917702-100ML |
| Cas.: NONE8540 | Purity: 0.075, filter sterilized, sterile without enzymes, suitable for cell culture | NaHCO3 Solution | ESD-917703-100ML |
| Cas.: NONE8541 | Purity: Does not contain calcium and magnesium ions, filter sterilized, sterile without enzymes, suitable for cell culture | D-PBS | ESD-917704-500ML |
| Cas.: NONE8542 | Purity: Does not contain calcium, magnesium and phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | D-PBS | ESD-917705-500ML |
| Cas.: NONE8543 | Purity: contains calcium and magnesium ions, does not contain phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | D-PBS | ESD-917706-500ML |
| Cas.: NONE8544 | Purity: Does not contain calcium, magnesium and phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | EBSS | ESD-917707-500ML |
| Cas.: NONE8545 | Purity: contains calcium and magnesium ions, does not contain phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | HBSS | ESD-917708-500ML |
| Cas.: NONE8546 | Purity: Does not contain calcium and magnesium ions, contains phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | HBSS | ESD-917709-500ML |
| Cas.: NONE8547 | Purity: Does not contain calcium, magnesium and phenol red, filter sterilized, sterile without enzymes, suitable for cell culture | HBSS | ESD-917710-500ML |
| Cas.: NONE8548 | Purity: pH7.2, filter sterilized, sterile without enzymes, suitable for cell culture | PBS | ESD-917711-500ML |
| Cas.: NONE8549 | Purity: 10×, filter sterilized, sterile without enzymes, for cell culture | PBS | ESD-917712-250ML |
| Cas.: NONE8550 | Purity: 0.9%, filter sterilized, sterile without enzymes, suitable for cell culture | Sodium Chloride | ESD-917713-500ML |
| Cas.: NONE8551 | Purity: Use For DNA solution, filter sterilize | Endotoxin Erasol | ESD-917714-20ML |
| Cas.: NONE8551 | Purity: Use For DNA solution, filter sterilize | Endotoxin Erasol | ESD-917714-100ML |
| Cas.: NONE8552 | Purity: 0.05-0.5kb, 8 bands, filter sterilized | DNA Ladder | ESD-917715-50T/EA |
| Cas.: NONE8552 | Purity: 0.05-0.5kb, 8 bands, filter sterilized | DNA Ladder | ESD-917715-100T/EA |
| Cas.: NONE8554 | Purity: 0.2-0.6kb, 6 bands, filter sterilized | DNA Ladder | ESD-917717-50T/EA |
| Cas.: NONE8555 | Purity: 0.2-15kb, 6 bands, filter sterilized | DNA Ladder | ESD-917718-50T/EA |
| Cas.: NONE8556 | Purity: 0.25-5kb, 9 bands, filter sterilized | DNA Ladder | ESD-917719-50T/EA |
| Cas.: NONE8556 | Purity: 0.25-5kb, 9 bands, filter sterilized | DNA Ladder | ESD-917719-100T/EA |
| Cas.: NONE8557 | Purity: 0.3-10kb, 12 bands, filter sterilized | DNA Ladder | ESD-917720-50T/EA |
| Cas.: NONE8557 | Purity: 0.3-10kb, 12 bands, filter sterilized | DNA Ladder | ESD-917720-100T/EA |
| Cas.: NONE8558 | Purity: 0.5-10kb, 9 bands, filter sterilized | DNA Ladder | ESD-917721-50T/EA |
| Cas.: NONE8558 | Purity: 0.5-10kb, 9 bands, filter sterilized | DNA Ladder | ESD-917721-100T/EA |
| Cas.: NONE8559 | Purity: 0.5-15kb, 11 bands, filter sterilized | DNA Ladder | ESD-917722-50T/EA |
| Cas.: NONE8559 | Purity: 0.5-15kb, 11 bands, filter sterilized | DNA Ladder | ESD-917722-100T/EA |
| Cas.: NONE8560 | Purity: 0.5-15kb, 7 bands, filter sterilized | DNA Ladder | ESD-917723-50T/EA |
| Cas.: NONE8560 | Purity: 0.5-15kb, 7 bands, filter sterilized | DNA Ladder | ESD-917723-100T/EA |
| Cas.: NONE8561 | Purity: 2-5kb, 7 bands, filter sterilized | DNA Ladder | ESD-917724-50T/EA |
| Cas.: NONE8561 | Purity: 2-5kb, 7 bands, filter sterilized | DNA Ladder | ESD-917724-100T/EA |
| Cas.: NONE8562 | Purity: liquid phase, filter sterilization | RNase Erasol | ESD-917725-1.5ML |
| Cas.: NONE8563 | Purity: 20mg/mL, filter sterilized | Glycogen Solution | ESD-917726-500ΜL |
| Cas.: NONE8563 | Purity: 20mg/mL, filter sterilized | Glycogen Solution | ESD-917726-2ML |
| Cas.: NONE8564 | Purity: 100mM, filter sterilized | IPTG Solution | ESD-917727-10*1ML/EA |
| Cas.: NONE8565 | Purity: 20mg/mL, filter sterilized | X-Gal Solution | ESD-917728-1ML |
| Cas.: NONE8565 | Purity: 20mg/mL, filter sterilized | X-Gal Solution | ESD-917728-5ML |
| Cas.: NONE8566 | Purity: 100mg/mL, filter sterilized | Ampicillin Solution | ESD-917729-1ML |
| Cas.: NONE8566 | Purity: 100mg/mL, filter sterilized | Ampicillin Solution | ESD-917729-5ML |
| Cas.: NONE8566 | Purity: 100mg/mL, filter sterilized | Ampicillin Solution | ESD-917729-10ML |
| Cas.: NONE8567 | Purity: 100mg/mL, filter sterilized | Kanamycin Solution | ESD-917730-5ML |
| Cas.: NONE8567 | Purity: 100mg/mL, filter sterilized | Kanamycin Solution | ESD-917730-10ML |
| Cas.: NONE8568 | Purity: 50mg/mL, filter sterilized | Chloramphenicol Solution | ESD-917731-1ML |
| Cas.: NONE8568 | Purity: 50mg/mL, filter sterilized | Chloramphenicol Solution | ESD-917731-10ML |
| Cas.: NONE8569 | Purity: 10000×, dsDNA staining, PCR grade, filter sterilized | SYBR Green I | ESD-917732-50ΜL |
| Cas.: NONE8569 | Purity: 10000×, dsDNA staining, PCR grade, filter sterilized | SYBR Green I | ESD-917732-100ΜL |
| Cas.: NONE8569 | Purity: 10000×, dsDNA staining, PCR grade, filter sterilized | SYBR Green I | ESD-917732-1ML |
| Cas.: NONE8570 | Purity: RNA staining, filter sterilized | SYBR Green II | ESD-917733-50ΜL |
| Cas.: NONE8570 | Purity: RNA staining, filter sterilized | SYBR Green II | ESD-917733-100ΜL |
| Cas.: NONE8570 | Purity: RNA staining, filter sterilized | SYBR Green II | ESD-917733-1ML |
| Cas.: NONE8571 | Purity: 0.1-10kb, 21 bands, red Fluorescence, filter sterilized | DNA Ladder | ESD-917734-100T/EA |
| Cas.: NONE8572 | Purity: 0.2-12kb, 12 bands, red Fluorescence, filter sterilized | DNA Ladder | ESD-917735-100T/EA |
| Cas.: NONE8573 | Purity: 0.1-10kb, 21 bands, green Fluorescence, filter sterilized | DNA Ladder | ESD-917736-100T/EA |
| Cas.: NONE8574 | Purity: 0.2-12kb, 12 bands, green Fluorescence, filter sterilized | DNA Ladder | ESD-917737-100T/EA |
| Cas.: NONE8575 | Purity: 50×, filter sterilized | TAE Buffer | ESD-917738-500ML |
| Cas.: NONE8576 | Purity: 5×, filter sterilized | TBE Buffer | ESD-917739-500ML |
| Cas.: NONE8577 | Purity: 10000×, filter sterilized | Gel-Red DNA Stain | ESD-917740-1ML |
| Cas.: NONE8578 | Purity: pH8.0, filter sterilized | TE Buffer | ESD-917741-100ML |
| Cas.: NONE8579 | Purity: 3M, pH5.2, filter sterilized | NaAc Buffer | ESD-917742-100ML |
| Cas.: NONE8579 | Purity: 3M, pH5.2, filter sterilized | NaAc Buffer | ESD-917742-500ML |
| Cas.: NONE8580 | Purity: solid phase, filter sterilized | RNase Erasol | ESD-917743-100ML |
| Cas.: NONE8581 | Purity: EB scavenger, filter sterilized | Ethidium Bromide | ESD-917744-100T/EA |
| Cas.: NONE8582 | Purity: pH6.7, filter sterilized | Western Blot Stripping Buffer | ESD-917745-100ML |
| Cas.: NONE8582 | Purity: pH6.7, filter sterilized | Western Blot Stripping Buffer | ESD-917745-500ML |
| Cas.: NONE8583 | Purity: powder, filter sterilized | Western Blot Semi-dry Transfer Buffer | ESD-917746-1L |
| Cas.: NONE8583 | Purity: powder, filter sterilized | Western Blot Semi-dry Transfer Buffer | ESD-917746-10L |
| Cas.: NONE8585 | Purity: 6×, red Fluorescence, bromophenol blue, filter sterilized | DNA Loading Buffer | ESD-917748-1ML |
| Cas.: NONE8585 | Purity: 6×, red Fluorescence, bromophenol blue, filter sterilized | DNA Loading Buffer | ESD-917748-10ML |
| Cas.: NONE8586 | Purity: 6×, green Fluorescence, bromophenol blue, filter sterilized | DNA Loading Buffer | ESD-917749-1ML |
| Cas.: NONE8586 | Purity: 6×, green Fluorescence, bromophenol blue, filter sterilized | DNA Loading Buffer | ESD-917749-10ML |
| Cas.: NONE8587 | Purity: 2×, filter sterilized | TBE Urea Sample Buffer | ESD-917750-5ML |
| Cas.: NONE8588 | Purity: 6×, filter sterilized | TBE Urea Sample Buffer | ESD-917751-5ML |
| Cas.: NONE8589 | Purity: 2×, denatured, filter sterilized | RNA Loading Buffer | ESD-917752-1ML |
| Cas.: NONE8589 | Purity: 2×, denatured, filter sterilized | RNA Loading Buffer | ESD-917752-5X1ML |
| Cas.: NONE8590 | Purity: 5×, non-denaturing, filter sterilized | RNA Loading Buffer | ESD-917753-1ML |
| Cas.: NONE8590 | Purity: 5×, non-denaturing, filter sterilized | RNA Loading Buffer | ESD-917753-5X1ML |
| Cas.: NONE8591 | Purity: Dry Powder, suitable for use for cell culture | Recombinant Human Insulin | ESD-917754-100MG |
| Cas.: NONE8592 | Purity: for cell culture | Dexamethasone | ESD-917755-5MG |
| Cas.: NONE8593 | Purity: for cell culture | Hydrocortisone | ESD-917756-100MG |
| Cas.: NONE8594 | Purity: for cell culture | L-Glutamine | ESD-917757-1KG |
| Cas.: NONE8595 | Purity: No enzyme | Skim Milk | ESD-917758-10G |
| Cas.: NONE8595 | Purity: No enzyme | Skim Milk | ESD-917758-300G |
| Cas.: NONE8595 | Purity: No enzyme | Skim Milk | ESD-917758-100G |
| Cas.: NONE8596 | Purity: Filtration and high temperature double sterilization, electroporation competent cells recovery culture | SOC Medium | ESD-917759-250G |
| Cas.: NONE8597 | Purity: filter sterilized, for cell culture | MSVP Serum-free Medium Additive | ESD-917760-100ML |
| Cas.: NONE8598 | Purity: filter sterilized, for cell culture | MSC Amplification Medium | ESD-917761-100ML |
| Cas.: NONE8598 | Purity: filter sterilized, for cell culture | MSC Amplification Medium | ESD-917761-500ML |
| Cas.: NONE8599 | Purity: filter sterilized, for cell culture | Melanocyte Complete Medium | ESD-917762-100ML |
| Cas.: NONE8600 | Purity: filter sterilized, for cell culture | Keratinocyte Complete Medium | ESD-917763-100ML |
| Cas.: NONE8601 | Purity: filter sterilized, for cell culture | Endothelial Cell Complete Medium | ESD-917764-100ML |
| Cas.: NONE8602 | Purity: filter sterilized, for cell culture | TC-100 Medium | ESD-917765-500ML |
| Cas.: NONE8603 | Purity: filter sterilized, for cell culture | Red Blood Cell Lysis Buffer | ESD-917766-100ML |
| Cas.: NONE8603 | Purity: filter sterilized, for cell culture | Red Blood Cell Lysis Buffer | ESD-917766-500ML |
| Cas.: NONE8604 | Purity: filter sterilized, for cell culture | Anti Clumping Agent | ESD-917767-10ML |
| Cas.: NONE8604 | Purity: filter sterilized, for cell culture | Anti Clumping Agent | ESD-917767-100ML |
| Cas.: NONE8605 | Purity: filter sterilized, for cell culture | Block polyether F-68,10% | ESD-917768-100ML |
| Cas.: NONE8606 | Purity: filter sterilized, for cell culture | MCDB 153 Medium | ESD-917769-500ML |
| Cas.: NONE8607 | Purity: filter sterilized, for cell culture | Waymouth MB 752/1 Medium | ESD-917770-500ML |
| Cas.: NONE8608 | Purity: filter sterilized, for cell culture | Tumor Cell Line-Specific Medium | ESD-917771-500ML |
| Cas.: NONE8609 | Purity: filter sterilized, for cell culture | CHO Cell Medium Set | ESD-917772-1SET/EA |
| Cas.: NONE8610 | Purity: filter sterilized, for cell culture | CHO CD5 Serum-Free Medium | ESD-917773-500ML |
| Cas.: NONE8611 | Purity: filter sterilized, for cell culture | CHO CD Transfection Serum-Free Medium | ESD-917774-500ML |
| Cas.: NONE8612 | Purity: filter sterilized, for cell culture | 302 Serum-Free Medium | ESD-917775-500ML |
| Cas.: NONE8613 | Purity: filter sterilized, for cell culture | Component A of Feed 18 | ESD-917776-100ML |
| Cas.: NONE8613 | Purity: filter sterilized, for cell culture | Component A of Feed 18 | ESD-917776-500ML |
| Cas.: NONE8614 | Purity: filter sterilized, for cell culture | Component B of Feed 18 | ESD-917777-10ML |
| Cas.: NONE8614 | Purity: filter sterilized, for cell culture | Component B of Feed 18 | ESD-917777-50ML |
| Cas.: NONE8615 | Purity: filter sterilized, for cell culture | CEF Cell Low-Serum Medium | ESD-917778-500ML |
| Cas.: NONE8616 | Purity: filter sterilized, for cell culture | A549 Serum-free Medium | ESD-917779-500ML |
| Cas.: NONE8617 | Purity: filter sterilized, for cell culture | CD Hela Serum-free Medium | ESD-917780-500ML |
| Cas.: NONE8618 | Purity: filter sterilized, for cell culture | MDBK-S Serum-free Medium | ESD-917781-500ML |
| Cas.: NONE8619 | Purity: filter sterilized, for cell culture | MDCK-S Serum-free Medium | ESD-917782-500ML |
| Cas.: NONE8620 | Purity: filter sterilized, for cell culture | ST-A Low-Serum Medium | ESD-917783-500ML |
| Cas.: NONE8621 | Purity: filter sterilized, for cell culture | ST-A Serum-free Medium | ESD-917784-500ML |
| Cas.: NONE8622 | Purity: filter sterilized, for cell culture | CD Vero-S Serum-free Medium | ESD-917785-500ML |
| Cas.: NONE8623 | Purity: filter sterilized, for cell culture | Vero-A Serum-free Medium | ESD-917786-500ML |
| Cas.: NONE8624 | Purity: filter sterilized, for cell culture | DF-1 Serum-free Medium | ESD-917787-500ML |
| Cas.: NONE8625 | Purity: filter sterilized, for cell culture | LMH Serum-free Medium | ESD-917788-500ML |
| Cas.: NONE8626 | Purity: filter sterilized, for cell culture | HDC Low-Serum Medium | ESD-917789-500ML |
| Cas.: NONE8627 | Purity: filter sterilized, for cell culture | Neuron Basal Medium | ESD-917790-500ML |
| Cas.: NONE8628 | Purity: filter sterilized, for cell culture | Amniotic Fluid Cell Medium | ESD-917791-100ML |
| Cas.: NONE8629 | Purity: filter sterilized, for cell culture | Mycoplasma Serum-free Medium | ESD-917792-500ML |
| Cas.: NONE8630 | Purity: filter sterilized, for cell culture | Schneider’s Drosophila Medium | ESD-917793-500ML |
| Cas.: NONE8631 | Purity: filter sterilized, for cell culture | High Five Insect Serum-free Medium | ESD-917794-500ML |
| Cas.: NONE8632 | Purity: filter sterilized, for cell culture | Insect Serum-free Medium Feed | ESD-917795-500ML |
| Cas.: NONE8633 | Purity: filter sterilized, for cell culture | ST cell serum-free Maintenance Solution | ESD-917796-500ML |
| Cas.: NONE8634 | Purity: filter sterilized, for cell culture | Tyrosine/Cystine Concentrate | ESD-917797-100ML |
| Cas.: NONE8635 | Purity: filter sterilized, without enzymes | PBS-Casein Blocking Buffer | ESD-917798-53ML |
| Cas.: NONE8635 | Purity: filter sterilized, without enzymes | PBS-Casein Blocking Buffer | ESD-917798-100ML |
| Cas.: NONE8635 | Purity: filter sterilized, without enzymes | PBS-Casein Blocking Buffer | ESD-917798-250ML |
| Cas.: NONE8636 | Purity: filter sterilized, without enzymes | PBS-Gelatin Blocking Buffer | ESD-917799-54ML |
| Cas.: NONE8636 | Purity: filter sterilized, without enzymes | PBS-Gelatin Blocking Buffer | ESD-917799-100ML |
| Cas.: NONE8636 | Purity: filter sterilized, without enzymes | PBS-Gelatin Blocking Buffer | ESD-917799-250ML |
| Cas.: NONE8637 | Purity: filter sterilized, without enzymes | Prestained Fluorescent Protein Loading Buffer | ESD-917800-100ΜL |
| Cas.: NONE8638 | Purity: filter sterilized, without enzymes | Soaking and Activation Buffer for PVDF Membrane | ESD-917801-250ML |
| Cas.: NONE8638 | Purity: filter sterilized, without enzymes | Soaking and Activation Buffer for PVDF Membrane | ESD-917801-1000ML |
| Cas.: NONE8639 | Purity: filter sterilized, without enzymes | PBSTw-Casein Blocking Buffer | ESD-917802-50ML |
| Cas.: NONE8639 | Purity: filter sterilized, without enzymes | PBSTw-Casein Blocking Buffer | ESD-917802-100ML |
| Cas.: NONE8639 | Purity: filter sterilized, without enzymes | PBSTw-Casein Blocking Buffer | ESD-917802-250ML |
| Cas.: NONE8640 | Purity: filter sterilized, without enzymes | PBSTw-Gelatin Blocking Buffer | ESD-917803-51ML |
| Cas.: NONE8640 | Purity: filter sterilized, without enzymes | PBSTw-Gelatin Blocking Buffer | ESD-917803-100ML |
| Cas.: NONE8640 | Purity: filter sterilized, without enzymes | PBSTw-Gelatin Blocking Buffer | ESD-917803-250ML |
| Cas.: NONE8641 | Purity: filter sterilized, without enzymes | PBSTw-Skim Milk Powder Blocking Buffer | ESD-917804-52ML |
| Cas.: NONE8641 | Purity: filter sterilized, without enzymes | PBSTw-Skim Milk Powder Blocking Buffer | ESD-917804-100ML |
| Cas.: NONE8641 | Purity: filter sterilized, without enzymes | PBSTw-Skim Milk Powder Blocking Buffer | ESD-917804-250ML |
| Cas.: NONE8642 | Purity: filter sterilized, without enzymes | TBSTw-Casein Blocking Buffer | ESD-917805-55ML |
| Cas.: NONE8642 | Purity: filter sterilized, without enzymes | TBSTw-Casein Blocking Buffer | ESD-917805-100ML |
| Cas.: NONE8642 | Purity: filter sterilized, without enzymes | TBSTw-Casein Blocking Buffer | ESD-917805-250ML |
| Cas.: NONE8643 | Purity: filter sterilized, sterile enzyme-free, for cell culture | Hanks | ESD-917806-250ML |
| Cas.: NONE8644 | Purity: filter sterilized, sterile enzyme-free, for cell culture | D-Hanks Solution | ESD-917807-500ML |
| Cas.: NONE8645 | Purity: filter sterilized, sterile enzyme-free, for cell culture | D-PBS | ESD-917808-250ML |
| Cas.: NONE8646 | Purity: 1X, pH7.2-7.4, sterile without enzymes, for cell culture | PBS | ESD-917809-500ML |
| Cas.: NONE8647 | Purity: filter sterilized, sterile enzyme-free, for cell culture | D-PBS | ESD-917810-500ML |
| Cas.: NONE8648 | Purity: filter sterilized, sterile enzyme-free, for cell culture | D-Hanks | ESD-917811-500ML |
| Cas.: NONE8649 | Purity: filter sterilized, sterile enzyme-free, for cell culture | HBSS | ESD-917812-100ML |
| Cas.: NONE8649 | Purity: filter sterilized, sterile enzyme-free, for cell culture | HBSS | ESD-917812-500ML |
| Cas.: NONE8650 | Purity: filter sterilized, sterile enzyme-free, for cell culture | EBSS | ESD-917813-500ML |
| Cas.: NONE8651 | Purity: filter sterilized, sterile enzyme-free, for cell culture | Eagle’s | ESD-917814-500ML |
| Cas.: NONE8652 | Purity: filter sterilized, sterile enzyme-free, for cell culture | Cell Grade Ultrapure Water | ESD-917815-500ML |
| Cas.: NONE8653 | Purity: filter sterilization | RNase Inhibitor | ESD-917816-2000U |
| Cas.: NONE8653 | Purity: filter sterilization | RNase Inhibitor | ESD-917816-10000U |
| Cas.: NONE8653 | Purity: filter sterilization | RNase Inhibitor | ESD-917816-50000U |
| Cas.: NONE8654 | Purity: filter sterilization | RNA Stabilization Solution | ESD-917817-10ML |
| Cas.: NONE8654 | Purity: filter sterilization | RNA Stabilization Solution | ESD-917817-100ML |
| Cas.: NONE8654 | Purity: filter sterilization | RNA Stabilization Solution | ESD-917817-500ML |
| Cas.: NONE8655 | Purity: filter sterilization | Nuclease Erasol | ESD-917818-250ML |
| Cas.: NONE8656 | Purity: filter sterilization | RNase, DNase, RNA and DNA Erasol | ESD-917819-250ML |
| Cas.: NONE8657 | Purity: filter sterilization | Secondary Antibody Dilution Buffer for Western Blot | ESD-917820-100ML |
| Cas.: NONE8657 | Purity: filter sterilization | Secondary Antibody Dilution Buffer for Western Blot | ESD-917820-500ML |
| Cas.: NONE8658 | Purity: filter sterilization | Primary Antibody Dilution Buffer for Western Blot | ESD-917821-100ML |
| Cas.: NONE8658 | Purity: filter sterilization | Primary Antibody Dilution Buffer for Western Blot | ESD-917821-500ML |
| Cas.: NONE8659 | Purity: filter sterilization | Coomassie Blue Super Fast Staining Solution | ESD-917822-500ML |
| Cas.: NONE8659 | Purity: filter sterilization | Coomassie Blue Super Fast Staining Solution | ESD-917822-250ML |
| Cas.: NONE8660 | Purity: filter sterilization | Coomassie Blue Staining Solution | ESD-917823-500ML |
| Cas.: NONE8660 | Purity: filter sterilization | Coomassie Blue Staining Solution | ESD-917823-250ML |
| Cas.: NONE8661 | Purity: filter sterilization | Acryl Carrier | ESD-917824-1ML |
| Cas.: NONE8661 | Purity: filter sterilization | Acryl Carrier | ESD-917824-5ML |
| Cas.: NONE8662 | Rit VEGF ELISA Kit | ESD-917825-96T/EA | |
| Cas.: NONE8663 | BL21 (DE3) Chemically Competent Cells | ESD-917826-10X100ΜL | |
| Cas.: NONE8663 | BL21 (DE3) Chemically Competent Cells | ESD-917826-20X100ΜL | |
| Cas.: NONE8664 | DH5α Chemically Competent Cells | ESD-917827-10X100ΜL | |
| Cas.: NONE8664 | DH5α Chemically Competent Cells | ESD-917827-20X100ΜL | |
| Cas.: NONE8665 | JM109 Chemically Competent Cells | ESD-917828-10X100ΜL | |
| Cas.: NONE8665 | JM109 Chemically Competent Cells | ESD-917828-20X100ΜL | |
| Cas.: NONE8666 | TOP10 Chemically Competent Cells | ESD-917829-10X100ΜL | |
| Cas.: NONE8666 | TOP10 Chemically Competent Cells | ESD-917829-20X100ΜL | |
| Cas.: NONE8667 | Purity: 10-170 kDa | Prestained Color Protein Marker | ESD-917830-200ΜL |
| Cas.: NONE8668 | Purity: 11-180 kDa | Prestained Color Protein Marker | ESD-917831-100ΜL |
| Cas.: NONE8669 | Purity: 11-245 kDa | Prestained Color Protein Marker | ESD-917832-100ΜL |
| Cas.: NONE8670 | Purity: 15-120 kDa | Prestained Color Protein Marker | ESD-917833-200ΜL |
| Cas.: NONE8671 | Purity: 15-130 kDa | Prestained Color Protein Marker | ESD-917834-100ΜL |
| Cas.: NONE8672 | Purity: 5-245 kDa | Prestained Color Protein Marker | ESD-917835-100ΜL |
| Cas.: NONE8673 | Purity: 6.5-270 kDa | Prestained Color Protein Marker | ESD-917836-200ΜL |
| Cas.: NONE8674 | Purity: 14.4-97.4 kDa | Prestained Blue Protein Marker | ESD-917837-100ΜL |
| Cas.: NONE8675 | Purity: 19-117 kDa | Prestained Blue Protein Marker | ESD-917838-1000ΜL |
| Cas.: NONE8676 | Purity: 3.3-31.0 kDa | Prestained Blue Protein Marker | ESD-917839-100ΜL |
| Cas.: NONE8677 | Purity: 43-200 kDa | Prestained Blue Protein Marker | ESD-917840-50ΜL |
| Cas.: NONE8678 | Western Blot Protein Marker | ESD-917841-50ΜL | |
| Cas.: NONE8678 | Western Blot Protein Marker | ESD-917841-100ΜL | |
| Cas.: NONE8679 | Purity: 10-150 kDa | Unstained Protein Marker | ESD-917842-120ΜL |
| Cas.: NONE8680 | Purity: 10-200 kDa | Unstained Protein Marker | ESD-917843-120ΜL |
| Cas.: NONE8682 | Purity: 14.4-97.4 kDa | Unstained Protein Marker | ESD-917845-120ΜL |
| Cas.: NONE8683 | Purity: 3.3-20.1 kDa | Unstained Protein Marker | ESD-917846-60ΜL |
| Cas.: NONE8684 | Purity: 43-200 kDa | Unstained Protein Marker | ESD-917847-30ΜL |
| Cas.: NONE8685 | Purity: 53-220 kDa | Unstained Protein Marker | ESD-917848-120ΜL |
| Cas.: NONE8686 | Purity: 66-669 kDa | Unstained Protein Marker | ESD-917849-120ΜL |
| Cas.: NONE8687 | One-step Animal Tissue PCR Kit | ESD-917850-100T/EA | |
| Cas.: NONE8687 | One-step Animal Tissue PCR Kit | ESD-917850-500T/EA | |
| Cas.: NONE8688 | Purity: 2×, Red | PCR Kit | ESD-917851-1ML |
| Cas.: NONE8688 | Purity: 2×, Red | PCR Kit | ESD-917851-5ML |
| Cas.: NONE8688 | Purity: 2×, Red | PCR Kit | ESD-917851-10ML |
| Cas.: NONE8689 | Purity: 2× | Multiplex PCR Mix, | ESD-917852-100T/EA |
| Cas.: NONE8689 | Purity: 2× | Multiplex PCR Mix, | ESD-917852-500T/EA |
| Cas.: NONE8690 | Purity: 2× | One-step Blood PCR Mix | ESD-917853-100T/EA |
| Cas.: NONE8690 | Purity: 2× | One-step Blood PCR Mix | ESD-917853-500T/EA |
| Cas.: NONE8691 | Purity: 30U/ul | Phi29 DNA Polymerase | ESD-917854-1000U |
| Cas.: NONE8691 | Purity: 30U/ul | Phi29 DNA Polymerase | ESD-917854-5000U |
| Cas.: NONE8691 | Purity: 30U/ul | Phi29 DNA Polymerase | ESD-917854-20000U |
| Cas.: NONE8692 | Purity: 5U/μL | Taq DNA Polymerase with Buffer | ESD-917855-200U |
| Cas.: NONE8692 | Purity: 5U/μL | Taq DNA Polymerase with Buffer | ESD-917855-1000U |
| Cas.: NONE8692 | Purity: 5U/μL | Taq DNA Polymerase with Buffer | ESD-917855-5000U |
| Cas.: NONE8693 | Purity: 2.5U/μL, hot start | Taq DNA Polymerase with Buffer | ESD-917856-1000U |
| Cas.: NONE8693 | Purity: 2.5U/μL, hot start | Taq DNA Polymerase with Buffer | ESD-917856-5000U |
| Cas.: NONE8694 | Purity: 5U/μL, ultra-long fragment | Taq DNA Polymerase with Buffer | ESD-917857-200U |
| Cas.: NONE8694 | Purity: 5U/μL, ultra-long fragment | Taq DNA Polymerase with Buffer | ESD-917857-1000U |
| Cas.: NONE8695 | Purity: 5U/μL, high fidelity | Taq DNA Polymerase with Buffer | ESD-917858-200U |
| Cas.: NONE8695 | Purity: 5U/μL, high fidelity | Taq DNA Polymerase with Buffer | ESD-917858-1000U |
| Cas.: NONE8696 | Purity: anticoagulant | Taq DNA Polymerase with Buffer | ESD-917859-200T/EA |
| Cas.: NONE8696 | Purity: anticoagulant | Taq DNA Polymerase with Buffer | ESD-917859-1000T/EA |
| Cas.: NONE8697 | Purity: anticoagulant high fidelity | Taq DNA Polymerase with Buffer | ESD-917860-200T/EA |
| Cas.: NONE8697 | Purity: anticoagulant high fidelity | Taq DNA Polymerase with Buffer | ESD-917860-1000T/EA |
| Cas.: NONE8698 | Purity: Chlorophyll resistant | Taq DNA Polymerase with Buffer | ESD-917861-200T/EA |
| Cas.: NONE8698 | Purity: Chlorophyll resistant | Taq DNA Polymerase with Buffer | ESD-917861-1000T/EA |
| Cas.: NONE8699 | Purity: long segment | Taq DNA Polymerase with Buffer | ESD-917862-200U |
| Cas.: NONE8699 | Purity: long segment | Taq DNA Polymerase with Buffer | ESD-917862-1000U |
| Cas.: NONE8700 | 4 sets | GC-rich PCR Buffer | ESD-917863-2ML |
| Cas.: NONE8701 | Purity: 5U/μL, E. coli | Uracil-DNA Glycosylase | ESD-917864-1000U |
| Cas.: NONE8701 | Purity: 5U/μL, E. coli | Uracil-DNA Glycosylase | ESD-917864-5000U |
| Cas.: NONE8702 | Purity: 1U/μL, heat sensitive, cod | Uracil-DNA Glycosylase | ESD-917865-100U |
| Cas.: NONE8702 | Purity: 1U/μL, heat sensitive, cod | Uracil-DNA Glycosylase | ESD-917865-500U |
| Cas.: NONE8703 | Purity: 1U/μL, Thermosensitive, Bacterial | Uracil-DNA Glycosylase | ESD-917866-200U |
| Cas.: NONE8703 | Purity: 1U/μL, Thermosensitive, Bacterial | Uracil-DNA Glycosylase | ESD-917866-1000U |
| Cas.: NONE8704 | Purity: 0.2-10kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917867-20T/EA |
| Cas.: NONE8704 | Purity: 0.2-10kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917867-100T/EA |
| Cas.: NONE8704 | Purity: 0.2-10kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917867-500T/EA |
| Cas.: NONE8705 | Purity: 0.2-10kb, contains independent primers | First Strand cDNA Synthesis Kit | ESD-917868-20T/EA |
| Cas.: NONE8706 | Purity: 0.2-10kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917869-20T/EA |
| Cas.: NONE8706 | Purity: 0.2-10kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917869-100T/EA |
| Cas.: NONE8706 | Purity: 0.2-10kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917869-500T/EA |
| Cas.: NONE8707 | Purity: 0.2-12kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917870-20T/EA |
| Cas.: NONE8707 | Purity: 0.2-12kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917870-100T/EA |
| Cas.: NONE8707 | Purity: 0.2-12kb, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917870-500T/EA |
| Cas.: NONE8708 | Purity: 0.2-12kb, contains independent primers | First Strand cDNA Synthesis Kit | ESD-917871-20T/EA |
| Cas.: NONE8708 | Purity: 0.2-12kb, contains independent primers | First Strand cDNA Synthesis Kit | ESD-917871-100T/EA |
| Cas.: NONE8709 | Purity: 0.2-12kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917872-20T/EA |
| Cas.: NONE8709 | Purity: 0.2-12kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917872-100T/EA |
| Cas.: NONE8709 | Purity: 0.2-12kb, degenomic DNA, contains premixed primers | First Strand cDNA Synthesis Kit | ESD-917872-500T/EA |
| Cas.: NONE8710 | Purity: 0.2-12kb, high stability | M-MLV Reverse Transcriptase | ESD-917873-10KU |
| Cas.: NONE8710 | Purity: 0.2-12kb, high stability | M-MLV Reverse Transcriptase | ESD-917873-20KU |
| Cas.: NONE8710 | Purity: 0.2-12kb, high stability | M-MLV Reverse Transcriptase | ESD-917873-50KU |
| Cas.: NONE8711 | Purity: 0.2-12kb, M-MLV | Two-Step RT-PCR Kit | ESD-917874-25T/EA |
| Cas.: NONE8711 | Purity: 0.2-12kb, M-MLV | Two-Step RT-PCR Kit | ESD-917874-50T/EA |
| Cas.: NONE8711 | Purity: 0.2-12kb, M-MLV | Two-Step RT-PCR Kit | ESD-917874-100T/EA |
| Cas.: NONE8712 | Purity: 0.2-12kb, high copy, low copy gene detection | One-Step RT-PCR Kit | ESD-917875-200T/EA |
| Cas.: NONE8713 | Gram-positive Bacterium Plasmid Mini Prep Kit | ESD-917876-50T/EA | |
| Cas.: NONE8713 | Gram-positive Bacterium Plasmid Mini Prep Kit | ESD-917876-100T/EA | |
| Cas.: NONE8714 | Gram-positive Bacterium Plasmid Mass Extraction Kit | ESD-917877-10T/EA | |
| Cas.: NONE8715 | RNA Viral Genome Extraction Kit | ESD-917878-50T/EA | |
| Cas.: NONE8715 | RNA Viral Genome Extraction Kit | ESD-917878-100T/EA | |
| Cas.: NONE8716 | DNA Viral Genome Extraction Kit | ESD-917879-50T/EA | |
| Cas.: NONE8716 | DNA Viral Genome Extraction Kit | ESD-917879-100T/EA | |
| Cas.: NONE8717 | Purity: Magnetic bead method | Animal Tissue (Lung, Kidney, Spleen) Genomic DNA Kit | ESD-917880-50T/EA |
| Cas.: NONE8718 | Purity: Magnetic bead method | Magnetic Animal Tissue (Heart,Liver,Muscle) Genomic DNA Kit(Magnetic Beads) | ESD-917881-50T/EA |
| Cas.: NONE8719 | Animal Genomic DNA Quick Extraction Kit for PCR Analysis | ESD-917882-100T/EA | |
| Cas.: NONE8719 | Animal Genomic DNA Quick Extraction Kit for PCR Analysis | ESD-917882-500T/EA | |
| Cas.: NONE8720 | Animal Tissue/Cell Genomic DNA Extraction Kit | ESD-917883-50T/EA | |
| Cas.: NONE8720 | Animal Tissue/Cell Genomic DNA Extraction Kit | ESD-917883-100T/EA | |
| Cas.: NONE8721 | Stool Genomic DNA Extraction Kit | ESD-917884-50T/EA | |
| Cas.: NONE8721 | Stool Genomic DNA Extraction Kit | ESD-917884-100T/EA | |
| Cas.: NONE8722 | Gram-positive Bacterium Genomic DNA Extraction Kit | ESD-917885-50T/EA | |
| Cas.: NONE8722 | Gram-positive Bacterium Genomic DNA Extraction Kit | ESD-917885-100T/EA | |
| Cas.: NONE8723 | Universal Genomic DNA Mini Preparation Kit | ESD-917886-50T/EA | |
| Cas.: NONE8724 | Yeast Genome DNA Mass Extraction Kit | ESD-917887-10T/EA | |
| Cas.: NONE8725 | Yeast Genomic DNA Extraction Kit | ESD-917888-50T/EA | |
| Cas.: NONE8725 | Yeast Genomic DNA Extraction Kit | ESD-917888-100T/EA | |
| Cas.: NONE8726 | Purity: adsorption column method | Blood Genomic DNA Extraction Kit | ESD-917889-50T/EA |
| Cas.: NONE8726 | Purity: adsorption column method | Blood Genomic DNA Extraction Kit | ESD-917889-100T/EA |
| Cas.: NONE8727 | Purity: adsorption column method | Soil Genomic DNA Extraction Kit | ESD-917890-50T/EA |
| Cas.: NONE8727 | Purity: adsorption column method | Soil Genomic DNA Extraction Kit | ESD-917890-100T/EA |
| Cas.: NONE8728 | Bacterial Genomic DNA Extraction Kit | ESD-917891-50T/EA | |
| Cas.: NONE8728 | Bacterial Genomic DNA Extraction Kit | ESD-917891-100T/EA | |
| Cas.: NONE8729 | Fungi Genomic DNA Extraction Kit | ESD-917892-50T/EA | |
| Cas.: NONE8729 | Fungi Genomic DNA Extraction Kit | ESD-917892-100T/EA | |
| Cas.: NONE8730 | Plant Genomic DNA Extraction Kit | ESD-917893-50T/EA | |
| Cas.: NONE8730 | Plant Genomic DNA Extraction Kit | ESD-917893-100T/EA | |
| Cas.: NONE8731 | Purity: Freeze-dried powder | Proteinase K | ESD-917894-100MG |
| Cas.: NONE8731 | Purity: Freeze-dried powder | Proteinase K | ESD-917894-500MG |
| Cas.: NONE8731 | Purity: Freeze-dried powder | Proteinase K | ESD-917894-2G |
| Cas.: NONE8732 | Purity: 20mg/mL | Proteinase K Solution | ESD-917895-0.2ML |
| Cas.: NONE8732 | Purity: 20mg/mL | Proteinase K Solution | ESD-917895-1ML |
| Cas.: 9001-99-4 | Purity: 100mg/mL | RNase A Solution | ESD-917898-0.5ML |
| Cas.: NONE8736 | Purity: 1U/uL, no ribonuclease activity | DNAse | ESD-917899-200ΜL |
| Cas.: NONE8736 | Purity: 1U/uL, no ribonuclease activity | DNAse | ESD-917899-1000ΜL |
| Cas.: NONE8737 | Seamless Assembly and Cloning Kit | ESD-917900-20T/EA | |
| Cas.: NONE8737 | Seamless Assembly and Cloning Kit | ESD-917900-100T/EA | |
| Cas.: NONE8738 | One Step Seamless Cloning Kit | ESD-917901-20T/EA | |
| Cas.: NONE8738 | One Step Seamless Cloning Kit | ESD-917901-100T/EA | |
| Cas.: NONE8739 | Seamless Assembly and Cloning Kit | ESD-917902-20T/EA | |
| Cas.: NONE8739 | Seamless Assembly and Cloning Kit | ESD-917902-100T/EA | |
| Cas.: NONE8740 | One Step Seamless Cloning Kit | ESD-917903-20T/EA | |
| Cas.: NONE8740 | One Step Seamless Cloning Kit | ESD-917903-100T/EA | |
| Cas.: NONE8741 | Purity: blunt-ended, dual-resistant | Zero pTOPO Cloning Kit | ESD-917904-20T/EA |
| Cas.: NONE8741 | Purity: blunt-ended, dual-resistant | Zero pTOPO Cloning Kit | ESD-917904-100T/EA |
| Cas.: NONE8742 | Purity: blunt end | Zero pTOPO Cloning Kit | ESD-917905-20T/EA |
| Cas.: NONE8742 | Purity: blunt end | Zero pTOPO Cloning Kit | ESD-917905-100T/EA |
| Cas.: NONE8743 | Purity: Sticky ends, no multiple cloning sites | Zero pTOPO Cloning Kit | ESD-917906-20T/EA |
| Cas.: NONE8743 | Purity: Sticky ends, no multiple cloning sites | Zero pTOPO Cloning Kit | ESD-917906-100T/EA |
| Cas.: NONE8744 | Purity: sticky end, dual resistance | Zero pTOPO Cloning Kit | ESD-917907-20T/EA |
| Cas.: NONE8744 | Purity: sticky end, dual resistance | Zero pTOPO Cloning Kit | ESD-917907-100T/EA |
| Cas.: NONE8745 | Purity: sticky ends | Zero pTOPO Cloning Kit | ESD-917908-20T/EA |
| Cas.: NONE8745 | Purity: sticky ends | Zero pTOPO Cloning Kit | ESD-917908-100T/EA |
| Cas.: NONE8746 | T4 DNA Ligase | ESD-917909-40000U | |
| Cas.: NONE8746 | T4 DNA Ligase | ESD-917909-200000U | |
| Cas.: NONE8747 | Endonuclease ApaLI | ESD-917910-2000U | |
| Cas.: NONE8749 | Endonuclease BamHI | ESD-917912-2000U | |
| Cas.: NONE8750 | Endonuclease EagI | ESD-917913-250U | |
| Cas.: NONE8750 | Endonuclease EagI | ESD-917913-2*250U | |
| Cas.: NONE8751 | Endonuclease EcoRV | ESD-917914-1500U | |
| Cas.: NONE8753 | Endonuclease NcoI | ESD-917916-200U | |
| Cas.: NONE8754 | Endonuclease NheI | ESD-917917-200U | |
| Cas.: NONE8756 | Endonuclease PstI | ESD-917919-1000U | |
| Cas.: NONE8756 | Endonuclease PstI | ESD-917919-3000U | |
| Cas.: NONE8758 | Endonuclease SmaI | ESD-917921-500U | |
| Cas.: NONE8759 | Endonuclease XbaI | ESD-917922-1500U | |
| Cas.: NONE8760 | Long Site-directed Mutagenesis Kit | ESD-917923-10T/EA | |
| Cas.: NONE8761 | Site-directed Mutagenesis Kit | ESD-917924-10T/EA | |
| Cas.: NONE8762 | Random Mutagenesis Kit | ESD-917925-50T/EA | |
| Cas.: NONE8762 | Random Mutagenesis Kit | ESD-917925-200T/EA | |
| Cas.: NONE8763 | BCA Protein Quantification Kit | ESD-917926-200T/EA | |
| Cas.: NONE8764 | ImmunoFluorescence Primary Antibody Dilution Buffer | ESD-917927-100ML | |
| Cas.: NONE8765 | Purity: sterile, for protein extraction | RIPA Lysis Buffer | ESD-917928-100ML |
| Cas.: NONE8766 | Purity: 100X, double antibody, for cell culture | Penicillin-Streptomycin solution | ESD-917929-100ML |
| Cas.: NONE8767 | Purity: 2×, dye method, high ROX | qPCR Kits | ESD-917930-1ML |
| Cas.: NONE8767 | Purity: 2×, dye method, high ROX | qPCR Kits | ESD-917930-5X1ML |
| Cas.: NONE8767 | Purity: 2×, dye method, high ROX | qPCR Kits | ESD-917930-10X1ML |
| Cas.: NONE8768 | Purity: 2×, dye method, low ROX | qPCR Kits | ESD-917931-1ML |
| Cas.: NONE8768 | Purity: 2×, dye method, low ROX | qPCR Kits | ESD-917931-5X1ML |
| Cas.: NONE8768 | Purity: 2×, dye method, low ROX | qPCR Kits | ESD-917931-10X1ML |
| Cas.: NONE8769 | Purity: 2×, dye method, independent ROX | qPCR Kits | ESD-917932-1ML |
| Cas.: NONE8769 | Purity: 2×, dye method, independent ROX | qPCR Kits | ESD-917932-5X1ML |
| Cas.: NONE8769 | Purity: 2×, dye method, independent ROX | qPCR Kits | ESD-917932-10X1ML |
| Cas.: NONE8770 | Purity: dye method | One-Step qRT-PCR kit | ESD-917933-100T/EA |
| Cas.: NONE8770 | Purity: dye method | One-Step qRT-PCR kit | ESD-917933-500T/EA |
| Cas.: NONE8770 | Purity: dye method | One-Step qRT-PCR kit | ESD-917933-1000T/EA |
| Cas.: NONE8771 | Purity: Taqman probe | One-Step qRT-PCR PreMix | ESD-917934-100T/EA |
| Cas.: NONE8771 | Purity: Taqman probe | One-Step qRT-PCR PreMix | ESD-917934-500T/EA |
| Cas.: NONE8772 | Purity: 2×, dye method | Color qPCR Mix | ESD-917935-25ΜL |
| Cas.: NONE8772 | Purity: 2×, dye method | Color qPCR Mix | ESD-917935-100ΜL |
| Cas.: NONE8773 | Bind-Silane | ESD-917936-25ML | |
| Cas.: NONE8774 | Plasmid Mini Prep Kit | ESD-917937-50T/EA | |
| Cas.: NONE8774 | Plasmid Mini Prep Kit | ESD-917937-100T/EA | |
| Cas.: NONE8775 | Plasmid Mass Extraction Kit | ESD-917938-10T/EA | |
| Cas.: NONE8776 | Free Endotoxin Plasmid Mini Prep Kit | ESD-917939-50T/EA | |
| Cas.: NONE8776 | Free Endotoxin Plasmid Mini Prep Kit | ESD-917939-100T/EA | |
| Cas.: NONE8777 | Free Endotoxin Plasmid Mass Extraction Kit | ESD-917940-10T/EA | |
| Cas.: NONE8778 | Yeast Plasmid Extraction Kit | ESD-917941-50T/EA | |
| Cas.: NONE8779 | PCR Product Purification Kit | ESD-917942-50T/EA | |
| Cas.: NONE8780 | DNA Extraction Kit | ESD-917943-50T/EA | |
| Cas.: NONE8781 | Purity: Precipitation | Blood Genomic DNA Extraction Kit | ESD-917944-50T/EA |
| Cas.: NONE8781 | Purity: Precipitation | Blood Genomic DNA Extraction Kit | ESD-917944-200T/EA |
| Cas.: NONE8782 | Poly-Gel DNA Extraction Kit | ESD-917945-20T/EA | |
| Cas.: NONE8782 | Poly-Gel DNA Extraction Kit | ESD-917945-50T/EA | |
| Cas.: NONE8783 | Repel-Silane | ESD-917946-200ML | |
| Cas.: NONE8784 | Fast Silver Stain Kit | ESD-917947-1SET/EA | |
| Cas.: NONE8785 | Purity: EB | Ethidium Bromide | ESD-917948-5ML |
| Cas.: NONE8785 | Purity: EB | Ethidium Bromide | ESD-917948-25ML |
| Cas.: NONE8785 | Purity: EB | Ethidium Bromide | ESD-917948-100ML |
| Cas.: NONE8786 | Purity: 1×, premixed powder | TBE Buffer | ESD-917949-2L |
| Cas.: NONE8786 | Purity: 1×, premixed powder | TBE Buffer | ESD-917949-10X2L |
| Cas.: NONE8787 | Purity: 5×, premixed powder | TBE Buffer | ESD-917950-2X2L |
| Cas.: NONE8788 | Purity: low electroosmosis | Agarose | ESD-917951-50G |
| Cas.: NONE8788 | Purity: low electroosmosis | Agarose | ESD-917951-250G |
| Cas.: NONE8790 | Purity: 2M, pH8.0 | Tris-HCI Buffer | ESD-917953-100ML |
| Cas.: NONE8790 | Purity: 2M, pH8.0 | Tris-HCI Buffer | ESD-917953-250ML |
| Cas.: NONE8791 | Purity: sterile, for immunostaining | ImmunoFluorescence Secondary Antibody Dilution Buffer | ESD-917954-100ML |
| Cas.: NONE8795 | Purity: 12% | SDS/Native-PAGE Gel Kit | ESD-917958-25T/EA |
| Cas.: NONE8795 | Purity: 12% | SDS/Native-PAGE Gel Kit | ESD-917958-50T/EA |
| Cas.: NONE8795 | Purity: 12% | SDS/Native-PAGE Gel Kit | ESD-917958-125T/EA |
| Cas.: NONE8797 | Purity: Universal | SDS/Native-PAGE Gel Kit | ESD-917960-25T/EA |
| Cas.: NONE8797 | Purity: Universal | SDS/Native-PAGE Gel Kit | ESD-917960-50T/EA |
| Cas.: NONE8798 | Purity: Universal | Bis-Tris PAGE Gel Kit | ESD-917961-25T/EA |
| Cas.: NONE8798 | Purity: Universal | Bis-Tris PAGE Gel Kit | ESD-917961-50T/EA |
| Cas.: NONE8799 | Purity: Universal | Tris-Tricine PAGE Gel Kit | ESD-917962-25T/EA |
| Cas.: NONE8799 | Purity: Universal | Tris-Tricine PAGE Gel Kit | ESD-917962-50T/EA |
| Cas.: NONE8800 | Purity: Universal | Tris-Acetate PAGE Gel Kit | ESD-917963-25T/EA |
| Cas.: NONE8800 | Purity: Universal | Tris-Acetate PAGE Gel Kit | ESD-917963-50T/EA |
| Cas.: NONE8800 | Purity: Universal | Tris-Acetate PAGE Gel Kit | ESD-917963-125T/EA |
| Cas.: NONE8801 | Coomassie Blue Staining Kit | ESD-917964-1SET/EA | |
| Cas.: NONE8802 | Purity: 20× | AEC Peroxidase Substrate Kit | ESD-917965-3ML |
| Cas.: NONE8803 | Purity: Low Abundance Protein | ECL Western Blot Substrate Kit | ESD-917966-50ML |
| Cas.: NONE8803 | Purity: Low Abundance Protein | ECL Western Blot Substrate Kit | ESD-917966-250ML |
| Cas.: NONE8804 | Purity: High Abundance Protein | ECL Western Blot Substrate Kit | ESD-917967-50ML |
| Cas.: NONE8804 | Purity: High Abundance Protein | ECL Western Blot Substrate Kit | ESD-917967-250ML |
| Cas.: NONE8805 | Purity: Abundance protein | ECL Western Blot Substrate Kit | ESD-917968-50ML |
| Cas.: NONE8806 | Purity: ＞99%, 10-100fg | ECL Western Blot Substrate Kit | ESD-917969-12.5ML |
| Cas.: NONE8806 | Purity: ＞99%, 10-100fg | ECL Western Blot Substrate Kit | ESD-917969-50ML |
| Cas.: NONE8807 | Purity: ＞99%, Ultra Low-abundance Proteins | ECL Western Blot Substrate Kit | ESD-917970-12.5ML |
| Cas.: NONE8807 | Purity: ＞99%, Ultra Low-abundance Proteins | ECL Western Blot Substrate Kit | ESD-917970-50ML |
| Cas.: NONE8808 | Western Blot Enhancer | ESD-917971-100ML | |
| Cas.: NONE8808 | Western Blot Enhancer | ESD-917971-500ML | |
| Cas.: NONE8809 | Total RNA Extraction Kit | ESD-917972-50T/EA | |
| Cas.: NONE8809 | Total RNA Extraction Kit | ESD-917972-100T/EA | |
| Cas.: NONE8815 | Water-Saturated Phenol | ESD-917978-250ML | |
| Cas.: NONE8815 | Water-Saturated Phenol | ESD-917978-1L | |
| Cas.: NONE8816 | Purity: Trizol | Total RNA Extraction Reagent | ESD-917979-100ML |
| Cas.: NONE8818 | Purity: sterile enzyme-free, for cell culture | Fetal Bovine Serum (FBS) | ESD-917981-200ML |
| Cas.: NONE8819 | Purity: pH8.0 | Tris-saturated Phenol | ESD-917982-200ML |
| Cas.: NONE8820 | Giemsa Stain solution | ESD-917983-200ML | |
| Cas.: 389139-89-3 | Purity: 98% | Omadacycline | ESD-879220-10MG |
| Cas.: 389139-89-3 | Purity: 98% | Omadacycline | ESD-879220-50MG |
| Cas.: 162515-68-6 | Purity: 98% | 1-(Mercaptomethyl)cyclopropaneacetic Acid | ESD-849784-25G |
| Cas.: 162515-68-6 | Purity: 98% | 1-(Mercaptomethyl)cyclopropaneacetic Acid | ESD-849784-100G |
| Cas.: 5726-19-2 | Purity: 97% | 2-Methylcyclohexyl Acetate | ESD-869450-25ML |
| Cas.: 5726-19-2 | Purity: 97% | 2-Methylcyclohexyl Acetate | ESD-869450-100ML |
| Cas.: 53850-34-3 | Thaumatin | ESD-867636-1G | |
| Cas.: 299-11-6 | Purity: 98% | Phenazine methosulfate | ESD-815755-100G |
| Cas.: 53850-34-3 | Thaumatin | ESD-867636-5G | |
| Cas.: 53850-34-3 | Thaumatin | ESD-867636-25G | |
| Cas.: 53850-34-3 | Thaumatin | ESD-867636-100G | |
| Cas.: 33527-91-2 | Purity: 98% | Tris[2-(dimethylamino)ethyl]amine | ESD-823759-25G |
| Cas.: NONE8821 | Purity: ≥80% polyphenols | Grape seed polyphenols | ESD-917984-1G |
| Cas.: NONE8821 | Purity: ≥80% polyphenols | Grape seed polyphenols | ESD-917984-10G |
| Cas.: NONE8821 | Purity: ≥80% polyphenols | Grape seed polyphenols | ESD-917984-100G |
| Cas.: 768-32-1 | Purity: 96% | Trimethyl(phenyl)silane | ESD-819199-1ML |
| Cas.: 5975-78-0 | Purity: 98% | Zearalanone | ESD-912627-5MG |
| Cas.: 1228879-28-4 | Purity: 90% | 1-(2-fluorophenyl)cyclobutan-1-amine hydrochloride | ESD-889287-500MG |
| Cas.: 13978-85-3 | Purity: ≥93% | Bis(8-quinolinolato)zinc(II) Hydrate | ESD-865384-100G |
| Cas.: 146897-68-9 | Purity: 95% | Lactoferrin (from bovine milk) | ESD-890180-5G |
| Cas.: 15097-38-8 | Purity: 97% | Benzyl 2-(triphenylphosphoranylidene)acetate | ESD-843851-5G |
| Cas.: 15097-38-8 | Purity: 97% | Benzyl 2-(triphenylphosphoranylidene)acetate | ESD-843851-25G |
| Cas.: 15097-38-8 | Purity: 97% | Benzyl 2-(triphenylphosphoranylidene)acetate | ESD-843851-100G |
| Cas.: 3052-50-4 | Purity: 98% | Monomethyl Maleate | ESD-858358-1G |
| Cas.: 557-24-4 | Purity: 98% | (Z)-4-Amino-4-oxobut-2-enoic acid | ESD-838079-100G |
| Cas.: 28069-72-9 | Purity: >97.0%(GC) | trans,cis-2,6-Nonadien-1-ol | ESD-864517-1ML |
| Cas.: 544-13-8 | Purity: ≥98% | Glutaronitrile | ESD-834930-500G |
| Cas.: 51333-22-3 | Purity: 98% | Budesonide | ESD-829879-5G |
| Cas.: 3786-46-7 | Purity: 98% | 3,6-Dihydroxyphthalic acid | ESD-843645-1G |
| Cas.: 3786-46-7 | Purity: 98% | 3,6-Dihydroxyphthalic acid | ESD-843645-5G |
| Cas.: 5393-81-7 | Purity: 98% | 2-hydroxy Decanoic Acid | ESD-912463-250MG |
| Cas.: 1327-41-9 | Purity: 98% | Aluminum chlorohydrate | ESD-822731-10KG |
| Cas.: 22009-38-7 | Purity: 98% | 7-Hydroxy-3,4-dihydronaphthalen-1(2H)-one | ESD-842018-25G |
| Cas.: 22009-38-7 | Purity: 98% | 7-Hydroxy-3,4-dihydronaphthalen-1(2H)-one | ESD-842018-100G |
| Cas.: 29932-54-5 | Purity: 98,5% | Ethylendiamintetraacetic acid, di-sodium-magnesium salt | ESD-874793-2.5KG |
| Cas.: 15310-01-7 | Purity: >95% | Benodanil | ESD-803013-1G |
| Cas.: 1153279-80-1 | Purity: 98% | 5-Bromo-2-fluoro-3-nitrobenzoic acid | ESD-914086-5G |
| Cas.: 60518-41-4 | Purity: ≥95% | 7-Chloro-3,4-dihydroisoquinoline | ESD-898342-5G |
| Cas.: 124750-92-1 | Purity: 98% | Losartan Carboxylic Acid | ESD-910460-100MG |
| Cas.: 124750-92-1 | Purity: 98% | Losartan Carboxylic Acid | ESD-910460-250MG |
| Cas.: 124750-92-1 | Purity: 98% | Losartan Carboxylic Acid | ESD-910460-1G |
| Cas.: 122008-78-0 | Purity: ≥96% | Cyhalofop | ESD-883891-250MG |
| Cas.: 95388-79-7 | Purity: 98% | tert-Butyl (4-chlorobutyl)carbamate | ESD-875143-5G |
| Cas.: 95388-79-7 | Purity: 98% | tert-Butyl (4-chlorobutyl)carbamate | ESD-875143-250MG |
| Cas.: 74003-63-7 | Purity: >95% | 3-Methylquinoxaline-2-carboxylic Acid | ESD-849435-250MG |
| Cas.: 1126969-29-6 | Purity: 97% | 4-(Pentafluorothio)benzyl bromide | ESD-918002-200MG |
| Cas.: 1126969-29-6 | Purity: 97% | 4-(Pentafluorothio)benzyl bromide | ESD-918002-1G |
| Cas.: 67776-06-1 | Purity: ≥97% | SNAP [S-Nitroso-N-acetylpenicillamine] | ESD-864185-1G |
| Cas.: 144675-97-8 | Purity: 99% | BBR 2778 Dimaleate | ESD-873139-50MG |
| Cas.: 88546-55-8 | Purity: 98% | Omeprazole metabolite Omeprazole sulfone | ESD-876768-50MG |
| Cas.: 144675-97-8 | Purity: 99% | BBR 2778 Dimaleate | ESD-873139-100MG |
| Cas.: 154235-83-3 | Purity: 98% | Ampalex | ESD-823376-100MG |
| Cas.: 154235-83-3 | Purity: 98% | Ampalex | ESD-823376-500MG |
| Cas.: 21658-70-8 | Purity: 98% | BODIPY 505/515 | ESD-912182-1G |
| Cas.: 1674-62-0 | Purity: ≥98% | Metformin Related Compound B | ESD-835584-500MG |
| Cas.: 77479-02-8 | Purity: 97% | 2,5-Pyrazinedipropanoic Acid | ESD-858169-100MG |
| Cas.: 77479-02-8 | Purity: 97% | 2,5-Pyrazinedipropanoic Acid | ESD-858169-1G |
| Cas.: 1219810-16-8 | Purity: 98% | RSL3 | ESD-873891-100MG |
| Cas.: 1446486-33-4 | Purity: 98% | 9-Propenyladenine (Tenofovir Impurity) | ESD-911058-1MG |
| Cas.: 1446486-33-4 | Purity: 98% | 9-Propenyladenine (Tenofovir Impurity) | ESD-911058-25MG |
| Cas.: 1126-61-0 | Purity: ≥98% | 4-Allylpyrocatechol | ESD-868305-500MG |
| Cas.: 100490-36-6 | Purity: BR | Tosufloxacin | ESD-910784-50MG |
| Cas.: 65813-55-0 | Purity: 98% | Boc-3-(2-pyridyl)-L-alanine | ESD-873903-5MG |
| Cas.: 100490-36-6 | Purity: BR | Tosufloxacin | ESD-910784-10MG |
| Cas.: 65813-55-0 | Purity: 98% | Boc-3-(2-pyridyl)-L-alanine | ESD-873903-25MG |
| Cas.: 21312-10-7 | Purity: BR | N-Acetyl Sulfamethoxazole | ESD-873764-500MG |
| Cas.: 21312-10-7 | Purity: BR | N-Acetyl Sulfamethoxazole | ESD-873764-100MG |
| Cas.: 64622-17-9 | Purity: >95% | isopropyl 2-(4-isobutylphenyl)propanoate | ESD-917327-250MG |
| Cas.: 64622-17-9 | Purity: >95% | isopropyl 2-(4-isobutylphenyl)propanoate | ESD-917327-1G |
| Cas.: 50479-22-6 | Purity: 95% | tert-Butyl 4-Aminobutanoate | ESD-851241-5G |
| Cas.: 36039-36-8 | Purity: 95% | 2-(4-Isobutylphenyl)propan-1-ol | ESD-916182-5G |
| Cas.: 1464851-21-5 | Purity: 97% | (Z)-9-Propenyladenine ((Z)-Mutagenic Impurity of Tenofovir Disoproxil) | ESD-911063-10MG |
| Cas.: 476-34-6 | Purity: ≥98% | Iisoindigotin | ESD-873407-1G |
| Cas.: 5394-50-3 | Purity: ≥95% | 1,2-Dicarbobenzyloxyhydrazine | ESD-874002-500MG |
| Cas.: 6665-78-7 | Purity: 95% | 5,7-Diacetoxyflavone | ESD-877908-10MG |
| Cas.: 6665-78-7 | Purity: 95% | 5,7-Diacetoxyflavone | ESD-877908-50MG |
| Cas.: 735-06-8 | Purity: 95% | (2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone | ESD-843625-5G |
| Cas.: 138977-28-3 | Purity: 99% | Capsazepine | ESD-872557-10MG |
| Cas.: 138977-28-3 | Purity: 99% | Capsazepine | ESD-872557-50MG |
| Cas.: 192130-34-0 | Purity: 98% | 1-Boc-4-(2-aminoethyl)piperazine | ESD-830359-100G |
| Cas.: 36703-88-5 | Purity: 99% | isoprinosine | ESD-850068-100G |
| Cas.: 464916-25-4 | Purity: ≥98% | 1-Ethyl Ester Methyl-3-Methylimidazolium Chloride | ESD-856893-25G |
| Cas.: 464916-25-4 | Purity: ≥98% | 1-Ethyl Ester Methyl-3-Methylimidazolium Chloride | ESD-856893-100G |
| Cas.: 52089-54-0 | Purity: ≥95%(GC) | Ethyl 2-Hydroxybutyrate | ESD-863036-5G |
| Cas.: 1282616-74-3 | Purity: ≥98% | α-Ketoglutaric Acid Disodium Salt Dihydrate | ESD-918008-100G |
| Cas.: 1282616-74-3 | Purity: ≥98% | α-Ketoglutaric Acid Disodium Salt Dihydrate | ESD-918008-25G |
| Cas.: 1282616-74-3 | Purity: ≥98% | α-Ketoglutaric Acid Disodium Salt Dihydrate | ESD-918008-5G |
| Cas.: 1282616-74-3 | Purity: ≥98% | α-Ketoglutaric Acid Disodium Salt Dihydrate | ESD-918008-500G |
| Cas.: 137405-36-8 | Purity: Analysis control, ≥98%(HPLC) | Fructo-oligosaccharide DP11/GF10 | ESD-918009-5MG |
| Cas.: 1345-25-1 | Purity: 90% | Iron(II) oxide | ESD-864818-500G |
| Cas.: 63310-10-1 | Purity: 97% | Fluorescent whitening agent KCB | ESD-890832-100G |
| Cas.: 3901-77-7 | Purity: 97% | 2,4,6-Trimethyl-2,4,6-trivinyl-1,3,5,2,4,6-trioxatrisilinane | ESD-839218-5G |
| Cas.: 3901-77-7 | Purity: 97% | 2,4,6-Trimethyl-2,4,6-trivinyl-1,3,5,2,4,6-trioxatrisilinane | ESD-839218-25G |
| Cas.: 3901-77-7 | Purity: 97% | 2,4,6-Trimethyl-2,4,6-trivinyl-1,3,5,2,4,6-trioxatrisilinane | ESD-839218-100G |
| Cas.: 30093-29-9 | Purity: ≥99% | Tetraethylammonium trifluoroacetate | ESD-856924-100G |
| Cas.: 59122-46-2 | Purity: 99% | Misoprostol | ESD-814255-50MG |
| Cas.: 59122-46-2 | Purity: 99% | Misoprostol | ESD-814255-250MG |
| Cas.: 4385-76-6 | Purity: 98% | 4-(4-Pyridyl)benzoic acid | ESD-815525-25G |
| Cas.: 1035458-54-8 | Purity: 95% | 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)quinoline | ESD-846218-5G |
| Cas.: 7789-92-6 | Purity: ≥97% | 1,1,3-TRIETHOXYPROPANE | ESD-860250-25G |
| Cas.: 930-69-8 | Purity: 95% | Sodium thiophenolate | ESD-831261-500G |
| Cas.: 968-21-8 | Purity: ≥98%(T) | L-Leucyl-L-tyrosine | ESD-861834-500MG |
| Cas.: 137405-40-4 | Purity: Analysis control, ≥98%(HPLC) | Fructo-oligosaccharide DP12/GF11 | ESD-918010-5MG |
| Cas.: 1344-28-1 | Purity: 99.99% metals basis, γ phase, 40nm | aluminum oxide | ESD-918011-100G |
| Cas.: 1344-28-1 | Purity: 99.99% metals basis, γ phase, 40nm | aluminum oxide | ESD-918011-500G |
| Cas.: 1344-28-1 | Purity: 99.99% metals basis, γ phase, 40nm | aluminum oxide | ESD-918011-2.5KG |
| Cas.: 32752-54-8 | Purity: >96% | 4-(Bromomethyl)benzophenone | ESD-835107-25G |
| Cas.: 54048-10-1 | Purity: 98% | Etonogestrel | ESD-829955-5G |
| Cas.: 113942-30-6 | Purity: 97% | 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid | ESD-845628-1G |
| Cas.: 13477-39-9 | Purity: ≥99% | calcium bis(metaphosphate) | ESD-886527-2.5KG |
| Cas.: 1604-28-0 | Purity: 98% | 6-Methyl-3,5-heptadien-2-one | ESD-858534-100G |
| Cas.: 13677-79-7 | Purity: 98% | 3,4,5-Trihydroxybenzaldehyde | ESD-824198-5G |
| Cas.: 25662-28-6 | Purity: ≥95% | Methyl cyclopent-1-enecarboxylate | ESD-824734-100G |
| Cas.: 1670-89-9 | Purity: 97% | 1H-Indole-7-carboxamide | ESD-889962-5G |
| Cas.: 5315-79-7 | Purity: 98% | 1-Hydroxypyrene | ESD-811471-25G |
| Cas.: 32897-26-0 | Purity: 95% | 1-[3-(Dimethylamino)propyl]-3-ethylurea | ESD-852218-5G |
| Cas.: 620-72-4 | Purity: 98% | Phenyl bromoacetate | ESD-815530-500G |
| Cas.: 5053-08-7 | Purity: 98% | Fenspiride Hydrochloride | ESD-860684-25G |
| Cas.: 55368-42-8 | Purity: 98% | 4-Bromobenzimidamide hydrochloride | ESD-848518-5G |
| Cas.: 137405-37-9 | Purity: Analysis control, ≥98%(HPLC) | Fructo-oligosaccharide DP13/GF12 | ESD-918012-5MG |
| Cas.: 137405-38-0 | Purity: Analysis control, ≥98%(HPLC) | Fructo-oligosaccharide DP14/GF13 | ESD-918013-5MG |
| Cas.: 38980-96-0 | Purity: ≥95% | 4-(trifluoromethyl)benzamidine hydrochloride | ESD-825391-1G |
| Cas.: 38980-96-0 | Purity: ≥95% | 4-(trifluoromethyl)benzamidine hydrochloride | ESD-825391-25G |
| Cas.: 5426-55-1 | Purity: ≥97% | N,N-Diethylglycine Sodium Salt | ESD-865697-1G |
| Cas.: 24686-78-0 | Purity: 97% | 1-Benzoyl-4-piperidone | ESD-835171-25G |
| Cas.: 6066-49-5 | Purity: ≥95% | Butylphthalide | ESD-918014-1G |
| Cas.: 6066-49-5 | Purity: ≥95% | Butylphthalide | ESD-918014-250MG |
| Cas.: 6066-49-5 | Purity: ≥95% | Butylphthalide | ESD-918014-100MG |
| Cas.: 2869-34-3 | Purity: 98% | 1-Aminotridecane | ESD-837838-5G |
| Cas.: 40598-76-3 | Purity: 95% | 3,5-Dibromo-1H-indazole | ESD-845254-5G |
| Cas.: 143606-53-5 | Purity: Injection grade | Poly(1,4-butylene succinate) | ESD-909172-2.5KG |
| Cas.: 119198-88-8 | Purity: ≥95% | 2,4,6-Trimethylbenzene-1,3,5-tricarbaldehyde | ESD-914885-1G |
| Cas.: 127641-86-5 | Purity: Reagent grade | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | ESD-890285-100MG |
| Cas.: 127641-86-5 | Purity: Reagent grade | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | ESD-890285-500MG |
| Cas.: 16064-15-6 | Purity: ≥95% | 6,7-Dihydroxyquinazolin-4(3H)-one | ESD-891049-25MG |
| Cas.: 57852-57-0 | Purity: 99% | 4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl | ESD-872446-5MG |
| Cas.: 7134-04-5 | Purity: 65% | o-Cresolsulfonic acid | ESD-836715-500G |
| Cas.: 7134-04-5 | Purity: 65% | o-Cresolsulfonic acid | ESD-836715-2.5KG |
| Cas.: 307-24-4 | Purity: 98% | Undecafluorohexanoic acid | ESD-820310-500G |
| Cas.: 957-77-7 | Purity: 96% | 5-Hydroxyuridine | ESD-918015-50MG |
| Cas.: 957-77-7 | Purity: 96% | 5-Hydroxyuridine | ESD-918015-10MG |
| Cas.: 7720-78-7 | Purity: 90% | FERROUS SULFATE | ESD-903429-100G |
| Cas.: 7720-78-7 | Purity: 90% | FERROUS SULFATE | ESD-903429-1KG |
| Cas.: 7720-78-7 | Purity: 90% | FERROUS SULFATE | ESD-903429-5KG |
| Cas.: 964-21-6 | Purity: 90% | 2′-Deoxy-6-O-methyl-guanosine | ESD-918017-5MG |
| Cas.: 7720-78-7 | Purity: 98% | FERROUS SULFATE | ESD-918016-5G |
| Cas.: 7720-78-7 | Purity: 98% | FERROUS SULFATE | ESD-918016-25G |
| Cas.: 7720-78-7 | Purity: 98% | FERROUS SULFATE | ESD-918016-100G |
| Cas.: 5132-79-6 | Purity: 97% | 2′-Deoxy-1-methylguanosine | ESD-918018-1MG |
| Cas.: 14599-46-3 | Purity: 98% | 5-Carboxy-2′-deoxyuridine | ESD-918019-1MG |
| Cas.: 607-85-2 | Purity: 95% | Isopropyl Salicylate | ESD-918020-100ML |
| Cas.: 607-85-2 | Purity: 95% | Isopropyl Salicylate | ESD-918020-25ML |
| Cas.: 958-74-7 | Purity: 98% | N3-Methylthymidine | ESD-918021-5MG |
| Cas.: 5071-96-5 | Purity: 98% | 3-Methoxybenzylamine | ESD-813737-100G |
| Cas.: 25775-85-3 | Purity: 95% | N6-Isopentenyl-2′-deoxyadenosine | ESD-918022-50MG |
| Cas.: 101-31-5 | Purity: 97% | L-Hyoscyamine | ESD-918023-50MG |
| Cas.: 101-31-5 | Purity: 97% | L-Hyoscyamine | ESD-918023-250MG |
| Cas.: 79887-10-8 | Purity: 97% | 1-Ethynyl-4-pentylbenzene | ESD-809168-500G |
| Cas.: 68971-82-4 | Purity: 95% | 4-tert-Butylcalix[8]arene | ESD-835446-100G |
| Cas.: 600-15-7 | Purity: ≥95%(T) | DL-2-Hydroxybutyric Acid (contains Polymolecular esterification product) | ESD-862814-1G |
| Cas.: 41263-94-9 | Purity: 98% | 2′-FUCOSYLLACTOSE | ESD-918027-25MG |
| Cas.: 41263-94-9 | Purity: 98% | 2′-FUCOSYLLACTOSE | ESD-918027-5MG |
| Cas.: 41263-94-9 | Purity: 98% | 2′-FUCOSYLLACTOSE | ESD-918027-1MG |
| Cas.: 41263-94-9 | Purity: 95% | 2′-FUCOSYLLACTOSE | ESD-916915-5MG |
| Cas.: 41263-94-9 | Purity: 95% | 2′-FUCOSYLLACTOSE | ESD-916915-25MG |
| Cas.: 41263-94-9 | Purity: 90% | 2′-FUCOSYLLACTOSE | ESD-918028-250MG |
| Cas.: 1782970-28-8 | Purity: 99% | PTC-028 | ESD-872823-25MG |
| Cas.: 588-53-4 | Purity: 98% | 4-Benzylideneaminophenol | ESD-871080-10G |
| Cas.: 933-99-3 | Purity: 95% | 3-Ethylbenzene-1,2-diol | ESD-895125-50MG |
| Cas.: 62-90-8 | Purity: 98% | 17b-hydroxyestr-4-en-3-one 17-(3-phenylpropionate) | ESD-829996-25G |
| Cas.: 110-26-9 | Purity: 2% solution | Bis-Acrylamide Solution | ESD-885203-500ML |
| Cas.: 593-50-0 | Purity: Analysis control, 98% | 1-Triacontanol | ESD-819628-20MG |
| Cas.: 1445-07-4 | Purity: ≥98% | Pseudouridine | ESD-868378-100MG |
| Cas.: 71432-55-8 | Purity: 95% | tert-Butyl N,N’-diisopropylcarbamimidate | ESD-840957-25G |
| Cas.: 71432-55-8 | Purity: 95% | tert-Butyl N,N’-diisopropylcarbamimidate | ESD-840957-100G |
| Cas.: 110351-94-5 | Purity: ≥95% | (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | ESD-890482-1G |
| Cas.: 151841-65-5 | Purity: AR | Aluminium hydroxybis[2,2′-methylen-bis(4,6-di-tert-butylphenyl)phosphate] | ESD-872062-500G |
| Cas.: 1271738-74-9 | Purity: 95% | Febuxostat Impurity 6 | ESD-915965-5MG |
| Cas.: 7177-48-2 | Purity: 96% | Ampicillin trihydrate | ESD-800201-500G |
| Cas.: 1009816-48-1 | Purity: 99% | Thiamet G | ESD-873016-25MG |
| Cas.: 848259-27-8 | Purity: ≥99% | Pemafibrate | ESD-877085-25MG |
| Cas.: 13347-77-8 | Purity: 95% | Z-Gly-Gly-Leu | ESD-915875-250MG |
| Cas.: 10192-85-5 | Purity: 98% | PotassiumAcrylate | ESD-833966-500G |
| Cas.: 10192-85-5 | Purity: 98% | PotassiumAcrylate | ESD-833966-1KG |
| Cas.: 106-73-0 | Purity: ≥99% | Methyl heptanoate | ESD-859148-100G |
| Cas.: 106-73-0 | Purity: ≥99% | Methyl heptanoate | ESD-859148-500G |
| Cas.: 6326-27-8 | Purity: 95% | 4-Methylbenzamidine Hydrochloride | ESD-856917-5G |
| Cas.: 68007-08-9 | Purity: 99% | Imidazole Hydroiodide | ESD-824365-5G |
| Cas.: 2611-61-2 | Purity: 98% | Thiamphenicol glycinate hydrochloride | ESD-822019-1G |
| Cas.: 75498-96-3 | Purity: 99% | Cefminox Sodium | ESD-873619-25MG |
| Cas.: 462-05-5 | Purity: BF3: 25%-26% | Boron trifluoride phenol complex | ESD-915103-5G |
| Cas.: 7720-78-7 | Purity: 98% | FERROUS SULFATE | ESD-918016-500G |
| Cas.: 953787-55-8 | Purity: 98% | 6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole | ESD-918031-20MG |
| Cas.: 953787-55-8 | Purity: 98% | 6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole | ESD-918031-50MG |
| Cas.: 953787-55-8 | Purity: 98% | 6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole | ESD-918031-100MG |
| Cas.: 35271-74-0 | Purity: 97% | 3-(4-Chlorophenyl)glutaric acid | ESD-804796-100G |
| Cas.: 35271-74-0 | Purity: 97% | 3-(4-Chlorophenyl)glutaric acid | ESD-804796-500G |
| Cas.: 4385-35-7 | Purity: 97% | 3-Isochromanone | ESD-830758-500G |
| Cas.: 52304-36-6 | Purity: 97% | Ethyl 3-(N-butylacetamido)propanoate | ESD-850031-500G |
| Cas.: 63480-10-4 | Purity: 95% | 7-Nitro-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-845273-25G |
| Cas.: 761425-93-8 | Purity: HPLC, ≥98% | Clematichinenoside AR | ESD-918033-10MG |
| Cas.: 1256565-36-2 | Purity: ≥99% | PTC299 | ESD-883591-1MG |
| Cas.: 104504-43-0 | Purity: 95% | BOC-4-BENZOYL-L-PHENYLALANINE | ESD-833624-5G |
| Cas.: 16162-28-0 | Purity: 95% | Benzo[1,2-d:4,5-d’]bis(thiazole)-2,6-diamine | ESD-916707-100MG |
| Cas.: 105956-97-6 | Purity: 98% | Clinafloxacin | ESD-873526-100MG |
| Cas.: 105956-97-6 | Purity: 98% | Clinafloxacin | ESD-873526-250MG |
| Cas.: 12222-69-4 | Purity: 98% | Disperse black 9 | ESD-908986-500G |
| Cas.: 20120-33-6 | Purity: 80% | 3-(Dimethylphosphono)-N-methylolpropionamide | ESD-850121-5G |
| Cas.: 1053655-82-5 | Purity: ≥95% | 2-bromo-5-nitropyridine-4-carboxylic acid | ESD-825545-5G |
| Cas.: 19070-91-8 | Purity: 0.5mol/L in water | Dibutylammonium Acetate (ca. 0.5mol/L in Water) | ESD-871627-25ML |
| Cas.: 462-05-5 | Purity: BF3: 25%-26% | Boron trifluoride phenol complex | ESD-915103-500G |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with Methylhydroquinone) | N-(2-Hydroxyethyl)acrylamide | ESD-918034-2.5KG |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with Methylhydroquinone) | N-(2-Hydroxyethyl)acrylamide | ESD-918034-500G |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with Methylhydroquinone) | N-(2-Hydroxyethyl)acrylamide | ESD-918034-100G |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with Methylhydroquinone) | N-(2-Hydroxyethyl)acrylamide | ESD-918034-25G |
| Cas.: 7646-67-5 | Purity: 98%(stabilized with Methylhydroquinone) | N-(2-Hydroxyethyl)acrylamide | ESD-918034-5G |
| Cas.: 172611-72-2 | Purity: ≥99% | 5,5-Dimethyl-2-(3-methylbutanoyl)cyclohexane-1,3-dione | ESD-847331-25G |
| Cas.: 172611-72-2 | Purity: ≥99% | 5,5-Dimethyl-2-(3-methylbutanoyl)cyclohexane-1,3-dione | ESD-847331-5G |
| Cas.: 101020-79-5 | Purity: 97% | SAMe-1,4-Butanedisulfonate | ESD-846843-5G |
| Cas.: 548-24-3 | Purity: 90% | Eosin B | ESD-918035-25G |
| Cas.: 548-24-3 | Purity: 90% | Eosin B | ESD-918035-5G |
| Cas.: NONE8232 | Purity: 99%, 100,000U/g | Glucose Isomerase | ESD-916745-500G |
| Cas.: NONE8232 | Purity: 99%, 100,000U/g | Glucose Isomerase | ESD-916745-100G |
| Cas.: 406-58-6 | Purity: 99,5% | 1,1,1,3,3-Pentafluorobutane | ESD-916112-25G |
| Cas.: 406-58-6 | Purity: 99,5% | 1,1,1,3,3-Pentafluorobutane | ESD-916112-100G |
| Cas.: 406-58-6 | Purity: 99,5% | 1,1,1,3,3-Pentafluorobutane | ESD-916112-500G |
| Cas.: 13689-19-5 | Purity: 98% | Tricyclohexylphosphine oxide | ESD-854924-1G |
| Cas.: 29858-07-9 | Purity: 98% | Magnesium bromide diethyl etherate | ESD-836406-100G |
| Cas.: 108-74-7 | Purity: ≥98% | 1,3,5-Trimethylhexahydro-1,3,5-triazine | ESD-867248-5ML |
| Cas.: 2305-13-7 | Purity: ≥98%(HPLC) | 3-(4-Hydroxy-3-methoxyphenyl)-1-propanol | ESD-863103-1G |
| Cas.: 2305-13-7 | Purity: ≥98%(HPLC) | 3-(4-Hydroxy-3-methoxyphenyl)-1-propanol | ESD-863103-5G |
| Cas.: 10028-70-3 | Purity: 99% | Disodium terephthalate | ESD-835938-500G |
| Cas.: 4727-31-5 | Purity: 98% | Kartogenin | ESD-849160-250MG |
| Cas.: 116-31-4 | Purity: ≥98% | all |trans|-Retinal | ESD-801648-1G |
| Cas.: 116-31-4 | Purity: ≥98% | all |trans|-Retinal | ESD-801648-5G |
| Cas.: 79603-03-5 | Purity: 98% | 4-Bromo-2-nitrobenzonitrile | ESD-918037-1G |
| Cas.: 79603-03-5 | Purity: 98% | 4-Bromo-2-nitrobenzonitrile | ESD-918037-250MG |
| Cas.: 38099-82-0 | Purity: 98% | D-Fructose 1,6-bisphosphate trisodium salt hydrate | ESD-809687-500G |
| Cas.: 18550-98-6 | Purity: 99% | 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one | ESD-872919-250MG |
| Cas.: 1009307-13-4 | Purity: ≥98% | (E)-ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate | ESD-918038-5G |
| Cas.: 1009307-13-4 | Purity: ≥98% | (E)-ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate | ESD-918038-1G |
| Cas.: 3392-97-0 | Purity: 97% | 2,6-Dimethoxybenzaldehyde | ESD-838709-100G |
| Cas.: 18523-47-2 | Purity: 98% | 3-Azidopropionic Acid | ESD-916881-500MG |
| Cas.: 18523-47-2 | Purity: 98% | 3-Azidopropionic Acid | ESD-916881-1G |
| Cas.: 373-49-9 | Purity: 98,5% | Palmitoleic acid | ESD-816248-5G |
| Cas.: 113082-99-8 | Purity: 95% | Calcipotriol Impurity C | ESD-884464-1MG |
| Cas.: 17321-93-6 | Purity: 97% | 2-Amino-5-bromo-4-methylpyrimidine | ESD-842029-5G |
| Cas.: 17321-93-6 | Purity: 97% | 2-Amino-5-bromo-4-methylpyrimidine | ESD-842029-25G |
| Cas.: 1469894-57-2 | Purity: 98% | 7-(tert-Butoxy)-7-oxoheptanoic acid | ESD-899835-5G |
| Cas.: 1469894-57-2 | Purity: 98% | 7-(tert-Butoxy)-7-oxoheptanoic acid | ESD-899835-25G |
| Cas.: 36914-77-9 | Purity: ≥95% | 2,4-Difluorophenyl Acetate | ESD-918039-100MG |
| Cas.: 36914-77-9 | Purity: ≥95% | 2,4-Difluorophenyl Acetate | ESD-918039-500MG |
| Cas.: 23127-41-5 | Purity: 98% | N-Acetyl-S-allyl-L-cysteine | ESD-912270-25MG |
| Cas.: 23127-41-5 | Purity: 98% | N-Acetyl-S-allyl-L-cysteine | ESD-912270-100MG |
| Cas.: 992-78-9 | Purity: 98% | Ubiquinol | ESD-913253-250MG |
| Cas.: 9045-23-2 | Purity: ≥90%(PAGE), from milk | β-Lactoglobulin | ESD-861421-500MG |
| Cas.: 113082-99-8 | Purity: 95% | Calcipotriol Impurity C | ESD-884464-5MG |
| Cas.: 20246-53-1 | Purity: 90% | Gulonic acid | ESD-889323-25G |
| Cas.: 20246-53-1 | Purity: 90% | Gulonic acid | ESD-889323-100G |
| Cas.: 610-81-1 | Purity: 98% | 4-Amino-3-nitrophenol | ESD-800149-250G |
| Cas.: 105890-71-9 | Purity: 98% | Tributylhexylphosphonium Bromide | ESD-857104-5G |
| Cas.: 9050-06-0 | Purity: average Mn40, 000, powder | Poly(vinyl cinnamate) | ESD-918040-1G |
| Cas.: 9050-06-0 | Purity: average Mn40, 000, powder | Poly(vinyl cinnamate) | ESD-918040-250MG |
| Cas.: 129-00-0 | Purity: Sublimation purification, 99% | Pyrene | ESD-817274-500G |
| Cas.: 561064-15-1 | Purity: 98% | 2,6-dibromo-9,10-dinaphthalen-2-ylanthracene | ESD-835806-200MG |
| Cas.: 899422-06-1 | Purity: ≥98% | 2-Bromospiro[9H-fluorene-9,9′-[9H]xanthene] | ESD-866049-5G |
| Cas.: 899422-06-1 | Purity: ≥98% | 2-Bromospiro[9H-fluorene-9,9′-[9H]xanthene] | ESD-866049-25G |
| Cas.: 1698-16-4 | Purity: 98% | 10-Bromo-7H-benzo[c]carbazole | ESD-871200-1G |
| Cas.: 1698-16-4 | Purity: 98% | 10-Bromo-7H-benzo[c]carbazole | ESD-871200-5G |
| Cas.: 1698-16-4 | Purity: 98% | 10-Bromo-7H-benzo[c]carbazole | ESD-871200-25G |
| Cas.: 1056451-44-5 | Purity: 98% | 2-(3,5-Dimethylphenyl)quinoline | ESD-856506-5G |
| Cas.: 1056451-44-5 | Purity: 98% | 2-(3,5-Dimethylphenyl)quinoline | ESD-856506-1G |
| Cas.: 1056451-44-5 | Purity: 98% | 2-(3,5-Dimethylphenyl)quinoline | ESD-856506-250MG |
| Cas.: 4727-31-5 | Purity: 98% | Kartogenin | ESD-849160-1G |
| Cas.: 1199616-66-4 | Purity: 97% | CBZO;5H-Benzofuro[3,2-c]carbazole | ESD-856267-1G |
| Cas.: 1199616-66-4 | Purity: 97% | CBZO;5H-Benzofuro[3,2-c]carbazole | ESD-856267-25G |
| Cas.: 86-35-1 | Purity: 98% | Ethotoin ((±)-Ethotoin) | ESD-911530-25MG |
| Cas.: 86-35-1 | Purity: 98% | Ethotoin ((±)-Ethotoin) | ESD-911530-100MG |
| Cas.: 552-58-9 | Purity: 98% | Eriodictyol | ESD-914939-250MG |
| Cas.: 39028-27-8 | Purity: 98% | N-Succinimidyl Iodoacetate | ESD-855257-250MG |
| Cas.: 39028-27-8 | Purity: 98% | N-Succinimidyl Iodoacetate | ESD-855257-100MG |
| Cas.: 52248-03-0 | Purity: 80% | S-(5′-Adenosyl)-L-methionine ptoluenesulfonate salt | ESD-912413-500MG |
| Cas.: 52248-03-0 | Purity: 80% | S-(5′-Adenosyl)-L-methionine ptoluenesulfonate salt | ESD-912413-100MG |
| Cas.: 40846-94-4 | Purity: 96% | DL-α-Lipoic Acid-NHS | ESD-869268-1G |
| Cas.: 15442-91-8 | Purity: ≥98% | 1,2,4,5-Tetrakis(bromomethyl)benzene | ESD-918042-25G |
| Cas.: 15442-91-8 | Purity: ≥98% | 1,2,4,5-Tetrakis(bromomethyl)benzene | ESD-918042-5G |
| Cas.: 209395-32-4 | Purity: ≥98% | N-Propargylmaleimide | ESD-868138-500MG |
| Cas.: 1551-44-6 | Purity: ≥98% | Cyclohexyl Butyrate | ESD-859615-100G |
| Cas.: 1551-44-6 | Purity: ≥98% | Cyclohexyl Butyrate | ESD-859615-5G |
| Cas.: 33008-07-0 | Purity: 95% | 2-(3-Methylbut-2-enamido)acetic acid | ESD-890754-25MG |
| Cas.: 7652-46-2 | Purity: 98% | (R)-Methyl 2-acetamido-3-mercaptopropanoate | ESD-917013-5G |
| Cas.: 7652-46-2 | Purity: 98% | (R)-Methyl 2-acetamido-3-mercaptopropanoate | ESD-917013-100MG |
| Cas.: 17455-25-3 | Purity: 97% | Dibenzo-30-crown 10-Ether | ESD-869600-1G |
| Cas.: 106983-28-2 | Purity: ≥97.0% (HPLC) | N-Hexanoyl-DL-homoserine lactone | ESD-914811-25MG |
| Cas.: 106983-28-2 | Purity: ≥97.0% (HPLC) | N-Hexanoyl-DL-homoserine lactone | ESD-914811-100MG |
| Cas.: 5369-16-4 | Purity: 98% | 3-Isopropylaniline | ESD-811822-5ML |
| Cas.: 39207-65-3 | Purity: 95% | 2-Isobutyrylcyclohexanone | ESD-840172-5G |
| Cas.: 607-85-2 | Purity: 95% | Isopropyl Salicylate | ESD-918020-5ML |
| Cas.: 1076-43-3 | Purity: (D, 99.5%)+ 0.03% V/V TMS | Benzene-D6 | ESD-801868-50G |
| Cas.: 530-56-3 | Purity: ≥97% | 4-Hydroxy-3,5-dimethoxybenzyl alcohol | ESD-873639-5G |
| Cas.: 104-20-1 | Purity: ≥98% | 4-(4-Methoxyphenyl)-2-Butanone | ESD-859443-100G |
| Cas.: 104-20-1 | Purity: ≥98% | 4-(4-Methoxyphenyl)-2-Butanone | ESD-859443-500G |
| Cas.: 7446-34-6 | Purity: 97% | Selenium sulfide | ESD-918047-500G |
| Cas.: 83015-26-3 | Purity: 98% | Atomoxetine | ESD-912777-50MG |
| Cas.: 7446-34-6 | Purity: 97% | Selenium sulfide | ESD-918047-100G |
| Cas.: 7446-34-6 | Purity: 97% | Selenium sulfide | ESD-918047-25G |
| Cas.: 7446-34-6 | Purity: 97% | Selenium sulfide | ESD-918047-5G |
| Cas.: 2109-66-2 | Purity: ≥98%(GC) | (2-Hydroxypropyl)morpholine | ESD-863051-25ML |
| Cas.: 506-32-1 | Purity: ≥95% | Arachidonic acid | ESD-875622-1G |
| Cas.: 106797-53-9 | Purity: 98% | 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone | ESD-823464-1KG |
| Cas.: 5137-70-2 | Purity: 98% | Dodecylphosphonic Acid | ESD-849494-500G |
| Cas.: 7387-98-6 | Purity: 98% | D-ERYTHRO-CHLORAMPHENICOL | ESD-918053-1G |
| Cas.: 7387-98-6 | Purity: 98% | D-ERYTHRO-CHLORAMPHENICOL | ESD-918053-5G |
| Cas.: 7387-98-6 | Purity: 98% | D-ERYTHRO-CHLORAMPHENICOL | ESD-918053-25G |
| Cas.: 25038-54-4 | Purity: 150-200 Mesh | Nylon 6 | ESD-814809-2.5KG |
| Cas.: 25038-54-4 | Purity: 150-200 Mesh | Nylon 6 | ESD-814809-100G |
| Cas.: 35335-16-1 | Purity: 97% | 1,4-Dibromo-2,5-bis(bromomethyl)benzene | ESD-869614-1G |
| Cas.: 7387-98-6 | Purity: 98% | D-ERYTHRO-CHLORAMPHENICOL | ESD-918053-100G |
| Cas.: 7387-98-6 | Purity: 98% | D-ERYTHRO-CHLORAMPHENICOL | ESD-918053-500G |
| Cas.: 30459-70-2 | Purity: 95% | 2-Methyl-4-nitrobenzoyl Chloride | ESD-918055-50MG |
| Cas.: 113193-60-5 | Purity: 98% | Iron(II) Ethylenediammonium Sulfate Tetrahydrate | ESD-870305-100G |
| Cas.: 33703-08-1 | Purity: Branched chain isomer mixture | Diisononyl Adipate | ESD-918057-100ML |
| Cas.: 1713265-25-8 | Purity: ≥98%(LC) | L-Ascorbic Acid 2-Phosphate Sesquimagnesium Salt Hydrate | ESD-918058-5G |
| Cas.: 95-02-3 | Purity: ≥95%(LC&T) | 4-Amino-5-aminomethyl-2-methylpyrimidine | ESD-918059-250MG |
| Cas.: 78597-54-3 | Purity: ≥98%(LC&T) | 5-Amino-3-(4-methylphenyl)pyrazole | ESD-918060-1G |
| Cas.: 42059-48-3 | Purity: ≥98%(GC) | 4-Acetyl-3-hydroxyphenyl Acetate | ESD-918061-1G |
| Cas.: 7659-06-5 | Purity: ≥95%(GC&T) | 5-(Furan-2-yl)-1,3,4-oxadiazol-2-amine | ESD-918062-1G |
| Cas.: 92-62-6 | Purity: ≥96%(T&LC) | Acridine-3,6-diamine | ESD-918063-1G |
| Cas.: 117961-29-2 | Purity: ≥97%(LC) | Adenosine 5′-Triphosphate P3-[1-(2-Nitrophenyl)ethyl Ester] Trisodium Salt | ESD-918064-5MG |
| Cas.: 394735-23-0 | Purity: ≥95%(T), mixture of diastereomers | 3-Amino-4-cyclobutyl-2-hydroxybutanamide Hydrochloride | ESD-918065-100MG |
| Cas.: 1310827-26-9 | Purity: ≥98%(GC) | Acetylthio-PEG3-C2-Azide | ESD-918066-50MG |
| Cas.: 2249891-89-0 | Purity: ≥98%(GC&T) | 2-(Allylsulfonyl)-4-methylpyridine | ESD-918067-100MG |
| Cas.: 2249891-90-3 | Purity: ≥98%(GC&N) | 2-(Allylsulfonyl)-3-methylpyridine | ESD-918068-100MG |
| Cas.: 1343407-91-9 | Purity: ≥97%(LC&N) | Alloc-Val-Ala-PAB-OH | ESD-918069-50MG |
| Cas.: 1608127-09-8 | Purity: ≥96%(LC&N) | Alloc-Val-Cit-PAB-OH | ESD-918070-100MG |
| Cas.: 2249891-88-9 | Purity: ≥95%(GC) | 2-(Allylsulfonyl)-5-methylpyridine | ESD-918071-100MG |
| Cas.: 2249891-86-7 | Purity: ≥98%(GC) | 2-(Allylsulfonyl)-6-methylpyridine | ESD-918072-100MG |
| Cas.: 15180-02-6 | Purity: ≥97%(LC) | Amfonelic Acid | ESD-918073-1MG |
| Cas.: 80293-60-3 | Purity: ≥97%(LC&N) | 3-[(3-Acrylamidopropyl)dimethylammonio]propane-1-sulfonate | ESD-918074-1G |
| Cas.: 3207-04-3 | Purity: ≥98%(GC) | 3-[(Allyloxy)methyl]-3-ethyloxetane | ESD-918075-1G |
| Cas.: 146292-90-2 | Purity: ≥98%(GC) | 6-Azidohexan-1-ol | ESD-918076-50MG |
| Cas.: 88992-91-0 | Purity: ≥98%(LC&N) | 3-[[2-(Acryloyloxy)ethyl]dimethylammonio]propane-1-sulfonate | ESD-918077-5G |
| Cas.: 206872-01-7 | Purity: ≥98%(LC) | 2-Amino-6-bromo-4-methoxyphenol | ESD-918078-1G |
| Cas.: 1715-30-6 | Purity: ≥98%(LC&N) | Alexidine Dihydrochloride | ESD-918079-25MG |
| Cas.: 2244426-40-0 | Purity: ≥98%(LC) | 5-Adamantyl-IAA | ESD-918080-10MG |
| Cas.: 65592-36-1 | Purity: ≥98%(T) | 2-(1-Pyrrolidinyl)ethanamine Dihydrochloride | ESD-918081-1G |
| Cas.: 75238-09-4 | Purity: ≥98%(LC&T) | N-(6-Aminohexyl)maleimide Hydrochloride | ESD-918082-100MG |
| Cas.: 76259-32-0 | Purity: ≥98%(LC&T) | N-(2-Aminoethyl)methacrylamide Hydrochloride | ESD-918083-1G |
| Cas.: 2230958-14-0 | Purity: ≥98%(LC) | (S,R,S)-AHPC Hydrochloride | ESD-918084-10MG |
| Cas.: 202343-12-2 | N-Acetyl-2-deoxy-2-azido-alpha-neuraminic Acid | ESD-918085-1MG | |
| Cas.: 2451065-67-9 | Purity: ≥98%(LC&T) | N-(2-Aminoethyl)-N-benzylglycine Bis(trifluoroacetate) | ESD-918086-1G |
| Cas.: 385812-51-1 | Purity: ≥98%(LC&W) | Sodium Tetrakis(4-fluorophenyl)borate Hydrate | ESD-918087-1G |
| Cas.: 106006-86-4 | Purity: ≥95%(N) | cis-1-Benzyl-2,6-dicyanopiperidine | ESD-918088-100MG |
| Cas.: 95418-58-9 | Purity: ≥98%(GC), contains stabilizerTBC | 4-tert-Butoxystyrene | ESD-918089-100ML |
| Cas.: 5024-84-0 | Purity: ≥98%(GC) | 1,4-Bis(3-methoxyphenoxy)benzene | ESD-918090-1G |
| Cas.: 1138-56-3 | Purity: ≥98%(GC) | 4-Butoxybenzenesulfonyl Chloride | ESD-918091-1G |
| Cas.: 882980-43-0 | Purity: ≥97%(T) | 2-Benzyloxy-1-methylpyridinium Trifluoromethanesulfonate | ESD-918092-1G |
| Cas.: 21510-43-0 | Purity: ≥97%(LC) | 2-(4-Bromophenyl)-5-phenyl-1,3,4-oxadiazole | ESD-918093-1G |
| Cas.: 16926-73-1 | Purity: ≥98%(LC) | Bis(4-aminophenyl)Terephthalate | ESD-918094-5G |
| Cas.: 1010840-17-1 | Purity: ≥98%(GC) | 1,2-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyne | ESD-918095-100MG |
| Cas.: 56563-37-2 | Purity: ≥98%(GC) | 2-Butynyl p-Toluenesulfonate | ESD-918096-1G |
| Cas.: 2879-15-4 | Purity: ≥98%(T&LC) | 8-Benzyltheophylline | ESD-918097-5G |
| Cas.: 947488-89-3 | Purity: ≥98%(GC) | 3,6-Bis(trimethylsilyl)naphthalene-2,7-diyl Bis(trifluoromethanesulfonate) | ESD-918098-100MG |
| Cas.: 84359-61-5 | Purity: ≥98%(GC) | 9-(3-Bromopropyl)carbazole | ESD-918099-100MG |
| Cas.: 308088-29-1 | Purity: ≥98%(GC) | 2-Bromo-4-formyl-6-methoxyphenyl Acetate | ESD-918100-100MG |
| Cas.: 116784-97-5 | Purity: ≥98%(LC&N) | Benzyl (6-Bromohexyl)carbamate | ESD-918101-100MG |
| Cas.: 477789-30-3 | Purity: ≥98%(LC) | trans-1,2-Bis[5-(trimethylstannyl)thiophen-2-yl]ethene | ESD-918102-100MG |
| Cas.: 57357-20-7 | Purity: ≥98%(T) | [Bis(tert-butylcarbonyloxy)iodo]benzene | ESD-918103-1G |
| Cas.: 22393-36-8 | Purity: ≥98%(LC) | (2,2′-Bipyridyl)dichlorocopper(II) | ESD-918104-100MG |
| Cas.: 934368-79-3 | Purity: ≥98%(GC) | 2-Bromo-5-(4-hexylphenyl)thiophene | ESD-918105-100MG |
| Cas.: 2413847-26-2 | Purity: ≥92%(LC) | Biotin-PEG2-Hydrazide | ESD-918106-10MG |
| Cas.: 1449401-87-9 | Purity: ≥95%(GC) | 8-Bromo-5-phenyl-5H-pyrido[3,2-b]indole | ESD-918107-100MG |
| Cas.: 872466-50-7 | Purity: ≥98%(LC&N) | (E,E)-1,4-Bis[4-[bis(4-methoxyphenyl)amino]stylyl]benzene | ESD-918108-5G |
| Cas.: 838862-47-8 | Purity: ≥98%(LC) | 4,4′-Bis(3,6-di-tert-butyl-9H-carbazol-9-yl)-1,1′-biphenyl | ESD-918109-100MG |
| Cas.: 167218-39-5 | Purity: ≥95%(LC&N) | N,N-Bis(4′-diphenylamino-4-biphenylyl)amine | ESD-918110-1G |
| Cas.: 131890-26-1 | Purity: 10% in THF | Bis[2-(diisopropylphosphino)ethyl]amine | ESD-918111-1G |
| Cas.: 1268621-99-3 | Purity: ≥98%(LC&N) | N-([1,1′-Biphenyl]-4-yl)-N-(4′-bromo-[1,1′-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2 -amine | ESD-918112-100MG |
| Cas.: 525573-22-2 | Purity: ≥90%(LC) | Biotin-PEG3-Maleimide | ESD-918113-10MG |
| Cas.: 345924-29-0 | Purity: ≥98%(GC) | 1-(4-Bromophenyl)pyrene | ESD-918114-1G |
| Cas.: 846-20-8 | Purity: ≥98%(T) | 2-Bromonaphthalene-1,4,5,8-tetracarboxylic 1,8:4,5-Dianhydride | ESD-918115-1G |
| Cas.: 844856-42-4 | Purity: ≥98%(GC) | 3-Bromo-3′-chloro-1,1′-biphenyl | ESD-918116-5G |
| Cas.: 881415-72-1 | Purity: ≥95%(N) | Bis(3-sulfo-N-succinimidyl) Glutarate Disodium Salt | ESD-918117-50MG |
| Cas.: 1689576-03-1 | Purity: ≥98%(GC) | 2-([1,1′-Biphenyl]-3-yl)-4-chloro-6-phenyl-1,3,5-triazine | ESD-918118-1G |
| Cas.: 253158-13-3 | Purity: ≥98%(LC&N) | 2,4-Bis[4-(tert-butyl)phenyl]-6-chloro-1,3,5-triazine | ESD-918119-100MG |
| Cas.: 1379440-97-7 | Purity: ≥95%(GC) | (R)-3-(Bromomethyl)heptane | ESD-918120-100MG |
| Cas.: 1210469-11-6 | Purity: ≥98%(LC&N) | 10-Bromo-7-phenyl-7H-benzo[c]carbazole | ESD-918121-100MG |
| Cas.: 854952-59-3 | Purity: ≥98%(GC) | 3-(3-Bromophenyl)-9-phenyl-9H-carbazole | ESD-918122-1G |
| Cas.: 1606981-69-4 | Purity: ≥98%(N) | 2-[3′-Bromo[1,1′-biphenyl]-3-yl]-4,6-diphenyl-1,3,5-triazine | ESD-918123-1G |
| Cas.: 1067914-83-3 | Purity: ≥97%(GC) | 1-(tert-Butoxycarbonyl)-3,3-difluoro-4,4-dihydroxypiperidine | ESD-918124-1G |
| Cas.: 368879-17-8 | Purity: ≥98%(GC&T) | 1-(4-Bromobenzyl)-4-methylpiperazine | ESD-918125-100MG |
| Cas.: 117901-97-0 | Purity: ≥95%(N) | N,N’-Bis[3-(dimethylamino)propyl]perylene-3,4,9,10-tetracarboxylic Diimide | ESD-918126-100MG |
| Cas.: 325773-62-4 | Purity: ≥98%(GC) | 2,2′-Bis[bis(3,5-dimethylphenyl)phosphino]-1,1′-biphenyl | ESD-918127-100MG |
| Cas.: 605630-37-3 | Purity: ≥95%(GC) | 2-Bromo-7-chloro-9,9-dimethyl-9H-fluorene | ESD-918128-5G |
| Cas.: 1412448-63-5 | Purity: ≥95%(LC) | 2,5-Bis(2-decyltetradecyl)-3,6-bis[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]pyrrolo[ 3,4-c]pyrrole-1,4(2H,5H)-dione | ESD-918129-50MG |
| Cas.: 108549-21-9 | Purity: ≥98%(GC&T) | Benzyl N,N,N’,N’-Tetraisopropylphosphorodiamidite | ESD-918130-1G |
| Cas.: 950779-13-2 | Purity: ≥97%(GC&T) | 1,6-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-918131-1G |
| Cas.: 6336-92-1 | Purity: ≥98%(LC&N) | N-(4-Biphenylyl)-2-naphthylamine | ESD-918132-100MG |
| Cas.: 82469-79-2 | Purity: ≥92%(GC) | Trihexyl O-Butyrylcitrate | ESD-918133-100G |
| Cas.: 51870-56-5 | Purity: ≥95%(N) | N,N’-Bis(tri-p-tolylphosphoranylidene)benzene-1,4-diamine | ESD-918134-100MG |
| Cas.: 1446282-43-4 | Purity: ≥90%(LC) | Bromo-PEG3-Azide | ESD-918135-50MG |
| Cas.: 443965-64-8 | Purity: ≥98%(GC) | N-([1,1′-Biphenyl]-4-yl)phenanthren-9-amine | ESD-918136-100MG |
| Cas.: 944418-46-6 | Purity: ≥98%(LC&N) | N-[4-(tert-Butyl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine | ESD-918137-100MG |
| Cas.: 10075-51-1 | Purity: ≥98%(GC&N) | 1-Benzyl-5-bromo-1H-indole | ESD-918138-1G |
| Cas.: 13275-42-8 | Purity: ≥98%(GC&T) | 2-(2-Bromophenyl)-1H-benzimidazole | ESD-918139-1G |
| Cas.: 2455-43-8 | Purity: ≥97%(LC) | 1,4-Bis(4-phenoxyphenoxy)benzene | ESD-918140-100MG |
| Cas.: 22082-97-9 | Purity: ≥98%(GC) | 2-(2-Bromophenyl)naphthalene | ESD-918141-1G |
| Cas.: 2253748-36-4 | Purity: ≥98%(LC&N) | Br-BTXI | ESD-918142-50MG |
| Cas.: 5335-84-2 | Purity: ≥98%(LC) | Bis(4-bromophenyl) Disulfide | ESD-918143-1G |
| Cas.: 1004755-00-3 | Purity: ≥98%(LC) | tert-Butyl (R)-2-(2,6-Dichlorophenyl)-5-oxo-3-[(R)-1-phenylethyl]imidazolidine-1-carboxylate | ESD-918144-100MG |
| Cas.: 1149765-08-1 | Purity: ≥98%(LC&N) | tert-Butyl (S)-2-(2,6-Dichlorophenyl)-5-oxo-3-[(S)-1-phenylethyl]imidazolidine-1-carboxylate | ESD-918145-100MG |
| Cas.: 937372-45-7 | Purity: ≥98%(GC) | 4-(10-Bromoanthracen-9-yl)benzonitrile | ESD-918146-100MG |
| Cas.: 10276-85-4 | Purity: ≥95%(GC) | Benzyl Octanoate | ESD-918147-5G |
| Cas.: 2565-18-6 | Purity: ≥98%(GC), contains stabilizerMEHQ | N-Butylacrylamide | ESD-918148-5G |
| Cas.: 2156642-70-3 | Purity: ≥98%(LC) | BIP | ESD-918149-5MG |
| Cas.: 2205054-16-4 | Purity: ≥97%(LC&N) | N,N-Bis(4-bromophenyl)-[1,1′:4′,1”-terphenyl]-4-amine | ESD-918150-1G |
| Cas.: 1762-87-4 | Purity: ≥97%(GC) | 3-Bromo-1,1′:4′,1”-terphenyl | ESD-918151-1G |
| Cas.: 1609484-45-8 | Purity: ≥98%(GC) | 4-Bromospiro[fluorene-9,9′-xanthene] | ESD-918152-1G |
| Cas.: 1314713-40-0 | Purity: ≥95%(LC&T) | 3-[Bis[2-(methacryloyloxy)ethyl](methyl)ammonio]propane-1-sulfonate | ESD-918153-100MG |
| Cas.: 1644059-09-5 | Purity: ≥95%(LC&N) | N-(4-Bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine | ESD-918154-5G |
| Cas.: 1384207-26-4 | Purity: ≥98%(GC) | 9-Bromo-7,7-diphenyl-7H-benzo[c]fluorene | ESD-918155-100MG |
| Cas.: 570391-47-8 | Purity: ≥98%(LC&N) | N-([1,1′-Biphenyl]-4-yl)-[1,1′-biphenyl]-3-amine | ESD-918156-1G |
| Cas.: 132396-99-7 | Purity: ≥98%(N) | Diisopropylamine Hydroiodide | ESD-918157-1G |
| Cas.: 684283-51-0 | Purity: ≥98%(T)(HPLC) | 1,3-Diisopropylbenzimidazolium Bromide | ESD-918158-1G |
| Cas.: 925-76-8 | Purity: ≥98%(GC)(T) | N-[2-(Dimethylamino)ethyl]acrylamide | ESD-918159-5G |
| Cas.: 2377770-18-6 | Purity: ≥98%(T) | (2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid | ESD-918161-100MG |
| Cas.: 139346-57-9 | Purity: ≥98%(HPLC) | N-Succinimidyl 7-(Diethylamino)coumarin-3-carboxylate | ESD-918162-100MG |
| Cas.: 1005771-03-8 | Purity: ≥98%(T)(HPLC) | 2-[3-(9,9-Dimethyl-9H-fluoren-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918163-1G |
| Cas.: 1263001-82-6 | Purity: ≥95%(HPLC)(N) | 9,9-Dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine | ESD-918164-1G |
| Cas.: 1257321-41-7 | Purity: ≥97%(GC) | 4,4′-Dibromo-9,9′-spirobi[9H-fluorene] | ESD-918165-100MG |
| Cas.: 854952-90-2 | Purity: ≥97%(T)(HPLC) | 5,9-Dibromo-7,7-diphenyl-7H-benzo[c]fluorene | ESD-918166-100MG |
| Cas.: 897671-71-5 | Purity: ≥95%(T)(HPLC) | Di([1,1′:3′,1”-terphenyl]-4-yl)amine | ESD-918167-1G |
| Cas.: 2083617-82-5 | Purity: ≥98%(HPLC) | (5,6-Difluoro-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile | ESD-918168-100MG |
| Cas.: 1122-45-8 | Purity: ≥98%(GC) | 2,4-Dimethylpyridine N-Oxide | ESD-918169-1G |
| Cas.: 211638-02-7 | Purity: ≥95%(GC) | 1-(Diphenylphosphino)-N,N-dimethyl-2-propanamine | ESD-918170-100MG |
| Cas.: 1620408-04-9 | Purity: ≥98%(LC) | 1,8,13-Trihydroxytriptycene | ESD-918171-100MG |
| Cas.: 25343-70-8 | Purity: ≥95%(GC) | 1,3-Diisopropyl-2-isothiocyanatobenzene | ESD-918172-1G |
| Cas.: 22102-66-5 | Purity: ≥97%(GC) | N-Succinimidyl Decanoate | ESD-918173-100MG |
| Cas.: 40102-86-1 | Purity: ≥97%(HPLC) | 2,7-Dibromo-9H-thioxanthen-9-one | ESD-918174-1G |
| Cas.: 7334-96-5 | Purity: ≥98%(T) | Dipropylamine Hydrobromide | ESD-918175-1G |
| Cas.: 14488-46-1 | Purity: ≥97%(T) | Dipropylamine Hydriodide | ESD-918176-1G |
| Cas.: 143651-07-4 | Purity: ≥98%(T) | Dipropylammonium Trifluoroacetate | ESD-918177-1G |
| Cas.: 10435-44-6 | Purity: ≥95%(T) | Dibutylamine Hydrobromide | ESD-918178-1G |
| Cas.: 79886-80-9 | Purity: ≥98%(T) | Dibutylamine Hydroiodide | ESD-918179-1G |
| Cas.: 334-41-8 | Purity: ≥98%(T) | Dibutylamine Trifluoroacetate | ESD-918180-1G |
| Cas.: 52198-62-6 | Purity: ≥98%(T) | N,N-Diethyl-1,2-ethanediamine Dihydrochloride | ESD-918181-1G |
| Cas.: 99310-71-1 | Purity: ≥98%(T) | N,N-Diethyl-1,3-propanediamine Dihydrochloride | ESD-918182-1G |
| Cas.: 69386-35-2 | Purity: ≥98%(GC) | 2,7-Di-tert-butyl-9H-carbazole | ESD-918183-100MG |
| Cas.: 371-90-4 | Purity: ≥98%(GC) | 1,1-Difluorocyclohexane | ESD-918184-100MG |
| Cas.: 1214-24-0 | Purity: ≥98%(T)(HPLC) | 3,6-Dihydroxy-9H-xanthen-9-one | ESD-918185-100MG |
| Cas.: 74648-14-9 | Purity: ≥98%(HPLC)(N) | Di(N-succinimidyl) Pimelate | ESD-918186-100MG |
| Cas.: 943858-70-6 | Purity: ≥96%(HPLC) | Succinimidyl 4-Azidobutyrate | ESD-918187-100MG |
| Cas.: 1798293-53-4 | Purity: ≥95%(HPLC) | 1,8-Didodecyloxy-13-methoxytriptycene | ESD-918188-10MG |
| Cas.: 2247753-10-0 | Purity: ≥95%(HPLC) | DOP-DEDA | ESD-918189-10MG |
| Cas.: 2247605-87-2 | Purity: ≥98%(T) | Dichloro[8-(diisopropylphosphino)-5-fluoro-2-(2-pyridinyl)quinoline]iron(II) | ESD-918190-10MG |
| Cas.: 1253202-38-8 | SDAD | ESD-918191-1MG | |
| Cas.: 1895006-01-5 | Purity: ≥98%(HPLC) | Dimesityl(trifluoromethyl)sulfonium Trifluoromethanesulfonate | ESD-918192-1G |
| Cas.: 99578-68-4 | Purity: ≥98%(GC) | Diethyl [4-(Trifluoromethyl)benzyl]phosphonate | ESD-918193-1G |
| Cas.: 2066512-27-2 | Purity: ≥98%(GC)(T) | 2-(Diiodomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918194-100MG |
| Cas.: 1627606-00-1 | Purity: >99.5%(HPLC) | 2-Dodecyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene | ESD-918195-100MG |
| Cas.: 16715-83-6 | Purity: ≥98%, contains stabilizerMEHQ | 2-(Diisopropylamino)ethyl Methacrylate | ESD-918196-5G |
| Cas.: 435344-88-0 | Purity: ≥95%(GC) | 2,7-Dimethoxy-9H-thioxanthen-9-one | ESD-918197-100MG |
| Cas.: 1242077-24-2 | Purity: ≥98%(GC) | 2,6-Dibromobenzo[1,2-b:5,4-b’]dithiophene | ESD-918198-100MG |
| Cas.: 23638-66-6 | Purity: ≥98%(T) | Dichloro(dimethylglyoxime)(dimethylglyoximato)cobalt(III) | ESD-918199-1G |
| Cas.: 4324-38-3 | Purity: ≥98%(GC)(T) | 3-Ethoxypropionic Acid | ESD-918200-5ML |
| Cas.: 88358-65-0 | Purity: ≥98%(T) | 2-Ethylhexylamine Hydrobromide | ESD-918201-5G |
| Cas.: 930-52-9 | Purity: ≥98%(GC)(T) | 2-Ethyl-2-imidazoline | ESD-918202-1G |
| Cas.: 1067-08-9 | Purity: ≥99%(GC) | 3-Ethyl-3-methylpentane | ESD-918203-1ML |
| Cas.: 934-74-7 | Purity: ≥98%(GC) | 5-Ethyl-m-xylene | ESD-918204-1MG |
| Cas.: 32701-19-2 | Purity: ≥98%(T) | Ethylenediamine-N,N’-diacetic-N,N’-dipropionic Acid | ESD-918205-100MG |
| Cas.: 2146-38-5 | Purity: ≥95%(GC) | 1-Ethyl-1-cyclopentene | ESD-918206-1ML |
| Cas.: 19780-16-6 | Purity: ≥80%(GC) | 1,2-Epoxyeicosane | ESD-918207-1G |
| Cas.: 5063-65-0 | Purity: ≥96%(GC) | 1,2-Epoxyheptane | ESD-918208-1ML |
| Cas.: 2404-44-6 | Purity: ≥97%(GC) | 1,2-Epoxydecane | ESD-918209-100ML |
| Cas.: 42235-38-1 | Purity: ≥95%(GC) | Dimethyl Icosanedioate | ESD-918210-5G |
| Cas.: 13228-39-2 | Purity: ≥98%(HPLC) | 1-Ethyl-2-phenylindole | ESD-918211-100G |
| Cas.: 34322-82-2 | Purity: ≥97%(GC) | N-(2-Methoxyethyl)ethylamine | ESD-918212-5G |
| Cas.: 85721-25-1 | Purity: ≥96%(GC) | 1,2-Epoxy-9-decene | ESD-918213-1ML |
| Cas.: 77-84-9 | Purity: ≥97%(GC) | 2-Ethyl-2-methyl-1,3-propanediol | ESD-918214-5G |
| Cas.: 3728-55-0 | Purity: ≥98%(GC) | 1-Ethyl-3-methylcyclohexane | ESD-918215-1ML |
| Cas.: 3728-56-1 | Purity: ≥98%(GC) | 1-Ethyl-4-methylcyclohexane | ESD-918216-1ML |
| Cas.: 1585-06-4 | Purity: ≥97%(GC) | 4-Ethylphenetole | ESD-918217-5ML |
| Cas.: 33697-53-9 | Purity: ≥93%(GC) | Ethyl 2-Ethyl-2-methylacetoacetate | ESD-918218-5ML |
| Cas.: 938-54-5 | Purity: ≥98%(GC)(T) | Ethyl (S)-(-)-1-Ethyl-2-pyrrolidinecarboxylate | ESD-918219-1G |
| Cas.: 5205-39-0 | Purity: ≥98%(T) | Ethyl Glutaryl Chloride | ESD-918220-5G |
| Cas.: 74962-29-1 | Purity: ≥98%(GC) | 4,5-Ethylenedithio-1,3-dithiol-2-one | ESD-918221-1G |
| Cas.: 15679-09-1 | Purity: ≥98%(GC)(T) | 2-Ethylthiazole | ESD-918222-5G |
| Cas.: 2225-23-2 | Purity: ≥98%(LC) | Ethylene Di(thiotosylate) [Protecting Reagent for Active Methylene] | ESD-918223-5G |
| Cas.: 39216-86-9 | Purity: ≥98%(T) | 4-Ethylamino-1-butanol | ESD-918224-5G |
| Cas.: 57322-50-6 | Purity: ≥90%(GC) | N-Ethyl-N-(4-picolyl)atropamide | ESD-918225-10MG |
| Cas.: 627-01-0 | Purity: ≥98%(T) | N-Ethylglycine | ESD-918226-1G |
| Cas.: 35817-27-7 | Purity: ≥98%(GC) | 4-Ethoxycoumarin | ESD-918227-5G |
| Cas.: 20115-81-5 | Purity: ≥98%(GC) | 2,2′-Ethylenedioxydiphenol | ESD-918228-100MG |
| Cas.: 79887-11-9 | Purity: ≥95%(GC) | 1-Ethynyl-4-hexylbenzene | ESD-918229-5G |
| Cas.: 73819-76-8 | Purity: ≥98%(GC) | 4-Ethynylphthalic Anhydride | ESD-918230-1G |
| Cas.: 13147-25-6 | Purity: ≥97%(GC) | N-Ethyl-N-(2-hydroxyethyl)nitrosamine | ESD-918231-1G |
| Cas.: 13475-17-7 | Purity: ≥98%(GC) | Ethyl 4-Acetamidophenylacetate | ESD-918232-5G |
| Cas.: 3419-32-7 | Purity: ≥95%(GC) | Ethyl 6-Methyl-2-oxo-3-cyclohexene-1-carboxylate | ESD-918233-1G |
| Cas.: 86180-54-3 | Purity: ≥97%(GC) | 3,3′-(Ethylenedithio)dipropionitrile | ESD-918234-1G |
| Cas.: 72797-16-1 | Purity: ≥95%(GC)(T) | 2-Ethoxy-3-isopropylpyrazine | ESD-918235-1G |
| Cas.: 6942-61-6 | Purity: ≥95%(GC) | Ethyl 4-Oxo-4-(p-tolyl)butyrate | ESD-918236-1G |
| Cas.: 219773-47-4 | Purity: ≥98%(T)(HPLC) | Ecabet Sodium Hydrate | ESD-918237-5G |
| Cas.: 6104-48-9 | Purity: ≥98%(GC) | Ethynyl(diphenyl)phosphine Oxide | ESD-918238-100MG |
| Cas.: 77671-31-9 | Purity: ≥95%(HPLC) | Enoximone | ESD-918239-10MG |
| Cas.: 7126-27-4 | Purity: ≥98%(HPLC) | N,N’-Ethylenebis(maleamic Acid) | ESD-918240-100MG |
| Cas.: 13731-98-1 | Purity: ≥95%(GC) | 3-(Ethoxydimethylsilyl)propyl Methacrylate | ESD-918241-1G |
| Cas.: 326925-69-3 | Purity: ≥95%(GC) | 1-Ethylcyclopentyl Acrylate | ESD-918242-1G |
| Cas.: 274248-09-8 | Purity: ≥98%(GC) | 1-Ethylcyclohexyl Methacrylate | ESD-918243-1G |
| Cas.: 844502-63-2 | Purity: ≥98%(GC) | 3-Ethyl 4-Methyl 2-Aminothiophene-3,4-dicarboxylate | ESD-918244-1G |
| Cas.: 106185-75-5 | Purity: ≥90%(GC) | (E)-2-Ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol | ESD-918245-5G |
| Cas.: 204008-22-0 | Purity: ≥97%(GC) | 1-Ethyl-4-octylbenzene | ESD-918246-1G |
| Cas.: 815574-81-3 | Purity: ≥98%(T) | Ethylamine Trifluoroacetate | ESD-918247-1G |
| Cas.: 157057-20-0 | Purity: ≥98%(GC) | 1-(1-Ethoxyethoxy)-4-vinylbenzene (stabilized with TBC) | ESD-918248-5G |
| Cas.: 873842-06-9 | Purity: ≥97%(HPLC) | (R)-3-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,2-dimethylthiazolidine-4-carboxylic Acid | ESD-918249-100MG |
| Cas.: 412319-45-0 | Purity: ≥95%(HPLC) | 6-FAM-PEG3-Azide | ESD-918250-5MG |
| Cas.: 659-41-6 | Purity: ≥98%(T)(HPLC) | 4-Fluorobenzylamine Hydrochloride | ESD-918251-1G |
| Cas.: 2366993-30-6 | Purity: ≥98%(HPLC) | 5-Fluoro-3,3-bis(4-fluorophenyl)benzo[c][1,2]oxaborol-1(3H)-ol | ESD-918252-10MG |
| Cas.: 2146-07-8 | Purity: ≥98%(T)(HPLC) | 4-Fluoroaniline Hydrochloride | ESD-918253-5G |
| Cas.: 85734-18-5 | Purity: ≥98%(T)(HPLC) | 4-Fluoroaniline Hydrobromide | ESD-918254-5G |
| Cas.: 85734-19-6 | Purity: ≥98%(T)(HPLC) | 4-Fluoroaniline Hydroiodide | ESD-918255-1G |
| Cas.: 623-19-8 | Purity: ≥98%(GC) | Furfuryl Propionate | ESD-918256-5G |
| Cas.: 1195931-66-8 | Purity: ≥98%(HPLC) | Fluorescein Bis(trifluoromethanesulfonate) | ESD-918257-1G |
| Cas.: 1394238-91-5 | Purity: ≥98%(HPLC)(N) | Fmoc-Val-Ala-PAB-OH | ESD-918258-50MG |
| Cas.: 1450933-18-2 | Purity: >98.0%(GC) | 1-Bromo-9,9′-spirobi[9H-fluorene] | ESD-918259-1G |
| Cas.: 113963-68-1 | Purity: >97.0%(LC) | Bisindolylmaleimide V | ESD-918260-10MG |
| Cas.: 2102316-91-4 | Purity: >98.0%(LC), contains ≤5% of dichloromethane | (-)-4-tert-Butyl-2,6-bis[(4S,5S)-4,5-tetramethylene-1-(2,4,6-trimethylbenzenesulfonyl)imidazolin-2-yl]phenol | ESD-918261-10MG |
| Cas.: 74774-53-1 | Purity: >96.0%(LC&T) | 1,6-Bis(4-carboxyphenoxy)hexane | ESD-918262-1G |
| Cas.: 56467-43-7 | Purity: >98.0%(GC) | 4-Benzoylphenyl Methacrylate | ESD-918263-5G |
| Cas.: 20077-10-5 | Purity: >96.0%(GC) | 2-Bromo-9H-thioxanthen-9-one | ESD-918264-100MG |
| Cas.: 374934-77-7 | Purity: >98.0%(GC) | 1,4-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihexylbenzene | ESD-918265-100MG |
| Cas.: 23569-17-7 | Purity: >98.0%(GC) | 4-(tert-Butyl)pyridine 1-Oxide | ESD-918266-50MG |
| Cas.: 94427-22-2 | Purity: >98.0%(GC) | [[(7-Bromoheptyl)oxy]methyl]benzene | ESD-918267-100MG |
| Cas.: 141943-06-8 | Purity: >95.0%(GC) | 7-(Benzyloxy)heptan-1-ol | ESD-918268-100MG |
| Cas.: 1268060-77-0 | Purity: >95.0%(GC) | 2-Bromo-3-(2-octyldodecyl)thiophene | ESD-918269-100MG |
| Cas.: 1352745-18-6 | Purity: >95.0%(T) | [1,3-Bis(ethoxycarbonyl)-2,4,5-trimethylcyclopentadien-1-yl]rhodium(III) Dichloride Dimer | ESD-918270-50MG |
| Cas.: 89336-46-9 | Purity: >98.0%(T&LC) | 2-[2-[(tert-Butoxycarbonyl)amino]thiazol-4-yl]acetic Acid | ESD-918271-100MG |
| Cas.: 6051-98-5 | Purity: >98.0%(GC) | 7H-Benzo[c]fluoren-7-one | ESD-918272-100MG |
| Cas.: 500286-36-2 | Purity: >98.0%(GC) | 3-Bromo-9H-xanthen-9-one | ESD-918273-100MG |
| Cas.: 1030380-50-7 | Purity: >98.0%(LC&N) | 4,6-Bis(3,5-dichlorophenyl)-2-methylpyrimidine | ESD-918274-100MG |
| Cas.: 2754-40-7 | Purity: >98.0%(T) | Bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic 2,3:5,6-Dianhydride | ESD-918275-5G |
| Cas.: 2791-57-3 | Purity: >95.0%(GC) | 1-Bromo-3,7,11,15-tetramethylhexadecane | ESD-918276-1G |
| Cas.: 53358-54-6 | Purity: >98.0%(GC) | 4-Bromo-N,N-dibutylaniline | ESD-918277-1G |
| Cas.: 425604-49-5 | Purity: >98.0%(GC) | 4-Bromo-N,N-dihexylaniline | ESD-918278-1G |
| Cas.: 136039-69-5 | Purity: >95.0%(LC) | 1,3-Phenylenebis[(4-bromophenyl)methanone] | ESD-918279-100MG |
| Cas.: 18494-87-6 | Purity: >95.0%(GC&T) | Benzo[b]thiophene-3-sulfonyl Chloride | ESD-918280-100MG |
| Cas.: 1398397-58-4 | Purity: >95.0%(LC) | 2-Bromo[1]benzothieno[3,2-b][1]benzothiophene | ESD-918281-10MG |
| Cas.: 1781261-91-3 | Purity: >99.5%(LC) | 2-Butyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene [for organic electronics] | ESD-918282-100MG |
| Cas.: 1335047-34-1 | Purity: >90.0%(LC) | (4,4′-Di-tert-butyl-2,2′-bipyridine-kappa~2~N~1~,N~1’~)[bis[3,5-difluoro-2-(5-methyl- 2-pyridinyl-kappaN)phenyl-kappaC~1~]]iridium Hexafluorophosphate | ESD-918283-100MG |
| Cas.: 808142-88-3 | Purity: >90.0%(LC) | (4,4′-Di-tert-butyl-2,2′-bipyridine-kappa~2~N~1~,N~1’~)[bis[5-fluoro-2-(5-methyl-2- pyridinyl-kappaN)phenyl-kappaC~1~]]iridium Hexafluorophosphate | ESD-918284-100MG |
| Cas.: 1095957-23-5 | Purity: >98.0%(T) | [11-[(2-Bromo-2-methylpropanoyl)oxy]undecyl]phosphonic Acid | ESD-918285-100MG |
| Cas.: 267-61-8 | Purity: >98.0%(GC) | Benzo[1,2:b:5,4-b’]dithiophene | ESD-918286-100MG |
| Cas.: 198279-94-6 | Purity: >95.0%(T) | 2-Chlorophenylhydrazine Sulfate | ESD-918287-100G |
| Cas.: 207121-42-4 | Purity: >98.0%(T) | Barium 2-Cyanoethylphosphate Hydrate | ESD-918288-5G |
| Cas.: 89488-25-5 | Purity: 98% | 5-Chloro-2-hydroxyphenylboronic acid | ESD-918289-250MG |
| Cas.: 23779-97-7 | Purity: >98.0%(GC) | 4-Chloro-8-(trifluoromethyl)quinoline | ESD-918290-1G |
| Cas.: 59729-33-8 | Purity: >98.0%(GC) | Citalopram | ESD-918291-1G |
| Cas.: 28737-32-8 | Purity: >98.0%(T) | 3-Chloroindole-2-carboxylic Acid | ESD-918292-100MG |
| Cas.: 85502-87-0 | Purity: >98.0%(GC) | (E)-4′-Chloro-4-methoxychalcone | ESD-918293-100MG |
| Cas.: 1211-35-4 | Purity: >98.0%(GC) | 2-(4-Chlorophenyl)-1H-indole | ESD-918294-1G |
| Cas.: 142116-85-6 | Purity: >98.0%(GC) | 1-[4-(9H-Carbazol-9-yl)phenyl]ethanone | ESD-918295-100MG |
| Cas.: 1046099-39-1 | Purity: >98.0%(T) | Cerium(III) Bis(trifluoromethanesulfonyl)imide | ESD-918296-1G |
| Cas.: 1354749-13-5 | Purity: 98% | 4-Chloro-6-(4-chlorophenyl)-2-phenylpyrimidine | ESD-918297-250MG |
| Cas.: 1222105-48-7 | Purity: >98.0%(LC) | [11]Cycloparaphenylene | ESD-918298-1MG |
| Cas.: 1819341-33-7 | Purity: 95% | (R,R)-CASA-H | ESD-918299-10MG |
| Cas.: 1819341-28-0 | (R,R)-CASA-Na | ESD-918300-10MG | |
| Cas.: 1801869-83-9 | Purity: >98.0%(T) | (Cyclohexyl-CAAC)Rh(COD)Cl | ESD-918301-100MG |
| Cas.: 1037794-22-1 | Purity: >97.0%(LC) | Cit-PAB-OH | ESD-918302-100MG |
| Cas.: 186585-56-8 | Purity: 98%, contains stabilizer phenothiazine | 2-Cyclohexylpropan-2-yl Methacrylate | ESD-918303-100MG |
| Cas.: 10359-09-8 | Purity: >98.0%(GC) | 2-(4-Chlorophenyl)-1,3-dithiane | ESD-918304-1G |
| Cas.: 50555-04-9 | Purity: >98.0%(GC) | (E)-Cinnamyl Benzoate | ESD-918305-5G |
| Cas.: 20999-38-6 | Purity: >98.0%(LC&T) | 2PACz | ESD-918306-100MG |
| Cas.: 2058252-91-6 | Purity: Carbon contains amount: 43-48% | Chloro(p-cymene)[2-[(di-tert-butylphosphino)methyl]pyridine]ruthenium(II) Triflate | ESD-918307-50MG |
| Cas.: 7205-90-5 | Purity: >98.0%(GC) | Chloromethyl 4-Chlorophenyl Sulfide | ESD-918308-5G |
| Cas.: 117467-64-8 | Purity: >95.0%(LC&T) | Chitopentaose Pentahydrochloride Hydrate | ESD-918309-5MG |
| Cas.: 4637-59-6 | Purity: >97.0%(GC&T) | 4-Chloroquinoline 1-Oxide | ESD-918310-100MG |
| Cas.: 2311980-68-2 | Purity: >80.0%(LC) | 2-[(1E,3Z,5E,7E)-4-Carboxy-7-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)-1,3,5-heptatrien -1-yl]-1,3,3-trimethyl-3H-indolium Iodide | ESD-918311-1G |
| Cas.: 483979-48-2 | Purity: >98.0%(T) | Chlorobis(dimethylglyoximato)[4-(dimethylamino)pyridine]cobalt(III) | ESD-918312-250MG |
| Cas.: 23295-32-1 | Purity: >98.0%(T) | Chlorobis(dimethylglyoximato)(pyridine)cobalt(III) | ESD-918313-1G |
| Cas.: 69227-09-4 | Purity: >95.0%(T), hard type, mixture | Sodium Dodecylbenzenesulfonate | ESD-918314-100G |
| Cas.: 380482-29-1 | Purity: >98.0%(N) | 2,2-Dimethoxypropionamide | ESD-918315-1G |
| Cas.: 103956-09-8 | Purity: >97.0%(LC&T) | 3,4-Diaminobenzohydrazide | ESD-918316-1G |
| Cas.: 83622-41-7 | Purity: >98.0%(GC) | 2-(Dichloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918317-100MG |
| Cas.: 54376-65-7 | Purity: >95.0%(GC), mixture of isomers | 4-Diethylaminobenzaldoxime | ESD-918318-1G |
| Cas.: 869340-02-3 | Purity: >98.0%(GC) | 1,6-Dibromo-3,8-diisopropylpyrene | ESD-918319-250MG |
| Cas.: 33322-06-4 | Purity: >98.0%(T) | 1,4-Diazabicyclo[2.2.2]octane Dihydriodide | ESD-918320-1G |
| Cas.: 5556-13-8 | Purity: >98.0%(GC) | 4,4′-Dibromo-3,3′-bithiophene | ESD-918321-100MG |
| Cas.: 1402543-31-0 | Purity: >98.0%(LC&N) | 9,9”-Diphenyl-9H,9’H,9”H-3,2′:7′,3”-tercarbazole | ESD-918322-100MG |
| Cas.: 1873362-96-9 | Purity: >96.0%(LC&T) | 3,6-Dibromo-9-(2,4-dimethylphenyl)-9H-carbazole | ESD-918323-100MG |
| Cas.: 890653-54-0 | Purity: >98.0%(N) | 3,6-Dibromo-9-(m-tolyl)-9H-carbazole | ESD-918324-100MG |
| Cas.: 217176-83-5 | Purity: >98.0%(LC) | Dihydrorhodamine 6G | ESD-918325-10MG |
| Cas.: 373614-12-1 | Purity: >95.0%(N) | Bis-N-succinimidyl Diglycolic Acid | ESD-918326-100MG |
| Cas.: 7453-26-1 | Purity: >95.0%(GC) | 1,3-Dimethyl-1,1,3,3-tetraphenyldisilazane | ESD-918327-1G |
| Cas.: 211181-63-4 | Purity: >98.0%(W) | (4-Dodecyl-2-thienyl)trimethylstannane | ESD-918328-100MG |
| Cas.: 5272-18-4 | Purity: >98.0%(GC) | Dimethylphenylsilanol | ESD-918329-1G |
| Cas.: 1417407-35-2 | Purity: >93.0%(LC), cis-trans mixture | Diethyl 2,4-Dimethyl-5-[(triisopropylsilyl)methylene]-1,3-cyclopentadiene-1,3-dicarboxylate | ESD-918330-100MG |
| Cas.: 58166-38-4 | Purity: >98.0%(T) | (4R)-2,2-Dimethyl-4-thiazolidinecarboxylic Acid | ESD-918331-1G |
| Cas.: 329-17-9 | Purity: >98.0%(GC&T) | N,N-Dimethyl-4-(trifluoromethyl)aniline | ESD-918332-1G |
| Cas.: 1245570-04-0 | Purity: >98.0%(N) | N,N-Dimethylethylenediamine Dihydrobromide | ESD-918333-1G |
| Cas.: 244234-52-4 | Purity: >98.0%(N) | N,N-Dimethylethylenediamine Dihydroiodide | ESD-918334-1G |
| Cas.: 1066-12-2 | Purity: >86.0%(LC) | 2-trans-Dodecenoyl-Co A | ESD-918335-5MG |
| Cas.: 942132-66-3 | Purity: >98.0%(GC) | 3,5-Dibromo-5′-phenyl-1,1′:3′,1”-terphenyl | ESD-918336-100MG |
| Cas.: 1211417-77-4 | Purity: >98.0%(N) | (1,3-Dimethyl-1H-imidazol-3-ium-2-yl)trihydroborate | ESD-918337-100MG |
| Cas.: 121177-93-3 | Purity: >90.0%(GC), contains stabilizerBHT | [Dimethoxy(methyl)silyl]methyl Methacrylate | ESD-918338-5G |
| Cas.: 2229856-26-0 | Purity: >98.0%(GC) | (1S,4S,5R)-3,3-Dibenzyl-6,8-dioxabicyclo[3.2.1]octan-4-ol | ESD-918339-1G |
| Cas.: 85719-56-8 | Purity: >98.0%(T) | [(2-Dimethylamino)propyldiphenylphosphine]palladium(II) Dichloride | ESD-918340-50MG |
| Cas.: 32431-85-9 | Purity: >98.0%(GC) | 2,5-Dibromo-3-fluorothiophene | ESD-918341-1G |
| Cas.: 1558-23-2 | Purity: >98.0%(GC) | 3,6-Dimethyl-1,2,4,5-tetrazine | ESD-918342-50MG |
| Cas.: 78669-53-1 | Purity: >97.0%(GC) | 1,2-Di-tert-butoxy-1,1,2,2-tetramethyldisilane | ESD-918343-5G |
| Cas.: 1147124-21-7 | Purity: >96.0%(LC&N) | 6,6′-Dibromoisoindigo | ESD-918344-1G |
| Cas.: 1147124-24-0 | Purity: >98.0%(LC&N) | 6,6′-Dibromo-1,1′-bis(2-hexyldecyl)isoindigo | ESD-918345-50MG |
| Cas.: 1801592-76-6 | Purity: >98.0%(N) | 6,6′-Dibromo-1,1′-bis(2-decyltetradecyl)isoindigo | ESD-918346-50MG |
| Cas.: 1334295-79-2 | Purity: >98.0%(LC&N) | 6,6′-Dibromo-1,1′-di(n-octyl)isoindigo | ESD-918347-50MG |
| Cas.: 2250187-15-4 | Purity: >99.0%(LC) | 10-[4-[4,6-Di(adamantan-1-yl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethyl-9,10-dihydroacridine | ESD-918348-50MG |
| Cas.: 2250187-17-6 | Purity: >99.0%(LC) | 10-[4-[4,6-Di(adamantan-1-yl)-1,3,5-triazin-2-yl]phenyl]-9,9-diphenyl-9,10-dihydroacridine | ESD-918349-50MG |
| Cas.: 2250187-16-5 | Purity: >99.0%(LC) | 10-[4-[4,6-Di(1-adamantyl)-1,3,5-triazin-2-yl]phenyl]-10H-spiro[acridine-9,9′-fluorene] | ESD-918350-50MG |
| Cas.: 3600-24-6 | Purity: >98.0%(GC) | Diethyltrisulfane | ESD-918351-1G |
| Cas.: 220524-71-0 | Purity: >95.0%(LC) | Green DND-26 | ESD-918352-5MG |
| Cas.: 34764-02-8 | Purity: >98.0%(GC) | Decanal Diethyl Acetal | ESD-918353-1ML |
| Cas.: 2230140-59-5 | Purity: >98.0%(T) | (1,3-Dimesitylimidazol-2-ylidene)nickel(0) Bis(di-tert-butyl Fumarate) | ESD-918354-10MG |
| Cas.: 1373934-14-5 | Purity: >98.0%(LC), contains ≤5%hexane | N,2-Diphenyl[60]fulleropyrrolidine | ESD-918355-10MG |
| Cas.: 1239017-80-1 | Purity: Nitrogen contains amount: 18.1-18.7% | NHS-Diazirine | ESD-918356-1MG |
| Cas.: 2370885-20-2 | Purity: >95.0%(LC&T) | 2,6-DBEAQ | ESD-918357-1G |
| Cas.: 2370885-23-5 | Purity: >90.0%(T) | 2,6-DPPEAQ | ESD-918358-1G |
| Cas.: 30321-74-5 | Purity: >98.0%(N) | Diisopropylamine Hydrobromide | ESD-918359-1G |
| Cas.: 687-38-7 | Purity: ≥98% | Glycyl-DL-serine | ESD-918360-100MG |
| Cas.: 18865-38-8 | Purity: ≥98%(LC) | Glycinexylidide | ESD-918362-50MG |
| Cas.: 42224-53-3 | Purity: 98% | (E)-2-Hydroxychalcone | ESD-918363-5G |
| Cas.: 888-12-0 | Purity: ≥98%(LC) | (E)-2′-Hydroxychalcone | ESD-918364-5G |
| Cas.: 80466-34-8 | Purity: ≥95%(GC) | 2,4-Hexadienal (mixture of isomers) | ESD-918365-5ML |
| Cas.: 38239-55-3 | Purity: ≥97%(LC&T) | (E)-4-Hydroxychalcone | ESD-918366-1G |
| Cas.: 613-14-9 | Purity: 98% | 2-Hydroxyanthracene | ESD-918367-100MG |
| Cas.: 79140-20-8 | Purity: ≥98%(LC) | (E)-2′-Hydroxy-3,4-dimethoxychalcone | ESD-918368-100MG |
| Cas.: 40573-09-9 | Purity: ≥97%(GC) | 1,1,2,2,3,3-Hexafluoro-1-(trifluoromethoxy)-3-[(1,2,2-trifluorovinyl)oxy]propane | ESD-918369-5G |
| Cas.: 13846-22-5 | Purity: ≥98%(GC) | 1,1,2,2,3,3-Hexafluoro-1,3-bis[(1,2,2-trifluorovinyl)oxy]propane | ESD-918370-5G |
| Cas.: 61546-01-8 | Purity: ≥96%(T&LC) | 1-Hexadecyl-3-methylimidazolium Chloride | ESD-918371-5G |
| Cas.: 2419249-92-4 | Purity: ≥98%(LC&N) | 1,1′-(Hexane-1,6-diyl)bis[3-(2-nitrophenyl)urea] | ESD-918372-1G |
| Cas.: 154717-22-3 | Purity: ≥98%(W) | (4-Hexyl-2-thienyl)trimethylstannane | ESD-918373-100MG |
| Cas.: 873013-93-5 | Purity: ≥95%(LC) | 4,7,10,13,16,19,22,25,32,35,38,41,44,47,50,53-Hexadecaoxa-28,29-dithiahexapentacontanedioic Acid | ESD-918374-10MG |
| Cas.: 485-64-3 | Purity: ≥98%(LC&T) | Hydrocinchonidine | ESD-918375-1G |
| Cas.: 4359-57-3 | Purity: ≥97%(GC) | 2-Heptyl-1,3-dioxolane | ESD-918376-5G |
| Cas.: 2271090-84-5 | Purity: ≥90%(GC) | (S)-4-Hydroxy-2-(hydroxymethyl)-2-cyclopenten-1-one | ESD-918377-10MG |
| Cas.: 76374-26-0 | Purity: ≥90%(GC) | 4-Hydroxy-2-(hydroxymethyl)-2-cyclopenten-1-one | ESD-918378-10MG |
| Cas.: 65490-09-7 | Purity: ≥98%(GC) | 1-[2-Hydroxy-4,6-bis(methoxymethoxy)phenyl]ethanone | ESD-918379-100MG |
| Cas.: 50396-87-7 | Purity: ≥98%(GC) | (E)-4-Hexen-3-one | ESD-918380-5ML |
| Cas.: 95507-66-7 | Hyaluronic Acid, High-Sulfated | ESD-918381-1MG | |
| Cas.: 412343-56-7 | Purity: ≥98%(GC) | 2-(2-Hydroxycyclohexyl)phenol (cis- and trans-mixture, predominantly cis-isomer) | ESD-918382-1G |
| Cas.: 931-23-7 | Purity: 98% | 5-Hydroxy-3-methyl-2(5H)-furanone | ESD-918383-100MG |
| Cas.: 2005487-65-8 | Purity: ≥98%(T&LC) | (2-Hydroxy-5-methylphenyl)triphenylphosphonium Bromide | ESD-918384-1G |
| Cas.: 2005487-70-5 | Purity: ≥98%(T&LC) | (2-Hydroxy-5-methylphenyl)triphenylphosphonium Iodide | ESD-918385-1G |
| Cas.: 189324-13-8 | Purity: ≥97%(GC) | 2-Hydroxyethyl 2-Bromo-2-methylpropanoate | ESD-918386-1G |
| Cas.: 1009321-13-4 | Purity: ≥98%(T) | 1-Hexyl-1,4-diazabicyclo[2.2.2]octan-1-ium Iodide | ESD-918387-1G |
| Cas.: 53053-08-0 | Purity: ≥95%(LC) | N-Hydroxysuccinimide 4-azidobenzoate | ESD-918388-10MG |
| Cas.: 13092-57-4 | Purity: ≥95%(GC) | 6-Hydroxyhexyl Methacrylate (stabilized with MEHQ) | ESD-918389-1G |
| Cas.: 33530-51-7 | Purity: ≥98%(GC) | anti-1,2,2,3,4,4-Hexamethylphosphetane 1-Oxide | ESD-918390-1G |
| Cas.: 1781261-93-5 | Purity: ≥99.5%(LC) | 2-Hexyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene | ESD-918391-100MG |
| Cas.: 551-72-4 | Purity: ≥98%(LC) | 1L-chiro-Inositol | ESD-918392-50MG |
| Cas.: 933672-32-3 | Purity: ≥98%(GC) | 5-Iodo-2-methoxybenzonitrile | ESD-918393-1G |
| Cas.: 2245104-25-8 | Purity: ≥97%(LC) | (6,6)Carbon Nanobelt Bis(tetrahydrofuran) Adduct | ESD-918394-1MG |
| Cas.: 243-59-4 | Purity: ≥98%(GC&T) | 6H-Indolo[2,3-b]quinoxaline | ESD-918395-50MG |
| Cas.: 1820802-04-7 | Purity: ≥97%(GC&N) | 2-Iodo-N-isopropyl-5-methoxybenzamide | ESD-918396-10MG |
| Cas.: 1399008-27-5 | Purity: ≥96%(LC) | N,N’-[(2S,2’S)-[(2-Iodo-1,3-phenylene)bis(oxy)]bis(propane-2,1-diyl)]bis(mesitylamide) | ESD-918397-50MG |
| Cas.: 16669-59-3 | Purity: ≥98%(T) | N-(Isobutoxymethyl)acrylamide | ESD-918398-5ML |
| Cas.: 2130906-05-5 | Purity: ≥98%(LC) | 1-(1H-Indol-3-yl)-1lambda3-benzo[d][1,2]iodaoxol-3(1H)-one | ESD-918399-50MG |
| Cas.: 191487-52-2 | Purity: ≥98%(LC&T) | 2-Amino-N-[3-(benzyloxy)-1-[1-(methylsulfonyl)spiro[indoline-3,4′-pipidin]-1′-yl]-1-oxopropan-2-yl]-2- methylpropanamide Methanesulfonate | ESD-918400-100MG |
| Cas.: 51828-94-5 | Purity: ≥97%(T) | Calcium 3-Methyl-2-oxobutyrate | ESD-918401-1G |
| Cas.: 2071715-99-4 | Purity: ≥95%(LC) | KNI-1293 Biotin | ESD-918402-1MG |
| Cas.: 34015-48-0 | Purity: ≥98%(N) | DL-Lysine Methyl Ester Dihydrochloride | ESD-918403-5G |
| Cas.: 7104-38-3 | Purity: ≥98%(LC) | Levomepromazine Maleate | ESD-918404-5G |
| Cas.: 2407442-47-9 | Purity: ≥97%(LC) | Lipoamido-PEG12-carboxylic Acid | ESD-918405-10MG |
| Cas.: 7596-88-5 | Purity: ≥98%(T&LC) | N-Lauroylglycine | ESD-918406-1G |
| Cas.: 7330-46-3 | Purity: ≥96%(T&LC) | 5,5′-Methylenebis(2-aminobenzoic Acid) | ESD-918407-5G |
| Cas.: 28140-60-5 | Purity: ≥98%(LC&T) | Malonaldehyde Dianilide Hydrochloride | ESD-918408-5G |
| Cas.: 1895-97-2 | Purity: ≥98%(GC&T) | (E)-alpha-Methylcinnamic Acid | ESD-918409-5G |
| Cas.: 756525-99-2 | Purity: ≥98%(LC) | Maleimide-PEG4-NHS Ester | ESD-918410-50MG |
| Cas.: 862873-06-1 | Purity: ≥95%(GC) | N-Methoxy-N-methyl-1H-imidazole-1-carboxamide | ESD-918411-50MG |
| Cas.: 119-17-5 | Purity: ≥98%(LC&T) | 3-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonic Acid | ESD-918412-5G |
| Cas.: 23676-08-6 | Purity: ≥98%(GC) | Methyl 4-Ethoxybenzoate | ESD-918413-5G |
| Cas.: 14802-30-3 | Purity: ≥98%(GC) | (E)-4′-Methylchalcone | ESD-918414-1G |
| Cas.: 28302-50-3 | Purity: ≥98%(N) | Methylammonium Hexafluorophosphate | ESD-918415-1G |
| Cas.: 2414546-93-1 | Purity: ≥98%(LC&N) | 1,1′-[Methylenebis(2,6-diethyl-4,1-phenylene)]bis[3-(2-nitrophenyl)urea] | ESD-918416-1G |
| Cas.: 75423-15-3 | Purity: ≥98%(GC&T) | 4-Methyl-1,2,3-thiadiazole-5-carbohydrazide | ESD-918417-100MG |
| Cas.: 927021-43-0 | Purity: ≥98%(T) | 1-Methyl-1-n-octylpyrrolidinium Bis(trifluoromethanesulfonyl)imide | ESD-918418-5G |
| Cas.: 24173-43-1 | Purity: ≥98%(LC&T) | 5-Methyl-2-(p-tolylamino)benzoic Acid | ESD-918419-100MG |
| Cas.: 19500-95-9 | Purity: ≥96%(GC&T) | 2-Methoxyacetic Anhydride | ESD-918420-5G |
| Cas.: 62723-61-9 | Purity: ≥98%(LC) | 2-[[2-(Methacryloyloxy)ethyl]dimethylammonio]acetate | ESD-918421-1G |
| Cas.: 57367-08-5 | Purity: ≥98%(LC&T) | 1-Methyl-1H-imidazol-3-ium Hexafluorophosphate | ESD-918422-5G |
| Cas.: 510709-83-8 | Purity: ≥96%(LC) | N-(5-Aminopentyl)maleimide Hydrochloride | ESD-918423-100MG |
| Cas.: 107326-29-4 | Purity: ≥98%(N) | Methylamine Trifluoroacetate | ESD-918424-1G |
| Cas.: 40662-29-1 | Purity: ≥97%(LC&T) | 3-Methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic Acid | ESD-918425-100MG |
| Cas.: 92944-71-3 | Purity: ≥98%(GC) | 4-(N-Maleimido)benzophenone | ESD-918426-50MG |
| Cas.: 178889-49-1 | Purity: ≥98%(GC) | 1-Methylcyclopentyl Acrylate (stabilized with MEHQ) | ESD-918427-1G |
| Cas.: 1415800-35-9 | Purity: ≥98%(LC) | Maleimide-C2-Amido-PEG4-Carboxylic Acid tert-Butyl Ester | ESD-918428-50MG |
| Cas.: 75853-49-5 | Purity: 95%(stabilized with BHT) | 12-Methyltridecanal | ESD-918429-250MG |
| Cas.: 113486-29-6 | Purity: ≥97%(GC) | 3-Methylnonane-2,4-dione | ESD-918430-1G |
| Cas.: 5925-75-7 | Purity: ≥98%(GC) | S-Methyl Thiopropionate | ESD-918431-5G |
| Cas.: 2445-77-4 | Purity: ≥98%(GC) | 2-Methylbutyl Isovalerate | ESD-918432-5ML |
| Cas.: 6377-82-8 | Purity: ≥98%(T) | Morpholine Hydrobromide | ESD-918433-5G |
| Cas.: 58464-45-2 | Purity: ≥98%(N) | Morpholine Hydroiodide | ESD-918434-5G |
| Cas.: 663941-77-3 | Purity: ≥98%(N&T) | 2-Methoxyethylamine Hydrobromide | ESD-918435-1G |
| Cas.: 2059082-61-8 | Purity: ≥98%(T&N) | 2-Methoxyethylamine Hydroiodide | ESD-918436-1G |
| Cas.: 6613-65-6 | Purity: ≥97%(LC&N) | 4-[[2-(Methacryloyloxy)ethyl]dimethylammonio]butane-1-sulfonate | ESD-918437-1G |
| Cas.: 83623-32-9 | Purity: ≥98%(LC&N) | 4-[(3-Methacrylamidopropyl)dimethylammonio]butane-1-sulfonate | ESD-918438-100MG |
| Cas.: 5406-30-4 | Purity: ≥98%(GC&T) | 6-Methylcyclohex-3-ene-1-carboxylic Acid | ESD-918439-1G |
| Cas.: 1514864-84-6 | Purity: ≥98%(GC) | 2-Methoxy-9,9-dimethyl-9H-fluorene | ESD-918440-1G |
| Cas.: 6891-44-7 | Purity: ≥98%(T) | 2-(Methacryloyloxy)-N,N,N-trimethylethanaminium Methyl Sulfate | ESD-918441-5G |
| Cas.: 20185-55-1 | Purity: ≥98%(GC) | Methyl 4-Isopropylbenzoate | ESD-918442-1G |
| Cas.: 14073-00-8 | Purity: ≥98%(T&LC) | 3-Methyl-4-nitroquinoline 1-Oxide | ESD-918443-100MG |
| Cas.: 6510-65-2 | Purity: ≥98%(GC) | 1-Methyl-9H-carbazole | ESD-918444-50MG |
| Cas.: 93632-75-8 | Purity: ≥98%(GC) | 3-Methoxypropyl Acrylate (stabilized with MEHQ) | ESD-918445-1G |
| Cas.: 404857-69-8 | Purity: ≥95%(LC&T) | 11-Mercaptoundecyl 2-Bromo-2-methylpropanoate | ESD-918446-100MG |
| Cas.: 18368-65-5 | Purity: ≥95%(LC&T) | 4-Methylpyridine-2(1H)-thione | ESD-918447-100MG |
| Cas.: 18368-66-6 | Purity: ≥98%(LC&T) | 3-Methylpyridine-2(1H)-thione | ESD-918448-100MG |
| Cas.: 18368-58-6 | Purity: ≥95%(LC&T) | 5-Methylpyridine-2(1H)-thione | ESD-918449-1G |
| Cas.: 22568-11-2 | Purity: ≥98%(GC&T) | 3-[(E)-2-Nitroethenyl]pyridine | ESD-918450-1G |
| Cas.: 31642-67-8 | Purity: ≥97%(GC&T) | 8-Nonenoic Acid | ESD-918451-5G |
| Cas.: 2149582-14-7 | Purity: ≥97%(LC) | Neu5Ac alpha(2-3)Gal beta(1-4)Glc-beta-pNP | ESD-918452-1MG |
| Cas.: 1061350-97-7 | Purity: ≥97% | 2-(2-Naphthyl)phenylboronic Acid | ESD-918453-100MG |
| Cas.: 1133057-98-3 | Purity: ≥97% | [9-(Naphthalen-2-yl)-9H-carbazol-3-yl]boronic Acid | ESD-918454-100MG |
| Cas.: 18315-84-9 | Purity: ≥98%(GC) | (E)-(2-Nitroprop-1-en-1-yl)benzene | ESD-918455-5G |
| Cas.: 1166232-68-3 | Purity: ≥95%(LC) | N,N’-(Naphthalene-1,5-diyl)bis[2-(aminooxy)acetamide] | ESD-918456-10MG |
| Cas.: 95983-78-1 | Purity: ≥95%(LC) | N-Acetylneuraminic Acid Dimer alpha(2-8) | ESD-918457-1MG |
| Cas.: 76152-09-5 | Purity: ≥95%(LC) | N-Acetylneuraminic Acid Trimer alpha(2-8) | ESD-918458-1MG |
| Cas.: 96425-83-1 | Purity: ≥95%(LC) | N-Acetylneuraminic Acid Tetramer alpha(2-8) | ESD-918459-1MG |
| Cas.: 110935-75-6 | Purity: >95%(LC) | N-Acetylneuraminic Acid Pentamer alpha(2-8) | ESD-918460-1MG |
| Cas.: 75030-48-7 | Purity: >98%(GC) | Nonadecan-9-one | ESD-918461-100MG |
| Cas.: 10519-20-7 | Ethyl 2-Octynoate | ESD-918462-5ML | |
| Cas.: 869718-81-0 | Purity: >95%(GC) | 2,5,8,11,14,17,20,23-Octaoxapentacosan-25-amine | ESD-918463-50MG |
| Cas.: 65603-19-2 | Octadecyl Rhodamine B Chloride | ESD-918464-10MG | |
| Cas.: 24367-66-6 | Purity: >95%(T) | Sodium Pyridine-2-sulfinate | ESD-918465-100MG |
| Cas.: 116008-37-8 | Purity: >95%(LC&T) | Sodium Pyridine-4-sulfinate | ESD-918466-100MG |
| Cas.: 2188151-68-8 | Purity: >97%(T&LC) | Sodium Pyrimidine-2-sulfinate | ESD-918467-100MG |
| Cas.: 2098851-48-8 | Purity: >98%(LC&T) | Sodium 5-(Trifluoromethyl)pyridine-2-sulfinate | ESD-918468-100MG |
| Cas.: 13818-44-5 | Purity: >98%(GC) | (2-Oxo-1,3-dioxolan-4-yl)methyl Methacrylate (stabilized with MEHQ) | ESD-918469-100MG |
| Cas.: 1268060-76-9 | Purity: >96%(GC) | 3-(2-Octyldodecyl)thiophene | ESD-918470-100MG |
| Cas.: 1781261-95-7 | Purity: >99.5%(LC) | 2-Octyl-7-phenyl-benzo[d][1]benzothieno[3,2-b]thiophene [for organic electronics] | ESD-918471-100MG |
| Cas.: 17026-83-4 | Purity: >75%(GC) | Sodium Monododecyl Phosphate (contains <10% Sodium Didodecyl Phosphate) | ESD-918472-100G |
| Cas.: 645-72-7 | Purity: >95%(GC) | 3,7,11,15-Tetramethylhexadecan-1-ol | ESD-918473-1G |
| Cas.: 6262-22-2 | Purity: >98%(GC) | N,N’-(1,4-Phenylene)diformamide | ESD-918474-100MG |
| Cas.: 43038-37-5 | Purity: >98%(GC&T) | 2-Phenoxybenzohydrazide | ESD-918475-1G |
| Cas.: 2377369-59-8 | 4-(3-Pyridyl)phenylboronic Acid Hydrochloride (contains varying amounts of Anhydride) | ESD-918476-100MG | |
| Cas.: 161358-46-9 | ULTROXA(regR) Poly(2-methyl-2-oxazoline) (n=approx. 100) | ESD-918477-50MG | |
| Cas.: 161358-47-0 | ULTROXA(regR) Poly(2-ethyl-2-oxazoline) (n=approx. 100) | ESD-918478-100MG | |
| Cas.: 941228-32-6 | ULTROXA(regR) Poly(2-propyl-2-oxazoline) (n=approx. 100) | ESD-918479-50MG | |
| Cas.: 110134-47-9 | Poly(3-hexylthiophene-2,5-diyl) (regioregular) [for organic electronics] | ESD-918480-100MG | |
| Cas.: 25154-86-3 | Poly[2-(Dimethylamino)ethyl Methacrylate] Number Average Molecular Wt. 10000 | ESD-918481-100MG | |
| Cas.: 25232-27-3 | Poly(tert-butyl Acrylate) Number Average Molecular Wt. 10000 | ESD-918482-100MG | |
| Cas.: 1240372-42-2 | PBTTPD | ESD-918483-10MG | |
| Cas.: 1605274-62-1 | Purity: >98%(LC) | 4-(Pentafluorosulfanyl)phenyldiazonium Tetrafluoroborate | ESD-918484-1G |
| Cas.: 5616-55-7 | Purity: >98%(GC) | 2-Phenyl-1,3-dithiolane | ESD-918485-1G |
| Cas.: 1426332-00-4 | Purity: >98%(LC) | N-Phenyl-2-hexyl[60]fulleropyrrolidine | ESD-918486-10MG |
| Cas.: 2305752-57-0 | Purity: >98%(LC) | Sphynolactone-7 | ESD-918487-5MG |
| Cas.: 84538-49-8 | Purity: >95%(GC) | 2-(Piperidine-1-carbonyl)benzaldehyde | ESD-918488-1G |
| Cas.: 52496-08-9 | Polypropylene Glycol Diacrylate (n=approx. 12) (stabilized with MEHQ) | ESD-918489-100G | |
| Cas.: 35648-87-4 | Purity: >98%(GC) | 2,2′-[1,4-Phenylenebis(oxy-2,1-ethanediyloxy)]diethanol | ESD-918490-1G |
| Cas.: 7695-69-4 | Purity: >98%(GC) | Phenylbis(phenylthio)methane | ESD-918491-1G |
| Cas.: 1628817-49-1 | Purity: >95%(LC&T) | 9-Phenyl-3-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole | ESD-918492-1G |
| Cas.: 1131-33-5 | Purity: >98%(T&LC) | 2-Phenylpyridine 1-Oxide | ESD-918493-100MG |
| Cas.: 25999-13-7 | Purity: >98%(GC) | N-Propylacrylamide (stabilized with MEHQ) | ESD-918494-1G |
| Cas.: 1981-38-0 | Purity: >98%(GC) | 2-Phenylanthracene | ESD-918495-100MG |
| Cas.: 14802-41-6 | Purity: >98%(GC) | (E)-2-[2-(Pyridin-4-yl)vinyl]pyridine | ESD-918496-100MG |
| Cas.: 2288769-59-3 | Poly(Fe-btpyb) Purple | ESD-918497-100MG | |
| Cas.: 484-33-3 | Purity: >98%(LC) | Pongamol | ESD-918498-100MG |
| Cas.: 93960-21-5 | Purity: >98%(T&LC) | 3-(3-Pyridyl)-D-alanine Dihydrochloride | ESD-918499-100MG |
| Cas.: 910128-59-5 | Purity: >98%(LC) | 2-(2-Pyridinyldithio)ethyl Methacrylate (stabilized with MEHQ) | ESD-918500-100MG |
| Cas.: 111625-28-6 | Purity: >95%(LC) | 2-(2-Pyridinyldithio)ethanol | ESD-918501-1G |
| Cas.: 361447-81-6 | Purity: >98%(LC) | 1-Phenyl-1H-imidazol-3-ium Trifluoromethanesulfonate | ESD-918502-5G |
| Cas.: 1006613-82-6 | Purity: >98%(LC) | 1-(Phenylsulfonyl)cyclopropan-1-ol | ESD-918503-100MG |
| Cas.: 1293990-73-4 | Purity: >98%(T) | O-Pivaloylhydroxylammonium Trifluoromethanesulfonate | ESD-918504-100MG |
| Cas.: 6935-29-1 | Purity: >97%(GC&T) | Quinoxaline 1-Oxide | ESD-918505-100MG |
| Cas.: 2423-66-7 | Purity: >95%(LC&T) | Quinoxaline 1,4-Dioxide | ESD-918506-100MG |
| Cas.: 374067-50-2 | Ru(OAc)2[(R)-xylbinap] | ESD-918507-100MG | |
| Cas.: 374067-49-9 | Ru(OAc)2[(S)-xylbinap] | ESD-918508-100MG | |
| Cas.: 30195-30-3 | Purity: >98%(LC) | Ro 5-3335 | ESD-918509-10MG |
| Cas.: 1478704-03-8 | Purity: >90%(T) | Sodium [(S)-1,2-Diaminopropane-N,N,N’,N’-tetraacetato]samarate(III) | ESD-918510-10MG |
| Cas.: 92638-81-8 | Purity: >98%(LC&N) | 10H-Spiro[acridine-9,9′-fluorene] | ESD-918511-250MG |
| Cas.: 66134-67-6 | Purity: >98%(LC&N) | N-Succinimidyl 4-Fluorobenzoate | ESD-918512-1G |
| Cas.: 355-04-4 | Purity: >99%(GC) | Tetradecafluoro-2-methylpentane | ESD-918513-5ML |
| Cas.: 98386-81-3 | Purity: >98%(GC&T) | (E)-2-(Trifluoromethyl)cinnamic Acid | ESD-918514-5G |
| Cas.: 2001054-66-4 | Purity: >98%(LC) | Tetrakis[N-tetrachlorophthaloyl-(R)-tert-leucinato]dirhodium Bis(ethyl Acetate) Adduct | ESD-918515-10MG |
| Cas.: 1032-95-7 | Purity: >98%(GC) | Tetramethyl cis,trans,cis-1,2,3,4-Cyclobutanetetracarboxylate | ESD-918516-1G |
| Cas.: 5496-71-9 | Purity: >98%(T) | N,N,N’,N’-Tetrakis(4-dibutylaminophenyl)-1,4-benzoquinone Diiminium Bis(hexafluoroantimonate) | ESD-918517-1G |
| Cas.: 853377-11-4 | Purity: >98%(GC) | 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-918518-1G |
| Cas.: 6044-50-4 | Purity: >97%(GC&T) | N-Methyl-3-(triethoxysilyl)propan-1-amine | ESD-918519-5G |
| Cas.: 43020-38-8 | Purity: >98%(GC) | 2,3,4-Trimethoxybenzonitrile | ESD-918520-5G |
| Cas.: 1073-31-0 | Purity: >98%(GC) | 3,4-Thiophenedicarboxaldehyde | ESD-918521-100MG |
| Cas.: 21120-65-0 | Purity: >96%(GC&T) | 4-(4-Methylphenoxy)benzoic Acid | ESD-918522-1G |
| Cas.: 2737-22-6 | Purity: >98%(GC) | 2,4,6-Tribromo-3-hydroxybenzaldehyde | ESD-918523-5G |
| Cas.: 303111-06-0 | Purity: >98%(LC) | 4,4′,4”-Tris[9,9-dimethylfluoren-2-yl(phenyl)amino]triphenylamine | ESD-918524-100MG |
| Cas.: 6326-64-3 | Purity: >98%(LC) | 1,3,5-Tris(4-biphenylyl)benzene | ESD-918525-100MG |
| Cas.: 5624-60-2 | Purity: >95%(GC) | 1,3,5-Tris(trimethylsilyl)benzene | ESD-918526-1G |
| Cas.: 553611-81-7 | Purity: >98%(GC) | Tetrakis(3-bromophenyl)silane | ESD-918527-100MG |
| Cas.: 67-78-7 | Purity: >98%(LC) | Triamcinolone Diacetate | ESD-918528-50MG |
| Cas.: 1422540-88-2 | Purity: >98%(GC) | Acetylthio-PEG4-Alkyne | ESD-918529-50MG |
| Cas.: 15968-37-3 | Purity: >97%(T) | 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione | ESD-918530-100MG |
| Cas.: 1372778-68-1 | Purity: >97%(LC&N) | N-([1,1′:3′,1”-Terphenyl]-5′-yl)-9,9-dimethyl-9H-fluoren-2-amine | ESD-918531-100MG |
| Cas.: 90774-69-9 | Purity: >98%(LC&T) | 4-(Trifluoromethyl)aniline Hydrochloride | ESD-918532-1G |
| Cas.: 148819-81-2 | Purity: >98%(LC) | 4-(Trifluoromethyl)aniline Hydrobromide | ESD-918533-1G |
| Cas.: 880339-31-1 | Purity: >93%(GC) | 3-(Triethoxysilyl)propyl 2-Bromo-2-methylpropanoate | ESD-918534-100MG |
| Cas.: 2195419-19-1 | Purity: >95%(LC) | 10-(Triethylsilyl)benzo[lmn]thieno[2,3-f][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone | ESD-918535-10MG |
| Cas.: 888950-09-2 | Purity: >98%(GC&T) | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene | ESD-918536-50MG |
| Cas.: 2125-23-7 | Purity: >98%(LC) | 2,4,6-Tris(2,4-dihydroxyphenyl)-1,3,5-triazine | ESD-918537-100MG |
| Cas.: 3135-19-1 | Purity: >98%(LC&N) | 2,4,6-Tris(4-butoxy-2-hydroxyphenyl)-1,3,5-triazine | ESD-918538-1G |
| Cas.: 1385826-84-5 | Purity: >98%(GC&T) | 2-([1,1′:3′,1”-Terphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918539-100MG |
| Cas.: 1401577-23-8 | Purity: >98%(GC&T) | 2-([1,1′:4′,1”-Terphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918540-1G |
| Cas.: 4182-80-3 | Purity: >98%(LC) | N,N,N’,N’-Tetrakis[4-(dibutylamino)phenyl]-1,4-phenylenediamine | ESD-918541-1G |
| Cas.: 33016-12-5 | Purity: >98%(LC&N) | TN-16 | ESD-918542-10MG |
| Cas.: 6558-85-6 | Purity: >98%(GC&N) | 1,3,6,8-Tetramethyl-9H-carbazole | ESD-918543-100MG |
| Cas.: 56637-44-6 | Purity: >98%(GC) | 2-(p-Tolyl)-1,3-dithiane | ESD-918544-1G |
| Cas.: 136455-49-7 | Purity: >95%(LC) | Octaethyl [Benzene-1,2,4,5-tetrayltetrakis(methylene)]tetrakis(phosphonate) | ESD-918545-1G |
| Cas.: 56491-86-2 | Purity: >98%(LC) | 2,2′,2”-(1,4,7-Triazonane-1,4,7-triyl)triacetic Acid | ESD-918546-100MG |
| Cas.: 171408-77-8 | Purity: >98%(LC&T) | 2,2′,7-Tribromo-9,9′-spirobi[fluorene] | ESD-918547-100MG |
| Cas.: 1458041-70-7 | Purity: >98%(LC) | TU-1 [for organic electronics] | ESD-918548-50MG |
| Cas.: 2472802-21-2 | Purity: >95%(LC) | TFMAQ-8Ph | ESD-918549-2MG |
| Cas.: 96131-57-6 | Purity: >95%(T) | Tetrabutylphosphonium O,O-Diethyl Phosphorodithioate | ESD-918550-5G |
| Cas.: 55962-05-5 | Purity: >95%(T) | 4-Methyl-N-(phenyl-lambda3-iodaneylidene)benzenesulfonamide | ESD-918551-100MG |
| Cas.: 2106819-64-9 | UltraNitroCat | ESD-918552-10MG | |
| Cas.: 215312-86-0 | Purity: >95%(LC) | Sulfo-EMCS | ESD-918553-10MG |
| Cas.: 1431850-88-2 | ULTROXA(regR) Poly(2-ethyl-2-oxazoline) Azide Terminated (n=approx. 50) | ESD-918554-100MG | |
| Cas.: 1616777-37-7 | ULTROXA(regR) Poly(2-ethyl-2-oxazoline) Amine Terminated (n=approx. 50) | ESD-918555-100MG | |
| Cas.: 1262975-46-1 | ULTROXA(regR) Poly(2-methyl-2-oxazoline) Azide Terminated (n=approx. 50) | ESD-918556-100MG | |
| Cas.: 2055540-61-7 | Purity: >90%(LC) | UltraCat (contains 5% Nitromethane at maximum) | ESD-918557-10MG |
| Cas.: 40538-11-2 | Purity: >98%(GC) | Diphenyl(4-vinylphenyl)phosphine (stabilized with BHT) | ESD-918558-5G |
| Cas.: 62855-80-5 | Purity: >98%(GC) | p-Xylylene Dithiocyanate | ESD-918559-5G |
| Cas.: 89690-11-9 | Purity: >98%(T) | Xylemin Dihydrochloride | ESD-918560-100MG |
| Cas.: 2786-07-4 | Purity: 1.0 M in THF/hexanes, MKSeal | 2-THIENYLLITHIUM | ESD-918561-100ML |
| Cas.: 2786-07-4 | Purity: 1.0 M in THF/hexanes, MKSeal | 2-THIENYLLITHIUM | ESD-918561-500ML |
| Cas.: 2786-07-4 | Purity: 1.0 M in THF/hexanes, MKSeal | 2-THIENYLLITHIUM | ESD-918561-800ML |
| Cas.: 17400-77-0 | Purity: ≥98% | P-NITROPHENYL-ALPHA-D-MALTOSIDE | ESD-918562-100MG |
| Cas.: 17400-77-0 | Purity: ≥98% | P-NITROPHENYL-ALPHA-D-MALTOSIDE | ESD-918562-250MG |
| Cas.: 17400-77-0 | Purity: ≥98% | P-NITROPHENYL-ALPHA-D-MALTOSIDE | ESD-918562-500MG |
| Cas.: 312693-17-7 | Purity: 0.5 M solution in THF, MKSeal | 4-METHOXYBENZYLZINC CHLORIDE | ESD-918563-100ML |
| Cas.: 312693-17-7 | Purity: 0.5 M solution in THF, MKSeal | 4-METHOXYBENZYLZINC CHLORIDE | ESD-918563-25ML |
| Cas.: 312693-17-7 | Purity: 0.5 M solution in THF, MKSeal | 4-METHOXYBENZYLZINC CHLORIDE | ESD-918563-500ML |
| Cas.: 81012-88-6 | Purity: ≥96% | Inosine 5′-diphosphate sodium salt | ESD-918564-100MG |
| Cas.: 81012-88-6 | Purity: ≥96% | Inosine 5′-diphosphate sodium salt | ESD-918564-25MG |
| Cas.: 81012-88-6 | Purity: ≥96% | Inosine 5′-diphosphate sodium salt | ESD-918564-500MG |
| Cas.: 78859-42-4 | Purity: 95% (TLC) | 5′-P-FLUOROSULFONYL-BENZOYLADENOSINE HYDROCHLORIDE | ESD-918565-100MG |
| Cas.: 78859-42-4 | Purity: 95% (TLC) | 5′-P-FLUOROSULFONYL-BENZOYLADENOSINE HYDROCHLORIDE | ESD-918565-25MG |
| Cas.: 78859-42-4 | Purity: 95% (TLC) | 5′-P-FLUOROSULFONYL-BENZOYLADENOSINE HYDROCHLORIDE | ESD-918565-500MG |
| Cas.: 26124-78-7 | Purity: mol wt >30,000 | POLY-L-LYSINE HYDROCHLORIDE | ESD-918566-25MG |
| Cas.: 165522-16-7 | Purity: 90% | 2-CHLORO-4-NITROPHENYL-BETA-D-MALTOTRIOSIDE | ESD-918567-250MG |
| Cas.: 165522-16-7 | Purity: 90% | 2-CHLORO-4-NITROPHENYL-BETA-D-MALTOTRIOSIDE | ESD-918567-100MG |
| Cas.: 165522-16-7 | Purity: 90% | 2-CHLORO-4-NITROPHENYL-BETA-D-MALTOTRIOSIDE | ESD-918567-500MG |
| Cas.: 3234-02-4 | Purity: 98% | 2,3-Dibromobut-2-ene-1,4-diol | ESD-918568-25G |
| Cas.: 3234-02-4 | Purity: 98% | 2,3-Dibromobut-2-ene-1,4-diol | ESD-918568-100G |
| Cas.: 3234-02-4 | Purity: 98% | 2,3-Dibromobut-2-ene-1,4-diol | ESD-918568-500G |
| Cas.: 67533-12-4 | Purity: 97% | TETRAETHYLAMMONIUM ACETATE TETRAHYDRATE | ESD-918569-25G |
| Cas.: 67533-12-4 | Purity: 97% | TETRAETHYLAMMONIUM ACETATE TETRAHYDRATE | ESD-918569-100G |
| Cas.: 67533-12-4 | Purity: 97% | TETRAETHYLAMMONIUM ACETATE TETRAHYDRATE | ESD-918569-500G |
| Cas.: 25486-55-9 | Purity: ≥98.0% (HPLC) | Vitamin K1 2,3-epoxide | ESD-918570-100MG |
| Cas.: 25486-55-9 | Purity: ≥98.0% (HPLC) | Vitamin K1 2,3-epoxide | ESD-918570-10MG |
| Cas.: 25486-55-9 | Purity: ≥98.0% (HPLC) | Vitamin K1 2,3-epoxide | ESD-918570-500MG |
| Cas.: 39691-62-8 | Purity: 0.5M solution in THF, MKSeal | NONYLMAGNESIUM BROMIDE | ESD-918571-100ML |
| Cas.: 39691-62-8 | Purity: 0.5M solution in THF, MKSeal | NONYLMAGNESIUM BROMIDE | ESD-918571-1L |
| Cas.: 39691-62-8 | Purity: 0.5M solution in THF, MKSeal | NONYLMAGNESIUM BROMIDE | ESD-918571-500ML |
| Cas.: 4958-39-8 | Purity: from yeast | Adenosine-3′-monophosphate Sodium Salt | ESD-918572-100MG |
| Cas.: 4958-39-8 | Purity: from yeast | Adenosine-3′-monophosphate Sodium Salt | ESD-918572-1G |
| Cas.: 4958-39-8 | Purity: from yeast | Adenosine-3′-monophosphate Sodium Salt | ESD-918572-500MG |
| Cas.: 67909-30-2 | Purity: ≥95% | 4-METHYLUMBELLIFERYL BETA-D-MANNOPYRANOSIDE | ESD-918573-100MG |
| Cas.: 67909-30-2 | Purity: ≥95% | 4-METHYLUMBELLIFERYL BETA-D-MANNOPYRANOSIDE | ESD-918573-250MG |
| Cas.: 67909-30-2 | Purity: ≥95% | 4-METHYLUMBELLIFERYL BETA-D-MANNOPYRANOSIDE | ESD-918573-50MG |
| Cas.: 4419-94-7 | Purity: ≥98% | P-NITROPHENYL BETA-D-LACTOPYRANOSIDE | ESD-918574-100MG |
| Cas.: 4419-94-7 | Purity: ≥98% | P-NITROPHENYL BETA-D-LACTOPYRANOSIDE | ESD-918574-250MG |
| Cas.: 4419-94-7 | Purity: ≥98% | P-NITROPHENYL BETA-D-LACTOPYRANOSIDE | ESD-918574-50MG |
| Cas.: 67423-45-4 | 4-HYDROXY-3-METHOXYPHENYLGLYCOL HEMIPIPERAZINIUM SALT | ESD-918575-100MG | |
| Cas.: 67423-45-4 | 4-HYDROXY-3-METHOXYPHENYLGLYCOL HEMIPIPERAZINIUM SALT | ESD-918575-25MG | |
| Cas.: 67423-45-4 | 4-HYDROXY-3-METHOXYPHENYLGLYCOL HEMIPIPERAZINIUM SALT | ESD-918575-50MG | |
| Cas.: 84325-23-5 | Purity: ≥95% | 4-METHYLUMBELLIFERYL-BETA-D-LACTOSIDE | ESD-918576-10MG |
| Cas.: 84325-23-5 | Purity: ≥95% | 4-METHYLUMBELLIFERYL-BETA-D-LACTOSIDE | ESD-918576-25MG |
| Cas.: 84325-23-5 | Purity: ≥95% | 4-METHYLUMBELLIFERYL-BETA-D-LACTOSIDE | ESD-918576-50MG |
| Cas.: 781652-57-1 | Purity: 97% | 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | ESD-918577-5MG |
| Cas.: 781652-57-1 | Purity: 97% | 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | ESD-918577-10MG |
| Cas.: 781652-57-1 | Purity: 97% | 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | ESD-918577-50MG |
| Cas.: 1360705-96-9 | Purity: 98% | (4-(Bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone | ESD-918578-5MG |
| Cas.: 1360705-96-9 | Purity: 98% | (4-(Bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone | ESD-918578-10MG |
| Cas.: 1360705-96-9 | Purity: 98% | (4-(Bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone | ESD-918578-50MG |
| Cas.: 56010-88-9 | Purity: 95% | 4-METHYLPYRAZOLE HYDROCHLORIDE | ESD-918579-100MG |
| Cas.: 56010-88-9 | Purity: 95% | 4-METHYLPYRAZOLE HYDROCHLORIDE | ESD-918579-1G |
| Cas.: 56010-88-9 | Purity: 95% | 4-METHYLPYRAZOLE HYDROCHLORIDE | ESD-918579-50MG |
| Cas.: 108321-17-1 | Purity: ≥97% (enzymatic) | PHOSPHOCREATINE DI-TRIS SALT | ESD-918580-1G |
| Cas.: 108321-17-1 | Purity: ≥97% (enzymatic) | PHOSPHOCREATINE DI-TRIS SALT | ESD-918580-500MG |
| Cas.: 108321-17-1 | Purity: ≥97% (enzymatic) | PHOSPHOCREATINE DI-TRIS SALT | ESD-918580-5G |
| Cas.: 179334-18-0 | Purity: 97% | 1-(2,5-Difluorobenzyl)piperazine | ESD-918581-1G |
| Cas.: 179334-18-0 | Purity: 97% | 1-(2,5-Difluorobenzyl)piperazine | ESD-918581-250MG |
| Cas.: 179334-18-0 | Purity: 97% | 1-(2,5-Difluorobenzyl)piperazine | ESD-918581-5G |
| Cas.: 1239478-87-5 | Purity: 97% | 5-[Di(1-adaMantyl)phosphino](1,3,5-triphenyl-1H-pyrazol-4-yl)-1H-pyrazole | ESD-918582-1G |
| Cas.: 1239478-87-5 | Purity: 97% | 5-[Di(1-adaMantyl)phosphino](1,3,5-triphenyl-1H-pyrazol-4-yl)-1H-pyrazole | ESD-918582-250MG |
| Cas.: 1239478-87-5 | Purity: 97% | 5-[Di(1-adaMantyl)phosphino](1,3,5-triphenyl-1H-pyrazol-4-yl)-1H-pyrazole | ESD-918582-5G |
| Cas.: 100828-16-8 | (±)-CPP | ESD-918583-100MG | |
| Cas.: 100828-16-8 | (±)-CPP | ESD-918583-25MG | |
| Cas.: 100828-16-8 | (±)-CPP | ESD-918583-5MG | |
| Cas.: 75614-89-0 | Purity: ≥98% (HPLC) | HISTAMINE DIHYDROCHLORIDE R(-)-A-METHYL | ESD-918584-100MG |
| Cas.: 75614-89-0 | Purity: ≥98% (HPLC) | HISTAMINE DIHYDROCHLORIDE R(-)-A-METHYL | ESD-918584-25MG |
| Cas.: 75614-89-0 | Purity: ≥98% (HPLC) | HISTAMINE DIHYDROCHLORIDE R(-)-A-METHYL | ESD-918584-5MG |
| Cas.: 78095-19-9 | Purity: ≥98% (HPLC) | (R)-(+)-8-Hydroxy-DPAT hydrobromide | ESD-918585-100MG |
| Cas.: 78095-19-9 | Purity: ≥98% (HPLC) | (R)-(+)-8-Hydroxy-DPAT hydrobromide | ESD-918585-25MG |
| Cas.: 78095-19-9 | Purity: ≥98% (HPLC) | (R)-(+)-8-Hydroxy-DPAT hydrobromide | ESD-918585-5MG |
| Cas.: 7289-92-1 | Purity: 99%(99.99%-Sb) | TRIS(DIMETHYLAMINO)ANTIMONY | ESD-918586-1G |
| Cas.: 7289-92-1 | Purity: 99%(99.99%-Sb) | TRIS(DIMETHYLAMINO)ANTIMONY | ESD-918586-25G |
| Cas.: 7289-92-1 | Purity: 99%(99.99%-Sb) | TRIS(DIMETHYLAMINO)ANTIMONY | ESD-918586-5G |
| Cas.: 3010-04-6 | Purity: ≥95% | (N-BUTYLAMINO)ACETONITRILE | ESD-918587-1G |
| Cas.: 3010-04-6 | Purity: ≥95% | (N-BUTYLAMINO)ACETONITRILE | ESD-918587-25G |
| Cas.: 3010-04-6 | Purity: ≥95% | (N-BUTYLAMINO)ACETONITRILE | ESD-918587-5G |
| Cas.: 32395-58-7 | Purity: 95% | DIMETHYLOCTADECYLSILANE | ESD-918588-1G |
| Cas.: 32395-58-7 | Purity: 95% | DIMETHYLOCTADECYLSILANE | ESD-918588-25G |
| Cas.: 32395-58-7 | Purity: 95% | DIMETHYLOCTADECYLSILANE | ESD-918588-5G |
| Cas.: 21373-30-8 | Purity: ≥98% (HPLC) | 2,4,5-TRIHYDROXY-DL-PHENYLALANINE | ESD-918589-100MG |
| Cas.: 21373-30-8 | Purity: ≥98% (HPLC) | 2,4,5-TRIHYDROXY-DL-PHENYLALANINE | ESD-918589-10MG |
| Cas.: 21373-30-8 | Purity: ≥98% (HPLC) | 2,4,5-TRIHYDROXY-DL-PHENYLALANINE | ESD-918589-5MG |
| Cas.: 89976-15-8 | Purity: 95% | 7-Iodo-1H-indole | ESD-918590-250MG |
| Cas.: 89976-15-8 | Purity: 95% | 7-Iodo-1H-indole | ESD-918590-1G |
| Cas.: 89976-15-8 | Purity: 95% | 7-Iodo-1H-indole | ESD-918590-5G |
| Cas.: 1699-59-8 | Purity: 97% | 3,4-Dibenzyloxybenzyl chloride | ESD-918591-250MG |
| Cas.: 1699-59-8 | Purity: 97% | 3,4-Dibenzyloxybenzyl chloride | ESD-918591-1G |
| Cas.: 1699-59-8 | Purity: 97% | 3,4-Dibenzyloxybenzyl chloride | ESD-918591-5G |
| Cas.: 163295-74-7 | Purity: 95% | (3,5-Difluorophenyl)methanesulfonyl chloride | ESD-918592-250MG |
| Cas.: 163295-74-7 | Purity: 95% | (3,5-Difluorophenyl)methanesulfonyl chloride | ESD-918592-1G |
| Cas.: 163295-74-7 | Purity: 95% | (3,5-Difluorophenyl)methanesulfonyl chloride | ESD-918592-5G |
| Cas.: 145106-43-0 | Purity: 97% | tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate | ESD-918593-250MG |
| Cas.: 145106-43-0 | Purity: 97% | tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate | ESD-918593-1G |
| Cas.: 145106-43-0 | Purity: 97% | tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate | ESD-918593-5G |
| Cas.: 26387-66-6 | Purity: 95% | 2-Bromo-3-(dimethylamino)acrylaldehyde | ESD-918594-250MG |
| Cas.: 26387-66-6 | Purity: 95% | 2-Bromo-3-(dimethylamino)acrylaldehyde | ESD-918594-1G |
| Cas.: 26387-66-6 | Purity: 95% | 2-Bromo-3-(dimethylamino)acrylaldehyde | ESD-918594-5G |
| Cas.: 13007-90-4 | Purity: 98% | Bis(triphenylphosphine)dicarbonylnickel | ESD-918595-250MG |
| Cas.: 13007-90-4 | Purity: 98% | Bis(triphenylphosphine)dicarbonylnickel | ESD-918595-1G |
| Cas.: 13007-90-4 | Purity: 98% | Bis(triphenylphosphine)dicarbonylnickel | ESD-918595-5G |
| Cas.: 1195995-72-2 | Purity: 96% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-918596-250MG |
| Cas.: 1195995-72-2 | Purity: 96% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-918596-1G |
| Cas.: 1195995-72-2 | Purity: 96% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-918596-5G |
| Cas.: 1053658-49-3 | Purity: 95% | 1,3,6-Trichloroisoquinoline | ESD-918597-250MG |
| Cas.: 1053658-49-3 | Purity: 95% | 1,3,6-Trichloroisoquinoline | ESD-918597-1G |
| Cas.: 1053658-49-3 | Purity: 95% | 1,3,6-Trichloroisoquinoline | ESD-918597-5G |
| Cas.: 1215372-00-1 | Purity: 97% | 5-(Aminomethyl)thiazole dihydrochloride | ESD-918598-250MG |
| Cas.: 1215372-00-1 | Purity: 97% | 5-(Aminomethyl)thiazole dihydrochloride | ESD-918598-1G |
| Cas.: 1215372-00-1 | Purity: 97% | 5-(Aminomethyl)thiazole dihydrochloride | ESD-918598-5G |
| Cas.: 913574-95-5 | Purity: 95% | Cis-1-Cbz-3-Fluoro-4-Hydroxypiperidine | ESD-918599-250MG |
| Cas.: 913574-95-5 | Purity: 95% | Cis-1-Cbz-3-Fluoro-4-Hydroxypiperidine | ESD-918599-1G |
| Cas.: 913574-95-5 | Purity: 95% | Cis-1-Cbz-3-Fluoro-4-Hydroxypiperidine | ESD-918599-5G |
| Cas.: 50478-16-5 | Purity: 95% | 5-Chlorothiophene-2-carbonitrile | ESD-918600-250MG |
| Cas.: 50478-16-5 | Purity: 95% | 5-Chlorothiophene-2-carbonitrile | ESD-918600-1G |
| Cas.: 50478-16-5 | Purity: 95% | 5-Chlorothiophene-2-carbonitrile | ESD-918600-5G |
| Cas.: 151978-50-6 | Purity: 95% | tert-Butylpent-4-yn-1-ylcarbamate | ESD-918601-250MG |
| Cas.: 151978-50-6 | Purity: 95% | tert-Butylpent-4-yn-1-ylcarbamate | ESD-918601-1G |
| Cas.: 151978-50-6 | Purity: 95% | tert-Butylpent-4-yn-1-ylcarbamate | ESD-918601-5G |
| Cas.: 1074-91-5 | Purity: 98% | 1-Bromo-2,3,4,5-tetrafluorobenzene | ESD-918602-250MG |
| Cas.: 1074-91-5 | Purity: 98% | 1-Bromo-2,3,4,5-tetrafluorobenzene | ESD-918602-1G |
| Cas.: 1074-91-5 | Purity: 98% | 1-Bromo-2,3,4,5-tetrafluorobenzene | ESD-918602-5G |
| Cas.: 7145-99-5 | Purity: 95% | 5-Methylbenzo[d][1,3]dioxole | ESD-918603-250MG |
| Cas.: 7145-99-5 | Purity: 95% | 5-Methylbenzo[d][1,3]dioxole | ESD-918603-1G |
| Cas.: 7145-99-5 | Purity: 95% | 5-Methylbenzo[d][1,3]dioxole | ESD-918603-5G |
| Cas.: 946681-88-5 | Purity: 95% | 5-Bromo-4,6-difluoropyrimidine | ESD-918604-250MG |
| Cas.: 946681-88-5 | Purity: 95% | 5-Bromo-4,6-difluoropyrimidine | ESD-918604-1G |
| Cas.: 946681-88-5 | Purity: 95% | 5-Bromo-4,6-difluoropyrimidine | ESD-918604-5G |
| Cas.: 18261-42-2 | Purity: 95% | 6-Chloro-5-methylpyrimidin-4-ol | ESD-918605-250MG |
| Cas.: 18261-42-2 | Purity: 95% | 6-Chloro-5-methylpyrimidin-4-ol | ESD-918605-1G |
| Cas.: 18261-42-2 | Purity: 95% | 6-Chloro-5-methylpyrimidin-4-ol | ESD-918605-5G |
| Cas.: 1122410-32-5 | Purity: 98% | Benzyl (isopropoxymethyl)carbamate | ESD-918606-250MG |
| Cas.: 1122410-32-5 | Purity: 98% | Benzyl (isopropoxymethyl)carbamate | ESD-918606-1G |
| Cas.: 1122410-32-5 | Purity: 98% | Benzyl (isopropoxymethyl)carbamate | ESD-918606-5G |
| Cas.: 10527-16-9 | Purity: 97% | 10-Chloroanthracene-9-carbaldehyde | ESD-918607-250MG |
| Cas.: 10527-16-9 | Purity: 97% | 10-Chloroanthracene-9-carbaldehyde | ESD-918607-1G |
| Cas.: 18934-81-1 | Purity: 98% | 12-((tert-Butoxycarbonyl)amino)dodecanoic acid | ESD-918608-250MG |
| Cas.: 18934-81-1 | Purity: 98% | 12-((tert-Butoxycarbonyl)amino)dodecanoic acid | ESD-918608-1G |
| Cas.: 18934-81-1 | Purity: 98% | 12-((tert-Butoxycarbonyl)amino)dodecanoic acid | ESD-918608-5G |
| Cas.: 7334-51-2 | Purity: ≥97% | N,N,N’,N’-Tetramethylsuccinamide | ESD-918609-250MG |
| Cas.: 7334-51-2 | Purity: ≥97% | N,N,N’,N’-Tetramethylsuccinamide | ESD-918609-1G |
| Cas.: 7334-51-2 | Purity: ≥97% | N,N,N’,N’-Tetramethylsuccinamide | ESD-918609-5G |
| Cas.: 343-01-1 | Purity: 98% | 2-Fluoro-9H-fluoren-9-one | ESD-918610-250MG |
| Cas.: 4056-73-9 | Purity: 97% | 2-Acetylcyclohexane-1,3-dione | ESD-918611-250MG |
| Cas.: 4056-73-9 | Purity: 97% | 2-Acetylcyclohexane-1,3-dione | ESD-918611-1G |
| Cas.: 4056-73-9 | Purity: 97% | 2-Acetylcyclohexane-1,3-dione | ESD-918611-5G |
| Cas.: 5112-95-8 | Purity: 98% | 1,2-Bis(diphenylphosphino)ethyne | ESD-918612-250MG |
| Cas.: 5112-95-8 | Purity: 98% | 1,2-Bis(diphenylphosphino)ethyne | ESD-918612-1G |
| Cas.: 5112-95-8 | Purity: 98% | 1,2-Bis(diphenylphosphino)ethyne | ESD-918612-5G |
| Cas.: 78725-46-9 | Purity: 95% | 3-(3-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-918613-250MG |
| Cas.: 78725-46-9 | Purity: 95% | 3-(3-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-918613-1G |
| Cas.: 78725-46-9 | Purity: 95% | 3-(3-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-918613-5G |
| Cas.: 4684-12-2 | Purity: 97% | 4-Chloronaphthalen-1-amine | ESD-918614-250MG |
| Cas.: 4684-12-2 | Purity: 97% | 4-Chloronaphthalen-1-amine | ESD-918614-1G |
| Cas.: 4684-12-2 | Purity: 97% | 4-Chloronaphthalen-1-amine | ESD-918614-5G |
| Cas.: 1485-07-0 | Purity: 95% | 2-(Naphthalen-2-yl)ethanol | ESD-918615-250MG |
| Cas.: 1485-07-0 | Purity: 95% | 2-(Naphthalen-2-yl)ethanol | ESD-918615-1G |
| Cas.: 1485-07-0 | Purity: 95% | 2-(Naphthalen-2-yl)ethanol | ESD-918615-5G |
| Cas.: 6064-63-7 | Purity: 95% | 2-Hydroxyhexanoic acid | ESD-918616-250MG |
| Cas.: 6064-63-7 | Purity: 95% | 2-Hydroxyhexanoic acid | ESD-918616-1G |
| Cas.: 6064-63-7 | Purity: 95% | 2-Hydroxyhexanoic acid | ESD-918616-5G |
| Cas.: 35373-63-8 | Purity: 95% | 2-Amino-3-(4-chlorophenyl)propan-1-ol | ESD-918617-250MG |
| Cas.: 35373-63-8 | Purity: 95% | 2-Amino-3-(4-chlorophenyl)propan-1-ol | ESD-918617-1G |
| Cas.: 35373-63-8 | Purity: 95% | 2-Amino-3-(4-chlorophenyl)propan-1-ol | ESD-918617-5G |
| Cas.: 3973-70-4 | Purity: 96% | 1-Amino-4-(2-hydroxyethyl)piperazine | ESD-918618-250MG |
| Cas.: 3973-70-4 | Purity: 96% | 1-Amino-4-(2-hydroxyethyl)piperazine | ESD-918618-1G |
| Cas.: 3973-70-4 | Purity: 96% | 1-Amino-4-(2-hydroxyethyl)piperazine | ESD-918618-5G |
| Cas.: 14193-38-5 | Purity: 98% | trans-1,2-Dithiane-4,5-diol | ESD-918619-250MG |
| Cas.: 14193-38-5 | Purity: 98% | trans-1,2-Dithiane-4,5-diol | ESD-918619-1G |
| Cas.: 14193-38-5 | Purity: 98% | trans-1,2-Dithiane-4,5-diol | ESD-918619-5G |
| Cas.: 574-92-5 | Purity: 95% | 4-Hydroxy-7-(trifluoromethyl)quinoline-3-carboxylic acid | ESD-918620-250MG |
| Cas.: 574-92-5 | Purity: 95% | 4-Hydroxy-7-(trifluoromethyl)quinoline-3-carboxylic acid | ESD-918620-1G |
| Cas.: 574-92-5 | Purity: 95% | 4-Hydroxy-7-(trifluoromethyl)quinoline-3-carboxylic acid | ESD-918620-5G |
| Cas.: 35975-00-9 | Purity: 97% | 6-Nitroquinolin-5-amine | ESD-918621-250MG |
| Cas.: 35975-00-9 | Purity: 97% | 6-Nitroquinolin-5-amine | ESD-918621-1G |
| Cas.: 35975-00-9 | Purity: 97% | 6-Nitroquinolin-5-amine | ESD-918621-5G |
| Cas.: 49757-42-8 | Purity: 95% | 4,4′,4”-(Chloromethanetriyl)tris(methoxybenzene) | ESD-918622-250MG |
| Cas.: 49757-42-8 | Purity: 95% | 4,4′,4”-(Chloromethanetriyl)tris(methoxybenzene) | ESD-918622-1G |
| Cas.: 49757-42-8 | Purity: 95% | 4,4′,4”-(Chloromethanetriyl)tris(methoxybenzene) | ESD-918622-5G |
| Cas.: 1466-48-4 | Purity: 97% | 1,1,1-Tris(2-cyanoethyl)nitromethane | ESD-918623-250MG |
| Cas.: 1466-48-4 | Purity: 97% | 1,1,1-Tris(2-cyanoethyl)nitromethane | ESD-918623-1G |
| Cas.: 1466-48-4 | Purity: 97% | 1,1,1-Tris(2-cyanoethyl)nitromethane | ESD-918623-5G |
| Cas.: 88-86-8 | Purity: 98% | 2,5-Dichloro-3-nitrobenzoic acid | ESD-918624-250MG |
| Cas.: 88-86-8 | Purity: 98% | 2,5-Dichloro-3-nitrobenzoic acid | ESD-918624-1G |
| Cas.: 88-86-8 | Purity: 98% | 2,5-Dichloro-3-nitrobenzoic acid | ESD-918624-5G |
| Cas.: 596-31-6 | Purity: 97% | (Methoxymethanetriyl)tribenzene | ESD-918625-250MG |
| Cas.: 596-31-6 | Purity: 97% | (Methoxymethanetriyl)tribenzene | ESD-918625-1G |
| Cas.: 596-31-6 | Purity: 97% | (Methoxymethanetriyl)tribenzene | ESD-918625-5G |
| Cas.: 2708-97-6 | Purity: 97% | 1,2-Diiodotetrafluorobenzene | ESD-918626-250MG |
| Cas.: 2708-97-6 | Purity: 97% | 1,2-Diiodotetrafluorobenzene | ESD-918626-1G |
| Cas.: 2708-97-6 | Purity: 97% | 1,2-Diiodotetrafluorobenzene | ESD-918626-5G |
| Cas.: 5711-41-1 | Purity: 95% | 4-(4-Methoxyphenyl)-4-oxobut-2-enoic acid | ESD-918627-250MG |
| Cas.: 5711-41-1 | Purity: 95% | 4-(4-Methoxyphenyl)-4-oxobut-2-enoic acid | ESD-918627-1G |
| Cas.: 5711-41-1 | Purity: 95% | 4-(4-Methoxyphenyl)-4-oxobut-2-enoic acid | ESD-918627-5G |
| Cas.: 5394-36-5 | Purity: 95% | 5-Ethyl-5-methylimidazolidine-2,4-dione | ESD-918628-250MG |
| Cas.: 5394-36-5 | Purity: 95% | 5-Ethyl-5-methylimidazolidine-2,4-dione | ESD-918628-1G |
| Cas.: 5394-36-5 | Purity: 95% | 5-Ethyl-5-methylimidazolidine-2,4-dione | ESD-918628-5G |
| Cas.: 91893-72-0 | Purity: 95% | Potassium 2-(1,3-dioxoisoindolin-2-yl)ethanesulfonate | ESD-918629-250MG |
| Cas.: 91893-72-0 | Purity: 95% | Potassium 2-(1,3-dioxoisoindolin-2-yl)ethanesulfonate | ESD-918629-1G |
| Cas.: 91893-72-0 | Purity: 95% | Potassium 2-(1,3-dioxoisoindolin-2-yl)ethanesulfonate | ESD-918629-5G |
| Cas.: 18791-79-2 | Purity: 95% | 5-Bromothiophene-3-carbaldehyde | ESD-918630-250MG |
| Cas.: 18791-79-2 | Purity: 95% | 5-Bromothiophene-3-carbaldehyde | ESD-918630-1G |
| Cas.: 18791-79-2 | Purity: 95% | 5-Bromothiophene-3-carbaldehyde | ESD-918630-5G |
| Cas.: 13398-94-2 | Purity: 99% | 2-(3-Hydroxyphenyl)ethanol | ESD-918631-250MG |
| Cas.: 13398-94-2 | Purity: 99% | 2-(3-Hydroxyphenyl)ethanol | ESD-918631-1G |
| Cas.: 13398-94-2 | Purity: 99% | 2-(3-Hydroxyphenyl)ethanol | ESD-918631-5G |
| Cas.: 100516-98-1 | Purity: 97% | 4-Methylthiazole-2-carbonitrile | ESD-918632-250MG |
| Cas.: 100516-98-1 | Purity: 97% | 4-Methylthiazole-2-carbonitrile | ESD-918632-1G |
| Cas.: 100516-98-1 | Purity: 97% | 4-Methylthiazole-2-carbonitrile | ESD-918632-5G |
| Cas.: 50866-56-3 | Purity: 97% | 1-Benzylpiperidine-3,5-dione | ESD-918633-250MG |
| Cas.: 50866-56-3 | Purity: 97% | 1-Benzylpiperidine-3,5-dione | ESD-918633-1G |
| Cas.: 50866-56-3 | Purity: 97% | 1-Benzylpiperidine-3,5-dione | ESD-918633-5G |
| Cas.: 540475-45-4 | Purity: 97% | 1,1-Bis((2R,5R)-2,5-dimethylphospholano)ferrocene | ESD-918634-250MG |
| Cas.: 540475-45-4 | Purity: 97% | 1,1-Bis((2R,5R)-2,5-dimethylphospholano)ferrocene | ESD-918634-1G |
| Cas.: 540475-45-4 | Purity: 97% | 1,1-Bis((2R,5R)-2,5-dimethylphospholano)ferrocene | ESD-918634-5G |
| Cas.: 946607-10-9 | Purity: 97% | 1,3-Di-t-butylbenzimidazolium chloride | ESD-918635-250MG |
| Cas.: 946607-10-9 | Purity: 97% | 1,3-Di-t-butylbenzimidazolium chloride | ESD-918635-1G |
| Cas.: 946607-10-9 | Purity: 97% | 1,3-Di-t-butylbenzimidazolium chloride | ESD-918635-5G |
| Cas.: 1025718-91-5 | Purity: 95% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-918636-250MG |
| Cas.: 1025718-91-5 | Purity: 95% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-918636-1G |
| Cas.: 1025718-91-5 | Purity: 95% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-918636-5G |
| Cas.: 56741-34-5 | Purity: 98% | Methyl 5-amino-2-fluorobenzoate | ESD-918637-250MG |
| Cas.: 56741-34-5 | Purity: 98% | Methyl 5-amino-2-fluorobenzoate | ESD-918637-1G |
| Cas.: 56741-34-5 | Purity: 98% | Methyl 5-amino-2-fluorobenzoate | ESD-918637-5G |
| Cas.: 162412-87-5 | Purity: 97% | 1,1-Bis((2S,5S)-2,5-dimethylphospholano)ferrocene | ESD-918638-250MG |
| Cas.: 162412-87-5 | Purity: 97% | 1,1-Bis((2S,5S)-2,5-dimethylphospholano)ferrocene | ESD-918638-1G |
| Cas.: 162412-87-5 | Purity: 97% | 1,1-Bis((2S,5S)-2,5-dimethylphospholano)ferrocene | ESD-918638-5G |
| Cas.: 695816-47-8 | Purity: 98% | (2S,5S)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918639-250MG |
| Cas.: 695816-47-8 | Purity: 98% | (2S,5S)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918639-1G |
| Cas.: 695816-47-8 | Purity: 98% | (2S,5S)-1-(2-(1,3-dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918639-5G |
| Cas.: 1314246-02-0 | Purity: 98% | (2S,5S)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-918640-250MG |
| Cas.: 1314246-02-0 | Purity: 98% | (2S,5S)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-918640-1G |
| Cas.: 1314246-02-0 | Purity: 98% | (2S,5S)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-diethylphospholane | ESD-918640-5G |
| Cas.: 13321-73-8 | Purity: 95% | 2-bromo-1,5-dimethoxy-3-methylbenzene | ESD-918641-250MG |
| Cas.: 13321-73-8 | Purity: 95% | 2-bromo-1,5-dimethoxy-3-methylbenzene | ESD-918641-1G |
| Cas.: 13321-73-8 | Purity: 95% | 2-bromo-1,5-dimethoxy-3-methylbenzene | ESD-918641-5G |
| Cas.: 147762-89-8 | Purity: 98% | 1,1′-Bis[(2R,5R)-2,5-diethylphospholano]ferrocene | ESD-918642-250MG |
| Cas.: 147762-89-8 | Purity: 98% | 1,1′-Bis[(2R,5R)-2,5-diethylphospholano]ferrocene | ESD-918642-1G |
| Cas.: 147762-89-8 | Purity: 98% | 1,1′-Bis[(2R,5R)-2,5-diethylphospholano]ferrocene | ESD-918642-5G |
| Cas.: 436863-50-2 | Purity: 98% | 1,1-Bis[(2S,5S)-2,5-diethylphospholano]ferrocene | ESD-918643-250MG |
| Cas.: 436863-50-2 | Purity: 98% | 1,1-Bis[(2S,5S)-2,5-diethylphospholano]ferrocene | ESD-918643-1G |
| Cas.: 436863-50-2 | Purity: 98% | 1,1-Bis[(2S,5S)-2,5-diethylphospholano]ferrocene | ESD-918643-5G |
| Cas.: 950603-39-1 | Purity: 98% | 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)morpholine | ESD-918644-250MG |
| Cas.: 950603-39-1 | Purity: 98% | 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)morpholine | ESD-918644-1G |
| Cas.: 950603-39-1 | Purity: 98% | 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)morpholine | ESD-918644-5G |
| Cas.: 638132-66-8 | Purity: 98%, 99%ee | [1-(2R,5R)-2,5-dimethylphospholanyl]-[2-(2R,5R)-2,5-dimethylphospholanyl-1-oxide]benzene | ESD-918645-250MG |
| Cas.: 638132-66-8 | Purity: 98%, 99%ee | [1-(2R,5R)-2,5-dimethylphospholanyl]-[2-(2R,5R)-2,5-dimethylphospholanyl-1-oxide]benzene | ESD-918645-1G |
| Cas.: 638132-66-8 | Purity: 98%, 99%ee | [1-(2R,5R)-2,5-dimethylphospholanyl]-[2-(2R,5R)-2,5-dimethylphospholanyl-1-oxide]benzene | ESD-918645-5G |
| Cas.: 75712-74-2 | Purity: 95% | 4-Chloro-2,5-dimethylpyrimidine | ESD-918646-250MG |
| Cas.: 75712-74-2 | Purity: 95% | 4-Chloro-2,5-dimethylpyrimidine | ESD-918646-1G |
| Cas.: 75712-74-2 | Purity: 95% | 4-Chloro-2,5-dimethylpyrimidine | ESD-918646-5G |
| Cas.: 862893-81-0 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium chloride | ESD-918647-250MG |
| Cas.: 862893-81-0 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium chloride | ESD-918647-1G |
| Cas.: 862893-81-0 | Purity: 97% | 2-Mesiyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium chloride | ESD-918647-5G |
| Cas.: 82121-08-2 | Purity: 97% | 7-Methylquinolin-4-ol | ESD-918648-250MG |
| Cas.: 82121-08-2 | Purity: 97% | 7-Methylquinolin-4-ol | ESD-918648-1G |
| Cas.: 82121-08-2 | Purity: 97% | 7-Methylquinolin-4-ol | ESD-918648-5G |
| Cas.: 72418-40-7 | Purity: 95% | 3-Phenylisoxazole-5-carbaldehyde | ESD-918649-250MG |
| Cas.: 72418-40-7 | Purity: 95% | 3-Phenylisoxazole-5-carbaldehyde | ESD-918649-1G |
| Cas.: 72418-40-7 | Purity: 95% | 3-Phenylisoxazole-5-carbaldehyde | ESD-918649-5G |
| Cas.: 161942-89-8 | Purity: 97% | 2-(4-Bromothiophen-2-yl)acetic acid | ESD-918650-250MG |
| Cas.: 161942-89-8 | Purity: 97% | 2-(4-Bromothiophen-2-yl)acetic acid | ESD-918650-1G |
| Cas.: 161942-89-8 | Purity: 97% | 2-(4-Bromothiophen-2-yl)acetic acid | ESD-918650-5G |
| Cas.: 1044256-04-3 | Purity: 97%, 99%ee | (2R,5R)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918651-250MG |
| Cas.: 1044256-04-3 | Purity: 97%, 99%ee | (2R,5R)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918651-1G |
| Cas.: 1044256-04-3 | Purity: 97%, 99%ee | (2R,5R)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-dimethylphospholane | ESD-918651-5G |
| Cas.: 69611-01-4 | Purity: 95% | (Z)-2-(But-2-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918652-250MG |
| Cas.: 69611-01-4 | Purity: 95% | (Z)-2-(But-2-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918652-1G |
| Cas.: 69611-01-4 | Purity: 95% | (Z)-2-(But-2-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918652-5G |
| Cas.: 16357-83-8 | Purity: 95% | 4-Aminopyrimidine-5-carbaldehyde | ESD-918653-250MG |
| Cas.: 16357-83-8 | Purity: 95% | 4-Aminopyrimidine-5-carbaldehyde | ESD-918653-1G |
| Cas.: 16357-83-8 | Purity: 95% | 4-Aminopyrimidine-5-carbaldehyde | ESD-918653-5G |
| Cas.: 944580-98-7 | Purity: 95% | 8-Trifluoromethyl-Imidazo[1,2-A]Pyridine | ESD-918654-250MG |
| Cas.: 944580-98-7 | Purity: 95% | 8-Trifluoromethyl-Imidazo[1,2-A]Pyridine | ESD-918654-1G |
| Cas.: 944580-98-7 | Purity: 95% | 8-Trifluoromethyl-Imidazo[1,2-A]Pyridine | ESD-918654-5G |
| Cas.: 5411-61-0 | Purity: 95% | 4-Bromo-7-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918655-250MG |
| Cas.: 5411-61-0 | Purity: 95% | 4-Bromo-7-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918655-1G |
| Cas.: 5411-61-0 | Purity: 95% | 4-Bromo-7-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918655-5G |
| Cas.: 886747-03-1 | Purity: 95% | Pent-4-en-1-ylboronic acid | ESD-918656-250MG |
| Cas.: 886747-03-1 | Purity: 95% | Pent-4-en-1-ylboronic acid | ESD-918656-1G |
| Cas.: 886747-03-1 | Purity: 95% | Pent-4-en-1-ylboronic acid | ESD-918656-5G |
| Cas.: 124215-44-7 | Purity: 98% | 2-(3-Bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918657-250MG |
| Cas.: 124215-44-7 | Purity: 98% | 2-(3-Bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918657-1G |
| Cas.: 1040681-74-0 | Purity: 97% | 2-Fluoro-4-(trifluoromethyl)nicotinic acid | ESD-918658-250MG |
| Cas.: 1040681-74-0 | Purity: 97% | 2-Fluoro-4-(trifluoromethyl)nicotinic acid | ESD-918658-1G |
| Cas.: 1040681-74-0 | Purity: 97% | 2-Fluoro-4-(trifluoromethyl)nicotinic acid | ESD-918658-5G |
| Cas.: 1097192-04-5 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-azidopentanoic acid | ESD-918659-250MG |
| Cas.: 1097192-04-5 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-azidopentanoic acid | ESD-918659-1G |
| Cas.: 1097192-04-5 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-azidopentanoic acid | ESD-918659-5G |
| Cas.: 16657-10-6 | Purity: 95% | 4-Bromo-2,3-dihydro-1H-inden-1-ol | ESD-918660-250MG |
| Cas.: 16657-10-6 | Purity: 95% | 4-Bromo-2,3-dihydro-1H-inden-1-ol | ESD-918660-1G |
| Cas.: 16657-10-6 | Purity: 95% | 4-Bromo-2,3-dihydro-1H-inden-1-ol | ESD-918660-5G |
| Cas.: 910251-10-4 | Purity: 98% | Potassium (tert-butoxymethyl)trifluoroborate | ESD-918661-250MG |
| Cas.: 910251-10-4 | Purity: 98% | Potassium (tert-butoxymethyl)trifluoroborate | ESD-918661-1G |
| Cas.: 910251-10-4 | Purity: 98% | Potassium (tert-butoxymethyl)trifluoroborate | ESD-918661-5G |
| Cas.: 923977-18-8 | Purity: 95% | 5,7-Dibromo-1-indanone | ESD-918662-250MG |
| Cas.: 923977-18-8 | Purity: 95% | 5,7-Dibromo-1-indanone | ESD-918662-1G |
| Cas.: 923977-18-8 | Purity: 95% | 5,7-Dibromo-1-indanone | ESD-918662-5G |
| Cas.: 603122-79-8 | Purity: 97% | 2-Fluoro-4-(methoxycarbonyl)phenylboronic acid pinacol ester | ESD-918663-250MG |
| Cas.: 603122-79-8 | Purity: 97% | 2-Fluoro-4-(methoxycarbonyl)phenylboronic acid pinacol ester | ESD-918663-1G |
| Cas.: 603122-79-8 | Purity: 97% | 2-Fluoro-4-(methoxycarbonyl)phenylboronic acid pinacol ester | ESD-918663-5G |
| Cas.: 1171919-75-7 | Purity: 98% | 2-Chloro-4-iodonicotinonitrile | ESD-918664-250MG |
| Cas.: 1171919-75-7 | Purity: 98% | 2-Chloro-4-iodonicotinonitrile | ESD-918664-1G |
| Cas.: 1171919-75-7 | Purity: 98% | 2-Chloro-4-iodonicotinonitrile | ESD-918664-5G |
| Cas.: 1309980-11-7 | Purity: 98% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol | ESD-918665-250MG |
| Cas.: 1309980-11-7 | Purity: 98% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol | ESD-918665-1G |
| Cas.: 1309980-11-7 | Purity: 98% | 2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol | ESD-918665-5G |
| Cas.: 1239880-00-2 | Purity: 97% | 6-Bromoimidazo[1,5-a]pyridine | ESD-918666-250MG |
| Cas.: 1239880-00-2 | Purity: 97% | 6-Bromoimidazo[1,5-a]pyridine | ESD-918666-1G |
| Cas.: 1239880-00-2 | Purity: 97% | 6-Bromoimidazo[1,5-a]pyridine | ESD-918666-5G |
| Cas.: 127090-71-5 | Purity: 98% | 2,2′-(Propane-2,2-diylbis(oxy))diethanamine | ESD-918667-250MG |
| Cas.: 127090-71-5 | Purity: 98% | 2,2′-(Propane-2,2-diylbis(oxy))diethanamine | ESD-918667-1G |
| Cas.: 127090-71-5 | Purity: 98% | 2,2′-(Propane-2,2-diylbis(oxy))diethanamine | ESD-918667-5G |
| Cas.: 865186-62-5 | Purity: 95% | 2-Bromo-4-fluoro-5-methoxybenzaldehyde | ESD-918668-250MG |
| Cas.: 865186-62-5 | Purity: 95% | 2-Bromo-4-fluoro-5-methoxybenzaldehyde | ESD-918668-1G |
| Cas.: 865186-62-5 | Purity: 95% | 2-Bromo-4-fluoro-5-methoxybenzaldehyde | ESD-918668-5G |
| Cas.: 32717-95-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)copper(I) dimer | ESD-918669-250MG |
| Cas.: 32717-95-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)copper(I) dimer | ESD-918669-1G |
| Cas.: 32717-95-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)copper(I) dimer | ESD-918669-5G |
| Cas.: 51717-23-8 | Purity: 97% | Iodo(triethyl phosphite)copper(I) | ESD-918670-50G |
| Cas.: 51717-23-8 | Purity: 97% | Iodo(triethyl phosphite)copper(I) | ESD-918670-1G |
| Cas.: 51717-23-8 | Purity: 97% | Iodo(triethyl phosphite)copper(I) | ESD-918670-5G |
| Cas.: 74341-63-2 | (RS)-AMPA | ESD-918671-10MG | |
| Cas.: 74341-63-2 | (RS)-AMPA | ESD-918671-1MG | |
| Cas.: 74341-63-2 | (RS)-AMPA | ESD-918671-5MG | |
| Cas.: 171867-34-8 | Purity: 97% | (S)-Bis((S)-1-(naphthalen-1-yl)ethyl)amine hydrochloride | ESD-918672-50MG |
| Cas.: 171867-34-8 | Purity: 97% | (S)-Bis((S)-1-(naphthalen-1-yl)ethyl)amine hydrochloride | ESD-918672-100MG |
| Cas.: 171867-34-8 | Purity: 97% | (S)-Bis((S)-1-(naphthalen-1-yl)ethyl)amine hydrochloride | ESD-918672-250MG |
| Cas.: 2260543-73-3 | Purity: 97% | 2,4,6-Tris(diphenylamino)-5-fluoroisophthalonitrile | ESD-918673-50MG |
| Cas.: 2260543-73-3 | Purity: 97% | 2,4,6-Tris(diphenylamino)-5-fluoroisophthalonitrile | ESD-918673-100MG |
| Cas.: 2260543-73-3 | Purity: 97% | 2,4,6-Tris(diphenylamino)-5-fluoroisophthalonitrile | ESD-918673-250MG |
| Cas.: 1311386-93-2 | Purity: 98% | Ir[pF(t-Bu)-ppy]3 | ESD-918674-50MG |
| Cas.: 1311386-93-2 | Purity: 98% | Ir[pF(t-Bu)-ppy]3 | ESD-918674-100MG |
| Cas.: 1311386-93-2 | Purity: 98% | Ir[pF(t-Bu)-ppy]3 | ESD-918674-250MG |
| Cas.: 1221746-56-0 | Purity: 98% | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[(R)-phenylphosphinoyl]ferrocene | ESD-918675-50MG |
| Cas.: 1221746-56-0 | Purity: 98% | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[(R)-phenylphosphinoyl]ferrocene | ESD-918675-100MG |
| Cas.: 1221746-56-0 | Purity: 98% | (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[(R)-phenylphosphinoyl]ferrocene | ESD-918675-250MG |
| Cas.: 1221746-66-2 | Purity: 98% | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[(S)-phenylphosphinoyl]ferrocene | ESD-918676-50MG |
| Cas.: 1221746-66-2 | Purity: 98% | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[(S)-phenylphosphinoyl]ferrocene | ESD-918676-100MG |
| Cas.: 1221746-66-2 | Purity: 98% | (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[(S)-phenylphosphinoyl]ferrocene | ESD-918676-250MG |
| Cas.: 163169-15-1 | Purity: 97% | (S,Sp)-tBu-Phosferrox | ESD-918677-50MG |
| Cas.: 163169-15-1 | Purity: 97% | (S,Sp)-tBu-Phosferrox | ESD-918677-100MG |
| Cas.: 163169-15-1 | Purity: 97% | (S,Sp)-tBu-Phosferrox | ESD-918677-250MG |
| Cas.: 1276121-88-0 | Purity: 99% | (R)-10-Methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno [3,2-f]quinolin-8-one | ESD-918678-50MG |
| Cas.: 1276121-88-0 | Purity: 99% | (R)-10-Methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno [3,2-f]quinolin-8-one | ESD-918678-100MG |
| Cas.: 1276121-88-0 | Purity: 99% | (R)-10-Methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5′,6′:4,5]thieno [3,2-f]quinolin-8-one | ESD-918678-250MG |
| Cas.: 1167575-20-3 | Purity: 95% | Azido-PEG12-acid | ESD-918679-25MG |
| Cas.: 1167575-20-3 | Purity: 95% | Azido-PEG12-acid | ESD-918679-100MG |
| Cas.: 1167575-20-3 | Purity: 95% | Azido-PEG12-acid | ESD-918679-250MG |
| Cas.: 54322-38-2 | Purity: 95% | 4-Methyl-7-[(2S,3S,4R,5S,6S)-3,4,5-Trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-2-one | ESD-918680-500MG |
| Cas.: 54322-38-2 | Purity: 95% | 4-Methyl-7-[(2S,3S,4R,5S,6S)-3,4,5-Trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-2-one | ESD-918680-1G |
| Cas.: 54322-38-2 | Purity: 95% | 4-Methyl-7-[(2S,3S,4R,5S,6S)-3,4,5-Trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-2-one | ESD-918680-250MG |
| Cas.: 40290-32-2 | Purity: ≥99% | 1,2-DIPALMITOYL-RAC-GLYCEROL | ESD-918681-100MG |
| Cas.: 40290-32-2 | Purity: ≥99% | 1,2-DIPALMITOYL-RAC-GLYCEROL | ESD-918681-1G |
| Cas.: 40290-32-2 | Purity: ≥99% | 1,2-DIPALMITOYL-RAC-GLYCEROL | ESD-918681-250MG |
| Cas.: 543-38-4 | Purity: ≥98% (TLC) | L-Canavanine | ESD-918682-100MG |
| Cas.: 543-38-4 | Purity: ≥98% (TLC) | L-Canavanine | ESD-918682-250MG |
| Cas.: 150971-45-2 | Purity: 98% | (R)-(+)-2,2′-Bis(di-i-propylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918683-50MG |
| Cas.: 150971-45-2 | Purity: 98% | (R)-(+)-2,2′-Bis(di-i-propylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918683-100MG |
| Cas.: 150971-45-2 | Purity: 98% | (R)-(+)-2,2′-Bis(di-i-propylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918683-250MG |
| Cas.: 19824-55-6 | Purity: 99%, 99.99%-Hf, <0.2% | Tetrakis(diethylamino)hafnium | ESD-918684-1G |
| Cas.: 19824-55-6 | Purity: 99%, 99.99%-Hf, <0.2% | Tetrakis(diethylamino)hafnium | ESD-918684-5G |
| Cas.: 19824-55-6 | Purity: 99%, 99.99%-Hf, <0.2% | Tetrakis(diethylamino)hafnium | ESD-918684-25G |
| Cas.: 222970-61-8 | Purity: 95% | Methyl 6-hydroxy-5-nitronicotinate | ESD-918685-1G |
| Cas.: 222970-61-8 | Purity: 95% | Methyl 6-hydroxy-5-nitronicotinate | ESD-918685-5G |
| Cas.: 222970-61-8 | Purity: 95% | Methyl 6-hydroxy-5-nitronicotinate | ESD-918685-25G |
| Cas.: 36809-75-3 | Purity: 99.99%-Sn | TIN(IV) TERT-BUTOXIDE | ESD-918686-1G |
| Cas.: 36809-75-3 | Purity: 99.99%-Sn | TIN(IV) TERT-BUTOXIDE | ESD-918686-5G |
| Cas.: 36809-75-3 | Purity: 99.99%-Sn | TIN(IV) TERT-BUTOXIDE | ESD-918686-25G |
| Cas.: 2155-74-0 | Purity: 99% | Antimony(III) n-butoxide | ESD-918687-1G |
| Cas.: 2155-74-0 | Purity: 99% | Antimony(III) n-butoxide | ESD-918687-5G |
| Cas.: 2155-74-0 | Purity: 99% | Antimony(III) n-butoxide | ESD-918687-25G |
| Cas.: 1129-37-9 | Purity: 97% | 4-Nitrobenzaldehyde oxime | ESD-918688-1G |
| Cas.: 1129-37-9 | Purity: 97% | 4-Nitrobenzaldehyde oxime | ESD-918688-5G |
| Cas.: 1129-37-9 | Purity: 97% | 4-Nitrobenzaldehyde oxime | ESD-918688-25G |
| Cas.: 16156-58-4 | Purity: 98% | Propargyl methanesulfonate ester | ESD-918689-1G |
| Cas.: 16156-58-4 | Purity: 98% | Propargyl methanesulfonate ester | ESD-918689-5G |
| Cas.: 16156-58-4 | Purity: 98% | Propargyl methanesulfonate ester | ESD-918689-25G |
| Cas.: 18420-41-2 | Purity: 99% | 2-(Chloromethyl)tetrahydro-2H-pyran | ESD-918690-1G |
| Cas.: 18420-41-2 | Purity: 99% | 2-(Chloromethyl)tetrahydro-2H-pyran | ESD-918690-5G |
| Cas.: 7221-40-1 | Purity: 98% | N-Benzyl-2-hydroxy-N,N-dimethylethanaminium chloride | ESD-918691-1G |
| Cas.: 7221-40-1 | Purity: 98% | N-Benzyl-2-hydroxy-N,N-dimethylethanaminium chloride | ESD-918691-5G |
| Cas.: 7221-40-1 | Purity: 98% | N-Benzyl-2-hydroxy-N,N-dimethylethanaminium chloride | ESD-918691-25G |
| Cas.: 173436-66-3 | Purity: ≥98% | Methyl 3-(4-methylbenzenesulfonamido)benzoate | ESD-918692-1MG |
| Cas.: 173436-66-3 | Purity: ≥98% | Methyl 3-(4-methylbenzenesulfonamido)benzoate | ESD-918692-5MG |
| Cas.: 173436-66-3 | Purity: ≥98% | Methyl 3-(4-methylbenzenesulfonamido)benzoate | ESD-918692-25MG |
| Cas.: 6701-13-9 | Purity: 97% | Decane-1,10-diylbis(2-methylacrylate) | ESD-918693-1G |
| Cas.: 6701-13-9 | Purity: 97% | Decane-1,10-diylbis(2-methylacrylate) | ESD-918693-5G |
| Cas.: 6701-13-9 | Purity: 97% | Decane-1,10-diylbis(2-methylacrylate) | ESD-918693-25G |
| Cas.: 23250-03-5 | Purity: ≥95% | (2-Hydroxyethyl)triphenylphosphonium chloride | ESD-918694-1G |
| Cas.: 23250-03-5 | Purity: ≥95% | (2-Hydroxyethyl)triphenylphosphonium chloride | ESD-918694-5G |
| Cas.: 23250-03-5 | Purity: ≥95% | (2-Hydroxyethyl)triphenylphosphonium chloride | ESD-918694-25G |
| Cas.: 65408-67-5 | Purity: Terminated ester, Lactide: Caprolactone 70:30 | Poly(L-lactide-co-ε-caprolactone) | ESD-918695-1G |
| Cas.: 65408-67-5 | Purity: Terminated ester, Lactide: Caprolactone 70:30 | Poly(L-lactide-co-ε-caprolactone) | ESD-918695-5G |
| Cas.: 65408-67-5 | Purity: Terminated ester, Lactide: Caprolactone 70:30 | Poly(L-lactide-co-ε-caprolactone) | ESD-918695-25G |
| Cas.: 947-73-9 | Purity: 97% | Phenanthren-9-amine | ESD-918696-1G |
| Cas.: 947-73-9 | Purity: 97% | Phenanthren-9-amine | ESD-918696-5G |
| Cas.: 57382-97-5 | Purity: 95% | Ethyl 2-(thiophen-2-yl)acetate | ESD-918697-1G |
| Cas.: 57382-97-5 | Purity: 95% | Ethyl 2-(thiophen-2-yl)acetate | ESD-918697-5G |
| Cas.: 57382-97-5 | Purity: 95% | Ethyl 2-(thiophen-2-yl)acetate | ESD-918697-25G |
| Cas.: 2169-69-9 | Purity: 95% | (E)-Ethyl 2-cyano-3-phenylacrylate | ESD-918698-1G |
| Cas.: 2169-69-9 | Purity: 95% | (E)-Ethyl 2-cyano-3-phenylacrylate | ESD-918698-5G |
| Cas.: 2169-69-9 | Purity: 95% | (E)-Ethyl 2-cyano-3-phenylacrylate | ESD-918698-25G |
| Cas.: 62437-99-4 | Purity: 95% | 2-Hydrazinylpyridine dihydrochloride | ESD-918699-1G |
| Cas.: 62437-99-4 | Purity: 95% | 2-Hydrazinylpyridine dihydrochloride | ESD-918699-5G |
| Cas.: 62437-99-4 | Purity: 95% | 2-Hydrazinylpyridine dihydrochloride | ESD-918699-25G |
| Cas.: 10357-84-3 | Purity: 95% | 2,6-Dihydroxypyridine Hydrochloride | ESD-918700-1G |
| Cas.: 10357-84-3 | Purity: 95% | 2,6-Dihydroxypyridine Hydrochloride | ESD-918700-5G |
| Cas.: 10357-84-3 | Purity: 95% | 2,6-Dihydroxypyridine Hydrochloride | ESD-918700-25G |
| Cas.: 25784-83-2 | Purity: 97% | (4-Chlorophenylthio)acetone | ESD-918701-1G |
| Cas.: 25784-83-2 | Purity: 97% | (4-Chlorophenylthio)acetone | ESD-918701-5G |
| Cas.: 25784-83-2 | Purity: 97% | (4-Chlorophenylthio)acetone | ESD-918701-25G |
| Cas.: 3349-63-1 | Purity: 98% | 2-Indanoneoxime | ESD-918702-1G |
| Cas.: 3349-63-1 | Purity: 98% | 2-Indanoneoxime | ESD-918702-5G |
| Cas.: 3349-63-1 | Purity: 98% | 2-Indanoneoxime | ESD-918702-25G |
| Cas.: 16365-27-8 | Purity: 95% | 2-(4-Nitrophenoxy)ethanol | ESD-918703-1G |
| Cas.: 16365-27-8 | Purity: 95% | 2-(4-Nitrophenoxy)ethanol | ESD-918703-5G |
| Cas.: 16365-27-8 | Purity: 95% | 2-(4-Nitrophenoxy)ethanol | ESD-918703-25G |
| Cas.: 621-88-5 | Purity: 95% | 2-Phenoxyacetamide | ESD-918704-1G |
| Cas.: 621-88-5 | Purity: 95% | 2-Phenoxyacetamide | ESD-918704-5G |
| Cas.: 621-88-5 | Purity: 95% | 2-Phenoxyacetamide | ESD-918704-25G |
| Cas.: 14284-06-1 | Purity: 98% | Copper(II) ethylacetoacetate | ESD-918705-1G |
| Cas.: 14284-06-1 | Purity: 98% | Copper(II) ethylacetoacetate | ESD-918705-5G |
| Cas.: 14284-06-1 | Purity: 98% | Copper(II) ethylacetoacetate | ESD-918705-25G |
| Cas.: 520-03-6 | Purity: 95% | 2-Phenylisoindole-1,3-dione | ESD-918706-1G |
| Cas.: 520-03-6 | Purity: 95% | 2-Phenylisoindole-1,3-dione | ESD-918706-5G |
| Cas.: 520-03-6 | Purity: 95% | 2-Phenylisoindole-1,3-dione | ESD-918706-25G |
| Cas.: 2531-80-8 | Purity: 96% | Ethyl 2-nitropropionate | ESD-918707-1G |
| Cas.: 2531-80-8 | Purity: 96% | Ethyl 2-nitropropionate | ESD-918707-5G |
| Cas.: 2531-80-8 | Purity: 96% | Ethyl 2-nitropropionate | ESD-918707-25G |
| Cas.: 42877-08-7 | Purity: 97% | 2-Acetyl-3-bromothiophene | ESD-918708-1G |
| Cas.: 42877-08-7 | Purity: 97% | 2-Acetyl-3-bromothiophene | ESD-918708-5G |
| Cas.: 42877-08-7 | Purity: 97% | 2-Acetyl-3-bromothiophene | ESD-918708-25G |
| Cas.: 4284-50-8 | Purity: 97% | N-(4-Bromophenyl)methanesulfonamide | ESD-918709-1G |
| Cas.: 4284-50-8 | Purity: 97% | N-(4-Bromophenyl)methanesulfonamide | ESD-918709-5G |
| Cas.: 4284-50-8 | Purity: 97% | N-(4-Bromophenyl)methanesulfonamide | ESD-918709-25G |
| Cas.: 936827-87-1 | Purity: ≥90.0% (HPLC) | 3′-Phosphoadenosine 5′-phosphosulfate triethylammmnonium salt | ESD-918710-1MG |
| Cas.: 211374-81-1 | Purity: 98% | 4-Amino-2-chlorobenzamide | ESD-918711-1G |
| Cas.: 211374-81-1 | Purity: 98% | 4-Amino-2-chlorobenzamide | ESD-918711-5G |
| Cas.: 211374-81-1 | Purity: 98% | 4-Amino-2-chlorobenzamide | ESD-918711-25G |
| Cas.: 1515-88-4 | Purity: 97% | 1-Bromo-4-(methoxymethyl)benzene | ESD-918712-1G |
| Cas.: 1515-88-4 | Purity: 97% | 1-Bromo-4-(methoxymethyl)benzene | ESD-918712-5G |
| Cas.: 1515-88-4 | Purity: 97% | 1-Bromo-4-(methoxymethyl)benzene | ESD-918712-25G |
| Cas.: 622864-54-4 | Purity: 98% | PD 407824 | ESD-918713-1MG |
| Cas.: 622864-54-4 | Purity: 98% | PD 407824 | ESD-918713-5MG |
| Cas.: 622864-54-4 | Purity: 98% | PD 407824 | ESD-918713-25MG |
| Cas.: 23670-45-3 | Purity: 98% | Copper(II) tert-butylacetoacetate | ESD-918714-1G |
| Cas.: 23670-45-3 | Purity: 98% | Copper(II) tert-butylacetoacetate | ESD-918714-5G |
| Cas.: 23670-45-3 | Purity: 98% | Copper(II) tert-butylacetoacetate | ESD-918714-25G |
| Cas.: 1082951-62-9 | Purity: 95% | HDMC | ESD-918715-1G |
| Cas.: 1082951-62-9 | Purity: 95% | HDMC | ESD-918715-5G |
| Cas.: 1082951-62-9 | Purity: 95% | HDMC | ESD-918715-25G |
| Cas.: 135531-86-1 | Purity: 98% | 3-(1,3-Thiazol-2-yl)-1H-indole | ESD-918716-1MG |
| Cas.: 135531-86-1 | Purity: 98% | 3-(1,3-Thiazol-2-yl)-1H-indole | ESD-918716-5MG |
| Cas.: 135531-86-1 | Purity: 98% | 3-(1,3-Thiazol-2-yl)-1H-indole | ESD-918716-25MG |
| Cas.: 99438-28-5 | Purity: 95% | (+)-B-Methoxydiisopinocampheylborane | ESD-918717-1G |
| Cas.: 99438-28-5 | Purity: 95% | (+)-B-Methoxydiisopinocampheylborane | ESD-918717-5G |
| Cas.: 99438-28-5 | Purity: 95% | (+)-B-Methoxydiisopinocampheylborane | ESD-918717-25G |
| Cas.: 402-40-4 | 1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide | ESD-918718-100MG | |
| Cas.: 402-40-4 | 1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide | ESD-918718-250MG | |
| Cas.: 402-40-4 | 1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide | ESD-918718-25MG | |
| Cas.: 5266-48-8 | Nα-p-Tosyl-L-lysine methyl ester hydrochloride | ESD-918719-1G | |
| Cas.: 5266-48-8 | Nα-p-Tosyl-L-lysine methyl ester hydrochloride | ESD-918719-250MG | |
| Cas.: 5266-48-8 | Nα-p-Tosyl-L-lysine methyl ester hydrochloride | ESD-918719-25MG | |
| Cas.: 206752-33-2 | Purity: 98% | Baicalin hydrate | ESD-918720-100MG |
| Cas.: 206752-33-2 | Purity: 98% | Baicalin hydrate | ESD-918720-2.5G |
| Cas.: 206752-33-2 | Purity: 98% | Baicalin hydrate | ESD-918720-25MG |
| Cas.: 42203-78-1 | (±)-DOI hydrochloride | ESD-918721-10MG | |
| Cas.: 42203-78-1 | (±)-DOI hydrochloride | ESD-918721-25MG | |
| Cas.: 37739-05-2 | 2-Chloro-N6-cyclopentyladenosine 2-Chloro-N6-cyclopentyladenosine | ESD-918722-100MG | |
| Cas.: 37739-05-2 | 2-Chloro-N6-cyclopentyladenosine 2-Chloro-N6-cyclopentyladenosine | ESD-918722-10MG | |
| Cas.: 37739-05-2 | 2-Chloro-N6-cyclopentyladenosine 2-Chloro-N6-cyclopentyladenosine | ESD-918722-25MG | |
| Cas.: 14114-46-6 | Purity: ≥98% (HPLC) | 3,7-Dimethyl-1-(2-propynyl)xanthine | ESD-918723-100MG |
| Cas.: 14114-46-6 | Purity: ≥98% (HPLC) | 3,7-Dimethyl-1-(2-propynyl)xanthine | ESD-918723-10MG |
| Cas.: 14114-46-6 | Purity: ≥98% (HPLC) | 3,7-Dimethyl-1-(2-propynyl)xanthine | ESD-918723-25MG |
| Cas.: 5980-33-6 | Purity: ≥98% (HPLC) | 4-METHYLUMBELLIFERONE SODIUM SALT | ESD-918724-10G |
| Cas.: 4419-47-0 | Purity: 99.999% trace metals basis | Tetrakis (diethylamido) titanium (IV) | ESD-918725-5G |
| Cas.: 4419-47-0 | Purity: 99.999% trace metals basis | Tetrakis (diethylamido) titanium (IV) | ESD-918725-10G |
| Cas.: 4419-47-0 | Purity: 99.999% trace metals basis | Tetrakis (diethylamido) titanium (IV) | ESD-918725-25G |
| Cas.: 155877-83-1 | Purity: ≥98% | LE 135 | ESD-918726-5MG |
| Cas.: 155877-83-1 | Purity: ≥98% | LE 135 | ESD-918726-10MG |
| Cas.: 155877-83-1 | Purity: ≥98% | LE 135 | ESD-918726-25MG |
| Cas.: 2277-19-2 | Purity: 95% | cis-6-Nonenal | ESD-918727-2G |
| Cas.: 2277-19-2 | Purity: 95% | cis-6-Nonenal | ESD-918727-10G |
| Cas.: 2277-19-2 | Purity: 95% | cis-6-Nonenal | ESD-918727-25G |
| Cas.: 294646-77-8 | Purity: 99% | (R)-2-((9-Isopropyl-6-((4-(pyridin-2-yl)benzyl)amino)-9H-purin-2-yl)amino)butan-1-ol | ESD-918728-1MG |
| Cas.: 294646-77-8 | Purity: 99% | (R)-2-((9-Isopropyl-6-((4-(pyridin-2-yl)benzyl)amino)-9H-purin-2-yl)amino)butan-1-ol | ESD-918728-10MG |
| Cas.: 294646-77-8 | Purity: 99% | (R)-2-((9-Isopropyl-6-((4-(pyridin-2-yl)benzyl)amino)-9H-purin-2-yl)amino)butan-1-ol | ESD-918728-25MG |
| Cas.: 50912-92-0 | Purity: 95% | HD-ARG(NO2)-OME HCL | ESD-918729-10G |
| Cas.: 50912-92-0 | Purity: 95% | HD-ARG(NO2)-OME HCL | ESD-918729-1G |
| Cas.: 50912-92-0 | Purity: 95% | HD-ARG(NO2)-OME HCL | ESD-918729-25G |
| Cas.: 86308-26-1 | Purity: 98% | 2-Hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918730-1G |
| Cas.: 86308-26-1 | Purity: 98% | 2-Hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918730-5G |
| Cas.: 86308-26-1 | Purity: 98% | 2-Hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918730-25G |
| Cas.: 105752-04-3 | Purity: 97% | 4-Iodo-3-nitroaniline | ESD-918731-1G |
| Cas.: 105752-04-3 | Purity: 97% | 4-Iodo-3-nitroaniline | ESD-918731-5G |
| Cas.: 105752-04-3 | Purity: 97% | 4-Iodo-3-nitroaniline | ESD-918731-25G |
| Cas.: 143390-49-2 | Purity: 98% | N-(3-Iodophenyl)-1,1-dimethylethyl Ester Carbamic Acid | ESD-918732-1G |
| Cas.: 143390-49-2 | Purity: 98% | N-(3-Iodophenyl)-1,1-dimethylethyl Ester Carbamic Acid | ESD-918732-5G |
| Cas.: 143390-49-2 | Purity: 98% | N-(3-Iodophenyl)-1,1-dimethylethyl Ester Carbamic Acid | ESD-918732-25G |
| Cas.: 185915-25-7 | Purity: 97% | L-Menthyl lactate | ESD-918733-100G |
| Cas.: 185915-25-7 | Purity: 97% | L-Menthyl lactate | ESD-918733-500G |
| Cas.: 185915-25-7 | Purity: 97% | L-Menthyl lactate | ESD-918733-2.5KG |
| Cas.: 213343-65-8 | Purity: ≥98%(S, S)-Me-BPE-Rh | (-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-918734-100MG |
| Cas.: 213343-65-8 | Purity: ≥98%(S, S)-Me-BPE-Rh | (-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-918734-500MG |
| Cas.: 213343-65-8 | Purity: ≥98%(S, S)-Me-BPE-Rh | (-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-918734-2G |
| Cas.: 1352916-84-7 | Purity: Umicore | [2-(1-Methylethoxy-O)phenylmethyl-C](nitrato-O,O′){rel-(2R,5R,7R)-adamantane-2,1-diyl[3-(2,4,6- trimethylphenyl)-1-imidazolidinyl-2-y lidene]}ruthenium | ESD-918735-100MG |
| Cas.: 1352916-84-7 | Purity: Umicore | [2-(1-Methylethoxy-O)phenylmethyl-C](nitrato-O,O′){rel-(2R,5R,7R)-adamantane-2,1-diyl[3-(2,4,6- trimethylphenyl)-1-imidazolidinyl-2-y lidene]}ruthenium | ESD-918735-500MG |
| Cas.: 1352916-84-7 | Purity: Umicore | [2-(1-Methylethoxy-O)phenylmethyl-C](nitrato-O,O′){rel-(2R,5R,7R)-adamantane-2,1-diyl[3-(2,4,6- trimethylphenyl)-1-imidazolidinyl-2-y lidene]}ruthenium | ESD-918735-2G |
| Cas.: 38594-96-6 | (-)-N6-(2-PHENYLISOPROPYL)-ADENOSINE | ESD-918736-25MG | |
| Cas.: 38594-96-6 | (-)-N6-(2-PHENYLISOPROPYL)-ADENOSINE | ESD-918736-50MG | |
| Cas.: 38594-96-6 | (-)-N6-(2-PHENYLISOPROPYL)-ADENOSINE | ESD-918736-100MG | |
| Cas.: 208757-51-1 | Purity: >99% | 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt) | ESD-918737-10MG |
| Cas.: 208757-51-1 | Purity: >99% | 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt) | ESD-918737-25MG |
| Cas.: 208757-51-1 | Purity: >99% | 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt) | ESD-918737-100MG |
| Cas.: 467-69-6 | Purity: 97% | 9-Hydroxy-9-fluorenecarboxylic acid | ESD-918738-5G |
| Cas.: 467-69-6 | Purity: 97% | 9-Hydroxy-9-fluorenecarboxylic acid | ESD-918738-25G |
| Cas.: 467-69-6 | Purity: 97% | 9-Hydroxy-9-fluorenecarboxylic acid | ESD-918738-100G |
| Cas.: 10409-54-8 | Purity: 97% | 2-Bromoisobutyrophenone | ESD-918739-5G |
| Cas.: 10409-54-8 | Purity: 97% | 2-Bromoisobutyrophenone | ESD-918739-25G |
| Cas.: 10409-54-8 | Purity: 97% | 2-Bromoisobutyrophenone | ESD-918739-100G |
| Cas.: 22032-65-1 | Purity: 97% | (R)-Methyl 2-amino-3-(1H-indol-3-yl)propanoate | ESD-918740-5G |
| Cas.: 22032-65-1 | Purity: 97% | (R)-Methyl 2-amino-3-(1H-indol-3-yl)propanoate | ESD-918740-25G |
| Cas.: 22032-65-1 | Purity: 97% | (R)-Methyl 2-amino-3-(1H-indol-3-yl)propanoate | ESD-918740-100G |
| Cas.: 5464-11-9 | Purity: 97% | 2-(Methylthio)-4,5-dihydro-1H-imidazole hydroiodide | ESD-918741-5G |
| Cas.: 5464-11-9 | Purity: 97% | 2-(Methylthio)-4,5-dihydro-1H-imidazole hydroiodide | ESD-918741-25G |
| Cas.: 5464-11-9 | Purity: 97% | 2-(Methylthio)-4,5-dihydro-1H-imidazole hydroiodide | ESD-918741-100G |
| Cas.: 15029-30-8 | Purity: 95% | 3-Oxo-3-(pipidin-1-yl)propanenitrile | ESD-918742-5G |
| Cas.: 15029-30-8 | Purity: 95% | 3-Oxo-3-(pipidin-1-yl)propanenitrile | ESD-918742-25G |
| Cas.: 15029-30-8 | Purity: 95% | 3-Oxo-3-(pipidin-1-yl)propanenitrile | ESD-918742-100G |
| Cas.: 22948-06-7 | Purity: 97% | 4-Tritylaniline | ESD-918743-5G |
| Cas.: 22948-06-7 | Purity: 97% | 4-Tritylaniline | ESD-918743-25G |
| Cas.: 22948-06-7 | Purity: 97% | 4-Tritylaniline | ESD-918743-100G |
| Cas.: 2132-80-1 | Purity: 95% | 4,4′-Dimethoxy-1,1′-biphenyl | ESD-918744-5G |
| Cas.: 2132-80-1 | Purity: 95% | 4,4′-Dimethoxy-1,1′-biphenyl | ESD-918744-25G |
| Cas.: 2132-80-1 | Purity: 95% | 4,4′-Dimethoxy-1,1′-biphenyl | ESD-918744-100G |
| Cas.: 2215-21-6 | Purity: 95% | 2-Hydroxy-3,5-diisopropylbenzoic acid | ESD-918745-5G |
| Cas.: 2215-21-6 | Purity: 95% | 2-Hydroxy-3,5-diisopropylbenzoic acid | ESD-918745-25G |
| Cas.: 2215-21-6 | Purity: 95% | 2-Hydroxy-3,5-diisopropylbenzoic acid | ESD-918745-100G |
| Cas.: 16185-96-9 | Purity: 97% | 1-(2-(Trifluoromethyl)phenyl)propan-1-one | ESD-918746-5G |
| Cas.: 16185-96-9 | Purity: 97% | 1-(2-(Trifluoromethyl)phenyl)propan-1-one | ESD-918746-25G |
| Cas.: 16185-96-9 | Purity: 97% | 1-(2-(Trifluoromethyl)phenyl)propan-1-one | ESD-918746-100G |
| Cas.: 720-75-2 | Purity: 95% | Methyl [1,1′-biphenyl]-4-carboxylate | ESD-918747-5G |
| Cas.: 720-75-2 | Purity: 95% | Methyl [1,1′-biphenyl]-4-carboxylate | ESD-918747-25G |
| Cas.: 720-75-2 | Purity: 95% | Methyl [1,1′-biphenyl]-4-carboxylate | ESD-918747-100G |
| Cas.: 2211-94-1 | Purity: 99% | Glycidyl 4-methoxyphenyl ether | ESD-918748-5G |
| Cas.: 2211-94-1 | Purity: 99% | Glycidyl 4-methoxyphenyl ether | ESD-918748-25G |
| Cas.: 2211-94-1 | Purity: 99% | Glycidyl 4-methoxyphenyl ether | ESD-918748-100G |
| Cas.: 4877-93-4 | Purity: 97% | 2,2′-Dimethoxybiphenyl | ESD-918749-5G |
| Cas.: 4877-93-4 | Purity: 97% | 2,2′-Dimethoxybiphenyl | ESD-918749-25G |
| Cas.: 4877-93-4 | Purity: 97% | 2,2′-Dimethoxybiphenyl | ESD-918749-100G |
| Cas.: 52253-69-7 | Purity: 99% | 2-Amino-4-phenylthiazole hydrobromide | ESD-918750-5G |
| Cas.: 52253-69-7 | Purity: 99% | 2-Amino-4-phenylthiazole hydrobromide | ESD-918750-25G |
| Cas.: 52253-69-7 | Purity: 99% | 2-Amino-4-phenylthiazole hydrobromide | ESD-918750-100G |
| Cas.: 25612-73-1 | Purity: ≥93% (HPLC), powder | Adenosine 5′-(beta,gamma-imido)triphosphate lithium salt hydrate | ESD-918751-5MG |
| Cas.: 1104546-89-5 | Purity: 98% | 4-((1-Methyl-1H-pyrrol-2-yl)methylene)isoquinoline-1,3(2H,4H)-dione | ESD-918752-5MG |
| Cas.: 1104546-89-5 | Purity: 98% | 4-((1-Methyl-1H-pyrrol-2-yl)methylene)isoquinoline-1,3(2H,4H)-dione | ESD-918752-25MG |
| Cas.: 1104546-89-5 | Purity: 98% | 4-((1-Methyl-1H-pyrrol-2-yl)methylene)isoquinoline-1,3(2H,4H)-dione | ESD-918752-100MG |
| Cas.: 13865-19-5 | Purity: 95% | Methyl 4-oxobutanoate | ESD-918753-5G |
| Cas.: 13865-19-5 | Purity: 95% | Methyl 4-oxobutanoate | ESD-918753-1G |
| Cas.: 13865-19-5 | Purity: 95% | Methyl 4-oxobutanoate | ESD-918753-100MG |
| Cas.: 67268-37-5 | Purity: 98% | 4H-Furo[3,2-b]pyrrole-5-carboxylic acid | ESD-918754-5G |
| Cas.: 67268-37-5 | Purity: 98% | 4H-Furo[3,2-b]pyrrole-5-carboxylic acid | ESD-918754-1G |
| Cas.: 67268-37-5 | Purity: 98% | 4H-Furo[3,2-b]pyrrole-5-carboxylic acid | ESD-918754-100MG |
| Cas.: 662138-96-7 | Purity: 50-70% | 2-Pyridineboronic acid N-phenyldiethanolamine | ESD-918755-1G |
| Cas.: 662138-96-7 | Purity: 50-70% | 2-Pyridineboronic acid N-phenyldiethanolamine | ESD-918755-5G |
| Cas.: 662138-96-7 | Purity: 50-70% | 2-Pyridineboronic acid N-phenyldiethanolamine | ESD-918755-10G |
| Cas.: 1541011-97-5 | Purity: 98% | Pep2-8 | ESD-918756-1MG |
| Cas.: 1541011-97-5 | Purity: 98% | Pep2-8 | ESD-918756-5MG |
| Cas.: 1541011-97-5 | Purity: 98% | Pep2-8 | ESD-918756-10MG |
| Cas.: 470-99-5 | Purity: 95% | 3,5,5-Trimethyl-2-cyclohexen-1-ol | ESD-918757-1G |
| Cas.: 470-99-5 | Purity: 95% | 3,5,5-Trimethyl-2-cyclohexen-1-ol | ESD-918757-5G |
| Cas.: 470-99-5 | Purity: 95% | 3,5,5-Trimethyl-2-cyclohexen-1-ol | ESD-918757-10G |
| Cas.: 20007-72-1 | Purity: 98% | 8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione | ESD-918758-1G |
| Cas.: 20007-72-1 | Purity: 98% | 8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione | ESD-918758-5G |
| Cas.: 20007-72-1 | Purity: 98% | 8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione | ESD-918758-10G |
| Cas.: 6214-20-6 | Purity: 99% | Methyl 4-nitrobenzenesulfonate | ESD-918759-1G |
| Cas.: 6214-20-6 | Purity: 99% | Methyl 4-nitrobenzenesulfonate | ESD-918759-5G |
| Cas.: 6214-20-6 | Purity: 99% | Methyl 4-nitrobenzenesulfonate | ESD-918759-10G |
| Cas.: 220212-12-4 | Purity: 97% | 3-BroMo-pyrrolidine-1-carboxylic acid benzyl ester | ESD-918760-1G |
| Cas.: 220212-12-4 | Purity: 97% | 3-BroMo-pyrrolidine-1-carboxylic acid benzyl ester | ESD-918760-5G |
| Cas.: 220212-12-4 | Purity: 97% | 3-BroMo-pyrrolidine-1-carboxylic acid benzyl ester | ESD-918760-10G |
| Cas.: 936694-19-8 | Purity: 95% | 4-(4-Boc-1-piperazinylmethyl)benzeneboronic acid pinacol ester | ESD-918761-1G |
| Cas.: 936694-19-8 | Purity: 95% | 4-(4-Boc-1-piperazinylmethyl)benzeneboronic acid pinacol ester | ESD-918761-5G |
| Cas.: 936694-19-8 | Purity: 95% | 4-(4-Boc-1-piperazinylmethyl)benzeneboronic acid pinacol ester | ESD-918761-10G |
| Cas.: 24539-28-4 | Purity: 97% | 4-METHOXYCARBONYLCUBANECARBOXYLIC ACID | ESD-918762-250MG |
| Cas.: 24539-28-4 | Purity: 97% | 4-METHOXYCARBONYLCUBANECARBOXYLIC ACID | ESD-918762-500MG |
| Cas.: 24539-28-4 | Purity: 97% | 4-METHOXYCARBONYLCUBANECARBOXYLIC ACID | ESD-918762-1G |
| Cas.: 6106-22-5 | Purity: 97% | 4-Aminobenzenesulfonic acid, sodium salt dihydrate | ESD-918763-100G |
| Cas.: 6106-22-5 | Purity: 97% | 4-Aminobenzenesulfonic acid, sodium salt dihydrate | ESD-918763-500G |
| Cas.: 6106-22-5 | Purity: 97% | 4-Aminobenzenesulfonic acid, sodium salt dihydrate | ESD-918763-1KG |
| Cas.: 1978-20-7 | Purity: >95% | 3,4-BIS(TRIFLUOROMETHYL)NITROBENZENE | ESD-918764-5G |
| Cas.: 1978-20-7 | Purity: >95% | 3,4-BIS(TRIFLUOROMETHYL)NITROBENZENE | ESD-918764-500MG |
| Cas.: 1978-20-7 | Purity: >95% | 3,4-BIS(TRIFLUOROMETHYL)NITROBENZENE | ESD-918764-1G |
| Cas.: 1193-47-1 | Purity: 92% | 2,2-Dimethylcyclohexanone | ESD-918765-250MG |
| Cas.: 1193-47-1 | Purity: 92% | 2,2-Dimethylcyclohexanone | ESD-918765-5G |
| Cas.: 1193-47-1 | Purity: 92% | 2,2-Dimethylcyclohexanone | ESD-918765-1G |
| Cas.: 13237-88-2 | Purity: 97% | 7-BROMOBICYCLO[2.2.1]HEPTANE | ESD-918766-250MG |
| Cas.: 13237-88-2 | Purity: 97% | 7-BROMOBICYCLO[2.2.1]HEPTANE | ESD-918766-5G |
| Cas.: 13237-88-2 | Purity: 97% | 7-BROMOBICYCLO[2.2.1]HEPTANE | ESD-918766-1G |
| Cas.: 1461-23-0 | Purity: 95% | TRI-N-BUTYLTIN BROMIDE | ESD-918767-5G |
| Cas.: 1461-23-0 | Purity: 95% | TRI-N-BUTYLTIN BROMIDE | ESD-918767-1G |
| Cas.: 14220-21-4 | Purity: 98% | Bromopentacarbonylrhenium(I) | ESD-918768-100MG |
| Cas.: 14220-21-4 | Purity: 98% | Bromopentacarbonylrhenium(I) | ESD-918768-250MG |
| Cas.: 14220-21-4 | Purity: 98% | Bromopentacarbonylrhenium(I) | ESD-918768-1G |
| Cas.: 40771-26-4 | Purity: 95% | 1,2,3,4-Tetrahydronaphthalene-1,5-diol | ESD-918769-100MG |
| Cas.: 40771-26-4 | Purity: 95% | 1,2,3,4-Tetrahydronaphthalene-1,5-diol | ESD-918769-250MG |
| Cas.: 40771-26-4 | Purity: 95% | 1,2,3,4-Tetrahydronaphthalene-1,5-diol | ESD-918769-1G |
| Cas.: 799297-44-2 | Purity: 98% | (1R,2R)-1-(Diphenylphosphino)-1-phenylpropan-2-amine | ESD-918770-100MG |
| Cas.: 799297-44-2 | Purity: 98% | (1R,2R)-1-(Diphenylphosphino)-1-phenylpropan-2-amine | ESD-918770-250MG |
| Cas.: 799297-44-2 | Purity: 98% | (1R,2R)-1-(Diphenylphosphino)-1-phenylpropan-2-amine | ESD-918770-1G |
| Cas.: 3913-23-3 | Purity: 95% | 2-(Bromomethyl)-1-methoxy-4-nitrobenzene | ESD-918771-100MG |
| Cas.: 3913-23-3 | Purity: 95% | 2-(Bromomethyl)-1-methoxy-4-nitrobenzene | ESD-918771-250MG |
| Cas.: 3913-23-3 | Purity: 95% | 2-(Bromomethyl)-1-methoxy-4-nitrobenzene | ESD-918771-1G |
| Cas.: 51091-84-0 | Purity: 97% | (S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride | ESD-918772-100MG |
| Cas.: 51091-84-0 | Purity: 97% | (S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride | ESD-918772-250MG |
| Cas.: 51091-84-0 | Purity: 97% | (S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride | ESD-918772-1G |
| Cas.: 137037-20-8 | Purity: 98% | (2R,2’R)-2,2′-Bipyrrolidine | ESD-918773-100MG |
| Cas.: 137037-20-8 | Purity: 98% | (2R,2’R)-2,2′-Bipyrrolidine | ESD-918773-250MG |
| Cas.: 137037-20-8 | Purity: 98% | (2R,2’R)-2,2′-Bipyrrolidine | ESD-918773-1G |
| Cas.: 1086138-36-4 | Purity: 98% | Bis(2-(Di(adamantan-1-yl)phosphino)ethyl)amine | ESD-918774-100MG |
| Cas.: 1086138-36-4 | Purity: 98% | Bis(2-(Di(adamantan-1-yl)phosphino)ethyl)amine | ESD-918774-250MG |
| Cas.: 1086138-36-4 | Purity: 98% | Bis(2-(Di(adamantan-1-yl)phosphino)ethyl)amine | ESD-918774-1G |
| Cas.: 441771-60-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxanonadecane-19-thiol | ESD-918775-100MG |
| Cas.: 441771-60-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxanonadecane-19-thiol | ESD-918775-250MG |
| Cas.: 441771-60-4 | Purity: 95% | 2,5,8,11,14,17-Hexaoxanonadecane-19-thiol | ESD-918775-1G |
| Cas.: 2114-11-6 | Purity: 95% | Prop-2-en-1-yl carbamate | ESD-918776-100MG |
| Cas.: 2114-11-6 | Purity: 95% | Prop-2-en-1-yl carbamate | ESD-918776-250MG |
| Cas.: 2114-11-6 | Purity: 95% | Prop-2-en-1-yl carbamate | ESD-918776-1G |
| Cas.: 1246553-28-5 | Purity: 95% | 1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-918777-100MG |
| Cas.: 1246553-28-5 | Purity: 95% | 1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-918777-250MG |
| Cas.: 1246553-28-5 | Purity: 95% | 1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-918777-1G |
| Cas.: 3584-66-5 | Purity: 95% | 5-Chloro-2-(trichloromethyl)-1H-benzo[d]imidazole | ESD-918778-100MG |
| Cas.: 3584-66-5 | Purity: 95% | 5-Chloro-2-(trichloromethyl)-1H-benzo[d]imidazole | ESD-918778-250MG |
| Cas.: 3584-66-5 | Purity: 95% | 5-Chloro-2-(trichloromethyl)-1H-benzo[d]imidazole | ESD-918778-1G |
| Cas.: 15529-90-5 | Purity: 98% | Chlorotriethylphosphine gold(I) | ESD-918779-100MG |
| Cas.: 15529-90-5 | Purity: 98% | Chlorotriethylphosphine gold(I) | ESD-918779-250MG |
| Cas.: 63936-85-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)methylpalladium(II) | ESD-918780-100MG |
| Cas.: 63936-85-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)methylpalladium(II) | ESD-918780-250MG |
| Cas.: 63936-85-6 | Purity: 98% | Chloro(1,5-cyclooctadiene)methylpalladium(II) | ESD-918780-1G |
| Cas.: 22440-93-3 | Purity: 95% | N1,N1,N3,N3-tetramethylbenzene-1,3-diamine | ESD-918781-100MG |
| Cas.: 22440-93-3 | Purity: 95% | N1,N1,N3,N3-tetramethylbenzene-1,3-diamine | ESD-918781-250MG |
| Cas.: 22440-93-3 | Purity: 95% | N1,N1,N3,N3-tetramethylbenzene-1,3-diamine | ESD-918781-1G |
| Cas.: 799557-87-2 | Purity: 95% | 2-Chloro-5-(trifluoromethyl)pyrazine | ESD-918782-100MG |
| Cas.: 799557-87-2 | Purity: 95% | 2-Chloro-5-(trifluoromethyl)pyrazine | ESD-918782-250MG |
| Cas.: 799557-87-2 | Purity: 95% | 2-Chloro-5-(trifluoromethyl)pyrazine | ESD-918782-1G |
| Cas.: 123387-52-0 | Purity: 95% | 1-(Tert-Butoxycarbonyl)Hexahydroazepine | ESD-918783-100MG |
| Cas.: 123387-52-0 | Purity: 95% | 1-(Tert-Butoxycarbonyl)Hexahydroazepine | ESD-918783-250MG |
| Cas.: 123387-52-0 | Purity: 95% | 1-(Tert-Butoxycarbonyl)Hexahydroazepine | ESD-918783-1G |
| Cas.: 146476-37-1 | Purity: 98% | (S)-1-(Diphenylphosphino)-3-methylbutan-2-amine | ESD-918784-100MG |
| Cas.: 146476-37-1 | Purity: 98% | (S)-1-(Diphenylphosphino)-3-methylbutan-2-amine | ESD-918784-250MG |
| Cas.: 146476-37-1 | Purity: 98% | (S)-1-(Diphenylphosphino)-3-methylbutan-2-amine | ESD-918784-1G |
| Cas.: 286454-86-2 | Purity: 98% | (S)-1-(Diphenylphosphino)-3,3-dimethylbutan-2-amine | ESD-918785-100MG |
| Cas.: 286454-86-2 | Purity: 98% | (S)-1-(Diphenylphosphino)-3,3-dimethylbutan-2-amine | ESD-918785-250MG |
| Cas.: 286454-86-2 | Purity: 98% | (S)-1-(Diphenylphosphino)-3,3-dimethylbutan-2-amine | ESD-918785-1G |
| Cas.: 113110-58-0 | Purity: 98% | Tetrakis(pyridine)copper(II) triflate | ESD-918786-100MG |
| Cas.: 113110-58-0 | Purity: 98% | Tetrakis(pyridine)copper(II) triflate | ESD-918786-250MG |
| Cas.: 113110-58-0 | Purity: 98% | Tetrakis(pyridine)copper(II) triflate | ESD-918786-1G |
| Cas.: 10586-52-4 | Purity: ≥95% | 2-Phenyl-1H-pyrrolo[2,3-b]pyridine | ESD-918787-100MG |
| Cas.: 10586-52-4 | Purity: ≥95% | 2-Phenyl-1H-pyrrolo[2,3-b]pyridine | ESD-918787-250MG |
| Cas.: 10586-52-4 | Purity: ≥95% | 2-Phenyl-1H-pyrrolo[2,3-b]pyridine | ESD-918787-1G |
| Cas.: 610756-04-2 | Purity: 98% | Tricyclopentylphosphonium tetrafluoroborate | ESD-918788-100MG |
| Cas.: 610756-04-2 | Purity: 98% | Tricyclopentylphosphonium tetrafluoroborate | ESD-918788-250MG |
| Cas.: 610756-04-2 | Purity: 98% | Tricyclopentylphosphonium tetrafluoroborate | ESD-918788-1G |
| Cas.: 210825-31-3 | Purity: 98% | N-((4-Chloro-2,6-diisopropylphenyl)carbamoyl)-3-(2-hydroxypropan-2-yl)benzenesulfonamide | ESD-918789-100MG |
| Cas.: 210825-31-3 | Purity: 98% | N-((4-Chloro-2,6-diisopropylphenyl)carbamoyl)-3-(2-hydroxypropan-2-yl)benzenesulfonamide | ESD-918789-250MG |
| Cas.: 210825-31-3 | Purity: 98% | N-((4-Chloro-2,6-diisopropylphenyl)carbamoyl)-3-(2-hydroxypropan-2-yl)benzenesulfonamide | ESD-918789-1G |
| Cas.: 65034-88-0 | Purity: 98% | [Ru(bpm)3][Cl]2 | ESD-918790-100MG |
| Cas.: 65034-88-0 | Purity: 98% | [Ru(bpm)3][Cl]2 | ESD-918790-250MG |
| Cas.: 65034-88-0 | Purity: 98% | [Ru(bpm)3][Cl]2 | ESD-918790-1G |
| Cas.: 24444-72-2 | Purity: 98% | Iron tris(diisobutyrylmethane) | ESD-918791-100MG |
| Cas.: 24444-72-2 | Purity: 98% | Iron tris(diisobutyrylmethane) | ESD-918791-250MG |
| Cas.: 24444-72-2 | Purity: 98% | Iron tris(diisobutyrylmethane) | ESD-918791-1G |
| Cas.: 2030437-92-2 | Purity: 98% | Ir[dFFppy]2-(4,4′-dCF3bpy)PF6 | ESD-918792-100MG |
| Cas.: 2030437-92-2 | Purity: 98% | Ir[dFFppy]2-(4,4′-dCF3bpy)PF6 | ESD-918792-250MG |
| Cas.: 2030437-92-2 | Purity: 98% | Ir[dFFppy]2-(4,4′-dCF3bpy)PF6 | ESD-918792-1G |
| Cas.: 158966-92-8 | Purity: 99% | montelukast | ESD-918793-100MG |
| Cas.: 158966-92-8 | Purity: 99% | montelukast | ESD-918793-250MG |
| Cas.: 158966-92-8 | Purity: 99% | montelukast | ESD-918793-1G |
| Cas.: 444667-33-8 | Purity: ≥98% | (11bR)-(2R,5R)-1-(Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl)-2,5-diphenylpyrrolidine | ESD-918794-100MG |
| Cas.: 444667-33-8 | Purity: ≥98% | (11bR)-(2R,5R)-1-(Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl)-2,5-diphenylpyrrolidine | ESD-918794-250MG |
| Cas.: 444667-33-8 | Purity: ≥98% | (11bR)-(2R,5R)-1-(Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-yl)-2,5-diphenylpyrrolidine | ESD-918794-1G |
| Cas.: 138517-65-4 | Purity: 98% | N,N’-(11S,12S)-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosphino)benzamide] | ESD-918795-100MG |
| Cas.: 138517-65-4 | Purity: 98% | N,N’-(11S,12S)-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosphino)benzamide] | ESD-918795-250MG |
| Cas.: 138517-65-4 | Purity: 98% | N,N’-(11S,12S)-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosphino)benzamide] | ESD-918795-1G |
| Cas.: 886061-48-9 | Purity: ≥98% | Bis(1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)copper(I) tetrafluoroborate | ESD-918796-100MG |
| Cas.: 886061-48-9 | Purity: ≥98% | Bis(1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)copper(I) tetrafluoroborate | ESD-918796-250MG |
| Cas.: 886061-48-9 | Purity: ≥98% | Bis(1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)copper(I) tetrafluoroborate | ESD-918796-1G |
| Cas.: 38609-76-6 | Purity: 97% | 3,5-Bis(trifluoromethyl)pyridin-2(1H)-one | ESD-918797-100MG |
| Cas.: 38609-76-6 | Purity: 97% | 3,5-Bis(trifluoromethyl)pyridin-2(1H)-one | ESD-918797-250MG |
| Cas.: 38609-76-6 | Purity: 97% | 3,5-Bis(trifluoromethyl)pyridin-2(1H)-one | ESD-918797-1G |
| Cas.: 25423-56-7 | Purity: 97% | 1,4,7,10-Tetrathiacyclododecane | ESD-918798-100MG |
| Cas.: 25423-56-7 | Purity: 97% | 1,4,7,10-Tetrathiacyclododecane | ESD-918798-250MG |
| Cas.: 25423-56-7 | Purity: 97% | 1,4,7,10-Tetrathiacyclododecane | ESD-918798-1G |
| Cas.: 500539-08-2 | Purity: 95% | 6-Chloro-9-isopropyl-9H-purine | ESD-918799-100MG |
| Cas.: 500539-08-2 | Purity: 95% | 6-Chloro-9-isopropyl-9H-purine | ESD-918799-250MG |
| Cas.: 500539-08-2 | Purity: 95% | 6-Chloro-9-isopropyl-9H-purine | ESD-918799-1G |
| Cas.: 205584-69-6 | Purity: ≥95% | 4,6-Dichloro-7-methoxyquinazoline | ESD-918800-100MG |
| Cas.: 205584-69-6 | Purity: ≥95% | 4,6-Dichloro-7-methoxyquinazoline | ESD-918800-250MG |
| Cas.: 205584-69-6 | Purity: ≥95% | 4,6-Dichloro-7-methoxyquinazoline | ESD-918800-1G |
| Cas.: 956101-01-2 | Purity: ≥95% | 3-(Imidazo[1,2-a]pyrimidin-2-yl)propanoic acid | ESD-918801-100MG |
| Cas.: 956101-01-2 | Purity: ≥95% | 3-(Imidazo[1,2-a]pyrimidin-2-yl)propanoic acid | ESD-918801-250MG |
| Cas.: 956101-01-2 | Purity: ≥95% | 3-(Imidazo[1,2-a]pyrimidin-2-yl)propanoic acid | ESD-918801-1G |
| Cas.: 6344-62-3 | Purity: 95% | 1-Amino-9H-fluoren-9-one | ESD-918802-100MG |
| Cas.: 6344-62-3 | Purity: 95% | 1-Amino-9H-fluoren-9-one | ESD-918802-250MG |
| Cas.: 6344-62-3 | Purity: 95% | 1-Amino-9H-fluoren-9-one | ESD-918802-1G |
| Cas.: 7072-00-6 | Purity: 97% | 10-Methylanthracene-9-carbaldehyde | ESD-918803-100MG |
| Cas.: 7072-00-6 | Purity: 97% | 10-Methylanthracene-9-carbaldehyde | ESD-918803-250MG |
| Cas.: 7072-00-6 | Purity: 97% | 10-Methylanthracene-9-carbaldehyde | ESD-918803-1G |
| Cas.: 3929-47-3 | Purity: 97% | 3-(3,4-Dimethoxyphenyl)propan-1-ol | ESD-918804-100MG |
| Cas.: 3929-47-3 | Purity: 97% | 3-(3,4-Dimethoxyphenyl)propan-1-ol | ESD-918804-250MG |
| Cas.: 1672-63-5 | Purity: 98% | 4-Hydroxyantipyrine | ESD-918805-100MG |
| Cas.: 1672-63-5 | Purity: 98% | 4-Hydroxyantipyrine | ESD-918805-250MG |
| Cas.: 1672-63-5 | Purity: 98% | 4-Hydroxyantipyrine | ESD-918805-1G |
| Cas.: 63234-71-9 | Purity: 95% | Pyrrolidin-1-amine hydrochloride | ESD-918806-100MG |
| Cas.: 63234-71-9 | Purity: 95% | Pyrrolidin-1-amine hydrochloride | ESD-918806-250MG |
| Cas.: 63234-71-9 | Purity: 95% | Pyrrolidin-1-amine hydrochloride | ESD-918806-1G |
| Cas.: 4702-32-3 | Purity: 95% | Isocitric acid lactone | ESD-918807-100MG |
| Cas.: 4702-32-3 | Purity: 95% | Isocitric acid lactone | ESD-918807-250MG |
| Cas.: 4702-32-3 | Purity: 95% | Isocitric acid lactone | ESD-918807-1G |
| Cas.: 64415-07-2 | Purity: 97% | 7-(Trifluoromethyl)quinoline-4-thiol | ESD-918808-100MG |
| Cas.: 64415-07-2 | Purity: 97% | 7-(Trifluoromethyl)quinoline-4-thiol | ESD-918808-250MG |
| Cas.: 64415-07-2 | Purity: 97% | 7-(Trifluoromethyl)quinoline-4-thiol | ESD-918808-1G |
| Cas.: 53111-20-9 | Purity: 98% | (2-Methoxyphenyl)diphenylphosphine | ESD-918809-100MG |
| Cas.: 53111-20-9 | Purity: 98% | (2-Methoxyphenyl)diphenylphosphine | ESD-918809-250MG |
| Cas.: 53111-20-9 | Purity: 98% | (2-Methoxyphenyl)diphenylphosphine | ESD-918809-1G |
| Cas.: 34212-59-4 | Purity: 95% | bis((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) succinate | ESD-918810-100MG |
| Cas.: 34212-59-4 | Purity: 95% | bis((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) succinate | ESD-918810-250MG |
| Cas.: 34212-59-4 | Purity: 95% | bis((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) succinate | ESD-918810-1G |
| Cas.: 6864-20-6 | Purity: 97% | 2,4,6-Triphenylaniline | ESD-918811-100MG |
| Cas.: 6864-20-6 | Purity: 97% | 2,4,6-Triphenylaniline | ESD-918811-250MG |
| Cas.: 6864-20-6 | Purity: 97% | 2,4,6-Triphenylaniline | ESD-918811-1G |
| Cas.: 75732-01-3 | Purity: 30.6-39.0%Cu | Mesiylcopper(I) | ESD-918812-100MG |
| Cas.: 75732-01-3 | Purity: 30.6-39.0%Cu | Mesiylcopper(I) | ESD-918812-250MG |
| Cas.: 75732-01-3 | Purity: 30.6-39.0%Cu | Mesiylcopper(I) | ESD-918812-1G |
| Cas.: 388-82-9 | Purity: 95% | 2,2′-Difluorobiphenyl | ESD-918813-100MG |
| Cas.: 388-82-9 | Purity: 95% | 2,2′-Difluorobiphenyl | ESD-918813-250MG |
| Cas.: 388-82-9 | Purity: 95% | 2,2′-Difluorobiphenyl | ESD-918813-1G |
| Cas.: 4382-53-0 | Purity: 97% | 2-(5-(Benzyloxy)-1H-indol-3-yl)acetic acid | ESD-918814-100MG |
| Cas.: 4382-53-0 | Purity: 97% | 2-(5-(Benzyloxy)-1H-indol-3-yl)acetic acid | ESD-918814-250MG |
| Cas.: 4382-53-0 | Purity: 97% | 2-(5-(Benzyloxy)-1H-indol-3-yl)acetic acid | ESD-918814-1G |
| Cas.: 1355729-38-2 | Purity: 97% | Zinc difluoroMethanesulfinate | ESD-918815-100MG |
| Cas.: 1355729-38-2 | Purity: 97% | Zinc difluoroMethanesulfinate | ESD-918815-250MG |
| Cas.: 1355729-38-2 | Purity: 97% | Zinc difluoroMethanesulfinate | ESD-918815-1G |
| Cas.: 903130-30-3 | Purity: 95% | 7-Boc-3-chloro-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylic acid | ESD-918816-100MG |
| Cas.: 903130-30-3 | Purity: 95% | 7-Boc-3-chloro-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylic acid | ESD-918816-250MG |
| Cas.: 903130-30-3 | Purity: 95% | 7-Boc-3-chloro-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylic acid | ESD-918816-1G |
| Cas.: 851386-45-3 | Purity: 98% | 3,6-Difluoropicolinic acid | ESD-918817-100MG |
| Cas.: 851386-45-3 | Purity: 98% | 3,6-Difluoropicolinic acid | ESD-918817-250MG |
| Cas.: 851386-45-3 | Purity: 98% | 3,6-Difluoropicolinic acid | ESD-918817-1G |
| Cas.: 149005-33-4 | Purity: 98% | Tris(2-(p-tolyl)pyridine-C2,N)iridium(III) | ESD-918818-100MG |
| Cas.: 149005-33-4 | Purity: 98% | Tris(2-(p-tolyl)pyridine-C2,N)iridium(III) | ESD-918818-250MG |
| Cas.: 149005-33-4 | Purity: 98% | Tris(2-(p-tolyl)pyridine-C2,N)iridium(III) | ESD-918818-1G |
| Cas.: 444910-17-2 | Purity: 97% | Dichloro(di-μ-chloro)bis[1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]dipalladium(II) | ESD-918819-100MG |
| Cas.: 444910-17-2 | Purity: 97% | Dichloro(di-μ-chloro)bis[1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]dipalladium(II) | ESD-918819-250MG |
| Cas.: 444910-17-2 | Purity: 97% | Dichloro(di-μ-chloro)bis[1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]dipalladium(II) | ESD-918819-1G |
| Cas.: 884879-24-7 | Purity: 97% | Chloro[(1,2,3-h)-3-phenyl-2-propenyl][1,3-bis(2,6-diisopropylphenyl)-4,5-di-H-imidazol-2-ylidene]palladium( II) | ESD-918820-100MG |
| Cas.: 884879-24-7 | Purity: 97% | Chloro[(1,2,3-h)-3-phenyl-2-propenyl][1,3-bis(2,6-diisopropylphenyl)-4,5-di-H-imidazol-2-ylidene]palladium( II) | ESD-918820-250MG |
| Cas.: 884879-24-7 | Purity: 97% | Chloro[(1,2,3-h)-3-phenyl-2-propenyl][1,3-bis(2,6-diisopropylphenyl)-4,5-di-H-imidazol-2-ylidene]palladium( II) | ESD-918820-1G |
| Cas.: 192138-05-9 | Purity: 98% | (R)-(+)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918821-100MG |
| Cas.: 192138-05-9 | Purity: 98% | (R)-(+)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918821-250MG |
| Cas.: 192138-05-9 | Purity: 98% | (R)-(+)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918821-1G |
| Cas.: 167709-31-1 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918822-100MG |
| Cas.: 167709-31-1 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918822-250MG |
| Cas.: 167709-31-1 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918822-1G |
| Cas.: 145214-57-9 | Purity: 98% | (R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918823-100MG |
| Cas.: 145214-57-9 | Purity: 98% | (R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918823-250MG |
| Cas.: 145214-57-9 | Purity: 98% | (R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918823-1G |
| Cas.: 145214-59-1 | Purity: 98% | (S)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918824-100MG |
| Cas.: 145214-59-1 | Purity: 98% | (S)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918824-250MG |
| Cas.: 145214-59-1 | Purity: 98% | (S)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) | ESD-918824-1G |
| Cas.: 133545-24-1 | Purity: 98% | (R)-(+)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918825-100MG |
| Cas.: 133545-24-1 | Purity: 98% | (R)-(+)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918825-250MG |
| Cas.: 133545-24-1 | Purity: 98% | (R)-(+)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918825-1G |
| Cas.: 133545-25-2 | Purity: 98% | (S)-(-)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918826-100MG |
| Cas.: 133545-25-2 | Purity: 98% | (S)-(-)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918826-250MG |
| Cas.: 133545-25-2 | Purity: 98% | (S)-(-)-2,2′-Bis(di-p-tolylphosphino)-6,6′-dimethoxy-1,1′-biphenyl | ESD-918826-1G |
| Cas.: 362634-22-8 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-xylyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918827-100MG |
| Cas.: 362634-22-8 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-xylyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918827-250MG |
| Cas.: 362634-22-8 | Purity: 98% | (S)-(-)-2,2′-Bis[di(3,5-xylyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918827-1G |
| Cas.: 15178-48-0 | Purity: 97% | 4-Amino-3-fluorobenzenethiol | ESD-918828-100MG |
| Cas.: 15178-48-0 | Purity: 97% | 4-Amino-3-fluorobenzenethiol | ESD-918828-250MG |
| Cas.: 15178-48-0 | Purity: 97% | 4-Amino-3-fluorobenzenethiol | ESD-918828-1G |
| Cas.: 30235-12-2 | Purity: 98% | 6-Methyl-4-nitropyridine-2-carbonitrile | ESD-918829-100MG |
| Cas.: 30235-12-2 | Purity: 98% | 6-Methyl-4-nitropyridine-2-carbonitrile | ESD-918829-250MG |
| Cas.: 30235-12-2 | Purity: 98% | 6-Methyl-4-nitropyridine-2-carbonitrile | ESD-918829-1G |
| Cas.: 408492-28-4 | Purity: 97% | 2-(3-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918830-100MG |
| Cas.: 408492-28-4 | Purity: 97% | 2-(3-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918830-250MG |
| Cas.: 408492-28-4 | Purity: 97% | 2-(3-Iodophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-918830-1G |
| Cas.: 128311-06-8 | Purity: 98% | (S)-N-((R)-1-Phenylethyl)quinuclidin-3-amine dihydrochloride | ESD-918831-100MG |
| Cas.: 128311-06-8 | Purity: 98% | (S)-N-((R)-1-Phenylethyl)quinuclidin-3-amine dihydrochloride | ESD-918831-250MG |
| Cas.: 128311-06-8 | Purity: 98% | (S)-N-((R)-1-Phenylethyl)quinuclidin-3-amine dihydrochloride | ESD-918831-1G |
| Cas.: 934506-10-2 | Purity: 98% | 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl gold(I) bis(trifluoromethanesulfonyl)imide | ESD-918832-100MG |
| Cas.: 934506-10-2 | Purity: 98% | 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl gold(I) bis(trifluoromethanesulfonyl)imide | ESD-918832-250MG |
| Cas.: 934506-10-2 | Purity: 98% | 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl gold(I) bis(trifluoromethanesulfonyl)imide | ESD-918832-1G |
| Cas.: 652154-11-5 | Purity: 98% | 4,4′,4”,4”’-(Porphine-5,10,15,20-tetrayl)tetrakis(benzenesulfonic acid)tetrasodium salt xhydrate | ESD-918833-100MG |
| Cas.: 652154-11-5 | Purity: 98% | 4,4′,4”,4”’-(Porphine-5,10,15,20-tetrayl)tetrakis(benzenesulfonic acid)tetrasodium salt xhydrate | ESD-918833-250MG |
| Cas.: 666826-16-0 | Purity: 98% | Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl)borate | ESD-918834-100MG |
| Cas.: 666826-16-0 | Purity: 98% | Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl)borate | ESD-918834-250MG |
| Cas.: 666826-16-0 | Purity: 98% | Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl)borate | ESD-918834-1G |
| Cas.: 372147-50-7 | Purity: 97% | Imidazo[1,2-a]pyridine-5-carbaldehyde | ESD-918835-100MG |
| Cas.: 372147-50-7 | Purity: 97% | Imidazo[1,2-a]pyridine-5-carbaldehyde | ESD-918835-250MG |
| Cas.: 372147-50-7 | Purity: 97% | Imidazo[1,2-a]pyridine-5-carbaldehyde | ESD-918835-1G |
| Cas.: 163163-79-9 | Purity: 95% | 3-Bromo-5-(dimethoxymethyl)pyridine | ESD-918836-100MG |
| Cas.: 163163-79-9 | Purity: 95% | 3-Bromo-5-(dimethoxymethyl)pyridine | ESD-918836-250MG |
| Cas.: 163163-79-9 | Purity: 95% | 3-Bromo-5-(dimethoxymethyl)pyridine | ESD-918836-1G |
| Cas.: 885698-94-2 | Purity: 96% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-918837-100MG |
| Cas.: 885698-94-2 | Purity: 96% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-918837-250MG |
| Cas.: 885698-94-2 | Purity: 96% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-918837-1G |
| Cas.: 445303-70-8 | Purity: 97% | 1-Bromo-3-(1,1-difluoroethyl)benzene | ESD-918838-100MG |
| Cas.: 445303-70-8 | Purity: 97% | 1-Bromo-3-(1,1-difluoroethyl)benzene | ESD-918838-250MG |
| Cas.: 445303-70-8 | Purity: 97% | 1-Bromo-3-(1,1-difluoroethyl)benzene | ESD-918838-1G |
| Cas.: 352439-37-3 | Purity: 95% | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol | ESD-918839-100MG |
| Cas.: 352439-37-3 | Purity: 95% | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol | ESD-918839-250MG |
| Cas.: 352439-37-3 | Purity: 95% | 23-Amino-3,6,9,12,15,18,21-heptaoxatricosan-1-ol | ESD-918839-1G |
| Cas.: 187872-11-3 | Purity: 98% | 5-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918840-100MG |
| Cas.: 187872-11-3 | Purity: 98% | 5-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918840-250MG |
| Cas.: 187872-11-3 | Purity: 98% | 5-Bromo-6-methoxy-2,3-dihydro-1H-inden-1-one | ESD-918840-1G |
| Cas.: 40438-64-0 | Purity: 98% | 4-(Dicyclohexylphosphino)-N,N-dimethylaniline | ESD-918841-100MG |
| Cas.: 40438-64-0 | Purity: 98% | 4-(Dicyclohexylphosphino)-N,N-dimethylaniline | ESD-918841-250MG |
| Cas.: 40438-64-0 | Purity: 98% | 4-(Dicyclohexylphosphino)-N,N-dimethylaniline | ESD-918841-1G |
| Cas.: 100943-46-2 | Purity: 95% | 5-Hexylthiophene-2-carbaldehyde | ESD-918842-100MG |
| Cas.: 100943-46-2 | Purity: 95% | 5-Hexylthiophene-2-carbaldehyde | ESD-918842-250MG |
| Cas.: 100943-46-2 | Purity: 95% | 5-Hexylthiophene-2-carbaldehyde | ESD-918842-1G |
| Cas.: 884879-23-6 | Purity: 97% | (1,3-Bis(2,6-diisopropylphenyl)-1H-imidazol-2(3H)-ylidene)chloro(cinnamyl)palladate(II) | ESD-918843-100MG |
| Cas.: 884879-23-6 | Purity: 97% | (1,3-Bis(2,6-diisopropylphenyl)-1H-imidazol-2(3H)-ylidene)chloro(cinnamyl)palladate(II) | ESD-918843-250MG |
| Cas.: 884879-23-6 | Purity: 97% | (1,3-Bis(2,6-diisopropylphenyl)-1H-imidazol-2(3H)-ylidene)chloro(cinnamyl)palladate(II) | ESD-918843-1G |
| Cas.: 607389-84-4 | Purity: 98% | (R)-1-((S)-2-Diphenylphosphino)ferrocenylethylamine | ESD-918844-100MG |
| Cas.: 607389-84-4 | Purity: 98% | (R)-1-((S)-2-Diphenylphosphino)ferrocenylethylamine | ESD-918844-250MG |
| Cas.: 607389-84-4 | Purity: 98% | (R)-1-((S)-2-Diphenylphosphino)ferrocenylethylamine | ESD-918844-1G |
| Cas.: 1091606-67-5 | Purity: 97%, 99%ee | (1S,2S)-2-(Diphenylphosphino)-1,2-diphenylethanamine | ESD-918845-100MG |
| Cas.: 1091606-67-5 | Purity: 97%, 99%ee | (1S,2S)-2-(Diphenylphosphino)-1,2-diphenylethanamine | ESD-918845-250MG |
| Cas.: 1091606-67-5 | Purity: 97%, 99%ee | (1S,2S)-2-(Diphenylphosphino)-1,2-diphenylethanamine | ESD-918845-1G |
| Cas.: 872574-40-8 | Purity: 95% | 2-Amino-2-(2,4-difluorophenyl)ethanol | ESD-918846-100MG |
| Cas.: 872574-40-8 | Purity: 95% | 2-Amino-2-(2,4-difluorophenyl)ethanol | ESD-918846-250MG |
| Cas.: 872574-40-8 | Purity: 95% | 2-Amino-2-(2,4-difluorophenyl)ethanol | ESD-918846-1G |
| Cas.: 1104637-53-7 | Purity: 90% | Ethynylboronic acid MIDA ester | ESD-918847-100MG |
| Cas.: 1104637-53-7 | Purity: 90% | Ethynylboronic acid MIDA ester | ESD-918847-250MG |
| Cas.: 1104637-53-7 | Purity: 90% | Ethynylboronic acid MIDA ester | ESD-918847-1G |
| Cas.: 1218790-40-9 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918848-100MG |
| Cas.: 1218790-40-9 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918848-250MG |
| Cas.: 1218790-40-9 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918848-1G |
| Cas.: 851756-50-8 | Purity: 95% | (2,6-Dibromophenyl)boronic acid | ESD-918849-100MG |
| Cas.: 851756-50-8 | Purity: 95% | (2,6-Dibromophenyl)boronic acid | ESD-918849-250MG |
| Cas.: 851756-50-8 | Purity: 95% | (2,6-Dibromophenyl)boronic acid | ESD-918849-1G |
| Cas.: 101990-45-8 | Purity: 98% | 2-Bromo-5-(bromomethyl)pyridine | ESD-918850-100MG |
| Cas.: 101990-45-8 | Purity: 98% | 2-Bromo-5-(bromomethyl)pyridine | ESD-918850-250MG |
| Cas.: 101990-45-8 | Purity: 98% | 2-Bromo-5-(bromomethyl)pyridine | ESD-918850-1G |
| Cas.: 2145-27-9 | Purity: 97% | 7-Fluoro-4-hydroxy-2H-chromen-2-one | ESD-918851-100MG |
| Cas.: 2145-27-9 | Purity: 97% | 7-Fluoro-4-hydroxy-2H-chromen-2-one | ESD-918851-250MG |
| Cas.: 2145-27-9 | Purity: 97% | 7-Fluoro-4-hydroxy-2H-chromen-2-one | ESD-918851-1G |
| Cas.: 930790-40-2 | Purity: 97% | 7-Chloro-5-methoxy-1H-pyrrolo[2,3-c]pyridine | ESD-918852-100MG |
| Cas.: 930790-40-2 | Purity: 97% | 7-Chloro-5-methoxy-1H-pyrrolo[2,3-c]pyridine | ESD-918852-250MG |
| Cas.: 930790-40-2 | Purity: 97% | 7-Chloro-5-methoxy-1H-pyrrolo[2,3-c]pyridine | ESD-918852-1G |
| Cas.: 1168135-03-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-918853-100MG |
| Cas.: 1168135-03-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-918853-250MG |
| Cas.: 1168135-03-2 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole | ESD-918853-1G |
| Cas.: 753424-31-6 | Purity: 95% | 6-Methyl-Spiro[Chromene-2,4-Piperidin]-4-(3H)-One | ESD-918854-100MG |
| Cas.: 753424-31-6 | Purity: 95% | 6-Methyl-Spiro[Chromene-2,4-Piperidin]-4-(3H)-One | ESD-918854-250MG |
| Cas.: 753424-31-6 | Purity: 95% | 6-Methyl-Spiro[Chromene-2,4-Piperidin]-4-(3H)-One | ESD-918854-1G |
| Cas.: 689250-54-2 | Purity: 98% | 5-(4-Methoxyphenyl)-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-918855-100MG |
| Cas.: 689250-54-2 | Purity: 98% | 5-(4-Methoxyphenyl)-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-918855-250MG |
| Cas.: 689250-54-2 | Purity: 98% | 5-(4-Methoxyphenyl)-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-918855-1G |
| Cas.: 1025719-23-6 | Purity: 98% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918856-100MG |
| Cas.: 1025719-23-6 | Purity: 98% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918856-250MG |
| Cas.: 1025719-23-6 | Purity: 98% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole | ESD-918856-1G |
| Cas.: 637362-21-1 | Purity: 95% | tert-Butyl 5-chlorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-918857-100MG |
| Cas.: 637362-21-1 | Purity: 95% | tert-Butyl 5-chlorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-918857-250MG |
| Cas.: 637362-21-1 | Purity: 95% | tert-Butyl 5-chlorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-918857-1G |
| Cas.: 434-42-4 | Purity: 95% | (1-Bromo-2,2,2-trifluoroethyl)benzene | ESD-918858-100MG |
| Cas.: 434-42-4 | Purity: 95% | (1-Bromo-2,2,2-trifluoroethyl)benzene | ESD-918858-250MG |
| Cas.: 434-42-4 | Purity: 95% | (1-Bromo-2,2,2-trifluoroethyl)benzene | ESD-918858-1G |
| Cas.: 76509-17-6 | Purity: 95% | 3-(benzyloxy)pyridine | ESD-918859-100MG |
| Cas.: 76509-17-6 | Purity: 95% | 3-(benzyloxy)pyridine | ESD-918859-250MG |
| Cas.: 1233526-60-7 | Purity: 97% | 1-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-918860-100MG |
| Cas.: 1233526-60-7 | Purity: 97% | 1-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-918860-250MG |
| Cas.: 1233526-60-7 | Purity: 97% | 1-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-918860-1G |
| Cas.: 1333154-77-0 | Purity: 95% | Azido-PEG7-amine | ESD-918861-100MG |
| Cas.: 1333154-77-0 | Purity: 95% | Azido-PEG7-amine | ESD-918861-250MG |
| Cas.: 1333154-77-0 | Purity: 95% | Azido-PEG7-amine | ESD-918861-1G |
| Cas.: 60421-20-7 | Purity: 97% | Benzyl 2-amino-2-methylpropanoate hydrochloride | ESD-918862-100MG |
| Cas.: 60421-20-7 | Purity: 97% | Benzyl 2-amino-2-methylpropanoate hydrochloride | ESD-918862-250MG |
| Cas.: 60421-20-7 | Purity: 97% | Benzyl 2-amino-2-methylpropanoate hydrochloride | ESD-918862-1G |
| Cas.: 1204295-87-3 | Purity: 97% | 2-Bromo-4-(difluoromethyl)pyridine | ESD-918863-100MG |
| Cas.: 1204295-87-3 | Purity: 97% | 2-Bromo-4-(difluoromethyl)pyridine | ESD-918863-250MG |
| Cas.: 1204295-87-3 | Purity: 97% | 2-Bromo-4-(difluoromethyl)pyridine | ESD-918863-1G |
| Cas.: 1251009-46-7 | Purity: 97% | 2-(Tert-Butoxycarbonyl)-5-Oxa-2-Azaspiro[3.4]Octane-7-Carboxylic Acid | ESD-918864-100MG |
| Cas.: 1251009-46-7 | Purity: 97% | 2-(Tert-Butoxycarbonyl)-5-Oxa-2-Azaspiro[3.4]Octane-7-Carboxylic Acid | ESD-918864-250MG |
| Cas.: 1251009-46-7 | Purity: 97% | 2-(Tert-Butoxycarbonyl)-5-Oxa-2-Azaspiro[3.4]Octane-7-Carboxylic Acid | ESD-918864-1G |
| Cas.: 881189-74-8 | Purity: 95% | 6-Bromo-4-fluoro-2,3-dihydro-1H-inden-1-one | ESD-918865-100MG |
| Cas.: 881189-74-8 | Purity: 95% | 6-Bromo-4-fluoro-2,3-dihydro-1H-inden-1-one | ESD-918865-250MG |
| Cas.: 881189-74-8 | Purity: 95% | 6-Bromo-4-fluoro-2,3-dihydro-1H-inden-1-one | ESD-918865-1G |
| Cas.: 1202865-03-9 | Purity: 98% | 2-(Di-p-tolylphosphino)benzaldehyde | ESD-918866-100MG |
| Cas.: 1202865-03-9 | Purity: 98% | 2-(Di-p-tolylphosphino)benzaldehyde | ESD-918866-250MG |
| Cas.: 1202865-03-9 | Purity: 98% | 2-(Di-p-tolylphosphino)benzaldehyde | ESD-918866-1G |
| Cas.: 669091-00-3 | Purity: 98% | 2-[Bis(3,5-dimethylphenyl)phosphino]benzaldehyde | ESD-918867-100MG |
| Cas.: 669091-00-3 | Purity: 98% | 2-[Bis(3,5-dimethylphenyl)phosphino]benzaldehyde | ESD-918867-250MG |
| Cas.: 1202865-21-1 | Purity: 98% | 2-[Bis(3,5-di-t-butyl-4-methoxyphenyl)phosphino]benzaldehyde | ESD-918868-100MG |
| Cas.: 1202865-21-1 | Purity: 98% | 2-[Bis(3,5-di-t-butyl-4-methoxyphenyl)phosphino]benzaldehyde | ESD-918868-250MG |
| Cas.: 1202865-21-1 | Purity: 98% | 2-[Bis(3,5-di-t-butyl-4-methoxyphenyl)phosphino]benzaldehyde | ESD-918868-1G |
| Cas.: 190779-64-7 | Purity: 97% | (2,4,6-Triethylbenzene-1,3,5-triyl)trimethanamine trihydrochloride | ESD-918869-100MG |
| Cas.: 190779-64-7 | Purity: 97% | (2,4,6-Triethylbenzene-1,3,5-triyl)trimethanamine trihydrochloride | ESD-918869-250MG |
| Cas.: 369405-27-6 | Purity: 98% | N-((Diisopropylamino)methylene)-N-isopropylpropan-2-aminium tetrafluoroborate | ESD-918870-100MG |
| Cas.: 369405-27-6 | Purity: 98% | N-((Diisopropylamino)methylene)-N-isopropylpropan-2-aminium tetrafluoroborate | ESD-918870-250MG |
| Cas.: 369405-27-6 | Purity: 98% | N-((Diisopropylamino)methylene)-N-isopropylpropan-2-aminium tetrafluoroborate | ESD-918870-1G |
| Cas.: 18024-34-5 | Purity: 98% | Dichloro(DPPE)digold(I) | ESD-918871-100MG |
| Cas.: 18024-34-5 | Purity: 98% | Dichloro(DPPE)digold(I) | ESD-918871-250MG |
| Cas.: 18024-34-5 | Purity: 98% | Dichloro(DPPE)digold(I) | ESD-918871-1G |
| Cas.: 1034287-04-1 | Purity: 95% | 4-Ethynylphenylboronic acid pinacol ester | ESD-918872-100MG |
| Cas.: 1034287-04-1 | Purity: 95% | 4-Ethynylphenylboronic acid pinacol ester | ESD-918872-250MG |
| Cas.: 1034287-04-1 | Purity: 95% | 4-Ethynylphenylboronic acid pinacol ester | ESD-918872-1G |
| Cas.: 925706-40-7 | Purity: 97% | (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2- ium tetrafluoroborate | ESD-918873-100MG |
| Cas.: 925706-40-7 | Purity: 97% | (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2- ium tetrafluoroborate | ESD-918873-250MG |
| Cas.: 925706-40-7 | Purity: 97% | (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2- ium tetrafluoroborate | ESD-918873-1G |
| Cas.: 474432-56-9 | Purity: 95% | Methyl 5-(hydroxymethyl)pyrazolo[1,5-a]pyridine-3-carboxylate | ESD-918874-100MG |
| Cas.: 474432-56-9 | Purity: 95% | Methyl 5-(hydroxymethyl)pyrazolo[1,5-a]pyridine-3-carboxylate | ESD-918874-250MG |
| Cas.: 474432-56-9 | Purity: 95% | Methyl 5-(hydroxymethyl)pyrazolo[1,5-a]pyridine-3-carboxylate | ESD-918874-1G |
| Cas.: 192057-60-6 | Purity: 98%, 99%ee | (R)-1-(2-(Diphenylphosphino)phenyl)ethanamine | ESD-918875-100MG |
| Cas.: 192057-60-6 | Purity: 98%, 99%ee | (R)-1-(2-(Diphenylphosphino)phenyl)ethanamine | ESD-918875-250MG |
| Cas.: 192057-60-6 | Purity: 98%, 99%ee | (R)-1-(2-(Diphenylphosphino)phenyl)ethanamine | ESD-918875-1G |
| Cas.: 550373-32-5 | Purity: 98% | Bis(2-(dicyclohexylphosphino)ethyl)amine | ESD-918877-100MG |
| Cas.: 550373-32-5 | Purity: 98% | Bis(2-(dicyclohexylphosphino)ethyl)amine | ESD-918877-250MG |
| Cas.: 550373-32-5 | Purity: 98% | Bis(2-(dicyclohexylphosphino)ethyl)amine | ESD-918877-1G |
| Cas.: 226387-11-7 | Purity: 97%, 99%ee | (S)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-918878-100MG |
| Cas.: 226387-11-7 | Purity: 97%, 99%ee | (S)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-918878-250MG |
| Cas.: 226387-11-7 | Purity: 97%, 99%ee | (S)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-918878-1G |
| Cas.: 1355170-97-6 | Purity: 98% | 5-(Tert-Butoxycarbonyl)-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A][1,4]Diazepine-2-Carboxylic Acid | ESD-918879-100MG |
| Cas.: 1355170-97-6 | Purity: 98% | 5-(Tert-Butoxycarbonyl)-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A][1,4]Diazepine-2-Carboxylic Acid | ESD-918879-250MG |
| Cas.: 1355170-97-6 | Purity: 98% | 5-(Tert-Butoxycarbonyl)-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A][1,4]Diazepine-2-Carboxylic Acid | ESD-918879-1G |
| Cas.: 134391-76-7 | Purity: 95% | 3-(trimethylsilyl)pyridin-2-yl trifluoromethanesulfonate | ESD-918880-100MG |
| Cas.: 134391-76-7 | Purity: 95% | 3-(trimethylsilyl)pyridin-2-yl trifluoromethanesulfonate | ESD-918880-250MG |
| Cas.: 134391-76-7 | Purity: 95% | 3-(trimethylsilyl)pyridin-2-yl trifluoromethanesulfonate | ESD-918880-1G |
| Cas.: 4887-94-9 | Purity: 95% | 2-Chloro-5-methyl-1H-benzo[d]imidazole | ESD-918881-100MG |
| Cas.: 4887-94-9 | Purity: 95% | 2-Chloro-5-methyl-1H-benzo[d]imidazole | ESD-918881-250MG |
| Cas.: 4887-94-9 | Purity: 95% | 2-Chloro-5-methyl-1H-benzo[d]imidazole | ESD-918881-1G |
| Cas.: 25680-59-5 | Purity: 95% | 3-isopropylpyrazin-2-ol | ESD-918882-100MG |
| Cas.: 25680-59-5 | Purity: 95% | 3-isopropylpyrazin-2-ol | ESD-918882-250MG |
| Cas.: 25680-59-5 | Purity: 95% | 3-isopropylpyrazin-2-ol | ESD-918882-1G |
| Cas.: 1226898-27-6 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4-(1,1-Dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-918883-100MG |
| Cas.: 1226898-27-6 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4-(1,1-Dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-918883-250MG |
| Cas.: 1226898-27-6 | Purity: 98%, 99%ee | (2S)-1-[(4R)-4-(1,1-Dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)ferrocene | ESD-918883-1G |
| Cas.: 1300746-79-5 | Purity: 90% | (1,10-Phenanthroline)(trifluoromethyl)copper(I) | ESD-918884-100MG |
| Cas.: 1300746-79-5 | Purity: 90% | (1,10-Phenanthroline)(trifluoromethyl)copper(I) | ESD-918884-250MG |
| Cas.: 1300746-79-5 | Purity: 90% | (1,10-Phenanthroline)(trifluoromethyl)copper(I) | ESD-918884-1G |
| Cas.: 1337532-51-0 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-918885-100MG |
| Cas.: 1337532-51-0 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-918885-250MG |
| Cas.: 1337532-51-0 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-918885-1G |
| Cas.: 199659-03-5 | Purity: 97% | (S)-benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-918886-100MG |
| Cas.: 199659-03-5 | Purity: 97% | (S)-benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-918886-250MG |
| Cas.: 199659-03-5 | Purity: 97% | (S)-benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-918886-1G |
| Cas.: 97443-80-6 | Purity: 97% | 2-Bromo-1,3,5-tricyclohexylbenzene | ESD-918887-100MG |
| Cas.: 97443-80-6 | Purity: 97% | 2-Bromo-1,3,5-tricyclohexylbenzene | ESD-918887-250MG |
| Cas.: 97443-80-6 | Purity: 97% | 2-Bromo-1,3,5-tricyclohexylbenzene | ESD-918887-1G |
| Cas.: 147409-41-4 | Purity: 98% | 6,6′-Bis(4-(S)-isopropyl-2-oxazolinyl)-2,2′-bipyridine | ESD-918888-100MG |
| Cas.: 147409-41-4 | Purity: 98% | 6,6′-Bis(4-(S)-isopropyl-2-oxazolinyl)-2,2′-bipyridine | ESD-918888-250MG |
| Cas.: 147409-41-4 | Purity: 98% | 6,6′-Bis(4-(S)-isopropyl-2-oxazolinyl)-2,2′-bipyridine | ESD-918888-1G |
| Cas.: 951776-24-2 | Purity: 98% | [1,3-Bis(2,6-di-i-propylphenyl)imidazol-2-ylidene][bis(trifluoromethanesulfonyl)imide]gold(I) | ESD-918889-100MG |
| Cas.: 951776-24-2 | Purity: 98% | [1,3-Bis(2,6-di-i-propylphenyl)imidazol-2-ylidene][bis(trifluoromethanesulfonyl)imide]gold(I) | ESD-918889-250MG |
| Cas.: 951776-24-2 | Purity: 98% | [1,3-Bis(2,6-di-i-propylphenyl)imidazol-2-ylidene][bis(trifluoromethanesulfonyl)imide]gold(I) | ESD-918889-1G |
| Cas.: 942939-38-0 | Purity: 98%, 99%ee | (S)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a’]dinaphthalen-4-yl)-5H-dibenz[b,f]azepine | ESD-918890-100MG |
| Cas.: 942939-38-0 | Purity: 98%, 99%ee | (S)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a’]dinaphthalen-4-yl)-5H-dibenz[b,f]azepine | ESD-918890-250MG |
| Cas.: 942939-38-0 | Purity: 98%, 99%ee | (S)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a’]dinaphthalen-4-yl)-5H-dibenz[b,f]azepine | ESD-918890-1G |
| Cas.: 1040683-00-8 | Purity: 97% | 5-Chloro-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-918891-50MG |
| Cas.: 1040683-00-8 | Purity: 97% | 5-Chloro-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-918891-250MG |
| Cas.: 1040683-00-8 | Purity: 97% | 5-Chloro-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-918891-1G |
| Cas.: 1021176-69-1 | Purity: 98% | 5-(Dicyclohexylphosphino)-1′,3′,5′-triphenyl-[1,4′]-bi-1H-pyrazole | ESD-918892-50MG |
| Cas.: 1021176-69-1 | Purity: 98% | 5-(Dicyclohexylphosphino)-1′,3′,5′-triphenyl-[1,4′]-bi-1H-pyrazole | ESD-918892-250MG |
| Cas.: 1021176-69-1 | Purity: 98% | 5-(Dicyclohexylphosphino)-1′,3′,5′-triphenyl-[1,4′]-bi-1H-pyrazole | ESD-918892-1G |
| Cas.: 852445-81-9 | Purity: 98% | Chloro(1,3-dimesityl-1H-imidazol-2(3H)-ylidene)aurate(I) | ESD-918893-50MG |
| Cas.: 852445-81-9 | Purity: 98% | Chloro(1,3-dimesityl-1H-imidazol-2(3H)-ylidene)aurate(I) | ESD-918893-250MG |
| Cas.: 852445-81-9 | Purity: 98% | Chloro(1,3-dimesityl-1H-imidazol-2(3H)-ylidene)aurate(I) | ESD-918893-1G |
| Cas.: 16920-94-8 | Purity: 99% | POTASSIUM HEXACYANOPLATINATE(IV) | ESD-918894-5G |
| Cas.: 16920-94-8 | Purity: 99% | POTASSIUM HEXACYANOPLATINATE(IV) | ESD-918894-250MG |
| Cas.: 16920-94-8 | Purity: 99% | POTASSIUM HEXACYANOPLATINATE(IV) | ESD-918894-1G |
| Cas.: 64312-89-6 | Purity: 98% | (+/-)-1-METHOXY-1-(TRIFLUOROMETHYL)PHENYLACETYL CHLORIDE | ESD-918895-5G |
| Cas.: 64312-89-6 | Purity: 98% | (+/-)-1-METHOXY-1-(TRIFLUOROMETHYL)PHENYLACETYL CHLORIDE | ESD-918895-250MG |
| Cas.: 64312-89-6 | Purity: 98% | (+/-)-1-METHOXY-1-(TRIFLUOROMETHYL)PHENYLACETYL CHLORIDE | ESD-918895-1G |
| Cas.: 55854-45-0 | Purity: 97% | 5-METHYL-2-THIOPHENESULFONYL CHLORIDE | ESD-918896-5G |
| Cas.: 55854-45-0 | Purity: 97% | 5-METHYL-2-THIOPHENESULFONYL CHLORIDE | ESD-918896-250MG |
| Cas.: 55854-45-0 | Purity: 97% | 5-METHYL-2-THIOPHENESULFONYL CHLORIDE | ESD-918896-1G |
| Cas.: 62927-99-5 | Purity: 95% | CYCLOPENTADIENYLMOLYBDENUM (V) TETRACHLORIDE | ESD-918897-5G |
| Cas.: 62927-99-5 | Purity: 95% | CYCLOPENTADIENYLMOLYBDENUM (V) TETRACHLORIDE | ESD-918897-250MG |
| Cas.: 62927-99-5 | Purity: 95% | CYCLOPENTADIENYLMOLYBDENUM (V) TETRACHLORIDE | ESD-918897-1G |
| Cas.: 88863-33-6 | Purity: 96% | STRONTIUM ISOPROPOXIDE | ESD-918898-5G |
| Cas.: 88863-33-6 | Purity: 96% | STRONTIUM ISOPROPOXIDE | ESD-918898-25G |
| Cas.: 88863-33-6 | Purity: 96% | STRONTIUM ISOPROPOXIDE | ESD-918898-1G |
| Cas.: 81453-98-7 | Purity: 98% | 3-Acetyl-1-(phenylsulfonyl)pyrrole | ESD-918899-5G |
| Cas.: 81453-98-7 | Purity: 98% | 3-Acetyl-1-(phenylsulfonyl)pyrrole | ESD-918899-25G |
| Cas.: 81453-98-7 | Purity: 98% | 3-Acetyl-1-(phenylsulfonyl)pyrrole | ESD-918899-1G |
| Cas.: 10304-39-9 | Purity: 97% | 8-(TOSYLAMINO)QUINOLINE | ESD-918900-5G |
| Cas.: 10304-39-9 | Purity: 97% | 8-(TOSYLAMINO)QUINOLINE | ESD-918900-25G |
| Cas.: 10304-39-9 | Purity: 97% | 8-(TOSYLAMINO)QUINOLINE | ESD-918900-1G |
| Cas.: 13618-91-2 | Purity: 98% | 4,5,6,7-Tetrahydroindole | ESD-918901-100MG |
| Cas.: 13618-91-2 | Purity: 98% | 4,5,6,7-Tetrahydroindole | ESD-918901-200MG |
| Cas.: 13618-91-2 | Purity: 98% | 4,5,6,7-Tetrahydroindole | ESD-918901-1G |
| Cas.: 5257-24-9 | Purity: 97% | 3-Methyl-1H-indole-2-carboxaldehyde | ESD-918902-250MG |
| Cas.: 5257-24-9 | Purity: 97% | 3-Methyl-1H-indole-2-carboxaldehyde | ESD-918902-100MG |
| Cas.: 5257-24-9 | Purity: 97% | 3-Methyl-1H-indole-2-carboxaldehyde | ESD-918902-1G |
| Cas.: 22202-68-2 | Purity: ≥98% (titration) | ALPHA-KETOGLUTARIC ACID MONOSODIUM SALT | ESD-918903-100G |
| Cas.: 22202-68-2 | Purity: ≥98% (titration) | ALPHA-KETOGLUTARIC ACID MONOSODIUM SALT | ESD-918903-1G |
| Cas.: 22202-68-2 | Purity: ≥98% (titration) | ALPHA-KETOGLUTARIC ACID MONOSODIUM SALT | ESD-918903-1KG |
| Cas.: 415678-40-9 | Purity: 98% | (2S,5S)-(–)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imid azolidinone | ESD-918904-100MG |
| Cas.: 415678-40-9 | Purity: 98% | (2S,5S)-(–)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imid azolidinone | ESD-918904-250MG |
| Cas.: 415678-40-9 | Purity: 98% | (2S,5S)-(–)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imid azolidinone | ESD-918904-1G |
| Cas.: 877303-84-9 | Purity: 98% | (2R,5R)-(+)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imidaz olidinone | ESD-918905-100MG |
| Cas.: 877303-84-9 | Purity: 98% | (2R,5R)-(+)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imidaz olidinone | ESD-918905-250MG |
| Cas.: 877303-84-9 | Purity: 98% | (2R,5R)-(+)-5-Benzyl-3-methyl-2-(5-methyl2-furyl)-4-imidaz olidinone | ESD-918905-1G |
| Cas.: 12170-97-7 | Purity: 98% | Dichloro(2,6,10-dodecatriene-1,12-diyl)ruthenium(IV) | ESD-918906-100MG |
| Cas.: 12170-97-7 | Purity: 98% | Dichloro(2,6,10-dodecatriene-1,12-diyl)ruthenium(IV) | ESD-918906-250MG |
| Cas.: 12170-97-7 | Purity: 98% | Dichloro(2,6,10-dodecatriene-1,12-diyl)ruthenium(IV) | ESD-918906-1G |
| Cas.: 1246841-00-8 | Purity: 98% | (S)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine | ESD-918907-100MG |
| Cas.: 1246841-00-8 | Purity: 98% | (S)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine | ESD-918907-250MG |
| Cas.: 1246841-00-8 | Purity: 98% | (S)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine | ESD-918907-1G |
| Cas.: 223121-01-5 | Purity: 98% | (1S)-1-[Bis(1,1-dimethylethyl)phosphino]-2-[(1S)-1-(diphenylphosphino)ethyl]ferrocene | ESD-918908-100MG |
| Cas.: 223121-01-5 | Purity: 98% | (1S)-1-[Bis(1,1-dimethylethyl)phosphino]-2-[(1S)-1-(diphenylphosphino)ethyl]ferrocene | ESD-918908-250MG |
| Cas.: 223121-01-5 | Purity: 98% | (1S)-1-[Bis(1,1-dimethylethyl)phosphino]-2-[(1S)-1-(diphenylphosphino)ethyl]ferrocene | ESD-918908-1G |
| Cas.: 53590-48-0 | Purity: 95% | (5-bromo-1H-indol-2-yl)methanol | ESD-918909-100MG |
| Cas.: 53590-48-0 | Purity: 95% | (5-bromo-1H-indol-2-yl)methanol | ESD-918909-250MG |
| Cas.: 53590-48-0 | Purity: 95% | (5-bromo-1H-indol-2-yl)methanol | ESD-918909-1G |
| Cas.: 1034449-15-4 | Purity: 98% | 1,3-Dicyclohexyl-1H-benzo[d]imidazol-3-ium chloride | ESD-918910-100MG |
| Cas.: 1034449-15-4 | Purity: 98% | 1,3-Dicyclohexyl-1H-benzo[d]imidazol-3-ium chloride | ESD-918910-250MG |
| Cas.: 1034449-15-4 | Purity: 98% | 1,3-Dicyclohexyl-1H-benzo[d]imidazol-3-ium chloride | ESD-918910-1G |
| Cas.: 849924-78-3 | Purity: 98% | (RP,R’P)-1,1′-Bis(dicyclohexylphosphino)-2,2′-bis[(S)-α-(dimethylamino)benzyl]ferrocene | ESD-918911-50MG |
| Cas.: 849924-78-3 | Purity: 98% | (RP,R’P)-1,1′-Bis(dicyclohexylphosphino)-2,2′-bis[(S)-α-(dimethylamino)benzyl]ferrocene | ESD-918911-250MG |
| Cas.: 849924-78-3 | Purity: 98% | (RP,R’P)-1,1′-Bis(dicyclohexylphosphino)-2,2′-bis[(S)-α-(dimethylamino)benzyl]ferrocene | ESD-918911-1G |
| Cas.: 849924-48-7 | Purity: 98% | (S)-1-{(S)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5-xylyl)phosphine | ESD-918912-50MG |
| Cas.: 849924-48-7 | Purity: 98% | (S)-1-{(S)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5-xylyl)phosphine | ESD-918912-250MG |
| Cas.: 849924-48-7 | Purity: 98% | (S)-1-{(S)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5-xylyl)phosphine | ESD-918912-1G |
| Cas.: 352655-61-9 | Purity: 98% | (R)-(-)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918913-50MG |
| Cas.: 352655-61-9 | Purity: 98% | (R)-(-)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918913-250MG |
| Cas.: 352655-61-9 | Purity: 98% | (R)-(-)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918913-1G |
| Cas.: 910134-30-4 | Purity: 98% | (S)-(+)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918914-50MG |
| Cas.: 910134-30-4 | Purity: 98% | (S)-(+)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918914-250MG |
| Cas.: 910134-30-4 | Purity: 98% | (S)-(+)-2,2′-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-918914-1G |
| Cas.: 111822-69-6 | Purity: 98% | (R)-3,3′-Bis(triphenylsilyl)-[1,1′-binaphthalene]-2,2′-diol | ESD-918915-50MG |
| Cas.: 111822-69-6 | Purity: 98% | (R)-3,3′-Bis(triphenylsilyl)-[1,1′-binaphthalene]-2,2′-diol | ESD-918915-250MG |
| Cas.: 111822-69-6 | Purity: 98% | (R)-3,3′-Bis(triphenylsilyl)-[1,1′-binaphthalene]-2,2′-diol | ESD-918915-1G |
| Cas.: 913617-04-6 | Purity: 97% | (11bR)-2,6-Bis(diphenylphosphino)-N,N-dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-918916-50MG |
| Cas.: 913617-04-6 | Purity: 97% | (11bR)-2,6-Bis(diphenylphosphino)-N,N-dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-918916-250MG |
| Cas.: 913617-04-6 | Purity: 97% | (11bR)-2,6-Bis(diphenylphosphino)-N,N-dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-918916-1G |
| Cas.: 71186-53-3 | Purity: ≥97% (HPLC) | 5-Hydroxydecanoate Sodium Salt | ESD-918917-25MG |
| Cas.: 71186-53-3 | Purity: ≥97% (HPLC) | 5-Hydroxydecanoate Sodium Salt | ESD-918917-100MG |
| Cas.: 71186-53-3 | Purity: ≥97% (HPLC) | 5-Hydroxydecanoate Sodium Salt | ESD-918917-500MG |
| Cas.: 187733-50-2 | Purity: 98% | (R)-1-[(R)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldi-tert-butylphosphine | ESD-918918-50MG |
| Cas.: 187733-50-2 | Purity: 98% | (R)-1-[(R)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldi-tert-butylphosphine | ESD-918918-100MG |
| Cas.: 187733-50-2 | Purity: 98% | (R)-1-[(R)-2-[Bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}ethyldi-tert-butylphosphine | ESD-918918-250MG |
| Cas.: 1539-06-6 | Purity: 98% | 4-Acetamido-3-Nitrobenzoic Acid | ESD-918919-5G |
| Cas.: 1539-06-6 | Purity: 98% | 4-Acetamido-3-Nitrobenzoic Acid | ESD-918919-25G |
| Cas.: 1539-06-6 | Purity: 98% | 4-Acetamido-3-Nitrobenzoic Acid | ESD-918919-100G |
| Cas.: 316173-57-6 | Purity: 98% | 2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin- 5-amine | ESD-918920-5MG |
| Cas.: 316173-57-6 | Purity: 98% | 2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin- 5-amine | ESD-918920-25MG |
| Cas.: 316173-57-6 | Purity: 98% | 2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin- 5-amine | ESD-918920-100MG |
| Cas.: 24683-26-9 | Purity: 98% | Ethyl 4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-918921-5G |
| Cas.: 24683-26-9 | Purity: 98% | Ethyl 4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-918921-25G |
| Cas.: 24683-26-9 | Purity: 98% | Ethyl 4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxylate 1,1-dioxide | ESD-918921-100G |
| Cas.: 21816-08-0 | Purity: 97% | 3-Bromoadamantane-1-carboxylic acid | ESD-918922-1G |
| Cas.: 21816-08-0 | Purity: 97% | 3-Bromoadamantane-1-carboxylic acid | ESD-918922-5G |
| Cas.: 21816-08-0 | Purity: 97% | 3-Bromoadamantane-1-carboxylic acid | ESD-918922-25G |
| Cas.: 7652-29-1 | Purity: 97% | 6-chloro-2H-1,4-benzoxazin-3(4H)-one | ESD-918923-1G |
| Cas.: 7652-29-1 | Purity: 97% | 6-chloro-2H-1,4-benzoxazin-3(4H)-one | ESD-918923-5G |
| Cas.: 7652-29-1 | Purity: 97% | 6-chloro-2H-1,4-benzoxazin-3(4H)-one | ESD-918923-25G |
| Cas.: 7747-35-5 | Purity: 98% | 7a-Ethyltetrahydro-1H-oxazolo[3,4-c]oxazole | ESD-918924-1G |
| Cas.: 7747-35-5 | Purity: 98% | 7a-Ethyltetrahydro-1H-oxazolo[3,4-c]oxazole | ESD-918924-5G |
| Cas.: 7747-35-5 | Purity: 98% | 7a-Ethyltetrahydro-1H-oxazolo[3,4-c]oxazole | ESD-918924-25G |
| Cas.: 34648-11-8 | Purity: ≥95% | 5-(TRICHLOROMETHYL)-4,5-DIHYDROISOXAZOL-5-OL | ESD-918925-1G |
| Cas.: 34648-11-8 | Purity: ≥95% | 5-(TRICHLOROMETHYL)-4,5-DIHYDROISOXAZOL-5-OL | ESD-918925-5G |
| Cas.: 34648-11-8 | Purity: ≥95% | 5-(TRICHLOROMETHYL)-4,5-DIHYDROISOXAZOL-5-OL | ESD-918925-25G |
| Cas.: 65038-36-0 | Purity: 98% | 1,4-Bis(dicyclohexylphosphino)butane | ESD-918926-1G |
| Cas.: 65038-36-0 | Purity: 98% | 1,4-Bis(dicyclohexylphosphino)butane | ESD-918926-5G |
| Cas.: 65038-36-0 | Purity: 98% | 1,4-Bis(dicyclohexylphosphino)butane | ESD-918926-25G |
| Cas.: 56227-55-5 | Purity: 97% | 1-benzoylpiperazine hydrochloride | ESD-918927-1G |
| Cas.: 56227-55-5 | Purity: 97% | 1-benzoylpiperazine hydrochloride | ESD-918927-5G |
| Cas.: 56227-55-5 | Purity: 97% | 1-benzoylpiperazine hydrochloride | ESD-918927-25G |
| Cas.: 6148-34-1 | Purity: 95% | Methyl 2,5-dimethylfuran-3-carboxylate | ESD-918928-1G |
| Cas.: 6148-34-1 | Purity: 95% | Methyl 2,5-dimethylfuran-3-carboxylate | ESD-918928-5G |
| Cas.: 6148-34-1 | Purity: 95% | Methyl 2,5-dimethylfuran-3-carboxylate | ESD-918928-25G |
| Cas.: 439937-61-8 | Purity: 98% | 4-(3-BUTYL-2,3-DIHYDRO-1H-IMIDAZOL-1-YL)BUTANE-1-SULPHONIC ACID | ESD-918929-25G |
| Cas.: 439937-61-8 | Purity: 98% | 4-(3-BUTYL-2,3-DIHYDRO-1H-IMIDAZOL-1-YL)BUTANE-1-SULPHONIC ACID | ESD-918929-50G |
| Cas.: 439937-61-8 | Purity: 98% | 4-(3-BUTYL-2,3-DIHYDRO-1H-IMIDAZOL-1-YL)BUTANE-1-SULPHONIC ACID | ESD-918929-5G |
| Cas.: 13455-12-4 | Purity: 98%, Pt: 55.0 ± 1.3% | Platinum(II) Bromide | ESD-918930-250MG |
| Cas.: 13455-12-4 | Purity: 98%, Pt: 55.0 ± 1.3% | Platinum(II) Bromide | ESD-918930-1G |
| Cas.: 26934-35-0 | Purity: 95% | 4-(3-(Dimethylamino)propoxy)benzaldehyde | ESD-918931-250MG |
| Cas.: 26934-35-0 | Purity: 95% | 4-(3-(Dimethylamino)propoxy)benzaldehyde | ESD-918931-1G |
| Cas.: 26934-35-0 | Purity: 95% | 4-(3-(Dimethylamino)propoxy)benzaldehyde | ESD-918931-5G |
| Cas.: 1998-66-9 | Purity: 98% | 4-Bromo-2,3,5,6-tetrafluoroaniline | ESD-918932-250MG |
| Cas.: 1998-66-9 | Purity: 98% | 4-Bromo-2,3,5,6-tetrafluoroaniline | ESD-918932-1G |
| Cas.: 1998-66-9 | Purity: 98% | 4-Bromo-2,3,5,6-tetrafluoroaniline | ESD-918932-5G |
| Cas.: 40365-61-5 | Purity: 95% | 2-(But-3-yn-1-Yloxy)Tetrahydropyran | ESD-918933-250MG |
| Cas.: 40365-61-5 | Purity: 95% | 2-(But-3-yn-1-Yloxy)Tetrahydropyran | ESD-918933-1G |
| Cas.: 40365-61-5 | Purity: 95% | 2-(But-3-yn-1-Yloxy)Tetrahydropyran | ESD-918933-5G |
| Cas.: 3230-23-7 | Purity: 95% | 4-Ethylpiperidine | ESD-918934-250MG |
| Cas.: 3230-23-7 | Purity: 95% | 4-Ethylpiperidine | ESD-918934-1G |
| Cas.: 3230-23-7 | Purity: 95% | 4-Ethylpiperidine | ESD-918934-5G |
| Cas.: 160347-90-0 | Purity: 97% | (R)-Boc-5-oxopyrrolidine-2-carboxylic acid | ESD-918935-250MG |
| Cas.: 160347-90-0 | Purity: 97% | (R)-Boc-5-oxopyrrolidine-2-carboxylic acid | ESD-918935-1G |
| Cas.: 160347-90-0 | Purity: 97% | (R)-Boc-5-oxopyrrolidine-2-carboxylic acid | ESD-918935-5G |
| Cas.: 58653-97-7 | Purity: 97% | Methyl2-methylglycidate | ESD-918936-250MG |
| Cas.: 58653-97-7 | Purity: 97% | Methyl2-methylglycidate | ESD-918936-1G |
| Cas.: 58653-97-7 | Purity: 97% | Methyl2-methylglycidate | ESD-918936-5G |
| Cas.: 20443-74-7 | Purity: 97% | 4-(4-chlorophenyl)benzenesulfonyl chloride | ESD-918937-250MG |
| Cas.: 20443-74-7 | Purity: 97% | 4-(4-chlorophenyl)benzenesulfonyl chloride | ESD-918937-1G |
| Cas.: 20443-74-7 | Purity: 97% | 4-(4-chlorophenyl)benzenesulfonyl chloride | ESD-918937-5G |
| Cas.: 65705-44-4 | Purity: 98% | 2-Amino-4-(4-bromophenyl)-5-methylthiazole | ESD-918938-250MG |
| Cas.: 65705-44-4 | Purity: 98% | 2-Amino-4-(4-bromophenyl)-5-methylthiazole | ESD-918938-1G |
| Cas.: 65705-44-4 | Purity: 98% | 2-Amino-4-(4-bromophenyl)-5-methylthiazole | ESD-918938-5G |
| Cas.: 53370-51-7 | Purity: 95% | N’-hydroxy-2-thiophenecarboximidamide | ESD-918939-250MG |
| Cas.: 53370-51-7 | Purity: 95% | N’-hydroxy-2-thiophenecarboximidamide | ESD-918939-1G |
| Cas.: 53370-51-7 | Purity: 95% | N’-hydroxy-2-thiophenecarboximidamide | ESD-918939-5G |
| Cas.: 4604-72-2 | Purity: 97% | Pyrazine-2-carbothioamide | ESD-918940-250MG |
| Cas.: 4604-72-2 | Purity: 97% | Pyrazine-2-carbothioamide | ESD-918940-1G |
| Cas.: 4604-72-2 | Purity: 97% | Pyrazine-2-carbothioamide | ESD-918940-5G |
| Cas.: 3017-70-7 | Purity: ≥95% | 2-Bromo-3-methyl-2-butene | ESD-918941-250MG |
| Cas.: 3017-70-7 | Purity: ≥95% | 2-Bromo-3-methyl-2-butene | ESD-918941-1G |
| Cas.: 3017-70-7 | Purity: ≥95% | 2-Bromo-3-methyl-2-butene | ESD-918941-5G |
| Cas.: 34702-60-8 | Purity: ≥97% | BOC-L-Pentafluorophenylalanine | ESD-918942-250MG |
| Cas.: 34702-60-8 | Purity: ≥97% | BOC-L-Pentafluorophenylalanine | ESD-918942-1G |
| Cas.: 34702-60-8 | Purity: ≥97% | BOC-L-Pentafluorophenylalanine | ESD-918942-5G |
| Cas.: 23936-11-0 | Purity: 97%(GC) | 3-Methyl-piperazin-2-one | ESD-918943-250MG |
| Cas.: 23936-11-0 | Purity: 97%(GC) | 3-Methyl-piperazin-2-one | ESD-918943-1G |
| Cas.: 23936-11-0 | Purity: 97%(GC) | 3-Methyl-piperazin-2-one | ESD-918943-5G |
| Cas.: 17310-26-8 | Purity: ≥95% | 3-(2-Phenylhydrazono)-1H-indole-2-one | ESD-918944-250MG |
| Cas.: 17310-26-8 | Purity: ≥95% | 3-(2-Phenylhydrazono)-1H-indole-2-one | ESD-918944-1G |
| Cas.: 17310-26-8 | Purity: ≥95% | 3-(2-Phenylhydrazono)-1H-indole-2-one | ESD-918944-5G |
| Cas.: 94741-70-5 | Purity: 97% | 4-Amino-2-bromopyrimidine-5-carbonitrile | ESD-918945-250MG |
| Cas.: 94741-70-5 | Purity: 97% | 4-Amino-2-bromopyrimidine-5-carbonitrile | ESD-918945-1G |
| Cas.: 94741-70-5 | Purity: 97% | 4-Amino-2-bromopyrimidine-5-carbonitrile | ESD-918945-5G |
| Cas.: 175137-35-6 | Purity: 97% | Ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-918946-250MG |
| Cas.: 175137-35-6 | Purity: 97% | Ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-918946-1G |
| Cas.: 175137-35-6 | Purity: 97% | Ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-918946-5G |
| Cas.: 14651-42-4 | Purity: 98% | 1-(Bromomethyl)adamantane | ESD-918947-250MG |
| Cas.: 14651-42-4 | Purity: 98% | 1-(Bromomethyl)adamantane | ESD-918947-1G |
| Cas.: 14651-42-4 | Purity: 98% | 1-(Bromomethyl)adamantane | ESD-918947-5G |
| Cas.: 59760-01-9 | Purity: 97% | (S)-3-((Benzyloxy)carbonyl)-2-oxoimidazolidine-4-carboxylic acid | ESD-918948-250MG |
| Cas.: 59760-01-9 | Purity: 97% | (S)-3-((Benzyloxy)carbonyl)-2-oxoimidazolidine-4-carboxylic acid | ESD-918948-1G |
| Cas.: 59760-01-9 | Purity: 97% | (S)-3-((Benzyloxy)carbonyl)-2-oxoimidazolidine-4-carboxylic acid | ESD-918948-5G |
| Cas.: 89856-44-0 | Purity: 97% | 2-AMINO-5-BROMO-4 6-DIMETHYLPYRIDINE | ESD-918949-200MG |
| Cas.: 89856-44-0 | Purity: 97% | 2-AMINO-5-BROMO-4 6-DIMETHYLPYRIDINE | ESD-918949-1G |
| Cas.: 89856-44-0 | Purity: 97% | 2-AMINO-5-BROMO-4 6-DIMETHYLPYRIDINE | ESD-918949-5G |
| Cas.: 74470-23-8 | Purity: 98% | 2-(Methylthio)nicotinic acid | ESD-918950-100MG |
| Cas.: 74470-23-8 | Purity: 98% | 2-(Methylthio)nicotinic acid | ESD-918950-250MG |
| Cas.: 74470-23-8 | Purity: 98% | 2-(Methylthio)nicotinic acid | ESD-918950-1G |
| Cas.: 62497-19-2 | Purity: ≥97% | 2,4,6-Tris(4-fluorophenyl)pyrylium tetrafluoroborate | ESD-918951-100MG |
| Cas.: 62497-19-2 | Purity: ≥97% | 2,4,6-Tris(4-fluorophenyl)pyrylium tetrafluoroborate | ESD-918951-250MG |
| Cas.: 62497-19-2 | Purity: ≥97% | 2,4,6-Tris(4-fluorophenyl)pyrylium tetrafluoroborate | ESD-918951-1G |
| Cas.: 580-34-7 | Purity: ≥97% | 2,4,6-Tris(4-methoxyphenyl)pyrylium tetrafluoroborate | ESD-918952-100MG |
| Cas.: 580-34-7 | Purity: ≥97% | 2,4,6-Tris(4-methoxyphenyl)pyrylium tetrafluoroborate | ESD-918952-250MG |
| Cas.: 580-34-7 | Purity: ≥97% | 2,4,6-Tris(4-methoxyphenyl)pyrylium tetrafluoroborate | ESD-918952-1G |
| Cas.: 37873-29-3 | Purity: 97% | 5,7-Dimethyl-8-hydroxyquinoline | ESD-918953-100MG |
| Cas.: 37873-29-3 | Purity: 97% | 5,7-Dimethyl-8-hydroxyquinoline | ESD-918953-250MG |
| Cas.: 37873-29-3 | Purity: 97% | 5,7-Dimethyl-8-hydroxyquinoline | ESD-918953-1G |
| Cas.: 150639-33-1 | Purity: 98% | 2-((S)-4-Phenyl-4,5-dihydrooxazol-2-yl)-2-((S)-4-phenyloxazolidin-2-ylidene)acetonitrile | ESD-918954-100MG |
| Cas.: 150639-33-1 | Purity: 98% | 2-((S)-4-Phenyl-4,5-dihydrooxazol-2-yl)-2-((S)-4-phenyloxazolidin-2-ylidene)acetonitrile | ESD-918954-250MG |
| Cas.: 150639-33-1 | Purity: 98% | 2-((S)-4-Phenyl-4,5-dihydrooxazol-2-yl)-2-((S)-4-phenyloxazolidin-2-ylidene)acetonitrile | ESD-918954-1G |
| Cas.: 175277-44-8 | Purity: ≥95% | (E)-N’-hydroxy-5-(trifluoromethyl)pyridine-2-carboximidamide | ESD-918955-100MG |
| Cas.: 175277-44-8 | Purity: ≥95% | (E)-N’-hydroxy-5-(trifluoromethyl)pyridine-2-carboximidamide | ESD-918955-250MG |
| Cas.: 175277-44-8 | Purity: ≥95% | (E)-N’-hydroxy-5-(trifluoromethyl)pyridine-2-carboximidamide | ESD-918955-1G |
| Cas.: 19429-30-2 | Purity: 98% | Di-tert-butyltin dichloride | ESD-918956-100MG |
| Cas.: 19429-30-2 | Purity: 98% | Di-tert-butyltin dichloride | ESD-918956-500MG |
| Cas.: 2503-13-1 | Purity: ≥98% | Ennlatin A | ESD-918957-100ΜG |
| Cas.: 2503-13-1 | Purity: ≥98% | Ennlatin A | ESD-918957-500ΜG |
| Cas.: 15627-86-8 | Purity: 99% | Calcium perchlorate tetrahydrate, pure | ESD-918958-100G |
| Cas.: 117235-10-6 | Purity: 97% | 3-Mercaptopropionic acid NHS ester | ESD-918959-100MG |
| Cas.: 60177-39-1 | Amberlite IRA-400 chloride form | ESD-918960-100G | |
| Cas.: 60177-39-1 | Amberlite IRA-400 chloride form | ESD-918960-500G | |
| Cas.: 831226-39-2 | Purity: 97% | (R,R)-(+)-2,2′-Bis[(S)-(N,N-dimethylamino)(phenyl)methyl]-1,1′-bis(di(2-methylphenyl)phosphino)ferrocene | ESD-918961-100MG |
| Cas.: 831226-39-2 | Purity: 97% | (R,R)-(+)-2,2′-Bis[(S)-(N,N-dimethylamino)(phenyl)methyl]-1,1′-bis(di(2-methylphenyl)phosphino)ferrocene | ESD-918961-500MG |
| Cas.: 16473-11-3 | Purity: 97% | BICYCLO[3.3.1]NONANE-2,6-DIONE | ESD-918962-100MG |
| Cas.: 16473-11-3 | Purity: 97% | BICYCLO[3.3.1]NONANE-2,6-DIONE | ESD-918962-500MG |
| Cas.: 166172-69-6 | BIS(3,5-DI(TRIFLUOROMETHYL)PHENYL)PHOSPHINE | ESD-918963-100MG | |
| Cas.: 25036-25-3 | Poly(Bisphenol A-co-epichlorohydrin) glycidyl end-capped | ESD-918964-100ML | |
| Cas.: 25036-25-3 | Poly(Bisphenol A-co-epichlorohydrin) glycidyl end-capped | ESD-918964-500ML | |
| Cas.: 934762-68-2 | Purity: 96% | (r)-n-((1r,2r)-2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)cyclohexyl)-2-methylpropane-2-sulfinamide | ESD-918965-100MG |
| Cas.: 934762-68-2 | Purity: 96% | (r)-n-((1r,2r)-2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)cyclohexyl)-2-methylpropane-2-sulfinamide | ESD-918965-500MG |
| Cas.: 27661-42-3 | Purity: ~90% (T) | BIS(2,4,4-TRIMETHYLPENTYL)PHOSPHINIC ACID | ESD-918966-100ML |
| Cas.: 27661-42-3 | Purity: ~90% (T) | BIS(2,4,4-TRIMETHYLPENTYL)PHOSPHINIC ACID | ESD-918966-500ML |
| Cas.: 62669-60-7 | OXAZINE 170 PERCHLORATE | ESD-918967-100MG | |
| Cas.: 62669-60-7 | OXAZINE 170 PERCHLORATE | ESD-918967-500MG | |
| Cas.: 40951-21-1 | Purity: ≥95.0% (GC) | 2-hydroxypentanedioic acid | ESD-918968-100MG |
| Cas.: 40951-21-1 | Purity: ≥95.0% (GC) | 2-hydroxypentanedioic acid | ESD-918968-500MG |
| Cas.: 29925-17-5 | Purity: ≥95% | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one solid | ESD-918969-100MG |
| Cas.: 35873-49-5 | Purity: ≥98% (HPLC) | 8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE | ESD-918970-100MG |
| Cas.: 35873-49-5 | Purity: ≥98% (HPLC) | 8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE | ESD-918970-500MG |
| Cas.: 857303-87-8 | Purity: 97% | (5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID | ESD-918971-2G |
| Cas.: 857303-87-8 | Purity: 97% | (5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID | ESD-918971-500MG |
| Cas.: 918871-44-0 | Purity: 90% | ruthenium, dichloro-[[2-isopropoxy-5-(n-dimethylamino-sulfonyl)phenyl]methylene](tricyclohexylphosphine) | ESD-918972-2G |
| Cas.: 918871-44-0 | Purity: 90% | ruthenium, dichloro-[[2-isopropoxy-5-(n-dimethylamino-sulfonyl)phenyl]methylene](tricyclohexylphosphine) | ESD-918972-500MG |
| Cas.: 516-92-7 | Purity: ≥95% | 5BETA-CHOLESTAN-3ALPHA-OL | ESD-918973-1G |
| Cas.: 516-92-7 | Purity: ≥95% | 5BETA-CHOLESTAN-3ALPHA-OL | ESD-918973-500MG |
| Cas.: 6154-45-6 | N-Benzoyl-L-tyrosine p-nitroanilide | ESD-918974-1G | |
| Cas.: 6154-45-6 | N-Benzoyl-L-tyrosine p-nitroanilide | ESD-918974-500MG | |
| Cas.: 149341-33-3 | Purity: 95.0% (qNMR) | (S)-()-1-(2-Diphenylphosphino-1-naphthyl)isoquinoline | ESD-918975-250MG |
| Cas.: 149341-33-3 | Purity: 95.0% (qNMR) | (S)-()-1-(2-Diphenylphosphino-1-naphthyl)isoquinoline | ESD-918975-50MG |
| Cas.: 927-20-8 | Purity: ~85% (KT) | DL-ALPHA-GLYCEROL PHOSPHATE MAGNESIUM SALT HYDRATE | ESD-918976-50G |
| Cas.: 922-54-3 | Purity: ≥98% (TLC) | (2S,6R)-2,6-Diaminoheptanedioic acid | ESD-918977-250MG |
| Cas.: 922-54-3 | Purity: ≥98% (TLC) | (2S,6R)-2,6-Diaminoheptanedioic acid | ESD-918977-50MG |
| Cas.: 142962-95-6 | (S)-Ru(OAc)2(H8-BINAP) | ESD-918978-100MG | |
| Cas.: 142962-95-6 | (S)-Ru(OAc)2(H8-BINAP) | ESD-918978-50MG | |
| Cas.: 69113-63-9 | Purity: ~95% (TLC) | (±)-6-Methyl-5,6,7,8-tetrahydropterine dihydrochloride | ESD-918979-100MG |
| Cas.: 69113-63-9 | Purity: ~95% (TLC) | (±)-6-Methyl-5,6,7,8-tetrahydropterine dihydrochloride | ESD-918979-50MG |
| Cas.: 55259-49-9 | Purity: 97% | Tetramethyltetraselenafulvalene | ESD-918980-10MG |
| Cas.: 55259-49-9 | Purity: 97% | Tetramethyltetraselenafulvalene | ESD-918980-50MG |
| Cas.: 63348-81-2 | Purity: ≥95% | BORON MONOCHLORIDE-METHYL SULFIDE COMPLEX | ESD-918981-10G |
| Cas.: 63348-81-2 | Purity: ≥95% | BORON MONOCHLORIDE-METHYL SULFIDE COMPLEX | ESD-918981-50G |
| Cas.: 76231-76-0 | Purity: ~70% alpha-thujone basis, ~10% beta-thujone basis | ALPHA+BETA-THUJONE | ESD-918982-10ML |
| Cas.: 76231-76-0 | Purity: ~70% alpha-thujone basis, ~10% beta-thujone basis | ALPHA+BETA-THUJONE | ESD-918982-50ML |
| Cas.: 62284-30-4 | Purity: 97.0% (HPLC) | 1-(Azidomethyl)-2-fluorobenzene solution | ESD-918983-10ML |
| Cas.: 62284-30-4 | Purity: 97.0% (HPLC) | 1-(Azidomethyl)-2-fluorobenzene solution | ESD-918983-50ML |
| Cas.: 3296-05-7 | Purity: ≥95.0% (HPLC) | 1-Azido-4-chlorobenzene solution | ESD-918984-10ML |
| Cas.: 3296-05-7 | Purity: ≥95.0% (HPLC) | 1-Azido-4-chlorobenzene solution | ESD-918984-50ML |
| Cas.: 2101-87-3 | Purity: ≥90.0% (HPLC) | 4-METHOXYPHENYLAZIDE | ESD-918985-10ML |
| Cas.: 2101-87-3 | Purity: ≥90.0% (HPLC) | 4-METHOXYPHENYLAZIDE | ESD-918985-50ML |
| Cas.: 9014-81-7 | Purity: ≥99% | Fetuin, Fetal Bovine Serum | ESD-918986-10MG |
| Cas.: 9014-81-7 | Purity: ≥99% | Fetuin, Fetal Bovine Serum | ESD-918986-50MG |
| Cas.: 14236-57-8 | Purity: 98% | 6-Chloro-3,5-diamino-2-pyrazinecarboxamide | ESD-918987-10MG |
| Cas.: 14236-57-8 | Purity: 98% | 6-Chloro-3,5-diamino-2-pyrazinecarboxamide | ESD-918987-50MG |
| Cas.: 22255-16-9 | Purity: ≥95% | 3-Azabicyclo[3.1.0]hexane-2-carboxylic acid | ESD-918988-10MG |
| Cas.: 22255-16-9 | Purity: ≥95% | 3-Azabicyclo[3.1.0]hexane-2-carboxylic acid | ESD-918988-50MG |
| Cas.: 14352-61-5 | Purity: 96% | Methyl cyclohexylacetate | ESD-918989-10G |
| Cas.: 14352-61-5 | Purity: 96% | Methyl cyclohexylacetate | ESD-918989-50G |
| Cas.: 19312-06-2 | Purity: 96% | 4,4-Dimethyl-2-phenyl-2-oxazoline | ESD-918990-10G |
| Cas.: 10397-30-5 | Purity: 99% | 4-Methyl-3-nitrobenzoyl chloride | ESD-918991-10ML |
| Cas.: 10397-30-5 | Purity: 99% | 4-Methyl-3-nitrobenzoyl chloride | ESD-918991-50ML |
| Cas.: 2386-28-9 | Purity: 95% | 4-ACETYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID | ESD-918992-10G |
| Cas.: 2386-28-9 | Purity: 95% | 4-ACETYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID | ESD-918992-50G |
| Cas.: 37278-89-0 | Purity: ≥2500 units/g, expressed in Aspergillus oryzae | Xylanase recombinant | ESD-918993-10G |
| Cas.: 37278-89-0 | Purity: ≥2500 units/g, expressed in Aspergillus oryzae | Xylanase recombinant | ESD-918993-50G |
| Cas.: 409344-71-4 | Purity: ≥95% (HPLC) | PSB 1115 POTASSIUM SALT | ESD-918994-10MG |
| Cas.: 409344-71-4 | Purity: ≥95% (HPLC) | PSB 1115 POTASSIUM SALT | ESD-918994-50MG |
| Cas.: 23418-82-8 | Purity: 98% | CIS-1,5-CYCLOOCTANEDIOL | ESD-918995-10G |
| Cas.: 23418-82-8 | Purity: 98% | CIS-1,5-CYCLOOCTANEDIOL | ESD-918995-50G |
| Cas.: 13147-57-4 | Purity: ≥95.0% (HPLC) | 2-PHOSPHOGLYCOLIC ACID LITHIUM SALT | ESD-918997-10MG |
| Cas.: 3992-45-8 | Purity: 97.0% (TLC) | Decanoyl-L-carnitine | ESD-918998-10MG |
| Cas.: 137173-46-7 | Purity: ≥96% (HPLC) | N-Dodecanoyl-L-homoserine lactone | ESD-918999-10MG |
| Cas.: 137173-46-7 | Purity: ≥96% (HPLC) | N-Dodecanoyl-L-homoserine lactone | ESD-918999-50MG |
| Cas.: 109784-74-9 | Purity: ≥96% (HPLC) | (6S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN SULFATE | ESD-919001-10MG |
| Cas.: 109784-74-9 | Purity: ≥96% (HPLC) | (6S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN SULFATE | ESD-919001-50MG |
| Cas.: 212515-11-2 | Purity: ≥95.0% (HPLC) | 5-BROMO-4-CHLORO-3-INDOXYL MYO-INOSITOL-1-PHOSPHATE, AMMONIUM SALT | ESD-919002-10MG |
| Cas.: 51239-26-0 | Purity: ≥95% (HPLC) | 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3′,5′-CYCLIC MONOPHOSPHATE SODIUM SALT | ESD-919003-10MG |
| Cas.: 51239-26-0 | Purity: ≥95% (HPLC) | 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3′,5′-CYCLIC MONOPHOSPHATE SODIUM SALT | ESD-919003-50MG |
| Cas.: 299442-43-6 | Purity: 99,5% | 2-AMINO-7-FURAN-2-YL-7,8-DIHYDRO-6H-QUINAZOLIN-5-ONE | ESD-919004-10MG |
| Cas.: 299442-43-6 | Purity: 99,5% | 2-AMINO-7-FURAN-2-YL-7,8-DIHYDRO-6H-QUINAZOLIN-5-ONE | ESD-919004-50MG |
| Cas.: 32990-47-9 | Purity: 97% | 4-METHYLTHIOPHENE-2-CARBONYL CHLORIDE | ESD-919005-25G |
| Cas.: 32990-47-9 | Purity: 97% | 4-METHYLTHIOPHENE-2-CARBONYL CHLORIDE | ESD-919005-5G |
| Cas.: 13455-00-0 | Purity: 95% | DIPHOSPHORUS TETRAIODIDE | ESD-919006-25G |
| Cas.: 13455-00-0 | Purity: 95% | DIPHOSPHORUS TETRAIODIDE | ESD-919006-5G |
| Cas.: 188591-67-5 | Purity: ≥98% (HPLC) | Traxoprodil mesylate | ESD-919007-25MG |
| Cas.: 188591-67-5 | Purity: ≥98% (HPLC) | Traxoprodil mesylate | ESD-919007-5MG |
| Cas.: 3146-39-2 | Purity: 97% | EXO-2,3-EPOXYNORBORNANE | ESD-919008-25G |
| Cas.: 3146-39-2 | Purity: 97% | EXO-2,3-EPOXYNORBORNANE | ESD-919008-5G |
| Cas.: 85116-38-7 | Purity: 1 M in pentane | (-)-Ipc2B(allyl)borane solution | ESD-919010-25ML |
| Cas.: 85116-38-7 | Purity: 1 M in pentane | (-)-Ipc2B(allyl)borane solution | ESD-919010-5ML |
| Cas.: 113439-83-1 | Purity: 97% | N-(2-Butynyl)phthalimide | ESD-919011-25G |
| Cas.: 113439-83-1 | Purity: 97% | N-(2-Butynyl)phthalimide | ESD-919011-5G |
| Cas.: 33421-43-1 | Purity: 98% | 2,2′-DipyridylN-oxide | ESD-919012-25G |
| Cas.: 33421-43-1 | Purity: 98% | 2,2′-DipyridylN-oxide | ESD-919012-5G |
| Cas.: 3580-38-9 | Purity: 98% | 2-Benzoylcyclohexanone | ESD-919013-25G |
| Cas.: 3580-38-9 | Purity: 98% | 2-Benzoylcyclohexanone | ESD-919013-5G |
| Cas.: 16555-77-4 | Purity: 98% | ALPHA-HYDROXYHIPPURIC ACID | ESD-919014-25G |
| Cas.: 16555-77-4 | Purity: 98% | ALPHA-HYDROXYHIPPURIC ACID | ESD-919014-5G |
| Cas.: 17906-35-3 | Purity: ≥99.99% | TRIS(TERT-PENTOXY)SILANOL | ESD-919015-25G |
| Cas.: 17906-35-3 | Purity: ≥99.99% | TRIS(TERT-PENTOXY)SILANOL | ESD-919015-5G |
| Cas.: 1268524-69-1 | Purity: ≥98% (HPLC) | (+/-)-JQ1 | ESD-919016-25MG |
| Cas.: 1268524-69-1 | Purity: ≥98% (HPLC) | (+/-)-JQ1 | ESD-919016-5MG |
| Cas.: 329932-55-0 | Purity: 98% (HPLC) | FM19G11 | ESD-919017-25MG |
| Cas.: 329932-55-0 | Purity: 98% (HPLC) | FM19G11 | ESD-919017-5MG |
| Cas.: 326477-70-7 | Purity: 96% | Copper(I) 3-methylsalicylate | ESD-919018-25G |
| Cas.: 326477-70-7 | Purity: 96% | Copper(I) 3-methylsalicylate | ESD-919018-5G |
| Cas.: 1898-06-2 | Purity: 98% | 2-METHYL-3-AMINO-4-QUINAZOLONE | ESD-919019-5G |
| Cas.: 18381-45-8 | Purity: 98% | 3-CYANOPROPIONALDEHYDE DIETHYL ACETAL | ESD-919020-25G |
| Cas.: 18381-45-8 | Purity: 98% | 3-CYANOPROPIONALDEHYDE DIETHYL ACETAL | ESD-919020-5G |
| Cas.: 21892-80-8 | Purity: ≥97.5% (GC); 98% | 3-Methyl-2-benzoxazolinone | ESD-919021-25G |
| Cas.: 21892-80-8 | Purity: ≥97.5% (GC); 98% | 3-Methyl-2-benzoxazolinone | ESD-919021-5G |
| Cas.: 127582-36-9 | Purity: 97% | BENZYLTRIMETHYLAMMONIUM FLUORIDE HYDRATE | ESD-919022-25G |
| Cas.: 127582-36-9 | Purity: 97% | BENZYLTRIMETHYLAMMONIUM FLUORIDE HYDRATE | ESD-919022-5G |
| Cas.: 7493-90-5 | Purity: 97% | threitol | ESD-919023-25G |
| Cas.: 7493-90-5 | Purity: 97% | threitol | ESD-919023-5G |
| Cas.: 61985-23-7 | Purity: 95% | METHYL 1H-IMIDAZOLE-1-CARBOXYLATE | ESD-919024-25G |
| Cas.: 61985-23-7 | Purity: 95% | METHYL 1H-IMIDAZOLE-1-CARBOXYLATE | ESD-919024-5G |
| Cas.: 16645-06-0 | Purity: 99% | N,N-DIMETHYLHYDROXYLAMINE HYDROCHLORIDE | ESD-919025-5G |
| Cas.: 129986-67-0 | Purity: 98% | N-METHOXY-N-METHYL(TRIPHENYL-PHOSPHORANYLIDENE)ACETAMIDE | ESD-919026-25G |
| Cas.: 129986-67-0 | Purity: 98% | N-METHOXY-N-METHYL(TRIPHENYL-PHOSPHORANYLIDENE)ACETAMIDE | ESD-919026-5G |
| Cas.: 1262770-54-6 | Purity: >95% | N-SucciniMidyl 4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononanoate | ESD-919027-25MG |
| Cas.: 1262770-54-6 | Purity: >95% | N-SucciniMidyl 4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononanoate | ESD-919027-5MG |
| Cas.: 171259-81-7 | Purity: ≥98% (HPLC) | (±)-AMPA hydrobromide | ESD-919028-25MG |
| Cas.: 171259-81-7 | Purity: ≥98% (HPLC) | (±)-AMPA hydrobromide | ESD-919028-5MG |
| Cas.: 457639-26-8 | Purity: ≥98% (HPLC) | 2,5-DiMethyl Celecoxib | ESD-919029-25MG |
| Cas.: 457639-26-8 | Purity: ≥98% (HPLC) | 2,5-DiMethyl Celecoxib | ESD-919029-5MG |
| Cas.: 22140-20-1 | Purity: ≥98% (HPLC) | 2-Methylthioadenosine 5′-monophosphate triethylammonium salt hydrate | ESD-919030-25MG |
| Cas.: 22140-20-1 | Purity: ≥98% (HPLC) | 2-Methylthioadenosine 5′-monophosphate triethylammonium salt hydrate | ESD-919030-5MG |
| Cas.: 78033-08-6 | Purity: ≥98% | 8-METHOXYMETHYL-3-ISOBUTYL-1-METHYLXANTHINE | ESD-919031-25MG |
| Cas.: 78033-08-6 | Purity: ≥98% | 8-METHOXYMETHYL-3-ISOBUTYL-1-METHYLXANTHINE | ESD-919031-5MG |
| Cas.: 82820-87-9 | Purity: 90% | 2,4-Dibromobutyryl chloride | ESD-919032-10G |
| Cas.: 82820-87-9 | Purity: 90% | 2,4-Dibromobutyryl chloride | ESD-919032-5G |
| Cas.: 71324-20-4 | Purity: ≥98% (HPLC) | 4-HYDROXY-3-METHOXY-D3-PHENYLETHYLENE GLYCOL 4-SULPHATE POTASSIUM SALT | ESD-919033-5MG |
| Cas.: 145414-76-2 | 6′,7′-DIHYDROXYBERGAMOTTIN | ESD-919035-10MG | |
| Cas.: 145414-76-2 | 6′,7′-DIHYDROXYBERGAMOTTIN | ESD-919035-5MG | |
| Cas.: 51304-58-6 | Purity: 96% | 4-phenylpiperidine-4-carbonitrile hydrochloride | ESD-919036-1G |
| Cas.: 51304-58-6 | Purity: 96% | 4-phenylpiperidine-4-carbonitrile hydrochloride | ESD-919036-5G |
| Cas.: 16413-26-6 | Purity: 98% | 3-Cyanophenyl isocyanate | ESD-919037-1G |
| Cas.: 16413-26-6 | Purity: 98% | 3-Cyanophenyl isocyanate | ESD-919037-5G |
| Cas.: 69922-28-7 | Purity: 97% | 5-Isocyanatobenzo[d][1,3]dioxole | ESD-919038-1G |
| Cas.: 69922-28-7 | Purity: 97% | 5-Isocyanatobenzo[d][1,3]dioxole | ESD-919038-5G |
| Cas.: 435273-49-7 | Purity: 97% | 2-Bromo-1-(3-bromo-4-fluorophenyl)ethanone | ESD-919039-1G |
| Cas.: 435273-49-7 | Purity: 97% | 2-Bromo-1-(3-bromo-4-fluorophenyl)ethanone | ESD-919039-5G |
| Cas.: 3528-17-4 | Purity: 97% | Thiochroman-4-one | ESD-919040-1G |
| Cas.: 3528-17-4 | Purity: 97% | Thiochroman-4-one | ESD-919040-5G |
| Cas.: 16205-84-8 | Purity: 98% | Ethyl 3-(trimethylsilyl)propiolate | ESD-919041-1G |
| Cas.: 16205-84-8 | Purity: 98% | Ethyl 3-(trimethylsilyl)propiolate | ESD-919041-5G |
| Cas.: 2146-61-4 | Purity: 97% | 1-(2-Bromoethyl)-3-methoxybenzene | ESD-919042-1G |
| Cas.: 2146-61-4 | Purity: 97% | 1-(2-Bromoethyl)-3-methoxybenzene | ESD-919042-5G |
| Cas.: 28240-69-9 | Purity: 97% | 1,2-Bis(dichlorophosphino)ethane | ESD-919043-1G |
| Cas.: 28240-69-9 | Purity: 97% | 1,2-Bis(dichlorophosphino)ethane | ESD-919043-5G |
| Cas.: 2767-54-6 | Purity: 95% | Triethyltin bromide | ESD-919044-1G |
| Cas.: 2767-54-6 | Purity: 95% | Triethyltin bromide | ESD-919044-5G |
| Cas.: 28240-68-8 | Purity: 95% | Bis(dichlorophosphino)methane | ESD-919045-1G |
| Cas.: 4397-55-1 | Purity: ≥96.5% (HPLC); 96.5-103.5% (AT); 97% | methyl 2-(chlorocarbonyl)benzoate | ESD-919046-1G |
| Cas.: 4397-55-1 | Purity: ≥96.5% (HPLC); 96.5-103.5% (AT); 97% | methyl 2-(chlorocarbonyl)benzoate | ESD-919046-5G |
| Cas.: 86030-43-5 | Purity: 95% | CHLORO(DIISOPROPYLAMINO)METHOXYPHOSPHINE | ESD-919047-1G |
| Cas.: 86030-43-5 | Purity: 95% | CHLORO(DIISOPROPYLAMINO)METHOXYPHOSPHINE | ESD-919047-5G |
| Cas.: 2614-88-2 | Purity: ≥80.0% | Sorbic chloride | ESD-919048-1G |
| Cas.: 2614-88-2 | Purity: ≥80.0% | Sorbic chloride | ESD-919048-5G |
| Cas.: 7144-37-8 | Purity: 98% | Copper(II) tosylate | ESD-919049-1G |
| Cas.: 7144-37-8 | Purity: 98% | Copper(II) tosylate | ESD-919049-5G |
| Cas.: 39234-83-8 | Purity: 95% | 4-Nitro-3-(trifluoromethyl)benzene-1-sulfonyl chloride | ESD-919050-1G |
| Cas.: 39234-83-8 | Purity: 95% | 4-Nitro-3-(trifluoromethyl)benzene-1-sulfonyl chloride | ESD-919050-5G |
| Cas.: 351003-54-8 | Purity: 97% | 4-Bromo-2,6-dichlorobenzene-1-sulfonyl chloride | ESD-919051-1G |
| Cas.: 351003-54-8 | Purity: 97% | 4-Bromo-2,6-dichlorobenzene-1-sulfonyl chloride | ESD-919051-5G |
| Cas.: 6881-57-8 | Purity: 97% | Benzylphosphonic acid | ESD-919052-1G |
| Cas.: 6881-57-8 | Purity: 97% | Benzylphosphonic acid | ESD-919052-5G |
| Cas.: 25054-53-9 | Purity: ≥98% | Piperonyloyl chloride | ESD-919053-1G |
| Cas.: 25054-53-9 | Purity: ≥98% | Piperonyloyl chloride | ESD-919053-5G |
| Cas.: 34732-09-7 | Purity: 97% | 2,3,4-Trichlorobenzenesulfonyl chloride | ESD-919054-1G |
| Cas.: 1269119-14-3 | Purity: 95% | 4,6-Dichloro-2-(methylthio)pyrimidine-5-carbonyl Chloride | ESD-919055-1G |
| Cas.: 1269119-14-3 | Purity: 95% | 4,6-Dichloro-2-(methylthio)pyrimidine-5-carbonyl Chloride | ESD-919055-5G |
| Cas.: 1611-57-0 | Purity: 98% | TERT-OCTYL ISOCYANATE | ESD-919056-1G |
| Cas.: 1611-57-0 | Purity: 98% | TERT-OCTYL ISOCYANATE | ESD-919056-5G |
| Cas.: 160256-75-7 | Purity: 98% | Dibenzyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-919057-1G |
| Cas.: 160256-75-7 | Purity: 98% | Dibenzyl (azanediylbis(ethane-2,1-diyl))dicarbamate | ESD-919057-5G |
| Cas.: 70916-89-1 | Purity: 98% | Methyl 4′-formyl-[1,1′-biphenyl]-4-carboxylate | ESD-919058-1G |
| Cas.: 70916-89-1 | Purity: 98% | Methyl 4′-formyl-[1,1′-biphenyl]-4-carboxylate | ESD-919058-5G |
| Cas.: 5748-41-4 | Purity: 95% | 4′-Chloro-[1,1′-biphenyl]-4-carboxylic acid | ESD-919059-1G |
| Cas.: 5748-41-4 | Purity: 95% | 4′-Chloro-[1,1′-biphenyl]-4-carboxylic acid | ESD-919059-5G |
| Cas.: 82572-04-1 | Purity: 98% | (R)-1-(Naphthalen-1-yl)ethanamine hydrochloride | ESD-919060-1G |
| Cas.: 82572-04-1 | Purity: 98% | (R)-1-(Naphthalen-1-yl)ethanamine hydrochloride | ESD-919060-5G |
| Cas.: 443998-73-0 | Purity: 97% | 4′-AMINOBIPHENYL-3-CARBONITRILE | ESD-919061-1G |
| Cas.: 443998-73-0 | Purity: 97% | 4′-AMINOBIPHENYL-3-CARBONITRILE | ESD-919061-5G |
| Cas.: 78725-51-6 | Purity: 97% | 4-(2 4-DICHLOROPHENOXY)BENZALDEHYDE | ESD-919062-1G |
| Cas.: 78725-51-6 | Purity: 97% | 4-(2 4-DICHLOROPHENOXY)BENZALDEHYDE | ESD-919062-5G |
| Cas.: 78725-47-0 | Purity: 97% | 4-(4-METHOXYPHENOXY)BENZALDEHYDE | ESD-919063-1G |
| Cas.: 78725-47-0 | Purity: 97% | 4-(4-METHOXYPHENOXY)BENZALDEHYDE | ESD-919063-5G |
| Cas.: 61343-83-7 | Purity: 97% | 4-(4-METHYLPHENOXY)BENZALDEHYDE | ESD-919064-1G |
| Cas.: 61343-83-7 | Purity: 97% | 4-(4-METHYLPHENOXY)BENZALDEHYDE | ESD-919064-5G |
| Cas.: 430-51-3 | Purity: 97% | Fluoroacetone | ESD-919065-1G |
| Cas.: 430-51-3 | Purity: 97% | Fluoroacetone | ESD-919065-5G |
| Cas.: 21378-21-2 | Purity: 96% | 3-Methyl-2-cyclohexen-1-ol | ESD-919066-1G |
| Cas.: 21378-21-2 | Purity: 96% | 3-Methyl-2-cyclohexen-1-ol | ESD-919066-5G |
| Cas.: 168899-61-4 | Purity: 97% | 3-Amino-2-bromobenzoic acid | ESD-919067-1G |
| Cas.: 168899-61-4 | Purity: 97% | 3-Amino-2-bromobenzoic acid | ESD-919067-5G |
| Cas.: 79667-91-7 | Purity: 98% | 2,2-Difluoroethanamine hydrochloride | ESD-919068-1G |
| Cas.: 79667-91-7 | Purity: 98% | 2,2-Difluoroethanamine hydrochloride | ESD-919068-5G |
| Cas.: 277319-62-7 | Purity: 97% | 4-Amino-N’-hydroxybenzimidamide | ESD-919069-1G |
| Cas.: 277319-62-7 | Purity: 97% | 4-Amino-N’-hydroxybenzimidamide | ESD-919069-5G |
| Cas.: 84370-87-6 | Purity: ≥97% | 2,4-Dimethoxyphenyl isocyanate | ESD-919070-1G |
| Cas.: 84370-87-6 | Purity: ≥97% | 2,4-Dimethoxyphenyl isocyanate | ESD-919070-5G |
| Cas.: 625-53-6 | Purity: 99% | N-Ethylthiourea | ESD-919071-1G |
| Cas.: 625-53-6 | Purity: 99% | N-Ethylthiourea | ESD-919071-5G |
| Cas.: 1016-19-9 | Purity: 97% | 3,4,5-Trimethoxyphenyl isocyanate | ESD-919072-1G |
| Cas.: 1016-19-9 | Purity: 97% | 3,4,5-Trimethoxyphenyl isocyanate | ESD-919072-5G |
| Cas.: 870704-26-0 | Purity: 96% | 3-Cyclopropylpyrazole-4-carboxylic acid | ESD-919073-1G |
| Cas.: 870704-26-0 | Purity: 96% | 3-Cyclopropylpyrazole-4-carboxylic acid | ESD-919073-5G |
| Cas.: 40173-90-8 | Purity: 97% | 3 4-DIMETHOXYPHENETHYL BROMIDE | ESD-919074-1G |
| Cas.: 40173-90-8 | Purity: 97% | 3 4-DIMETHOXYPHENETHYL BROMIDE | ESD-919074-5G |
| Cas.: 52727-99-8 | Purity: 97% | 2-BROMO-5′-CHLORO-2′-HYDROXYACETOPHENONE | ESD-919075-1G |
| Cas.: 52727-99-8 | Purity: 97% | 2-BROMO-5′-CHLORO-2′-HYDROXYACETOPHENONE | ESD-919075-5G |
| Cas.: 1401089-31-3 | Purity: 98% | PACMA 31 | ESD-919076-1MG |
| Cas.: 1401089-31-3 | Purity: 98% | PACMA 31 | ESD-919076-5MG |
| Cas.: 108649-59-8 | Purity: 95% | 1-(2-Bromoethyl)-2,4-dichlorobenzene | ESD-919077-1G |
| Cas.: 108649-59-8 | Purity: 95% | 1-(2-Bromoethyl)-2,4-dichlorobenzene | ESD-919077-5G |
| Cas.: 53911-92-5 | Purity: 90% | TRIBUTYL(3-METHYL-2-BUTENYL)TIN | ESD-919078-1G |
| Cas.: 53911-92-5 | Purity: 90% | TRIBUTYL(3-METHYL-2-BUTENYL)TIN | ESD-919078-5G |
| Cas.: 1577233-73-8 | SnAP DA Reagent | ESD-919079-1G | |
| Cas.: 1577233-73-8 | SnAP DA Reagent | ESD-919079-5G | |
| Cas.: 22195-47-7 | Purity: 97% | (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANAMINE | ESD-919080-1G |
| Cas.: 22195-47-7 | Purity: 97% | (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANAMINE | ESD-919080-5G |
| Cas.: 20529-23-1 | Purity: ≥97.0% (HPLC) | 1-(3-Aminopropyl)-4-(2-methoxyphenyl)piperazine | ESD-919081-1G |
| Cas.: 64353-29-3 | Purity: 97% | 4-ETHYLPHENETHYLAMINE | ESD-919082-1G |
| Cas.: 64353-29-3 | Purity: 97% | 4-ETHYLPHENETHYLAMINE | ESD-919082-5G |
| Cas.: 101927-33-7 | Purity: 99% (CP) | 2-IODOPROPANE-D7 | ESD-919083-1G |
| Cas.: 101927-33-7 | Purity: 99% (CP) | 2-IODOPROPANE-D7 | ESD-919083-5G |
| Cas.: 75746-71-3 | Purity: 95% | 2-ETHYL-6-METHYLPHENYL ISOCYANATE | ESD-919084-1G |
| Cas.: 75746-71-3 | Purity: 95% | 2-ETHYL-6-METHYLPHENYL ISOCYANATE | ESD-919084-5G |
| Cas.: 15501-33-4 | Purity: 98% | 1-Iodo-2,2-dimethylpropane | ESD-919085-1G |
| Cas.: 42588-57-8 | Purity: 95% | (2Z)-3-Ethoxy-2-methylacrylaldehyde | ESD-919086-1G |
| Cas.: 42588-57-8 | Purity: 95% | (2Z)-3-Ethoxy-2-methylacrylaldehyde | ESD-919086-5G |
| Cas.: 17327-22-9 | Purity: 95% | 5,6-DIHYDRO-4-METHOXY-2H-PYRAN | ESD-919087-1G |
| Cas.: 17327-22-9 | Purity: 95% | 5,6-DIHYDRO-4-METHOXY-2H-PYRAN | ESD-919087-5G |
| Cas.: 463-11-6 | Purity: 98% | 1-Fluorooctane | ESD-919088-1G |
| Cas.: 463-11-6 | Purity: 98% | 1-Fluorooctane | ESD-919088-5G |
| Cas.: 1978-37-6 | Purity: 97% | 3-Fluoro-N-methylaniline | ESD-919089-1G |
| Cas.: 1978-37-6 | Purity: 97% | 3-Fluoro-N-methylaniline | ESD-919089-5G |
| Cas.: 992-91-6 | Purity: 98% | Germanium(IV) methoxide | ESD-919090-1G |
| Cas.: 992-91-6 | Purity: 98% | Germanium(IV) methoxide | ESD-919090-5G |
| Cas.: 3970-62-5 | Purity: 97% | 2,2-Dimethyl-3-pentanol | ESD-919091-1G |
| Cas.: 1122-85-6 | Purity: 95% | Phenyl Cyanate | ESD-919092-1G |
| Cas.: 1122-85-6 | Purity: 95% | Phenyl Cyanate | ESD-919092-5G |
| Cas.: 12005-86-6 | Purity: 98% | Sodium hexafluoroarsenate(V) | ESD-919093-1G |
| Cas.: 12005-86-6 | Purity: 98% | Sodium hexafluoroarsenate(V) | ESD-919093-5G |
| Cas.: 1567-75-5 | Purity: 95% | Methyl 1-methylcyclopropyl ketone | ESD-919094-1G |
| Cas.: 1567-75-5 | Purity: 95% | Methyl 1-methylcyclopropyl ketone | ESD-919094-5G |
| Cas.: 15364-56-4 | Purity: 98% | (Dimethylamino)acetone | ESD-919095-1G |
| Cas.: 15364-56-4 | Purity: 98% | (Dimethylamino)acetone | ESD-919095-5G |
| Cas.: 42097-42-7 | Purity: ≥95% | 2,6-Lutidine-alpha2,3-diol | ESD-919096-1G |
| Cas.: 42097-42-7 | Purity: ≥95% | 2,6-Lutidine-alpha2,3-diol | ESD-919096-5G |
| Cas.: 69556-70-3 | Purity: 97% | 4-Methoxy-2(5H)-furanone | ESD-919097-1G |
| Cas.: 69556-70-3 | Purity: 97% | 4-Methoxy-2(5H)-furanone | ESD-919097-5G |
| Cas.: 74685-00-0 | Purity: ≥95% | 1-(tert-Butyldimethylsilyoxy)-2-propanone | ESD-919098-1G |
| Cas.: 74685-00-0 | Purity: ≥95% | 1-(tert-Butyldimethylsilyoxy)-2-propanone | ESD-919098-5G |
| Cas.: 83647-42-1 | Purity: 97% | (3-Amino-2-methylphenyl)methanol | ESD-919099-1G |
| Cas.: 83647-42-1 | Purity: 97% | (3-Amino-2-methylphenyl)methanol | ESD-919099-5G |
| Cas.: 17579-99-6 | Purity: 95% | Methyltriphenoxyphosphonium Iodide | ESD-919100-1G |
| Cas.: 17579-99-6 | Purity: 95% | Methyltriphenoxyphosphonium Iodide | ESD-919100-5G |
| Cas.: 622-29-7 | Purity: ≥97% | N-Benzylidenemethanamine | ESD-919101-1G |
| Cas.: 622-29-7 | Purity: ≥97% | N-Benzylidenemethanamine | ESD-919101-5G |
| Cas.: 17145-91-4 | Purity: ≥98% | Ethyl 2-(Diethoxyphosphoryl)butanoate | ESD-919102-1G |
| Cas.: 17145-91-4 | Purity: ≥98% | Ethyl 2-(Diethoxyphosphoryl)butanoate | ESD-919102-5G |
| Cas.: 52305-30-3 | Purity: esterterminated, L-Lactide:D, L-Lactide70:30 | Poly(L-lactide-co-D,L-lactide) | ESD-919103-1G |
| Cas.: 52305-30-3 | Purity: esterterminated, L-Lactide:D, L-Lactide70:30 | Poly(L-lactide-co-D,L-lactide) | ESD-919103-5G |
| Cas.: 52829-98-8 | Purity: ≥95% | 1-cyclopentylethanol | ESD-919104-1G |
| Cas.: 52829-98-8 | Purity: ≥95% | 1-cyclopentylethanol | ESD-919104-5G |
| Cas.: 332360-07-3 | Purity: ≥98% | 4-Methyl-2-oxopentanoic acid sodium salt hydrate | ESD-919105-1G |
| Cas.: 332360-07-3 | Purity: ≥98% | 4-Methyl-2-oxopentanoic acid sodium salt hydrate | ESD-919105-5G |
| Cas.: 161401-82-7 | Purity: ≥98% | Z-VAD(OH)-FMK | ESD-919106-1MG |
| Cas.: 161401-82-7 | Purity: ≥98% | Z-VAD(OH)-FMK | ESD-919106-5MG |
| Cas.: 75772-01-9 | Purity: ≥95% | ((Benzyloxy)methyl)triphenylphosphonium chloride | ESD-919107-1G |
| Cas.: 75772-01-9 | Purity: ≥95% | ((Benzyloxy)methyl)triphenylphosphonium chloride | ESD-919107-5G |
| Cas.: 113162-02-0 | Purity: 97% | Dihydroquinidine 4-chlorobenzoate | ESD-919108-1G |
| Cas.: 113162-02-0 | Purity: 97% | Dihydroquinidine 4-chlorobenzoate | ESD-919108-5G |
| Cas.: 154589-96-5 | Purity: 99% | Stauprimide | ESD-919109-1MG |
| Cas.: 154589-96-5 | Purity: 99% | Stauprimide | ESD-919109-5MG |
| Cas.: 109944-15-2 | Purity: 98% | Kifunensine | ESD-919110-1MG |
| Cas.: 109944-15-2 | Purity: 98% | Kifunensine | ESD-919110-5MG |
| Cas.: 14068-53-2 | Purity: 98% | 5-ethyl-1,3,4-thiadiazol-2-amine | ESD-919111-1G |
| Cas.: 14068-53-2 | Purity: 98% | 5-ethyl-1,3,4-thiadiazol-2-amine | ESD-919111-5G |
| Cas.: 6141-58-8 | Purity: 95% | Methyl 2-methyl-3-furoate | ESD-919112-1G |
| Cas.: 6141-58-8 | Purity: 95% | Methyl 2-methyl-3-furoate | ESD-919112-5G |
| Cas.: 22346-75-4 | Purity: 98% | 4-PyridylcarbinolN-oxide | ESD-919113-1G |
| Cas.: 22346-75-4 | Purity: 98% | 4-PyridylcarbinolN-oxide | ESD-919113-5G |
| Cas.: 54303-30-9 | Purity: 98% | 2-(Ethylthio)ethylamine hydrochloride | ESD-919114-1G |
| Cas.: 54303-30-9 | Purity: 98% | 2-(Ethylthio)ethylamine hydrochloride | ESD-919114-5G |
| Cas.: 10123-62-3 | Purity: 95% | Diethyl (2-cyanoethyl)phosphonate | ESD-919115-1G |
| Cas.: 10123-62-3 | Purity: 95% | Diethyl (2-cyanoethyl)phosphonate | ESD-919115-5G |
| Cas.: 13465-93-5 | Purity: 99% | Silver tungstate | ESD-919116-1G |
| Cas.: 13465-93-5 | Purity: 99% | Silver tungstate | ESD-919116-5G |
| Cas.: 34352-74-4 | Purity: 97% | 2-(4-Biphenylyl)-2-propanol | ESD-919117-1G |
| Cas.: 34352-74-4 | Purity: 97% | 2-(4-Biphenylyl)-2-propanol | ESD-919117-5G |
| Cas.: 5000-46-4 | Purity: 98% | Methylsulfonylacetone | ESD-919118-1G |
| Cas.: 5000-46-4 | Purity: 98% | Methylsulfonylacetone | ESD-919118-5G |
| Cas.: 4335-90-4 | Purity: 98% | 3-Benzylidenepentane-2,4-dione | ESD-919119-1G |
| Cas.: 4335-90-4 | Purity: 98% | 3-Benzylidenepentane-2,4-dione | ESD-919119-5G |
| Cas.: 51632-29-2 | Purity: 95% | 3-Phenoxyphenylacetonitrile | ESD-919120-1G |
| Cas.: 51632-29-2 | Purity: 95% | 3-Phenoxyphenylacetonitrile | ESD-919120-5G |
| Cas.: 4814-80-6 | Purity: 95% | N-(Cyanomethyl)acetamide | ESD-919121-1G |
| Cas.: 4814-80-6 | Purity: 95% | N-(Cyanomethyl)acetamide | ESD-919121-5G |
| Cas.: 65570-43-6 | Purity: 97% | N-(2-chloro-4-nitrophenyl)-1-hydroxynaphthalene-2-carboxamide | ESD-919122-1G |
| Cas.: 65570-43-6 | Purity: 97% | N-(2-chloro-4-nitrophenyl)-1-hydroxynaphthalene-2-carboxamide | ESD-919122-5G |
| Cas.: 39905-45-8 | Purity: 98% | 4-n-Octyloxyanilin | ESD-919123-1G |
| Cas.: 39905-45-8 | Purity: 98% | 4-n-Octyloxyanilin | ESD-919123-5G |
| Cas.: 4286-15-1 | Purity: 99% | (S)-(+)-2-Phenylbutyric acid | ESD-919124-1G |
| Cas.: 4286-15-1 | Purity: 99% | (S)-(+)-2-Phenylbutyric acid | ESD-919124-5G |
| Cas.: 166953-64-6 | Purity: 96% | 4-Bromo-NZ-piperidine | ESD-919125-1G |
| Cas.: 166953-64-6 | Purity: 96% | 4-Bromo-NZ-piperidine | ESD-919125-5G |
| Cas.: 129423-29-6 | Purity: 95% | trans-3-Phenyl-1-propen-1-ylboronic acid | ESD-919126-1G |
| Cas.: 39516-03-5 | Purity: 97% | (R)-(-)-4-Phenyl-2-butanol | ESD-919127-1G |
| Cas.: 39516-03-5 | Purity: 97% | (R)-(-)-4-Phenyl-2-butanol | ESD-919127-5G |
| Cas.: 17027-51-9 | Purity: 98% | 2-(4-Biphenyl)ethylamine | ESD-919128-1G |
| Cas.: 356570-52-0 | Purity: 97% | 4-Methylbenzylboronic acid pinacol ester | ESD-919129-1G |
| Cas.: 356570-52-0 | Purity: 97% | 4-Methylbenzylboronic acid pinacol ester | ESD-919129-5G |
| Cas.: 21319-43-7 | Purity: 97% | Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)lead(II) | ESD-919130-1G |
| Cas.: 21319-43-7 | Purity: 97% | Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)lead(II) | ESD-919130-5G |
| Cas.: 1243312-43-7 | Purity: 97% | 3-Methoxy-4-pyridineboronic acid pinacol ester | ESD-919131-1G |
| Cas.: 1243312-43-7 | Purity: 97% | 3-Methoxy-4-pyridineboronic acid pinacol ester | ESD-919131-5G |
| Cas.: 74331-69-4 | Purity: 95% | 1-Ethynyl-4-methoxy-2-methylbenzene | ESD-919132-1G |
| Cas.: 646-14-0 | Purity: 98% | 1-NITROHEXANE | ESD-919133-1G |
| Cas.: 40276-93-5 | Purity: 96% | 3-METHYL-1-HEXYNE | ESD-919134-1G |
| Cas.: 40276-93-5 | Purity: 96% | 3-METHYL-1-HEXYNE | ESD-919134-5G |
| Cas.: 142172-51-8 | Purity: 96% | 4-Bromo-1-butylboronic acid catechol ester | ESD-919135-1G |
| Cas.: 480424-86-0 | Purity: 97% | 9 9-DIDODECYLFLUORENE-2 7-DIBORONIC ACID | ESD-919136-1G |
| Cas.: 480424-86-0 | Purity: 97% | 9 9-DIDODECYLFLUORENE-2 7-DIBORONIC ACID | ESD-919136-5G |
| Cas.: 114346-31-5 | Purity: 95% | BOC-PHE(4-NHFMOC)-OH | ESD-919137-1G |
| Cas.: 114346-31-5 | Purity: 95% | BOC-PHE(4-NHFMOC)-OH | ESD-919137-5G |
| Cas.: 63216-49-9 | Purity: 97% | BOC-1,2-CIS-ACHC-OH | ESD-919138-1G |
| Cas.: 63216-49-9 | Purity: 97% | BOC-1,2-CIS-ACHC-OH | ESD-919138-5G |
| Cas.: 76393-16-3 | Purity: 98% | ETHYL 2-ISOCYANATOBENZOATE | ESD-919139-1G |
| Cas.: 76393-16-3 | Purity: 98% | ETHYL 2-ISOCYANATOBENZOATE | ESD-919139-5G |
| Cas.: 52939-06-7 | Purity: 97% | 5-(4-AMINOPHENYL)FURAN-2-CARBOXYLIC ACID METHYL ESTER | ESD-919140-1G |
| Cas.: 52939-06-7 | Purity: 97% | 5-(4-AMINOPHENYL)FURAN-2-CARBOXYLIC ACID METHYL ESTER | ESD-919140-5G |
| Cas.: 50700-49-7 | Purity: 98% | N-ACETYL-4-BENZOQUINONE IMINE | ESD-919141-1MG |
| Cas.: 50700-49-7 | Purity: 98% | N-ACETYL-4-BENZOQUINONE IMINE | ESD-919141-5MG |
| Cas.: 139004-96-9 | Purity: 95% | (R)-PIPERIDIN-2-YLMETHYL-CARBAMIC ACID TERT-BUTYL ESTER | ESD-919142-1G |
| Cas.: 139004-96-9 | Purity: 95% | (R)-PIPERIDIN-2-YLMETHYL-CARBAMIC ACID TERT-BUTYL ESTER | ESD-919142-5G |
| Cas.: 7699-38-9 | Purity: ≥98% | P-NITROPHENYL BETA-DN,N’,N”-TRIACETYLCHITOTRIOSE | ESD-919143-1MG |
| Cas.: 7699-38-9 | Purity: ≥98% | P-NITROPHENYL BETA-DN,N’,N”-TRIACETYLCHITOTRIOSE | ESD-919143-5MG |
| Cas.: 38064-90-3 | Purity: 99% | 2,4-DIMETHOXYTOLUENE | ESD-919144-1G |
| Cas.: 38064-90-3 | Purity: 99% | 2,4-DIMETHOXYTOLUENE | ESD-919144-5G |
| Cas.: 207671-42-9 | Purity: ≥98% | PYRIDINE-2,4-DICARBOXYLIC ACID MONOHYDRATE | ESD-919145-1G |
| Cas.: 207671-42-9 | Purity: ≥98% | PYRIDINE-2,4-DICARBOXYLIC ACID MONOHYDRATE | ESD-919145-5G |
| Cas.: 33738-48-6 | Purity: 98% | 4-METHYL-1-NAPHTHALDEHYDE | ESD-919146-1G |
| Cas.: 33738-48-6 | Purity: 98% | 4-METHYL-1-NAPHTHALDEHYDE | ESD-919146-5G |
| Cas.: 1943-67-5 | Purity: 97% | 4-TERT-BUTYLPHENYL ISOCYANATE | ESD-919147-1G |
| Cas.: 1943-67-5 | Purity: 97% | 4-TERT-BUTYLPHENYL ISOCYANATE | ESD-919147-5G |
| Cas.: 67023-84-1 | Purity: 97% | TRANS,TRANS-1-CHLORO-3,7,11-TRIMETHYL-2,6,10-DODECATRIENE | ESD-919148-1G |
| Cas.: 21249-93-4 | Purity: 97% | (2,2,2-TRIFLUOROETHYL)BENZENE | ESD-919149-1G |
| Cas.: 21249-93-4 | Purity: 97% | (2,2,2-TRIFLUOROETHYL)BENZENE | ESD-919149-5G |
| Cas.: 51673-59-7 | Purity: 98% | 1-(2-Nitrophenyl)-1,2-ethanediol | ESD-919150-1G |
| Cas.: 6299-92-9 | Purity: 97% | 1-Aminobenzimidazole | ESD-919151-1G |
| Cas.: 6299-92-9 | Purity: 97% | 1-Aminobenzimidazole | ESD-919151-5G |
| Cas.: 2017-67-6 | Purity: 97% | 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE | ESD-919152-1G |
| Cas.: 2017-67-6 | Purity: 97% | 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE | ESD-919152-5G |
| Cas.: 942-70-1 | 5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-amine | ESD-919153-1G | |
| Cas.: 942-70-1 | 5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-amine | ESD-919153-5G | |
| Cas.: 35699-44-6 | Purity: 97% | 2-METHYL-1-NAPHTHALDEHYDE | ESD-919154-1G |
| Cas.: 35699-44-6 | Purity: 97% | 2-METHYL-1-NAPHTHALDEHYDE | ESD-919154-5G |
| Cas.: 14401-75-3 | Purity: 97% | 4-(4-CHLOROPHENOXY)IODOBENZENE | ESD-919155-1G |
| Cas.: 14401-75-3 | Purity: 97% | 4-(4-CHLOROPHENOXY)IODOBENZENE | ESD-919155-5G |
| Cas.: 870704-28-2 | Purity: 97% | 3-ISOPROPYLPYRAZOLE-4-CARBOXYLIC ACID | ESD-919156-1G |
| Cas.: 870704-28-2 | Purity: 97% | 3-ISOPROPYLPYRAZOLE-4-CARBOXYLIC ACID | ESD-919156-5G |
| Cas.: 34064-86-3 | 3-PIPERAZIN-1-YL-PROPIONITRILE | ESD-919157-1G | |
| Cas.: 34064-86-3 | 3-PIPERAZIN-1-YL-PROPIONITRILE | ESD-919157-5G | |
| Cas.: 29886-67-7 | Purity: 97% | 4-(THIOPHEN-3-YL)PHENOL | ESD-919158-1G |
| Cas.: 29886-67-7 | Purity: 97% | 4-(THIOPHEN-3-YL)PHENOL | ESD-919158-5G |
| Cas.: 870238-65-6 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylethynyl-trimethylsilane | ESD-919159-1G |
| Cas.: 870238-65-6 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylethynyl-trimethylsilane | ESD-919159-5G |
| Cas.: 3339-80-8 | Purity: >97% | 5,5′-Diiodo-2,2′-bithiophene | ESD-919160-1G |
| Cas.: 3339-80-8 | Purity: >97% | 5,5′-Diiodo-2,2′-bithiophene | ESD-919160-5G |
| Cas.: 1015-55-0 | Purity: 99% | 5 8-DIMETHOXY-1-TETRALONE | ESD-919161-1G |
| Cas.: 1015-55-0 | Purity: 99% | 5 8-DIMETHOXY-1-TETRALONE | ESD-919161-5G |
| Cas.: 61704-30-1 | Purity: 97% | 6-(4-Chlorophenyl)picolinaldehyde | ESD-919162-1G |
| Cas.: 61704-30-1 | Purity: 97% | 6-(4-Chlorophenyl)picolinaldehyde | ESD-919162-5G |
| Cas.: 78213-03-3 | Purity: 97% | 6-Hydroxy-2-benzoxazolinone | ESD-919163-1G |
| Cas.: 78213-03-3 | Purity: 97% | 6-Hydroxy-2-benzoxazolinone | ESD-919163-5G |
| Cas.: 32996-24-0 | Purity: 97% | 6-Isopropyl indole | ESD-919164-1G |
| Cas.: 32996-24-0 | Purity: 97% | 6-Isopropyl indole | ESD-919164-5G |
| Cas.: 1104637-37-7 | Purity: 97% | Cyclobutylboronic acid MIDA ester | ESD-919165-1G |
| Cas.: 1104637-37-7 | Purity: 97% | Cyclobutylboronic acid MIDA ester | ESD-919165-5G |
| Cas.: 51163-24-7 | Purity: 97% | CYCLOHEXANEMETHYL ISOCYANATE | ESD-919166-1G |
| Cas.: 51163-24-7 | Purity: 97% | CYCLOHEXANEMETHYL ISOCYANATE | ESD-919166-5G |
| Cas.: 6000-41-5 | Purity: 99% | D-GLYCERIC ACID CALCIUM SALT DIHYDRATE | ESD-919167-1G |
| Cas.: 6000-41-5 | Purity: 99% | D-GLYCERIC ACID CALCIUM SALT DIHYDRATE | ESD-919167-5G |
| Cas.: 23147-59-3 | Purity: 95% | Dihydroxyacetonedimer | ESD-919168-1G |
| Cas.: 23147-59-3 | Purity: 95% | Dihydroxyacetonedimer | ESD-919168-5G |
| Cas.: 115186-37-3 | Purity: 98% | N-(TERT-BUTOXYCARBONYL)-L-PROLINE N’-METHOXY-N’-METHYLAMIDE | ESD-919169-1G |
| Cas.: 115186-37-3 | Purity: 98% | N-(TERT-BUTOXYCARBONYL)-L-PROLINE N’-METHOXY-N’-METHYLAMIDE | ESD-919169-5G |
| Cas.: 104845-82-1 | Purity: 98% | O,Oμ-Diaminopropane-1,3-diol dihydrochloride | ESD-919170-1G |
| Cas.: 104845-82-1 | Purity: 98% | O,Oμ-Diaminopropane-1,3-diol dihydrochloride | ESD-919170-5G |
| Cas.: 7288-28-0 | Purity: 97% | BIS(O-TRIMETHYLSILYL)THYMINE | ESD-919171-1G |
| Cas.: 7288-28-0 | Purity: 97% | BIS(O-TRIMETHYLSILYL)THYMINE | ESD-919171-5G |
| Cas.: 1152427-91-2 | Purity: 95% | Oxiranyl boronic acid MIDA ester | ESD-919172-1G |
| Cas.: 1152427-91-2 | Purity: 95% | Oxiranyl boronic acid MIDA ester | ESD-919172-5G |
| Cas.: 17043-94-6 | Purity: 97% | Pyrimidinen-oxide | ESD-919173-1G |
| Cas.: 17043-94-6 | Purity: 97% | Pyrimidinen-oxide | ESD-919173-5G |
| Cas.: 28290-41-7 | Purity: 95% | TRANS,TRANS-FARNESYL BROMIDE | ESD-919174-1G |
| Cas.: 35845-66-0 | Purity: ≥80% (GC); 80% | (E)-1-phenylbut-2-en-1-one | ESD-919175-1G |
| Cas.: 35845-66-0 | Purity: ≥80% (GC); 80% | (E)-1-phenylbut-2-en-1-one | ESD-919175-5G |
| Cas.: 871125-84-7 | Purity: 97% | E-2-(3-Chlorophenyl)vinylboronic acid,pinacol ester | ESD-919176-1G |
| Cas.: 871125-84-7 | Purity: 97% | E-2-(3-Chlorophenyl)vinylboronic acid,pinacol ester | ESD-919176-5G |
| Cas.: 849062-22-2 | Purity: ≥95% | trans-2-(3-Fluorophenyl)vinylboronic acid | ESD-919177-1G |
| Cas.: 849062-22-2 | Purity: ≥95% | trans-2-(3-Fluorophenyl)vinylboronic acid | ESD-919177-5G |
| Cas.: 72316-17-7 | Purity: 97% | (4-Methylstyryl)boronic acid | ESD-919178-1G |
| Cas.: 72316-17-7 | Purity: 97% | (4-Methylstyryl)boronic acid | ESD-919178-5G |
| Cas.: 55444-67-2 | Purity: 95% | 4-BROMO-1,1,1-TRIMETHOXYBUTANE | ESD-919179-1G |
| Cas.: 55444-67-2 | Purity: 95% | 4-BROMO-1,1,1-TRIMETHOXYBUTANE | ESD-919179-5G |
| Cas.: 591-57-1 | Purity: 97%, 10mg/mL solution in water | Triose phosphate | ESD-919180-1ML |
| Cas.: 80226-00-2 | Purity: ≥95.0% (HPLC) | ENTERODIOL | ESD-919181-1MG |
| Cas.: 34787-28-5 | N-desferriferrichrome | ESD-919182-1MG | |
| Cas.: 34787-28-5 | N-desferriferrichrome | ESD-919182-5MG | |
| Cas.: 67368-29-0 | Purity: ≥90% (HPLC) | Met-Arg-Phe-Ala acetate salt | ESD-919183-1MG |
| Cas.: 67368-29-0 | Purity: ≥90% (HPLC) | Met-Arg-Phe-Ala acetate salt | ESD-919183-5MG |
| Cas.: 133407-86-0 | Purity: ≥90% (HPLC) | MG-115 | ESD-919184-1MG |
| Cas.: 133407-86-0 | Purity: ≥90% (HPLC) | MG-115 | ESD-919184-5MG |
| Cas.: 26161-42-2 | Purity: average Mn 50,000 | POLY(L-LACTIDE) | ESD-919185-1G |
| Cas.: 26161-42-2 | Purity: average Mn 50,000 | POLY(L-LACTIDE) | ESD-919185-5G |
| Cas.: 69648-38-0 | Purity: ≥98% (HPLC) | (R)-BUTAPROST | ESD-919186-1MG |
| Cas.: 69648-38-0 | Purity: ≥98% (HPLC) | (R)-BUTAPROST | ESD-919186-5MG |
| Cas.: 83643-88-3 | Purity: ≥98% | (S)-AMPA | ESD-919187-1MG |
| Cas.: 83643-88-3 | Purity: ≥98% | (S)-AMPA | ESD-919187-5MG |
| Cas.: 26112-88-9 | Purity: ≥95% | 2-O-(4-Nitrophenyl)-aDN-acetylneuraminic acid | ESD-919188-1MG |
| Cas.: 51005-14-2 | Purity: ≥85% (SDS-PAGE) | ACTIN FROM BOVINE MUSCLE | ESD-919189-1MG |
| Cas.: 51005-14-2 | Purity: ≥85% (SDS-PAGE) | ACTIN FROM BOVINE MUSCLE | ESD-919189-5MG |
| Cas.: 130-49-4 | ADENOSINE 2′-& 3′-MONOPHOSPHATE FREE | ESD-919190-1G | |
| Cas.: 130-49-4 | ADENOSINE 2′-& 3′-MONOPHOSPHATE FREE | ESD-919190-5G | |
| Cas.: 73554-93-5 | Purity: protein C substrate | Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin | ESD-919191-1MG |
| Cas.: 73554-93-5 | Purity: protein C substrate | Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin | ESD-919191-5MG |
| Cas.: 15555-77-8 | Purity: 95% | Dichlorotetrakis(triphenylphosphine)ruthenium(II) | ESD-919192-1G |
| Cas.: 15555-77-8 | Purity: 95% | Dichlorotetrakis(triphenylphosphine)ruthenium(II) | ESD-919192-5G |
| Cas.: 779335-05-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylic acid | ESD-919193-1G |
| Cas.: 779335-05-6 | Purity: 95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylic acid | ESD-919193-5G |
| Cas.: 1012868-70-0 | Purity: 95% | Potassium 2-fluoro-5-formylphenyltrifluoroborate | ESD-919194-1G |
| Cas.: 1012868-70-0 | Purity: 95% | Potassium 2-fluoro-5-formylphenyltrifluoroborate | ESD-919194-5G |
| Cas.: 54450-84-9 | Purity: 95% | Cyclobutane-1,1-dicarboxylic acid ethyl ester | ESD-919195-1G |
| Cas.: 54450-84-9 | Purity: 95% | Cyclobutane-1,1-dicarboxylic acid ethyl ester | ESD-919195-5G |
| Cas.: 1027642-26-7 | Purity: 98% | Potassium trifluoro(((4-methoxybenzyl)oxy)methyl)borate | ESD-919196-1G |
| Cas.: 1027642-26-7 | Purity: 98% | Potassium trifluoro(((4-methoxybenzyl)oxy)methyl)borate | ESD-919196-5G |
| Cas.: 1169942-85-1 | Purity: 95% | (4-Methylphenylboronic acid pinacol ester)triphenylphosphonium bromide | ESD-919197-1G |
| Cas.: 1169942-85-1 | Purity: 95% | (4-Methylphenylboronic acid pinacol ester)triphenylphosphonium bromide | ESD-919197-5G |
| Cas.: 30955-94-3 | Purity: 97% | 1-(5-Iodothiophen-2-yl)ethanone | ESD-919198-1G |
| Cas.: 30955-94-3 | Purity: 97% | 1-(5-Iodothiophen-2-yl)ethanone | ESD-919198-5G |
| Cas.: 135620-04-1 | Purity: 98% | (S,S)-[N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine]manganese(III) chloride | ESD-919199-1G |
| Cas.: 135620-04-1 | Purity: 98% | (S,S)-[N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine]manganese(III) chloride | ESD-919199-5G |
| Cas.: 35274-53-4 | Purity: 95% | 2-Bromo-3,4,5-trimethoxybenzaldehyde | ESD-919200-1G |
| Cas.: 35274-53-4 | Purity: 95% | 2-Bromo-3,4,5-trimethoxybenzaldehyde | ESD-919200-5G |
| Cas.: 5321-47-1 | Purity: 97% | 1-(2-Methylbenzyl)-piperazine | ESD-919201-1G |
| Cas.: 5321-47-1 | Purity: 97% | 1-(2-Methylbenzyl)-piperazine | ESD-919201-5G |
| Cas.: 31329-64-3 | Purity: 95% | 3,5-Dimethylisoxazol-4-amine | ESD-919202-1G |
| Cas.: 31329-64-3 | Purity: 95% | 3,5-Dimethylisoxazol-4-amine | ESD-919202-5G |
| Cas.: 99655-68-2 | Purity: 97% | 3-Bromo-1-(phenylsulfonyl)-1H-indole | ESD-919203-1G |
| Cas.: 99655-68-2 | Purity: 97% | 3-Bromo-1-(phenylsulfonyl)-1H-indole | ESD-919203-5G |
| Cas.: 40757-09-3 | Purity: 97% | Methyl 5-iodo-2-methoxybenzoate | ESD-919204-1G |
| Cas.: 40757-09-3 | Purity: 97% | Methyl 5-iodo-2-methoxybenzoate | ESD-919204-5G |
| Cas.: 164931-83-3 | Purity: 98% | (R,R)-N,N’-BIs(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride Catalytic reagent | ESD-919205-1G |
| Cas.: 164931-83-3 | Purity: 98% | (R,R)-N,N’-BIs(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride Catalytic reagent | ESD-919205-5G |
| Cas.: 219143-92-7 | Purity: 98% | (S,S)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride | ESD-919206-1G |
| Cas.: 219143-92-7 | Purity: 98% | (S,S)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride | ESD-919206-5G |
| Cas.: 161282-57-1 | Purity: 95% | tert-Butyl 2-formyl-1H-pyrrole-1-carboxylate | ESD-919208-1G |
| Cas.: 161282-57-1 | Purity: 95% | tert-Butyl 2-formyl-1H-pyrrole-1-carboxylate | ESD-919208-5G |
| Cas.: 331-33-9 | Purity: 95% | Ethyl 2-(3-(trifluoromethyl)phenyl)acetate | ESD-919209-1G |
| Cas.: 331-33-9 | Purity: 95% | Ethyl 2-(3-(trifluoromethyl)phenyl)acetate | ESD-919209-5G |
| Cas.: 33167-21-4 | Purity: 95% | Ethyl (3-chlorobenzoyl)acetate | ESD-919210-1G |
| Cas.: 33167-21-4 | Purity: 95% | Ethyl (3-chlorobenzoyl)acetate | ESD-919210-5G |
| Cas.: 53078-70-9 | Purity: 95% | 2-Methoxy-5-methylbenzonitrile | ESD-919211-1G |
| Cas.: 53078-70-9 | Purity: 95% | 2-Methoxy-5-methylbenzonitrile | ESD-919211-5G |
| Cas.: 480438-74-2 | Purity: 97% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-919212-1G |
| Cas.: 480438-74-2 | Purity: 97% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-919212-5G |
| Cas.: 63590-62-5 | Purity: 97% | 1-(2-Tetrahydrofuroyl)piperazine hydrobromide | ESD-919213-1G |
| Cas.: 63590-62-5 | Purity: 97% | 1-(2-Tetrahydrofuroyl)piperazine hydrobromide | ESD-919213-5G |
| Cas.: 95333-95-2 | Purity: 97% | 3-(3,5-Dichlorophenyl)propanoic acid | ESD-919214-1G |
| Cas.: 95333-95-2 | Purity: 97% | 3-(3,5-Dichlorophenyl)propanoic acid | ESD-919214-5G |
| Cas.: 61008-98-8 | Purity: 98% | (R)-2-(3-Chlorophenyl)-2-hydroxyacetic acid | ESD-919215-1G |
| Cas.: 61008-98-8 | Purity: 98% | (R)-2-(3-Chlorophenyl)-2-hydroxyacetic acid | ESD-919215-5G |
| Cas.: 704884-74-2 | Purity: 95% | 5-Fluoro-2-hydroxy-3-methylbenzaldehyde | ESD-919216-1G |
| Cas.: 704884-74-2 | Purity: 95% | 5-Fluoro-2-hydroxy-3-methylbenzaldehyde | ESD-919216-5G |
| Cas.: 156808-79-6 | Purity: 95% | 1-(2-Bromophenyl)piperidine | ESD-919217-1G |
| Cas.: 156808-79-6 | Purity: 95% | 1-(2-Bromophenyl)piperidine | ESD-919217-5G |
| Cas.: 87350-77-4 | Purity: 98% | 4-(4-Iodophenyl)morpholine | ESD-919218-1G |
| Cas.: 87350-77-4 | Purity: 98% | 4-(4-Iodophenyl)morpholine | ESD-919218-5G |
| Cas.: 870718-06-2 | Purity: 95% | (2,4-Difluoro-3-formylphenyl)boronic acid | ESD-919219-1G |
| Cas.: 870718-06-2 | Purity: 95% | (2,4-Difluoro-3-formylphenyl)boronic acid | ESD-919219-5G |
| Cas.: 161344-84-9 | Purity: 95% | 2-Butyl-1,3,2-dioxaborolane-4s,5s-dicarboxylicacidbis(dimethylamidE) | ESD-919220-1G |
| Cas.: 161344-84-9 | Purity: 95% | 2-Butyl-1,3,2-dioxaborolane-4s,5s-dicarboxylicacidbis(dimethylamidE) | ESD-919220-5G |
| Cas.: 1192657-83-2 | Purity: 97% (HPLC) | Glycocholic acid hydrate | ESD-919221-1G |
| Cas.: 1192657-83-2 | Purity: 97% (HPLC) | Glycocholic acid hydrate | ESD-919221-5G |
| Cas.: 39538-68-6 | Purity: 96% | 2-Methoxy-4-methylaniline | ESD-919222-1G |
| Cas.: 39538-68-6 | Purity: 96% | 2-Methoxy-4-methylaniline | ESD-919222-5G |
| Cas.: 33574-02-6 | Purity: 95% (stabilized with Copper chip) | (Iodomethyl)cyclopropane | ESD-919223-1G |
| Cas.: 33574-02-6 | Purity: 95% (stabilized with Copper chip) | (Iodomethyl)cyclopropane | ESD-919223-5G |
| Cas.: 192376-68-4 | Purity: 98% | (3-Fluoro-4-propoxyphenyl)boronic acid | ESD-919224-1G |
| Cas.: 192376-68-4 | Purity: 98% | (3-Fluoro-4-propoxyphenyl)boronic acid | ESD-919224-5G |
| Cas.: 156487-13-7 | Purity: 95% | (4-Butoxy-3-fluorophenyl)boronic acid | ESD-919225-1G |
| Cas.: 156487-13-7 | Purity: 95% | (4-Butoxy-3-fluorophenyl)boronic acid | ESD-919225-5G |
| Cas.: 480438-60-6 | Purity: 95% | (4-Fluoro-2-propoxyphenyl)boronic acid | ESD-919226-1G |
| Cas.: 480438-60-6 | Purity: 95% | (4-Fluoro-2-propoxyphenyl)boronic acid | ESD-919226-5G |
| Cas.: 63113-79-1 | Purity: 95% | Methyl 2-methoxy-5-methylbenzoate | ESD-919227-1G |
| Cas.: 63113-79-1 | Purity: 95% | Methyl 2-methoxy-5-methylbenzoate | ESD-919227-5G |
| Cas.: 852228-08-1 | Purity: 95% | 2-(Piperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-919228-1G |
| Cas.: 852228-08-1 | Purity: 95% | 2-(Piperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-919228-5G |
| Cas.: 688809-94-1 | Purity: 97% | 3-Methoxypiperidine hydrochloride | ESD-919229-1G |
| Cas.: 688809-94-1 | Purity: 97% | 3-Methoxypiperidine hydrochloride | ESD-919229-5G |
| Cas.: 60144-52-7 | Purity: 97% | tert-butyl (3-methoxyphenyl)carbamate | ESD-919230-1G |
| Cas.: 60144-52-7 | Purity: 97% | tert-butyl (3-methoxyphenyl)carbamate | ESD-919230-5G |
| Cas.: 154150-18-2 | Purity: 95% | tert-Butyl (2-methoxyphenyl)carbamate | ESD-919231-1G |
| Cas.: 154150-18-2 | Purity: 95% | tert-Butyl (2-methoxyphenyl)carbamate | ESD-919231-5G |
| Cas.: 64187-47-9 | Purity: 98% | (S)-1-((Benzyloxy)carbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-919232-1G |
| Cas.: 64187-47-9 | Purity: 98% | (S)-1-((Benzyloxy)carbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-919232-5G |
| Cas.: 128833-03-4 | Purity: 97% | Diethyl 3-Bromobenzylphosphonate | ESD-919233-1G |
| Cas.: 128833-03-4 | Purity: 97% | Diethyl 3-Bromobenzylphosphonate | ESD-919233-5G |
| Cas.: 556112-20-0 | Purity: 97% | 1,2-Dichloro-4-ethynylbenzene | ESD-919234-1G |
| Cas.: 556112-20-0 | Purity: 97% | 1,2-Dichloro-4-ethynylbenzene | ESD-919234-5G |
| Cas.: 870778-87-3 | Purity: 98% | 4,5-Difluoro-2-ethoxyphenylboronic acid | ESD-919235-1G |
| Cas.: 870778-87-3 | Purity: 98% | 4,5-Difluoro-2-ethoxyphenylboronic acid | ESD-919235-5G |
| Cas.: 145878-50-8 | Purity: 98% | tert-Butyl (3-cyanophenyl)carbamate | ESD-919236-1G |
| Cas.: 145878-50-8 | Purity: 98% | tert-Butyl (3-cyanophenyl)carbamate | ESD-919236-5G |
| Cas.: 51640-52-9 | Purity: 97% | 2-Aminothiazole-5-carbonitrile | ESD-919237-1G |
| Cas.: 51640-52-9 | Purity: 97% | 2-Aminothiazole-5-carbonitrile | ESD-919237-5G |
| Cas.: 5153-71-9 | Purity: ≥95% | (E)-1-Bromo-4-(2-nitrovinyl)benzene | ESD-919238-250MG |
| Cas.: 5153-71-9 | Purity: ≥95% | (E)-1-Bromo-4-(2-nitrovinyl)benzene | ESD-919238-250G |
| Cas.: 166770-70-3 | Purity: 98% | 2-Chloro-4-(trifluoromethyl)pyridin-3-amine | ESD-919239-100MG |
| Cas.: 166770-70-3 | Purity: 98% | 2-Chloro-4-(trifluoromethyl)pyridin-3-amine | ESD-919239-250MG |
| Cas.: 1408074-46-3 | Purity: 95% | Tert-Butyl 7-Hydroxy-5-Oxa-2-Azaspiro[3.4]Octane-2-Carboxylate | ESD-919240-100MG |
| Cas.: 1408074-46-3 | Purity: 95% | Tert-Butyl 7-Hydroxy-5-Oxa-2-Azaspiro[3.4]Octane-2-Carboxylate | ESD-919240-250MG |
| Cas.: 1951438-84-8 | Purity: 95% | Propargyl-peg6-acid | ESD-919241-100MG |
| Cas.: 1951438-84-8 | Purity: 95% | Propargyl-peg6-acid | ESD-919241-250MG |
| Cas.: 146548-59-6 | Purity: ≥98% | 2,4,6-Trimethoxybenzylamine hydrochloride | ESD-919242-100MG |
| Cas.: 146548-59-6 | Purity: ≥98% | 2,4,6-Trimethoxybenzylamine hydrochloride | ESD-919242-250MG |
| Cas.: 1445085-92-6 | Purity: ≥95% | t-BuDavePhos Pd G3 | ESD-919243-100MG |
| Cas.: 1445085-92-6 | Purity: ≥95% | t-BuDavePhos Pd G3 | ESD-919243-250MG |
| Cas.: 124038-37-5 | Purity: ≥95% | Methyl 3-(2-oxoethyl)benzoate | ESD-919244-100MG |
| Cas.: 124038-37-5 | Purity: ≥95% | Methyl 3-(2-oxoethyl)benzoate | ESD-919244-250MG |
| Cas.: 150253-59-1 | Purity: 98% | 4-[(E)-Phenylethenyl)]benzyl chloride | ESD-919245-100MG |
| Cas.: 150253-59-1 | Purity: 98% | 4-[(E)-Phenylethenyl)]benzyl chloride | ESD-919245-250MG |
| Cas.: 1061659-74-2 | Purity: 95% | (R)-2-(Piperidin-2-yl)pyridine | ESD-919246-100MG |
| Cas.: 1061659-74-2 | Purity: 95% | (R)-2-(Piperidin-2-yl)pyridine | ESD-919246-250MG |
| Cas.: 955575-53-8 | Purity: 98% | 4-(4-Bromophenyl)-5-methyl-1H-pyrazol-3-amine | ESD-919247-100MG |
| Cas.: 955575-53-8 | Purity: 98% | 4-(4-Bromophenyl)-5-methyl-1H-pyrazol-3-amine | ESD-919247-250MG |
| Cas.: 1179361-66-0 | Purity: 97% | 4-Methoxypicolinimidamide hydrochloride | ESD-919248-100MG |
| Cas.: 1179361-66-0 | Purity: 97% | 4-Methoxypicolinimidamide hydrochloride | ESD-919248-250MG |
| Cas.: 1192620-83-9 | Purity: 98% | {N-[3-(η6-phenyl)propyl]-[(1R-2R)-1,2-diphenyl-1-4-methylbenzenesulfonylamidato(kN’)-ethyl-2-amino-(kN)]}ruthenium( II) | ESD-919249-100MG |
| Cas.: 1192620-83-9 | Purity: 98% | {N-[3-(η6-phenyl)propyl]-[(1R-2R)-1,2-diphenyl-1-4-methylbenzenesulfonylamidato(kN’)-ethyl-2-amino-(kN)]}ruthenium( II) | ESD-919249-250MG |
| Cas.: 105333-10-6 | Purity: 95% | Cyclopentadienyl[(1,2,3-n)-1-phenyl-2-propenyl]palladium(II) | ESD-919250-100MG |
| Cas.: 105333-10-6 | Purity: 95% | Cyclopentadienyl[(1,2,3-n)-1-phenyl-2-propenyl]palladium(II) | ESD-919250-250MG |
| Cas.: 1219080-77-9 | Purity: 97% | 2-(Di(adamantan-1-yl)phosphino)-N,N-dimethylaniline | ESD-919251-100MG |
| Cas.: 1219080-77-9 | Purity: 97% | 2-(Di(adamantan-1-yl)phosphino)-N,N-dimethylaniline | ESD-919251-250MG |
| Cas.: 894779-28-3 | Purity: 98% | Ethyl 4-hydroxy-2-methylbenzofuran-6-carboxylate | ESD-919252-100MG |
| Cas.: 894779-28-3 | Purity: 98% | Ethyl 4-hydroxy-2-methylbenzofuran-6-carboxylate | ESD-919252-250MG |
| Cas.: 1340481-81-3 | Purity: 95% | 2-(tert-Butoxycarbonyl)-5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide | ESD-919253-100MG |
| Cas.: 1340481-81-3 | Purity: 95% | 2-(tert-Butoxycarbonyl)-5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide | ESD-919253-250MG |
| Cas.: 1013921-36-2 | Purity: 97% | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine | ESD-919254-100MG |
| Cas.: 1013921-36-2 | Purity: 97% | 3,6,9,12-Tetraoxapentadec-14-yn-1-amine | ESD-919254-250MG |
| Cas.: 1824343-92-1 | Purity: 95% | 3-Cyclobutyl-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-919255-100MG |
| Cas.: 1824343-92-1 | Purity: 95% | 3-Cyclobutyl-1-methyl-1H-pyrazole-4-carbaldehyde | ESD-919255-250MG |
| Cas.: 4053-38-7 | Purity: 97% | 8-Methylquinoline 1-oxide | ESD-919256-100MG |
| Cas.: 4053-38-7 | Purity: 97% | 8-Methylquinoline 1-oxide | ESD-919256-250MG |
| Cas.: 415941-58-1 | Purity: 97% | [2-(N,N-Dimethylamino)phenyl]di-t-butylphosphine | ESD-919257-100MG |
| Cas.: 415941-58-1 | Purity: 97% | [2-(N,N-Dimethylamino)phenyl]di-t-butylphosphine | ESD-919257-250MG |
| Cas.: 224311-55-1 | Purity: 97% | (2-Biphenyl)di-1-adamantylphosphine | ESD-919258-50MG |
| Cas.: 224311-55-1 | Purity: 97% | (2-Biphenyl)di-1-adamantylphosphine | ESD-919258-250MG |
| Cas.: 852913-16-7 | Purity: 97% | 1-[3,5-bis(trifluoromethyl)phenyl]-3-[(S)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl] (6-methoxyquinolin-4-yl)methyl]thiourea | ESD-919259-50MG |
| Cas.: 852913-16-7 | Purity: 97% | 1-[3,5-bis(trifluoromethyl)phenyl]-3-[(S)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl] (6-methoxyquinolin-4-yl)methyl]thiourea | ESD-919259-250MG |
| Cas.: 155106-15-3 | Purity: ≥95% | (R)-2-Ethylpiperidine hydrochloride | ESD-919260-50MG |
| Cas.: 155106-15-3 | Purity: ≥95% | (R)-2-Ethylpiperidine hydrochloride | ESD-919260-250MG |
| Cas.: 1428327-31-4 | Purity: 97% | 2-(Phenylthio)-N-[[tetrahydro-4-(4-phenyl-1-piperazinyl)-2H-pyran-4-yl]methyl]-3-pyridinecarboxamide | ESD-919261-50MG |
| Cas.: 1428327-31-4 | Purity: 97% | 2-(Phenylthio)-N-[[tetrahydro-4-(4-phenyl-1-piperazinyl)-2H-pyran-4-yl]methyl]-3-pyridinecarboxamide | ESD-919261-250MG |
| Cas.: 176298-44-5 | Purity: 97% | 1,4-Bis[(9S)-10,11-dihydro-6′-methoxycinchonan-9-yl]-9,10-anthracenedione | ESD-919262-50MG |
| Cas.: 176298-44-5 | Purity: 97% | 1,4-Bis[(9S)-10,11-dihydro-6′-methoxycinchonan-9-yl]-9,10-anthracenedione | ESD-919262-250MG |
| Cas.: 1810068-31-5 | Purity: 98% | 2-[Bis(3,5-trifluoromethylphenylphosphino)-3,6-dimethoxy]- 2′,6′-di-i-propoxy-1,1′-biphenyl | ESD-919263-50MG |
| Cas.: 1810068-31-5 | Purity: 98% | 2-[Bis(3,5-trifluoromethylphenylphosphino)-3,6-dimethoxy]- 2′,6′-di-i-propoxy-1,1′-biphenyl | ESD-919263-250MG |
| Cas.: 220108-54-3 | Purity: 97% | (R)-4-Phenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-919264-50MG |
| Cas.: 220108-54-3 | Purity: 97% | (R)-4-Phenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-919264-250MG |
| Cas.: 1252576-13-8 | Purity: 97% | (S)-4-Phenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-919265-50MG |
| Cas.: 1252576-13-8 | Purity: 97% | (S)-4-Phenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-919265-250MG |
| Cas.: 1973375-72-2 | Purity: 98% | [5,5′-Bis(trifluoromethyl)-2,2′-bipyridine-κN,κN]bis[3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-κN]phenyl] iridium hexafluorophosphate | ESD-919266-50MG |
| Cas.: 1973375-72-2 | Purity: 98% | [5,5′-Bis(trifluoromethyl)-2,2′-bipyridine-κN,κN]bis[3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-κN]phenyl] iridium hexafluorophosphate | ESD-919266-250MG |
| Cas.: 2042201-18-1 | Purity: 98% | [4,4′-Bis(1,1-dimethylethyl)-2,2′-bipyridine]bis[3,5-difluoro-2-(5-fluoro-2-pyridinyl)phenyl]iridium hexafluorophosphate | ESD-919267-50MG |
| Cas.: 2042201-18-1 | Purity: 98% | [4,4′-Bis(1,1-dimethylethyl)-2,2′-bipyridine]bis[3,5-difluoro-2-(5-fluoro-2-pyridinyl)phenyl]iridium hexafluorophosphate | ESD-919267-250MG |
| Cas.: 152140-65-3 | Purity: 98% | N,N’-(11R,12R)-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosphino)benzamide] | ESD-919268-50MG |
| Cas.: 152140-65-3 | Purity: 98% | N,N’-(11R,12R)-(9,10-Dihydro-9,10-ethanoanthracene-11,12-diyl)bis[2-(diphenylphosphino)benzamide] | ESD-919268-250MG |
| Cas.: 79549-89-6 | Purity: ≥95% | Ethyl (1α,8α,9α)-bicyclo[6.1.0]non-4-ene-9-carboxylate | ESD-919269-50MG |
| Cas.: 79549-89-6 | Purity: ≥95% | Ethyl (1α,8α,9α)-bicyclo[6.1.0]non-4-ene-9-carboxylate | ESD-919269-250MG |
| Cas.: 81542-51-0 | Purity: 97% | 3-Amino-4-iodo-1H-pyrazole | ESD-919270-50MG |
| Cas.: 81542-51-0 | Purity: 97% | 3-Amino-4-iodo-1H-pyrazole | ESD-919270-250MG |
| Cas.: 37778-99-7 | Purity: ≥98% | (S)-(-)-2-Phenyl-1-propanol | ESD-919271-50MG |
| Cas.: 37778-99-7 | Purity: ≥98% | (S)-(-)-2-Phenyl-1-propanol | ESD-919271-250MG |
| Cas.: 10294-50-5 | Purity: 98% | COBALT(II) PHOSPHATE OCTAHYDRATE | ESD-919272-50G |
| Cas.: 10294-50-5 | Purity: 98% | COBALT(II) PHOSPHATE OCTAHYDRATE | ESD-919272-250G |
| Cas.: 130727-41-2 | Purity: 95% | 1-(9-MERCAPTONONYL)-3,6,9-TRIOXAUNDECAN-11-OL | ESD-919273-50MG |
| Cas.: 130727-41-2 | Purity: 95% | 1-(9-MERCAPTONONYL)-3,6,9-TRIOXAUNDECAN-11-OL | ESD-919273-250MG |
| Cas.: 20411-31-8 | Purity: ≥60% (HPLC) | TRIGLYCEROL | ESD-919274-50ML |
| Cas.: 185913-98-8 | Purity: 98% | (S)-(-)-5,5′-Dichloro-6,6′-dimethoxy-2,2′-bis(diphenylphosphino)-1,1′-biphenyl | ESD-919275-50MG |
| Cas.: 185913-98-8 | Purity: 98% | (S)-(-)-5,5′-Dichloro-6,6′-dimethoxy-2,2′-bis(diphenylphosphino)-1,1′-biphenyl | ESD-919275-250MG |
| Cas.: 263717-53-9 | Purity: 99% | 4,4′,4”-(4-Propyl-1H-pyrazole-1,3,5-triyl)triphenol | ESD-919276-50MG |
| Cas.: 263717-53-9 | Purity: 99% | 4,4′,4”-(4-Propyl-1H-pyrazole-1,3,5-triyl)triphenol | ESD-919276-250MG |
| Cas.: 179162-34-6 | Purity: 98% | Tetrakis[(S)-N-(p-dodecylphenylsulfonyl)prolinato]dirhodium(II) | ESD-919277-50MG |
| Cas.: 179162-34-6 | Purity: 98% | Tetrakis[(S)-N-(p-dodecylphenylsulfonyl)prolinato]dirhodium(II) | ESD-919277-250MG |
| Cas.: 304655-78-5 | Purity: 98% | 3-Amino-1,2,4-triazole-5-carboxylic acid hydrate | ESD-919278-50G |
| Cas.: 304655-78-5 | Purity: 98% | 3-Amino-1,2,4-triazole-5-carboxylic acid hydrate | ESD-919278-250G |
| Cas.: 168395-26-4 | Purity: 97% | (S)-Tetrahydrofuran-3-carboxylic acid | ESD-919279-50MG |
| Cas.: 168395-26-4 | Purity: 97% | (S)-Tetrahydrofuran-3-carboxylic acid | ESD-919279-250MG |
| Cas.: 104486-98-8 | Purity: ≥95% (HPLC) | (±)-Dihydrokaempferol | ESD-919280-10MG |
| Cas.: 104486-98-8 | Purity: ≥95% (HPLC) | (±)-Dihydrokaempferol | ESD-919280-250MG |
| Cas.: 100900-26-3 | Arg-Arg beta-Naphthylamide Trihydrochloride | ESD-919281-5MG | |
| Cas.: 100900-26-3 | Arg-Arg beta-Naphthylamide Trihydrochloride | ESD-919281-250MG | |
| Cas.: 1092542-31-8 | Purity: 95% | 2-Bromo-6-(trimethylsilyl)phenyl triflate | ESD-919282-1G |
| Cas.: 1092542-31-8 | Purity: 95% | 2-Bromo-6-(trimethylsilyl)phenyl triflate | ESD-919282-250MG |
| Cas.: 73755-28-9 | Purity: 97% | Rhodium(II) heptafluorobutyrate dimer | ESD-919283-1G |
| Cas.: 73755-28-9 | Purity: 97% | Rhodium(II) heptafluorobutyrate dimer | ESD-919283-250MG |
| Cas.: 13293-47-5 | Purity: 95% | (1S,2S,3S,5R)-(+)-Isopinocampheylamine | ESD-919284-1G |
| Cas.: 13293-47-5 | Purity: 95% | (1S,2S,3S,5R)-(+)-Isopinocampheylamine | ESD-919284-250MG |
| Cas.: 143262-21-9 | Purity: 97% | 7-INDOLINECARBOXALDEHYDE | ESD-919285-1G |
| Cas.: 143262-21-9 | Purity: 97% | 7-INDOLINECARBOXALDEHYDE | ESD-919285-250MG |
| Cas.: 27057-09-6 | Purity: 99% | Chloro(2-methylphenyl)bis(triphenylphosphine)nickel(II) | ESD-919286-1G |
| Cas.: 27057-09-6 | Purity: 99% | Chloro(2-methylphenyl)bis(triphenylphosphine)nickel(II) | ESD-919286-250MG |
| Cas.: 4874-17-3 | Purity: 95% | N~3~-methyl-beta-alaninamide (SALTDATA: HCl) | ESD-919287-1G |
| Cas.: 4874-17-3 | Purity: 95% | N~3~-methyl-beta-alaninamide (SALTDATA: HCl) | ESD-919287-250MG |
| Cas.: 1086391-08-3 | Purity: 95% | 3-broMo-1H-indazol-5-carbaldehyde | ESD-919288-1G |
| Cas.: 1086391-08-3 | Purity: 95% | 3-broMo-1H-indazol-5-carbaldehyde | ESD-919288-250MG |
| Cas.: 5502-78-3 | Purity: ≥98.0% (HPLC) | 9-METHYLGUANINE | ESD-919289-1G |
| Cas.: 5502-78-3 | Purity: ≥98.0% (HPLC) | 9-METHYLGUANINE | ESD-919289-250MG |
| Cas.: 12132-87-5 | Dicarbonylcyclopentadienylruthenium dimer | ESD-919290-1G | |
| Cas.: 12132-87-5 | Dicarbonylcyclopentadienylruthenium dimer | ESD-919290-250MG | |
| Cas.: 147831-75-2 | Purity: 98% | CYCLOPENTADIENYL(P-CYMENE)RUTHENIUM (II) HEXAFLUOROPHOSPHATE, MIN | ESD-919291-1G |
| Cas.: 147831-75-2 | Purity: 98% | CYCLOPENTADIENYL(P-CYMENE)RUTHENIUM (II) HEXAFLUOROPHOSPHATE, MIN | ESD-919291-250MG |
| Cas.: 227000-59-1 | N-tert-Butyl-N-(2-Methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylaMine | ESD-919292-1G | |
| Cas.: 227000-59-1 | N-tert-Butyl-N-(2-Methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylaMine | ESD-919292-250MG | |
| Cas.: 134874-49-0 | O-(2-Mercaptoethyl)-O’-methylpolyethylene glycol | ESD-919293-1G | |
| Cas.: 134874-49-0 | O-(2-Mercaptoethyl)-O’-methylpolyethylene glycol | ESD-919293-250MG | |
| Cas.: 110851-65-5 | MW : 30000-100000 | POLY(3-DECYLTHIOPHENE-2,5-DIYL) | ESD-919294-1G |
| Cas.: 110851-65-5 | MW : 30000-100000 | POLY(3-DECYLTHIOPHENE-2,5-DIYL) | ESD-919294-250MG |
| Cas.: 1449472-59-6 | Purity: 95% | 2-chloro-6-(trimethylsilyl)phenyl trifluoromethanesulfonate | ESD-919295-1G |
| Cas.: 1449472-59-6 | Purity: 95% | 2-chloro-6-(trimethylsilyl)phenyl trifluoromethanesulfonate | ESD-919295-250MG |
| Cas.: 1219589-99-7 | Purity: ≥96.0% (GC); ≥96.0% | Sodium 3-hydroxy-2-methylpropionate | ESD-919296-1G |
| Cas.: 1219589-99-7 | Purity: ≥96.0% (GC); ≥96.0% | Sodium 3-hydroxy-2-methylpropionate | ESD-919296-250MG |
| Cas.: 2504-11-2 | ACETYL-DL-CARNITINE HYDROCHLORIDE | ESD-919297-1G | |
| Cas.: 2504-11-2 | ACETYL-DL-CARNITINE HYDROCHLORIDE | ESD-919297-250MG | |
| Cas.: 2280-42-4 | Purity: ≥98% (TLC) | dl-3-hydroxynorvaline | ESD-919298-1G |
| Cas.: 2280-42-4 | Purity: ≥98% (TLC) | dl-3-hydroxynorvaline | ESD-919298-250MG |
| Cas.: 1114-81-4 | O-PHOSPHO-L-THREONINE | ESD-919299-250MG | |
| Cas.: 51023-76-8 | Purity: ≥80% | 4-Acetamido-4′-isothiocyanatostilbene-2,2′-disulfonic Acid, Sodium Salt | ESD-919300-1G |
| Cas.: 51023-76-8 | Purity: ≥80% | 4-Acetamido-4′-isothiocyanatostilbene-2,2′-disulfonic Acid, Sodium Salt | ESD-919300-250MG |
| Cas.: 17016-46-5 | Purity: 95% | 5-BROMO-4-CHLORO-3-INDOXYL-BETA-D-FUCOPYRANOSIDE | ESD-919301-1G |
| Cas.: 17016-46-5 | Purity: 95% | 5-BROMO-4-CHLORO-3-INDOXYL-BETA-D-FUCOPYRANOSIDE | ESD-919301-250MG |
| Cas.: 70145-42-5 | Purity: 1.0 M Solution In Hexanes, MKSeal | B-IODO-9-BBN | ESD-919303-100ML |
| Cas.: 70145-42-5 | Purity: 1.0 M Solution In Hexanes, MKSeal | B-IODO-9-BBN | ESD-919303-25ML |
| Cas.: 307531-80-2 | Purity: 0.5 M solution in THF, MKSeal | 2,6-DICHLOROBENZYLZINC CHLORIDE | ESD-919304-100ML |
| Cas.: 307531-80-2 | Purity: 0.5 M solution in THF, MKSeal | 2,6-DICHLOROBENZYLZINC CHLORIDE | ESD-919304-25ML |
| Cas.: 77928-70-2 | Purity: ≥97.0% (TLC) | N1-ACETYLSPERMINE TRIHYDROCHLORIDE | ESD-919305-100MG |
| Cas.: 77928-70-2 | Purity: ≥97.0% (TLC) | N1-ACETYLSPERMINE TRIHYDROCHLORIDE | ESD-919305-25MG |
| Cas.: 1234203-45-2 | Purity: 97% | 5-Norbornene-2-acetic Acid Succinimidyl Ester | ESD-919306-100MG |
| Cas.: 1234203-45-2 | Purity: 97% | 5-Norbornene-2-acetic Acid Succinimidyl Ester | ESD-919306-25MG |
| Cas.: 10183-34-3 | H-ALA-ALA-ALA-ALA-ALA-OH | ESD-919307-100MG | |
| Cas.: 10183-34-3 | H-ALA-ALA-ALA-ALA-ALA-OH | ESD-919307-25MG | |
| Cas.: 69861-89-8 | Z-LYS-SBZL HCL | ESD-919308-100MG | |
| Cas.: 69861-89-8 | Z-LYS-SBZL HCL | ESD-919308-25MG | |
| Cas.: 100991-92-2 | 1,4-DIDEOXY-1,4-IMINO-D-ARABINITOL HYDROCHLORIDE | ESD-919309-10MG | |
| Cas.: 100991-92-2 | 1,4-DIDEOXY-1,4-IMINO-D-ARABINITOL HYDROCHLORIDE | ESD-919309-25MG | |
| Cas.: 35520-41-3 | Purity: 95% | trans-3-(Dimethylamino)acrylonitrile | ESD-919310-5G |
| Cas.: 6898-84-6 | Purity: 95% | SODIUM 1-PROPANETHIOLATE | ESD-919311-5G |
| Cas.: 6898-84-6 | Purity: 95% | SODIUM 1-PROPANETHIOLATE | ESD-919311-25G |
| Cas.: 1064-10-4 | Purity: 97% | Hexaphenylditin(IV) | ESD-919312-5G |
| Cas.: 1064-10-4 | Purity: 97% | Hexaphenylditin(IV) | ESD-919312-25G |
| Cas.: 17102-64-6 | Purity: 98% | trans,trans-2,4-Hexadien-1-ol | ESD-919313-5G |
| Cas.: 17102-64-6 | Purity: 98% | trans,trans-2,4-Hexadien-1-ol | ESD-919313-25G |
| Cas.: 15205-15-9 | Purity: 98% | 2-Chloro-6-fluorobenzylamine | ESD-919314-5G |
| Cas.: 15205-15-9 | Purity: 98% | 2-Chloro-6-fluorobenzylamine | ESD-919314-25G |
| Cas.: 10433-06-4 | Purity: 99.9% (metals basis) | Antimony(III) ethoxide | ESD-919315-5G |
| Cas.: 10433-06-4 | Purity: 99.9% (metals basis) | Antimony(III) ethoxide | ESD-919315-25G |
| Cas.: 1620-14-0 | Purity: 96% | (Diethylamino)acetone | ESD-919317-5G |
| Cas.: 1620-14-0 | Purity: 96% | (Diethylamino)acetone | ESD-919317-25G |
| Cas.: 32830-97-0 | Purity: 85% | 1-CHLORO-3-PENTANONE | ESD-919318-5G |
| Cas.: 32830-97-0 | Purity: 85% | 1-CHLORO-3-PENTANONE | ESD-919318-25G |
| Cas.: 1082532-95-3 | Purity: ≥95%(HPLC) | NSC130813 | ESD-919319-5MG |
| Cas.: 1082532-95-3 | Purity: ≥95%(HPLC) | NSC130813 | ESD-919319-25MG |
| Cas.: 1841460-82-9 | Purity: 98% | 4-((4-Benzyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)pyrido[3′,2′:4,5]thieno[3, 2-d]pyrimidine | ESD-919320-5MG |
| Cas.: 1841460-82-9 | Purity: 98% | 4-((4-Benzyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)pyrido[3′,2′:4,5]thieno[3, 2-d]pyrimidine | ESD-919320-25MG |
| Cas.: 1193-92-6 | Purity: 98% | nicotinaldehyde oxime | ESD-919321-5G |
| Cas.: 1193-92-6 | Purity: 98% | nicotinaldehyde oxime | ESD-919321-25G |
| Cas.: 953-26-4 | Purity: ≥95% | Ethyl 4-nitrocinnamate | ESD-919322-5G |
| Cas.: 953-26-4 | Purity: ≥95% | Ethyl 4-nitrocinnamate | ESD-919322-25G |
| Cas.: 3385-34-0 | Purity: 95% | Ethyl isodehydracetate | ESD-919323-5G |
| Cas.: 3385-34-0 | Purity: 95% | Ethyl isodehydracetate | ESD-919323-25G |
| Cas.: 40225-14-7 | Purity: ≥95%(HPLC) | Valerylcarnitine | ESD-919324-5MG |
| Cas.: 2898-76-2 | Purity: ≥98% | Benzamil | ESD-919325-5MG |
| Cas.: 2898-76-2 | Purity: ≥98% | Benzamil | ESD-919325-25MG |
| Cas.: 1239600-18-0 | Purity: ≥98% (HPLC) | LMT-28 | ESD-919326-5MG |
| Cas.: 1193-81-3 | Purity: 97% | 1-Cyclohexylethanol | ESD-919327-5G |
| Cas.: 1193-81-3 | Purity: 97% | 1-Cyclohexylethanol | ESD-919327-25G |
| Cas.: 89-35-0 | Purity: 97% | 3,5-Dihydroxynapthalene-2-carboxylic Acid | ESD-919328-5G |
| Cas.: 89-35-0 | Purity: 97% | 3,5-Dihydroxynapthalene-2-carboxylic Acid | ESD-919328-25G |
| Cas.: 618-71-3 | Purity: 98% | Ethyl 3,5-dinitrobenzoate | ESD-919329-5G |
| Cas.: 618-71-3 | Purity: 98% | Ethyl 3,5-dinitrobenzoate | ESD-919329-25G |
| Cas.: 2243-80-3 | Purity: 97% | 3-Nitrobenzophenone | ESD-919330-5G |
| Cas.: 2243-80-3 | Purity: 97% | 3-Nitrobenzophenone | ESD-919330-25G |
| Cas.: 1604-11-1 | Purity: 98% | Dimethyl methylsuccinate | ESD-919331-5G |
| Cas.: 1604-11-1 | Purity: 98% | Dimethyl methylsuccinate | ESD-919331-25G |
| Cas.: 120-33-2 | Purity: 98% | Ethyl 3-Methylbenzoate | ESD-919332-5G |
| Cas.: 120-33-2 | Purity: 98% | Ethyl 3-Methylbenzoate | ESD-919332-25G |
| Cas.: 41994-51-8 | Purity: 96% | 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid hydrochloride | ESD-919333-5G |
| Cas.: 41994-51-8 | Purity: 96% | 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid hydrochloride | ESD-919333-25G |
| Cas.: 24731-17-7 | Purity: 97% | Ethyl 2-cyclohexanone acetate | ESD-919334-5G |
| Cas.: 24731-17-7 | Purity: 97% | Ethyl 2-cyclohexanone acetate | ESD-919334-25G |
| Cas.: 3354-58-3 | Purity: 98% | 2-Allyl-6-methylphenol | ESD-919335-5G |
| Cas.: 3354-58-3 | Purity: 98% | 2-Allyl-6-methylphenol | ESD-919335-25G |
| Cas.: 2902-96-7 | Purity: 95% | 2-Nitro-1-propanol | ESD-919336-5G |
| Cas.: 2103-88-0 | Purity: 98% | 2-Mercapto-4-phenylthiazole | ESD-919337-5G |
| Cas.: 2103-88-0 | Purity: 98% | 2-Mercapto-4-phenylthiazole | ESD-919337-25G |
| Cas.: 32434-42-7 | Purity: 95% (HPLC) | Febrifugine dihydrochloride | ESD-919338-5MG |
| Cas.: 32434-42-7 | Purity: 95% (HPLC) | Febrifugine dihydrochloride | ESD-919338-25MG |
| Cas.: 110127-07-6 | Purity: 95% | 2,6-Dibromo-4-nitrotoluene | ESD-919339-5G |
| Cas.: 110127-07-6 | Purity: 95% | 2,6-Dibromo-4-nitrotoluene | ESD-919339-25G |
| Cas.: 4316-35-2 | Purity: 97% | (1,1-Dimethoxyethyl)benzene | ESD-919340-5G |
| Cas.: 4316-35-2 | Purity: 97% | (1,1-Dimethoxyethyl)benzene | ESD-919340-25G |
| Cas.: 98841-68-0 | Purity: 97% | N-(2-HYDROXYBENZOYL)PYRROLIDINE | ESD-919341-5G |
| Cas.: 98841-68-0 | Purity: 97% | N-(2-HYDROXYBENZOYL)PYRROLIDINE | ESD-919341-25G |
| Cas.: 1686-22-2 | Purity: 95% | VANADIUM(V) OXYTRIETHOXIDE | ESD-919342-5ML |
| Cas.: 1686-22-2 | Purity: 95% | VANADIUM(V) OXYTRIETHOXIDE | ESD-919342-25ML |
| Cas.: 25357-81-7 | Purity: ≥95% (GC) | 3-AMINOPROPYLTRIS(TRIMETHYLSILOXY)SILANE | ESD-919343-5ML |
| Cas.: 25357-81-7 | Purity: ≥95% (GC) | 3-AMINOPROPYLTRIS(TRIMETHYLSILOXY)SILANE | ESD-919343-25ML |
| Cas.: 73568-29-3 | Purity: 99% | 2-CHLORO-6-METHOXYQUINOLINE-3-CARBALDEHYDE | ESD-919344-5G |
| Cas.: 73568-29-3 | Purity: 99% | 2-CHLORO-6-METHOXYQUINOLINE-3-CARBALDEHYDE | ESD-919344-25G |
| Cas.: 3647-71-0 | Purity: 99% | N-BENZYL-2-PHENYLETHYLAMINE | ESD-919345-5G |
| Cas.: 488-47-1 | Purity: 96% | TETRABROMOCATECHOL | ESD-919346-5G |
| Cas.: 488-47-1 | Purity: 96% | TETRABROMOCATECHOL | ESD-919346-25G |
| Cas.: 768404-03-1 | Purity: ≥98% (HPLC) | 5-BDBD | ESD-919347-5MG |
| Cas.: 768404-03-1 | Purity: ≥98% (HPLC) | 5-BDBD | ESD-919347-25MG |
| Cas.: 163239-22-3 | Purity: ≥98% (HPLC) | 6-Fluoro-3-[(1E)-2-(3-pyridinyl)ethenyl]-1H-indole | ESD-919348-5MG |
| Cas.: 163239-22-3 | Purity: ≥98% (HPLC) | 6-Fluoro-3-[(1E)-2-(3-pyridinyl)ethenyl]-1H-indole | ESD-919348-25MG |
| Cas.: 200006-08-2 | Purity: ≥98% (HPLC) | ALX 5407 hydrochloride | ESD-919350-5MG |
| Cas.: 200006-08-2 | Purity: ≥98% (HPLC) | ALX 5407 hydrochloride | ESD-919350-25MG |
| Cas.: 153322-06-6 | Purity: ≥97% (HPLC) | AZD6765 dihydrochloride | ESD-919351-5MG |
| Cas.: 153322-06-6 | Purity: ≥97% (HPLC) | AZD6765 dihydrochloride | ESD-919351-25MG |
| Cas.: 148556-27-8 | Purity: ≥95% V basis | bpV(pic) | ESD-919352-5MG |
| Cas.: 148556-27-8 | Purity: ≥95% V basis | bpV(pic) | ESD-919352-25MG |
| Cas.: 64816-14-4 | Purity: 95% | D-Val-Leu-Arg p-nitroanilide diacetate salt | ESD-919353-5MG |
| Cas.: 64816-14-4 | Purity: 95% | D-Val-Leu-Arg p-nitroanilide diacetate salt | ESD-919353-25MG |
| Cas.: 20244-86-4 | Purity: 90% | 7-Methylguanosine | ESD-919354-5MG |
| Cas.: 20244-86-4 | Purity: 90% | 7-Methylguanosine | ESD-919354-25MG |
| Cas.: 215804-67-4 | Purity: 98% | SB-277011 hydrochloride | ESD-919355-5MG |
| Cas.: 215804-67-4 | Purity: 98% | SB-277011 hydrochloride | ESD-919355-25MG |
| Cas.: 489-17-8 | Purity: 95% | 4-Fluoro-2-methylbenzenesulfonamide | ESD-919356-5G |
| Cas.: 489-17-8 | Purity: 95% | 4-Fluoro-2-methylbenzenesulfonamide | ESD-919356-25G |
| Cas.: 149418-41-7 | Purity: 95% | 3,4-Dibromofuran-2(5H)-one | ESD-919357-5G |
| Cas.: 149418-41-7 | Purity: 95% | 3,4-Dibromofuran-2(5H)-one | ESD-919357-25G |
| Cas.: 1810-67-9 | Purity: 98% | 6-Chloro-2-hydroxyquinoline | ESD-919358-5G |
| Cas.: 1810-67-9 | Purity: 98% | 6-Chloro-2-hydroxyquinoline | ESD-919358-25G |
| Cas.: 98139-72-1 | Purity: 97% | Isopentylboronic acid | ESD-919359-5G |
| Cas.: 98139-72-1 | Purity: 97% | Isopentylboronic acid | ESD-919359-25G |
| Cas.: 92112-69-1 | Purity: ≥98% | Hexanes, mixed isomers | ESD-919360-500ML |
| Cas.: 92112-69-1 | Purity: ≥98% | Hexanes, mixed isomers | ESD-919360-2.5L |
| Cas.: 90170-80-2 | Purity: lyophilized powder, ≥95% (SDS-PAGE) | Antithrombin III from human plasma | ESD-919362-25ΜG |
| Cas.: 90170-80-2 | Purity: lyophilized powder, ≥95% (SDS-PAGE) | Antithrombin III from human plasma | ESD-919362-125ΜG |
| Cas.: 9012-56-0 | Purity: hydroxamate transferase ≥200units/mg protein (biuret) | Amidase from Pseudomonas aeruginosa recombinant, expressed in E. coli, buffered aqueous glycerol solution, hydroxamate transferase | ESD-919363-250U |
| Cas.: 9012-56-0 | Purity: hydroxamate transferase ≥200units/mg protein (biuret) | Amidase from Pseudomonas aeruginosa recombinant, expressed in E. coli, buffered aqueous glycerol solution, hydroxamate transferase | ESD-919363-1000U |
| Cas.: 569650-64-2 | Purity: 97% | (+)-1,2-BIS((2R,5R)-2,5-DI-I-PROPYLPHOSPHOLANO)BENZENE)1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE | ESD-919364-500MG |
| Cas.: 569650-64-2 | Purity: 97% | (+)-1,2-BIS((2R,5R)-2,5-DI-I-PROPYLPHOSPHOLANO)BENZENE)1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE | ESD-919364-100MG |
| Cas.: 41908-11-6 | Purity: 95% | 3-ACETYLBENZALDEHYDE 97 | ESD-919365-250MG |
| Cas.: 41908-11-6 | Purity: 95% | 3-ACETYLBENZALDEHYDE 97 | ESD-919365-100MG |
| Cas.: 37793-53-6 | Purity: 95% | 4-(N-((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)-2,2,2-trifluoroacetamido)benzoic acid | ESD-919366-25MG |
| Cas.: 37793-53-6 | Purity: 95% | 4-(N-((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)-2,2,2-trifluoroacetamido)benzoic acid | ESD-919366-100MG |
| Cas.: 4137-10-4 | Purity: ratiocarbondioxide/dimethylamine<2:1 | Dimethylammonium-dimethylcarbamate | ESD-919367-25G |
| Cas.: 405204-22-0 | Purity: 0.6MinTHF | Lanthanum(III) chloride bis(lithium chloride)complex solution | ESD-919368-25ML |
| Cas.: 405204-22-0 | Purity: 0.6MinTHF | Lanthanum(III) chloride bis(lithium chloride)complex solution | ESD-919368-100ML |
| Cas.: 307531-79-9 | Purity: 0.5 M solution in THF, MKSeal | 3,4-DIMETHOXYBENZYLZINC CHLORIDE | ESD-919369-25ML |
| Cas.: 307531-79-9 | Purity: 0.5 M solution in THF, MKSeal | 3,4-DIMETHOXYBENZYLZINC CHLORIDE | ESD-919369-100ML |
| Cas.: 1453315-97-3 | Purity: 95% | 2-Boc-8-oxo-5-oxa-2-azaspiro[3.4]octane | ESD-919370-25MG |
| Cas.: 1453315-97-3 | Purity: 95% | 2-Boc-8-oxo-5-oxa-2-azaspiro[3.4]octane | ESD-919370-100MG |
| Cas.: 1208395-99-6 | Purity: ≥95% | (4-Hydroxyphenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone | ESD-919371-25MG |
| Cas.: 1208395-99-6 | Purity: ≥95% | (4-Hydroxyphenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone | ESD-919371-100MG |
| Cas.: 185986-76-9 | Purity: ≥95% | Tert-butyl Pent-4-ynoate | ESD-919372-25MG |
| Cas.: 185986-76-9 | Purity: ≥95% | Tert-butyl Pent-4-ynoate | ESD-919372-100MG |
| Cas.: 184023-77-6 | Purity: 98% | Tris(1,10-phenanthroline-5,6-dione)ruthenium(II)bis | ESD-919373-25MG |
| Cas.: 184023-77-6 | Purity: 98% | Tris(1,10-phenanthroline-5,6-dione)ruthenium(II)bis | ESD-919373-100MG |
| Cas.: 62649-23-4 | Mw520, 000, Mn150, 000(Typical), acrylamide~80wt.% | 2-Propenamide, polymer with 2-propenoic acid and sodium 2-propenoate | ESD-919374-25G |
| Cas.: 62649-23-4 | Mw520, 000, Mn150, 000(Typical), acrylamide~80wt.% | 2-Propenamide, polymer with 2-propenoic acid and sodium 2-propenoate | ESD-919374-100G |
| Cas.: 9042-11-9 | AMBERLITE CG-50 | ESD-919375-25G | |
| Cas.: 9042-11-9 | AMBERLITE CG-50 | ESD-919375-100G | |
| Cas.: 15513-18-5 | Purity: ≥95% | N-Isopropylpyridin-2-amine | ESD-919376-25MG |
| Cas.: 15513-18-5 | Purity: ≥95% | N-Isopropylpyridin-2-amine | ESD-919376-100MG |
| Cas.: 1859379-85-3 | Purity: 98% | 3-(2-(Prop-2-yn-1-yloxy)ethoxy)propanoic acid | ESD-919377-25MG |
| Cas.: 1859379-85-3 | Purity: 98% | 3-(2-(Prop-2-yn-1-yloxy)ethoxy)propanoic acid | ESD-919377-100MG |
| Cas.: 76078-28-9 | Purity: >99% | 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine | ESD-919378-25MG |
| Cas.: 76078-28-9 | Purity: >99% | 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine | ESD-919378-100MG |
| Cas.: 203719-54-4 | Purity: 97.0% (sum of isomers, GC) | (+)-Limonene 1,2-epoxide | ESD-919379-25ML |
| Cas.: 203719-54-4 | Purity: 97.0% (sum of isomers, GC) | (+)-Limonene 1,2-epoxide | ESD-919379-100ML |
| Cas.: 51756-08-2 | Purity: 97% | METHYL 2-ETHYLACETOACETATE | ESD-919380-25G |
| Cas.: 51756-08-2 | Purity: 97% | METHYL 2-ETHYLACETOACETATE | ESD-919380-100G |
| Cas.: 13573-11-0 | Purity: 99% | MAGNESIUM TUNGSTATE | ESD-919381-25G |
| Cas.: 13573-11-0 | Purity: 99% | MAGNESIUM TUNGSTATE | ESD-919381-100G |
| Cas.: 207233-90-7 | Purity: 80% (elemental analysis) | 4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid disodium salt hydrate | ESD-919382-25MG |
| Cas.: 207233-90-7 | Purity: 80% (elemental analysis) | 4,4′-Diisothiocyanatostilbene-2,2′-disulfonic acid disodium salt hydrate | ESD-919382-100MG |
| Cas.: 71997-40-5 | Purity: ≥97% | Adenosine 5′-triphosphate, periodate oxidized sodium salt | ESD-919383-25MG |
| Cas.: 71997-40-5 | Purity: ≥97% | Adenosine 5′-triphosphate, periodate oxidized sodium salt | ESD-919383-100MG |
| Cas.: 1558598-41-6 | Purity: 98% | (Z)-5-(4-Hydroxybenzylidene)-3-isobutyl-2-thioxothiazolidin-4-one | ESD-919384-25MG |
| Cas.: 1558598-41-6 | Purity: 98% | (Z)-5-(4-Hydroxybenzylidene)-3-isobutyl-2-thioxothiazolidin-4-one | ESD-919384-100MG |
| Cas.: 81702-42-3 | Purity: ≥98% (HPLC) | (R)-(+)-SKF-38393 hydrochloride | ESD-919385-5MG |
| Cas.: 81702-42-3 | Purity: ≥98% (HPLC) | (R)-(+)-SKF-38393 hydrochloride | ESD-919385-100MG |
| Cas.: 2465-32-9 | Purity: ≥99% (GC) | 1,3-DIOLEIN | ESD-919386-100MG |
| Cas.: 2465-32-9 | Purity: ≥99% (GC) | 1,3-DIOLEIN | ESD-919386-10MG |
| Cas.: 1247-64-9 | Purity: ≥98% | Pregnenolone monosulfate | ESD-919387-5MG |
| Cas.: 1247-64-9 | Purity: ≥98% | Pregnenolone monosulfate | ESD-919387-10MG |
| Cas.: 606-58-6 | Purity: 98% | toyocamycin | ESD-919388-5MG |
| Cas.: 606-58-6 | Purity: 98% | toyocamycin | ESD-919388-10MG |
| Cas.: 2230731-99-2 | Purity: 98% | KDOAM-25 | ESD-919389-5MG |
| Cas.: 2230731-99-2 | Purity: 98% | KDOAM-25 | ESD-919389-10MG |
| Cas.: 6918-48-5 | Purity: >98% | D-erythro-sphingosine (C17 base) | ESD-919390-5MG |
| Cas.: 6918-48-5 | Purity: >98% | D-erythro-sphingosine (C17 base) | ESD-919390-10MG |
| Cas.: 1533438-83-3 | Purity: ≥98% (HPLC) | TVB-3166 | ESD-919391-5MG |
| Cas.: 1533438-83-3 | Purity: ≥98% (HPLC) | TVB-3166 | ESD-919391-10MG |
| Cas.: 71-62-5 | Purity: ≥98% | Veratridine | ESD-919392-5MG |
| Cas.: 71-62-5 | Purity: ≥98% | Veratridine | ESD-919392-10MG |
| Cas.: 921-56-2 | Purity: 98% | D-Mannuronic acid sodium salt | ESD-919393-5MG |
| Cas.: 921-56-2 | Purity: 98% | D-Mannuronic acid sodium salt | ESD-919393-10MG |
| Cas.: 5461-32-5 | Purity: 98% | 2-Nitrophenylpyruvic acid | ESD-919394-5G |
| Cas.: 5461-32-5 | Purity: 98% | 2-Nitrophenylpyruvic acid | ESD-919394-10G |
| Cas.: 62580-84-1 | rac 4-Hydroxydebrisoquine Hemisulfate | ESD-919395-5MG | |
| Cas.: 62580-84-1 | rac 4-Hydroxydebrisoquine Hemisulfate | ESD-919395-10MG | |
| Cas.: 116748-66-4 | Purity: 97% | 4′-Fluoro[1,1′-biphenyl]-4-sulfonyl chloride | ESD-919396-1G |
| Cas.: 116748-66-4 | Purity: 97% | 4′-Fluoro[1,1′-biphenyl]-4-sulfonyl chloride | ESD-919396-10G |
| Cas.: 7252-53-1 | Purity: 97% | (Aminomethyl)cyclopropane hydrochloride | ESD-919397-1G |
| Cas.: 7252-53-1 | Purity: 97% | (Aminomethyl)cyclopropane hydrochloride | ESD-919397-10G |
| Cas.: 119386-71-9 | Purity: 95% | (1S,2S)-1,2-Bis(2-hydroxyphenyl)-1,2-ethanediamine | ESD-919398-1G |
| Cas.: 119386-71-9 | Purity: 95% | (1S,2S)-1,2-Bis(2-hydroxyphenyl)-1,2-ethanediamine | ESD-919398-10G |
| Cas.: 942-05-2 | Purity: 95% | 2-(1-Naphthyl)ethylamine hydrochloride | ESD-919399-500MG |
| Cas.: 942-05-2 | Purity: 95% | 2-(1-Naphthyl)ethylamine hydrochloride | ESD-919399-1G |
| Cas.: 6759-78-0 | Purity: 98% | 8-Hydroxyquinoline-2-carbonitrile | ESD-919400-250MG |
| Cas.: 6759-78-0 | Purity: 98% | 8-Hydroxyquinoline-2-carbonitrile | ESD-919400-1G |
| Cas.: 10349-38-9 | Purity: 95% | 1-Isocyano-4-methoxybenzene | ESD-919401-250MG |
| Cas.: 10349-38-9 | Purity: 95% | 1-Isocyano-4-methoxybenzene | ESD-919401-1G |
| Cas.: 126581-65-5 | Purity: 98% | 2-Bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone | ESD-919402-250MG |
| Cas.: 126581-65-5 | Purity: 98% | 2-Bromo-1-(5-fluoro-2-hydroxyphenyl)ethanone | ESD-919402-1G |
| Cas.: 52407-43-9 | Purity: 95% | 2-(3-Benzofuranyl)acetonitrile | ESD-919403-250MG |
| Cas.: 52407-43-9 | Purity: 95% | 2-(3-Benzofuranyl)acetonitrile | ESD-919403-1G |
| Cas.: 131922-05-9 | Purity: 98% | 2-(Trifluoromethyl)piperazine | ESD-919404-250MG |
| Cas.: 131922-05-9 | Purity: 98% | 2-(Trifluoromethyl)piperazine | ESD-919404-1G |
| Cas.: 186584-73-6 | Purity: 98% | 2-Fluoro-5-iodobenzoyl chloride | ESD-919405-250MG |
| Cas.: 186584-73-6 | Purity: 98% | 2-Fluoro-5-iodobenzoyl chloride | ESD-919405-1G |
| Cas.: 115010-10-1 | Purity: 98% | Benzo[d][1,3]dioxole-5-sulfonyl chloride | ESD-919406-250MG |
| Cas.: 115010-10-1 | Purity: 98% | Benzo[d][1,3]dioxole-5-sulfonyl chloride | ESD-919406-1G |
| Cas.: 52205-85-3 | Purity: 97% | 5-indanesulfonoyl chloride | ESD-919407-250MG |
| Cas.: 52205-85-3 | Purity: 97% | 5-indanesulfonoyl chloride | ESD-919407-1G |
| Cas.: 128073-33-6 | Purity: 97% | 2,2-Difluoro-1-methylcyclopropanecarboxylic acid | ESD-919408-250MG |
| Cas.: 128073-33-6 | Purity: 97% | 2,2-Difluoro-1-methylcyclopropanecarboxylic acid | ESD-919408-1G |
| Cas.: 1486-50-6 | Purity: 95% | 4-(Benzyloxy)benzoyl chloride | ESD-919409-250MG |
| Cas.: 1486-50-6 | Purity: 95% | 4-(Benzyloxy)benzoyl chloride | ESD-919409-1G |
| Cas.: 82964-91-8 | Purity: 95% | 4-(Methylsulphonyl)benzenesulphonyl chloride | ESD-919410-250MG |
| Cas.: 82964-91-8 | Purity: 95% | 4-(Methylsulphonyl)benzenesulphonyl chloride | ESD-919410-1G |
| Cas.: 2848-01-3 | Purity: 98% | 3-(diphenylphosphino)-propanoic acid | ESD-919411-250MG |
| Cas.: 2848-01-3 | Purity: 98% | 3-(diphenylphosphino)-propanoic acid | ESD-919411-1G |
| Cas.: 2905-27-3 | Purity: 97% | 3,5-Dimethylbenzenesulfonyl chloride | ESD-919412-250MG |
| Cas.: 2905-27-3 | Purity: 97% | 3,5-Dimethylbenzenesulfonyl chloride | ESD-919412-1G |
| Cas.: 3954-13-0 | Purity: ≥98% | Pentyl isocyanate | ESD-919413-1G |
| Cas.: 139502-80-0 | Purity: 97% | 4′-Chloro[1,1′-biphenyl]-3-carbaldehyde | ESD-919414-250MG |
| Cas.: 139502-80-0 | Purity: 97% | 4′-Chloro[1,1′-biphenyl]-3-carbaldehyde | ESD-919414-1G |
| Cas.: 116470-54-3 | Purity: 97% | 4′-Methyl-[1,1′-biphenyl]-3-carbaldehyde | ESD-919415-250MG |
| Cas.: 116470-54-3 | Purity: 97% | 4′-Methyl-[1,1′-biphenyl]-3-carbaldehyde | ESD-919415-1G |
| Cas.: 118628-68-5 | Purity: ≥97% | (1R,2R)-N,N’-dimethyl-1,2-diphenyl-1,2-diethylamine | ESD-919416-250MG |
| Cas.: 118628-68-5 | Purity: ≥97% | (1R,2R)-N,N’-dimethyl-1,2-diphenyl-1,2-diethylamine | ESD-919416-1G |
| Cas.: 1050501-64-8 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-azido-2-methylhexanoic acid | ESD-919417-250MG |
| Cas.: 1050501-64-8 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-azido-2-methylhexanoic acid | ESD-919417-1G |
| Cas.: 1064678-14-3 | Purity: 97% | Methyl 4-Bromo-2-Chloronicotinate | ESD-919418-250MG |
| Cas.: 1064678-14-3 | Purity: 97% | Methyl 4-Bromo-2-Chloronicotinate | ESD-919418-1G |
| Cas.: 69922-27-6 | Purity: 97% | 2-Fluoro-5-(trifluoromethyl)phenyl isocyanate | ESD-919419-250MG |
| Cas.: 69922-27-6 | Purity: 97% | 2-Fluoro-5-(trifluoromethyl)phenyl isocyanate | ESD-919419-1G |
| Cas.: 158985-36-5 | Purity: 97% | ert-Butyl 4-[4-(methoxycarbonyl)phenyl]tetrahydro-1(2H)-pyrazinecarboxylate | ESD-919420-250MG |
| Cas.: 158985-36-5 | Purity: 97% | ert-Butyl 4-[4-(methoxycarbonyl)phenyl]tetrahydro-1(2H)-pyrazinecarboxylate | ESD-919420-1G |
| Cas.: 331767-56-7 | Purity: 97% | tert-Butyl 4-(6-bromopyridin-2-yl)piperazine-1-carboxylate | ESD-919421-250MG |
| Cas.: 331767-56-7 | Purity: 97% | tert-Butyl 4-(6-bromopyridin-2-yl)piperazine-1-carboxylate | ESD-919421-1G |
| Cas.: 299165-92-7 | Purity: 95% | 2-(4,6-Dichloro-2-methyl-1H-indol-3-yl)ethanamine | ESD-919422-250MG |
| Cas.: 299165-92-7 | Purity: 95% | 2-(4,6-Dichloro-2-methyl-1H-indol-3-yl)ethanamine | ESD-919422-1G |
| Cas.: 42298-41-9 | Purity: 95% | 5-Iodo-2-methoxybenzaldehyde | ESD-919423-250MG |
| Cas.: 42298-41-9 | Purity: 95% | 5-Iodo-2-methoxybenzaldehyde | ESD-919423-1G |
| Cas.: 387824-61-5 | Purity: 95% | 3-(Trifluoromethyl)pyridin-4-amine | ESD-919424-250MG |
| Cas.: 387824-61-5 | Purity: 95% | 3-(Trifluoromethyl)pyridin-4-amine | ESD-919424-1G |
| Cas.: 758-33-8 | Purity: 95% | (+/-)-1,1,1-Trifluoro-2-butanamine hydrochloride | ESD-919425-250MG |
| Cas.: 758-33-8 | Purity: 95% | (+/-)-1,1,1-Trifluoro-2-butanamine hydrochloride | ESD-919425-1G |
| Cas.: 75365-73-0 | Purity: 98% | Methyl Viologen hydrate | ESD-919426-250MG |
| Cas.: 75365-73-0 | Purity: 98% | Methyl Viologen hydrate | ESD-919426-1G |
| Cas.: 32846-66-5 | Purity: 97% | 1,4-Cubanedicarboxylic acid | ESD-919427-250MG |
| Cas.: 32846-66-5 | Purity: 97% | 1,4-Cubanedicarboxylic acid | ESD-919427-1G |
| Cas.: 89179-60-2 | Purity: 97% | 5-cyclopropyl-1,3,4-oxadiazol-2-amine | ESD-919428-250MG |
| Cas.: 89179-60-2 | Purity: 97% | 5-cyclopropyl-1,3,4-oxadiazol-2-amine | ESD-919428-1G |
| Cas.: 3213-29-4 | 2,3-Dimethoxyphenethylamine | ESD-919429-250MG | |
| Cas.: 3213-29-4 | 2,3-Dimethoxyphenethylamine | ESD-919429-1G | |
| Cas.: 7242-92-4 | Purity: ≥95% | (1R,2R,4S)-rel-Bicyclo[2.2.1]heptan-2-amine | ESD-919430-250MG |
| Cas.: 7242-92-4 | Purity: ≥95% | (1R,2R,4S)-rel-Bicyclo[2.2.1]heptan-2-amine | ESD-919430-1G |
| Cas.: 65295-69-4 | Purity: 97% | 2,6-Difluorophenyl isocyanate | ESD-919431-250MG |
| Cas.: 65295-69-4 | Purity: 97% | 2,6-Difluorophenyl isocyanate | ESD-919431-1G |
| Cas.: 56651-60-6 | Purity: 95% | 4-Methoxybenzyl isocyanate | ESD-919432-250MG |
| Cas.: 56651-60-6 | Purity: 95% | 4-Methoxybenzyl isocyanate | ESD-919432-1G |
| Cas.: 19654-32-1 | Purity: 97% | 2,4-Dichlorobenzyl Isocyanate | ESD-919433-250MG |
| Cas.: 19654-32-1 | Purity: 97% | 2,4-Dichlorobenzyl Isocyanate | ESD-919433-1G |
| Cas.: 132740-43-3 | Purity: ≥97% | 4-Fluorobenzyl isocyanate | ESD-919434-250MG |
| Cas.: 132740-43-3 | Purity: ≥97% | 4-Fluorobenzyl isocyanate | ESD-919434-1G |
| Cas.: 56651-57-1 | Purity: 97% | 4-Methylbenzylisocyanate | ESD-919435-250MG |
| Cas.: 56651-57-1 | Purity: 97% | 4-Methylbenzylisocyanate | ESD-919435-1G |
| Cas.: 351003-65-1 | Purity: 98% | 4-Fluoro-3-methylphenyl isocyanate | ESD-919436-250MG |
| Cas.: 351003-65-1 | Purity: 98% | 4-Fluoro-3-methylphenyl isocyanate | ESD-919436-1G |
| Cas.: 2802-61-1 | Purity: 97% | 2,4-Difluoropyrimidine | ESD-919437-250MG |
| Cas.: 2802-61-1 | Purity: 97% | 2,4-Difluoropyrimidine | ESD-919437-1G |
| Cas.: 827614-66-4 | Purity: 96% | 1-Isobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-919438-250MG |
| Cas.: 827614-66-4 | Purity: 96% | 1-Isobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-919438-1G |
| Cas.: 13714-86-8 | Purity: 95% | 5-Methylfuran-2-carbonitrile | ESD-919439-250MG |
| Cas.: 13714-86-8 | Purity: 95% | 5-Methylfuran-2-carbonitrile | ESD-919439-1G |
| Cas.: 161395-96-6 | Purity: 98% | (E)-1-Pentene-1-boronic Acid Pinacol Ester | ESD-919440-250MG |
| Cas.: 161395-96-6 | Purity: 98% | (E)-1-Pentene-1-boronic Acid Pinacol Ester | ESD-919440-1G |
| Cas.: 97845-58-4 | Purity: 95% | 5-(2-Bromoethyl)-2,2-dimethyl-1,3-dioxane | ESD-919441-250MG |
| Cas.: 97845-58-4 | Purity: 95% | 5-(2-Bromoethyl)-2,2-dimethyl-1,3-dioxane | ESD-919441-1G |
| Cas.: 32017-76-8 | Purity: 96% | 2-(4-Bromophenyl)oxirane | ESD-919442-250MG |
| Cas.: 32017-76-8 | Purity: 96% | 2-(4-Bromophenyl)oxirane | ESD-919442-1G |
| Cas.: 4753-75-7 | Purity: ≥95% | N-METHYLFURFURYLAMINE | ESD-919443-250MG |
| Cas.: 4753-75-7 | Purity: ≥95% | N-METHYLFURFURYLAMINE | ESD-919443-1G |
| Cas.: 5573-62-6 | Purity: 90% | (Ethylthio)trimethylsilane | ESD-919444-250MG |
| Cas.: 5573-62-6 | Purity: 90% | (Ethylthio)trimethylsilane | ESD-919444-1G |
| Cas.: 4025-77-8 | Purity: ≥95% | Chlorosulfonylacetyl chloride | ESD-919445-250MG |
| Cas.: 4025-77-8 | Purity: ≥95% | Chlorosulfonylacetyl chloride | ESD-919445-1G |
| Cas.: 460096-11-1 | Purity: 98% | Indium(III) tris(trifluoromethanesulfonimide) | ESD-919446-250MG |
| Cas.: 460096-11-1 | Purity: 98% | Indium(III) tris(trifluoromethanesulfonimide) | ESD-919446-1G |
| Cas.: 25474-85-5 | Purity: 95% | 4-Methoxybenzyloxycarbonyl azide | ESD-919447-250MG |
| Cas.: 25474-85-5 | Purity: 95% | 4-Methoxybenzyloxycarbonyl azide | ESD-919447-1G |
| Cas.: 1445085-87-9 | Purity: 98% | Methanesulfonato[2-(dicyclohexylphosphino)-2′-(N,N-dimethylamino)-1,1′-biphenyl](2′-amino-1,1′-biphenyl-2-yl)palladium(II) | ESD-919448-250MG |
| Cas.: 1445085-87-9 | Purity: 98% | Methanesulfonato[2-(dicyclohexylphosphino)-2′-(N,N-dimethylamino)-1,1′-biphenyl](2′-amino-1,1′-biphenyl-2-yl)palladium(II) | ESD-919448-1G |
| Cas.: 1160556-64-8 | Purity: 98% | Cphos | ESD-919449-250MG |
| Cas.: 1160556-64-8 | Purity: 98% | Cphos | ESD-919449-1G |
| Cas.: 1237588-13-4 | Purity: ≥95% | Di(1-adamantyl)-1-piperidinylphenylphosphine | ESD-919450-250MG |
| Cas.: 1237588-13-4 | Purity: ≥95% | Di(1-adamantyl)-1-piperidinylphenylphosphine | ESD-919450-1G |
| Cas.: 1621274-11-0 | Purity: 98% | Methanesulfonato(tri-t-butylphosphino)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-919451-250MG |
| Cas.: 1621274-11-0 | Purity: 98% | Methanesulfonato(tri-t-butylphosphino)(2′-methylamino-1,1′-biphenyl-2-yl)palladium(II) | ESD-919451-1G |
| Cas.: 1621019-96-2 | Purity: 98% | 9-Mesiyl-10-phenylacridin-10-ium tetrafluoroborate | ESD-919452-250MG |
| Cas.: 1621019-96-2 | Purity: 98% | 9-Mesiyl-10-phenylacridin-10-ium tetrafluoroborate | ESD-919452-1G |
| Cas.: 1848244-75-6 | Purity: 98% | [2′,4′-Bis(1,1-dimethylethyl)-6′-methoxy[1,1′-biphenyl]-2-yl]dicyclohexylphosphine | ESD-919453-250MG |
| Cas.: 1848244-75-6 | Purity: 98% | [2′,4′-Bis(1,1-dimethylethyl)-6′-methoxy[1,1′-biphenyl]-2-yl]dicyclohexylphosphine | ESD-919453-1G |
| Cas.: 2172794-56-6 | Purity: 98% | (4-Acetamidophenyl)(fluorosulfonyl)sulfamoyl fluoride | ESD-919454-250MG |
| Cas.: 2172794-56-6 | Purity: 98% | (4-Acetamidophenyl)(fluorosulfonyl)sulfamoyl fluoride | ESD-919454-1G |
| Cas.: 1034901-50-2 | Purity: 97% | [4,4′-Bis(1,1-dimethylethyl)-2,2′-bipyridine] nickel (II) dichloride | ESD-919455-250MG |
| Cas.: 1034901-50-2 | Purity: 97% | [4,4′-Bis(1,1-dimethylethyl)-2,2′-bipyridine] nickel (II) dichloride | ESD-919455-1G |
| Cas.: 1621019-97-3 | Purity: 97% | 9-Mesiyl-2,7,10-trimethylacridin-10-ium tetrafluoroborate | ESD-919456-250MG |
| Cas.: 1621019-97-3 | Purity: 97% | 9-Mesiyl-2,7,10-trimethylacridin-10-ium tetrafluoroborate | ESD-919456-1G |
| Cas.: 33636-93-0 | Purity: 95% | (Triphenylphosphine)copper hydride hexamer | ESD-919457-250MG |
| Cas.: 33636-93-0 | Purity: 95% | (Triphenylphosphine)copper hydride hexamer | ESD-919457-1G |
| Cas.: 938-79-4 | Purity: 99% | (R)-(-)-2-Phenylbutyric acid | ESD-919458-250MG |
| Cas.: 938-79-4 | Purity: 99% | (R)-(-)-2-Phenylbutyric acid | ESD-919458-1G |
| Cas.: 333-49-3 | Purity: 97% | 4-Amino-2-mercaptopyrimidine | ESD-919459-250MG |
| Cas.: 333-49-3 | Purity: 97% | 4-Amino-2-mercaptopyrimidine | ESD-919459-1G |
| Cas.: 52055-23-9 | Purity: 98% | 5-Benzyloxytryptamine hydrochloride | ESD-919460-250MG |
| Cas.: 52055-23-9 | Purity: 98% | 5-Benzyloxytryptamine hydrochloride | ESD-919460-1G |
| Cas.: 2430-16-2 | Purity: 97% | 6-Phenylhexanol | ESD-919461-250MG |
| Cas.: 12636-72-5 | Purity: 98% | Bis(Cyclopentadienyl)Dimethylzirconium | ESD-919462-250MG |
| Cas.: 12636-72-5 | Purity: 98% | Bis(Cyclopentadienyl)Dimethylzirconium | ESD-919462-1G |
| Cas.: 98014-14-3 | Purity: 97% | cis-Bis(2,2′-bipyridine)dichlororuthenium(II) hydrate | ESD-919463-250MG |
| Cas.: 98014-14-3 | Purity: 97% | cis-Bis(2,2′-bipyridine)dichlororuthenium(II) hydrate | ESD-919463-1G |
| Cas.: 1504-72-9 | Purity: 97% | Ethyl trans-β-Methylcinnamate | ESD-919464-250MG |
| Cas.: 1504-72-9 | Purity: 97% | Ethyl trans-β-Methylcinnamate | ESD-919464-1G |
| Cas.: 14273-85-9 | Purity: 95% | Methyl 4-iodobutanoate | ESD-919465-250MG |
| Cas.: 14273-85-9 | Purity: 95% | Methyl 4-iodobutanoate | ESD-919465-1G |
| Cas.: 22919-26-2 | Purity: ≥98% | 4-Methylumbelliferyl phosphate disodium salt | ESD-919466-250MG |
| Cas.: 22919-26-2 | Purity: ≥98% | 4-Methylumbelliferyl phosphate disodium salt | ESD-919466-1G |
| Cas.: 326822-02-0 | Purity: ≥98% | (Bathocuproine)NiBr2 | ESD-919467-250MG |
| Cas.: 326822-02-0 | Purity: ≥98% | (Bathocuproine)NiBr2 | ESD-919467-1G |
| Cas.: 945375-77-9 | Purity: 95% | Bis[(dicyclohexyl)(4-dimethylaminophenyl)phosphine] palladium(II) chloride | ESD-919468-250MG |
| Cas.: 945375-77-9 | Purity: 95% | Bis[(dicyclohexyl)(4-dimethylaminophenyl)phosphine] palladium(II) chloride | ESD-919468-1G |
| Cas.: 4468-59-1 | Purity: 97% | 4-Hydroxy-3-methoxyphenylacetonitrile | ESD-919469-250MG |
| Cas.: 4468-59-1 | Purity: 97% | 4-Hydroxy-3-methoxyphenylacetonitrile | ESD-919469-1G |
| Cas.: 7649-92-5 | Purity: 95% | 2-(4-Fluorobenzoyl)benzoic acid | ESD-919470-250MG |
| Cas.: 7649-92-5 | Purity: 95% | 2-(4-Fluorobenzoyl)benzoic acid | ESD-919470-1G |
| Cas.: 701-70-2 | Purity: 95% | 1-Phenylbutan-2-ol | ESD-919471-250MG |
| Cas.: 701-70-2 | Purity: 95% | 1-Phenylbutan-2-ol | ESD-919471-1G |
| Cas.: 4119-41-9 | Purity: 98%, stabilized with Copper chip | 1-Iodo-3-phenylpropane | ESD-919472-250MG |
| Cas.: 4119-41-9 | Purity: 98%, stabilized with Copper chip | 1-Iodo-3-phenylpropane | ESD-919472-1G |
| Cas.: 15093-42-2 | Purity: 95% | 1-(b-Phenethyl)-3-phenyl-2-thiourea | ESD-919473-250MG |
| Cas.: 15093-42-2 | Purity: 95% | 1-(b-Phenethyl)-3-phenyl-2-thiourea | ESD-919473-1G |
| Cas.: 181657-57-8 | Purity: 97.5% (GC) | (1S,2S)-1-Amino-2-benzyloxycyclopentane | ESD-919474-250MG |
| Cas.: 181657-57-8 | Purity: 97.5% (GC) | (1S,2S)-1-Amino-2-benzyloxycyclopentane | ESD-919474-1G |
| Cas.: 42599-16-6 | Purity: 98% | trans-1-Octen-1-ylboronic acid | ESD-919475-250MG |
| Cas.: 42599-16-6 | Purity: 98% | trans-1-Octen-1-ylboronic acid | ESD-919475-1G |
| Cas.: 4807-55-0 | Purity: 97% | 3-Methyl-2-thioxothiazolidin-4-one | ESD-919476-250MG |
| Cas.: 4807-55-0 | Purity: 97% | 3-Methyl-2-thioxothiazolidin-4-one | ESD-919476-1G |
| Cas.: 58808-59-6 | Purity: 97% | 4-(TRIFLUOROACETYL)BENZOIC ACID | ESD-919477-250MG |
| Cas.: 58808-59-6 | Purity: 97% | 4-(TRIFLUOROACETYL)BENZOIC ACID | ESD-919477-1G |
| Cas.: 1027642-30-3 | Purity: 95% | Potassium phenoxy-methyltrifluoroborate | ESD-919478-250MG |
| Cas.: 1027642-30-3 | Purity: 95% | Potassium phenoxy-methyltrifluoroborate | ESD-919478-1G |
| Cas.: 13161-28-9 | Purity: 96% | RHODAMINE 6G PERCHLORATE | ESD-919479-250MG |
| Cas.: 13161-28-9 | Purity: 96% | RHODAMINE 6G PERCHLORATE | ESD-919479-1G |
| Cas.: 216312-53-7 | Purity: 95% | BOC-L-2-CYANOPHENYLALANINE | ESD-919480-250MG |
| Cas.: 216312-53-7 | Purity: 95% | BOC-L-2-CYANOPHENYLALANINE | ESD-919480-1G |
| Cas.: 83947-55-1 | Purity: 97% | TRANS-4,4,5,5-TETRAMETHYL-2-OCT-1-ENYL-1,3,2-DIOXABOROLANE | ESD-919481-250MG |
| Cas.: 585570-08-7 | Purity: 98% | N,N-Bis(4-Bromophenyl)Benzidine | ESD-919482-250MG |
| Cas.: 585570-08-7 | Purity: 98% | N,N-Bis(4-Bromophenyl)Benzidine | ESD-919482-1G |
| Cas.: 866889-02-3 | Purity: 95% | O-(2-Carboxyethyl)-O′-(2-mercaptoethyl)heptaethylene glycol | ESD-919483-250MG |
| Cas.: 866889-02-3 | Purity: 95% | O-(2-Carboxyethyl)-O′-(2-mercaptoethyl)heptaethylene glycol | ESD-919483-1G |
| Cas.: 214554-18-4 | Purity: 97% | 2-Fluoro-4-(hydroxymethyl)benzoic acid | ESD-919484-250MG |
| Cas.: 214554-18-4 | Purity: 97% | 2-Fluoro-4-(hydroxymethyl)benzoic acid | ESD-919484-1G |
| Cas.: 68471-58-9 | Purity: 95% | 1-Cbz-3,4-dihydro-2H-pyridine | ESD-919485-250MG |
| Cas.: 68471-58-9 | Purity: 95% | 1-Cbz-3,4-dihydro-2H-pyridine | ESD-919485-1G |
| Cas.: 1256355-32-4 | Purity: 97% | 4-Amino-3-fluorophenylboronic acid hydrochloride | ESD-919486-250MG |
| Cas.: 1256355-32-4 | Purity: 97% | 4-Amino-3-fluorophenylboronic acid hydrochloride | ESD-919486-1G |
| Cas.: 124467-23-8 | Purity: 95% | 2-Chloro-8-fluoroquinoline | ESD-919487-250MG |
| Cas.: 124467-23-8 | Purity: 95% | 2-Chloro-8-fluoroquinoline | ESD-919487-1G |
| Cas.: 1067883-58-2 | Purity: 97% | 2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indole | ESD-919488-250MG |
| Cas.: 1067883-58-2 | Purity: 97% | 2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indole | ESD-919488-1G |
| Cas.: 3989-13-7 | Purity: 95% | ((3-Bromophenyl)ethynyl)trimethylsilane | ESD-919489-250MG |
| Cas.: 3989-13-7 | Purity: 95% | ((3-Bromophenyl)ethynyl)trimethylsilane | ESD-919489-1G |
| Cas.: 39096-01-0 | Purity: 95% | N,N-Diethyl-2-hydroxyacetamide | ESD-919490-250MG |
| Cas.: 39096-01-0 | Purity: 95% | N,N-Diethyl-2-hydroxyacetamide | ESD-919490-1G |
| Cas.: 28697-09-8 | Purity: 98% | (R)-1-((Benzyloxy)carbonyl)piperidine-2-carboxylic acid | ESD-919491-250MG |
| Cas.: 28697-09-8 | Purity: 98% | (R)-1-((Benzyloxy)carbonyl)piperidine-2-carboxylic acid | ESD-919491-1G |
| Cas.: 79047-41-9 | Purity: 98% | (2-Butyl-4-chloro-1H-imidazol-5-yl)methanol | ESD-919492-250MG |
| Cas.: 79047-41-9 | Purity: 98% | (2-Butyl-4-chloro-1H-imidazol-5-yl)methanol | ESD-919492-1G |
| Cas.: 213598-15-3 | Purity: 97% | 3-Chloro-4-ethoxybenzoic acid | ESD-919493-250MG |
| Cas.: 213598-15-3 | Purity: 97% | 3-Chloro-4-ethoxybenzoic acid | ESD-919493-1G |
| Cas.: 72744-54-8 | Purity: 97% | 5-Bromobenzo[d][1,3]dioxole-4-carbaldehyde | ESD-919494-250MG |
| Cas.: 72744-54-8 | Purity: 97% | 5-Bromobenzo[d][1,3]dioxole-4-carbaldehyde | ESD-919494-1G |
| Cas.: 5775-88-2 | Purity: 96% | 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic acid | ESD-919495-250MG |
| Cas.: 5775-88-2 | Purity: 96% | 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic acid | ESD-919495-1G |
| Cas.: 149833-95-4 | Purity: 98% | 4-((4-Bromobenzyl)oxy)benzaldehyde | ESD-919496-250MG |
| Cas.: 149833-95-4 | Purity: 98% | 4-((4-Bromobenzyl)oxy)benzaldehyde | ESD-919496-1G |
| Cas.: 21909-49-9 | Purity: 97% | Ethyl 2-(2-methyl-1H-indol-3-yl)acetate | ESD-919497-250MG |
| Cas.: 21909-49-9 | Purity: 97% | Ethyl 2-(2-methyl-1H-indol-3-yl)acetate | ESD-919497-1G |
| Cas.: 756520-78-2 | Purity: 98% | (2-(Methylsulfonamido)phenyl)boronic acid | ESD-919498-250MG |
| Cas.: 756520-78-2 | Purity: 98% | (2-(Methylsulfonamido)phenyl)boronic acid | ESD-919498-1G |
| Cas.: 380430-60-4 | Purity: 98% | N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide | ESD-919499-250MG |
| Cas.: 380430-60-4 | Purity: 98% | N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide | ESD-919499-1G |
| Cas.: 701911-46-8 | Purity: 95% | 1-Ethyl-3,5-dimethyl-1H-pyrazole-4-carbaldehyde | ESD-919500-250MG |
| Cas.: 701911-46-8 | Purity: 95% | 1-Ethyl-3,5-dimethyl-1H-pyrazole-4-carbaldehyde | ESD-919500-1G |
| Cas.: 18268-68-3 | Purity: 95% | 3-Chloro-4,5-dimethoxybenzaldehyde | ESD-919501-250MG |
| Cas.: 18268-68-3 | Purity: 95% | 3-Chloro-4,5-dimethoxybenzaldehyde | ESD-919501-1G |
| Cas.: 27640-33-1 | Purity: 97% | (S)-Indolin-2-yl methanol | ESD-919502-250MG |
| Cas.: 27640-33-1 | Purity: 97% | (S)-Indolin-2-yl methanol | ESD-919502-1G |
| Cas.: 80696-29-3 | Purity: 95% | (S)-2-Aminohexan-1-ol | ESD-919503-250MG |
| Cas.: 80696-29-3 | Purity: 95% | (S)-2-Aminohexan-1-ol | ESD-919503-1G |
| Cas.: 41870-24-0 | Purity: 95% | (4-Methoxy-3-nitrophenyl)methanol | ESD-919504-250MG |
| Cas.: 41870-24-0 | Purity: 95% | (4-Methoxy-3-nitrophenyl)methanol | ESD-919504-1G |
| Cas.: 198084-12-7 | Purity: 98% | 4-(Pyrimidin-5-yl)benzaldehyde | ESD-919505-250MG |
| Cas.: 198084-12-7 | Purity: 98% | 4-(Pyrimidin-5-yl)benzaldehyde | ESD-919505-1G |
| Cas.: 84512-08-3 | Purity: 95% | 4-(Piperidin-4-yl)butanoic acid hydrochloride | ESD-919506-250MG |
| Cas.: 84512-08-3 | Purity: 95% | 4-(Piperidin-4-yl)butanoic acid hydrochloride | ESD-919506-1G |
| Cas.: 201551-23-7 | Purity: 97% 99%ee | N,N’-((1R,2R)-cyclohexane-1,2-diyl)dipicolinamide | ESD-919507-250MG |
| Cas.: 201551-23-7 | Purity: 97% 99%ee | N,N’-((1R,2R)-cyclohexane-1,2-diyl)dipicolinamide | ESD-919507-1G |
| Cas.: 307926-51-8 | Purity: 98% | (S,S)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride | ESD-919508-250MG |
| Cas.: 307926-51-8 | Purity: 98% | (S,S)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride | ESD-919508-1G |
| Cas.: 212210-87-2 | Purity: 98% | Dichloro[(R)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium(II) | ESD-919509-250MG |
| Cas.: 212210-87-2 | Purity: 98% | Dichloro[(R)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium(II) | ESD-919509-1G |
| Cas.: 6309-46-2 | Purity: 95% | 4-Acetoxybenzyl alcohol | ESD-919510-250MG |
| Cas.: 6309-46-2 | Purity: 95% | 4-Acetoxybenzyl alcohol | ESD-919510-1G |
| Cas.: 22148-86-3 | Purity: 98% | (S)-(+)-4-Phenylbutan-2-ol | ESD-919511-250MG |
| Cas.: 22148-86-3 | Purity: 98% | (S)-(+)-4-Phenylbutan-2-ol | ESD-919511-1G |
| Cas.: 191090-40-1 | Purity: 98% | (R)-(+)-5,5-Diphenyl-4-benzyl-2-oxazolidinone | ESD-919512-250MG |
| Cas.: 191090-40-1 | Purity: 98% | (R)-(+)-5,5-Diphenyl-4-benzyl-2-oxazolidinone | ESD-919512-1G |
| Cas.: 129704-13-8 | Purity: 97% | (S)-()-2-Amino-1,1,2-triphenylethanol | ESD-919513-250MG |
| Cas.: 129704-13-8 | Purity: 97% | (S)-()-2-Amino-1,1,2-triphenylethanol | ESD-919513-1G |
| Cas.: 162955-48-8 | Purity: 98% | (S)-tert-Butyl (1,5-dihydroxypentan-2-yl)carbamate | ESD-919514-250MG |
| Cas.: 162955-48-8 | Purity: 98% | (S)-tert-Butyl (1,5-dihydroxypentan-2-yl)carbamate | ESD-919514-1G |
| Cas.: 380430-65-9 | Purity: 98% | (3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride | ESD-919515-250MG |
| Cas.: 380430-65-9 | Purity: 98% | (3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride | ESD-919515-1G |
| Cas.: 89424-17-9 | Purity: 95% | Ethyl 3-oxo-3-(2-(trifluoromethyl)phenyl)propanoate | ESD-919516-250MG |
| Cas.: 89424-17-9 | Purity: 95% | Ethyl 3-oxo-3-(2-(trifluoromethyl)phenyl)propanoate | ESD-919516-1G |
| Cas.: 52119-39-8 | Purity: 95% | Ethyl 3-(2-nitrophenyl)-3-oxopropanoate | ESD-919517-250MG |
| Cas.: 52119-39-8 | Purity: 95% | Ethyl 3-(2-nitrophenyl)-3-oxopropanoate | ESD-919517-1G |
| Cas.: 203927-98-4 | Purity: 97% | (9,9-Dihexyl-9H-fluorene-2,7-diyl)diboronic acid | ESD-919518-250MG |
| Cas.: 203927-98-4 | Purity: 97% | (9,9-Dihexyl-9H-fluorene-2,7-diyl)diboronic acid | ESD-919518-1G |
| Cas.: 173340-19-7 | Purity: 97% | (S)-5-Oxo-1-((S)-1-phenylethyl)pyrrolidine-3-carboxylic acid | ESD-919519-250MG |
| Cas.: 173340-19-7 | Purity: 97% | (S)-5-Oxo-1-((S)-1-phenylethyl)pyrrolidine-3-carboxylic acid | ESD-919519-1G |
| Cas.: 500770-69-4 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid | ESD-919520-250MG |
| Cas.: 500770-69-4 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid | ESD-919520-1G |
| Cas.: 479064-90-9 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-919521-250MG |
| Cas.: 479064-90-9 | Purity: 95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-919521-1G |
| Cas.: 329013-12-9 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid | ESD-919522-250MG |
| Cas.: 329013-12-9 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid | ESD-919522-1G |
| Cas.: 501015-19-6 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid | ESD-919523-250MG |
| Cas.: 501015-19-6 | Purity: 98% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid | ESD-919523-1G |
| Cas.: 737000-77-0 | Purity: 98% | 3-Fluoropiperidine hydrochloride | ESD-919524-250MG |
| Cas.: 737000-77-0 | Purity: 98% | 3-Fluoropiperidine hydrochloride | ESD-919524-1G |
| Cas.: 26170-87-6 | Purity: 97% | 4-Phenylthiophene-2-carbaldehyde | ESD-919525-250MG |
| Cas.: 26170-87-6 | Purity: 97% | 4-Phenylthiophene-2-carbaldehyde | ESD-919525-1G |
| Cas.: 115822-57-6 | Purity: 96% | Chroman-3-carboxylic acid | ESD-919526-250MG |
| Cas.: 115822-57-6 | Purity: 96% | Chroman-3-carboxylic acid | ESD-919526-1G |
| Cas.: 150308-80-8 | Purity: 98% | Fmoc-Sec(Mob)-OH | ESD-919527-250MG |
| Cas.: 150308-80-8 | Purity: 98% | Fmoc-Sec(Mob)-OH | ESD-919527-1G |
| Cas.: 251300-28-4 | Purity: 95% | 5-Bromo-3-fluoro-2-hydroxybenzaldehyde | ESD-919528-250MG |
| Cas.: 251300-28-4 | Purity: 95% | 5-Bromo-3-fluoro-2-hydroxybenzaldehyde | ESD-919528-1G |
| Cas.: 480424-95-1 | Purity: 95% | N-(4-Phenylboronic)succinamic acid | ESD-919529-250MG |
| Cas.: 480424-95-1 | Purity: 95% | N-(4-Phenylboronic)succinamic acid | ESD-919529-1G |
| Cas.: 215050-11-6 | Purity: 97% | 1,3-Di-Boc-2-(2-Hydroxyethyl)Guanidine | ESD-919530-250MG |
| Cas.: 215050-11-6 | Purity: 97% | 1,3-Di-Boc-2-(2-Hydroxyethyl)Guanidine | ESD-919530-1G |
| Cas.: 120800-50-2 | Purity: 95% | 6-(Piperidin-1-yl)nicotinic acid | ESD-919531-250MG |
| Cas.: 120800-50-2 | Purity: 95% | 6-(Piperidin-1-yl)nicotinic acid | ESD-919531-1G |
| Cas.: 58481-01-9 | Purity: 98% | 2-Aminosonicotinohydrazide | ESD-919532-250MG |
| Cas.: 58481-01-9 | Purity: 98% | 2-Aminosonicotinohydrazide | ESD-919532-1G |
| Cas.: 4200-06-0 | Purity: 97% | 1-Ethynyl-4-phenoxybenzene | ESD-919533-250MG |
| Cas.: 4200-06-0 | Purity: 97% | 1-Ethynyl-4-phenoxybenzene | ESD-919533-1G |
| Cas.: 852362-22-2 | Purity: 98% | (1-Benzyl-1H-pyrazol-4-yl)boronic acid | ESD-919534-250MG |
| Cas.: 852362-22-2 | Purity: 98% | (1-Benzyl-1H-pyrazol-4-yl)boronic acid | ESD-919534-1G |
| Cas.: 268551-65-1 | Purity: 98% | tert-Butylcarbamothioylcarbamate | ESD-919535-250MG |
| Cas.: 268551-65-1 | Purity: 98% | tert-Butylcarbamothioylcarbamate | ESD-919535-1G |
| Cas.: 870704-22-6 | Purity: 95% | 5-(4-Fluorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-919536-250MG |
| Cas.: 870704-22-6 | Purity: 95% | 5-(4-Fluorophenyl)-1H-pyrazole-3-carboxylic acid | ESD-919536-1G |
| Cas.: 27913-86-6 | Purity: 95% | 4-(Bis(2-hydroxyethyl)amino)benzaldehyde | ESD-919537-250MG |
| Cas.: 27913-86-6 | Purity: 95% | 4-(Bis(2-hydroxyethyl)amino)benzaldehyde | ESD-919537-1G |
| Cas.: 490023-37-5 | Purity: 98% 99%ee | (11bS)-N-Benzyl-N-methyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-919538-250MG |
| Cas.: 490023-37-5 | Purity: 98% 99%ee | (11bS)-N-Benzyl-N-methyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-919538-1G |
| Cas.: 914089-00-2 | Purity: 98% | (1R)-1-(Dicyclohexylphosphino)-2-[(S)-[2-(dicyclohexylphosphino)phenyl](dimethylamino)methyl]ferrocene | ESD-919539-250MG |
| Cas.: 914089-00-2 | Purity: 98% | (1R)-1-(Dicyclohexylphosphino)-2-[(S)-[2-(dicyclohexylphosphino)phenyl](dimethylamino)methyl]ferrocene | ESD-919539-1G |
| Cas.: 1003012-96-1 | Purity: 98% | (2S)-1-[(R)-α-(Dimethylamino)-2-(diphenylphosphino)benzyl]-2-diphenylphosphinoferrocene | ESD-919540-250MG |
| Cas.: 1003012-96-1 | Purity: 98% | (2S)-1-[(R)-α-(Dimethylamino)-2-(diphenylphosphino)benzyl]-2-diphenylphosphinoferrocene | ESD-919540-1G |
| Cas.: 19529-00-1 | Purity: 98% | Dihydridotetrakis(triphenylphosphine)ruthenium(II) | ESD-919541-250MG |
| Cas.: 19529-00-1 | Purity: 98% | Dihydridotetrakis(triphenylphosphine)ruthenium(II) | ESD-919541-1G |
| Cas.: 33282-21-2 | Purity: 97% | 5-(p-Tolyl)isoxazole-3-carboxylic acid | ESD-919542-250MG |
| Cas.: 33282-21-2 | Purity: 97% | 5-(p-Tolyl)isoxazole-3-carboxylic acid | ESD-919542-1G |
| Cas.: 892155-19-0 | Purity: 98% | 4-((3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)thio)phenol | ESD-919543-250MG |
| Cas.: 892155-19-0 | Purity: 98% | 4-((3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)thio)phenol | ESD-919543-1G |
| Cas.: 305448-92-4 | Purity: 98% | N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide | ESD-919544-250MG |
| Cas.: 305448-92-4 | Purity: 98% | N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide | ESD-919544-1G |
| Cas.: 777061-36-6 | Purity: 97% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-919545-250MG |
| Cas.: 777061-36-6 | Purity: 97% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-919545-1G |
| Cas.: 480425-30-7 | Purity: 98% | (E)-tert-Butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane | ESD-919546-250MG |
| Cas.: 480425-30-7 | Purity: 98% | (E)-tert-Butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane | ESD-919546-1G |
| Cas.: 89951-56-4 | Purity: 95% | 5-amino-2chlorobenzylalcohol | ESD-919547-250MG |
| Cas.: 89951-56-4 | Purity: 95% | 5-amino-2chlorobenzylalcohol | ESD-919547-1G |
| Cas.: 579503-59-6 | Purity: 95% | 2-(5′-Hexyl-[2,2′-bithiophen]-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-919548-250MG |
| Cas.: 579503-59-6 | Purity: 95% | 2-(5′-Hexyl-[2,2′-bithiophen]-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-919548-1G |
| Cas.: 832114-06-4 | Purity: 97% | (4-Methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone | ESD-919549-250MG |
| Cas.: 832114-06-4 | Purity: 97% | (4-Methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone | ESD-919549-1G |
| Cas.: 24257-93-0 | Purity: 95% | 2-Acetylbenzaldehyde | ESD-919550-250MG |
| Cas.: 24257-93-0 | Purity: 95% | 2-Acetylbenzaldehyde | ESD-919550-1G |
| Cas.: 33282-22-3 | Purity: 95% | 5-(4-Chlorophenyl)isoxazole-3-carboxylic acid | ESD-919551-250MG |
| Cas.: 33282-22-3 | Purity: 95% | 5-(4-Chlorophenyl)isoxazole-3-carboxylic acid | ESD-919551-1G |
| Cas.: 161513-47-9 | Purity: 98% | (S)-1-(tert-butoxycarbonyl)-2,3-oxiranylmethylamine | ESD-919552-250MG |
| Cas.: 161513-47-9 | Purity: 98% | (S)-1-(tert-butoxycarbonyl)-2,3-oxiranylmethylamine | ESD-919552-1G |
| Cas.: 16116-80-6 | Purity: 95% | 4-[(Trimethylsilyl)ethynyl]benzoic acid | ESD-919553-250MG |
| Cas.: 16116-80-6 | Purity: 95% | 4-[(Trimethylsilyl)ethynyl]benzoic acid | ESD-919553-1G |
| Cas.: 74385-37-8 | Purity: 98% | Methyl 4-fluoro-3-methoxybenzoate | ESD-919554-250MG |
| Cas.: 74385-37-8 | Purity: 98% | Methyl 4-fluoro-3-methoxybenzoate | ESD-919554-1G |
| Cas.: 34253-01-5 | Purity: 95% | Methyl pyrimidine-5-carboxylate | ESD-919555-250MG |
| Cas.: 34253-01-5 | Purity: 95% | Methyl pyrimidine-5-carboxylate | ESD-919555-1G |
| Cas.: 395-01-7 | Purity: 95% | 2,2-Difluoro-1-phenylethanone | ESD-919556-250MG |
| Cas.: 395-01-7 | Purity: 95% | 2,2-Difluoro-1-phenylethanone | ESD-919556-1G |
| Cas.: 486429-99-6 | Purity: 98% | (S)-1,13-Bis(diphenylphosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine | ESD-919557-250MG |
| Cas.: 486429-99-6 | Purity: 98% | (S)-1,13-Bis(diphenylphosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxonine | ESD-919557-1G |
| Cas.: 649559-65-9 | Purity: 97% 99%ee | (2R)-1-[(1R)-1-[Bis(3,5-dimethylphenyl)phosphino]ethyl]-2-(di-2-furanylphosphino)ferrocene | ESD-919558-250MG |
| Cas.: 649559-65-9 | Purity: 97% 99%ee | (2R)-1-[(1R)-1-[Bis(3,5-dimethylphenyl)phosphino]ethyl]-2-(di-2-furanylphosphino)ferrocene | ESD-919558-1G |
| Cas.: 53317-87-6 | Purity: 99% Au Assay: 39.91 ± 0.8% | Tris[triphenylphosphinegold(I)]oxonium tetrafluoroborate | ESD-919559-250MG |
| Cas.: 53317-87-6 | Purity: 99% Au Assay: 39.91 ± 0.8% | Tris[triphenylphosphinegold(I)]oxonium tetrafluoroborate | ESD-919559-1G |
| Cas.: 106850-34-4 | Purity: 98% | Imidazo[1,2-a]pyridine-6-carbonitrile | ESD-919560-250MG |
| Cas.: 106850-34-4 | Purity: 98% | Imidazo[1,2-a]pyridine-6-carbonitrile | ESD-919560-1G |
| Cas.: 889949-09-1 | Purity: 95% | tert-Butyl (1-(aminomethyl)cyclopentyl)carbamate | ESD-919561-250MG |
| Cas.: 889949-09-1 | Purity: 95% | tert-Butyl (1-(aminomethyl)cyclopentyl)carbamate | ESD-919561-1G |
| Cas.: 1138011-22-9 | Purity: 95% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanamine hydrochloride | ESD-919562-250MG |
| Cas.: 1138011-22-9 | Purity: 95% | 2,2,2-Trifluoro-1-(pyridin-3-yl)ethanamine hydrochloride | ESD-919562-1G |
| Cas.: 118000-43-4 | Purity: 96% | Imidazo[1,2-a]pyridine-2-carbaldehyde | ESD-919563-250MG |
| Cas.: 118000-43-4 | Purity: 96% | Imidazo[1,2-a]pyridine-2-carbaldehyde | ESD-919563-1G |
| Cas.: 121099-07-8 | Purity: 98% | Triisopropylphosphonium tetrafluoroborate | ESD-919564-250MG |
| Cas.: 121099-07-8 | Purity: 98% | Triisopropylphosphonium tetrafluoroborate | ESD-919564-1G |
| Cas.: 113775-22-7 | Purity: 97% | (1S,4S)-tert-Butyl 3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | ESD-919565-250MG |
| Cas.: 113775-22-7 | Purity: 97% | (1S,4S)-tert-Butyl 3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | ESD-919565-1G |
| Cas.: 246547-26-2 | Purity: 97% | Ethyl 4-aminotetrahydro-2H-pyran-4-carboxylate | ESD-919566-250MG |
| Cas.: 246547-26-2 | Purity: 97% | Ethyl 4-aminotetrahydro-2H-pyran-4-carboxylate | ESD-919566-1G |
| Cas.: 60964-09-2 | Purity: 95% | 2,6-Dichloro-4-hydroxybenzaldehyde | ESD-919567-250MG |
| Cas.: 60964-09-2 | Purity: 95% | 2,6-Dichloro-4-hydroxybenzaldehyde | ESD-919567-1G |
| Cas.: 870777-28-9 | Purity: 98% | (3-Chloro-4-((2-fluorobenzyl)oxy)phenyl)boronic acid | ESD-919568-250MG |
| Cas.: 870777-28-9 | Purity: 98% | (3-Chloro-4-((2-fluorobenzyl)oxy)phenyl)boronic acid | ESD-919568-1G |
| Cas.: 16793-89-8 | Purity: 97% | 1-(2-Bromoethyl)-2-nitrobenzene | ESD-919569-250MG |
| Cas.: 16793-89-8 | Purity: 97% | 1-(2-Bromoethyl)-2-nitrobenzene | ESD-919569-1G |
| Cas.: 876890-28-7 | Purity: 98% | 2-(Ethylthio)pyrimidine-5-carbaldehyde | ESD-919570-250MG |
| Cas.: 876890-28-7 | Purity: 98% | 2-(Ethylthio)pyrimidine-5-carbaldehyde | ESD-919570-1G |
| Cas.: 24152-96-3 | Purity: 98% | 2-Amino-1-morpholinoethanone hydrochloride | ESD-919571-250MG |
| Cas.: 24152-96-3 | Purity: 98% | 2-Amino-1-morpholinoethanone hydrochloride | ESD-919571-1G |
| Cas.: 887580-55-4 | Purity: 97% | 2-(2-Chloropyridin-4-yl)acetic acid | ESD-919572-250MG |
| Cas.: 887580-55-4 | Purity: 97% | 2-(2-Chloropyridin-4-yl)acetic acid | ESD-919572-1G |
| Cas.: 426844-23-7 | Purity: 98% | (2S,4S)-4-Fluoropyrrolidine-2-carboxamide hydrochloride | ESD-919573-250MG |
| Cas.: 426844-23-7 | Purity: 98% | (2S,4S)-4-Fluoropyrrolidine-2-carboxamide hydrochloride | ESD-919573-1G |
| Cas.: 23108-72-7 | Purity: 98% | Methyl(triphenylphosphine)gold(I) | ESD-919574-250MG |
| Cas.: 23108-72-7 | Purity: 98% | Methyl(triphenylphosphine)gold(I) | ESD-919574-1G |
| Cas.: 65003-40-9 | Purity: 95% | 2-((Methoxycarbonyl)amino)-1H-benzo[d]imidazole-5-carboxylic acid | ESD-919575-250MG |
| Cas.: 65003-40-9 | Purity: 95% | 2-((Methoxycarbonyl)amino)-1H-benzo[d]imidazole-5-carboxylic acid | ESD-919575-1G |
| Cas.: 78551-38-9 | Purity: 95% | (S)-3-Methylpiperazin-2-one | ESD-919576-250MG |
| Cas.: 78551-38-9 | Purity: 95% | (S)-3-Methylpiperazin-2-one | ESD-919576-1G |
| Cas.: 89466-07-9 | Purity: 98% | 4-Amino-3-nitrophenylboronicacid | ESD-919577-250MG |
| Cas.: 89466-07-9 | Purity: 98% | 4-Amino-3-nitrophenylboronicacid | ESD-919577-1G |
| Cas.: 116355-16-9 | Purity: 96% | Imidazo[1,2-a]pyridine-6-carbaldehyde | ESD-919578-250MG |
| Cas.: 116355-16-9 | Purity: 96% | Imidazo[1,2-a]pyridine-6-carbaldehyde | ESD-919578-1G |
| Cas.: 71397-33-6 | Purity: 98% | Chloro(cyclopentadienyl)[bis(diphenylphosphino)methane]ruthenium(II) | ESD-919579-250MG |
| Cas.: 71397-33-6 | Purity: 98% | Chloro(cyclopentadienyl)[bis(diphenylphosphino)methane]ruthenium(II) | ESD-919579-1G |
| Cas.: 1073371-93-3 | Purity: 98% | 2-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-919580-250MG |
| Cas.: 1073371-93-3 | Purity: 98% | 2-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-919580-1G |
| Cas.: 1052707-11-5 | Purity: 97% | (1S, 2S)-1,2-Bis(4-fluorophenyl)ethylenediamine | ESD-919581-100MG |
| Cas.: 1052707-11-5 | Purity: 97% | (1S, 2S)-1,2-Bis(4-fluorophenyl)ethylenediamine | ESD-919581-1G |
| Cas.: 42232-82-6 | Purity: ≥99% | ARACHIDIC ACID LAURYL ESTER | ESD-919582-100MG |
| Cas.: 42232-82-6 | Purity: ≥99% | ARACHIDIC ACID LAURYL ESTER | ESD-919582-1G |
| Cas.: 26536-13-0 | Purity: ≥99% | 1,2,3-TRINONADECANOYLGLYCEROL | ESD-919583-100MG |
| Cas.: 26536-13-0 | Purity: ≥99% | 1,2,3-TRINONADECANOYLGLYCEROL | ESD-919583-1G |
| Cas.: 147740-73-6 | Purity: ≥95% (HPLC) | Amyloid β-Protein (35-25) | ESD-919584-1MG |
| Cas.: 1624-02-8 | Purity: 96% | BIS(TRIPHENYLSILYL)CHROMATE | ESD-919585-10G |
| Cas.: 1624-02-8 | Purity: 96% | BIS(TRIPHENYLSILYL)CHROMATE | ESD-919585-1G |
| Cas.: 23485-68-9 | Purity: 97% | 3-(5-PHENYL-1,3-OXAZOL-2-YL)PROPANOIC ACID | ESD-919587-10G |
| Cas.: 23485-68-9 | Purity: 97% | 3-(5-PHENYL-1,3-OXAZOL-2-YL)PROPANOIC ACID | ESD-919587-1G |
| Cas.: 654-47-7 | Purity: 97% | 2-FLUOROPHENYLMETHYLSULFONE | ESD-919588-10G |
| Cas.: 654-47-7 | Purity: 97% | 2-FLUOROPHENYLMETHYLSULFONE | ESD-919588-1G |
| Cas.: 698999-65-4 | Purity: 19-23% Ce basis | Cerium trifluoromethanesulfonate | ESD-919589-10G |
| Cas.: 698999-65-4 | Purity: 19-23% Ce basis | Cerium trifluoromethanesulfonate | ESD-919589-1G |
| Cas.: 57635-48-0 | Purity: >94% | GLYCOLIC ACID ETHOXYLATE OLEYL ETHER | ESD-919590-10L |
| Cas.: 57635-48-0 | Purity: >94% | GLYCOLIC ACID ETHOXYLATE OLEYL ETHER | ESD-919590-1L |
| Cas.: 5769-15-3 | Purity: 97% | 4-Chlorobenzenesulfonyl isocyanate | ESD-919591-5G |
| Cas.: 5769-15-3 | Purity: 97% | 4-Chlorobenzenesulfonyl isocyanate | ESD-919591-1G |
| Cas.: 51163-29-2 | Purity: 98% | 2,4-DIMETHYLPHENYL ISOCYANATE | ESD-919592-5G |
| Cas.: 51163-29-2 | Purity: 98% | 2,4-DIMETHYLPHENYL ISOCYANATE | ESD-919592-1G |
| Cas.: 40397-98-6 | Purity: 97% | 2,5-DIMETHYLPHENYL ISOCYANATE | ESD-919593-5G |
| Cas.: 40397-98-6 | Purity: 97% | 2,5-DIMETHYLPHENYL ISOCYANATE | ESD-919593-1G |
| Cas.: 37260-88-1 | Purity: 97% | Dimethylbis(cyclopentadienyl)hafnium(IV) | ESD-919594-5G |
| Cas.: 37260-88-1 | Purity: 97% | Dimethylbis(cyclopentadienyl)hafnium(IV) | ESD-919594-1G |
| Cas.: 6240-96-6 | Purity: 98% | (R)-1-(Cyclopropylethyl)amine | ESD-919595-1G |
| Cas.: 57404-76-9 | Purity: 98% | TRANS-HEPTENYLBORONIC ACID | ESD-919596-5G |
| Cas.: 57404-76-9 | Purity: 98% | TRANS-HEPTENYLBORONIC ACID | ESD-919596-1G |
| Cas.: 163913-87-9 | Purity: ≥97% (HPLC) | Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55 Rat, Mouse | ESD-919597-0.5MG |
| Cas.: 163913-87-9 | Purity: ≥97% (HPLC) | Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55 Rat, Mouse | ESD-919597-1MG |
| Cas.: 100938-10-1 | Purity: ≥97% (HPLC) | AMASTATIN HYDROCHLORIDE | ESD-919598-0.5MG |
| Cas.: 100938-10-1 | Purity: ≥97% (HPLC) | AMASTATIN HYDROCHLORIDE | ESD-919598-1MG |
| Cas.: 8049-22-7 | Wood’s metal | ESD-919599-100G | |
| Cas.: 8049-22-7 | Wood’s metal | ESD-919599-500G | |
| Cas.: 21969-32-4 | Purity: 0.5 M in THF | 1-Methyl-2-propenylmagnesium chloride solution | ESD-919600-100ML |
| Cas.: 21969-32-4 | Purity: 0.5 M in THF | 1-Methyl-2-propenylmagnesium chloride solution | ESD-919600-500ML |
| Cas.: 1000343-89-4 | Purity: 97% | 6-Bromo-7-methyl-1H-indole | ESD-919601-100MG |
| Cas.: 1000343-89-4 | Purity: 97% | 6-Bromo-7-methyl-1H-indole | ESD-919601-250MG |
| Cas.: 68166-83-6 | Purity: 97% | (R)-tert-Butyl 2-hydroxypropanoate | ESD-919602-100MG |
| Cas.: 68166-83-6 | Purity: 97% | (R)-tert-Butyl 2-hydroxypropanoate | ESD-919602-250MG |
| Cas.: 139021-82-2 | Purity: 97% | Bis((4R,5S)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)methane | ESD-919603-100MG |
| Cas.: 139021-82-2 | Purity: 97% | Bis((4R,5S)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)methane | ESD-919603-250MG |
| Cas.: 51-59-2 | Purity: 97% | 5-ACETAMIDO-2-HYDROXYBENZOIC ACID | ESD-919604-100MG |
| Cas.: 51-59-2 | Purity: 97% | 5-ACETAMIDO-2-HYDROXYBENZOIC ACID | ESD-919604-250MG |
| Cas.: 312619-39-9 | Purity: ≥95% | BIS((R)-(-)-1-(1-NAPHTHYL)ETHYL)AMINE | ESD-919605-100MG |
| Cas.: 312619-39-9 | Purity: ≥95% | BIS((R)-(-)-1-(1-NAPHTHYL)ETHYL)AMINE | ESD-919605-250MG |
| Cas.: 219967-69-8 | Purity: 98% | Fmoc-Ot-butyl-L-beta-homotyrosine | ESD-919606-100MG |
| Cas.: 219967-69-8 | Purity: 98% | Fmoc-Ot-butyl-L-beta-homotyrosine | ESD-919606-250MG |
| Cas.: 352351-55-4 | Purity: 97% | (9H-Fluoren-9-yl)methyl (2-aminoethyl)carbamate hydrobromide | ESD-919607-100MG |
| Cas.: 352351-55-4 | Purity: 97% | (9H-Fluoren-9-yl)methyl (2-aminoethyl)carbamate hydrobromide | ESD-919607-250MG |
| Cas.: 138485-82-2 | Purity: 96% | 6-(Methylthio)-1-indanone | ESD-919608-100MG |
| Cas.: 138485-82-2 | Purity: 96% | 6-(Methylthio)-1-indanone | ESD-919608-250MG |
| Cas.: 155861-77-1 | Purity: 97% | 3,4-Propylenedioxythiophene | ESD-919609-100MG |
| Cas.: 155861-77-1 | Purity: 97% | 3,4-Propylenedioxythiophene | ESD-919609-250MG |
| Cas.: 376355-58-7 | Purity: 98% | N,N-Bis((S)-1-phenylethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine | ESD-919610-100MG |
| Cas.: 376355-58-7 | Purity: 98% | N,N-Bis((S)-1-phenylethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine | ESD-919610-250MG |
| Cas.: 51793-93-2 | Purity: 97% | 7-Chlorobenzo[d]oxazole-2(3H)-thione | ESD-919611-100MG |
| Cas.: 51793-93-2 | Purity: 97% | 7-Chlorobenzo[d]oxazole-2(3H)-thione | ESD-919611-250MG |
| Cas.: 12148-72-0 | Purity: 98%, Rh>42% | Methoxy(cyclooctadiene)rhodium(I) dimer | ESD-919612-100MG |
| Cas.: 12148-72-0 | Purity: 98%, Rh>42% | Methoxy(cyclooctadiene)rhodium(I) dimer | ESD-919612-250MG |
| Cas.: 139139-86-9 | Purity: 98% | (R)-2,2′-Bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl | ESD-919613-50MG |
| Cas.: 139139-86-9 | Purity: 98% | (R)-2,2′-Bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl | ESD-919613-250MG |
| Cas.: 139139-93-8 | Purity: 98% | (S)-(-)-2,2′-Bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl | ESD-919614-50MG |
| Cas.: 139139-93-8 | Purity: 98% | (S)-(-)-2,2′-Bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl | ESD-919614-250MG |
| Cas.: 270065-74-2 | Purity: ≥98% | BOC-(S)-3-AMINO-4-(2-TRIFLUOROMETHYL-PHENYL)-BUTYRIC ACID | ESD-919615-50MG |
| Cas.: 270065-74-2 | Purity: ≥98% | BOC-(S)-3-AMINO-4-(2-TRIFLUOROMETHYL-PHENYL)-BUTYRIC ACID | ESD-919615-250MG |
| Cas.: 639820-61-4 | Purity: 97% | 1-(Adamantan-1-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-919616-50MG |
| Cas.: 639820-61-4 | Purity: 97% | 1-(Adamantan-1-yl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-919616-250MG |
| Cas.: 1016971-66-6 | Purity: 98% | tert-Butyl ((1R,2R)-2-aminocyclopentyl)carbamate | ESD-919617-50MG |
| Cas.: 1016971-66-6 | Purity: 98% | tert-Butyl ((1R,2R)-2-aminocyclopentyl)carbamate | ESD-919617-100MG |
| Cas.: 35264-07-4 | Purity: 99% | Boc-allo-Ile-OH | ESD-919618-25MG |
| Cas.: 35264-07-4 | Purity: 99% | Boc-allo-Ile-OH | ESD-919618-100MG |
| Cas.: 108789-36-2 | Purity: ≥98% | 5-Bromo-4-chloro-3-indolyl-aD-glucopyranoside | ESD-919619-25MG |
| Cas.: 108789-36-2 | Purity: ≥98% | 5-Bromo-4-chloro-3-indolyl-aD-glucopyranoside | ESD-919619-100MG |
| Cas.: 108464-88-6 | Purity: 98% | 1,3-Phenylenebis((4-fluorophenyl)methanone) | ESD-919620-25G |
| Cas.: 108464-88-6 | Purity: 98% | 1,3-Phenylenebis((4-fluorophenyl)methanone) | ESD-919620-100G |
| Cas.: 18437-66-6 | Purity: 97% | 4-Chloro-(N-Boc)aniline | ESD-919621-25G |
| Cas.: 18437-66-6 | Purity: 97% | 4-Chloro-(N-Boc)aniline | ESD-919621-100G |
| Cas.: 90719-30-5 | Purity: 98% (HPLC) | Locostatin (s,e)-4-benzyl-3-(but-2-enoyl)oxazolidin-2-one | ESD-919622-10MG |
| Cas.: 90719-30-5 | Purity: 98% (HPLC) | Locostatin (s,e)-4-benzyl-3-(but-2-enoyl)oxazolidin-2-one | ESD-919622-50MG |
| Cas.: 77794-93-5 | Purity: 95% | Benzyltriethylammonium tetrafluoroborate | ESD-919623-10G |
| Cas.: 77794-93-5 | Purity: 95% | Benzyltriethylammonium tetrafluoroborate | ESD-919623-50G |
| Cas.: 41270-96-6 | Purity: 98% | 4-IPP | ESD-919624-10MG |
| Cas.: 41270-96-6 | Purity: 98% | 4-IPP | ESD-919624-25MG |
| Cas.: 138605-00-2 | Purity: ≥98%(HPLC) | NKH 477 | ESD-919625-5MG |
| Cas.: 138605-00-2 | Purity: ≥98%(HPLC) | NKH 477 | ESD-919625-25MG |
| Cas.: 106513-42-2 | Purity: ≥95% | (S)-Ethyl 2-((tert-Butyldimethylsilyl)oxy)propanoate | ESD-919626-5G |
| Cas.: 106513-42-2 | Purity: ≥95% | (S)-Ethyl 2-((tert-Butyldimethylsilyl)oxy)propanoate | ESD-919626-25G |
| Cas.: 21744-84-3 | Purity: 98% | 4-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE | ESD-919627-5G |
| Cas.: 21744-84-3 | Purity: 98% | 4-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE | ESD-919627-25G |
| Cas.: 34840-23-8 | Purity: 96% | 1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura | ESD-919628-5G |
| Cas.: 34840-23-8 | Purity: 96% | 1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura | ESD-919628-25G |
| Cas.: 174689-39-5 | Purity: ≥98% | (S)-1-(2-Ethylphenoxy)-3-(((S)-1,2,3,4-tetrahydronaphthalen-1-yl)amino)propan-2-ol oxalate | ESD-919629-5MG |
| Cas.: 174689-39-5 | Purity: ≥98% | (S)-1-(2-Ethylphenoxy)-3-(((S)-1,2,3,4-tetrahydronaphthalen-1-yl)amino)propan-2-ol oxalate | ESD-919629-25MG |
| Cas.: 392721-37-8 | Purity: ≥98% | N-(4-Chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide | ESD-919630-5MG |
| Cas.: 392721-37-8 | Purity: ≥98% | N-(4-Chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide | ESD-919630-25MG |
| Cas.: 18402-83-0 | Purity: 95% | (E)-Non-3-en-2-one | ESD-919631-5G |
| Cas.: 18402-83-0 | Purity: 95% | (E)-Non-3-en-2-one | ESD-919631-25G |
| Cas.: 620-32-6 | Purity: 99% | Benzyl sulfone | ESD-919632-5G |
| Cas.: 620-32-6 | Purity: 99% | Benzyl sulfone | ESD-919632-25G |
| Cas.: 65604-89-9 | Purity: 97% | Tris[2-(methylamino)ethyl]amine 97% | ESD-919634-1G |
| Cas.: 65604-89-9 | Purity: 97% | Tris[2-(methylamino)ethyl]amine 97% | ESD-919634-5G |
| Cas.: 216144-68-2 | Purity: 95% | 3-Fluoro-4-(trifluoromethyl)benzoyl chloride | ESD-919635-1G |
| Cas.: 216144-68-2 | Purity: 95% | 3-Fluoro-4-(trifluoromethyl)benzoyl chloride | ESD-919635-5G |
| Cas.: 302911-98-4 | Purity: 97% | 2,5-Bis(trifluoromethyl)benzyl bromide | ESD-919636-1G |
| Cas.: 302911-98-4 | Purity: 97% | 2,5-Bis(trifluoromethyl)benzyl bromide | ESD-919636-5G |
| Cas.: 70931-28-1 | Purity: 98% | 1-(4-Fluorobenzyl)piperazine | ESD-919637-1G |
| Cas.: 70931-28-1 | Purity: 98% | 1-(4-Fluorobenzyl)piperazine | ESD-919637-5G |
| Cas.: 23489-36-3 | Purity: 96% | 1-(Benzofuran-2-yl)-2-bromoethanone | ESD-919638-1G |
| Cas.: 23489-36-3 | Purity: 96% | 1-(Benzofuran-2-yl)-2-bromoethanone | ESD-919638-5G |
| Cas.: 14683-47-7 | Purity: 98% | N-Methyl-1,1-diphenylmethanamine | ESD-919639-1G |
| Cas.: 14683-47-7 | Purity: 98% | N-Methyl-1,1-diphenylmethanamine | ESD-919639-5G |
| Cas.: 261951-96-6 | Purity: 97% | 1-Bromo-2-methyl-4-(trifluoromethoxy)benzene | ESD-919640-1G |
| Cas.: 261951-96-6 | Purity: 97% | 1-Bromo-2-methyl-4-(trifluoromethoxy)benzene | ESD-919640-5G |
| Cas.: 16309-45-8 | Purity: 97% | 4-(4-Nitrophenoxy)benzoic Acid | ESD-919641-1G |
| Cas.: 16309-45-8 | Purity: 97% | 4-(4-Nitrophenoxy)benzoic Acid | ESD-919641-5G |
| Cas.: 126120-85-2 | Purity: 98% | 2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid | ESD-919642-1G |
| Cas.: 126120-85-2 | Purity: 98% | 2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid | ESD-919642-5G |
| Cas.: 21120-67-2 | Purity: 97% | 4-(4-Chlorophenoxy)Benzoic Acid | ESD-919643-1G |
| Cas.: 21120-67-2 | Purity: 97% | 4-(4-Chlorophenoxy)Benzoic Acid | ESD-919643-5G |
| Cas.: 69026-14-8 | Purity: 96% | 3-(Benzyloxy)benzoic acid | ESD-919644-1G |
| Cas.: 69026-14-8 | Purity: 96% | 3-(Benzyloxy)benzoic acid | ESD-919644-5G |
| Cas.: 13320-48-4 | Purity: 95% | 4-(4-Bromophenoxy)phenol | ESD-919645-1G |
| Cas.: 13320-48-4 | Purity: 95% | 4-(4-Bromophenoxy)phenol | ESD-919645-5G |
| Cas.: 1561-11-1 | Purity: ≥96% | 4-METHYLHEXANOIC ACID | ESD-919646-1G |
| Cas.: 1561-11-1 | Purity: ≥96% | 4-METHYLHEXANOIC ACID | ESD-919646-5G |
| Cas.: 15009-91-3 | Purity: 97% | 2-Nitropyridine | ESD-919647-1G |
| Cas.: 64951-58-2 | Purity: 97% | 4-Chloro-8-methoxy-2-methylquinoline | ESD-919648-1G |
| Cas.: 64951-58-2 | Purity: 97% | 4-Chloro-8-methoxy-2-methylquinoline | ESD-919648-5G |
| Cas.: 175205-85-3 | Purity: 97% | 3,5-Dibromobenzamide | ESD-919649-1G |
| Cas.: 175205-85-3 | Purity: 97% | 3,5-Dibromobenzamide | ESD-919649-5G |
| Cas.: 1826-23-9 | Purity: 97% | 2-Chloro-4-phenylthiazole | ESD-919650-1G |
| Cas.: 1826-23-9 | Purity: 97% | 2-Chloro-4-phenylthiazole | ESD-919650-5G |
| Cas.: 2103-95-9 | Purity: 97% | 4-(4-Bromophenyl)-2-thiazolethiol | ESD-919651-1G |
| Cas.: 2103-95-9 | Purity: 97% | 4-(4-Bromophenyl)-2-thiazolethiol | ESD-919651-5G |
| Cas.: 181657-56-7 | Purity: ≥95% | (1R,2R)-(-)-2-Benzyloxycyclopentylamine | ESD-919652-1G |
| Cas.: 181657-56-7 | Purity: ≥95% | (1R,2R)-(-)-2-Benzyloxycyclopentylamine | ESD-919652-5G |
| Cas.: 7688-51-9 | Purity: 95% | N-Allyl-N,N-bis(trimethylsilyl)amine | ESD-919653-1G |
| Cas.: 7688-51-9 | Purity: 95% | N-Allyl-N,N-bis(trimethylsilyl)amine | ESD-919653-5G |
| Cas.: 29935-35-1 | Purity: 99% | Lithium hexafluoroarsenate(V) | ESD-919654-1G |
| Cas.: 29935-35-1 | Purity: 99% | Lithium hexafluoroarsenate(V) | ESD-919654-5G |
| Cas.: 13049-01-9 | Purity: ≥95% | Glycine N-Propyl Ester Hydrochloride | ESD-919655-1G |
| Cas.: 13049-01-9 | Purity: ≥95% | Glycine N-Propyl Ester Hydrochloride | ESD-919655-5G |
| Cas.: 41031-50-9 | Purity: 99% | 2-(1-ADAMANTYL)-4-METHYLPHENOL | ESD-919656-1G |
| Cas.: 41031-50-9 | Purity: 99% | 2-(1-ADAMANTYL)-4-METHYLPHENOL | ESD-919656-5G |
| Cas.: 37888-03-2 | Purity: 97% | TRANS-3-CHLORO-BETA-NITROSTYRENE | ESD-919657-1G |
| Cas.: 37888-03-2 | Purity: 97% | TRANS-3-CHLORO-BETA-NITROSTYRENE | ESD-919657-5G |
| Cas.: 4683-50-5 | Purity: 97% | 3-Methoxy-2-cyclopenten-1-one | ESD-919658-1G |
| Cas.: 4683-50-5 | Purity: 97% | 3-Methoxy-2-cyclopenten-1-one | ESD-919658-5G |
| Cas.: 39634-42-9 | Purity: 97% | 4-[4-(trifluoromethyl)phenoxy]phenol | ESD-919659-1G |
| Cas.: 39634-42-9 | Purity: 97% | 4-[4-(trifluoromethyl)phenoxy]phenol | ESD-919659-5G |
| Cas.: 73991-95-4 | Purity: ≥95% | (S)-2-(2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic acid | ESD-919660-1G |
| Cas.: 73991-95-4 | Purity: ≥95% | (S)-2-(2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic acid | ESD-919660-5G |
| Cas.: 15264-63-8 | Purity: 97% | 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol | ESD-919661-1G |
| Cas.: 15264-63-8 | Purity: 97% | 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol | ESD-919661-5G |
| Cas.: 41019-45-8 | Purity: 97% | 5-(4-Chlorophenyl)-2-furoic acid | ESD-919662-1G |
| Cas.: 41019-45-8 | Purity: 97% | 5-(4-Chlorophenyl)-2-furoic acid | ESD-919662-5G |
| Cas.: 72198-83-5 | Purity: 97% | 3-methyl-4-nitrobenzohydrazide | ESD-919663-1G |
| Cas.: 72198-83-5 | Purity: 97% | 3-methyl-4-nitrobenzohydrazide | ESD-919663-5G |
| Cas.: 347-55-7 | Purity: 98% | 2-[(Trifluoromethyl)thio]aniline | ESD-919664-1G |
| Cas.: 934389-88-5 | Purity: 98% (HPLC) | LY 294002, Hydrochloride Salt | ESD-919665-1MG |
| Cas.: 934389-88-5 | Purity: 98% (HPLC) | LY 294002, Hydrochloride Salt | ESD-919665-5MG |
| Cas.: 61535-21-5 | Purity: 95% | 1-Benzyloxy-3-methyl-2-nitrobenzene | ESD-919666-1G |
| Cas.: 61535-21-5 | Purity: 95% | 1-Benzyloxy-3-methyl-2-nitrobenzene | ESD-919666-5G |
| Cas.: 127132-38-1 | Purity: 95% | BOC-L-TYR(ALL)-OH | ESD-919667-1G |
| Cas.: 127132-38-1 | Purity: 95% | BOC-L-TYR(ALL)-OH | ESD-919667-5G |
| Cas.: 1023-01-4 | Purity: 97% | 2-(4-Bromophenyl)-6-methylimidazo[1,2-a]pyridine | ESD-919668-1G |
| Cas.: 1023-01-4 | Purity: 97% | 2-(4-Bromophenyl)-6-methylimidazo[1,2-a]pyridine | ESD-919668-5G |
| Cas.: 6183-35-3 | Purity: 98% | Benzene-1,2,4,5-tetracarboxamide | ESD-919669-1G |
| Cas.: 6183-35-3 | Purity: 98% | Benzene-1,2,4,5-tetracarboxamide | ESD-919669-5G |
| Cas.: 18773-93-8 | Purity: ≥98% | 1-Acetyl-1H-benzotriazole | ESD-919670-1G |
| Cas.: 18773-93-8 | Purity: ≥98% | 1-Acetyl-1H-benzotriazole | ESD-919670-5G |
| Cas.: 57356-64-6 | Purity: 98% | 5-Bromo-2-(pipidin-1-yl)pyrimidine | ESD-919671-1G |
| Cas.: 57356-64-6 | Purity: 98% | 5-Bromo-2-(pipidin-1-yl)pyrimidine | ESD-919671-5G |
| Cas.: 21487-45-6 | Purity: 97% | 1,3-Diphenyl-1H-pyrazole-4-carbaldehyde | ESD-919672-1G |
| Cas.: 21487-45-6 | Purity: 97% | 1,3-Diphenyl-1H-pyrazole-4-carbaldehyde | ESD-919672-5G |
| Cas.: 22174-29-4 | Purity: 97% | 3-(2,4-Dimethoxyphenyl)propionic Acid | ESD-919673-1G |
| Cas.: 22174-29-4 | Purity: 97% | 3-(2,4-Dimethoxyphenyl)propionic Acid | ESD-919673-5G |
| Cas.: 30709-67-2 | Purity: 97% | 5-METHYL-4-PHENYL-THIAZOL-2-YLAMINE | ESD-919674-1G |
| Cas.: 30709-67-2 | Purity: 97% | 5-METHYL-4-PHENYL-THIAZOL-2-YLAMINE | ESD-919674-5G |
| Cas.: 3817-05-8 | Purity: 97% | 2-(Chloromethyl)quinazolin-4(3H)-one | ESD-919675-1G |
| Cas.: 3817-05-8 | Purity: 97% | 2-(Chloromethyl)quinazolin-4(3H)-one | ESD-919675-5G |
| Cas.: 77113-48-5 | Purity: 97% | 1-Chloro-5-trimethylsilyl-4-pentyne | ESD-919676-1G |
| Cas.: 77113-48-5 | Purity: 97% | 1-Chloro-5-trimethylsilyl-4-pentyne | ESD-919676-5G |
| Cas.: 205526-27-8 | Purity: 95% | FMOC-L-3-Trifluoromethylphe | ESD-919677-1G |
| Cas.: 205526-27-8 | Purity: 95% | FMOC-L-3-Trifluoromethylphe | ESD-919677-5G |
| Cas.: 158922-07-7 | Purity: ≥97% | FMOC-NIP-OH | ESD-919678-1G |
| Cas.: 158922-07-7 | Purity: ≥97% | FMOC-NIP-OH | ESD-919678-5G |
| Cas.: 66866-69-1 | Purity: 98% | N-Methyl-L-leucine hydrochloride | ESD-919679-1G |
| Cas.: 66866-69-1 | Purity: 98% | N-Methyl-L-leucine hydrochloride | ESD-919679-5G |
| Cas.: 51524-84-6 | Purity: 97% | 3-(Methylamino)benzoic acid | ESD-919680-1G |
| Cas.: 51524-84-6 | Purity: 97% | 3-(Methylamino)benzoic acid | ESD-919680-5G |
| Cas.: 13939-69-0 | Purity: 97% | 1-Piperidinecarbonyl chloride | ESD-919681-1G |
| Cas.: 13939-69-0 | Purity: 97% | 1-Piperidinecarbonyl chloride | ESD-919681-5G |
| Cas.: 14678-93-4 | Purity: 97% | 5-Amino-1-(4-Methylphenyl)-1h-Pyrazole-4-Carboxylic Acid | ESD-919682-1G |
| Cas.: 14678-93-4 | Purity: 97% | 5-Amino-1-(4-Methylphenyl)-1h-Pyrazole-4-Carboxylic Acid | ESD-919682-5G |
| Cas.: 28004-62-8 | Purity: 95% | 5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-919683-1G |
| Cas.: 28004-62-8 | Purity: 95% | 5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-919683-5G |
| Cas.: 72411-52-0 | Purity: ≥95% | 5-Amino-3-(4-fluorophenyl)pyrazole | ESD-919684-1G |
| Cas.: 72411-52-0 | Purity: ≥95% | 5-Amino-3-(4-fluorophenyl)pyrazole | ESD-919684-5G |
| Cas.: 215951-86-3 | Purity: 95% | TRANS-2-CHLOROMETHYLVINYLBORONIC ACID | ESD-919685-1G |
| Cas.: 215951-86-3 | Purity: 95% | TRANS-2-CHLOROMETHYLVINYLBORONIC ACID | ESD-919685-5G |
| Cas.: 23173-57-1 | Purity: 95% | 1-(4-Methylbenzyl)piperazine | ESD-919686-1G |
| Cas.: 36160-82-4 | Purity: 97% | 4-(4-Fluorophenoxy)aniline | ESD-919687-1G |
| Cas.: 36160-82-4 | Purity: 97% | 4-(4-Fluorophenoxy)aniline | ESD-919687-5G |
| Cas.: 139937-37-4 | Purity: 97% | 4-Bromo-2-methylbenzene-1-sulfonyl chloride | ESD-919688-1G |
| Cas.: 139937-37-4 | Purity: 97% | 4-Bromo-2-methylbenzene-1-sulfonyl chloride | ESD-919688-5G |
| Cas.: 144584-66-7 | Purity: 96% | 4-Bromo-2,2-difluoro-1,3-benzodioxole | ESD-919689-1G |
| Cas.: 144584-66-7 | Purity: 96% | 4-Bromo-2,2-difluoro-1,3-benzodioxole | ESD-919689-5G |
| Cas.: 86232-28-2 | Purity: 95% | 5-Chloro-2,3-dimethoxybenzaldehyde | ESD-919690-1G |
| Cas.: 86232-28-2 | Purity: 95% | 5-Chloro-2,3-dimethoxybenzaldehyde | ESD-919690-5G |
| Cas.: 74965-38-1 | Purity: 97% | 2-BOC-AMINO-BENZALDEHYDE | ESD-919691-1G |
| Cas.: 74965-38-1 | Purity: 97% | 2-BOC-AMINO-BENZALDEHYDE | ESD-919691-5G |
| Cas.: 327156-94-5 | Purity: 97% | BOC-D-LYS(ALOC)-OH DCHA | ESD-919692-1G |
| Cas.: 327156-94-5 | Purity: 97% | BOC-D-LYS(ALOC)-OH DCHA | ESD-919692-5G |
| Cas.: 101203-31-0 | Purity: 98% | 3,3′-Di-tert-butyl-5,5′,6,6′-tetramethyl-[1,1′-biphenyl]-2,2′-diol | ESD-919693-1G |
| Cas.: 101203-31-0 | Purity: 98% | 3,3′-Di-tert-butyl-5,5′,6,6′-tetramethyl-[1,1′-biphenyl]-2,2′-diol | ESD-919693-5G |
| Cas.: 158747-10-5 | Purity: 98% | N,3,3-Trimethyl-1,5-dioxaspiro[5.5]undecan-9-amine hydrochloride | ESD-919694-1G |
| Cas.: 158747-10-5 | Purity: 98% | N,3,3-Trimethyl-1,5-dioxaspiro[5.5]undecan-9-amine hydrochloride | ESD-919694-5G |
| Cas.: 395-35-7 | Purity: 98% | 4-(Trifluoromethyl)mandelic acid | ESD-919695-1G |
| Cas.: 395-35-7 | Purity: 98% | 4-(Trifluoromethyl)mandelic acid | ESD-919695-5G |
| Cas.: 21860-03-7 | Purity: 99% | 2,5-Di-tert-butylaniline | ESD-919696-1G |
| Cas.: 21860-03-7 | Purity: 99% | 2,5-Di-tert-butylaniline | ESD-919696-5G |
| Cas.: 130333-46-9 | Purity: 95% | 5-Bromo-2,4-dimethoxybenzaldehyde | ESD-919697-1G |
| Cas.: 130333-46-9 | Purity: 95% | 5-Bromo-2,4-dimethoxybenzaldehyde | ESD-919697-5G |
| Cas.: 932-62-7 | Purity: 99% | 3-Acetyl-1-methylpyrrole | ESD-919698-1G |
| Cas.: 932-62-7 | Purity: 99% | 3-Acetyl-1-methylpyrrole | ESD-919698-5G |
| Cas.: 871125-86-9 | Purity: 95% | 2-Piperazinopyridine-5-boronic acid, pinacol ester | ESD-919699-1G |
| Cas.: 871125-86-9 | Purity: 95% | 2-Piperazinopyridine-5-boronic acid, pinacol ester | ESD-919699-5G |
| Cas.: 12167-74-7 | Purity: 34-40%Ca | Calcium phosphate tribasic | ESD-919700-500G |
| Cas.: 12167-74-7 | Purity: 34-40%Ca | Calcium phosphate tribasic | ESD-919700-2.5KG |
| Cas.: 57293-19-3 | Purity: 95% | 1-(3-Bromopropyl)-4-methoxybenzene | ESD-919701-250MG |
| Cas.: 57293-19-3 | Purity: 95% | 1-(3-Bromopropyl)-4-methoxybenzene | ESD-919701-1G |
| Cas.: 181257-35-2 | Purity: 85% | Bis(2-furyl)chlorophosphine | ESD-919702-250MG |
| Cas.: 181257-35-2 | Purity: 85% | Bis(2-furyl)chlorophosphine | ESD-919702-1G |
| Cas.: 215178-39-5 | Purity: 95% | (R)-1-FMOC-3-Pyrrolidinol | ESD-919703-250MG |
| Cas.: 215178-39-5 | Purity: 95% | (R)-1-FMOC-3-Pyrrolidinol | ESD-919703-1G |
| Cas.: 57731-40-5 | Purity: 98% | Tris(dimethylamido)gallium(III) | ESD-919704-250MG |
| Cas.: 57731-40-5 | Purity: 98% | Tris(dimethylamido)gallium(III) | ESD-919704-1G |
| Cas.: 54788-17-9 | Purity: 95% | 1-(Bromomethyl)-2-chloro-4-methoxybenzene | ESD-919705-250MG |
| Cas.: 54788-17-9 | Purity: 95% | 1-(Bromomethyl)-2-chloro-4-methoxybenzene | ESD-919705-1G |
| Cas.: 67669-19-6 | Purity: ≥95% | N-(2,4-Dichloro-5-hydroxyphenyl)acetamide | ESD-919706-250MG |
| Cas.: 67669-19-6 | Purity: ≥95% | N-(2,4-Dichloro-5-hydroxyphenyl)acetamide | ESD-919706-1G |
| Cas.: 190774-50-6 | Purity: ≥95% | 2-Fluoro-5-methylphenyl isocyanate | ESD-919707-250MG |
| Cas.: 190774-50-6 | Purity: ≥95% | 2-Fluoro-5-methylphenyl isocyanate | ESD-919707-1G |
| Cas.: 705-28-2 | Purity: 98% | 3-(Trifluoromethyl)phenylacetylene | ESD-919708-250MG |
| Cas.: 705-28-2 | Purity: 98% | 3-(Trifluoromethyl)phenylacetylene | ESD-919708-1G |
| Cas.: 57598-33-1 | Purity: ≥95% | 2-(2-Methoxyphenyl)-4,4-dimethyl-4,5-dihydrooxazole | ESD-919709-250MG |
| Cas.: 57598-33-1 | Purity: ≥95% | 2-(2-Methoxyphenyl)-4,4-dimethyl-4,5-dihydrooxazole | ESD-919709-1G |
| Cas.: 200335-40-6 | Purity: ≥95% | FMOC-L-ISOASPARAGINE | ESD-919710-250MG |
| Cas.: 200335-40-6 | Purity: ≥95% | FMOC-L-ISOASPARAGINE | ESD-919710-1G |
| Cas.: 22607-75-6 | Purity: ≥95% | 4-azatricyclo[4.3.1.1~3,8~]undecan-5-one | ESD-919711-250MG |
| Cas.: 22607-75-6 | Purity: ≥95% | 4-azatricyclo[4.3.1.1~3,8~]undecan-5-one | ESD-919711-1G |
| Cas.: 3034-62-6 | Purity: 97% | 2-Iodoimidazole | ESD-919712-250MG |
| Cas.: 3034-62-6 | Purity: 97% | 2-Iodoimidazole | ESD-919712-1G |
| Cas.: 53174-06-4 | Purity: 98% | (S)-(-)-6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID | ESD-919713-250MG |
| Cas.: 2026-08-6 | Purity: 97% | Naphthalene-1,8-diyldimethanol | ESD-919714-250MG |
| Cas.: 2026-08-6 | Purity: 97% | Naphthalene-1,8-diyldimethanol | ESD-919714-1G |
| Cas.: 14363-14-5 | Purity: 97% | BIS(2,2,6,6-TETRAMETHYL-3,5-HEPTANEDIONATO)ZINC | ESD-919715-250MG |
| Cas.: 14363-14-5 | Purity: 97% | BIS(2,2,6,6-TETRAMETHYL-3,5-HEPTANEDIONATO)ZINC | ESD-919715-1G |
| Cas.: 94160-25-5 | Purity: 98% | Ethyl 3-hydroxycyclohexanecarboxylate | ESD-919716-250MG |
| Cas.: 94160-25-5 | Purity: 98% | Ethyl 3-hydroxycyclohexanecarboxylate | ESD-919716-1G |
| Cas.: 60410-16-4 | Purity: 95% | (1R,4S)-4-Hydroxycyclopent-2-en-1-yl acetate | ESD-919717-250MG |
| Cas.: 60410-16-4 | Purity: 95% | (1R,4S)-4-Hydroxycyclopent-2-en-1-yl acetate | ESD-919717-1G |
| Cas.: 68867-18-5 | Purity: 96% | 2-METHYL-1,3-BENZOTHIAZOL-6-OL | ESD-919718-250MG |
| Cas.: 68867-18-5 | Purity: 96% | 2-METHYL-1,3-BENZOTHIAZOL-6-OL | ESD-919718-1G |
| Cas.: 5554-54-1 | Purity: 97% | 1,2,2,6,6-Pentamethyl-4-piperidone | ESD-919719-250MG |
| Cas.: 5554-54-1 | Purity: 97% | 1,2,2,6,6-Pentamethyl-4-piperidone | ESD-919719-1G |
| Cas.: 96539-87-6 | Purity: ≥98% | 3-Cyclopentyl-DL-alanine | ESD-919720-250MG |
| Cas.: 96539-87-6 | Purity: ≥98% | 3-Cyclopentyl-DL-alanine | ESD-919720-1G |
| Cas.: 111061-55-3 | Purity: 98% (HPLC) | FMOC-HOMOSER(TRT)-OH | ESD-919721-250MG |
| Cas.: 111061-55-3 | Purity: 98% (HPLC) | FMOC-HOMOSER(TRT)-OH | ESD-919721-1G |
| Cas.: 36209-51-5 | Purity: ≥95% | 4-AMINO-5-(4-PYRIDYL)-4H-1,2,4-TRIAZOLE-3-THIOL | ESD-919722-250MG |
| Cas.: 36209-51-5 | Purity: ≥95% | 4-AMINO-5-(4-PYRIDYL)-4H-1,2,4-TRIAZOLE-3-THIOL | ESD-919722-1G |
| Cas.: 5503-73-1 | Purity: 98% | 2-amino-4,5-diphenyl-3-furonitrile | ESD-919723-250MG |
| Cas.: 5503-73-1 | Purity: 98% | 2-amino-4,5-diphenyl-3-furonitrile | ESD-919723-1G |
| Cas.: 28736-42-7 | Purity: 95% | 1,4-Difluoroanthraquinone | ESD-919724-250MG |
| Cas.: 28736-42-7 | Purity: 95% | 1,4-Difluoroanthraquinone | ESD-919724-1G |
| Cas.: 50907-21-6 | Purity: 97% | 5-(4-Fluorophenyl)-1H-tetrazole | ESD-919725-250MG |
| Cas.: 50907-21-6 | Purity: 97% | 5-(4-Fluorophenyl)-1H-tetrazole | ESD-919725-1G |
| Cas.: 36640-40-1 | Purity: 98% | 3-(4-Fluorophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde | ESD-919726-250MG |
| Cas.: 36640-40-1 | Purity: 98% | 3-(4-Fluorophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde | ESD-919726-1G |
| Cas.: 201207-66-1 | Purity: 95% | 1,3,5-trimethyl-1H-pyrazole-4-sulfonic acid | ESD-919727-250MG |
| Cas.: 201207-66-1 | Purity: 95% | 1,3,5-trimethyl-1H-pyrazole-4-sulfonic acid | ESD-919727-1G |
| Cas.: 14231-57-3 | Purity: 98% | (R)-()-N-Benzyl-2-phenylglycinol | ESD-919728-250MG |
| Cas.: 14231-57-3 | Purity: 98% | (R)-()-N-Benzyl-2-phenylglycinol | ESD-919728-1G |
| Cas.: 7622-22-2 | Purity: 95% | (R)-Benzyl 2-hydroxy-3-phenylpropanoate | ESD-919729-250MG |
| Cas.: 7622-22-2 | Purity: 95% | (R)-Benzyl 2-hydroxy-3-phenylpropanoate | ESD-919729-1G |
| Cas.: 34576-96-0 | Purity: 95% | 3-Chloro-6-methylbenzo[b]thiophene-2-carboxylic acid | ESD-919730-250MG |
| Cas.: 34576-96-0 | Purity: 95% | 3-Chloro-6-methylbenzo[b]thiophene-2-carboxylic acid | ESD-919730-1G |
| Cas.: 72776-05-7 | Purity: 97% | (S)-BENZYL 2-AZETIDINONE-4-CARBOXYLATE | ESD-919731-250MG |
| Cas.: 72776-05-7 | Purity: 97% | (S)-BENZYL 2-AZETIDINONE-4-CARBOXYLATE | ESD-919731-1G |
| Cas.: 50888-84-1 | Purity: 97% | (S)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate | ESD-919732-250MG |
| Cas.: 50888-84-1 | Purity: 97% | (S)-Benzyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate | ESD-919732-1G |
| Cas.: 24484-22-8 | Purity: 97% | 5-(4-Fluorophenyl)pentanoic acid | ESD-919733-250MG |
| Cas.: 24484-22-8 | Purity: 97% | 5-(4-Fluorophenyl)pentanoic acid | ESD-919733-1G |
| Cas.: 60795-38-2 | Purity: 97% | Benzyl 1H-pyrrole-1-carbodithioate | ESD-919734-250MG |
| Cas.: 60795-38-2 | Purity: 97% | Benzyl 1H-pyrrole-1-carbodithioate | ESD-919734-1G |
| Cas.: 37490-33-8 | Purity: 95% | 2-CYCLOHEXYLETHENYLBORONIC ACID | ESD-919735-250MG |
| Cas.: 37490-33-8 | Purity: 95% | 2-CYCLOHEXYLETHENYLBORONIC ACID | ESD-919735-1G |
| Cas.: 159896-15-8 | Purity: 96% | 4-(trans-2-Carboxyvinyl)phenylboronic acid | ESD-919736-250MG |
| Cas.: 159896-15-8 | Purity: 96% | 4-(trans-2-Carboxyvinyl)phenylboronic acid | ESD-919736-1G |
| Cas.: 99636-32-5 | Purity: 98% | (S)-(+)-1-METHOXY-2-PROPYLAMINE | ESD-919737-250MG |
| Cas.: 99636-32-5 | Purity: 98% | (S)-(+)-1-METHOXY-2-PROPYLAMINE | ESD-919737-1G |
| Cas.: 216394-04-6 | Purity: 97% | 4-(E-2-Nitrovinyl)phenylboronic acid | ESD-919738-250MG |
| Cas.: 216394-04-6 | Purity: 97% | 4-(E-2-Nitrovinyl)phenylboronic acid | ESD-919738-1G |
| Cas.: 219297-10-6 | Purity: ≥98% | Boc-(R)-3-amino-4-(2-naphthyl)-butyric Acid | ESD-919739-250MG |
| Cas.: 219297-10-6 | Purity: ≥98% | Boc-(R)-3-amino-4-(2-naphthyl)-butyric Acid | ESD-919739-1G |
| Cas.: 36926-83-7 | Purity: ≥95% | Ethyl 2-aminoquinoline-3-carboxylate | ESD-919740-250MG |
| Cas.: 36926-83-7 | Purity: ≥95% | Ethyl 2-aminoquinoline-3-carboxylate | ESD-919740-1G |
| Cas.: 31952-16-6 | Purity: ≥95% | 2,2-Dibenzyl-1,3-propanediol | ESD-919741-250MG |
| Cas.: 31952-16-6 | Purity: ≥95% | 2,2-Dibenzyl-1,3-propanediol | ESD-919741-1G |
| Cas.: 69806-40-2 | Purity: 97% | Methyl 2-(4-((3-chloro-5-(trifluoromethyl)-2-pyridinyl)oxy)phenoxy)propanoate | ESD-919742-250MG |
| Cas.: 69806-40-2 | Purity: 97% | Methyl 2-(4-((3-chloro-5-(trifluoromethyl)-2-pyridinyl)oxy)phenoxy)propanoate | ESD-919742-1G |
| Cas.: 1461-96-7 | Purity: 97% | cis-Cyclopentane-1,2-dicarboxylic acid | ESD-919743-250MG |
| Cas.: 1461-96-7 | Purity: 97% | cis-Cyclopentane-1,2-dicarboxylic acid | ESD-919743-1G |
| Cas.: 34418-48-9 | Purity: 96% | 4-Methyl-2-(2-pyridinyl)-1,3-thiazole-5-carboxylic acid | ESD-919744-250MG |
| Cas.: 34418-48-9 | Purity: 96% | 4-Methyl-2-(2-pyridinyl)-1,3-thiazole-5-carboxylic acid | ESD-919744-1G |
| Cas.: 216393-63-4 | Purity: 98% | 5-Isopropyl-2-methoxyphenylboronic acid | ESD-919745-250MG |
| Cas.: 216393-63-4 | Purity: 98% | 5-Isopropyl-2-methoxyphenylboronic acid | ESD-919745-1G |
| Cas.: 312496-16-5 | Purity: 97% | 2-Pyridin-3-yl-3H-benzoimidazole-5-carboxylic acid | ESD-919746-250MG |
| Cas.: 312496-16-5 | Purity: 97% | 2-Pyridin-3-yl-3H-benzoimidazole-5-carboxylic acid | ESD-919746-1G |
| Cas.: 5654-92-2 | Purity: 98% | N,N-Dimethyl-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)methanamine | ESD-919747-250MG |
| Cas.: 5654-92-2 | Purity: 98% | N,N-Dimethyl-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)methanamine | ESD-919747-1G |
| Cas.: 105751-19-7 | Purity: ≥98% | N-Fmoc-piperidine-2-carboxylic acid | ESD-919748-250MG |
| Cas.: 105751-19-7 | Purity: ≥98% | N-Fmoc-piperidine-2-carboxylic acid | ESD-919748-1G |
| Cas.: 73476-30-9 | Purity: ≥95% | 1,5-Dimethyl-1H-pyrrole-2-carboxylic acid | ESD-919749-250MG |
| Cas.: 73476-30-9 | Purity: ≥95% | 1,5-Dimethyl-1H-pyrrole-2-carboxylic acid | ESD-919749-1G |
| Cas.: 4282-24-0 | Purity: 95% | Furan-2,3-dicarboxylic acid | ESD-919750-250MG |
| Cas.: 4282-24-0 | Purity: 95% | Furan-2,3-dicarboxylic acid | ESD-919750-1G |
| Cas.: 153645-26-2 | Purity: ≥95% | (S)-N-BOC-TERT-LEUCINOL | ESD-919751-250MG |
| Cas.: 153645-26-2 | Purity: ≥95% | (S)-N-BOC-TERT-LEUCINOL | ESD-919751-1G |
| Cas.: 17996-13-3 | Purity: 98% (HPLC) | 4-(Z-AMINO)-1-BUTANOL | ESD-919752-250MG |
| Cas.: 17996-13-3 | Purity: 98% (HPLC) | 4-(Z-AMINO)-1-BUTANOL | ESD-919752-1G |
| Cas.: 82066-37-3 | Purity: ≥98% | Bis(tetramethylcyclopentadienyl)chromium | ESD-919753-250MG |
| Cas.: 82066-37-3 | Purity: ≥98% | Bis(tetramethylcyclopentadienyl)chromium | ESD-919753-1G |
| Cas.: 101932-75-6 | Purity: ≥98% | BIS(TETRAMETHYLCYCLOPENTADIENYL)MANGANESE | ESD-919754-250MG |
| Cas.: 101932-75-6 | Purity: ≥98% | BIS(TETRAMETHYLCYCLOPENTADIENYL)MANGANESE | ESD-919754-1G |
| Cas.: 52988-34-8 | Purity: 96% | 4′-Methoxybiphenyl-4-carbaldehyde | ESD-919755-250MG |
| Cas.: 52988-34-8 | Purity: 96% | 4′-Methoxybiphenyl-4-carbaldehyde | ESD-919755-1G |
| Cas.: 323196-43-6 | Purity: 95% | (R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride | ESD-919756-250MG |
| Cas.: 323196-43-6 | Purity: 95% | (R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride | ESD-919756-1G |
| Cas.: 866926-59-2 | Purity: 98% | 1-(2,6-Diisopropylphenyl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-919757-250MG |
| Cas.: 866926-59-2 | Purity: 98% | 1-(2,6-Diisopropylphenyl)-3-mesityl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-919757-1G |
| Cas.: 339268-21-2 | Purity: Ru 23.0% min | POTASSIUM HEXACYANORUTHENATE(II) HYDRATE | ESD-919758-200MG |
| Cas.: 339268-21-2 | Purity: Ru 23.0% min | POTASSIUM HEXACYANORUTHENATE(II) HYDRATE | ESD-919758-1G |
| Cas.: 37289-07-9 | Purity: ≥100 units/mg protein | Choloylglycine Hydrolase, from Clostridium perfringens (C. welchii) | ESD-919759-1500U |
| Cas.: 158113-12-3 | Purity: -200 Mesh | Copper-tin alloy | ESD-919760-1000G |
| Cas.: 55466-22-3 | Purity: ≥4000 units/mg protein (biuret) | Mutanolysin | ESD-919761-1000U |
| Cas.: 9023-83-0 | Purity: Type I, partially purified powder, ≥40 units/mg protein (biuret) | Phosphoriboisomerase from spinach | ESD-919762-1000U |
| Cas.: 627533-08-8 | Purity: 96% | 2-(TrifluoroMethyl)piperidine hydrochloride | ESD-919764-500MG |
| Cas.: 111773-24-1 | Purity: ≥95.0% | Ethyl 3-bromo-2,2-difluoropropionate | ESD-919765-500MG |
| Cas.: 47743-70-4 | Purity: 99% | TRIS(4-(DIETHYLAMINO)PHENYL)AMINE | ESD-919766-500MG |
| Cas.: 141410-06-2 | Purity: 97.0% (HPLC) | 1H-Indole-2-carboxylicacid,2,3-dihydro-,methylester,(2S)-(9CI) | ESD-919767-500MG |
| Cas.: 171856-09-0 | Purity: ≥98.0% (HPLC) | FMOC-N-(4-BOC-AMINOBUTYL)-GLYCINE | ESD-919768-500MG |
| Cas.: 10294-38-9 | Purity: 98% | CHLORANILIC ACID BARIUM SALT TRIHYDRATE | ESD-919769-500G |
| Cas.: 76896-80-5 | Purity: 98% | TRIACSIN C | ESD-919770-500ΜG |
| Cas.: 347186-49-6 | Purity: 97% (HPLC) | 2-(4-Boc-Piperazinyl)-2-phenylacetic acid | ESD-919771-500MG |
| Cas.: 20263-07-4 | Purity: 95% | (±)-2-Amino-4-phosphonobutyric acid | ESD-919772-500MG |
| Cas.: 213343-64-7 | Purity: 97% | (+)-1,2-Bis[(2S,5S)-2,5-diethylphospholano]benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-919773-500MG |
| Cas.: 13138-78-8 | Purity: ≥97.5%; 97.5-102.5% (titration); 98% | 1-METHYL-4-NITRO-1H-PYRROLE-2-CARBOXYLIC ACID | ESD-919774-500MG |
| Cas.: 900503-36-8 | Purity: 96% | (R)-2-(tert-Butyl)-3-Methyl-4-iMidazolidinone trifluoroacetic acid | ESD-919775-500MG |
| Cas.: 53597-70-9 | Purity: 97% | 1,3,5-Triaza-7-phosphatricyclo[3.3.1.13,7]decane, 7-oxide | ESD-919776-500MG |
| Cas.: 253157-79-8 | DICHLORO[2,2′-BIS(DIPHENYLPHOSPHINO)-1,1′-BINAPHTHYL]PALLADIUM(II) | ESD-919777-500MG | |
| Cas.: 55942-41-1 | Purity: 97% | Ethyl 4-(trifluoromethyl)-1H-imidazole-5-carboxylate | ESD-919778-500MG |
| Cas.: 123334-21-4 | Purity: 99% | LITHIUM TETRACHLOROPALLADATE(II) HYDRATE | ESD-919779-500MG |
| Cas.: 186020-53-1 | Purity: average Mn2, 000 | O,O’-Bis[2-(N-Succinimidyl-succinylamino)ethyl]polyethylene glycol | ESD-919780-500MG |
| Cas.: 25119-62-4 | Purity: average Mw~2, 200, average Mn~1, 200, allyl alcohol 40mol % | Styrene allyl alcohol copolymer | ESD-919781-500G |
| Cas.: 52893-99-9 | Purity: 97% | Tris(N-methylpiperazino)phosphine | ESD-919782-500MG |
| Cas.: 42617-82-3 | Purity: mol wt 15,000-20,000 Da | Polyethyleneglycol Bisphenol A Epichlorohydrin Copolymer | ESD-919783-500G |
| Cas.: 1821791-75-6 | Purity: ≥95% | (R)-2-Boc-aminoethyl-piperidine | ESD-919784-500MG |
| Cas.: 1272031-55-6 | Purity: ≥95% | (R)-2-Methyl-2-phenylpiperidine | ESD-919785-500MG |
| Cas.: 1058705-40-0 | Vinyl N,N-Diisopropylcarbamate | ESD-919786-500MG | |
| Cas.: 19135-17-2 | Purity: ≥98% (TLC) | 4-Nitrophenyl 4-guanidinobenzoate hydrochloride protease inhibitor and substrate | ESD-919787-500MG |
| Cas.: 957486-82-7 | Purity: 98% | :O-(2-AMinoethyl)-O’-(2-azidoethyl)pentaethylene Glycol | ESD-919788-500MG |
| Cas.: 26250-90-8 | Purity: 96% (HPLC) | rac 3-Bocamino-2-benzyl-propionic acid | ESD-919789-500MG |
| Cas.: 46041-69-4 | Purity: 95% | 2-(2S)-2-Piperidinyl-pyridine | ESD-919790-500MG |
| Cas.: 1037597-73-1 | Purity: 97% | 2,4-Diiodooxazole | ESD-919791-500MG |
| Cas.: 1044553-58-3 | Purity: 97% | 2,3-Bis[(2R,5R)-2,5-diMethylphospholano]-N-(3,5-diMethylphenyl)MaleiMide | ESD-919792-500MG |
| Cas.: 1373945-21-1 | Purity: 96% | 1-(2-(Diphenylphosphino)phenyl)-N,N,N-trimethylmethanaminium trifluoromethanesulfonate | ESD-919793-500MG |
| Cas.: 81250-34-2 | Purity: 97% | 5,6-Diamino-1,3-dipropylpyrimidine-2,4-(1H,3H)-dione | ESD-919794-500MG |
| Cas.: 9014-08-8 | Purity: ≥50 units/mg protein | Enolase, from baker’s yeast (S. cerevisiae) | ESD-919795-500U |
| Cas.: 9026-51-1 | Purity: ≥1,000 units/mg protein (biuret) | Nucleoside 5′-Diphosphate Kinase, from bovine liver | ESD-919796-500U |
| Cas.: 9024-98-0 | Purity: ≥100 units/mg solid | OXALACETATE DECARBOXYLASE | ESD-919797-500U |
| Cas.: 9030-23-3 | Purity: recombinant, expressed in E. coli, buffered aqueous solution, ≥500 units/mL | Thymidine Phosphorylase, recombinant, from Escherichia coli | ESD-919799-500U |
| Cas.: 13989-98-5 | Purity: >99% (TLC) | 3-Hydroxy-2-naphthanilide phosphate | ESD-919800-500MG |
| Cas.: 31676-49-0 | 7-Iodo-1,3-dihydro-2H-indol-2-one | ESD-919801-500MG | |
| Cas.: 73096-27-2 | (2S)-1-[(4-Chlorophenyl)sulfonyl]-2-pyrrolidinecarboxylic acid | ESD-919802-500MG | |
| Cas.: 1327-36-2 | Purity: >30 % absorption capacity (water)(at 80% rel. humidity, 25°C) | Drying pearls Orange | ESD-919803-500G |
| Cas.: 63249-99-0 | Purity: 97% | 3,7-Diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane | ESD-919804-500MG |
| Cas.: 203-64-5 | Purity: 97% | Cyclopenta[d,e,f]phenanthrene | ESD-919805-500MG |
| Cas.: 615257-74-4 | (R,R,S)-DiazaPhos-PPE | ESD-919806-500MG | |
| Cas.: 29132-58-9 | Purity: average Mw 3, 000, 50 wt. % in H2O | Poly(acrylic acid-co-Maleic acid) solution | ESD-919808-250ML |
| Cas.: 91345-62-9 | Purity: 97% | 1-(4-BroMobenzyl)piperazine | ESD-919809-250MG |
| Cas.: 7727-33-5 | Purity: 95% | 1,1,2,2-Tetrakis(p-hydroxyphenyl)ethane | ESD-919810-250MG |
| Cas.: 101664-59-9 | Purity: 97% | 2-Chloro-3,4-dimethoxypyridine | ESD-919811-250MG |
| Cas.: 17300-02-6 | Purity: 97% | 1,2-Phenylenedimethanamine | ESD-919812-250MG |
| Cas.: 919101-04-5 | Purity: solid | 6-Phenyl-2-(3-phenyl-2-aziridinyl)-3-oxa-1-azabicyclo[3.1.0]hexan-4-ol | ESD-919813-250MG |
| Cas.: 31309-08-7 | Purity: 97% | 2-chloro-5-nitronicotinonitrile | ESD-919814-250MG |
| Cas.: 67276-04-4 | Purity: 1.0M in THF | N-Selectride | ESD-919815-250ML |
| Cas.: 32992-96-4 | Bis(ethylcyclopentadienyl)ruthenium(II) | ESD-919816-250MG | |
| Cas.: 30216-44-5 | Purity: 97% | 2-Bromothiobenzamide | ESD-919817-250MG |
| Cas.: 1648-99-3 | Purity: 99% | 2,2,2-Trifluoroethanesulphonylchloride | ESD-919818-250MG |
| Cas.: 20782-91-6 | Purity: 97% | 2-(Bromomethyl)-5-nitrofuran | ESD-919819-250MG |
| Cas.: 263369-88-6 | Purity: 98% | Chlorobis(2-methoxyphenyl)phosphine | ESD-919820-250MG |
| Cas.: 180918-40-5 | Purity: 97% | 1-(Trifluoromethyl)cyclohexane-1-carboxylic acid, | ESD-919821-250MG |
| Cas.: 20654-56-2 | Purity: 99.99% (metals basis) | Silver(I) perrhenate | ESD-919822-250MG |
| Cas.: 403-39-4 | 1-Fluoro-4-isopropylbenzene | ESD-919824-250MG | |
| Cas.: 149505-72-6 | Purity: 95% | 3′-Amino-[1,1′-biphenyl]-4-carbonitrile | ESD-919825-250MG |
| Cas.: 13695-46-0 | Purity: 95% | DISPERSE RED 1 ACRYLATE | ESD-919826-250MG |
| Cas.: 958638-02-3 | Purity: 99.9% trace metals basis | Nickel carbonate, basic hydrate | ESD-919827-250G |
| Cas.: 203861-62-5 | Purity: 97% | 4-Iodo-2-methoxyphenol | ESD-919828-250MG |
| Cas.: 401629-04-7 | Purity: 97% | 3-Cyclopropyl-1H-pyrazole-5-carboxylic acid | ESD-919829-250MG |
| Cas.: 1063734-02-0 | 3-[(CyclopropylMethoxy)Methyl]pyrrolidine | ESD-919830-250MG | |
| Cas.: 125117-96-6 | Purity: 99% | 2-Chloro-5-isocyanatopyridine | ESD-919831-250MG |
| Cas.: 94581-95-0 | Purity: 97% | 5-Bromo-α-terthienyl | ESD-919832-250MG |
| Cas.: 850501-35-8 | Purity: 95% | 6-Methoxy-2-(tributylstannyl)pyrimidine | ESD-919833-250MG |
| Cas.: 68285-23-4 | Purity: ≥95% | (R)-1-(2-Methoxyphenyl)ethanamine | ESD-919834-250MG |
| Cas.: 64715-85-1 | Purity: 95% | (R)-(-)-1-AMINO-1-PHENYL-2-METHOXYETHANE | ESD-919835-250MG |
| Cas.: 68295-45-4 | Purity: 98% | (R)-(-)-2-(Anilinomethyl)pyrrolidine | ESD-919836-250MG |
| Cas.: 527-54-8 | Purity: 97% | 3,4,5-Trimethylphenol | ESD-919837-250MG |
| Cas.: 211943-12-3 | Purity: ≥98% | 5-(5-Bromothiophen-2-yl)-1H-tetrazole | ESD-919838-250MG |
| Cas.: 80077-72-1 | Purity: ≥95% | Diethyl (difluoro(trimethylsilyl)methyl)phosphonate | ESD-919839-250MG |
| Cas.: 109074-67-1 | Purity: 97% | 2-Trifluoromethylpyrrolidine | ESD-919840-250MG |
| Cas.: 3197-42-0 | Purity: 97% | (S)-(+)-2-Methylpiperidine | ESD-919841-250MG |
| Cas.: 51776-71-7 | Purity: 95% | 1-Bromo-4-(difluoromethyl)benzene | ESD-919842-250MG |
| Cas.: 18459-51-3 | Purity: ≥95% | DI-N-BUTYLACETALDEHYDE | ESD-919843-250MG |
| Cas.: 6077-72-1 | Purity: 98%, cis-trans mixture | 2-Methylcyclopropanemethanol | ESD-919844-250MG |
| Cas.: 68002-20-0 | Purity: average Mn~432, 84wt.% in 1-butanol | 2,4,6-TRIS[BIS(METHOXYMETHYL)AMINO]-1,3,5-TRIAZINE | ESD-919845-250ML |
| Cas.: 362631-84-3 | Purity: 97% | 2-(Trifluoromethoxy)ethanol | ESD-919846-250MG |
| Cas.: 87188-50-9 | Purity: 97% | tert-Butyl (4-formylphenyl) carbonate | ESD-919847-250MG |
| Cas.: 81945-13-3 | Purity: ≥95% | 4-Bromo-7-hydroxy-2,3-dihydro-1H-inden-1-one | ESD-919848-250MG |
| Cas.: 3515-93-3 | Purity: ≥97% | 3-cyanopropanal | ESD-919849-250MG |
| Cas.: 16404-94-7 | Purity: 95% | (S)-4-Oxoazetidine-2-carboxylic acid | ESD-919850-250MG |
| Cas.: 40180-04-9 | Purity: 97% | Tienilic Acid | ESD-919851-250MG |
| Cas.: 37107-81-6 | Purity: 97% | 5-Vinyluracil | ESD-919852-250MG |
| Cas.: 53177-12-1 | Purity: 98% | [N,N 0-Disalicylidene-1,2-ethanediaminato-(2-)]manganese(III) Chloride | ESD-919853-250MG |
| Cas.: 2713-21-5 | Purity: 98% | 2,4,6-Tri-p-tolylpyrylium tetrafluoroborate | ESD-919854-250MG |
| Cas.: 59101-28-9 | Purity: 95% | 16-Bromohexadecan-1-ol | ESD-919855-250MG |
| Cas.: 76510-64-0 | Purity: 97% | 5-Iodo-6-methyl-2-(methylthio)-1H-pyrimidin-4-one | ESD-919856-250MG |
| Cas.: 89487-91-2 | Purity: 98% | 2-Iodo-4-nitrophenol | ESD-919857-250MG |
| Cas.: 1527-17-9 | Purity: 96% | 2-[2-(Phenylthio)phenyl]acetic acid | ESD-919858-250MG |
| Cas.: 83902-00-5 | Purity: 97% | 2-Ethyl-4-formylimidazole | ESD-919859-250MG |
| Cas.: 20016-85-7 | Purity: 95% | (R)-2-Hydroxybutanoic acid | ESD-919860-250MG |
| Cas.: 149968-36-5 | Purity: 97% | 1,3-Bis(di-tert-butylphosphinomethyl)benzene | ESD-919861-250MG |
| Cas.: 5369-03-9 | Purity: ≥98% | QX-314 (chloride) | ESD-919862-250MG |
| Cas.: 269398-91-6 | Purity: 98% | (R)-3-(Fmoc-amino)-4-(2-naphthyl)butyric acid | ESD-919863-250MG |
| Cas.: 270065-80-0 | Purity: ≥98% | BOC-(S)-3-AMINO-4-(4-TRIFLUOROMETHYL-PHENYL)-BUTYRIC ACID | ESD-919864-250MG |
| Cas.: 40829-04-7 | Purity: ≥95% | D-Tyrosinol hydrochloride | ESD-919865-250MG |
| Cas.: 226387-12-8 | Purity: 97% | (S)-4-(tert-Butyl)-2-(quinolin-2-yl)-4,5-dihydrooxazole | ESD-919866-250MG |
| Cas.: 2132978-44-8 | Purity: 97% | EPhos Pd G4 | ESD-919867-250MG |
| Cas.: 83-05-6 | Purity: 98% | Bis(4-chlorophenyl)acetic acid | ESD-919868-250MG |
| Cas.: 53957-33-8 | Purity: 97% | 2,5-Dimethylbenzyl alcohol | ESD-919869-250MG |
| Cas.: 2460-59-5 | Purity: 98% | 3,5-Dinitrosalicylaldehyde | ESD-919870-250MG |
| Cas.: 12184-22-4 | Purity: 95% | Bis(cyclopentadienyl)molybdenum(IV) dichloride | ESD-919871-250MG |
| Cas.: 12082-08-5 | Purity: 98% | Benzene-chromium(0) tricarbonyl | ESD-919872-250MG |
| Cas.: 14319-13-2 | Purity: 98% | Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)lanthanum(III) | ESD-919873-250MG |
| Cas.: 7790-39-8 | Purity: 99.99% (metals basis) | Platinum(II) iodide | ESD-919874-250MG |
| Cas.: 3731-59-7 | Purity: 99% | Moroxydine hydrochloride | ESD-919875-250MG |
| Cas.: 728-80-3 | Purity: 97% | 3-(Trifluoromethyl)benzhydrol | ESD-919876-250MG |
| Cas.: 693-06-1 | Purity: 97% | N-(2-Hydroxyethyl)formamide | ESD-919877-250MG |
| Cas.: 32741-89-2 | Purity: 98% | 5-tert-butylazepan-2-one | ESD-919878-250MG |
| Cas.: 84468-52-0 | Purity: 95% | 2,3-Dimethylpiperazine, cis + trans | ESD-919879-250MG |
| Cas.: 352439-36-2 | Purity: ≥95% (oligomer purity) | alpha-Azido-omega-hydroxy octa(ethylene glycol) | ESD-919880-250MG |
| Cas.: 15580-66-2 | Purity: 97% | 4-AMINO-1-METHYL-4-PIPERIDINECARBOXYLIC ACID | ESD-919881-250MG |
| Cas.: 1217840-61-3 | Purity: 95% | FMOC-N-ME-HIS(TRT)-OH | ESD-919882-250MG |
| Cas.: 92451-00-8 | O-[(N-Succinimidyl)succinyl-aminoethyl]-O’-methylpolyethylene glycol | ESD-919883-250MG | |
| Cas.: 159666-35-0 | 2-Propenoic acid, 2-methyl-, polymer with 1,1-dimethylethyl 2-propenoate and ethyl 2-propenoate | ESD-919884-250G | |
| Cas.: 1052707-24-0 | Purity: 95% | (1S, 2S)-1,2-Bis(2-chlorophenyl)-1,2-ethanediamine dihydrochloride | ESD-919885-250MG |
| Cas.: 1012042-02-2 | Purity: 97% | (S)-BnCH2-PyBox, (S,S)-2,6-Bis(4-benzylmethyl-2-oxazolin-2-yl)pyridine | ESD-919886-250MG |
| Cas.: 847616-84-6 | Chloro(triphenylphosphine) [2-(2′-amino-1,1′-biphenyl)]palladium(II) | ESD-919887-250MG | |
| Cas.: 217661-36-4 | Chlorohydridotris(triphenylphosphine) rutheniuM(II) toluene adduct | ESD-919888-250MG | |
| Cas.: 1384966-55-5 | Purity: 97% | Di(1-adamantyl)-(2-triisopropylsiloxyphenyl)phosphine | ESD-919889-250MG |
| Cas.: 108695-90-5 | Purity: 97% | OXOTRICHLORO(DIMETHYLSULFIDE)TRIPHENYLPHOSPHINE OXIDE)RHENIUM(V) | ESD-919892-250MG |
| Cas.: 60260-17-5 | OXOTRICHLORO(BIS(DIPHENYLPHOSPHINO)METHANE)RHENIUM(V) | ESD-919893-250MG | |
| Cas.: 34398-57-7 | POLY (BENZIMIDAZOBENZOPHENANTHROLINE) | ESD-919894-250MG | |
| Cas.: 71750-71-5 | Purity: average Mn~460, crystalline | POLYETHYLENE MONOALCOHOL | ESD-919895-250G |
| Cas.: 1454681-04-9 | Purity: 95% | 2,3,4,5,6-Pentafluoroanilino(oxo)acetic acid | ESD-919896-250MG |
| Cas.: 1220-80-0 | Purity: ≥95% (GC) | (S)-4-Methyl-2-(4-methylphenylsulfonamido)pentanoic acid | ESD-919897-250MG |
| Cas.: 60934-46-5 | Purity: ≥97% (HPLC) | (+/-)-ALPHA-TOCOPHEROL PHOSPHATE DISODIUM SALT | ESD-919898-250MG |
| Cas.: 69068-97-9 | Cholesterol-PEG 600MFCD00151772 | ESD-919899-250MG | |
| Cas.: 93965-35-6 | 3,3-DIETHOXY-1,2-PROPANEDIOL 1-PHOSPHATE BARIUM SALT | ESD-919900-250MG | |
| Cas.: 40492-96-4 | L-Lysine p-nitroanilide dihydrobromide | ESD-919902-250MG | |
| Cas.: 1848244-57-4 | Purity: 95% | VPhos Pd G4 | ESD-919903-250MG |
| Cas.: 9027-42-3 | Purity: 150 units/mg protein (biuret), lyophilized powder | Acetate Kinase from Escherichia coli lyophilized powder | ESD-919904-250U |
| Cas.: 136705-62-9 | Purity: ≥97% | (+)-1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane | ESD-919905-250MG |
| Cas.: 127986-84-9 | Purity: 97% | (S)-(-)-α,α-Di(2-naphthyl)-2-pyrrolidinemethanol | ESD-919906-250MG |
| Cas.: 1645-93-8 | Form: liquid | 1-BroMo-2-trifluoroMethoxy-ethane | ESD-919907-250MG |
| Cas.: 1294455-24-5 | Purity: 95% | trifluoro(2,5-diMethyl-thiophen-3-yl)-Borate potassiuM salt | ESD-919908-250MG |
| Cas.: 178397-71-2 | Purity: 97% | Bis(norbornadiene)rhodium(I) trifluoromethanesulfonate | ESD-919909-250MG |
| Cas.: 159239-33-5 | Purity: 95% | 12-Mercaptododecylphosphonic acid | ESD-919910-250MG |
| Cas.: 20226-99-7 | Purity: ≥98.0% (NT) | (+)-Potassium Ds-threo-isocitrate monobasic | ESD-919911-250MG |
| Cas.: 113825-16-4 | Purity: 95% | 4-Methyl-1H-imidazole-2-carbaldehyde | ESD-919912-250MG |
| Cas.: 76774-25-9 | Purity: solid | Poly(acrylic acid) partial sodium salt | ESD-919913-250G |
| Cas.: 25736-61-2 | Form: liquid | Poly(styrene-alt-Maleic acid) sodiuM salt solution | ESD-919914-250ML |
| Cas.: 60624-60-4 | Purity: solid | Trioxo(triphenylsilyloxy)rhenium(VII) | ESD-919915-250MG |
| Cas.: 477873-22-6 | Purity: 98.5-101.5% (AT) | (1S,2S)-trans-1,2-CyclopentanediaMine dihydrochloride | ESD-919916-250MG |
| Cas.: 137846-38-9 | Purity: solid | Bis(diphenylphosphino)propane]palladium(II) triflate | ESD-919918-250MG |
| Cas.: 207569-02-6 | Purity: 95% | 1,5-Naphthalenedisulfonic acid disodiuM salt hydrate | ESD-919919-250G |
| Cas.: 84278-00-2 | Purity: white powder | 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-D-galactopyranose | ESD-919920-250MG |
| Cas.: 13673-92-2 | Purity: 97% | 3,5-Dichlorocatechol | ESD-919921-250MG |
| Cas.: 141524-74-5 | Purity: 95% | 4-BroMo-1-Methyl-1H-iMidazole-5-carboxaldehyde | ESD-919922-250MG |
| Cas.: 446043-85-2 | Purity: solid | 5,5′-Bis((5-perfluorohexyl)thiophen-2-yl)-2,2′-bithiophene | ESD-919923-250MG |
| Cas.: 1246088-50-5 | Purity: solid | 5-Bromo-2-ethyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-919924-250MG |
| Cas.: 601-54-7 | Purity: ≥95% | 3-Keto Cholesterol | ESD-919925-250MG |
| Cas.: 90178-71-5 | Purity: 96% | 4-(4-Formylphenoxy)benzonitrile | ESD-919926-250MG |
| Cas.: 886362-07-8 | Purity: 96% | 3-Amino-4-methoxy-1H-indazole | ESD-919927-250MG |
| Cas.: 221187-50-4 | Purity: 97% | 2′-(Dicyclohexylphosphino)acetophenone ethylene ketal | ESD-919928-250MG |
| Cas.: 915402-03-8 | Purity: 97% | 3-[2-(Trimethylsilyl)ethynyl]benzeneboronic acid pinacol ester | ESD-919929-250MG |
| Cas.: 332343-84-7 | Purity: 96% | 1,2-Bis(2-methoxyphenyl)-1,1,2,2-tetramethyldisilane | ESD-919930-250MG |
| Cas.: 63136-61-8 | 4-chloro-7-methylquinoline | ESD-919931-250MG | |
| Cas.: 1065010-88-9 | Purity: 97% | Potassium cyclobutyltrifluoroborate | ESD-919932-250MG |
| Cas.: 69611-02-5 | Purity: 95% | (E)-2-(But-2-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-919933-250MG |
| Cas.: 959996-58-8 | Purity: 97% | 6-(Trifluoromethyl)pyridine-3-sulfonyl chloride | ESD-919934-250MG |
| Cas.: 134575-17-0 | Purity: 97% | Tert-Butyl (Meso-1R,5S,6S)-3-Azabicyclo[3.1.0]Hexan-6-Ylcarbamate | ESD-919935-250MG |
| Cas.: 849681-64-7 | Purity: 95% | 4,4,5,5-tetramethyl-2-(4-{2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethynyl}phenyl)-1,3,2-dioxaborolane | ESD-919936-250MG |
| Cas.: 154312-86-4 | 4-(Chloromethyl)-1-methyl-1H-pyrazole hydrochloride | ESD-919937-250MG | |
| Cas.: 67108-80-9 | Purity: 98% | Dimethylbis(pentamethylcyclopentadienyl)zirconium(IV) | ESD-919938-250MG |
| Cas.: 211943-13-4 | Purity: 97% | 3-Bromo-5-(1H-tetrazol-5-yl)pyridine | ESD-919939-250MG |
| Cas.: 4220-66-0 | Purity: 97% | Methyl 4,4-dimethoxybutanoate | ESD-919940-250MG |
| Cas.: 161832-74-2 | Purity: 99% (HPLC), 98% | (R)-(+)-2-Amino-4-methyl-1,1-diphenyl-1-pentanol | ESD-919941-250MG |
| Cas.: 351003-64-0 | Purity: 97% | 4-Bromo-3-(trifluoromethyl)benzenesulphonamide | ESD-919942-250MG |
| Cas.: 175172-61-9 | MW 13,000 | Polyethylene glycol monomethyl ether methanesulfonate | ESD-919943-250MG |
| Cas.: 19232-05-4 | Purity: 97% | Dichlorobis(trimethylphosphine)nickel(II) | ESD-919944-250MG |
| Cas.: 138485-81-1 | Purity: 97% | 3-(4-(Methylthio)phenyl)propanoic Acid | ESD-919945-250MG |
| Cas.: 101327-84-8 | Purity: 97% | 1-Nitro-2-naphthaldehyde | ESD-919946-250MG |
| Cas.: 26725-50-8 | Purity: 97% | 1H-Benzotriazole-4-sulfonic acid | ESD-919947-250MG |
| Cas.: 480424-71-3 | Purity: 95% | tert-Butyl (2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl) carbonate | ESD-919948-250MG |
| Cas.: 40401-39-6 | Purity: 95% | 1-(4-chlorophenyl)-3-methyl-1H-pyrazol-5-ylamine | ESD-919949-250MG |
| Cas.: 18698-73-2 | 3-(Methylthio)phenylacetic acid | ESD-919950-250MG | |
| Cas.: 1083-11-0 | Purity: 95% | 4-(2,5-dimethoxyphenyl)butanoic acid | ESD-919951-250MG |
| Cas.: 375853-79-5 | tert-Butyl (5-Iodopyridin-2-yl)carbamate | ESD-919952-250MG | |
| Cas.: 442850-89-7 | Purity: 95% | Vinylboronic anhydride pyridine complex | ESD-919953-250MG |
| Cas.: 50690-09-0 | Purity: 95% | 2-Chloro-1-(4-ethylphenyl)ethanone | ESD-919954-250MG |
| Cas.: 57266-56-5 | Purity: 95% | cis-6-Amino-3-cyclohexene-1-carboxylic acid hydrochloride | ESD-919955-250MG |
| Cas.: 64559-06-4 | Purity: 97% | 3-Methoxybenzenecarbothioamide | ESD-919956-250MG |
| Cas.: 10553-11-4 | Purity: 97% | 4-Nitro-1H-indole-3-carbaldehyde | ESD-919957-250MG |
| Cas.: 1038398-68-3 | Purity: 95% | 5-(4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carboxylic acid | ESD-919958-250MG |
| Cas.: 58484-76-7 | Purity: 95% | N-Hydroxy-2-(4-hydroxyphenyl)acetimidamide | ESD-919959-250MG |
| Cas.: 32025-65-3 | Purity: 97% | (3-Methoxyphenyl)glyoxal | ESD-919960-250MG |
| Cas.: 352535-84-3 | Purity: 98% | 3-Bromo-2,6-difluorobenzeneboronic acid | ESD-919961-250MG |
| Cas.: 42365-68-4 | Purity: 97% | 5-(Aminomethyl)-2-methoxyphenol hydrochloride | ESD-919963-250MG |
| Cas.: 672937-61-0 | Purity: 95% | N-Phenylpyrrol-2-yldi-tert-butylphosphine | ESD-919964-250MG |
| Cas.: 890652-03-6 | Purity: 95% | 1-(4-Fluorophenyl)-1H-pyrazole-4-carbaldehyde | ESD-919965-250MG |
| Cas.: 90381-44-5 | Purity: 97% | 4,7-Dimethoxy-1-naphthaldehyde | ESD-919966-250MG |
| Cas.: 583844-38-6 | Purity: 97% | 1,5-Cyclooctadiene{[dibenzyl((4S,5S)-5-methyl-2-phenyl-4,5-dihydro-4-oxazolyl)methyl]dicyclohexylphosphinite κN:κP}iridium(I) tetrakis(3,5- bis(trifluoromethyl)phenyl)borate | ESD-919967-250MG |
| Cas.: 852918-02-6 | Purity: 97% | 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide | ESD-919968-250MG |
| Cas.: 362661-83-4 | Purity: 97% | Pyrazolo[1,5-a]pyridine-7-carbaldehyde | ESD-919969-250MG |
| Cas.: 260430-93-1 | Purity: 96% | 6-fluoroquinoline-2-carbaldehyde | ESD-919970-250MG |
| Cas.: 601514-62-9 | Purity: 95% | 6-Benzyl-5,6,7,8-tetrahydro-2,6-naphthyridin-1(2H)-one | ESD-919971-250MG |
| Cas.: 5504-65-4 | 3-Phenyl-1H-pyrazole-4-carboxylic acid | ESD-919973-250MG | |
| Cas.: 124845-04-1 | Purity: 97% | 5-Cyclopropylisoxazole-4-carboxylic acid | ESD-919974-250MG |
| Cas.: 834884-84-3 | Purity: 97% | 6-[4-(Methylsulfonyl)phenyl]-2-pyridinecarboxaldehyde | ESD-919975-250MG |
| Cas.: 307496-23-7 | Purity: 98% | 2-Pyridin-3-ylethanamine dihydrobromide | ESD-919976-250MG |
| Cas.: 853331-52-9 | Purity: 97% | 2-Chloro-3-methoxybenzonitrile | ESD-919977-250MG |
| Cas.: 75867-40-2 | Purity: 97% | 4-[(Trimethylsilyl)ethynyl]benzonitrile | ESD-919978-250MG |
| Cas.: 9030-19-7 | Purity: ≥9 units/mg solid | Maltose Phosphorylase, from Enterococcus sp. | ESD-919979-250U |
| Cas.: 54576-84-0 | Purity: ≥200 units/mg protein (E1%/280, 3′-5′-Phosphodiesterase) | Nuclease P1, from Penicillium citrinum | ESD-919980-250U |
| Cas.: 9025-32-5 | Purity: ≥100 units/mg protein | Prolidase, from porcine kidney | ESD-919981-250U |
| Cas.: 9074-06-0 | Purity: recombinant, expressed in E. coli, lyophilized powder, ≥45 units/mg solid | Sucrose Phosphorylase | ESD-919982-250U |
| Cas.: 167427-23-8 | Purity: ≥95% (HPLC) | FO 2546L | ESD-919983-250ΜG |
| Cas.: 18600-51-6 | 2-(4-fluorophenyl)-4H-3,1-benzoxazin-4-one | ESD-919984-250MG | |
| Cas.: 33130-97-1 | Purity: 98% | Boc-(R)-3-thienylglycine | ESD-919985-250MG |
| Cas.: 71261-64-8 | Purity: 98 atom % 15N | DL-Alanine-15N | ESD-919986-250MG |
| Cas.: 1245748-66-6 | Purity: 97% | (S)-1,1′-Binaphthyl-2,2′-disulfonimide | ESD-919987-250MG |
| Cas.: 135137-87-0 | Purity: ≥96.0% (reversed phase HPLC) | DMT-Biotin-C6 Phosphoramidite | ESD-919988-250MG |
| Cas.: 502964-53-6 | Purity: CARBON 64.7 – 70.2% | Chloro(η2-P,C-tris(2,4-di-tert butylphenyl)phosphite)(tri cyclohexylphosphine)palladium(II) | ESD-919989-250MG |
| Cas.: 2741-06-2 | 1-Ethyl-3-phenyl-2-thiourea | ESD-919990-250MG | |
| Cas.: 13140-47-1 | 1-PHENYL-3-PROPYL-2-THIOUREA | ESD-919991-250MG | |
| Cas.: 420095-74-5 | Purity: 99 atom % 13C, 98 atom % D | 2-Keto-3-methylbutyric acid-13C5,3-d sodium salt | ESD-919992-250MG |
| Cas.: 67439-82-1 | Purity: ≥98.0% (GC) | 3,7-Dioxa-1,9-nonanediol | ESD-919993-250MG |
| Cas.: 71501-40-1 | 4-CHLOROBENZYL 2-HYDROXYETHYL SULFIDE | ESD-919994-250MG | |
| Cas.: 96749-32-5 | N-(3-Chlorophenyl)-3-MethylbenzaMide | ESD-919996-250MG | |
| Cas.: 63064-49-3 | Purity: 95% | Allyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside | ESD-919997-250MG |
| Cas.: 849052-18-2 | Purity: 97% | 3-Bromo-2-(4′-chlorobenzyloxy)-5-methylphenylboronic acid | ESD-919998-250MG |
| Cas.: 43224-81-3 | 2-phenoxyethyl 4-methylbenzenesulfonate | ESD-919999-250MG | |
| Cas.: 88-56-2 | 2-AMINO-5-CHLORO-4-ETHYLBENZENESULFONIC ACID | ESD-920000-250MG | |
| Cas.: 438243-87-9 | 5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID | ESD-920001-250MG | |
| Cas.: 132202-29-0 | Purity: 99 atom % 13C | D-Mannitol-1-13C | ESD-920002-250MG |
| Cas.: 102587-39-3 | 3′,4′-DICHLORO-3-METHYLBENZANILIDE | ESD-920003-250MG | |
| Cas.: 31822-03-4 | 2-IODOBENZOIC ACID HYDRAZIDE | ESD-920004-250MG | |
| Cas.: 532-96-7 | BENZOIC ACID N2-PHENYLHYDRAZIDE | ESD-920005-250MG | |
| Cas.: 3930-11-8 | Purity: ≥95.0% (NT) | Potassium β-hydroxypyruvate | ESD-920006-250MG |
| Cas.: 4151-98-8 | 1-CHLORO-3-ETHOXY-2-PROPANOL | ESD-920007-250MG | |
| Cas.: 905442-42-4 | Purity: 98% (HPLC) | (S)-2-Amino-4-(7-hydroxy-2-oxo-2H-chromen-4-yl)butanoic acid | ESD-920008-250MG |
| Cas.: 9033-12-9 | Purity: ≥400 units/mg protein | Glyoxalase I, from Saccharomyces cerevisiae | ESD-920009-200U |
| Cas.: 9075-65-4 | Purity: Type I, ammonium sulfate suspension, 100-300 units/mg protein | α-Glycerophosphate Dehydrogenase, from rabbit muscle | ESD-920010-200U |
| Cas.: 9024-25-3 | Aconitase from porcine heart | ESD-920011-150MG | |
| Cas.: 9001-90-5 | Purity: ≥2.0 units/mg protein | Plasmin, from human plasma | ESD-920012-150ΜG |
| Cas.: 14092-04-7 | Purity: 0.5M solution in THF | 1-Propenylmagnesium bromide | ESD-920013-100ML |
| Cas.: 17979-81-6 | Purity: 1M solution in THF | Sodium triethylborohydride | ESD-920014-100ML |
| Cas.: 104-45-0 | Purity: 97% | p-Propyl anisole | ESD-920015-100G |
| Cas.: 71031-48-6 | Purity: 95% | 4-Hydroxy-3-iodobiphenyl | ESD-920016-100MG |
| Cas.: 72749-59-8 | Purity: Colorless Liquid | Adogen(R) 464 | ESD-920017-100ML |
| Cas.: 180675-22-3 | Purity: 0.5M solution in THF | (1,3-Dioxolan-2-ylMethyl)MagnesiuM broMide | ESD-920018-100ML |
| Cas.: 36637-44-2 | Purity: 0.5M in 2-MeTHF | 4-(2-Tetrahydro-2H-pyranoxy)phenylMagnesiuM broMide | ESD-920019-100ML |
| Cas.: 62890-98-6 | Purity: 0.5 M in THF | 2,5-DiMethoxyphenylMagnesiuM broMide | ESD-920020-100ML |
| Cas.: 14187-31-6 | Purity: 97% | 1,1′-Diethyl-2,2′-dicarbocyanine iodide | ESD-920023-100MG |
| Cas.: 4261-68-1 | Purity: 98% | 2-DiisopropylaMinoethyl chloride hydrochloride | ESD-920024-100G |
| Cas.: 134098-68-3 | Purity: 97% | 3-(2-Acetoxy-4,6-dimethylphenyl)-3-methylbutyric acid | ESD-920025-100MG |
| Cas.: 352530-36-0 | Purity: 0.5M Solution In THF | (2-Chloro-5-pyridyl)Methylzinc chloride | ESD-920026-100ML |
| Cas.: 17628-73-8 | Purity: 97% | (R)-1,1,1-Trifluoro-2-propanol | ESD-920027-100MG |
| Cas.: 927429-60-5 | Dichloro[1,3-Bis(2-methylphenyl)-2-imidazolidinylidene](benzylidene)(tricyclohexylphosphine)ruthenium(II) | ESD-920028-100MG | |
| Cas.: 21450-64-6 | Purity: 0.5M in 2-MeTHF | 2,6-DIMETHYLPHENYLMAGNESIUM BROMIDE | ESD-920029-100ML |
| Cas.: 36281-96-6 | Purity: 1.0 M solution in THF, MKSeal | 3-Benzyloxyphenylmagnesium bromide solution | ESD-920030-100ML |
| Cas.: 1068-22-0 | Purity: 95% | O,O-Diethyl DithiophoC4H14NO2PS2sphate AMMoniuM Salt | ESD-920031-100G |
| Cas.: 59776-60-2 | Purity: 95% | 3,5-Dinitrophenyl isocyanate | ESD-920032-100MG |
| Cas.: 54082-95-0 | Bromotricarbonyl(tetrahydrofuran)rhenium(I) dimer | ESD-920033-100MG | |
| Cas.: 2396-78-3 | Purity: ≥97% | Methyl hex-3-enoate | ESD-920034-100G |
| Cas.: 20194-18-7 | Purity: 1M solution in benzyl alcohol | SODIUM BENZYLOXIDE | ESD-920035-100ML |
| Cas.: 22265-37-8 | Purity: 95% | 4-Methoxybenzimidamide | ESD-920036-100MG |
| Cas.: 3786-91-2 | Purity: 90% | 1,2,3,4-CYCLOPENTANETETRACARBOXYLIC ACID | ESD-920037-100G |
| Cas.: 90952-27-5 | Purity: 95% | Thiol-PEG4-alcohol | ESD-920038-100MG |
| Cas.: 18921-13-6 | Purity: 99% | ZINC BROMIDE DIHYDRATE | ESD-920039-100G |
| Cas.: 391860-55-2 | (11bR, 11′bR)-4,4′-(Oxydi-2,1-phenylene)bis-dinaphtho[2,1-d:, 1′, 2′-f][1,3,2]dioxaphosphepin | ESD-920040-100MG | |
| Cas.: 454675-76-4 | Purity: 97% | 13,6-N-SULFINYLACETAMIDOPENTACEN | ESD-920041-100MG |
| Cas.: 52079-10-4 | Purity: Pharmaceutical Secondary Standard; Certified Reference Material | Naproxen Impurity A | ESD-920042-100MG |
| Cas.: 794586-44-0 | Purity: 99% (HPLC) | Pentacene-N-sulfinyl-tert-butylcarbamate | ESD-920043-100MG |
| Cas.: 480438-50-4 | Purity: 0.50 M in 2-MeTHF | 3-Chloro-5-fluorophenylmagnesium bromide | ESD-920044-100ML |
| Cas.: 112780-67-3 | Purity: 0.50 M in 2-MeTHF | 3-FLUORO-4-METHOXYPHENYLMAGNESIUM BROMIDE | ESD-920045-100ML |
| Cas.: 17680-04-5 | Purity: 0.5M in 2-MeTHF | 3,4-(METHYLENEDIOXY)PHENYLMAGNESIUM BROMIDE | ESD-920046-100ML |
| Cas.: 65567-06-8 | Purity: 0.5M solution in THF, MkSeal | LITHIUM DIPHENYLPHOSPHIDE | ESD-920047-100ML |
| Cas.: 55652-52-3 | Purity: 1.0 M solution in methylene chloride, MKSeal | MONOBROMOBORANE-METHYL SULFIDE COMPLEX | ESD-920048-100ML |
| Cas.: 1211583-40-2 | Purity: 97% | 4-(Trimethylsilyl)pyridin-3-yl trifluoromethanesulfonate | ESD-920049-100MG |
| Cas.: 1340481-94-8 | Purity: 95% | tert-Butyl 8-hydroxy-6-thia-2-azaspiro[3.4]octane-2-carboxylate 6,6-dioxide | ESD-920050-100MG |
| Cas.: 100929-81-5 | DL-FLUOROCITRIC ACID BARIUM SALT | ESD-920051-100MG | |
| Cas.: 869896-76-4 | Purity: 97% | 2,2′-Bis[4-(trifluoromethyl)phenyl]-5,5′-bithiazole | ESD-920052-100MG |
| Cas.: 312-45-8 | Purity: ≥95% (HPLC) | Hemicolinium-3 | ESD-920053-100MG |
| Cas.: 63939-65-1 | Oxotremorine M | ESD-920054-100MG | |
| Cas.: 513-00-8 | Purity: butyrylcholinesterase inhibitor | Tetraisopropyl pyrophosphoramide | ESD-920055-100MG |
| Cas.: 1408074-44-1 | Purity: 95% | tert-butyl 8-amino-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-920056-100MG |
| Cas.: 1453315-99-5 | Purity: 95% | tert-Butyl-8-hydroxy-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-920057-100MG |
| Cas.: 1413439-82-3 | Purity: 95% | Garg 5-bromo-3,4-pyridyne precursor | ESD-920058-100MG |
| Cas.: 53694-87-4 | 1-AZIDO-4-IODOBENZENE SOLUTION | ESD-920059-100MG | |
| Cas.: 55121-08-9 | Purity: ≥95% | 4-CHLOROPHENETHYL ISOCYANATE | ESD-920060-100MG |
| Cas.: 120186-59-6 | Purity: 0.8M solution in THF, MKSeal | 4-Benzyloxyphenylmagnesium bromide | ESD-920061-100ML |
| Cas.: 51294-16-7 | Purity: 85% | Perfluoro(Methyldecahydronaphthalene) | ESD-920062-100G |
| Cas.: 65099-79-8 | Purity: Particle Size 60-200 μm | Sepharose CL-2B | ESD-920063-100ML |
| Cas.: 84940-46-5 | Purity: 95% | 2,3,6-TRIFLUORO-4-(TRIFLUOROMETHYL)PYRIDINE | ESD-920064-100MG |
| Cas.: 112426-02-5 | Purity: solution 0.25 M in THF | LITHIUM 2-THIENYLCYANOCUPRATE | ESD-920065-100ML |
| Cas.: 125995-00-8 | Purity: 98% | (S)-3,3,3-Trifluoro-2-hydroxypropanoic acid | ESD-920066-100MG |
| Cas.: 8023-70-9 | LYCOPODIUM | ESD-920067-100G | |
| Cas.: 42371-63-1 | Purity: 0.5M in THF | S-Alpine-Borane solution | ESD-920068-100ML |
| Cas.: 160191-65-1 | Purity: 97% | (4S,4’S)-(-)-2 2′-(3-Pentylidene)bis(4-isopropyloxazoline) | ESD-920069-100MG |
| Cas.: 14783-10-9 | Purity: 95% | Dichloro(1,10-phenanthroline)palladium(II) | ESD-920070-100MG |
| Cas.: 136705-77-6 | Purity: 97% | 1,2-Bis[(2R,5R)-2,5-diethylphospholano]benzene(1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate | ESD-920071-100MG |
| Cas.: 137743-46-5 | Purity: ≥95% | tert-butyl N-(2-isothiocyanatoethyl)carbamate | ESD-920072-100MG |
| Cas.: 50909-86-9 | Purity: >98% | COELENTERAZINE H | ESD-920073-100ΜG |
| Cas.: 210057-23-1 | Purity: 98% | (-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-920074-100MG |
| Cas.: 205064-10-4 | Purity: 98% | (+)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-920075-100MG |
| Cas.: 336182-07-1 | Purity: 97% | (R)-3-Amino-5-(methylthio)pentanoic acid hydrochloride | ESD-920076-100MG |
| Cas.: 336182-11-7 | Purity: 95% | L-beta-Homohydroxyproline hydrochloride | ESD-920077-100MG |
| Cas.: 156329-62-3 | Purity: 95% | Methyl 3-cyanobicyclo[1.1.1]pentane-1-carboxylate | ESD-920078-100MG |
| Cas.: 61-49-4 | Purity: 99% | N-Methyltryptamine | ESD-920079-100MG |
| Cas.: 1236862-45-5 | Purity: 98% | Spiro[azetidine-3,2′-[2H-1]benzopyran]-4′(3’H)-one, hydrochloride | ESD-920080-100MG |
| Cas.: 70289-33-7 | Purity: 98% | 4-(Diisobutylamino)-1-Butanol | ESD-920081-100MG |
| Cas.: 877858-16-7 | Purity: 97% | 4-(((tert-Butoxycarbonyl)amino)methyl)-3-methylbenzoic acid | ESD-920082-100MG |
| Cas.: 129203-60-7 | Purity: ≥98% | Iberiotoxin | ESD-920083-100ΜG |
| Cas.: 146-17-8 | Purity: ≥95% | Riboflavine phosphate | ESD-920084-100MG |
| Cas.: 799812-70-7 | Purity: >99% | 1-oleoyl-2-[12-biotinyl(aminododecanoyl)]-sn-glycero-3-phosphoinositol-3,4,5-trisphosphate (sodium salt) | ESD-920085-100ΜG |
| Cas.: 6841-96-9 | Purity: 98% | tert-Nitrosobutane dimer | ESD-920086-100MG |
| Cas.: 11065-24-0 | Purity: 98% | Tetrairidium dodecacarbonyl | ESD-920087-100MG |
| Cas.: 18552-90-4 | Purity: 95% | 6-Chloro-2-iodopurine | ESD-920088-100MG |
| Cas.: 207300-76-3 | Purity: 98% | Glycine sodium salt hydrate | ESD-920089-100G |
| Cas.: 3395-35-5 | Purity: 98% | 3,4-DEHYDRO-DL-PROLINE | ESD-920090-100MG |
| Cas.: 514209-42-8 | Purity: 95% | 3-(4-Methylpiperazin-1-ylmethyl)benzoic acid | ESD-920091-100MG |
| Cas.: 1052707-27-3 | Purity: 97% | (1S, 2S)-1,2-di-1-Naphthyl-ethylenediaMine dihydrochloride | ESD-920092-100MG |
| Cas.: 950842-71-4 | Purity: 97% | (5R,6S)-2-Mesiyl-5,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-iuM tetrafluoroborate | ESD-920093-100MG |
| Cas.: 704-00-7 | Purity: 99% | 1,2-Diacetylbenzene | ESD-920094-100MG |
| Cas.: 22287-56-5 | Purity: 98% | 4,4′-Bis(4-chlorophenyl)sulfonyl-1,1′-biphenyl | ESD-920095-100G |
| Cas.: 947601-98-1 | Purity: ≥94% (oligomer purity) | N-HYDROXY-SUCCINIMIDY-PROPIONATE OCTA(ETHYLENE GLYCOL)-DISULFIDE | ESD-920096-100MG |
| Cas.: 34788-82-4 | Purity: 98% | EUROPIUM TRIS[3-(HEPTAFLUOROPROPYLHYDROXYMETHYLENE)-(+)-CAMPHORATE] | ESD-920097-100MG |
| Cas.: 9003-29-6 | POLYBUTENES | ESD-920099-100ML | |
| Cas.: 123409-00-7 | Purity: ≥900ug/mg | Vancomycin Hydrochloride | ESD-920100-100MG |
| Cas.: 349114-63-2 | (11bR,11’bR)-4,4′-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis-dinaphtho[2,1-d:1′, 2′-f][1 ,3,2]dioxaphosphepin | ESD-920101-100MG | |
| Cas.: 55511-44-9 | Purity: ≥95% | (R)-(+)-Aminoglutethimide | ESD-920102-100MG |
| Cas.: 218460-00-5 | Purity: 97% | (S)-2-[2-[Bis(2-tolyl)phosphino]phenyl]-4-tert-butyl-4,5-dihydro-oxazole | ESD-920103-100MG |
| Cas.: 332064-85-4 | Purity: ≥94.0% (TLC); 94% | (S)-3-Amino-5-Hexynoic Acid Hydrochloride | ESD-920104-100MG |
| Cas.: 18300-31-7 | Purity: Dye content 90% | 1 1′-DIETHYL-4 4′-DICARBOCYANINE IODIDE | ESD-920105-100MG |
| Cas.: 59404-86-3 | Purity: 95% | 4-BENZYLOXY-3-CHLOROANILINE | ESD-920106-100MG |
| Cas.: 1975-81-1 | Purity: 99% | N-Methyl Serotonin Oxalate Salt | ESD-920107-100MG |
| Cas.: 143925-92-2 | Purity: 65% | Bis(octadecyl)hydroxylamine | ESD-920108-100G |
| Cas.: 106100-55-4 | BISPHENOL A PROPOXYLATE DIGLYCIDYL ETHER | ESD-920109-100ML | |
| Cas.: 32627-01-3 | Purity: 99% | DICARBONYL(PENTAMETHYLCYCLOPENTADIENYL)RHODIUM (I) | ESD-920111-100MG |
| Cas.: 802912-44-3 | Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene][3-(2-pyridinyl)propylidene]ruthenium(II) | ESD-920112-100MG | |
| Cas.: 935280-42-5 | Purity: 99% | Dinaphtho[2,3-b:2′,3′-f]thieno[3,2-b]thiophene | ESD-920113-100MG |
| Cas.: 290835-83-5 | Purity: ≥98.0% (TLC) | L-β-Homolysine dihydrochloride | ESD-920114-100MG |
| Cas.: 20911-93-7 | Purity: 98% | Nα-Acetyl-L-lysine Methyl Ester Hydrochloride | ESD-920115-100MG |
| Cas.: 85214-70-6 | Purity: Dye content 80% | SILICON 2 9 16 23-TETRA-TERT-BUTYL-29H | ESD-920117-100MG |
| Cas.: 29463-06-7 | Purity: ≥95% | Tris(2-hydroxyethyl)methylammonium methylsulfate | ESD-920118-100G |
| Cas.: 114168-16-0 | Purity: 99.9% trace metals basis (purity excludes ~2% HfO2) | Yttria stabilized zirconia | ESD-920119-100G |
| Cas.: 2179-15-9 | Z-LYS-ONP HCL | ESD-920120-100MG | |
| Cas.: 1453315-76-8 | Purity: 95% | 7-Amino-5-thia-2-azaspiro[3.4]octane-2-carboxylic acid-5,5-dioxide 1,1-dimethylethyl ester | ESD-920121-100MG |
| Cas.: 1428232-73-8 | Szymczak Active Dehydrogenation Precatalyst | ESD-920122-100MG | |
| Cas.: 1428232-72-7 | Purity: 95% | Ru(bmpi)(PPh(3))Cl | ESD-920123-100MG |
| Cas.: 1340481-90-4 | Purity: ≥95% | tert-Butyl 8-hydroxy-5-thia-2-azaspiro[3.4]octane-2-carboxylate 5,5-dioxide | ESD-920124-100MG |
| Cas.: 1340481-91-5 | tert-Butyl 8-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate 5,5-dioxide | ESD-920125-100MG | |
| Cas.: 904304-57-0 | Purity: ≥98% (TLC); ≥98% (as erucic acid) | 1,2-Dierucoyl-sn-glycero-3-phosphoethanolamine | ESD-920126-100MG |
| Cas.: 62868-79-5 | Purity: ≥97% (TLC) | 2,3-DIPHOSPHOGLYCERIC ACID, PENTACYCLOHEXYLAMMONIUM SALT | ESD-920127-100MG |
| Cas.: 94525-01-6 | POLY-(ALPHA,BETA)-DL-ASPARTIC ACID SODIUM SALT | ESD-920128-100MG | |
| Cas.: 30000-61-4 | Purity: 95% | (PYRROLYL-3)-4 BUTANOIC ACID | ESD-920129-100MG |
| Cas.: 35984-93-1 | Purity: Dye content 97% | 2,9,16,23-TETRA-TERT-BUTYL-29H,31H-PHTHALOCYANINE | ESD-920130-100MG |
| Cas.: 1821799-30-7 | Purity: ≥95% | (S)-2-Boc-aminoethyl-piperidine | ESD-920131-100MG |
| Cas.: 1364783-04-9 | Purity: ≥95% | (S)-2-methyl-2-phenylpiperidine | ESD-920132-100MG |
| Cas.: 1236196-77-2 | Purity: ≥95% | 4-(4-(prop-2-ynyloxy)benzoyl)benzoic acid | ESD-920133-100MG |
| Cas.: 756526-04-2 | Amino-dPEG8-acid | ESD-920134-100MG | |
| Cas.: 1334170-00-1 | Bis-dPEG13-PFP ester | ESD-920135-100MG | |
| Cas.: 1256262-67-5 | cis-[1,2-Bis(diphenylphosphino)ethane](2-methylphenyl)nickel(II) chloride | ESD-920136-100MG | |
| Cas.: 1224728-09-9 | Diamido-dPEG11-diamine | ESD-920137-100MG | |
| Cas.: 37288-67-8 | Purity: 50-150units/mg protein | Aminopeptidase from Aeromonas proteolytica lyophilized powder | ESD-920139-100U |
| Cas.: 652154-13-7 | Purity: 90.0% (HPLC) | Cytidine 5′-Triphosphate DisodiuM Salt Hydrate | ESD-920140-100MG |
| Cas.: 37762-06-4 | Purity: 98% | Zaprinast;2-(2-Propyloxyphenyl)-8-azapurin-6-one | ESD-920141-100MG |
| Cas.: 26643-91-4 | Purity: 88% | 4-Methyl-2-phenyl-2-pentenal | ESD-920142-100G |
| Cas.: 528814-26-8 | Purity: white to light yellowpowder | (1R,1’R,2S,2’S)-2,2′-Bis(1,1-dimethylethyl)-2,2′,3,3′-tetrahydro-1,1′-bi-1H-isophosphindole | ESD-920143-100MG |
| Cas.: 63524-04-9 | Purity: 99% | D-(-)-Isoascorbic acid sodiuM salt Monohydrate | ESD-920144-100G |
| Cas.: 1016985-24-2 | Purity: 97% | (RP)-1-Dicyclohexylphosphino-2-[(R)-α-(dimethylamino)-2-(dicyclohexylphosphino)benzyl]ferrocene | ESD-920145-100MG |
| Cas.: 228121-39-9 | Purity: 98% | (-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-920146-100MG |
| Cas.: 136705-75-4 | Purity: 97% | (+)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)benzene(1,5-cyclooctadiene)rhodium(I)trifluoromethanesulfonate | ESD-920147-100MG |
| Cas.: 872598-44-2 | Purity: 97% | 1-Methyl-2-azaadamantane-N-oxyl | ESD-920148-100MG |
| Cas.: 27860-55-5 | Purity: 95% | Vanadyl octaethylporphine | ESD-920149-100MG |
| Cas.: 1033772-47-2 | Purity: 97% | Bis[(2-diMethylaMino)phenyl]aMine Nickel(II) Chloride | ESD-920150-100MG |
| Cas.: 1340481-83-5 | Purity: 95% | 2-Boc-8-amino-5-thia-2-azaspiro[3.4]octane 5,5-dioxide | ESD-920151-100MG |
| Cas.: 1453315-78-0 | Purity: 95% | 7-Hydroxy-5-thia-2-azaspiro[3.4]octane-2-carboxylic acid-5,5-dioxide 1,1-dimethylethyl ester | ESD-920152-100MG |
| Cas.: 70867-33-3 | Purity: ≥98% (TLC) | (2-Nitrophenyl)-β-D-cellobioside | ESD-920153-100MG |
| Cas.: 6578-07-0 | 5-Bromo-4-chloro-3-indolyl sulfate potassium salt | ESD-920154-100MG | |
| Cas.: 79416-87-8 | Purity: 96% (TLC) | L-Lysine, N6,N6-diMethyl-, Monohydrochloride | ESD-920156-100MG |
| Cas.: 106508-62-7 | Purity: 95% | Ethyl 4-isocyanatobutyrate | ESD-920157-100MG |
| Cas.: 220622-96-8 | Purity: Colorless Liquid | Glycolic acid ethoxylate lauryl ether | ESD-920158-100ML |
| Cas.: 313222-91-2 | Purity: 97% | Lithium citrate hydrate | ESD-920159-100G |
| Cas.: 10255-67-1 | Purity: 97.0-103.0% (NT) | SodiuM Mercaptopyruvate | ESD-920160-100MG |
| Cas.: 349114-57-4 | Purity: solid | (11bS,11′bS)-4,4′-(9,9-DiMethyl-9H-xanthene-4,5-diyl)bis-dinaphtho[2,1-d:1′,2′-f][1 ,3,2]dioxaphosphepin | ESD-920161-100MG |
| Cas.: 94964-58-6 | Purity: 95% | (R)-(+)-1-Benzyl-2,2-diphenylethylaMine | ESD-920162-100MG |
| Cas.: 394248-45-4 | Purity: ≥97% (CHN) | (R)-(+)-2,2′-Bis[di(3,5-xylyl)phosphino]-6,6′-dimethoxy-1,1′-biphenyl | ESD-920163-100MG |
| Cas.: 503859-61-8 | Purity: 98% | (Rp)-2-(tert-Butylthio)-1-(diphenylphosphino)ferrocene | ESD-920164-100MG |
| Cas.: 849925-17-3 | Purity: ≥97% | (Diphenylphosphino)phenyl]ferroceny l}ethylbis[3,5-bis- (trifluoromethyl)phenyl]phosphine | ESD-920165-100MG |
| Cas.: 1242421-77-7 | Purity: 95% | (11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dithiazepine 3,3,5, 5-tetraoxide | ESD-920166-100MG |
| Cas.: 62214-39-5 | Purity: 97.0% (GC) | (S)-But-3-ene-1,2-diol | ESD-920167-100MG |
| Cas.: 863971-62-4 | Purity: 98% | Carbonylchlorohydrido[6-(di-t-butylphosphinomethyl)-2-(N,N-diethylaminomethyl)pyridine]ruthenium(II) | ESD-920168-100MG |
| Cas.: 16409-44-2 | Purity: >97% (sum of isomers, GC) | 3,7-DiMethyl-2,6-octadienyl acetate | ESD-920171-100ML |
| Cas.: 870778-95-3 | Purity: 98% | 3-Acetyl-2-fluorophenylboronic acid | ESD-920172-100G |
| Cas.: 1228665-91-5 | Purity: solid | 4-Chloro-5-fluoro-6-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-920173-100MG |
| Cas.: 398128-81-9 | Purity: ≥99% (HPLC) | 6,13-Bis((triethylsilyl)ethynyl)pentacene | ESD-920174-100MG |
| Cas.: 387868-06-6 | Purity: 98% | (R)-1-{(RP)-2-[2- (Diphenylphosphino)phenyl]ferroceny l}ethylbis[3,5-bis- (trifluoromethyl)phenyl]phosphine | ESD-920175-100MG |
| Cas.: 385815-83-8 | Purity: 98% | Chloro[tris(para-trifluoromethylphenyl)phosphine]gold(I) | ESD-920176-100MG |
| Cas.: 467220-49-1 | Purity: 96% | 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene(1,4-naphthoquinone)palladium (0) dimer | ESD-920177-100MG |
| Cas.: 36748-89-7 | Purity: 97% | 2-Iodobenzo[b]thiophene | ESD-920178-100MG |
| Cas.: 649736-75-4 | Purity: 96% | 1,3-Bis(2,6-di-i-propylphenyl)imidazol-2-ylidene(1,4-naphthoquinone)palladium (0) dimer | ESD-920179-100MG |
| Cas.: 126643-37-6 | Purity: 99% | KT5823 | ESD-920180-100MG |
| Cas.: 942518-29-8 | Purity: 98% | (S)-2-Amino-4-azidobutanoic acid hydrochloride | ESD-920181-100MG |
| Cas.: 1252257-56-9 | Purity: BR | LC-PEG8-SPDP | ESD-920182-100MG |
| Cas.: 1243481-60-8 | Purity: 95% | tert-Butyl 4-aminospiro[chroman-2,4′-piperidine]-1′-carboxylate hydrochloride | ESD-920183-100MG |
| Cas.: 701-14-4 | Purity: 95% | 2-Amino-7-chloro-1H-benzimidazole | ESD-920184-100MG |
| Cas.: 51450-36-3 | Purity: 97% | 4,6-O-Isopropylidene-D-glucal | ESD-920185-100MG |
| Cas.: 1516140-99-0 | Sodium tetrahydropyransulfinate | ESD-920186-100MG | |
| Cas.: 199588-80-2 | Purity: 85% | 1-[(Anthracen-9-yl)methyl]cinchonidinium chloride | ESD-920187-100MG |
| Cas.: 7547-97-9 | Purity: 98% | (E)-Prop-1-en-1-ylboronic acid | ESD-920188-100MG |
| Cas.: 329736-05-2 | Purity: 95% | Dichloro[(S)-(-)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]ruthenium(II) | ESD-920189-100MG |
| Cas.: 88082-66-0 | Purity: 97% | (1R,2R)-2-Amino-1,2-diphenylethanol | ESD-920190-100MG |
| Cas.: 23190-17-2 | Purity: ≥99.5% (HPLC) | (1S,2S)-2-Amino-1,2-diphenylethanol | ESD-920191-100MG |
| Cas.: 884494-44-4 | Purity: 97% | (2-Chloro-4-iodopyridin-3-yl)methanol | ESD-920192-100MG |
| Cas.: 18627-38-8 | Purity: 95% | N-(2-Oxotetrahydrofuran-3-yl)dodecanamide | ESD-920193-100MG |
| Cas.: 51791-26-5 | Purity: 95% | (E)-3-(4-Fluorophenyl)acrylaldehyde | ESD-920194-100MG |
| Cas.: 185913-97-7 | Purity: ≥95.0% (H-NMR) | (R)-(5,5′-Dichloro-6,6′-dimethoxy-[1,1′-biphenyl]-2,2′-diyl)bis(diphenylphosphine) | ESD-920195-100MG |
| Cas.: 700377-76-0 | Purity: ≥95.0% (HPLC) | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(3-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl) guanidino)hexanoic acid | ESD-920196-100MG |
| Cas.: 95209-83-9 | Purity: 95% | (2-Oxopyrimdin-1(2H)-Yl)Acetic Acid | ESD-920197-100MG |
| Cas.: 89640-51-7 | Purity: 95% | 4-Amino-2-iodophenol | ESD-920198-100MG |
| Cas.: 129704-91-2 | Purity: Purum, ≥98.0% (TLC) | (S)-Alpha-allyl-proline, HCl | ESD-920199-100MG |
| Cas.: 1032759-30-0 | Purity: 98% | N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-920200-100MG |
| Cas.: 107200-92-0 | Purity: ≥0.2 units/mg protein | Cathepsin G from human sputum | ESD-920201-100ΜG |
| Cas.: 1391-06-6 | Purity: ≥98% (agarose gel electrophoresis) | Conalbumin, from chicken egg white | ESD-920202-100MG |
| Cas.: 9001-80-3 | Purity: Type VII, lyophilized powder, ≥50 units/mg protein | Fructose-6-phosphate Kinase, from Bacillus stearothermophilus | ESD-920203-100U |
| Cas.: 9032-88-6 | Purity: ≥95% (SDS-PAGE) | Fumarase human | ESD-920204-100ΜG |
| Cas.: 9001-36-9 | Purity: ≥250 units/mg protein | Glucokinase, from Bacillus stearothermophilus | ESD-920205-100U |
| Cas.: 42761-76-2 | Purity: ≥98% (TLC) | Gly-Pro 4-methoxy-β-naphthylamid | ESD-920206-100MG |
| Cas.: 744-46-7 | Purity: ≥98% (TLC) | Hippuryl-Arg | ESD-920207-100MG |
| Cas.: 732-85-4 | Purity: ≥98% (TLC) | L-Leucine β-naphthylamide | ESD-920208-100MG |
| Cas.: 9023-70-5 | Purity: 400-2,000 units/mg protein | L-Glutamine Synthetase, from Escherichia coli | ESD-920209-100U |
| Cas.: 3395-37-7 | Purity: ≥97% (TLC) | Naphthol AS-BI N-acetyl-β-D-glucosaminide | ESD-920211-100MG |
| Cas.: 35245-26-2 | Purity: ≥98% (TLC) | Naphthol AS-D chloroacetate | ESD-920212-100MG |
| Cas.: 4264-93-1 | Purity: ≥99% (HPLC) | Naphthol AS-TR phosphate disodium salt | ESD-920213-100MG |
| Cas.: 6865-14-1 | Purity: ≥98% (TLC) | Palmitoyl-DL-carnitine chloride | ESD-920214-100MG |
| Cas.: 37318-49-3 | Purity: >95% (SDS-PAGE), ≥100 units/mg protein | Protein Disulfide Isomerase, from bovine liver | ESD-920215-100ΜG |
| Cas.: 9001-98-3 | Purity: ≥20 units/mg protein | Rennin, from calf stomach | ESD-920216-100MG |
| Cas.: 863394-07-4 | Purity: ≥95% (TLC) | Se-(Methyl)selenocysteine hydrochloride | ESD-920217-100MG |
| Cas.: 9015-85-4 | Purity: 4,000 U/mL | DNA Ligase, from T4-infected Escherichia coli | ESD-920218-100U |
| Cas.: 43195-60-4 | Purity: 98-100% | UDP-GlcA | ESD-920219-100MG |
| Cas.: 108321-53-5 | Purity: Type VI, ≥90% | Uridine 5′-triphosphate tris salt | ESD-920220-100MG |
| Cas.: 141176-92-3 | Purity: ≥92.5% (SDS-PAGE), lyophilized powder | α1-Antichymotrypsin, from human plasma | ESD-920221-100ΜG |
| Cas.: 9074-98-0 | Purity: U/mg | β-Glucanase, from Aspergillus niger | ESD-920222-100MG |
| Cas.: 14000-28-3 | Purity: ≥98.0% (TLC) | (S)-6-Amino-2-(methylamino)hexanoic acid hydrochloride | ESD-920223-100MG |
| Cas.: 17436-02-1 | Purity: 97% | L-Serine O-sulfate potassium salt | ESD-920224-100MG |
| Cas.: 2914-38-7 | Monosodium methylphosphonate | ESD-920225-100MG | |
| Cas.: 22582-68-9 | 1-(1H-INDOL-3-YL)-PROPAN-1-ONE | ESD-920226-100MG | |
| Cas.: 799812-61-6 | Purity: >99% (TLC) | 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium salt) | ESD-920227-100ΜG |
| Cas.: 136779-27-6 | Purity: 97% | (-)-1,2-Bis[(2S,5S)-2,5-diethyl-1-phospholanyl]ethane | ESD-920228-100MG |
| Cas.: 1173019-25-4 | Purity: 99 atom % 13C, 99% (CP) | Ethanolamine-13C2 hydrochloride | ESD-920229-100MG |
| Cas.: 19184-67-9 | 3,3-DIMETHYL-PENTANEDIOIC ACID DIMETHYL ESTER | ESD-920230-100MG | |
| Cas.: 51-16-1 | Purity: ≥99% | 2-AP nitrate salt | ESD-920231-100MG |
| Cas.: 18692-68-7 | ACETIC ACID 2-METHOXY-4-(5-OXO-2-PHENYL-OXAZOL-4-YLIDENEMETHYL)-PHENYL ESTER | ESD-920232-100MG | |
| Cas.: 36701-01-6 | Purity: ≥97%, FG | Furfuryl pentanoate | ESD-920233-100G |
| Cas.: 519-32-4 | Purity: 97% | 1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione | ESD-920234-100MG |
| Cas.: 52200-05-2 | METHANESULFONIC ACID 4-FORMYL-2-METHOXY-PHENYL ESTER | ESD-920235-100MG | |
| Cas.: 30377-62-9 | ETHYL-(2-NITRO-4-TRIFLUOROMETHYL-PHENYL)-AMINE | ESD-920236-100MG | |
| Cas.: 136694-18-3 | Methyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate | ESD-920237-100MG | |
| Cas.: 14103-61-8 | Purity: ≥ 99.0 % | Bis(3,5,5-trimethylhexyl) phthalate | ESD-920238-100ML |
| Cas.: 180683-37-8 | Purity: United States Pharmacopeia (USP) Reference Standard | Indinavir | ESD-920239-100MG |
| Cas.: 193065-68-8 | Purity: 0.5M in THF | 3-Ethoxy-3-oxopropylzinc broMide | ESD-920240-50ML |
| Cas.: 171860-68-7 | Purity: 0.5M in THF | Cyclopentylzinc broMide | ESD-920241-50ML |
| Cas.: 126403-67-6 | Purity: 0.5M in THF | 2-Methylpropylzinc bromide | ESD-920242-50ML |
| Cas.: 156567-57-6 | Purity: 0.5M in THF | n-Propylzinc bromide | ESD-920243-50ML |
| Cas.: 135579-85-0 | Purity: 0.5M in THF | 3-Cyanopropylzinc broMide | ESD-920244-50ML |
| Cas.: 257876-05-4 | Purity: 0.5M in THF | :5-Methyl-2-pyridylzinc broMide | ESD-920245-50ML |
| Cas.: 308795-98-4 | Purity: 0.5M in THF | 6-Methyl-2-pyridylzinc broMide | ESD-920246-50ML |
| Cas.: 124397-96-2 | Purity: 0.5M in THF | 1-Hexylzinc broMide | ESD-920247-50ML |
| Cas.: 38111-44-3 | Purity: 0.5M in THF | Phenylzinc bromide | ESD-920248-50ML |
| Cas.: 226570-68-9 | Purity: 0.5M in THF | 4-Cyanobutylzinc broMide | ESD-920249-50ML |
| Cas.: 308796-09-0 | Purity: 0.5M in THF | 3-Pentylzinc broMide | ESD-920250-50ML |
| Cas.: 92274-43-6 | Purity: 0.5M in THF | 3-Methylbutylzinc broMide | ESD-920251-50ML |
| Cas.: 79175-35-2 | Purity: 0.5M solution in THF | 3,4-DichlorophenylMagnesiuM broMide | ESD-920252-50ML |
| Cas.: 26905-40-8 | Purity: 0.25M solution in THF | 3-Methoxybenzylmagnesium chloride | ESD-920253-50ML |
| Cas.: 312693-07-5 | Purity: 0.5M solution in THF | 4-Fluorobenzylzinc chloride | ESD-920254-50ML |
| Cas.: 312693-05-3 | Purity: 0.5M solution in THF | 2-Fluorobenzylzinc chloride | ESD-920255-50ML |
| Cas.: 352530-44-0 | Purity: 0.5M in THF | 4-BroMo-2-fluorophenylzinc iodide | ESD-920256-50ML |
| Cas.: 62673-31-8 | Purity: 0.5M in THF | Benzylzinc bromide | ESD-920257-50ML |
| Cas.: 312624-11-6 | Purity: 0.5M in THF | 2-Chlorobenzylzinc chloride | ESD-920258-50ML |
| Cas.: 312624-13-8 | Purity: 0.5M in THF | 3-Chlorobenzylzinc chloride | ESD-920259-50ML |
| Cas.: 131379-16-3 | Purity: 0.5M in THF | 4-(Ethoxycarbonyl)phenylzinc iodide solution 0.5M in THF | ESD-920260-50ML |
| Cas.: 307531-83-5 | Purity: 0.5M in THF | 2-(1,3-Dioxolan-2-yl)]ethyl]zinc bromide solution | ESD-920261-50ML |
| Cas.: 131379-15-2 | Purity: 0.5M in THF | 4-(Ethoxycarbonyl)phenylzinc bromide solution | ESD-920262-50ML |
| Cas.: 312693-21-3 | Purity: 0.5 M in Tetrahydrofuran | 4-Methylbenzylzinc chloride solution | ESD-920263-50ML |
| Cas.: 12053-18-8 | Purity: grey powder | Copper chromMite | ESD-920264-50G |
| Cas.: 218777-23-2 | Purity: 0.5MsolutioninTHF, MKSeal | 2-PYRIDYLZINC BROMIDE | ESD-920265-50ML |
| Cas.: 131379-17-4 | Purity: 0.5 M solution in THF, MKSeal | 2-Cyanophenylzinc bromide solution | ESD-920266-50ML |
| Cas.: 308796-07-8 | Purity: 0.5M in THF | 1-METHYLBUTYLZINC BROMIDE | ESD-920267-50ML |
| Cas.: 265330-98-1 | Purity: 0.5M in THF | 5-ETHOXY-5-OXOPENTYLZINC BROMIDE | ESD-920268-50ML |
| Cas.: 226570-65-6 | Purity: 0.5M in THF | 4-PENTENYLZINC BROMIDE | ESD-920269-50ML |
| Cas.: 171860-66-5 | Purity: 0.5M in THF | 2-BUTYLZINC BROMIDE | ESD-920270-50ML |
| Cas.: 7565-59-5 | Purity: 0.5M in THF | TERT-BUTYLZINC BROMIDE | ESD-920271-50ML |
| Cas.: 115055-85-1 | Purity: 0.5M in THF | 4-Bromobenzylzinc bromide solution | ESD-920272-50ML |
| Cas.: 1222630-32-1 | Purity: 97% | 2-(Diphenylphosphino)ethanaminium tetrafluoroborate | ESD-920273-50MG |
| Cas.: 10017-39-7 | Purity: 95% | 2-(Aminomethyl)benzoic Acid Hydrochloride | ESD-920274-50MG |
| Cas.: 277756-44-2 | Purity: 97% | 1-(Trifluoromethyl)cyclopentane-1-carboxylic acid | ESD-920275-50MG |
| Cas.: 135579-86-1 | Purity: 0.5M in THF | (Cyclohexylmethyl)zinc bromide solution | ESD-920276-50ML |
| Cas.: 312624-15-0 | Purity: 0.5M in THF | 1-ADAMANTYLZINC BROMIDE | ESD-920277-50ML |
| Cas.: 312693-01-9 | Purity: 0.5M in THF | 6-ETHOXY-6-OXOHEXYLZINC BROMIDE | ESD-920278-50ML |
| Cas.: 308796-14-7 | Purity: 0.5M in THF | PHENETHYLZINC BROMIDE | ESD-920279-50ML |
| Cas.: 173382-28-0 | Purity: 0.5M in THF | 2-THIAZOLYLZINC BROMIDE | ESD-920280-50ML |
| Cas.: 149923-10-4 | Purity: 0.5M in THF | 4-CHLOROBENZYLZINC CHLORIDE | ESD-920281-50ML |
| Cas.: 7565-57-3 | Purity: 0.5M in THF | CYCLOHEXYLZINC BROMIDE | ESD-920282-50ML |
| Cas.: 312624-26-3 | Purity: 0.5M in THF | 2-CYANOETHYLZINC BROMIDE | ESD-920283-50ML |
| Cas.: 312693-15-5 | Purity: 0.5MTHF | 2-METHOXYBENZYLZINC CHLORIDE | ESD-920284-50ML |
| Cas.: 312693-16-6 | Purity: 0.5MTHF | 3-METHOXYBENZYLZINC CHLORIDE | ESD-920285-50ML |
| Cas.: 300766-53-4 | Purity: 0.5M in THF | 4-METHYLPHENYLZINC IODIDE | ESD-920286-50ML |
| Cas.: 308796-10-3 | Purity: 0.5M in THF | 1-PENTYLZINC BROMIDE | ESD-920287-50ML |
| Cas.: 352534-75-9 | Purity: 0.5 M in THF | 2,3,4,5,6-Pentafluorobenzylzinc bromide solution | ESD-920288-50ML |
| Cas.: 307531-84-6 | Purity: 0.5 M in THF | 5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide solution | ESD-920289-50ML |
| Cas.: 186000-44-2 | Purity: 0.5 M in THF | 3-Bromophenylzinc iodide solution | ESD-920290-50ML |
| Cas.: 3070-65-3 | Purity: 96% | Ethyl 2-ethylacrylate | ESD-920291-50MG |
| Cas.: 307496-26-0 | Purity: 0.5M in THF | 2,4-DIFLUOROBENZYLZINC BROMIDE | ESD-920292-50ML |
| Cas.: 14468-90-7 | Purity: 96% | 1-TriMethylsilyl-2-pyrrolidinone | ESD-920293-50G |
| Cas.: 11138-11-7 | Purity: nanopowder, <100nm particle size (BET), >97% trace metals basis | BARIUM FERRITE | ESD-920294-50G |
| Cas.: 207500-00-3 | Purity: 98% | LEAD(II) PERCHLORATE HYDRATE | ESD-920295-50G |
| Cas.: 171860-65-4 | Purity: 0.5 M in THF | 2-Adamantylzinc bromide solution | ESD-920296-50ML |
| Cas.: 5158-46-3 | Purity: 2.0 M solution in THF | Methylzinc chloride | ESD-920297-50ML |
| Cas.: 121288-39-9 | Purity: 95% | 7-Allyl-7,8-dihydro-8-oxoguanosine | ESD-920298-50MG |
| Cas.: 89854-70-6 | Purity: 95% | 1-Methyl-cyclohexylamine hydrochloride | ESD-920299-50MG |
| Cas.: 1019842-99-9 | Purity: 97% | PPT | ESD-920300-50MG |
| Cas.: 1507403-85-1 | Purity: ≥95% | 4MetBuXPhos Pd G3 | ESD-920301-50MG |
| Cas.: 3184-35-8 | Purity: 95% | 2-Oxoadipic acid | ESD-920302-50MG |
| Cas.: 6232-19-5 | Purity: 98% | β-cyano-L-Alanine | ESD-920303-50MG |
| Cas.: 24365-65-9 | Purity: 98% | 3,4-Dihydro-3-methyl-2(1H)-quinazolinone | ESD-920304-50G |
| Cas.: 69403-12-9 | L-PHENYLALANINE DEHYDROGENASE | ESD-920306-50U | |
| Cas.: 4282-44-4 | Purity: 98% | 1-IODOUNDECANE | ESD-920307-50G |
| Cas.: 7420-89-5 | GLUTARALDEHYDE SODIUM BISULFITE ADDITION COMPOUND | ESD-920308-50G | |
| Cas.: 14468-80-5 | N-CBZ-2-Pyrrolidinone | ESD-920309-50ML | |
| Cas.: 254454-47-2 | Purity: 0.5M in THF | 4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid | ESD-920310-50ML |
| Cas.: 946843-80-7 | Purity: 99.9% trace metals basis | Copper(II) tartrate hydrate | ESD-920311-50G |
| Cas.: 1426151-00-9 | Maleimide-PEG12-succinimidyl ester | ESD-920312-50MG | |
| Cas.: 6291-65-2 | Purity: ≥99.0% (T) | Dipotassium methanedisulfonate | ESD-920313-50G |
| Cas.: 928789-96-2 | Purity: 96% | SN-(3,5-Di-tert-butylphenyl)-3-methyl-2-(N-formyl-N-methylamino)butanamide | ESD-920314-50MG |
| Cas.: 149341-34-4 | Purity: ≥95.0% (qNMR) | (R)-(+)-1-(2-DIPHENYLPHOSPHINO-1-NAPHTHYL)ISOQUINOLINE | ESD-920315-50MG |
| Cas.: 40299-61-4 | Purity: 97% | (4-METHOXYBENZYL)PHOSPHONIC ACID | ESD-920316-50MG |
| Cas.: 8013-89-6 | ACID CITRATE-DEXTROSE | ESD-920317-50ML | |
| Cas.: 160369-83-5 | Purity: ≥95% (TLC) | N-(5-AMINO-1-CARBOXYPENTYL)IMINODIACETIC ACID | ESD-920318-50MG |
| Cas.: 36001-88-4 | Purity: analytical standard analytical standard | Amiprofos methyl | ESD-920319-50MG |
| Cas.: 10190-99-5 | Purity: powder, ≥97% | Aristolocholic acid for system suitability | ESD-920320-50MG |
| Cas.: 14064-21-2 | Purity: 98% | 2-Furaldehyde dimethylhydrazone | ESD-920321-50G |
| Cas.: 668985-31-7 | Purity: 98% (HPLC) | (S)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | ESD-920322-50MG |
| Cas.: 16587-71-6 | Purity: 97% | 4-tert-Pentylcyclohexanone | ESD-920323-50G |
| Cas.: 944451-12-1 | Purity: reddish brown powder | Dimethylammoniumdichlorotri(μ-chloro)bis[(S)-(-)-2,2′-bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1, 1′-binaphthyl]diruthenate(II)[NH2Me2][{RuCl((S)-H8-binap)}2(μ-Cl)3] | ESD-920324-50MG |
| Cas.: 37787-90-9 | Purity: 98% | (-)-tert-Butyl (S)-2-hydroxybutyrate | ESD-920325-50MG |
| Cas.: 105299-45-4 | Purity: 97% | 4-[(4′-hydroxyphenyl)diazenyl]benzoic acid | ESD-920326-50MG |
| Cas.: 1001500-41-9 | Purity: solid | 4-AMino-N,1-diMethyl-1H-pyrazole-3-carboxaMide | ESD-920327-50MG |
| Cas.: 130369-04-9 | Purity: 95% | (3-Methylenecyclobutyl)carbamic acid tert-butyl ester | ESD-920328-50MG |
| Cas.: 684270-46-0 | Purity: 98% | Fmoc-β-azido-Ala-OH | ESD-920329-50MG |
| Cas.: 102014-58-4 | Purity: 97% | 1-Amino-1-methylcyclopentane hydrochloride | ESD-920330-50MG |
| Cas.: 357154-16-6 | Purity: 95% | Ethyl (R)-(+)-1-Boc-4-oxopiperidine-2-carboxylate | ESD-920331-50MG |
| Cas.: 301847-89-2 | Purity: 97% | (R)-C3-TunaPhos | ESD-920332-50MG |
| Cas.: 528565-84-6 | Purity: 98%, 99%ee | (-)-1,2-Bis((2R,5R)-2,5-diphenylphospholano)ethane(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | ESD-920333-50MG |
| Cas.: 128230-76-2 | Purity: 95% | 2,2-Difluoro-1-methylcyclopropanamine hydrochloride | ESD-920334-50MG |
| Cas.: 102525-11-1 | 1,5-Cyclooctadiene(η5-indenyl)iridium(I) | ESD-920335-50MG | |
| Cas.: 902837-14-3 | Purity: 95% | 2-(3-((2-Fluorobenzyl)oxy)phenyl)acetic Acid | ESD-920336-50MG |
| Cas.: 344349-71-9 | Purity: 99% | 4-(Phenoxymethyl)phenylacetic acid | ESD-920337-50MG |
| Cas.: 4294-45-5 | Purity: ≥98% (TLC) | DL-threo-β-Hydroxyaspartic acid | ESD-920338-50MG |
| Cas.: 207569-04-8 | Purity: ≥98.5% (HPLC) | Naphthol AS-BI phosphate disodium salt hydrate | ESD-920339-50MG |
| Cas.: 12634-43-4 | Purity: buffered aqueous glycerol solution | Spectrin, from human erythrocytes | ESD-920341-50ΜG |
| Cas.: 23295-92-3 | Purity: ≥80% (CE) | L-2-Phosphoglyceric acid disodium salt hydrate | ESD-920342-50MG |
| Cas.: 28910-89-6 | Purity: Pharmaceutical Secondary Standard; Certified Reference Material | Alprazolam Related Compound A | ESD-920343-50MG |
| Cas.: 25116-90-9 | 2′,4′-DIMETHYLBENZENESULFONANILIDE | ESD-920344-50MG | |
| Cas.: 19368-24-2 | 3′,4′-DICHLOROPHTHALANILIC ACID | ESD-920345-50MG | |
| Cas.: 14580-01-9 | N-Anilinosuccinamic acid | ESD-920346-50MG | |
| Cas.: 374067-51-3 | Purity: CARBON 64.4 – 71.2% | (R)-Ru(OAc)2(H8-BINAP) | ESD-920347-50MG |
| Cas.: 4424-17-3 | 2-AMINOBENZANILIDE | ESD-920348-50MG | |
| Cas.: 5825-62-7 | 4′-NITROMETHANESULFONANILIDE | ESD-920349-50MG | |
| Cas.: 13664-49-8 | 4-METHOXY-N-PHENYLBENZOHYDROXAMIC ACID | ESD-920350-50MG | |
| Cas.: 1206-55-9 | 3,6-DIMETHOXY-2-NITROBENZALDEHYDE | ESD-920351-50MG | |
| Cas.: 14949-01-0 | 2-CHLORO-4′-SULFAMOYLACETANILIDE | ESD-920352-50MG | |
| Cas.: 25706-29-0 | 6-AMINO-2-(METHYLTHIO)-BENZOTHIAZOLE | ESD-920353-50MG | |
| Cas.: 110190-08-4 | 1,2-DIIODO-4,5-DIMETHOXYBENZENE | ESD-920354-50MG | |
| Cas.: 13665-98-0 | 2,3,4,5,6-PENTABROMOANILINE | ESD-920355-50MG | |
| Cas.: 68399-76-8 | Purity: ≥98.0% | Orotic acid zinc salt dihydrate | ESD-920356-50G |
| Cas.: 9050-76-4 | Purity: recombinant, expressed in E. coli, buffered aqueous glycerol solution, 1,000-4,000 units/mL | Ribonuclease H, from Escherichia coli | ESD-920357-30U |
| Cas.: 92273-73-9 | Purity: 0.5M in THF | Butylzinc Bromide | ESD-920358-25ML |
| Cas.: 23378-88-3 | Purity: 99% | 3,5-Dichloro-2-hydroxybenzenesulfonyl chloride | ESD-920359-25G |
| Cas.: 83646-41-7 | Purity: 97% | Julolidine hydrobromide | ESD-920360-25G |
| Cas.: 153447-97-3 | Purity: 96% | Octenyltrichlorosilane | ESD-920362-25ML |
| Cas.: 594-60-5 | Purity: 98% | 2,3-Dimethyl-2-butanol | ESD-920365-25G |
| Cas.: 807329-97-1 | Purity: 1M in MeTHF | Isopropylmagnesium chloride lithium chloride complex | ESD-920366-25ML |
| Cas.: 17346-16-6 | Purity: 97% | 2,4-Dibromo-2,4-dimethyl-3-pentanone | ESD-920367-25G |
| Cas.: 4598-61-2 | Purity: ~20% in H2O | TETRAPENTYLAMMONIUM HYDROXIDE | ESD-920368-25ML |
| Cas.: 2171-99-5 | Purity: 99% | Hafnium(IV) isopropoxide isopropanol complex | ESD-920369-25G |
| Cas.: 52488-29-6 | Purity: 97% | 3-IODO-4-NITROTOLUENE | ESD-920370-25G |
| Cas.: 1071-27-8 | Purity: 98% | 3-CYANOPROPYLTRICHLOROSILANE | ESD-920371-25G |
| Cas.: 332382-54-4 | Purity: ≥95% (HPLC) | ML-SA1 | ESD-920374-25MG |
| Cas.: 63701-56-4 | Purity: ≥98% (TLC) | S()-Baclofen hydrochloride | ESD-920375-25MG |
| Cas.: 706-79-6 | Purity: 97% | 1,2-DICHLOROHEXAFLUOROCYCLOPENTENE | ESD-920376-25G |
| Cas.: 26389-60-6 | N-Propylcyclopropanemethylamine | ESD-920377-25G | |
| Cas.: 305808-21-3 | Purity: 98% | TRIETHYLENETETRAMINE HYDRATE | ESD-920378-25G |
| Cas.: 73624-47-2 | Purity: 97% | R-Alpine-Borane | ESD-920379-25ML |
| Cas.: 1974-04-5 | 2-Bromoheptane | ESD-920380-25G | |
| Cas.: 88468-45-5 | Purity: 97% | Isooctyl trimethoxysilane, mixture of isomers | ESD-920381-25G |
| Cas.: 14370-23-1 | Purity: 96% | 2-ISOTHIOCYANATO-BICYCLO[2.2.1]HEPTANE | ESD-920382-25G |
| Cas.: 36885-31-1 | Purity: 99.99% trace metals | Barium bis(6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionate) | ESD-920383-25G |
| Cas.: 100641-13-2 | Purity: 99.9% trace metals basis | Dysprosium(III) nitrate hydrate | ESD-920384-25G |
| Cas.: 111941-71-0 | Purity: ≥99.9% trace metals basis | Yttrium(III) butoxide solution 0.5 M in toluene | ESD-920385-25ML |
| Cas.: 321673-30-7 | Purity: ≥98% | [(2-Hexylcyclopentylidene)amino]thiourea | ESD-920386-25MG |
| Cas.: 204451-47-8 | Purity: Abundance: 98atom%; Chemical purity: ≥98.5% | L-Asparagine-(amide-15N) monohydrate | ESD-920387-25MG |
| Cas.: 2363165-42-6 | Purity: 98% | M89 | ESD-920388-5MG |
| Cas.: 1947408-74-3 | Purity: ≥95% | Methyl (4-bromobenzoyl)-L-cysteinate | ESD-920389-25MG |
| Cas.: 2115897-23-7 | Purity: ≥98% | (S,S,S)-AHPC hydrochloride | ESD-920390-25MG |
| Cas.: 91742-11-9 | Purity: >99% | 1,2-dilignoceroyl-sn-glycero-3-phosphocholine | ESD-920391-25MG |
| Cas.: 46492-08-4 | Purity: 99% | Benz[g]isoquinoline-5,10-dione | ESD-920392-25MG |
| Cas.: 15244-37-8 | Purity: 99.9985% (metals basis) | Nickel(II) sulfate hydrate | ESD-920393-25G |
| Cas.: 17632-19-8 | Purity: 98% | 2,3,7,8,12,13,17,18-Octaethylporphyrinato Cobalt | ESD-920394-25MG |
| Cas.: 1193-96-0 | Purity: ≥99% | syn-2-Pyridinealdoxime | ESD-920395-25G |
| Cas.: 61166-00-5 | Purity: 85% | 3,3′-ETHYLENEDIOXYDIPHENOL | ESD-920397-25G |
| Cas.: 89776-74-9 | Purity: 97% | 5-Isopropylisoxazole-3-carboxylic acid | ESD-920398-25G |
| Cas.: 2181-44-4 | Purity: 98% | TRIMETHYLSULFONIUM METHYL SULFATE | ESD-920399-25G |
| Cas.: 15112-89-7 | Purity: 99,999% | TRIS(DIMETHYLAMINO)SILANE | ESD-920400-25G |
| Cas.: 6820-54-8 | Purity: ≥98% | PHENOLPHTHALEIN GLUCURONIC ACID SODIUM SALT | ESD-920401-25MG |
| Cas.: 1071466-61-9 | Purity: 90% | 2,2′-Diallyl bisphenol A diacetate ether | ESD-920402-25G |
| Cas.: 80866-91-7 | Purity: 97% | 2-Bromopyridine N-oxide hydrochloride | ESD-920403-25G |
| Cas.: 10490-07-0 | Purity: 99% | ALPHA-(PHENYLTHIO)PHENYLACETIC ACID | ESD-920404-25G |
| Cas.: 109037-77-6 | Purity: MIXED, 50% IN PROPYLENE CARBONAT | TRIARYLSULFONIUM HEXAFLUOROPHOSPHATE SAL TS | ESD-920405-25ML |
| Cas.: 4885-03-4 | Purity: 95% | DICHLORODIPHENOXYMETHANE | ESD-920406-25G |
| Cas.: 199926-21-1 | Purity: 97% | L-Lysine hydrate | ESD-920407-25G |
| Cas.: 4093-41-8 | Purity: 98% | Methyl 4-(acetylamino)-2-methoxy-5-nitrobenzoate | ESD-920408-25G |
| Cas.: 852527-45-8 | Purity: ≥95% | N-Succinimidyl 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoate | ESD-920409-25MG |
| Cas.: 4409-98-7 | Purity: 98% | DI-POTASSIUM PHTHALATE | ESD-920410-25G |
| Cas.: 494211-79-9 | Purity: ≥97.0% (TLC) | 3-Dehydroquinic acid potassium salt, (1R,3R,4S)-1,3,4-Trihydroxy-5-oxocyclohexanecarboxylic acid potassium salt | ESD-920411-25MG |
| Cas.: 14857-77-3 | L-2-AMINO-4-SULFOBUTYRIC ACID | ESD-920412-25MG | |
| Cas.: 119039-80-4 | Purity: D-Glu:D-Lys (6:4), mol wt 20,000-50,000 | Poly(D-Glu, D-Lys) hydrobromide | ESD-920413-25MG |
| Cas.: 25281-63-4 | POLY-DL-ALANINE | ESD-920414-25MG | |
| Cas.: 35899-53-7 | S-(5′-Adenosyl)-L-cysteine | ESD-920415-25MG | |
| Cas.: 71636-61-8 | Purity: ≥98% (HPLC) | (±)-6-Chloro-PB hydrobromide | ESD-920416-25MG |
| Cas.: 36940-87-1 | Purity: ≥98% | 2′-O-Monosuccinyladenosine 3′:5′-cyclic monophosphate | ESD-920417-25MG |
| Cas.: 5455-98-1 | Purity: ≥95% | N-(2,3-Epoxypropyl)phthalimide | ESD-920418-25G |
| Cas.: 24765-57-9 | Purity: 97% | 2,2-Di-n-butyl-1,3-propanediol | ESD-920419-25G |
| Cas.: 2040-01-9 | Purity: 98% | 2′,3′,4′,5′,6′-PentaMethylacetophenone | ESD-920421-25G |
| Cas.: 13451-05-3 | Purity: 99,9% | Strontium tungsten oxide | ESD-920422-25G |
| Cas.: 5561-87-5 | Purity: ≥98% | rac 3-Hydroxydecanoic Acid | ESD-920423-25MG |
| Cas.: 457961-34-1 | Purity: 98% (HPLC) | 1-(4-methoxy-3-methylbenzenesulfonyl)piperidine | ESD-920424-25MG |
| Cas.: 17685-05-1 | Purity: 99.0% (HPLC) | Phenyl-beta-D-glucuronide hydrate | ESD-920425-25MG |
| Cas.: 25508-20-7 | Purity: 95% | 1,3-Bis(benzyloxycarbonyl)-2-Methyl-2-thiopseudourea | ESD-920426-25G |
| Cas.: 474944-16-6 | Purity: >99% | 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[3-(2-pyridyldithio)propionate] (sodium salt) | ESD-920427-25MG |
| Cas.: 1190-24-5 | Purity: 98% | N-ForMylurea | ESD-920428-25G |
| Cas.: 199926-38-0 | Purity: 95% | 2,3-dihydroxyfuMaric acid hydrate | ESD-920429-25G |
| Cas.: 73891-15-3 | Purity: solid | (-)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid | ESD-920430-25MG |
| Cas.: 2708-77-2 | Purity: 97% | DL-4-FluoroglutaMic acid | ESD-920431-25MG |
| Cas.: 528854-34-4 | Purity: 88% | 1,2-Bis[(2S,5S)-2,5-diisopropylphospholano]ethane | ESD-920432-25MG |
| Cas.: 851051-43-9 | Purity: 95% | [(S,S)-Teth-TsDpen RuCl] | ESD-920433-25MG |
| Cas.: 880262-14-6 | Purity: 97% | 1,5-Cyclooctadiene{[dibenzyl((4R,5R)-5-methyl-2-phenyl-4,5-dihydro-4-oxazolyl)methyl]dicyclohexylphosphinite kappaN:kappaP}iridium(I)tetrakis(3,5- bis(trifluoromethyl)phenyl)borate | ESD-920434-25MG |
| Cas.: 410544-56-8 | Purity: 90% | 5-Bromo-N-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide | ESD-920435-25MG |
| Cas.: 329735-87-7 | Purity: 95% | Dichloro[(S)-(-)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl][(1R,2R)-(+)-1,2-diphenylethylenediamine]ruthenium(II) | ESD-920436-25MG |
| Cas.: 120934-96-5 | Purity: ≥98% (HPLC) | 2,5-Dimethyl-4-[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxlic acid methyl ester | ESD-920437-25MG |
| Cas.: 103192-39-8 | Purity: Type VI, ≥92.5% | Guanosine 5′-diphosphate tris salt, from Saccharomyces cerevisiae | ESD-920438-25MG |
| Cas.: 85737-04-8 | Purity: 95% (HPLC) | Guanosine 5′-triphosphate lithium salt | ESD-920439-25MG |
| Cas.: 9064-47-5 | Purity: Type III-S ≥60% protein basis (biuret) | Histone, from calf thymus | ESD-920440-25MG |
| Cas.: 103404-54-2 | Purity: ≥98% (HPLC) | Hippuryl-His-Leu acetate salt | ESD-920441-25MG |
| Cas.: 96594-10-4 | Purity: ≥98% (HPLC) | L-Alanine 7-amido-4-methylcoumarin trifluoroacetate salt | ESD-920442-25MG |
| Cas.: 9028-47-1 | Purity: 10-30 units/mg protein | Malic Dehydrogenase (oxalacetate-decarboxylating) from chicken liver | ESD-920443-25U |
| Cas.: 70253-67-7 | Purity: ≥97.5% (HPLC) | N6-Monobutyryladenosine 3′:5′-cyclic monophosphate sodium salt | ESD-920444-25MG |
| Cas.: 104809-38-3 | Purity: ≥92% | Nicotinamide hypoxanthine dinucleotide sodium salt | ESD-920445-25MG |
| Cas.: 104809-30-5 | Purity: ≥98% | Nicotinic acid adenine dinucleotide sodium salt | ESD-920446-25MG |
| Cas.: 72252-90-5 | Purity: Km = 140uM | Elastase Substrate V, Fluorogenic | ESD-920447-25MG |
| Cas.: 106956-32-5 | Purity: ≥97% (SDS-PAGE) | Oncostatin M from mouse | ESD-920448-25ΜG |
| Cas.: 97612-24-3 | Purity: ≥98% (HPLC) | FLB 131 | ESD-920449-25MG |
| Cas.: 98185-20-7 | Purity: >97% | S()-Raclopride (+)-tartrate salt | ESD-920450-25MG |
| Cas.: 98179-10-3 | Purity: ≥98% (HPLC) | Thymidine 5′-monophosphate p-nitrophenyl ester sodium salt | ESD-920451-25MG |
| Cas.: 234757-41-6 | Purity: ≥98% (HPLC) | 5,6-Dimethoxy-2-(di-n-propylamino)indan maleate salt | ESD-920452-25MG |
| Cas.: 9026-22-6 | Purity: Type X, lyophilized powder, ≥40 units/mg protein | Uridine-5′-diphosphoglucose pyrophosphorylase, from baker’s yeast | ESD-920453-25U |
| Cas.: 9041-92-3 | Purity: ≥60% (biuret) | α1-Antitrypsin, from human plasma | ESD-920454-25MG |
| Cas.: 9066-45-9 | Purity: ≥90% (PAGE) | β-Lactoglobulin B, from bovine milk | ESD-920455-25MG |
| Cas.: 27098-24-4 | Purity: >99% (TLC) | 1-stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine | ESD-920456-25MG |
| Cas.: 56782-46-8 | Purity: >99% (TLC) | 1,2-dielaidoyl-sn-glycero-3-phosphocholine | ESD-920457-25MG |
| Cas.: 89874-80-6 | Purity: solid | R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride | ESD-920458-25MG |
| Cas.: 474943-26-5 | Purity: >99% (TLC) | 1-stearoyl-2-linoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) | ESD-920459-25MG |
| Cas.: 15151-51-6 | Purity: 98% | 3-Aminobenzoic acid hydrochloride | ESD-920460-25G |
| Cas.: 24008-82-0 | Purity: ≥98% (TLC) | Ser-Tyr β-naphthylamide | ESD-920461-25MG |
| Cas.: 384835-50-1 | 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p maleimidophenyl)butyramide] (sodium salt) | ESD-920462-25MG | |
| Cas.: 155401-41-5 | 1-oleoyl-2-cholesterylhemisuccinoyl-sn-glycero-3-phosphocholine | ESD-920463-25MG | |
| Cas.: 384835-45-4 | Purity: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC) | 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt) | ESD-920464-25MG |
| Cas.: 384835-49-8 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (sodium salt) | ESD-920465-25MG | |
| Cas.: 56391-91-4 | Purity: >99% (TLC) | 1,2-dipetroselenoyl-sn-glycero-3-phosphocholine | ESD-920466-25MG |
| Cas.: 115288-21-6 | Form: powder | 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-(hexanoylamine) | ESD-920467-25MG |
| Cas.: 518-41-2 | 2-(4,5,6-Trihydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid | ESD-920468-25MG | |
| Cas.: 253678-66-9 | Purity: >99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC) | 1-nonanoyl-2-hydroxy-sn-glycero-3-phosphocholine | ESD-920469-25MG |
| Cas.: 4724-96-3 | Purity: >99% (TLC) | 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine | ESD-920470-25MG |
| Cas.: 322729-38-4 | Purity: >99% (TLC) | 1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) | ESD-920471-25MG |
| Cas.: 56816-00-3 | Purity: >99% (TLC) | 1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine | ESD-920472-25MG |
| Cas.: 56750-90-4 | Purity: >99% (TLC) | 1,2-dimyristoleoyl-sn-glycero-3-phosphocholine | ESD-920473-25MG |
| Cas.: 72450-62-5 | Piperidine-4-sulfonic acid | ESD-920474-25MG | |
| Cas.: 151379-99-6 | Purity: >99% (TLC) | 1,2-dioleoyl-sn-glycero-3-phosphomethanol (sodium salt) | ESD-920475-25MG |
| Cas.: 474923-47-2 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(dodecanyl) (sodium salt) | ESD-920476-25MG | |
| Cas.: 11028-00-5 | Purity: Analysis control, ≥98% | Stevenleaf | ESD-920477-20MG |
| Cas.: 9001-04-1 | Purity: ammonium sulfate suspension, 5.0-20.0 units/mg protein (biuret) | Pyruvate Decarboxylase from baker’s yeast (S. cerevisiae) | ESD-920478-20U |
| Cas.: 9016-11-9 | Purity: Type IV, lyophilized powder, 20-60 units/mg protein (modified Warburg-Christian) | Galactose-1-phosphate Uridyltransferase, from galactose-adapted yeast | ESD-920479-20U |
| Cas.: 66-28-4 | Purity: ≥90.0% (HPLC) | Corchorin | ESD-920480-20MG |
| Cas.: 9031-02-1 | Purity: buffered aqueous glycerol solution, 0.1-1.0 units/mg protein (Lowry) | α-Ketoglutarate Dehydrogenase, from porcine heart | ESD-920481-20U |
| Cas.: 17672-53-6 | Purity: 98% | Bis(2,2,2-trichloroethyl) phosphorochloridate | ESD-920482-10G |
| Cas.: 38775-38-1 | Purity: 98% | 1-Hexadecanesulfonyl chloride | ESD-920483-10G |
| Cas.: 471-05-6 | Purity: ≥98% (HPLC) | zerumbone | ESD-920485-10MG |
| Cas.: 17271-89-5 | Purity: 95% (HPLC) | 1-(Azidomethyl)-4-methylbenzene solution | ESD-920486-10ML |
| Cas.: 3296-02-4 | Purity: ≥95.0% (HPLC) | 1-Azido-4-fluorobenzene solution | ESD-920487-10ML |
| Cas.: 2101-86-2 | Purity: ≥95.0% (HPLC) | 4-Azidotoluene solution | ESD-920488-10ML |
| Cas.: 924-41-4 | Purity: 95% | 1,5-Hexadien-3-ol | ESD-920489-10G |
| Cas.: 79490-00-9 | Purity: 99.999% trace metals basis | Cadmium perchlorate hydrate | ESD-920490-10G |
| Cas.: 13773-69-8 | Purity: 99.99% trace metals basis | Yttrium(III) nitrate tetrahydrate | ESD-920491-10G |
| Cas.: 126403-68-7 | Purity: 0.5MinTHF | Cyclopropylzinc bromide | ESD-920492-10ML |
| Cas.: 17218-47-2 | Purity: 99% | Potassium hexafluoronickelate(IV) | ESD-920493-10G |
| Cas.: 32093-39-3 | Tris(dimethylamido)aluminum(III) | ESD-920495-10G | |
| Cas.: 88280-58-4 | Purity: 97% | 3-BROMODIPHENYLAMINE | ESD-920496-10G |
| Cas.: 676593-65-0 | Basolite Z377 | ESD-920497-10G | |
| Cas.: 96850-13-4 | Purity: solid | Indatraline hydrochloride | ESD-920498-10MG |
| Cas.: 111686-79-4 | Purity: ≥98% (HPLC) | Remacemide hydrochloride | ESD-920499-10MG |
| Cas.: 40252-74-2 | Purity: ≥98% (HPLC) | 3-Methoxybenzaldehyde [(3-methoxyphenyl)methylene]hydrazone | ESD-920500-10MG |
| Cas.: 56310-18-0 | Purity: 97% | DI-TERT-BUTYLCHLOROSILANE | ESD-920501-10G |
| Cas.: 1345866-68-3 | Purity: 95% | (4-(1,2,4,5-Tetrazin-3-yl)phenyl)methanamine | ESD-920502-10MG |
| Cas.: 496-65-1 | Purity: ≥95.0% (HPLC) | (R)-2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethylbutyramide | ESD-920503-10MG |
| Cas.: 66794-74-9 | Purity: ≥98% (HPLC) | Encainide hydrochloride | ESD-920504-10MG |
| Cas.: 502486-89-7 | Purity: ≥97% (HPLC) | NIDA-41020 | ESD-920505-10MG |
| Cas.: 209266-80-8 | Purity: ≥90% (HPLC) | Okadaic acid sodium salt, from Prorocentrum concavum | ESD-920506-10ΜG |
| Cas.: 155751-72-7 | Purity: ≥90% (HPLC) | Okadaic acid potassium salt, from Prorocentrum concavum | ESD-920507-10ΜG |
| Cas.: 155716-06-6 | Purity: ≥90% (HPLC) | Okadaic acid ammonium salt, from Prorocentrum concavum | ESD-920508-10ΜG |
| Cas.: 53186-57-5 | Purity: ≥98.0% (HPLC) | S-(5′-Adenosyl)-3-thiopropylamine | ESD-920509-10MG |
| Cas.: 113170-86-8 | Purity: ≥98% (HPLC) | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine mono(2-hydroxyethanesulfonate) | ESD-920510-10MG |
| Cas.: 89007-45-4 | Purity: 96% | 4-Isopropylphenyl isothiocyanate | ESD-920511-10G |
| Cas.: 352525-65-6 | Purity: 0.5 M in THF | 4-Bromo-3-fluorophenylzinc iodide solution | ESD-920512-10ML |
| Cas.: 6651-43-0 | Purity: 98% | 1-TRIMETHYLSILOXY-1,3-BUTADIENE | ESD-920513-10G |
| Cas.: 11113-88-5 | Silver oxide | ESD-920514-10G | |
| Cas.: 2295-12-7 | Purity: 95% | 1,1-Dimethylsiletane | ESD-920515-10ML |
| Cas.: 1515-76-0 | Purity: 90% | 1-Acetoxy-1,3-butadiene | ESD-920516-10G |
| Cas.: 25518-49-4 | Purity: ≥97% | Isobutyryl-L-carnitine | ESD-920517-10MG |
| Cas.: 47326-86-3 | Purity: 99% | WR99210 | ESD-920518-10MG |
| Cas.: 2271036-47-4 | Purity: ≥95% | Pomalidomide-PEG4-azide | ESD-920519-10MG |
| Cas.: 724771-61-3 | Purity: ≥95% | 4-(3-Fluoro-4-methoxyphenyl)dihydro-2H-pyran-2,6(3H)-dione | ESD-920520-10MG |
| Cas.: 1458576-00-5 | Purity: ≥98% | Biotin-PEG4-alkyne | ESD-920521-10MG |
| Cas.: 4792-78-3 | Purity: 98% | 2-(2-Hydroxyethoxy)phenol | ESD-920522-10G |
| Cas.: 21211-07-4 | Purity: 97% | Methyl 3-chlorobenzo[b]thiophene-2-carboxylate | ESD-920523-10G |
| Cas.: 27816-36-0 | Purity: 98% | 2-CHLOROPROPIONAMIDE | ESD-920524-10G |
| Cas.: 956-04-7 | Purity: 98% | 4-Chlorochalcone | ESD-920525-10G |
| Cas.: 100634-91-1 | Purity: ≥99.9% trace metals basis | GADOLINIUM(III) HYDROXIDE | ESD-920527-10G |
| Cas.: 12645-50-0 | Purity: ≥99% trace metals basis | NICKEL ZINC IRON OXIDE NANOPOWDER | ESD-920528-10G |
| Cas.: 223911-98-6 | Purity: 99% | HOLMIUM BROMIDE HYDRATE | ESD-920529-10G |
| Cas.: 548-51-6 | Purity: 98% | 2-HYDROXY-3-ISOPROPYL-6-METHYLBENZOIC ACID | ESD-920531-10G |
| Cas.: 12014-44-7 | Purity: 99% trace metals basis | CERIUM ALUMINUM OXIDE NANOPOWDER | ESD-920532-10G |
| Cas.: 66072-40-0 | BENZYL ALCOHOL, POLYMER-BOUND | ESD-920533-10G | |
| Cas.: 24327-08-0 | Form: powder | ENDO-BICYCLO[2.2.2]OCT-5-ENE-2,3-DICARBOXYLIC ANHYDRIDE | ESD-920534-10G |
| Cas.: 6485-81-0 | Purity: 99% | TRIISOBUTYLSILANE | ESD-920537-10G |
| Cas.: 1255502-07-8 | Purity: ≥93.0% (qNMR) | R-MVA-Li | ESD-920538-10MG |
| Cas.: 27792-36-5 | Purity: ≥93% | Dicyanocobinamide | ESD-920539-10MG |
| Cas.: 6000-40-4 | Purity: ≥95% (TLC) | D-Glyceric acid sodium salt | ESD-920540-10MG |
| Cas.: 3422-31-9 | Purity: ≥98% | DL-B-HYDROXYMYRISTIC ACID | ESD-920541-10MG |
| Cas.: 97105-00-5 | Purity: Glu:Tyr (4:1), mol wt 20, 000-50, 000 | Poly(Glu, Tyr) sodium salt | ESD-920542-10MG |
| Cas.: 26936-40-3 | POLYCYTIDYLIC ACID (5′) POTASSIUM SALT | ESD-920543-10MG | |
| Cas.: 61857-39-4 | Purity: mol wt 5000 | Poly-L-histidine hydrochloride | ESD-920544-10MG |
| Cas.: 26982-21-8 | poly-l-ornithine hydrochloride | ESD-920545-10MG | |
| Cas.: 720675-90-1 | Purity: ≥98% (HPLC) | 6,2′,4′-TRIMETHOXYFLAVONE | ESD-920546-10MG |
| Cas.: 104809-16-7 | Purity: ≥92.5% | 7-Methylguanosine 5′-diphosphate sodium salt | ESD-920547-10MG |
| Cas.: 345909-31-1 | Purity: 99% | CalciuM 2,4-pentanedionate hydrate, | ESD-920548-10G |
| Cas.: 7153-66-4 | Purity: 95% | cis-4-Chloro-2-butenylaMine hydrochloride | ESD-920549-10G |
| Cas.: 53643-12-2 | Purity: ≥98% (TLC) | 4-Methylumbelliferyl N,N-diacetyl-β-D-chitobioside | ESD-920550-10MG |
| Cas.: 73029-73-9 | Purity: ≥98% (HPLC) | N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine | ESD-920551-10MG |
| Cas.: 132489-69-1 | Purity: ≥95% (HPLC) | O-(2-Acetamido-2-deoxy-D-glucopyranosylidene)amino N-phenyl carbamate | ESD-920552-10MG |
| Cas.: 125440-91-7 | Purity: ≥90% | Resorufin-β-D-glucuronide sodium salt | ESD-920553-10MG |
| Cas.: 192065-56-8 | Purity: 98% (HPLC) | 4-(8-Methyl-9H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline hydrochloride | ESD-920554-10MG |
| Cas.: 1548-68-1 | Purity: ≥95.0% (HPLC) | 1-Azido-2-(trifluoroMethyl)benzene solution | ESD-920555-10ML |
| Cas.: 18085-02-4 | Purity: 98% | 3,4-Diacetoxy-1-butene | ESD-920556-10G |
| Cas.: 13293-59-9 | Purity: ≥95% | 3-Methyl-1-cyclohexanecarboxylic acid | ESD-920557-10G |
| Cas.: 15178-63-9 | Purity: orange crystal | N-(1-Oxyl-2,2,6,6-tetraMethyl-4-piperidinyl)MaleiMide | ESD-920558-10MG |
| Cas.: 1225146-53-1 | Purity: 97% | 5-[4-(1,2,4,5-Tetrazin-3-yl)benzylamino]-5-oxopentanoic acid | ESD-920559-10MG |
| Cas.: 138470-70-9 | Purity: 98% | Mozavaptan hydrochloride | ESD-920560-10MG |
| Cas.: 1174157-65-3 | Purity: 88% | Propargyl-N-hydroxysuccinimidyl ester | ESD-920561-10MG |
| Cas.: 118343-19-4 | Purity: ≥98% (HPLC) | 2-[2H-(1-Methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole maleate salt | ESD-920562-10MG |
| Cas.: 160521-72-2 | Purity: ≥98% (HPLC) | α-methyl-5-(2-thienylmethoxy)-1H-Indole-3-ethanamine monohydrochloride | ESD-920563-10MG |
| Cas.: 125-85-9 | Purity: ≥98% (HPLC) | Caramiphen hydrochloride | ESD-920564-10MG |
| Cas.: 9032-68-2 | Purity: ≥5 units/mg protein | Cathepsin C, from bovine spleen | ESD-920565-10U |
| Cas.: 51570-20-8 | Purity: >50 units/mg protein (Bradford) | Chitosanase, from Streptomyces griseus | ESD-920566-10U |
| Cas.: 70107-07-2 | Purity: solid | Chloroethylclonidine dihydrochloride | ESD-920567-10MG |
| Cas.: 9047-57-8 | Purity: ≥200 units/mg protein, For Chondroitin Sulfate Analysis | Chondroitinase AC, from Flavobacterium heparinum | ESD-920568-10U |
| Cas.: 163163-23-3 | Purity: ≥98% (HPLC), powder | Chromanol 293B | ESD-920569-10MG |
| Cas.: 100678-32-8 | Purity: ≥98% (HPLC) | Cibenzoline succinate | ESD-920570-10MG |
| Cas.: 32771-64-5 | Purity: ≥90% (HPLC) | cis-Zeatin | ESD-920571-10MG |
| Cas.: 118081-33-7 | Purity: for use at 320 nm | Collagenase Chromophore-Substrate | ESD-920572-10MG |
| Cas.: 17363-08-5 | Purity: ≥95% (NMR) | CORM-A1 | ESD-920573-10MG |
| Cas.: 52497-36-6 | Purity: ≥98% (HPLC), powder | Dihydrokainic acid | ESD-920574-10MG |
| Cas.: 881997-86-0 | Purity: ≥98% (HPLC) | Eptifibatide acetate | ESD-920575-10MG |
| Cas.: 9013-66-5 | Purity: ≥300 units/mg protein | Glutathione Peroxidase, from bovine erythrocytes | ESD-920576-10U |
| Cas.: 21027-72-5 | Purity: ≥98% (TLC) | Gly-Phe p-nitroanilide | ESD-920577-10MG |
| Cas.: 144625-51-4 | Purity: ≥98% (HPLC) | 1-[2-[(Methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate | ESD-920578-10MG |
| Cas.: 103192-46-7 | Purity: ≥93% (HPLC) | Guanosine 5′-triphosphate tris salt | ESD-920579-10MG |
| Cas.: 149371-12-0 | Purity: ≥100 units/mg protein (enzyme + BSA) | Heparinase II, from Flavobacterium heparinum | ESD-920580-10U |
| Cas.: 34433-31-3 | Purity: ≥98% (HPLC) | Transant | ESD-920581-10MG |
| Cas.: 32385-58-3 | Purity: ≥98% (HPLC) | Imetit dihydrobromide | ESD-920582-10MG |
| Cas.: 159190-45-1 | Purity: ≥97% (HPLC) | L-N6-(1-Iminoethyl)lysine dihydrochloride | ESD-920583-10MG |
| Cas.: 94099-57-7 | Purity: ≥98% (TLC) | L-Tyrosine 7-amido-4-methylcoumarin | ESD-920584-10MG |
| Cas.: 116928-84-8 | Purity: ≥90% (HPLC) | Malonyl coenzyme A tetralithium salt | ESD-920585-10MG |
| Cas.: 104807-46-7 | Purity: ≥97% (NMR) | Methoctramine hydrate | ESD-920586-10MG |
| Cas.: 636582-62-2 | Purity: ≥98% (HPLC) | Mosapride citrate salt dihydrate | ESD-920587-10MG |
| Cas.: 55096-26-9 | Purity: 98% | Nalmefene | ESD-920588-10MG |
| Cas.: 184241-44-9 | Purity: ≥98% (HPLC) | NBI 27914 | ESD-920589-10MG |
| Cas.: 70968-04-6 | Purity: protease substrate | N-Succinyl-Ala-Ala-Pro-Leu p-nitroanilide | ESD-920590-10MG |
| Cas.: 5502-96-5 | Purity: ≥92.5% | Nicotinic acid adenine dinucleotide phosphate sodium salt | ESD-920591-10MG |
| Cas.: 68982-90-1 | Purity: ≥98% (TLC) | N-Succinyl-Gly-Gly-Phe-p-nitroanilide | ESD-920592-10MG |
| Cas.: 16503-22-3 | Nα-Methylhistamine dihydrochloride | ESD-920593-10MG | |
| Cas.: 102783-40-4 | P1,P3-Di(adenosine-5′) triphosphate ammonium salt | ESD-920594-10MG | |
| Cas.: 102783-36-8 | Purity: ≥95% (HPLC) | P1,P4-Di(adenosine-5′)tetraphosphate ammonium salt | ESD-920595-10MG |
| Cas.: 64006-44-6 | Purity: ≥98% (HPLC) | Paroxetine maleate salt | ESD-920596-10MG |
| Cas.: 9032-10-4 | Purity: 20-30 units/mg protein | Phosphorylase a, from rabbit muscle | ESD-920597-10MG |
| Cas.: 419538-69-5 | Purity: ≥98% (HPLC) | Pyrabactin | ESD-920598-10MG |
| Cas.: 9014-20-4 | Purity: buffered aqueous glycerol solution, 0.1-1.0 units/mg protein (Lowry) | Pyruvate Dehydrogenase, from porcine heart | ESD-920599-10U |
| Cas.: 81166-47-4 | Purity: ≥98% (HPLC) | R-(+)-DIOA | ESD-920600-10MG |
| Cas.: 9042-08-4 | Purity: Type II ≥4% protein basis (Lowry) | Rennet from Mucor miehei | ESD-920601-10G |
| Cas.: 101490-85-1 | Purity: ≥95% | Resorufin β-D-glucopyranoside | ESD-920602-10MG |
| Cas.: 75241-23-5 | Purity: ≥97% (HPLC) | Sar-Pro-Arg p-nitroanilide dihydrochloride | ESD-920603-10MG |
| Cas.: 37330-34-0 | Purity: Protein, 70-90% biuret | Trypsin-chymotrypsin inhibitor, from Glycine max (soybean) | ESD-920604-10MG |
| Cas.: 94948-59-1 | Purity: TNF-α, recombinant, expressed in HEK 293 cells, suitable for cell culture ≥95% (SDS-PAGE) ≤1.0 ng/mL ED50 | Tumor Necrosis Factor-α, human | ESD-920605-10ΜG |
| Cas.: 122955-42-4 | Purity: ≥98% (HPLC) | XE-991 | ESD-920606-10MG |
| Cas.: 241800-98-6 | Purity: ≥98% (HPLC) | Zoniporide hydrochloride hydrate | ESD-920607-10MG |
| Cas.: 97469-12-0 | Purity: ≥98% (HPLC) | α-Methylserotonin maleate salt | ESD-920608-10MG |
| Cas.: 9044-93-3 | Purity: ≥0.2 U/mg | BETA-1,3-D-GLUCANASE | ESD-920609-10MG |
| Cas.: 7298-93-3 | Purity: from Saccharomyces cerevisiae, ≤1% β-isomer, ≥95% | α-Nicotinamide adenine dinucleotide | ESD-920610-10MG |
| Cas.: 50863-92-8 | Purity: ≥90% (PAGE) | β-Lactoglobulin A, from bovine milk | ESD-920611-10MG |
| Cas.: 58856-73-8 | Purity: ≥5 μmol per mL | 6-Aminohexyl–Agarose | ESD-920613-10ML |
| Cas.: 324054-54-8 | Purity: >99% (TLC) | 1-hexadecanoyl-2-(11,12-dibromooctadecanoyl)-sn-glycero-3-phosphocholine | ESD-920614-10MG |
| Cas.: 4753-19-9 | Purity: ≥98.5% (HPLC) | 4-Pyridoxolactone | ESD-920615-10MG |
| Cas.: 177093-58-2 | Purity: BioReagent, suitable for Fluorescence, ≥98.0% (N) | 3-[4-(Bromomethyl)phenyl]-7-(diethylamino)coumarin | ESD-920616-10MG |
| Cas.: 1188-85-8 | 18:0 Diether PC | ESD-920617-10MG | |
| Cas.: 19431-21-1 | Purity: ≥55% peptide basis | Lys-Lys-Lys-Lys-Lys | ESD-920618-10MG |
| Cas.: 18687-42-8 | Purity: ≥95.0% (TLC) | Isopentenyl phosphate dilithium salt | ESD-920619-10MG |
| Cas.: 484-78-6 | Purity: analytical standard ≥97.0% (HPLC) | 3-Hydroxy-DL-kynurenine | ESD-920620-10MG |
| Cas.: 267228-70-6 | Purity: ≥97.0% (TLC) | 2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) ammonium salt | ESD-920621-10MG |
| Cas.: 799268-51-2 | Purity: >99% (TLC) | 1,2-diheptadecanoyl-sn-glycero-3-phospho-L serine (sodium salt) | ESD-920622-10MG |
| Cas.: 126799-83-5 | Purity: ~0.5 M in tert-butyl methyl ether, ≥97.0% (HPLC) | o-Methylbenzyl azide solution | ESD-920623-10ML |
| Cas.: 26700-39-0 | Purity: mol wt 20,000-50,000 | Poly(Lys, Phe) 1:1 hydrobromide | ESD-920624-10MG |
| Cas.: 474943-59-4 | Purity: >99% (TLC) | 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (sodium salt) | ESD-920625-10MG |
| Cas.: 22480-91-7 | (2,3,4-TRIMETHOXYPHENYL)ACETIC ACID | ESD-920627-10MG | |
| Cas.: 18191-20-3 | Purity: ≥97.0% (HPLC) | N-Acetyl-D-galactosamine-6-phosphate | ESD-920628-10MG |
| Cas.: 352535-01-4 | Purity: 99% | Tetrakis(ethylmethylamino)hafnium | ESD-920629-5G |
| Cas.: 13314-52-8 | Purity: 97% | Diethylgermanium dichloride | ESD-920631-5G |
| Cas.: 49763-65-7 | Purity: 98% | 4-pentylbenzoyl chloride | ESD-920632-5G |
| Cas.: 38701-73-4 | Purity: 99% (CP) | 1,1,1,3,3,3-Hexafluoro-2-propan(ol-d) | ESD-920633-5G |
| Cas.: 3840-30-0 | Purity: 98.0% (AT) | 3,4,5-TriMethoxybenzyl chloride | ESD-920635-5G |
| Cas.: 2902-98-9 | Purity: 97% | 2-Chloro-2,2-diphenylacetyl chloride | ESD-920636-5G |
| Cas.: 5434-47-9 | Purity: 96% | 5-BroMo-6-broMoMethyl-1,3-benzodioxole | ESD-920637-5G |
| Cas.: 870703-70-1 | Purity: 95% | 2-BroMo-2′,6′-diisopropoxy-1,1′-biphenyl | ESD-920638-5G |
| Cas.: 102422-56-0 | Purity: 98% | 1-Fluoro-3-(isocyanatomethyl)benzene | ESD-920639-5G |
| Cas.: 892-20-6 | Purity: 97% | Triphenyltin hydride | ESD-920640-5G |
| Cas.: 26708-04-3 | Purity: 97% | 2-Ethyl-9,10-diMethoxyanthracene | ESD-920641-5G |
| Cas.: 17950-40-2 | Triethyloxonium hexafluorophosphate | ESD-920642-5G | |
| Cas.: 5976-47-6 | Purity: 90% | 2-Chloroallyl alcohol | ESD-920643-5G |
| Cas.: 1066-37-1 | Purity: ≥98% | Trimethylgermanium bromide | ESD-920644-5G |
| Cas.: 289039-84-5 | Purity: 97% | Methyl 2-amino-5-chloro-3-iodobenzoate | ESD-920645-5G |
| Cas.: 29483-73-6 | Purity: 97% | 2-(2-Aminophenyl)benzothiazole | ESD-920646-5G |
| Cas.: 159465-27-7 | Purity: 97% | 3-Bromo-4-methoxyphenethylamine | ESD-920648-5G |
| Cas.: 30389-18-5 | Purity: 98% | 1-EthynylcyclohexylaMine | ESD-920649-5G |
| Cas.: 676-22-2 | Purity: 97% | trans,trans,trans-1,5,9-Cyclododecatriene | ESD-920650-5G |
| Cas.: 37527-66-5 | Purity: 98% | 4-Isocyanato-1,2-diMethoxybenzene | ESD-920651-5G |
| Cas.: 5497-67-6 | Purity: 97% | 2,2-Dimethyl-4-pentenal, stabilized | ESD-920652-5ML |
| Cas.: 77568-66-2 | Purity: 99% (CP) | 2,2,2,Trifluoroethanol-OD | ESD-920653-5ML |
| Cas.: 5187-82-6 | Purity: 97% | (Ethoxycarbonylmethyl)dimethylsulfonium bromide | ESD-920655-5G |
| Cas.: 3893-23-0 | Purity: 96% | alpha-Cyclohexylphenylacetonitrile | ESD-920656-5G |
| Cas.: 53641-60-4 | Purity: 95% | alpha-Phenylglycinonitrile hydrochloride | ESD-920657-5G |
| Cas.: 23138-53-6 | Purity: 98% | Methyl 4-isocyanatobenzoate | ESD-920658-5G |
| Cas.: 23056-94-2 | Purity: 97% | 2-METHYL-1-HEXEN-3-YNE | ESD-920659-5G |
| Cas.: 4497-92-1 | Purity: 97% | (+)-2-CARENE | ESD-920660-5ML |
| Cas.: 937-62-2 | Purity: 97% | P-TOLYL CHLOROFORMATE | ESD-920661-5G |
| Cas.: 4277-63-8 | Purity: 98% | Methyl 1-pyrrolecarboxylate | ESD-920662-5G |
| Cas.: 14315-97-0 | Purity: 98% | ,1,3-TRIMETHOXYPROPANE | ESD-920663-5G |
| Cas.: 2623-86-1 | Purity: ≥95.0% (GC) | 3-Bromobutyric acid | ESD-920664-5ML |
| Cas.: 85272-30-6 | Purity: 96% | DIISOPROPYLSILYL BIS (TRIFLUOROMETHANESULFONATE) | ESD-920665-5G |
| Cas.: 124-05-0 | Purity: 98% | Ethylenebis(chloroformate) | ESD-920666-5G |
| Cas.: 14065-32-8 | Purity: 97% | METHYL 10-CHLORO-10-OXODECANOATE | ESD-920667-5G |
| Cas.: 16894-10-3 | Purity: 97% | Tin(IV) bis(acetylacetonate) dibromide | ESD-920668-5G |
| Cas.: 264927-50-6 | Purity: 98% | 2-CHLORO-5-CHLOROSULFONYL-4-FLUOROBENZOIC ACID | ESD-920669-5G |
| Cas.: 403982-64-9 | Purity: BioUltra, ≥99.5% (GC) | Spermine dihydrate | ESD-920671-5G |
| Cas.: 19824-59-0 | Purity: 99% | PENTAKIS (DIMETHYLAMINO) TANTALUM | ESD-920672-5G |
| Cas.: 79124-76-8 | Purity: 94% | 3-(3,4-DICHLOROPHENOXY)BENZALDEHYDE | ESD-920673-5G |
| Cas.: 15917-65-4 | Purity: 99% | (Z)-2-(4-(1,2-Diphenylbut-1-en-1-yl)phenoxy)-N-methylethanamine hydrochloride | ESD-920674-5MG |
| Cas.: 37630-20-9 | Purity: ≥98% (HPLC) | TRANS-2 3-DIMETHOXY-BETA-NITROSTYRENE | ESD-920675-5MG |
| Cas.: 89759-80-8 | Purity: ≥99.99% trace metals basis | CADMIUM ACETATE HYDRATE | ESD-920676-5G |
| Cas.: 1214672-15-7 | Purity: 98% | (Rac)-LM11A-31 dihydrochloride | ESD-920677-5MG |
| Cas.: 292870-53-2 | Purity: ≥98% (HPLC) | BV02 | ESD-920678-5MG |
| Cas.: 29799-22-2 | Purity: ≥98% (HPLC) | Diapocynin | ESD-920679-5MG |
| Cas.: 161600-01-7 | Purity: ≥98% (HPLC) | 5-[[6-[(2-Fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione | ESD-920680-5MG |
| Cas.: 99196-74-4 | Purity: ≥98% (HPLC) | N-(P-Amylcinnamoyl)Anthranilic Acid | ESD-920681-5MG |
| Cas.: 287118-97-2 | Purity: ≥98% (HPLC) | NCX 4040 | ESD-920682-5MG |
| Cas.: 251917-79-0 | Purity: ≥98% (HPLC) | BLT-4 | ESD-920683-5MG |
| Cas.: 13154-25-1 | Purity: 99% | TRIISOBUTYLCHLOROSILANE | ESD-920684-5G |
| Cas.: 21959-01-3 | Purity: 98% | Tetrachlorobis(tetrahydrofuran)zirconium | ESD-920685-5G |
| Cas.: 18172-33-3 | Purity: ≥98% | Cyclopiazonic Acid | ESD-920686-5MG |
| Cas.: 253449-04-6 | Purity: 98% (HPLC) | Wiskostatin | ESD-920687-5MG |
| Cas.: 103420-77-5 | Purity: ≥98%(HPLC) | DEVAZEPIDE | ESD-920688-5MG |
| Cas.: 57186-25-1 | Purity: 99% | Paxilline | ESD-920689-5MG |
| Cas.: 1235397-05-3 | Purity: ≥95% | PF-04856264 | ESD-920690-5MG |
| Cas.: 14777-27-6 | Purity: 88% | Methyl acetimidate hydrochloride | ESD-920691-5G |
| Cas.: 41420-90-0 | Purity: 97% | 2-(4-bromophenyl)-1,3,4-oxadiazole | ESD-920692-5G |
| Cas.: 35512-29-9 | Purity: 97% | 4-(4-CHLOROPHENYL)-1H-IMIDAZOLE | ESD-920693-5G |
| Cas.: 1793-07-3 | Purity: 97% | Methyl 2-isocyanatobenzoate | ESD-920694-5G |
| Cas.: 70724-25-3 | Purity: ≥95% (HPLC) | Carbazeran | ESD-920695-5MG |
| Cas.: 1449747-00-5 | Purity: ≥98% (HPLC) | 1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile | ESD-920696-5MG |
| Cas.: 897-83-6 | Purity: ≥98% (HPLC), oil | Diethylumbelliferyl phosphate | ESD-920697-5MG |
| Cas.: 1382469-39-7 | Purity: ≥98% (HPLC) | DpC | ESD-920698-5MG |
| Cas.: 1141-41-9 | Purity: ≥98% (HPLC) | IDT307 | ESD-920699-5MG |
| Cas.: 7728-40-7 | Purity: ≥95% (HPLC) | MEGX | ESD-920700-5MG |
| Cas.: 1854061-19-0 | Purity: ≥97% (HPLC) | PF-06761281 | ESD-920701-5MG |
| Cas.: 831217-43-7 | Purity: ≥98% (HPLC) | 116-9e | ESD-920702-5MG |
| Cas.: 176977-56-3 | Purity: ≥98% (HPLC) | LY 320135 | ESD-920703-5MG |
| Cas.: 2457-01-4 | Purity: 99.8% (metals basis) | Barium 2-ethylhexanoate | ESD-920704-5G |
| Cas.: 92600-11-8 | Purity: 98% | 1-CHLORO-2-METHYLPROPYL CHLOROFORMATE | ESD-920705-5G |
| Cas.: 6628-00-8 | Purity: 98% | ALLYLCYCLOHEXYLAMINE | ESD-920706-5G |
| Cas.: 10602-36-5 | Purity: 97% | 3-Butenal diethyl acetal | ESD-920707-5G |
| Cas.: 29394-58-9 | (S)-(+)-1-Iodo-2-methylbutane | ESD-920708-5G | |
| Cas.: 17599-61-0 | Purity: 95% | N-Trimethylsilylbenzaldimine | ESD-920709-5G |
| Cas.: 3524-75-2 | Purity: 97% | Allylcyclopentane | ESD-920710-5G |
| Cas.: 33953-86-5 | Purity: 75% in H2O | Trifluoracetaldehyde monohydrate | ESD-920711-5ML |
| Cas.: 31704-80-0 | Purity: 99% | 3-(5-Methyl-2-furyl)butyraldehyde | ESD-920712-5G |
| Cas.: 918-85-4 | Purity: 98% | 3-METHYL-1-PENTEN-3-OL | ESD-920713-5G |
| Cas.: 799268-63-6 | Purity: >99% (TLC) | 1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphocholine | ESD-920714-5MG |
| Cas.: 147059-75-4 | Purity: ≥98%(HPLC) | Trovafloxacin Mesylate | ESD-920715-5MG |
| Cas.: 22980-09-2 | Purity: 98% | 3-Indoleglyoxylyl chloride | ESD-920716-5G |
| Cas.: 53847-30-6 | Purity: ≥98%(HPLC) | 2-Arachidonyl Glycerol | ESD-920717-5MG |
| Cas.: 59863-13-7 | BIS[BIS(TRIMETHYLSILYL)AMINO]TIN II | ESD-920718-5ML | |
| Cas.: 204401-84-3 | PAMAM-50% C(12) dendrimer, ethylenediamine | ESD-920719-5G | |
| Cas.: 1569-44-4 | Purity: 98% | 3-Methyl-5-hexen-3-ol | ESD-920721-5G |
| Cas.: 7397-43-5 | Purity: 98% | Tri-tert-butyl borate | ESD-920722-5G |
| Cas.: 627-15-6 | Purity: 98% | 1,3-DibroMo-1-propene | ESD-920724-5G |
| Cas.: 17869-76-0 | Purity: 97% | 3-(Trimethylsilyloxy)-1-butyne | ESD-920725-5G |
| Cas.: 6921-35-3 | Purity: 98% | 3,3-DiMethyloxetane | ESD-920726-5ML |
| Cas.: 3908-55-2 | Purity: 97% | (Methylthio)triMethylsilane | ESD-920727-5ML |
| Cas.: 930-29-0 | Purity: 97% | 1-Chloro-1-cyclopentene | ESD-920728-5G |
| Cas.: 130025-34-2 | Purity: 97% | :(2S)-3,3,3-Trifluoro-1,2-epoxypropane | ESD-920729-5G |
| Cas.: 28075-50-5 | Purity: 97% | 1-Cyclohexenyl trifluoroMethanesulfonate | ESD-920730-5G |
| Cas.: 56586-13-1 | Purity: 99% | 2-Methyl-1-cyclohexanecarboxylic acid | ESD-920731-5G |
| Cas.: 57754-86-6 | Purity: ≥98%(HPLC) | Nisoxetine hydrochloride | ESD-920732-5MG |
| Cas.: 3102-57-6 | Purity: ≥98% | C2 Ceramide | ESD-920733-5MG |
| Cas.: 20448-79-7 | Purity: 95% | 2-AMINOBICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID | ESD-920734-5MG |
| Cas.: 6698-26-6 | Purity: ≥98% | (2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-2-methyltetrahydrofuran-3-ol | ESD-920735-5MG |
| Cas.: 142878-12-4 | Purity: ≥98%(HPLC) | 1-[6-[((17β)-3-Methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-2,5-pyrrolidinedione | ESD-920736-5MG |
| Cas.: 155116-19-1 | Purity: 97% (HPLC) | (1,2-METHANOFULLERENE C60)-61-CARBOXYLIC ACID | ESD-920737-5MG |
| Cas.: 23766-28-1 | Purity: 97% | 5-(4-Chlorophenyl)-1,3,4-oxadiazole-2-thiol | ESD-920738-5G |
